data_1pus_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pus _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.824 0.345 . . . . 0.44 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -133.65 143.52 48.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.44 110.895 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 pp -145.94 127.93 15.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.44 110.947 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.447 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 41.4 mt-30 -102.65 154.07 19.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.337 0.589 . . . . 0.44 112.282 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.2 mm -146.55 132.72 13.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.106 -0.952 . . . . 0.44 109.675 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.45 124.59 42.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.205 -0.294 . . . . 0.44 110.205 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.486 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.1 m -121.0 162.51 19.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.3 0.571 . . . . 0.44 111.994 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.2 113.05 0.56 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.15 -0.932 . . . . 0.44 111.738 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.468 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.78 107.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.775 -0.454 . . . . 0.44 109.775 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.455 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.2 mt -71.43 124.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.049 0.452 . . . . 0.44 111.68 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.76 124.01 32.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.773 -0.649 . . . . 0.44 111.43 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.52 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -79.19 -172.7 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.295 -0.866 . . . . 0.44 111.805 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.507 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.3 tp10 -82.62 2.9 31.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.469 -1.241 . . . . 0.44 112.084 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -135.95 50.32 2.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.797 0.332 . . . . 0.44 111.227 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 p30 45.5 26.68 0.33 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.111 -0.495 . . . . 0.44 111.385 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 13.6 pt-20 -120.39 141.7 49.86 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.388 -0.597 . . . . 0.44 109.388 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' A' ' 105' ' ' MET . 17.6 mt -110.88 140.31 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.154 0.502 . . . . 0.44 111.716 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -89.42 122.6 32.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.515 -0.766 . . . . 0.44 110.689 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.04 162.25 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.44 110.262 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.43 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 3.7 p -95.67 111.8 23.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.348 -0.387 . . . . 0.44 110.57 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.404 -0.362 . . . . 0.44 110.996 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.556 0.217 . . . . 0.44 111.557 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 26.29 10.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.44 111.381 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.9 tt -46.84 96.11 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.786 -0.643 . . . . 0.44 110.855 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -114.49 -178.74 3.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.16 0.505 . . . . 0.44 111.711 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.465 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.6 164.23 22.98 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.593 -0.73 . . . . 0.44 111.432 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 19.8 Cg_endo -56.84 167.89 2.75 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.472 2.781 . . . . 0.44 112.012 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.18 59.47 0.76 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.257 -0.973 . . . . 0.44 113.613 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.17 126.79 5.12 Favored Glycine 0 C--N 1.313 -0.742 0 CA-C-N 114.581 -0.81 . . . . 0.44 112.101 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER 109.42 4.55 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.153 0.581 . . . . 0.44 112.125 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -58.65 -24.35 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.428 0.632 . . . . 0.44 110.791 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -49.83 -71.82 0.06 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.971 -1.013 . . . . 0.44 111.094 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.441 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER 23.54 -86.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.611 0.569 . . . . 0.44 112.252 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -159.7 23.82 0.29 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.771 -0.728 . . . . 0.44 112.787 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.24 -177.13 3.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.87 0.367 . . . . 0.44 111.026 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.56 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.68 157.47 38.31 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.44 109.872 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.79 -24.69 0.82 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.717 2.278 . . . . 0.44 112.413 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.57 -60.67 1.96 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.222 0.453 . . . . 0.44 112.222 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -80.43 -21.49 42.11 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.165 0.432 . . . . 0.44 112.165 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.73 -48.83 76.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.784 0.326 . . . . 0.44 111.095 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -78.4 -46.39 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.44 110.875 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 44.6 t -57.12 -36.56 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.44 110.902 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -78.29 -49.19 14.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.123 -0.49 . . . . 0.44 110.747 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.2 mm-40 -67.61 -20.0 65.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.44 110.992 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.449 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 1.3 tp -57.17 -44.64 83.72 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.866 0.365 . . . . 0.44 110.529 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -34.68 78.43 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.088 -0.708 . . . . 0.44 109.088 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.2 tm-20 -77.46 -24.09 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.226 -0.897 . . . . 0.44 110.873 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -108.47 5.15 25.0 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.926 0.343 . . . . 0.44 111.926 -179.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.539 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 38.5 t -134.65 -44.39 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.142 0.496 . . . . 0.44 109.836 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.541 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.99 -40.09 0.26 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.443 -0.798 . . . . 0.44 113.893 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.513 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.68 -176.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.009 0.433 . . . . 0.44 111.089 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.33 88.81 13.45 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.66 -0.7 . . . . 0.44 110.006 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.627 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.3 Cg_endo -110.57 145.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.362 2.708 . . . . 0.44 113.981 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 39.4 mt-30 -74.78 79.78 2.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 105.521 -2.029 . . . . 0.44 105.521 175.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.572 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.81 128.22 52.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.235 -1.348 . . . . 0.44 110.952 -176.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.4 t80 -179.34 167.89 1.49 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.44 111.76 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 14.6 m 84.51 149.14 0.07 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.71 -0.677 . . . . 0.44 110.544 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 pp -107.1 128.46 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.44 111.298 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -78.84 -41.29 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.955 -0.566 . . . . 0.44 110.252 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.502 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 10.3 tt0 -171.38 167.07 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.871 -0.604 . . . . 0.44 110.474 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.03 132.11 23.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.44 111.087 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.419 HD23 ' CG2' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -116.18 122.3 44.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.44 111.001 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -120.62 109.78 15.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.44 110.549 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -141.13 149.26 41.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.44 110.674 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 3.8 pt-20 -121.23 120.52 35.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.125 0.488 . . . . 0.44 111.198 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -69.98 163.74 58.24 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.597 -0.729 . . . . 0.44 110.354 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -50.94 83.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.221 2.614 . . . . 0.44 112.39 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.7 t70 94.74 16.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.333 -0.849 . . . . 0.44 111.357 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.449 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 27.1 ttt180 -137.38 146.44 44.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.44 110.641 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 9.4 t-160 -119.68 99.43 6.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.44 110.623 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 tt -106.79 121.08 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.44 111.093 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.76 122.82 48.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.44 110.424 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.1 mt -126.04 114.97 19.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.44 111.347 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.431 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.6 m0 -107.82 122.52 46.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.44 110.796 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.451 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 4.4 m-30 -93.37 109.61 21.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.87 -0.605 . . . . 0.44 109.817 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 28.2 m95 -96.82 148.75 22.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.025 0.441 . . . . 0.44 112.083 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 65' ' ' PHE . 7.1 tp -97.58 138.22 35.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.713 -0.676 . . . . 0.44 111.542 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.572 HG13 ' HA ' ' A' ' 64' ' ' HIS . 39.4 t -124.02 146.04 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-N 115.447 -0.797 . . . . 0.44 110.37 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -110.52 -26.34 9.54 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.098 1.147 . . . . 0.44 114.098 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.81 164.5 26.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.572 0.624 . . . . 0.44 111.548 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.627 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -157.37 123.48 4.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.272 -0.422 . . . . 0.44 111.381 178.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -73.88 147.2 43.45 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.199 -0.455 . . . . 0.44 111.141 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.67 -127.87 43.49 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.819 -0.705 . . . . 0.44 112.58 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 17.1 mt-10 -125.22 146.19 53.17 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.53 0.205 . . . . 0.44 110.727 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.47 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.58 128.74 10.46 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.827 2.351 . . . . 0.44 111.471 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.541 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.3 p-90 -132.58 -58.19 0.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.62 -0.432 . . . . 0.44 111.669 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.539 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.11 -97.11 0.01 OUTLIER Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.874 -0.679 . . . . 0.44 112.923 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.99 31.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.693 0.282 . . . . 0.44 111.172 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -40.78 95.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.78 0.324 . . . . 0.44 110.477 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.85 13.56 60.69 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.863 -0.684 . . . . 0.44 113.8 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.43 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 2.6 mp0 -140.31 92.02 9.58 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 117.18 0.49 . . . . 0.44 111.509 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -43.63 132.76 7.54 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.982 2.454 . . . . 0.44 112.688 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.25 177.1 19.42 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.787 -0.721 . . . . 0.44 112.856 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -134.22 157.29 46.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.641 0.257 . . . . 0.44 110.624 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.2 106.97 3.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.844 0.354 . . . . 0.44 110.323 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 18' ' ' ILE . 3.6 ptp -119.95 147.33 44.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.216 -0.447 . . . . 0.44 111.171 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t -66.63 114.87 5.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.44 110.734 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.97 -28.71 64.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.399 . . . . 0.44 110.914 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -53.25 -23.94 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.44 111.06 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.33 42.31 1.62 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.843 -0.694 . . . . 0.44 112.404 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.4 tt -62.56 150.16 41.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.209 -0.293 . . . . 0.44 110.209 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.22 127.67 54.96 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.656 0.613 . . . . 0.44 112.656 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -14.98 61.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.267 -0.879 . . . . 0.44 110.512 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.44 -49.31 13.69 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.363 -0.38 . . . . 0.44 111.78 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -38.84 87.21 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.885 0.374 . . . . 0.44 110.904 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.585 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.84 173.02 8.38 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.105 -0.498 . . . . 0.44 109.973 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.469 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 36.2 Cg_endo -65.7 127.79 18.67 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.087 1.858 . . . . 0.44 111.973 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.48 -21.18 53.59 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.576 2.184 . . . . 0.44 112.956 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.66 -9.59 57.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 0.44 111.85 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.77 34.26 5.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 0.44 111.179 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -75.15 -43.69 4.55 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 112.439 0.533 . . . . 0.44 112.439 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 85.8 Cg_exo -44.77 -33.16 6.82 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.184 1.923 . . . . 0.44 112.567 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.451 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 49.4 t -77.62 -51.08 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.44 110.419 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.585 HG13 ' CE2' ' A' ' 115' ' ' PHE . 12.4 mm -66.25 -30.45 49.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.744 -0.662 . . . . 0.44 110.979 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.73 -27.18 38.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.945 0.403 . . . . 0.44 110.485 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -80.18 -51.34 9.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.963 -0.562 . . . . 0.44 111.69 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.426 HD21 ' CE2' ' A' ' 68' ' ' PHE . 13.0 tp -78.09 -34.61 50.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.818 0.342 . . . . 0.44 111.599 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.4 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 42.6 tttp -53.19 -42.72 66.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.08 0.467 . . . . 0.44 111.137 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -73.02 -4.17 30.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.667 -0.697 . . . . 0.44 110.05 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.4 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-N 116.003 -0.544 . . . . 0.44 111.039 179.812 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.824 0.345 . . . . 0.44 110.951 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.85 126.33 20.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.865 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -130.41 136.65 49.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 0.44 110.707 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 27.8 mt-30 -102.95 153.29 20.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.335 0.588 . . . . 0.44 112.146 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -146.04 124.64 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.44 109.795 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.74 125.26 43.77 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.827 -0.349 . . . . 0.44 110.743 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.549 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.5 m -115.77 162.09 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.426 0.631 . . . . 0.44 111.867 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.13 111.57 0.58 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.006 -0.997 . . . . 0.44 111.27 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.585 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.85 102.31 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.011 -0.366 . . . . 0.44 110.011 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.469 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -71.2 121.46 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 121.125 0.488 . . . . 0.44 111.659 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.441 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -91.29 132.81 35.9 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.436 -0.802 . . . . 0.44 111.629 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.66 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 2.4 p30 -89.04 -173.24 3.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.256 -0.884 . . . . 0.44 111.473 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 8.2 tt0 -79.61 8.93 5.59 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.395 -0.82 . . . . 0.44 112.686 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -132.25 47.17 2.55 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.141 -0.35 . . . . 0.44 111.691 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.1 p30 45.06 25.94 0.19 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.087 0.47 . . . . 0.44 111.507 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.561 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 25.9 mt-10 -116.87 161.19 19.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.043 -0.725 . . . . 0.44 109.043 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -118.8 135.68 58.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.052 0.453 . . . . 0.44 111.74 -178.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -85.78 109.86 18.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.788 -0.642 . . . . 0.44 110.994 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.436 ' HB ' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -119.5 140.18 44.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.44 110.106 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.401 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 16.3 p -73.58 111.67 8.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.44 111.195 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.44 110.756 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.613 0.244 . . . . 0.44 111.437 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -114.41 26.41 10.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.886 0.374 . . . . 0.44 111.43 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -43.89 94.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.734 -0.666 . . . . 0.44 110.787 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -109.37 172.38 6.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.208 0.527 . . . . 0.44 112.076 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.475 ' CZ ' ' CZ ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -119.63 163.58 26.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.637 -0.71 . . . . 0.44 111.57 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.08 167.71 8.64 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.508 2.805 . . . . 0.44 112.03 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 101.99 59.53 0.77 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.215 -0.993 . . . . 0.44 113.73 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.619 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.15 118.66 2.46 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 114.552 -0.824 . . . . 0.44 111.999 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.619 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.31 2.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.185 0.594 . . . . 0.44 111.682 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.609 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -50.48 -28.92 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.57 0.7 . . . . 0.44 110.568 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.58 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.51 -79.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.613 -1.176 . . . . 0.44 110.964 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp 36.18 -85.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.5 0.5 . . . . 0.44 111.597 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.18 29.67 0.17 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.07 -0.586 . . . . 0.44 112.354 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.425 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 25.7 mp0 -97.32 -178.35 4.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.855 0.359 . . . . 0.44 111.155 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.564 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.33 159.34 32.46 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.44 109.995 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.564 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.87 -24.71 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.784 2.322 . . . . 0.44 112.479 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.1 -61.22 1.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.042 0.386 . . . . 0.44 112.042 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -80.54 -6.01 57.58 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.322 0.49 . . . . 0.44 112.322 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 40' ' ' ILE . . . -62.82 -55.13 29.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.44 110.884 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.489 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.5 m -78.22 -45.19 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 0.44 110.871 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.489 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 40.3 t -56.49 -41.47 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.44 111.128 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.32 -46.84 19.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.372 -0.376 . . . . 0.44 110.988 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -69.32 -21.66 63.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.197 -0.456 . . . . 0.44 111.034 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -55.43 -44.24 76.09 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.823 0.344 . . . . 0.44 110.12 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -34.86 73.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.893 -0.78 . . . . 0.44 108.893 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.8 -26.64 49.75 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.165 -0.925 . . . . 0.44 111.394 179.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.03 5.25 25.95 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.228 0.455 . . . . 0.44 112.228 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.573 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 19.9 t -134.79 -44.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.244 0.545 . . . . 0.44 110.053 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.549 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.13 -41.27 0.35 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.419 -0.81 . . . . 0.44 113.602 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.5 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.7 -176.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 120.977 0.418 . . . . 0.44 111.038 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.66 88.82 14.33 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-N 115.646 -0.707 . . . . 0.44 109.885 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.656 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.2 Cg_endo -110.74 146.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 123.276 2.651 . . . . 0.44 114.35 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 15.9 mt-30 -74.69 80.03 2.04 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 105.375 -2.083 . . . . 0.44 105.375 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.569 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.55 131.9 54.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.272 -1.331 . . . . 0.44 111.549 -175.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.515 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -176.22 -136.97 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.44 110.391 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 51.76 172.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.213 0.53 . . . . 0.44 112.258 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.6 tt -136.97 115.89 12.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.523 -0.762 . . . . 0.44 110.454 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.69 -56.3 4.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.44 109.982 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.647 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 mt-10 -171.46 131.51 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.44 110.138 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.445 ' NZ ' ' CH2' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -125.5 132.1 52.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.716 0.293 . . . . 0.44 110.679 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.403 ' O ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -124.22 168.29 13.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.44 110.857 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -140.16 123.62 17.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.44 110.72 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.468 ' CZ ' ' CG2' ' A' ' 80' ' ' ILE . 1.9 p90 -141.02 148.61 40.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.957 -0.565 . . . . 0.44 110.279 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -120.98 128.39 52.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.207 0.527 . . . . 0.44 111.487 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -86.48 162.86 44.12 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.426 -0.806 . . . . 0.44 110.193 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.5 Cg_endo -50.11 81.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.0 2.466 . . . . 0.44 112.31 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.4 t70 89.09 12.15 0.07 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.411 -0.813 . . . . 0.44 111.529 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -137.26 93.92 2.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.655 0.264 . . . . 0.44 110.938 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -77.15 108.73 10.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.44 110.854 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 2.7 tt -110.8 112.75 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.317 -0.401 . . . . 0.44 111.31 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.62 118.85 33.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.44 110.115 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.6 mt -112.01 114.15 26.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.888 0.375 . . . . 0.44 111.9 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.446 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 8.9 m0 -115.73 122.22 44.85 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.44 110.252 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.647 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 7.2 m-30 -106.15 123.08 47.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.731 -0.668 . . . . 0.44 110.97 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 31.5 m95 -105.13 149.0 26.25 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.078 -0.51 . . . . 0.44 110.611 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.515 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.3 tm? -98.7 103.47 15.42 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.597 0.713 . . . . 0.44 112.332 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.585 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 20.9 t -82.76 145.85 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 114.926 -1.034 . . . . 0.44 110.899 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -114.01 -25.38 8.58 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.006 1.113 . . . . 0.44 114.006 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -162.27 160.16 26.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.522 0.601 . . . . 0.44 111.49 -179.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.66 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -153.27 124.3 7.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.116 -0.493 . . . . 0.44 111.364 178.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -74.28 146.69 42.99 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 116.166 -0.47 . . . . 0.44 111.064 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.74 -130.99 51.3 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.716 -0.754 . . . . 0.44 112.559 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -121.32 144.79 40.74 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.572 0.225 . . . . 0.44 110.715 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.485 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.1 Cg_exo -76.66 128.74 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.934 2.422 . . . . 0.44 111.474 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.549 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.5 p-90 -135.23 -57.96 0.8 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.56 -0.456 . . . . 0.44 111.715 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.573 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.13 -94.56 0.01 OUTLIER Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.022 -0.609 . . . . 0.44 113.005 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 56' ' ' GLU . 4.7 tmtt? -177.23 32.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.767 0.317 . . . . 0.44 111.01 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.78 -38.65 73.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.44 110.342 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.81 21.25 63.96 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.975 -0.631 . . . . 0.44 113.337 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.401 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 1.5 mt-30 -140.23 91.85 9.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.022 0.439 . . . . 0.44 111.448 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -44.02 137.03 7.31 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.975 2.45 . . . . 0.44 112.626 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.16 177.05 19.44 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.735 -0.745 . . . . 0.44 112.874 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -145.07 157.38 44.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.583 0.23 . . . . 0.44 110.538 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.44 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.6 m0 -62.15 106.62 0.75 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.332 . . . . 0.44 110.474 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.439 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.05 147.34 44.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.193 -0.458 . . . . 0.44 110.67 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.04 114.7 12.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 0.44 110.801 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 30.1 tp -80.15 -18.92 48.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.239 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.0 t -50.59 -23.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.517 -0.31 . . . . 0.44 111.535 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.61 48.04 0.98 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.709 -0.757 . . . . 0.44 112.481 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.62 150.22 41.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.63 0.253 . . . . 0.44 110.47 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.02 135.19 54.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.169 0.509 . . . . 0.44 112.163 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.537 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.08 -15.25 62.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.622 -0.717 . . . . 0.44 110.493 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.98 -49.24 13.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.512 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -33.73 76.12 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.47 -0.332 . . . . 0.44 111.262 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.537 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -84.94 174.05 6.31 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.358 -0.383 . . . . 0.44 110.316 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.474 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.6 Cg_endo -71.05 127.8 14.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.05 1.833 . . . . 0.44 111.764 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.91 -15.02 46.68 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.606 2.204 . . . . 0.44 113.226 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.75 -9.63 58.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.025 0.38 . . . . 0.44 112.025 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.08 32.72 5.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.7 0.286 . . . . 0.44 111.303 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.523 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -76.18 -39.19 2.57 Favored Pre-proline 0 C--O 1.223 -0.305 0 N-CA-C 112.825 0.676 . . . . 0.44 112.825 -179.049 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 89.4 Cg_exo -44.9 -39.94 14.53 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 121.924 1.749 . . . . 0.44 113.024 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.422 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.4 t -77.53 -51.03 19.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.999 0.428 . . . . 0.44 110.924 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.532 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.0 mm -64.89 -32.13 56.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.803 -0.635 . . . . 0.44 111.405 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.74 -29.89 54.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.034 0.445 . . . . 0.44 110.497 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -76.49 -49.57 16.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.788 -0.642 . . . . 0.44 111.494 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -78.18 -31.37 49.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.47 -0.332 . . . . 0.44 111.672 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -54.07 -42.62 69.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.028 0.442 . . . . 0.44 111.01 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -69.99 -7.88 44.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.79 -0.641 . . . . 0.44 109.911 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-N 115.977 -0.556 . . . . 0.44 111.219 179.802 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.792 0.329 . . . . 0.44 110.911 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 146.76 28.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.44 110.884 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.7 pp -145.97 134.85 22.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.232 -0.44 . . . . 0.44 111.024 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -102.85 151.67 22.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.92 -0.582 . . . . 0.44 112.306 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.3 mm -146.64 129.39 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.165 -0.925 . . . . 0.44 109.981 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.68 125.05 43.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 121.037 -0.265 . . . . 0.44 110.556 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.547 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.5 m -118.07 161.45 16.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.249 0.547 . . . . 0.44 111.788 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.3 112.1 0.53 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.247 -0.888 . . . . 0.44 111.853 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.46 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.45 105.48 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.085 -0.339 . . . . 0.44 110.085 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.462 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.1 mt -71.74 124.83 29.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.12 0.486 . . . . 0.44 112.018 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.453 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -93.72 135.57 34.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.63 -0.714 . . . . 0.44 111.22 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.649 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.5 p30 -92.74 -173.45 3.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.457 -0.792 . . . . 0.44 111.905 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -75.31 -1.22 22.63 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.206 -0.907 . . . . 0.44 112.83 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -119.5 41.24 3.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.959 -0.296 . . . . 0.44 111.442 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p30 46.9 25.16 0.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.082 0.468 . . . . 0.44 111.201 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.545 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 25.1 mt-10 -114.44 160.94 18.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.966 -0.753 . . . . 0.44 108.966 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -116.85 138.64 46.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.078 0.466 . . . . 0.44 112.019 -178.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.476 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -82.27 99.84 9.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.788 -0.642 . . . . 0.44 110.79 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.474 ' CG2' ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -116.52 115.41 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.499 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 t -76.45 123.43 26.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.848 0.356 . . . . 0.44 111.009 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.44 110.624 179.748 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.25 0 N-CA-C 111.618 0.229 . . . . 0.44 111.618 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.6 26.3 10.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.941 0.401 . . . . 0.44 111.698 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -48.28 117.86 2.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.02 -0.536 . . . . 0.44 110.856 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -145.06 171.55 14.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.44 110.953 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.42 167.85 11.26 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 121.004 0.431 . . . . 0.44 111.934 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.4 Cg_endo -47.46 168.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.862 3.041 . . . . 0.44 112.694 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.07 59.99 0.72 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.549 -0.834 . . . . 0.44 113.851 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -131.83 132.62 6.8 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 114.391 -0.905 . . . . 0.44 112.14 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.8 ttmm 92.3 10.47 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.023 0.529 . . . . 0.44 112.388 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.587 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -56.79 -28.27 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.673 0.749 . . . . 0.44 109.993 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.575 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.83 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.341 -1.3 . . . . 0.44 110.896 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.98 -84.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.516 0.51 . . . . 0.44 111.709 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.44 32.74 0.1 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.904 -0.665 . . . . 0.44 112.57 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.479 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.3 mt-10 -93.21 -173.72 3.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.698 0.285 . . . . 0.44 111.194 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.521 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.19 154.02 37.85 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.313 -0.403 . . . . 0.44 110.316 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.99 -24.87 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.819 2.346 . . . . 0.44 112.494 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.62 -41.76 5.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.513 -0.312 . . . . 0.44 111.828 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -80.3 -13.6 59.06 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.706 0.262 . . . . 0.44 111.706 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.479 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -61.05 -52.95 62.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.752 0.31 . . . . 0.44 111.094 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -78.28 -44.64 27.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.434 -0.348 . . . . 0.44 110.921 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.466 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 45.2 t -55.87 -42.71 71.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.538 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -78.3 -49.94 12.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.916 0.388 . . . . 0.44 111.269 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -68.4 -20.01 64.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.44 111.254 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -56.71 -45.06 82.07 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.44 110.103 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -31.88 71.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.431 -0.581 . . . . 0.44 109.431 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -76.75 -25.35 53.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.6 -0.727 . . . . 0.44 109.981 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -106.42 6.59 30.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.44 111.544 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.569 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 0.5 OUTLIER -133.45 -44.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.135 0.493 . . . . 0.44 109.793 179.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.524 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.67 -37.17 0.17 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.553 -0.749 . . . . 0.44 114.65 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 58' ' ' VAL . 0.6 OUTLIER -85.06 -174.32 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.889 0.376 . . . . 0.44 110.796 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.11 88.59 12.52 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-N 115.926 -0.579 . . . . 0.44 110.469 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.623 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.7 Cg_endo -111.13 145.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.471 2.78 . . . . 0.44 113.886 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 11.5 mt-30 -74.86 79.82 2.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.63 -1.989 . . . . 0.44 105.63 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.568 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.07 127.43 51.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.095 -1.411 . . . . 0.44 110.596 -176.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 86' ' ' LEU . 17.4 t80 179.85 168.15 1.22 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.27 0.47 . . . . 0.44 112.27 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 82.28 149.83 0.09 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.666 -0.697 . . . . 0.44 110.696 179.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -105.69 128.76 53.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.44 111.077 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -80.5 -38.36 29.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.44 110.426 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.498 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 2.0 tt0 -171.29 160.65 6.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.44 110.336 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -143.25 132.2 22.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.968 0.414 . . . . 0.44 111.233 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.11 130.2 56.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.058 -0.519 . . . . 0.44 110.431 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -123.15 109.97 14.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.44 110.562 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -141.17 150.58 42.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.44 110.731 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.26 123.09 41.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.125 0.488 . . . . 0.44 111.121 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.99 163.15 63.61 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.578 -0.737 . . . . 0.44 110.46 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.8 Cg_endo -52.36 82.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.028 2.485 . . . . 0.44 112.097 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 8.8 t70 96.19 15.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.345 -0.843 . . . . 0.44 111.152 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -137.35 149.91 47.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.44 110.635 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -120.35 93.98 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.478 -0.328 . . . . 0.44 110.453 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.407 ' HA ' HD12 ' A' ' 4' ' ' LEU . 4.6 tt -100.56 111.94 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.44 111.23 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.3 118.73 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.44 110.24 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.43 HD23 ' CE1' ' A' ' 84' ' ' PHE . 5.5 tp -110.84 114.25 27.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.44 111.336 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -110.34 122.49 47.82 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.081 -0.509 . . . . 0.44 110.547 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.43 ' CE1' HD23 ' A' ' 82' ' ' LEU . 2.8 m-30 -105.37 109.82 21.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.952 -0.567 . . . . 0.44 110.174 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.596 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 35.0 m95 -99.39 148.67 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.512 . . . . 0.44 112.013 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 65' ' ' PHE . 31.2 tp -96.54 138.6 33.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.571 -0.741 . . . . 0.44 111.571 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.568 HG13 ' HA ' ' A' ' 64' ' ' HIS . 35.1 t -123.61 145.35 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-N 115.55 -0.75 . . . . 0.44 110.237 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.66 -24.48 9.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.252 1.204 . . . . 0.44 114.252 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.8 tpt180 -162.86 162.39 26.39 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.183 -0.607 . . . . 0.44 111.574 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.649 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -157.09 123.92 5.09 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.228 -0.442 . . . . 0.44 111.214 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.45 146.17 40.91 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.149 -0.478 . . . . 0.44 111.251 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.3 -126.73 43.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.876 -0.678 . . . . 0.44 112.723 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 60' ' ' ILE . 22.7 mt-10 -125.15 143.74 45.19 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 110.486 -0.19 . . . . 0.44 110.486 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.406 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 3.9 Cg_exo -76.48 128.64 10.48 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.713 2.275 . . . . 0.44 111.434 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.524 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 64.3 p-90 -131.93 -56.69 0.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.522 -0.471 . . . . 0.44 111.787 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.569 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.92 -95.04 0.01 OUTLIER Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.89 -0.672 . . . . 0.44 113.111 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -179.1 33.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.653 0.263 . . . . 0.44 111.196 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -76.8 -37.1 56.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.98 0.419 . . . . 0.44 110.243 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.13 30.1 51.85 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.018 -0.61 . . . . 0.44 113.101 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -140.35 91.63 9.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.055 0.455 . . . . 0.44 111.503 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -47.59 133.55 21.21 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.096 2.531 . . . . 0.44 112.428 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.07 177.09 19.4 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.504 -0.855 . . . . 0.44 112.914 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 105' ' ' MET . 2.6 mt-10 -142.5 157.81 44.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.539 0.209 . . . . 0.44 110.491 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.485 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.3 m0 -66.63 106.59 1.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.684 0.278 . . . . 0.44 110.537 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 2.9 mmm -119.89 148.19 43.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.404 -0.362 . . . . 0.44 110.944 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.04 114.78 8.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.476 . . . . 0.44 110.8 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.0 -28.28 68.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.44 110.919 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.49 -22.79 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.121 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -109.84 34.38 5.49 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.741 -0.742 . . . . 0.44 112.497 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.78 139.52 58.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.153 -0.314 . . . . 0.44 110.153 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.03 131.26 53.63 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.735 0.643 . . . . 0.44 112.735 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.59 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.4 -15.14 61.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.342 -0.845 . . . . 0.44 110.547 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -78.62 -49.44 13.21 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.402 -0.363 . . . . 0.44 111.703 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -35.75 79.74 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.791 0.329 . . . . 0.44 111.225 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.92 174.13 6.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.302 -0.408 . . . . 0.44 110.127 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.499 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 53.7 Cg_endo -70.11 127.75 14.75 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.026 1.818 . . . . 0.44 111.705 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.93 -15.04 46.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.6 2.2 . . . . 0.44 113.085 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.19 -9.46 58.74 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.029 0.381 . . . . 0.44 112.029 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.37 31.91 6.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.747 0.308 . . . . 0.44 111.426 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -73.14 -36.28 3.19 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 112.546 0.573 . . . . 0.44 112.546 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 70.4 Cg_exo -50.98 -44.97 39.04 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 121.92 1.747 . . . . 0.44 112.699 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.41 -51.21 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.413 . . . . 0.44 111.097 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.571 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.8 mm -62.83 -32.9 57.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.895 -0.593 . . . . 0.44 111.232 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.02 -33.72 62.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.08 0.467 . . . . 0.44 110.553 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -66.84 -49.65 65.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.44 110.843 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.14 -26.07 47.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.44 111.144 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -58.21 -42.6 86.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.002 0.43 . . . . 0.44 110.778 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.6 ttm-85 -73.86 -5.32 40.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.726 -0.67 . . . . 0.44 109.953 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.461 0.095 0 CA-C-N 116.002 -0.544 . . . . 0.44 111.325 179.769 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 0.44 110.97 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.27 37.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.44 110.903 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.9 pp -145.98 122.53 11.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.44 111.022 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -102.69 148.38 25.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.347 0.594 . . . . 0.44 111.888 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.5 mm -146.48 130.77 10.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.091 -0.959 . . . . 0.44 109.833 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.43 124.46 42.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.322 -0.251 . . . . 0.44 110.322 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.521 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -118.63 162.94 16.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.235 0.54 . . . . 0.44 111.933 -179.387 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.0 112.83 0.55 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.378 -0.828 . . . . 0.44 112.402 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.49 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -70.79 105.68 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.371 -0.603 . . . . 0.44 109.371 179.389 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 1.2 mt -71.54 124.0 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 112.635 0.606 . . . . 0.44 112.635 -177.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.28 126.86 34.04 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.695 -0.684 . . . . 0.44 111.456 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.557 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 24.8 t-20 -70.43 177.37 3.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.212 -0.904 . . . . 0.44 112.119 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.557 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 8.8 tt0 -56.62 -18.58 12.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.358 -1.292 . . . . 0.44 112.404 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -120.55 -82.74 0.65 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.615 0.245 . . . . 0.44 111.243 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.73 15.54 0.36 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.547 -0.297 . . . . 0.44 111.616 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 3.6 mt-10 -100.93 160.39 14.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.462 -0.57 . . . . 0.44 109.462 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 3.4 mt -138.12 140.72 39.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.014 0.435 . . . . 0.44 111.609 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.438 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -89.75 116.46 27.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.44 110.375 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.456 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.36 125.59 70.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.239 -0.437 . . . . 0.44 110.419 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 34' ' ' GLU . 15.0 p -75.46 111.85 11.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.82 0.343 . . . . 0.44 110.495 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 109.925 -0.398 . . . . 0.44 109.925 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.563 0.221 . . . . 0.44 111.476 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -114.54 26.32 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.44 111.585 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.7 tt -45.42 122.71 3.67 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.934 -0.576 . . . . 0.44 110.812 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 21' ' ' THR . 53.6 mt-10 -145.96 -175.32 4.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.894 0.378 . . . . 0.44 111.443 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.07 162.09 35.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.44 111.239 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 10.3 Cg_endo -50.09 167.91 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.387 2.725 . . . . 0.44 111.715 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.23 59.47 0.76 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 119.921 -1.133 . . . . 0.44 113.825 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.615 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.54 120.01 2.74 Favored Glycine 0 C--N 1.312 -0.78 0 CA-C-N 114.791 -0.705 . . . . 0.44 112.023 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.615 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 114.09 3.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.313 0.645 . . . . 0.44 111.937 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.2 pt -53.64 -26.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.43 0.633 . . . . 0.44 110.569 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.538 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.12 -82.62 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.769 -1.105 . . . . 0.44 111.143 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 34.87 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.39 0.432 . . . . 0.44 111.886 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.89 31.24 0.14 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.819 -0.705 . . . . 0.44 112.623 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -91.24 -174.38 3.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.75 0.31 . . . . 0.44 111.189 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.533 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.68 154.85 36.94 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.44 110.352 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.8 Cg_endo -44.53 -24.86 1.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.735 2.29 . . . . 0.44 112.603 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -102.2 -42.91 5.88 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.964 0.357 . . . . 0.44 111.964 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -80.22 -16.07 55.6 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 111.638 0.236 . . . . 0.44 111.638 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.454 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -60.08 -50.49 73.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.562 -0.29 . . . . 0.44 111.146 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.467 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -78.1 -45.11 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.798 0.332 . . . . 0.44 110.884 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.467 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 45.2 t -53.71 -37.92 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.219 -0.446 . . . . 0.44 110.92 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -51.99 9.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.987 -0.551 . . . . 0.44 111.018 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.8 mm-40 -63.97 -22.07 66.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.44 110.907 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.468 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 1.0 OUTLIER -56.47 -44.62 80.75 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.979 0.419 . . . . 0.44 110.409 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -62.96 -34.64 77.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.272 -0.64 . . . . 0.44 109.272 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.6 tm-20 -77.47 -25.0 50.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.221 -0.9 . . . . 0.44 111.14 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 69.2 mm-40 -108.15 5.36 25.82 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.889 0.329 . . . . 0.44 111.889 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.513 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 31.4 t -134.71 -44.26 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.183 0.516 . . . . 0.44 109.793 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.543 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.83 -41.1 0.32 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.308 -0.86 . . . . 0.44 113.711 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.501 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.66 -176.53 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.016 0.436 . . . . 0.44 111.057 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.04 88.87 12.76 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 115.575 -0.739 . . . . 0.44 109.991 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.644 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.1 Cg_endo -109.48 145.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.287 2.658 . . . . 0.44 113.917 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 11.8 mt-30 -74.78 79.76 2.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 105.54 -2.022 . . . . 0.44 105.54 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.578 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.81 128.06 52.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.137 -1.392 . . . . 0.44 110.926 -176.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.7 t80 -179.22 168.46 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.44 111.991 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.3 p 83.07 158.0 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.765 -0.652 . . . . 0.44 110.827 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -110.83 137.9 47.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.0 0.429 . . . . 0.44 111.381 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -94.92 -32.46 13.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.964 -0.562 . . . . 0.44 110.264 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.491 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 17.8 tt0 -171.38 155.57 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.766 -0.652 . . . . 0.44 110.393 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.51 132.03 22.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.711 0.291 . . . . 0.44 110.95 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.402 HD22 ' CB ' ' A' ' 82' ' ' LEU . 2.5 pt? -129.19 132.36 47.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.44 110.851 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -127.28 109.93 12.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.44 110.558 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.425 ' CE2' HG22 ' A' ' 80' ' ' ILE . 3.0 p90 -132.24 153.04 51.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.44 110.491 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.422 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 5.4 pt-20 -118.74 138.61 52.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.158 0.504 . . . . 0.44 111.406 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -98.81 163.06 19.59 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.498 -0.774 . . . . 0.44 110.209 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 6.0 Cg_endo -48.09 81.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.11 2.54 . . . . 0.44 112.342 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 m-20 85.61 13.55 0.18 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.413 -0.812 . . . . 0.44 111.586 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -137.44 93.83 2.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 0.44 110.998 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 64.4 t-80 -75.02 112.47 11.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.44 110.573 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.425 HG22 ' CE2' ' A' ' 73' ' ' TYR . 3.7 tt -109.7 112.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.44 111.325 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.11 124.03 47.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.033 -0.53 . . . . 0.44 110.241 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.402 ' CB ' HD22 ' A' ' 71' ' ' LEU . 20.6 mt -126.02 114.93 19.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.863 0.364 . . . . 0.44 111.607 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -106.48 122.48 46.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.44 110.523 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.3 m-85 -99.07 109.66 22.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.204 -0.453 . . . . 0.44 110.211 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 25.5 m95 -97.24 148.66 22.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.19 0.519 . . . . 0.44 112.358 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 65' ' ' PHE . 25.0 tp -95.94 138.68 33.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.454 -0.793 . . . . 0.44 111.132 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.578 HG13 ' HA ' ' A' ' 64' ' ' HIS . 33.2 t -123.47 145.88 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.848 -0.614 . . . . 0.44 110.459 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.3 -24.59 9.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.151 1.167 . . . . 0.44 114.151 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.511 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 5.4 tpt180 -162.64 162.43 27.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.548 0.613 . . . . 0.44 111.544 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.644 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -155.08 124.91 6.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.195 -0.457 . . . . 0.44 111.24 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.43 148.32 39.22 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.134 -0.485 . . . . 0.44 111.156 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.33 -129.27 43.21 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.887 -0.673 . . . . 0.44 112.54 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -122.73 144.16 41.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.573 0.225 . . . . 0.44 110.678 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.479 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.43 128.72 10.57 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.778 2.319 . . . . 0.44 111.493 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.543 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -132.41 -58.02 0.94 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.59 -0.444 . . . . 0.44 111.649 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.513 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.72 -99.61 0.02 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.658 -0.782 . . . . 0.44 112.924 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 175.0 38.49 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.6 0.238 . . . . 0.44 111.209 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -70.53 -11.73 61.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.714 0.292 . . . . 0.44 111.253 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.74 20.17 68.03 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.026 -0.607 . . . . 0.44 113.378 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -140.48 97.51 7.48 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.84 0.352 . . . . 0.44 111.384 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.62 132.71 7.53 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.836 2.357 . . . . 0.44 112.51 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.05 177.12 19.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.569 -0.824 . . . . 0.44 112.823 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -149.49 157.27 43.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.529 0.204 . . . . 0.44 110.516 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -71.24 106.78 3.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.824 0.345 . . . . 0.44 110.116 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.3 ptp -119.86 152.06 37.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.44 110.998 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.2 p -75.26 114.89 14.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.44 110.606 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.422 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -57.92 -20.56 38.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.44 111.24 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.67 -21.24 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.466 -0.334 . . . . 0.44 111.48 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.36 31.92 8.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.772 -0.728 . . . . 0.44 112.678 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.458 HD11 ' CG2' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -62.51 126.97 29.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.64 0.257 . . . . 0.44 110.324 179.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.417 ' N ' HD12 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -123.33 130.63 52.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.5 0.556 . . . . 0.44 112.5 -179.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.623 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.17 -14.7 61.88 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.463 -0.79 . . . . 0.44 110.146 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -78.31 -49.01 14.43 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.191 -0.459 . . . . 0.44 111.617 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -39.8 88.33 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.75 0.309 . . . . 0.44 110.913 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.623 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -79.06 172.1 10.78 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.283 -0.417 . . . . 0.44 109.995 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.534 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.7 Cg_endo -70.77 127.33 13.65 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 121.976 1.784 . . . . 0.44 111.404 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.57 -14.84 42.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.617 2.212 . . . . 0.44 113.275 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.65 -9.32 58.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.286 0.476 . . . . 0.44 112.286 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.98 36.7 4.55 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.942 0.349 . . . . 0.44 111.942 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -69.75 -41.03 14.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 112.111 0.412 . . . . 0.44 112.111 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.2 Cg_exo -55.23 -40.58 84.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.052 1.835 . . . . 0.44 112.625 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.44 -51.26 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.548 . . . . 0.44 110.793 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.52 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -66.12 -29.87 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.402 -0.817 . . . . 0.44 111.187 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.85 -31.97 60.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.049 0.452 . . . . 0.44 110.226 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -52.35 57.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.667 -0.697 . . . . 0.44 110.886 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tp -78.12 -29.81 49.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.44 111.24 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -55.98 -42.56 76.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.44 111.128 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -74.22 -4.78 38.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 0.44 110.115 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 116.031 -0.531 . . . . 0.44 111.189 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 tttp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.872 0.368 . . . . 0.44 110.925 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.03 131.91 27.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.44 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.714 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 3.0 pp -146.17 118.98 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.44 110.602 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 28.7 mt-30 -101.91 156.76 17.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.265 0.555 . . . . 0.44 112.219 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -146.19 130.76 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.434 -0.803 . . . . 0.44 110.575 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.585 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.44 124.43 42.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.928 -0.397 . . . . 0.44 109.928 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.457 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -127.99 158.36 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.915 0.388 . . . . 0.44 111.724 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.404 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.25 137.5 6.06 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.603 -0.726 . . . . 0.44 111.966 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.447 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.22 111.97 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.179 -0.304 . . . . 0.44 110.179 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 90' ' ' TRP . 1.5 mt -71.68 123.74 26.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.44 111.54 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -84.32 122.77 29.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.871 -0.604 . . . . 0.44 111.484 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.515 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.0 t-20 -79.65 -172.69 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.11 -0.95 . . . . 0.44 111.855 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.502 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -82.74 0.61 42.75 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.366 -1.288 . . . . 0.44 111.935 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -136.98 50.58 2.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.911 0.386 . . . . 0.44 111.241 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.51 26.38 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.163 -0.471 . . . . 0.44 111.263 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 13' ' ' ASN . 16.1 pt-20 -116.82 153.25 32.8 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.452 -0.573 . . . . 0.44 109.452 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 11' ' ' ILE . 5.2 mt -130.36 142.17 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 0.44 111.588 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.91 123.16 35.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.44 110.854 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.503 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -113.69 124.77 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.386 -0.37 . . . . 0.44 110.531 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 t -72.44 111.71 7.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 0.44 110.718 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.4 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 20.3 ptt180 . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.44 110.859 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.575 0.226 . . . . 0.44 111.458 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.33 26.2 10.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.44 111.394 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -43.35 116.55 0.95 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.838 -0.619 . . . . 0.44 110.403 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -170.85 2.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.24 0.543 . . . . 0.44 112.056 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.503 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.77 165.69 16.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.44 111.097 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 47.5 Cg_endo -67.7 167.51 20.91 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.087 2.525 . . . . 0.44 111.533 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.09 59.13 0.77 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.806 -1.188 . . . . 0.44 113.914 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -123.39 127.32 6.56 Favored Glycine 0 C--N 1.311 -0.828 0 CA-C-N 114.841 -0.68 . . . . 0.44 112.021 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER 100.39 6.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.142 0.577 . . . . 0.44 112.211 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.585 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.1 pt -50.34 -29.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.744 0.783 . . . . 0.44 110.118 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.557 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.86 -81.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.32 -1.309 . . . . 0.44 111.22 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.6 mmt 40.16 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.269 0.356 . . . . 0.44 111.548 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.0 29.83 0.14 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.815 -0.707 . . . . 0.44 112.669 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -95.07 -173.31 2.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.736 0.303 . . . . 0.44 111.122 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.555 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.95 158.01 34.12 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.42 -0.355 . . . . 0.44 110.37 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 5.9 Cg_endo -46.74 -24.71 3.14 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.668 2.245 . . . . 0.44 112.375 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.54 -44.19 5.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.296 -0.411 . . . . 0.44 111.888 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -80.19 -12.63 59.62 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.72 0.267 . . . . 0.44 111.72 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.482 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -60.54 -54.02 50.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 0.44 110.925 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -78.14 -44.21 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.075 -0.511 . . . . 0.44 111.587 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -50.52 -37.77 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.37 . . . . 0.44 110.805 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -78.6 -49.49 13.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.47 . . . . 0.44 110.791 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.0 -19.83 66.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 0.44 111.036 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' VAL . 2.7 tp -59.53 -44.71 93.11 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.788 0.328 . . . . 0.44 110.629 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.18 -34.21 77.55 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.079 -0.711 . . . . 0.44 109.079 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 97' ' ' LYS . 5.5 tm-20 -77.35 -24.13 50.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.35 -0.841 . . . . 0.44 110.832 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.482 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 50.3 mm-40 -108.29 5.66 25.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.483 -0.326 . . . . 0.44 111.768 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.567 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 41.7 t -134.2 -44.27 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.166 0.508 . . . . 0.44 109.656 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.529 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.89 -39.74 0.25 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.397 -0.819 . . . . 0.44 113.994 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.495 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.7 -177.43 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.018 0.437 . . . . 0.44 111.026 -179.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.83 88.54 14.31 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 115.695 -0.684 . . . . 0.44 109.807 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.618 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.0 Cg_endo -111.71 145.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 123.406 2.737 . . . . 0.44 113.994 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 36.7 mt-30 -74.86 79.63 2.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.604 -1.999 . . . . 0.44 105.604 175.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.559 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -120.11 128.67 53.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.145 -1.389 . . . . 0.44 110.832 -176.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.8 t80 -179.51 168.71 1.42 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.44 111.981 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER 83.91 155.66 0.1 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.742 -0.663 . . . . 0.44 110.675 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -113.84 123.11 49.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.44 111.212 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.83 -38.19 54.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 0.44 110.074 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -171.3 141.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.63 -0.714 . . . . 0.44 110.349 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.46 132.18 22.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.671 0.272 . . . . 0.44 110.939 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.426 ' CD2' ' CG2' ' A' ' 122' ' ' VAL . 4.4 pp -124.46 164.69 19.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.315 . . . . 0.44 110.954 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -139.77 116.91 11.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.44 110.733 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -141.15 153.07 45.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.44 110.654 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -118.34 124.28 47.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.44 111.319 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.0 163.22 61.32 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.581 -0.736 . . . . 0.44 110.477 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.487 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -52.8 82.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.989 2.459 . . . . 0.44 112.19 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 7.7 t0 90.92 10.73 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.425 -0.807 . . . . 0.44 111.479 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -137.36 95.89 3.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.294 . . . . 0.44 110.809 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -80.4 106.58 12.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.523 -0.308 . . . . 0.44 110.263 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 3.6 pt -120.39 127.09 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.131 0.491 . . . . 0.44 112.119 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.26 118.68 34.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.712 -0.676 . . . . 0.44 110.041 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.412 HD22 ' CE1' ' A' ' 84' ' ' PHE . 4.4 tp -104.78 113.7 27.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.44 110.965 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.402 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 9.6 m0 -115.58 122.52 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.574 . . . . 0.44 111.053 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.1 m-30 -105.32 109.68 21.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.951 -0.568 . . . . 0.44 109.702 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 66.0 m95 -94.85 148.67 22.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.882 -0.599 . . . . 0.44 112.307 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 65' ' ' PHE . 65.6 tp -94.52 138.28 32.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.621 -0.718 . . . . 0.44 110.917 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 64' ' ' HIS . 27.0 t -123.96 145.81 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 CA-C-N 115.894 -0.593 . . . . 0.44 110.418 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -112.82 -24.57 9.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.215 1.191 . . . . 0.44 114.215 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -162.79 160.73 25.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.595 0.634 . . . . 0.44 111.484 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.618 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -157.19 121.66 4.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.181 -0.463 . . . . 0.44 111.164 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -77.21 155.31 32.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.064 -0.516 . . . . 0.44 111.214 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.37 -132.78 46.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.901 -0.666 . . . . 0.44 112.619 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.2 mt-10 -122.2 147.06 48.44 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.577 0.227 . . . . 0.44 110.694 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.48 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.62 128.64 10.36 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.85 2.367 . . . . 0.44 111.353 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.529 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 63.4 p-90 -136.59 -58.84 0.73 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.462 -0.495 . . . . 0.44 111.892 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.567 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.49 -96.4 0.01 OUTLIER Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.765 -0.731 . . . . 0.44 112.939 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.7 tmtt? 177.67 33.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.584 0.231 . . . . 0.44 111.173 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -29.01 68.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.7 0.286 . . . . 0.44 110.679 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.91 -2.12 71.91 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.717 -0.754 . . . . 0.44 113.719 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -140.12 95.46 8.43 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.259 0.529 . . . . 0.44 111.556 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -43.71 141.04 4.19 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.909 2.406 . . . . 0.44 112.497 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.23 171.56 22.14 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.578 -0.82 . . . . 0.44 112.871 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.55 157.17 39.5 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.387 -0.227 . . . . 0.44 110.387 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.53 106.44 6.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.898 0.38 . . . . 0.44 110.523 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.405 ' HG2' ' CD1' ' A' ' 20' ' ' ILE . 5.1 ppp? -120.28 155.87 32.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.44 111.041 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.2 t -70.3 114.93 8.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.375 . . . . 0.44 110.579 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -18.98 60.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.44 111.341 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 t -57.45 -16.88 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.36 . . . . 0.44 111.458 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.06 43.54 1.43 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.842 -0.694 . . . . 0.44 112.432 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.7 tp -62.4 146.98 49.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.185 -0.302 . . . . 0.44 110.185 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.11 126.81 47.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.574 0.583 . . . . 0.44 112.574 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.58 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.33 -15.16 61.88 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.166 -0.925 . . . . 0.44 110.733 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -78.28 -49.39 13.77 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.864 0.32 . . . . 0.44 111.864 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -39.03 87.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.982 0.42 . . . . 0.44 110.857 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.58 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -80.11 173.82 7.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.946 -0.57 . . . . 0.44 110.341 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.476 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.2 Cg_endo -72.26 127.76 13.04 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.162 1.908 . . . . 0.44 111.697 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.89 -14.95 44.24 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.693 2.262 . . . . 0.44 113.061 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.42 58.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.033 0.382 . . . . 0.44 112.033 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -121.67 32.6 5.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.695 0.283 . . . . 0.44 111.488 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.454 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.3 mt-10 -73.77 -46.88 6.98 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 112.158 0.429 . . . . 0.44 112.158 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 80.9 Cg_exo -44.8 -35.05 9.19 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.33 2.02 . . . . 0.44 112.525 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.458 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 12.5 t -77.35 -43.39 30.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.066 0.46 . . . . 0.44 110.127 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.542 HG13 ' CE2' ' A' ' 115' ' ' PHE . 15.5 mm -67.65 -34.41 67.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 CA-C-N 115.685 -0.688 . . . . 0.44 110.888 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.4 -26.61 31.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.983 0.421 . . . . 0.44 110.465 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.13 -52.72 7.44 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.928 -0.578 . . . . 0.44 111.712 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -33.48 50.25 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.725 0.298 . . . . 0.44 111.519 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 6.0 ttpm? -53.57 -42.67 67.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.969 0.414 . . . . 0.44 111.058 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -69.37 -7.92 41.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.44 109.87 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-N 115.957 -0.565 . . . . 0.44 111.33 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.899 0.38 . . . . 0.44 110.768 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -140.08 131.65 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.44 110.935 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 pp -126.02 127.53 46.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.44 110.837 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -102.96 152.2 21.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.182 0.515 . . . . 0.44 111.255 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 mp -143.9 139.02 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.608 -0.724 . . . . 0.44 110.355 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.766 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -125.16 125.46 43.73 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 110.153 -0.314 . . . . 0.44 110.153 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.452 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -134.53 151.43 31.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.363 0.602 . . . . 0.44 111.833 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.46 122.11 1.3 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.162 -0.926 . . . . 0.44 111.907 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.556 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.56 114.26 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.787 -0.449 . . . . 0.44 109.787 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.467 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -71.31 121.7 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.024 0.44 . . . . 0.44 111.553 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.7 119.41 24.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.783 -0.644 . . . . 0.44 111.5 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.546 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.1 t-20 -79.04 -172.64 3.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.275 -0.875 . . . . 0.44 111.967 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.522 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 1.1 tm-20 -81.43 0.91 35.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.446 -1.252 . . . . 0.44 112.118 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -139.47 52.28 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.44 111.27 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.8 p30 45.61 26.59 0.34 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.099 -0.501 . . . . 0.44 111.358 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 16.4 pt-20 -117.23 151.41 36.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.433 -0.58 . . . . 0.44 109.433 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 105' ' ' MET . 4.3 mt -127.93 146.78 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.034 0.445 . . . . 0.44 111.655 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.427 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -97.24 121.76 39.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.676 -0.693 . . . . 0.44 110.855 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.71 141.19 35.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.379 -0.373 . . . . 0.44 110.17 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 p -80.2 125.45 29.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.44 110.778 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 31.1 ttt180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.405 . . . . 0.44 110.621 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.156 0 N-CA-C 111.525 0.195 . . . . 0.44 111.525 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -114.23 26.0 10.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.44 111.472 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -46.13 101.63 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.44 110.585 179.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -110.26 -169.34 1.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.03 0.443 . . . . 0.44 111.451 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.75 162.59 32.07 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.9 -0.591 . . . . 0.44 111.58 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.59 168.08 13.9 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.559 2.839 . . . . 0.44 111.989 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.766 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.41 59.17 0.76 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.263 -0.97 . . . . 0.44 113.872 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.611 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -127.64 127.73 5.89 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 114.242 -0.979 . . . . 0.44 111.688 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 111.7 -10.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.317 0.647 . . . . 0.44 110.974 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.532 ' O ' ' C ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -43.67 -74.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.848 0.356 . . . . 0.44 110.804 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER 6.31 -82.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.974 -1.012 . . . . 0.44 112.107 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 36.32 -141.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.105 -0.498 . . . . 0.44 111.373 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.9 11.27 9.44 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.558 -0.829 . . . . 0.44 113.077 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -169.08 0.29 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.585 0.231 . . . . 0.44 110.683 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.532 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.17 155.33 38.72 Favored Pre-proline 0 N--CA 1.454 -0.25 0 N-CA-C 109.865 -0.42 . . . . 0.44 109.865 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.74 -24.59 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.584 2.19 . . . . 0.44 112.226 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.6 -59.85 2.1 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.234 -0.439 . . . . 0.44 112.127 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -80.85 -4.84 56.19 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.293 0.479 . . . . 0.44 112.293 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.53 ' CB ' HD11 ' A' ' 40' ' ' ILE . . . -66.04 -57.26 8.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.638 0.256 . . . . 0.44 111.178 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.447 ' HB ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.55 -41.16 24.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.59 -0.277 . . . . 0.44 111.158 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.6 t -50.42 -35.62 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.44 110.811 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -78.35 -52.05 9.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 0.44 111.053 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.18 -23.37 66.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.44 110.763 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.439 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 2.2 tp -57.45 -44.66 84.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.307 -0.406 . . . . 0.44 110.782 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -62.74 -27.9 69.59 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.354 -0.61 . . . . 0.44 109.354 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.25 -27.03 53.13 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.481 -0.781 . . . . 0.44 111.001 179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -108.69 6.15 25.49 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.381 0.511 . . . . 0.44 112.381 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.542 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 25.4 t -133.51 -44.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.017 0.437 . . . . 0.44 109.928 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.95 -39.02 0.19 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.636 -0.711 . . . . 0.44 114.018 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.508 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.58 -176.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.979 0.419 . . . . 0.44 110.984 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.25 88.72 13.09 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 115.748 -0.66 . . . . 0.44 110.117 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.632 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.4 Cg_endo -111.41 144.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.426 2.75 . . . . 0.44 114.146 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.46 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 35.1 mt-30 -74.82 79.93 2.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.241 -2.133 . . . . 0.44 105.241 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.608 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.49 129.09 53.7 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.133 -1.394 . . . . 0.44 111.654 -175.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -177.77 -138.25 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.755 -0.657 . . . . 0.44 110.503 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.73 163.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.162 0.506 . . . . 0.44 112.045 179.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.1 tt -124.55 109.82 13.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.64 -0.709 . . . . 0.44 110.749 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.87 -43.43 35.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.44 110.164 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.4 tt0 -171.63 163.66 6.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.776 -0.647 . . . . 0.44 110.429 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.33 114.19 7.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.476 -0.329 . . . . 0.44 110.88 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -102.73 121.93 43.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 0.44 110.811 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -124.54 109.79 13.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.44 110.744 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.426 ' CZ ' HG22 ' A' ' 80' ' ' ILE . 2.5 p90 -141.09 152.1 44.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.44 110.635 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -121.17 118.82 30.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.047 0.451 . . . . 0.44 111.332 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -69.9 163.64 58.81 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.736 -0.666 . . . . 0.44 110.281 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -52.37 83.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.066 2.511 . . . . 0.44 112.362 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 4.6 t70 98.02 14.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.271 -0.877 . . . . 0.44 111.387 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.449 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -137.36 147.14 45.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.439 -0.346 . . . . 0.44 110.67 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.25 96.06 4.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.44 110.54 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.426 HG22 ' CZ ' ' A' ' 73' ' ' TYR . 1.1 tt -102.81 115.37 44.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 0.44 111.196 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.14 118.92 37.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.89 -0.596 . . . . 0.44 110.22 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.6 mt -118.69 114.57 22.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.44 111.489 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -104.81 122.51 45.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.057 -0.52 . . . . 0.44 110.217 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.428 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 4.4 m-30 -103.54 109.84 21.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.44 111.016 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 44.6 m95 -94.84 148.58 22.15 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.675 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.528 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.9 tm? -101.28 102.92 13.88 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.399 0.619 . . . . 0.44 111.75 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 64' ' ' HIS . 15.0 t -79.39 145.71 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-N 115.045 -0.98 . . . . 0.44 110.691 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -115.19 -23.02 9.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 114.214 1.19 . . . . 0.44 114.214 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -162.37 160.22 26.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.6 0.637 . . . . 0.44 111.556 -179.029 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.632 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -157.08 121.47 4.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.44 111.124 178.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.56 148.78 42.67 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.0 -0.545 . . . . 0.44 111.198 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.53 -128.93 47.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.804 -0.712 . . . . 0.44 112.589 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.0 mt-10 -123.57 147.57 53.35 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.615 0.245 . . . . 0.44 110.641 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.427 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 4.3 Cg_exo -76.47 128.71 10.53 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.793 2.329 . . . . 0.44 111.105 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.558 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.2 p-90 -135.5 -62.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.122 -0.631 . . . . 0.44 112.546 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.542 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.06 -97.75 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.64 -0.79 . . . . 0.44 112.614 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.9 tttp 171.32 34.98 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.578 0.228 . . . . 0.44 111.344 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -29.21 64.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.74 0.305 . . . . 0.44 110.568 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.44 64.72 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.777 -0.725 . . . . 0.44 113.374 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -140.18 94.78 8.6 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.007 0.432 . . . . 0.44 111.441 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.61 138.67 5.36 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.996 2.464 . . . . 0.44 112.398 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.4 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.19 177.07 19.43 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.628 -0.796 . . . . 0.44 112.915 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -142.06 157.31 45.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.58 0.229 . . . . 0.44 110.447 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -69.38 106.99 3.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.881 0.372 . . . . 0.44 110.332 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtt -119.68 163.13 17.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.134 -0.484 . . . . 0.44 110.837 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 p -80.36 114.75 19.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.405 -0.361 . . . . 0.44 110.925 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.23 -27.09 38.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.44 111.149 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -51.96 -23.46 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.44 111.493 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.21 44.62 1.22 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.677 -0.773 . . . . 0.44 112.591 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.57 150.24 41.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.588 0.232 . . . . 0.44 110.387 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.95 133.4 56.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.21 0.528 . . . . 0.44 112.344 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.588 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.15 -15.39 61.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.461 -0.79 . . . . 0.44 110.567 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.59 -49.13 13.8 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.208 -0.451 . . . . 0.44 111.538 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -33.8 76.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.849 0.357 . . . . 0.44 111.002 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -86.91 173.44 6.66 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.916 -0.402 . . . . 0.44 109.916 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.458 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.4 Cg_endo -67.7 127.69 16.71 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 121.947 1.765 . . . . 0.44 111.967 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.87 -20.56 58.24 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.519 2.146 . . . . 0.44 112.922 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.83 -9.49 58.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.883 0.327 . . . . 0.44 111.883 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.92 30.38 7.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.797 0.332 . . . . 0.44 111.397 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.611 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -76.23 -32.01 1.05 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.63 0.604 . . . . 0.44 112.63 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.3 Cg_exo -49.22 -43.52 36.9 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 121.957 1.771 . . . . 0.44 113.088 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.7 t -77.56 -51.32 18.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.44 111.542 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.462 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -65.95 -34.75 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.852 -0.613 . . . . 0.44 111.541 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -28.76 50.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.82 0.343 . . . . 0.44 110.95 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -74.81 -53.26 9.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.44 111.629 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tp -78.57 -32.97 48.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.472 -0.331 . . . . 0.44 111.638 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -53.85 -42.65 68.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.967 0.413 . . . . 0.44 111.019 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -65.94 -10.79 42.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.829 -0.623 . . . . 0.44 109.731 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--O 1.231 0.111 0 CA-C-N 115.99 -0.55 . . . . 0.44 111.048 179.709 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.838 0.351 . . . . 0.44 110.922 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -137.64 143.14 41.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.44 110.867 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.763 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.9 pp -146.14 120.09 9.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.44 110.757 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 7.8 mt-30 -102.12 155.48 18.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.371 0.605 . . . . 0.44 111.918 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.413 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -146.24 121.73 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.211 -0.904 . . . . 0.44 109.855 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.612 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -122.19 124.78 44.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.558 -0.292 . . . . 0.44 110.469 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.511 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -121.36 162.92 19.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.325 0.583 . . . . 0.44 111.952 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.99 120.66 1.35 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.255 -0.884 . . . . 0.44 111.987 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.51 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.81 105.52 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.812 -0.44 . . . . 0.44 109.812 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.451 HG21 ' CE3' ' A' ' 90' ' ' TRP . 1.5 mt -71.37 121.81 22.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 0.44 111.668 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.31 127.64 34.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.884 -0.598 . . . . 0.44 111.77 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.527 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.0 t-20 -83.63 -172.53 4.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.171 -0.922 . . . . 0.44 111.636 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.511 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 28.1 tt0 -83.95 5.66 24.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.589 -1.187 . . . . 0.44 112.141 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -141.25 52.66 1.56 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.44 111.367 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.0 p30 45.46 25.15 0.21 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.159 -0.473 . . . . 0.44 111.57 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 16.4 pt-20 -117.69 144.95 44.76 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 108.877 -0.786 . . . . 0.44 108.877 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 105' ' ' MET . 9.8 mt -115.13 135.94 53.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.248 0.546 . . . . 0.44 111.978 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.479 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -80.8 116.55 20.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.313 -0.858 . . . . 0.44 109.943 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.505 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -116.94 131.14 70.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.202 -0.454 . . . . 0.44 110.851 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 34' ' ' GLU . 62.9 p -71.92 111.87 7.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.181 -0.463 . . . . 0.44 111.07 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.44 110.146 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.703 0.287 . . . . 0.44 111.395 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -113.92 26.27 10.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.094 0.473 . . . . 0.44 111.401 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.2 tt -47.45 127.88 11.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.617 -0.719 . . . . 0.44 110.772 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -156.53 -173.91 4.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.44 111.496 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.511 ' CD1' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.94 162.71 31.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.44 111.469 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 10.6 Cg_endo -51.55 168.72 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.534 2.823 . . . . 0.44 111.657 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 7' ' ' ALA . . . 102.94 59.41 0.74 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.137 -1.03 . . . . 0.44 113.923 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.05 116.28 2.04 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.53 -0.835 . . . . 0.44 111.683 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.69 5.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.224 0.61 . . . . 0.44 111.682 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.612 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.2 pt -50.71 -28.92 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.572 0.701 . . . . 0.44 110.275 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.564 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.94 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.479 -1.237 . . . . 0.44 111.151 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' GLU . 56.6 mmm 30.83 -86.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.566 0.541 . . . . 0.44 112.054 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.84 32.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.745 -0.74 . . . . 0.44 112.524 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.2 mp0 -87.16 -174.8 5.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.827 0.346 . . . . 0.44 111.161 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.517 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.69 154.08 37.62 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.284 -0.416 . . . . 0.44 110.353 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.517 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.82 -26.33 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.835 2.357 . . . . 0.44 112.548 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -104.2 -38.72 6.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.44 111.746 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -80.29 -11.72 59.69 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.803 0.297 . . . . 0.44 111.803 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.447 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -60.01 -53.02 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.44 111.072 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.7 m -78.23 -45.87 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.197 -0.456 . . . . 0.44 111.038 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.488 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 38.9 t -56.04 -37.94 51.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.113 -0.494 . . . . 0.44 111.04 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -78.28 -47.2 18.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 0.44 110.629 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.66 -21.57 65.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.998 -0.547 . . . . 0.44 110.804 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.443 HD21 ' CG ' ' A' ' 64' ' ' HIS . 1.9 tp -55.64 -44.55 77.26 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.871 0.367 . . . . 0.44 110.534 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -34.07 77.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.368 -0.605 . . . . 0.44 109.368 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -77.39 -25.82 51.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.323 -0.853 . . . . 0.44 111.072 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.447 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 31.0 mm-40 -108.54 5.52 25.2 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.189 0.44 . . . . 0.44 112.189 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.547 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 25.8 t -134.34 -44.18 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.117 0.484 . . . . 0.44 109.96 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.99 -41.07 0.33 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.512 -0.767 . . . . 0.44 113.696 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.523 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.54 -175.52 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.983 0.421 . . . . 0.44 110.965 -179.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.3 89.0 11.48 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.683 -0.689 . . . . 0.44 110.29 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.631 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.8 Cg_endo -108.78 143.59 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.172 2.581 . . . . 0.44 114.008 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 38.4 mt-30 -74.9 79.87 2.14 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.717 -1.957 . . . . 0.44 105.717 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.596 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -119.28 129.6 54.99 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.114 -1.403 . . . . 0.44 110.682 -176.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.4 t80 178.79 167.41 0.9 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.44 111.749 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 87.06 155.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.735 -0.666 . . . . 0.44 110.476 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -102.22 156.44 17.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.05 0.453 . . . . 0.44 110.729 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -116.99 -42.81 2.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.834 -0.621 . . . . 0.44 109.866 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.6 tt0 -171.76 162.1 6.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.592 -0.731 . . . . 0.44 110.186 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -143.36 132.08 22.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.75 0.309 . . . . 0.44 110.71 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.475 ' CD2' ' CE1' ' A' ' 73' ' ' TYR . 4.4 tp -124.08 125.8 45.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.352 -0.386 . . . . 0.44 110.597 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -118.05 112.51 20.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.44 111.015 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.475 ' CE1' ' CD2' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -141.08 153.13 45.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.987 -0.551 . . . . 0.44 110.403 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -117.5 140.05 50.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.263 0.554 . . . . 0.44 111.54 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.481 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.8 m-85 -90.22 162.42 34.81 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.374 -0.83 . . . . 0.44 110.347 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 11.2 Cg_endo -54.53 82.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.884 2.389 . . . . 0.44 112.062 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 13.0 m-20 90.36 12.4 0.05 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.359 -0.837 . . . . 0.44 111.45 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -137.33 98.82 3.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.474 -0.33 . . . . 0.44 110.396 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -78.56 115.67 18.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.561 -0.29 . . . . 0.44 110.883 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.763 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 7.2 pt -118.94 154.27 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.106 0.479 . . . . 0.44 111.7 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.44 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -128.67 118.74 23.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.79 -0.641 . . . . 0.44 110.208 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.455 HD23 ' CE1' ' A' ' 84' ' ' PHE . 5.9 tp -106.28 114.31 28.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.44 111.592 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.436 ' CH2' ' HA ' ' A' ' 46' ' ' PRO . 6.7 m0 -112.11 122.63 48.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.101 -0.499 . . . . 0.44 110.088 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.455 ' CE1' HD23 ' A' ' 82' ' ' LEU . 5.1 m-30 -108.43 109.62 20.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.881 0.372 . . . . 0.44 110.433 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.458 ' CD2' HG23 ' A' ' 50' ' ' VAL . 40.8 m95 -99.96 149.08 23.8 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.1 -0.5 . . . . 0.44 112.013 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 65' ' ' PHE . 52.6 tp -92.07 138.56 31.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.749 -0.66 . . . . 0.44 111.885 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.596 HG11 ' HA ' ' A' ' 64' ' ' HIS . 21.6 t -123.75 145.97 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-N 115.394 -0.821 . . . . 0.44 110.322 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -112.8 -26.02 8.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.206 1.187 . . . . 0.44 114.206 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.471 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.47 159.69 25.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.725 0.693 . . . . 0.44 111.678 -179.012 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.631 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -152.78 123.62 7.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.102 -0.499 . . . . 0.44 111.254 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -73.17 145.63 46.17 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 116.198 -0.456 . . . . 0.44 111.101 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.8 -129.17 44.55 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.844 -0.693 . . . . 0.44 112.617 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 57.3 tt0 -122.19 142.38 36.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.521 0.2 . . . . 0.44 110.731 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.479 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.44 128.75 10.58 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.833 2.355 . . . . 0.44 111.376 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.1 p-90 -131.36 -58.59 0.99 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.592 -0.443 . . . . 0.44 111.845 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.547 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.17 -94.87 0.01 OUTLIER Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.878 -0.677 . . . . 0.44 112.909 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.37 33.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.44 110.99 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.53 -23.66 65.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.377 -0.374 . . . . 0.44 110.629 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.3 74.95 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.119 -0.563 . . . . 0.44 113.584 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.443 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 15.0 mt-30 -140.35 93.27 9.0 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.016 0.436 . . . . 0.44 111.362 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.65 134.14 7.4 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.969 2.446 . . . . 0.44 112.575 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.16 177.11 19.4 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.641 -0.79 . . . . 0.44 112.823 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -142.48 157.25 44.95 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.479 -0.193 . . . . 0.44 110.479 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -69.44 106.7 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.34 . . . . 0.44 110.219 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 18' ' ' ILE . 9.0 ptm -119.92 153.95 35.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.44 111.082 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.1 p -74.99 114.78 13.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.423 -0.353 . . . . 0.44 110.686 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -23.16 62.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.44 111.089 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.48 -19.02 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.44 111.306 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.13 44.19 1.29 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.84 -0.695 . . . . 0.44 112.393 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.64 149.4 43.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.395 -0.224 . . . . 0.44 110.395 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.2 127.07 48.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.782 0.66 . . . . 0.44 112.782 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.563 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.43 -14.58 61.73 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.267 -0.878 . . . . 0.44 110.557 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.21 -49.33 13.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.438 -0.346 . . . . 0.44 111.602 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -39.01 87.33 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.915 0.388 . . . . 0.44 110.736 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.579 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -78.9 173.93 6.91 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.972 -0.558 . . . . 0.44 110.169 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 63.7 Cg_endo -73.4 127.66 12.06 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.121 1.881 . . . . 0.44 111.606 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.14 -14.93 40.79 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.587 2.191 . . . . 0.44 113.203 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.0 -9.5 58.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.18 0.437 . . . . 0.44 112.18 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.12 31.98 5.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.68 0.276 . . . . 0.44 111.427 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.3 mt-10 -72.95 -36.0 3.16 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.475 0.546 . . . . 0.44 112.475 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 69.3 Cg_exo -51.15 -45.87 34.34 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 121.981 1.787 . . . . 0.44 112.854 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.407 ' CG2' ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -77.36 -51.29 18.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 0.44 110.926 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.567 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.7 mm -62.23 -32.27 54.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.624 -0.716 . . . . 0.44 111.255 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.86 -35.33 63.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.011 0.434 . . . . 0.44 110.419 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -65.36 -53.09 48.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.767 -0.652 . . . . 0.44 111.087 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 0.4 OUTLIER -78.35 -20.04 52.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.44 111.639 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 123' ' ' ILE . 31.5 tttp -74.55 -42.59 58.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.19 0.519 . . . . 0.44 110.599 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -66.98 -10.29 47.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.54 -0.755 . . . . 0.44 109.912 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.128 0 CA-C-N 116.337 -0.392 . . . . 0.44 110.611 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.785 0.326 . . . . 0.44 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.24 122.05 27.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.44 110.88 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.406 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 2.0 pp -131.33 140.95 49.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.529 . . . . 0.44 110.798 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -102.92 151.49 22.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.38 0.61 . . . . 0.44 112.05 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -144.97 116.61 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.137 -0.938 . . . . 0.44 109.659 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.618 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.76 152.27 44.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 110.089 -0.337 . . . . 0.44 110.089 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -145.08 162.6 13.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.339 0.59 . . . . 0.44 111.883 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.0 110.07 0.85 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.054 -0.975 . . . . 0.44 111.274 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.542 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -70.88 96.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.115 -0.328 . . . . 0.44 110.115 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.569 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -71.46 125.04 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 121.179 0.514 . . . . 0.44 112.052 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -93.64 142.61 27.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.533 -0.758 . . . . 0.44 110.857 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.663 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 5.1 p30 -99.08 -173.33 2.47 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.519 -0.764 . . . . 0.44 112.111 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -74.87 0.2 16.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.867 -1.06 . . . . 0.44 112.89 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -123.48 42.93 3.09 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.181 -0.324 . . . . 0.44 111.597 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 46.11 24.9 0.29 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.046 0.45 . . . . 0.44 111.263 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.521 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 24.4 mt-10 -113.83 160.88 18.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.878 -0.786 . . . . 0.44 108.878 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.479 HG13 ' HA ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -119.33 131.99 70.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.134 0.492 . . . . 0.44 112.294 -178.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.471 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -85.06 116.01 23.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.615 -0.72 . . . . 0.44 110.26 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.96 140.16 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.44 110.682 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.406 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 45.7 p -76.48 120.2 21.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.44 110.593 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 35.4 ptt180 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.467 -0.333 . . . . 0.44 110.512 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 111.533 0.198 . . . . 0.44 111.533 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -114.25 26.23 10.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.045 0.45 . . . . 0.44 111.353 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -48.81 103.19 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.715 -0.675 . . . . 0.44 110.656 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.26 -170.61 1.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.988 0.423 . . . . 0.44 111.731 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.484 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.53 168.29 10.41 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.44 111.392 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.546 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 89.2 Cg_endo -83.13 167.12 14.2 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.643 2.895 . . . . 0.44 112.981 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.7 -5.1 50.75 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.954 -0.566 . . . . 0.44 114.496 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -62.71 167.7 19.74 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.136 -0.554 . . . . 0.44 112.864 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 80.16 8.43 1.46 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 122.618 0.367 . . . . 0.44 111.759 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.618 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 2.1 pt -57.88 -26.94 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.651 0.739 . . . . 0.44 110.052 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -42.43 -69.27 0.14 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.391 -1.277 . . . . 0.44 111.121 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.478 ' C ' ' O ' ' A' ' 41' ' ' GLU . 44.0 mmm 19.73 -86.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.731 0.644 . . . . 0.44 112.467 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.46 30.02 0.11 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.762 -0.732 . . . . 0.44 112.856 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.402 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -88.2 -170.38 2.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.783 0.325 . . . . 0.44 111.124 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.544 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.11 156.1 35.66 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.324 -0.398 . . . . 0.44 110.385 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 5.0 Cg_endo -46.04 -24.88 2.51 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.781 2.321 . . . . 0.44 112.475 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -104.11 -39.96 6.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.433 -0.349 . . . . 0.44 111.526 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 6.0 mt-30 -80.1 -12.78 59.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.664 -0.244 . . . . 0.44 111.615 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -58.48 -52.78 64.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.869 0.366 . . . . 0.44 110.885 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.484 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 3.4 m -78.32 -45.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.44 111.373 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.484 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 33.4 t -61.17 -41.93 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.44 111.314 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 3.7 tpt180 -78.02 -37.69 46.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.889 0.376 . . . . 0.44 110.625 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' GLU . 7.9 tp10 -75.57 -19.93 58.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.046 -0.525 . . . . 0.44 110.627 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 3.8 tp -57.53 -44.37 85.07 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.442 -0.345 . . . . 0.44 110.575 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.89 -36.3 82.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.096 -0.705 . . . . 0.44 109.096 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.7 tm-20 -77.52 -24.49 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.315 -0.857 . . . . 0.44 111.042 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 53' ' ' GLU . 12.7 mm-40 -108.2 5.09 25.47 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.084 0.402 . . . . 0.44 112.084 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.565 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 39.5 t -134.79 -44.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.226 0.536 . . . . 0.44 109.756 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.554 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.29 -40.79 0.36 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.336 -0.847 . . . . 0.44 113.892 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.51 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.85 -176.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.983 0.42 . . . . 0.44 111.171 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.83 88.89 12.37 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.679 -0.691 . . . . 0.44 109.948 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.549 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.4 Cg_endo -109.45 154.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.399 2.733 . . . . 0.44 114.367 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.625 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -83.39 80.79 8.98 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 105.199 -2.149 . . . . 0.44 105.199 175.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.591 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -122.22 127.69 50.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.0 -1.455 . . . . 0.44 110.462 -175.534 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.513 ' O ' ' O ' ' A' ' 86' ' ' LEU . 6.1 t80 -179.11 163.41 1.31 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.928 0.394 . . . . 0.44 112.051 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER 85.72 153.33 0.08 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.68 -0.691 . . . . 0.44 110.725 179.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -112.14 129.4 56.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.44 110.925 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CE1' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.87 -51.09 11.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.44 110.152 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.636 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.4 mt-10 -171.26 131.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.44 110.425 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -111.95 131.97 55.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.725 0.298 . . . . 0.44 111.099 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.407 HD21 ' CE1' ' A' ' 73' ' ' TYR . 4.1 tp -110.28 131.14 55.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.44 110.649 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -121.1 109.89 15.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.44 110.617 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.407 ' CE1' HD21 ' A' ' 71' ' ' LEU . 35.3 p90 -141.1 146.32 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.44 110.843 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -121.15 140.03 52.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.151 0.501 . . . . 0.44 111.192 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.458 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -88.81 163.64 34.49 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.545 -0.752 . . . . 0.44 110.55 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -52.29 84.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.025 2.483 . . . . 0.44 112.205 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 20.5 m-20 93.68 15.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.162 -0.926 . . . . 0.44 111.235 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 30.7 ttt180 -137.37 150.09 47.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 0.44 110.452 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -126.18 101.97 7.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.44 110.979 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.5 tt -109.87 111.92 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.44 110.944 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.439 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -94.83 118.47 31.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.44 110.283 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.46 ' CD1' ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -108.45 114.32 28.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.44 111.421 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -113.14 122.71 48.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.089 -0.505 . . . . 0.44 111.042 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.636 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -106.86 109.71 21.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.766 -0.652 . . . . 0.44 109.449 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 47.2 m95 -97.99 148.5 23.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.44 112.173 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 65' ' ' PHE . 58.8 tp -92.9 134.74 34.8 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.721 -0.672 . . . . 0.44 111.436 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.591 HG13 ' HA ' ' A' ' 64' ' ' HIS . 20.7 t -124.7 146.13 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 115.584 -0.734 . . . . 0.44 111.03 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 4.8 tp10 -106.69 -35.3 7.05 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.561 1.319 . . . . 0.44 114.561 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.22 165.63 24.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.141 0.882 . . . . 0.44 111.945 -179.018 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.663 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.3 p90 -151.29 129.17 11.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 0.44 111.41 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -76.42 136.1 39.44 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.203 -0.453 . . . . 0.44 110.95 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.66 -126.78 24.95 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.777 -0.725 . . . . 0.44 112.556 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -125.85 143.44 45.28 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.549 0.214 . . . . 0.44 110.714 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.477 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.67 128.71 10.36 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.858 2.372 . . . . 0.44 111.489 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.554 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.9 p-90 -131.98 -58.8 0.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.592 -0.443 . . . . 0.44 111.726 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.565 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.94 -97.35 0.01 OUTLIER Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.771 -0.728 . . . . 0.44 112.968 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -179.97 33.88 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.685 0.279 . . . . 0.44 111.355 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -27.69 69.15 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.826 0.346 . . . . 0.44 110.432 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.8 12.45 84.44 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.005 -0.617 . . . . 0.44 113.425 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.406 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 41.7 mt-30 -140.35 98.15 7.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 117.075 0.438 . . . . 0.44 111.53 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -43.71 141.46 3.94 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.835 2.357 . . . . 0.44 112.461 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.15 177.18 19.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.591 -0.814 . . . . 0.44 112.949 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -147.64 157.4 43.54 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.275 -0.269 . . . . 0.44 110.275 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.46 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.7 OUTLIER -68.89 106.14 2.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.867 0.365 . . . . 0.44 110.495 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.472 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 3.1 mmm -120.24 151.93 38.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.125 -0.489 . . . . 0.44 110.838 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.32 114.79 13.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.44 110.572 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 25.9 tp -79.72 -18.95 50.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.44 111.269 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.97 -20.67 9.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.813 0.339 . . . . 0.44 111.176 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.12 49.74 0.88 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.831 -0.7 . . . . 0.44 112.255 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.45 150.22 40.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.701 0.286 . . . . 0.44 110.411 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -115.26 132.19 56.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.166 0.508 . . . . 0.44 112.184 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.62 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.25 -15.3 61.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.433 -0.803 . . . . 0.44 110.736 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -78.43 -49.19 13.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.391 -0.368 . . . . 0.44 111.325 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -27.67 67.4 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.77 0.319 . . . . 0.44 111.054 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.62 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -96.19 169.36 9.11 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.375 -0.375 . . . . 0.44 110.442 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.511 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 39.2 Cg_endo -67.07 127.71 17.3 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.353 2.036 . . . . 0.44 111.948 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.87 -19.88 58.44 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.535 2.157 . . . . 0.44 113.048 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.51 58.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.975 0.361 . . . . 0.44 111.975 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.33 32.4 6.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.789 0.328 . . . . 0.44 111.417 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.07 -40.21 2.92 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.571 0.582 . . . . 0.44 112.571 -179.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 86.4 Cg_exo -44.86 -36.61 11.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.135 1.89 . . . . 0.44 112.682 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 84' ' ' PHE . 7.0 t -77.57 -42.39 29.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.069 0.461 . . . . 0.44 110.339 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.556 HG13 ' CE2' ' A' ' 115' ' ' PHE . 6.0 mm -69.17 -34.14 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.44 110.954 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.62 -27.04 36.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.945 0.402 . . . . 0.44 110.416 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -50.76 9.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.921 -0.581 . . . . 0.44 111.693 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.474 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 7.1 tp -78.07 -32.05 50.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.781 0.324 . . . . 0.44 111.613 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 123' ' ' ILE . 5.9 ttpm? -53.81 -42.52 68.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.057 0.456 . . . . 0.44 111.002 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -71.87 -6.11 39.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.44 109.998 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-N 116.033 -0.531 . . . . 0.44 111.203 179.804 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 tptm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.807 0.337 . . . . 0.44 110.85 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 132.82 46.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.44 110.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.401 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 2.7 pp -130.41 140.49 50.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.44 110.89 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 10.9 mt-30 -107.37 149.45 27.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.276 0.56 . . . . 0.44 111.838 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.474 HD12 HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -142.92 123.55 10.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.201 -0.909 . . . . 0.44 110.037 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.51 124.53 42.47 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 110.171 -0.307 . . . . 0.44 110.171 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.454 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -116.99 155.75 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.45 0.643 . . . . 0.44 112.019 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -138.59 109.27 0.66 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.923 -1.035 . . . . 0.44 111.177 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.491 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -70.85 101.38 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.149 -0.315 . . . . 0.44 110.149 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.45 HG22 ' CE3' ' A' ' 90' ' ' TRP . 1.1 mt -71.58 124.49 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.124 0.488 . . . . 0.44 111.958 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.46 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -96.41 137.71 35.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.558 -0.746 . . . . 0.44 111.065 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.678 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.8 p30 -94.84 -173.43 2.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.556 -0.747 . . . . 0.44 112.222 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.69 -2.17 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.972 -1.013 . . . . 0.44 113.071 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -120.61 41.39 3.27 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.971 -0.291 . . . . 0.44 111.556 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p30 47.44 23.58 0.39 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.949 0.404 . . . . 0.44 111.18 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.584 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 20.2 mt-10 -111.41 160.94 16.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.716 -0.846 . . . . 0.44 108.716 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.46 HG13 ' HA ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -117.49 142.29 32.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.115 0.483 . . . . 0.44 112.137 -178.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -98.0 115.95 29.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.601 -0.727 . . . . 0.44 110.58 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.436 ' CD1' ' HG2' ' A' ' 105' ' ' MET . 0.2 OUTLIER -121.57 150.49 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.44 110.461 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.478 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 47.1 p -81.97 111.81 18.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.176 -0.465 . . . . 0.44 110.543 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.427 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.506 -0.315 . . . . 0.44 110.582 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 111.674 0.25 . . . . 0.44 111.674 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -114.16 26.02 10.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.063 0.459 . . . . 0.44 111.41 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -47.77 99.9 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.692 -0.685 . . . . 0.44 110.44 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.8 tt0 -106.68 -177.5 3.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.168 0.509 . . . . 0.44 111.919 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.87 166.37 15.13 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.742 -0.663 . . . . 0.44 111.347 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 56.3 Cg_endo -69.83 167.76 23.6 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.351 2.7 . . . . 0.44 111.887 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.3 59.65 0.76 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.194 -1.003 . . . . 0.44 114.062 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.544 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -123.01 132.51 8.65 Favored Glycine 0 C--N 1.311 -0.829 0 CA-C-N 114.679 -0.76 . . . . 0.44 112.055 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.0 OUTLIER 92.93 7.7 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.043 0.537 . . . . 0.44 112.377 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.587 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.1 pt -51.2 -29.23 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.706 0.765 . . . . 0.44 110.087 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.583 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.17 -80.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.425 -1.262 . . . . 0.44 110.876 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.2 mmm 37.13 -84.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.588 0.555 . . . . 0.44 111.605 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.57 31.37 0.13 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.971 -0.633 . . . . 0.44 112.456 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.456 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -90.94 -176.56 4.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.822 0.344 . . . . 0.44 111.287 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.521 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.4 153.9 37.55 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.44 110.325 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.93 -25.03 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.83 2.353 . . . . 0.44 112.589 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.02 -40.14 6.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.507 -0.315 . . . . 0.44 111.675 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -80.11 -13.92 58.9 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.652 0.242 . . . . 0.44 111.652 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -59.6 -51.13 71.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.719 0.295 . . . . 0.44 111.098 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.9 m -77.99 -45.48 27.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.418 -0.356 . . . . 0.44 111.037 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.494 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 40.1 t -57.73 -43.54 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.943 -0.571 . . . . 0.44 111.329 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -44.52 25.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 0.44 111.082 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.4 tm-20 -68.39 -25.52 65.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.855 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -53.7 -44.46 69.79 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.914 0.387 . . . . 0.44 110.385 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -60.42 -35.9 76.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.302 -0.629 . . . . 0.44 109.302 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.66 -26.61 50.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.391 -0.822 . . . . 0.44 111.487 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' CA ' ' OE1' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -108.11 6.17 26.64 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.197 0.444 . . . . 0.44 112.197 -178.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.592 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 48.3 t -134.02 -44.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.527 -0.546 . . . . 0.44 109.527 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.51 -40.24 0.29 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.442 -0.799 . . . . 0.44 114.065 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.51 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.84 -177.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.114 0.483 . . . . 0.44 111.092 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.38 88.81 13.58 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.512 -0.767 . . . . 0.44 109.821 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.678 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.2 Cg_endo -111.07 146.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 123.287 2.658 . . . . 0.44 114.159 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 38.6 mt-30 -74.84 79.71 2.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.585 -2.005 . . . . 0.44 105.585 175.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.551 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.82 127.46 50.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.102 -1.408 . . . . 0.44 110.562 -176.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.514 ' O ' ' O ' ' A' ' 86' ' ' LEU . 12.4 t80 -179.29 168.22 1.5 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.042 0.386 . . . . 0.44 112.042 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.5 m 84.43 154.73 0.09 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.733 -0.667 . . . . 0.44 110.742 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 pp -111.9 123.6 50.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.44 111.132 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.83 -38.69 53.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.198 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.2 mt-10 -171.29 148.33 2.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.716 -0.674 . . . . 0.44 110.342 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.4 132.15 22.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.633 0.254 . . . . 0.44 110.916 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.3 166.66 21.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.44 110.894 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -137.68 126.06 23.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.665 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.429 ' CE1' HG12 ' A' ' 80' ' ' ILE . 1.9 p90 -141.14 147.0 37.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.44 110.451 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -121.15 139.96 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.213 0.53 . . . . 0.44 111.424 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -88.28 163.26 37.42 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.382 -0.826 . . . . 0.44 110.353 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.6 Cg_endo -50.6 83.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.029 2.486 . . . . 0.44 112.126 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.5 m-20 93.15 18.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.3 -0.864 . . . . 0.44 111.215 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -137.45 150.08 47.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.44 110.515 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -123.11 106.59 10.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.412 -0.358 . . . . 0.44 110.774 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.429 HG12 ' CE1' ' A' ' 73' ' ' TYR . 3.6 tt -113.44 112.03 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.44 111.232 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.43 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -91.36 118.61 30.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.44 110.101 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.2 mt -109.19 114.26 27.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.997 0.427 . . . . 0.44 111.801 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -112.28 122.13 46.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.046 -0.524 . . . . 0.44 110.101 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.499 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.3 m-85 -106.63 109.79 21.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.128 -0.487 . . . . 0.44 110.244 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 39.4 m95 -98.38 148.7 23.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.44 112.081 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.514 ' O ' ' O ' ' A' ' 65' ' ' PHE . 18.7 tp -94.19 138.44 32.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.617 -0.719 . . . . 0.44 111.402 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 64' ' ' HIS . 34.5 t -123.66 145.41 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-N 115.737 -0.665 . . . . 0.44 110.439 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -111.87 -25.59 9.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.066 1.136 . . . . 0.44 114.066 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.528 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 5.8 tpt180 -162.79 163.54 26.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.511 0.596 . . . . 0.44 111.354 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.678 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -156.38 123.57 5.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.341 -0.391 . . . . 0.44 111.29 178.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -74.78 149.52 39.68 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.168 -0.469 . . . . 0.44 111.105 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.96 -131.76 48.08 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.863 -0.684 . . . . 0.44 112.596 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -121.4 145.05 41.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.44 0.162 . . . . 0.44 110.747 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.489 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.57 128.66 10.41 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.817 2.345 . . . . 0.44 111.386 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.54 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 59.5 p-90 -135.05 -58.27 0.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.502 -0.479 . . . . 0.44 111.921 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.592 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.79 -95.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.978 -0.629 . . . . 0.44 112.982 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -176.02 33.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.728 0.299 . . . . 0.44 111.234 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -26.21 60.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.421 -0.354 . . . . 0.44 110.41 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.99 16.8 73.03 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.057 -0.592 . . . . 0.44 113.632 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.478 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 48.8 mt-30 -140.28 92.08 9.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.129 0.49 . . . . 0.44 111.46 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -43.84 146.1 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.155 2.57 . . . . 0.44 112.935 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.45 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.1 177.11 19.38 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.882 -0.675 . . . . 0.44 112.576 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -142.26 157.28 45.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.569 0.223 . . . . 0.44 110.975 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.53 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -74.71 106.02 6.07 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.747 0.308 . . . . 0.44 110.503 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 4.7 ppp? -120.74 147.64 45.03 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.336 -0.393 . . . . 0.44 111.361 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.5 114.85 3.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.379 . . . . 0.44 110.823 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -80.13 -18.94 48.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.44 111.383 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.1 t -58.32 -15.13 4.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.493 -0.322 . . . . 0.44 111.586 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.07 51.92 0.78 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.729 -0.748 . . . . 0.44 112.315 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.32 149.75 41.29 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.403 -0.221 . . . . 0.44 110.403 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.23 132.21 53.95 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.786 0.662 . . . . 0.44 112.786 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.645 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.36 -15.32 61.86 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.439 -0.801 . . . . 0.44 110.497 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -78.56 -49.29 13.57 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.732 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -32.35 73.58 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.755 0.312 . . . . 0.44 111.031 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.645 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.68 170.74 10.48 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.187 -0.461 . . . . 0.44 110.312 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.538 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 55.5 Cg_endo -69.78 127.47 14.63 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.093 1.862 . . . . 0.44 111.669 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.57 -14.9 45.36 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.631 2.22 . . . . 0.44 113.385 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.64 -9.56 58.8 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.257 0.465 . . . . 0.44 112.257 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.61 34.3 5.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.762 0.315 . . . . 0.44 111.465 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -76.04 -31.87 1.06 Allowed Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.085 0.772 . . . . 0.44 113.085 -179.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 72.1 Cg_exo -49.06 -46.51 25.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 121.79 1.66 . . . . 0.44 112.817 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.418 HG12 ' CD2' ' A' ' 84' ' ' PHE . 1.5 t -77.41 -50.61 20.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.033 0.444 . . . . 0.44 110.622 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.586 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.4 mm -59.33 -35.06 56.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.701 -0.681 . . . . 0.44 111.248 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.73 -34.82 62.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.999 0.428 . . . . 0.44 110.489 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.75 -53.01 30.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.805 -0.634 . . . . 0.44 111.342 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.536 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -78.35 -19.74 52.79 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.311 -0.404 . . . . 0.44 111.699 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 123' ' ' ILE . 10.1 ttpp -66.24 -42.5 88.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.202 0.525 . . . . 0.44 110.334 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -70.03 -9.07 54.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.514 -0.766 . . . . 0.44 110.186 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.536 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.858 0.361 . . . . 0.44 110.652 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.81 0.338 . . . . 0.44 110.9 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -137.52 144.26 42.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.44 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.66 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 1.9 pp -146.14 119.15 8.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.44 110.724 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.443 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 16.7 mt-30 -102.01 152.33 21.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.505 0.669 . . . . 0.44 112.341 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -146.54 131.25 11.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.012 -0.995 . . . . 0.44 110.323 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.589 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.35 125.09 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.207 -0.294 . . . . 0.44 110.207 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.543 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 m -115.6 162.49 13.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.618 0.723 . . . . 0.44 112.714 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.86 112.93 0.66 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.682 -1.145 . . . . 0.44 111.251 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.512 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -70.93 96.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.212 -0.292 . . . . 0.44 110.212 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.52 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.7 tt -71.64 117.54 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.205 0.526 . . . . 0.44 112.318 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -94.92 147.38 23.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.943 -0.571 . . . . 0.44 111.88 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.823 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 9.7 p-10 -103.78 -173.05 2.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.512 0.672 . . . . 0.44 112.225 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.7 tm-20 -71.8 1.6 6.7 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.779 -1.1 . . . . 0.44 113.455 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -124.64 44.59 2.73 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.751 -0.38 . . . . 0.44 111.597 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.9 p30 44.98 28.1 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.44 111.303 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 106' ' ' SER . 3.2 mt-10 -114.96 161.19 18.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.814 -0.63 . . . . 0.44 109.635 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -124.58 128.39 73.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.913 0.387 . . . . 0.44 111.937 -178.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -76.33 113.31 13.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.182 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.43 ' HB ' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.13 126.17 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 0.44 109.957 179.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 3.7 p -71.03 112.15 6.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.854 0.359 . . . . 0.44 110.987 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.44 110.582 179.904 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 111.752 0.278 . . . . 0.44 111.752 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.18 26.25 10.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.115 0.483 . . . . 0.44 111.274 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.6 tt -45.77 100.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.633 -0.712 . . . . 0.44 110.657 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -125.12 179.08 5.21 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.227 0.537 . . . . 0.44 112.231 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.92 163.69 26.44 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.443 -0.799 . . . . 0.44 111.866 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 9.6 Cg_endo -51.49 168.61 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.884 3.056 . . . . 0.44 112.158 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.87 59.5 0.74 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.22 -0.99 . . . . 0.44 113.978 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.618 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.57 123.63 4.19 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 114.519 -0.84 . . . . 0.44 112.234 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.47 1.01 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.558 0.577 . . . . 0.44 112.558 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.589 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.1 pt -52.8 -27.07 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.627 0.727 . . . . 0.44 110.577 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.524 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -44.32 -60.72 1.79 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.586 -1.188 . . . . 0.44 111.233 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.511 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.3 ttp 11.02 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.936 0.773 . . . . 0.44 112.574 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.89 34.76 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.787 -0.72 . . . . 0.44 112.503 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -90.19 -174.73 4.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.935 0.398 . . . . 0.44 111.118 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.527 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.33 154.44 38.05 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.088 -0.506 . . . . 0.44 110.432 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.527 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.89 -25.6 1.09 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.818 2.345 . . . . 0.44 112.515 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.04 -38.91 6.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 0.44 111.446 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -80.1 -11.81 59.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.623 -0.262 . . . . 0.44 111.614 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.421 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -59.77 -52.9 63.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 0.44 110.815 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.507 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.4 m -78.16 -47.27 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 0.44 111.089 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.507 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 38.6 t -54.88 -37.27 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.177 -0.465 . . . . 0.44 111.159 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.26 -51.74 9.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.132 -0.485 . . . . 0.44 111.125 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.425 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.9 mm-40 -66.01 -23.48 66.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.44 111.009 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.2 tp -52.69 -44.67 66.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.744 0.307 . . . . 0.44 110.193 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -34.92 76.07 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.268 -0.641 . . . . 0.44 109.268 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.8 tt0 -77.43 -24.05 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.464 -0.789 . . . . 0.44 110.797 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.465 ' HG2' ' HA2' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -108.59 6.01 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.407 -0.361 . . . . 0.44 111.899 -179.172 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.576 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 16.1 t -133.97 -44.72 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 0.44 110.02 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.13 -39.42 0.2 Allowed Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.628 -0.715 . . . . 0.44 114.0 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.483 HG22 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -88.26 -174.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.018 0.437 . . . . 0.44 111.085 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -111.98 88.87 10.69 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.596 -0.729 . . . . 0.44 110.259 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.62 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -108.63 154.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.915 2.41 . . . . 0.44 114.658 -177.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 89' ' ' ARG . 81.3 mt-30 -75.02 79.72 2.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.067 -1.827 . . . . 0.44 106.067 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.617 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -126.37 121.28 32.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.961 -1.018 . . . . 0.44 111.07 -176.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.9 t80 179.43 171.27 0.98 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.44 111.436 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.3 t 92.79 147.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.792 -0.64 . . . . 0.44 110.814 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.421 HD23 ' CE3' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -96.12 126.7 41.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.44 111.406 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -92.13 -51.77 5.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.44 110.08 179.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 9.4 tt0 -171.63 163.75 6.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.724 -0.671 . . . . 0.44 110.31 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -143.34 132.1 22.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.773 0.321 . . . . 0.44 110.901 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.414 ' CD2' ' CD1' ' A' ' 73' ' ' TYR . 2.6 tp -122.71 128.52 50.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.44 110.658 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -117.2 110.72 18.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.44 110.734 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.419 ' CE2' HD13 ' A' ' 80' ' ' ILE . 11.8 p90 -140.97 146.04 36.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.44 110.699 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.37 131.81 54.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.134 0.492 . . . . 0.44 111.241 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -82.04 163.22 54.14 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.44 110.489 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.1 Cg_endo -53.36 82.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.895 2.397 . . . . 0.44 112.152 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 17.6 t0 90.96 11.5 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.421 -0.809 . . . . 0.44 111.36 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -137.35 94.25 2.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.584 -0.28 . . . . 0.44 110.711 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -76.24 119.79 20.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.564 -0.289 . . . . 0.44 110.422 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.66 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 5.0 pt -127.52 146.99 32.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.065 0.459 . . . . 0.44 112.179 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.443 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -113.52 118.82 35.52 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.44 109.704 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.432 HD23 ' CE1' ' A' ' 84' ' ' PHE . 14.8 tp -106.42 114.0 27.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.854 0.359 . . . . 0.44 111.279 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.407 ' CZ3' ' O ' ' A' ' 46' ' ' PRO . 9.5 m0 -112.52 122.49 47.86 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.992 -0.549 . . . . 0.44 110.555 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.434 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 4.8 m-30 -106.54 109.87 21.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.869 -0.605 . . . . 0.44 110.591 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.45 ' CD2' HG23 ' A' ' 50' ' ' VAL . 34.9 m95 -101.32 148.48 25.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.169 -0.469 . . . . 0.44 111.455 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 65' ' ' PHE . 22.4 tp -91.69 138.35 31.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.324 0.583 . . . . 0.44 112.05 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 64' ' ' HIS . 38.3 t -124.44 145.37 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.299 -0.864 . . . . 0.44 110.264 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -112.49 -32.34 6.51 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.412 1.264 . . . . 0.44 114.412 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.434 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -163.18 165.62 24.27 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.711 0.687 . . . . 0.44 111.645 -178.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.823 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.9 p90 -148.17 133.06 18.06 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.363 -0.38 . . . . 0.44 111.793 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -80.18 144.41 33.01 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.357 -0.383 . . . . 0.44 110.691 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.13 -115.23 7.32 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.636 -0.792 . . . . 0.44 112.45 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 43.2 mt-10 -134.92 138.6 29.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.468 0.175 . . . . 0.44 110.82 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.484 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 3.4 Cg_exo -76.62 128.89 10.52 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.786 2.324 . . . . 0.44 111.12 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.571 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 62.4 p-90 -137.08 -60.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.942 -0.703 . . . . 0.44 112.633 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.576 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 52.51 -94.2 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.56 -0.828 . . . . 0.44 112.693 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.1 tttp 179.02 30.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.565 0.221 . . . . 0.44 111.549 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.69 -32.4 70.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.027 0.441 . . . . 0.44 110.143 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.91 32.29 69.96 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.813 -0.631 . . . . 0.44 113.73 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.459 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 76.7 mt-30 -140.56 91.64 9.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.973 0.416 . . . . 0.44 111.527 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -44.7 126.53 7.28 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.197 2.598 . . . . 0.44 112.959 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.467 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.47 177.31 19.31 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.736 -0.745 . . . . 0.44 112.823 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.16 157.13 46.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.626 0.25 . . . . 0.44 110.699 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.44 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -68.47 106.71 2.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.887 0.375 . . . . 0.44 110.156 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.5 ptp -119.87 148.52 43.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.44 111.159 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.415 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 95.0 p -65.85 114.57 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.3 -0.409 . . . . 0.44 110.593 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 33.5 tp -78.11 -18.87 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.44 111.309 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.91 -20.13 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.491 -0.322 . . . . 0.44 111.442 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.99 45.2 1.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.649 -0.786 . . . . 0.44 112.698 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.9 tt -62.79 150.57 41.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.627 0.251 . . . . 0.44 110.49 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.91 129.61 56.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.201 0.524 . . . . 0.44 112.377 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.556 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.23 -14.98 61.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.445 -0.798 . . . . 0.44 110.666 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -78.36 -49.17 14.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.386 -0.37 . . . . 0.44 111.578 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -34.93 78.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.91 0.386 . . . . 0.44 110.876 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.556 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -84.74 173.23 7.47 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.111 -0.495 . . . . 0.44 110.345 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.3 Cg_endo -70.68 127.69 14.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.162 1.908 . . . . 0.44 111.857 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.41 -17.57 60.08 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.53 2.154 . . . . 0.44 113.023 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.25 -9.36 58.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.464 -0.334 . . . . 0.44 111.875 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.51 29.5 7.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.609 -0.269 . . . . 0.44 111.42 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.05 -43.17 3.65 Favored Pre-proline 0 C--O 1.224 -0.25 0 N-CA-C 112.203 0.446 . . . . 0.44 112.203 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 92.4 Cg_exo -44.89 -39.0 13.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.18 1.92 . . . . 0.44 112.971 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.21 -51.14 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.189 0.518 . . . . 0.44 110.77 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.516 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.2 mm -64.84 -31.23 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 0.44 111.197 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.82 -30.88 58.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.003 0.43 . . . . 0.44 110.477 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.9 -53.27 18.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.857 -0.61 . . . . 0.44 111.469 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.33 -33.07 49.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.479 -0.328 . . . . 0.44 111.565 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -53.15 -42.64 66.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.44 111.148 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -67.2 -10.59 52.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.804 -0.634 . . . . 0.44 109.688 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.232 0.155 0 CA-C-N 116.015 -0.539 . . . . 0.44 111.058 179.752 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.1 tptm . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.835 0.35 . . . . 0.44 110.944 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -140.06 137.87 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.955 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.07 131.95 19.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 0.44 110.736 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -102.84 155.43 18.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.44 111.666 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 81' ' ' THR . 5.3 mp -144.52 137.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.44 110.35 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.607 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -125.41 125.3 43.17 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.292 -0.413 . . . . 0.44 110.329 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.463 HG22 ' CE1' ' A' ' 35' ' ' PHE . 1.9 m -128.63 155.79 40.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.064 0.459 . . . . 0.44 111.283 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.7 127.09 2.21 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.591 -0.731 . . . . 0.44 112.106 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.493 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.99 107.65 13.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.49 -0.559 . . . . 0.44 109.49 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.613 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.17 123.33 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.975 0.417 . . . . 0.44 111.31 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.9 119.04 23.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.607 -0.724 . . . . 0.44 111.359 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 21.9 t-20 -74.77 -172.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.082 -0.963 . . . . 0.44 111.927 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.49 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 32.1 tt0 -82.57 4.11 25.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.236 -1.347 . . . . 0.44 112.151 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -140.08 52.2 1.68 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.44 111.454 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.64 25.21 0.24 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.235 -0.439 . . . . 0.44 111.552 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 5.3 pt-20 -120.32 149.88 41.61 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.916 -0.772 . . . . 0.44 108.916 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 18' ' ' ILE . 1.3 mp -113.36 140.76 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.149 0.5 . . . . 0.44 111.665 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -91.16 103.58 16.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.569 -0.741 . . . . 0.44 110.048 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.9 162.12 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.738 -0.665 . . . . 0.44 110.186 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.401 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 73.7 p -92.61 111.71 23.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.787 0.327 . . . . 0.44 110.873 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.44 110.85 179.975 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 N-CA-C 111.744 0.276 . . . . 0.44 111.744 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.27 26.34 10.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.44 111.465 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -46.05 97.44 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.768 -0.651 . . . . 0.44 110.67 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.78 176.94 4.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.168 0.509 . . . . 0.44 111.715 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.484 ' CE1' ' CZ ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -119.76 161.44 37.95 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.747 -0.66 . . . . 0.44 111.904 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -55.66 168.54 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.671 2.914 . . . . 0.44 111.611 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.67 59.49 0.74 Allowed Glycine 0 C--N 1.33 0.242 0 C-N-CA 119.826 -1.178 . . . . 0.44 113.965 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.604 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.15 121.7 2.64 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 114.576 -0.812 . . . . 0.44 112.086 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.49 -6.62 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.339 0.656 . . . . 0.44 111.565 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.507 HD13 ' CB ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -43.17 -57.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.303 0.573 . . . . 0.44 111.251 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -19.36 -78.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.335 -1.302 . . . . 0.44 112.305 -179.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.3 mmt 40.2 -93.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.423 -0.353 . . . . 0.44 111.774 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.47 22.06 0.08 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.488 -0.863 . . . . 0.44 113.359 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.45 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -78.84 -159.99 0.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.544 0.211 . . . . 0.44 110.863 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.535 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.14 154.7 38.63 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 110.323 -0.251 . . . . 0.44 110.323 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.2 Cg_endo -44.07 -24.91 0.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.777 2.318 . . . . 0.44 112.456 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -99.89 -48.77 4.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.371 -0.377 . . . . 0.44 111.919 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -80.5 -4.89 55.59 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 111.782 0.29 . . . . 0.44 111.782 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.507 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -65.49 -57.49 8.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.54 0.21 . . . . 0.44 110.955 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.465 HG13 ' CE2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.79 -44.01 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.821 -0.351 . . . . 0.44 110.706 179.163 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.9 t -50.61 -36.06 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.959 0.409 . . . . 0.44 110.73 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -78.59 -49.1 13.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.04 -0.527 . . . . 0.44 110.817 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -65.66 -23.75 66.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.44 110.932 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.431 HD23 ' CD2' ' A' ' 64' ' ' HIS . 2.5 tp -54.81 -44.56 73.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.393 -0.367 . . . . 0.44 110.467 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -31.29 71.13 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.337 -0.616 . . . . 0.44 109.337 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.3 tm-20 -77.44 -23.95 50.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.442 -0.799 . . . . 0.44 110.957 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.425 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 45.3 mm-40 -107.07 3.54 25.98 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.938 0.347 . . . . 0.44 111.938 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.516 ' CG1' HG13 ' A' ' 60' ' ' ILE . 21.9 t -134.91 -44.21 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.277 0.56 . . . . 0.44 109.847 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.57 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.2 -43.91 0.69 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.254 -0.885 . . . . 0.44 113.321 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.516 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.61 -175.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.105 0.478 . . . . 0.44 111.255 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.36 89.14 11.86 Favored Pre-proline 0 N--CA 1.442 -0.852 0 CA-C-N 115.521 -0.763 . . . . 0.44 110.196 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.645 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.8 Cg_endo -108.47 148.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.078 2.519 . . . . 0.44 114.133 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 21.3 mt-30 -74.64 79.95 2.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.939 -1.875 . . . . 0.44 105.939 175.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.596 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.76 127.52 48.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.989 -1.459 . . . . 0.44 110.675 -176.484 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.628 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.1 t80 -179.83 171.0 1.2 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.246 -0.433 . . . . 0.44 111.518 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 80.57 156.13 0.14 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.177 -0.465 . . . . 0.44 110.749 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.771 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.4 pp -117.09 129.28 55.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.237 -0.438 . . . . 0.44 111.436 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.8 -48.36 18.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.986 -0.552 . . . . 0.44 109.744 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -171.56 131.73 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.505 -0.77 . . . . 0.44 110.184 179.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 132.21 53.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.742 0.305 . . . . 0.44 110.719 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.68 162.25 26.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.44 111.185 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -140.14 128.28 22.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.44 110.656 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.408 ' O ' ' CG ' ' A' ' 73' ' ' TYR . 1.9 p90 -141.07 100.87 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.456 . . . . 0.44 110.643 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.8 pt-20 -74.83 122.42 23.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.44 111.446 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.99 162.89 60.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 0.44 110.303 179.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.0 Cg_endo -51.0 81.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.025 2.484 . . . . 0.44 112.287 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.4 t70 91.37 10.12 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.486 -0.779 . . . . 0.44 111.57 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -137.34 93.95 2.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.646 0.26 . . . . 0.44 110.854 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 52.7 t-80 -74.88 102.1 4.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.819 0.342 . . . . 0.44 110.703 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.6 tt -106.52 111.94 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.881 0.372 . . . . 0.44 111.071 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -103.28 128.55 50.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.44 110.413 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mt -126.25 114.54 18.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.98 0.419 . . . . 0.44 111.497 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -108.12 122.33 46.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.089 -0.505 . . . . 0.44 110.38 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.551 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 5.4 m-30 -100.5 113.77 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.344 -0.389 . . . . 0.44 110.754 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.771 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 35.8 m95 -94.29 148.74 21.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.288 -0.415 . . . . 0.44 111.258 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 65' ' ' PHE . 31.1 tp -98.35 103.43 15.38 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 121.159 0.504 . . . . 0.44 111.61 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.613 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 25.2 t -87.62 145.79 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-N 115.622 -0.717 . . . . 0.44 111.184 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -112.15 -26.74 8.67 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.542 1.312 . . . . 0.44 114.542 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.86 165.11 25.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.796 0.726 . . . . 0.44 111.796 -178.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.645 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.2 p90 -152.72 130.04 11.31 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.25 -0.432 . . . . 0.44 111.511 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -75.84 139.93 41.98 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.332 -0.395 . . . . 0.44 110.694 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.3 -117.82 12.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.44 112.347 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 8.0 mt-10 -135.05 140.12 33.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.414 0.149 . . . . 0.44 110.875 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.47 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 7.8 Cg_exo -75.5 128.58 11.2 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.943 2.429 . . . . 0.44 111.438 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.57 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 45.1 p-90 -128.45 -58.54 1.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.993 0.425 . . . . 0.44 111.383 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.489 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.77 -100.07 0.02 OUTLIER Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.62 -0.718 . . . . 0.44 112.877 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 179.08 36.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.44 111.321 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.99 -47.6 80.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.411 -0.359 . . . . 0.44 110.564 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.59 12.08 51.86 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.746 -0.74 . . . . 0.44 113.927 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.401 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 24.3 mt-30 -140.36 91.79 9.61 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 117.24 0.52 . . . . 0.44 111.386 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -44.23 125.39 5.68 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.837 2.358 . . . . 0.44 112.739 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.78 177.59 19.16 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.005 -0.617 . . . . 0.44 112.469 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -129.28 157.1 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.672 0.273 . . . . 0.44 110.773 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.45 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.12 107.1 3.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.901 0.381 . . . . 0.44 110.435 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 18' ' ' ILE . 12.5 ptm -119.62 158.1 27.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 0.44 111.018 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 p -71.83 121.32 18.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.44 111.094 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -80.11 -28.97 38.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.44 111.011 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 p -50.72 -24.58 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 0.44 111.232 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.7 43.34 1.4 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.875 -0.678 . . . . 0.44 112.382 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tt -62.55 150.14 41.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.256 -0.275 . . . . 0.44 110.256 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.97 132.91 56.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.178 0.513 . . . . 0.44 112.302 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.611 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.42 61.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.455 -0.793 . . . . 0.44 110.48 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -78.77 -49.27 13.31 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.321 -0.4 . . . . 0.44 111.755 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -32.77 74.26 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.799 0.333 . . . . 0.44 111.013 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.611 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -89.16 172.62 7.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 0.44 110.029 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.489 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.8 Cg_endo -67.51 127.58 16.69 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.032 1.822 . . . . 0.44 111.832 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.38 -18.64 60.67 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.552 2.168 . . . . 0.44 113.064 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.87 -9.38 58.24 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.915 0.339 . . . . 0.44 111.915 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.36 34.31 5.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.767 0.318 . . . . 0.44 111.464 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -75.6 -44.06 4.16 Favored Pre-proline 0 N--CA 1.463 0.217 0 N-CA-C 112.325 0.491 . . . . 0.44 112.325 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.6 Cg_exo -44.76 -35.38 9.43 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.224 1.949 . . . . 0.44 112.61 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.479 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 11.8 t -77.43 -41.05 29.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.136 0.493 . . . . 0.44 110.144 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.557 HG13 ' CE2' ' A' ' 115' ' ' PHE . 17.9 mm -70.28 -32.28 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.696 -0.684 . . . . 0.44 110.707 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.46 -26.96 34.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.086 0.47 . . . . 0.44 110.228 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.09 -50.89 9.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.807 -0.633 . . . . 0.44 111.669 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.475 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 8.1 tp -78.09 -33.5 50.69 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.856 0.36 . . . . 0.44 111.693 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -53.27 -42.53 66.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.135 -0.484 . . . . 0.44 111.133 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -71.71 -6.09 38.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.886 -0.597 . . . . 0.44 109.975 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-N 115.989 -0.55 . . . . 0.44 111.189 179.763 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.837 0.351 . . . . 0.44 110.896 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -140.02 137.53 34.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.44 110.854 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.423 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.7 pp -146.0 135.37 22.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.44 110.77 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -102.7 149.19 24.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.388 0.613 . . . . 0.44 112.107 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.423 ' CD1' ' CD1' ' A' ' 4' ' ' LEU . 3.4 mp -146.22 120.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.017 -0.992 . . . . 0.44 109.866 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.634 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.66 143.34 50.79 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 121.01 -0.276 . . . . 0.44 110.314 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.578 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -144.6 162.52 14.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.112 0.482 . . . . 0.44 111.487 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.02 123.4 2.01 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.481 -0.781 . . . . 0.44 112.037 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.625 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.75 108.91 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.158 -0.682 . . . . 0.44 109.158 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.486 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -70.83 120.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.224 0.535 . . . . 0.44 112.252 -178.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.95 122.7 28.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.55 -0.75 . . . . 0.44 111.615 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.557 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -81.62 -172.58 3.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.979 -1.01 . . . . 0.44 111.887 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.52 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -82.38 -0.95 48.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.406 -1.27 . . . . 0.44 112.112 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -135.69 49.58 2.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 0.44 111.331 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.27 23.7 0.59 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.233 -0.439 . . . . 0.44 111.183 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 13' ' ' ASN . 16.2 pt-20 -114.23 153.97 28.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.103 -0.703 . . . . 0.44 109.103 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.457 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 5.2 mt -128.44 143.32 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.44 112.04 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.455 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.18 122.74 34.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.496 -0.775 . . . . 0.44 110.324 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.444 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -118.69 133.36 65.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.359 -0.382 . . . . 0.44 110.274 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.4 p -70.82 115.94 10.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.325 -0.398 . . . . 0.44 111.082 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.414 ' HA ' HD22 ' A' ' 33' ' ' LEU . 18.3 ptt85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.44 110.704 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 CA--C 1.529 0.138 0 CA-C-O 120.561 0.22 . . . . 0.44 111.354 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -114.23 25.65 10.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.428 . . . . 0.44 111.28 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -46.47 97.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.831 -0.622 . . . . 0.44 110.37 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -106.79 -170.35 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.18 0.514 . . . . 0.44 112.251 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.494 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.19 168.59 9.62 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.505 -0.77 . . . . 0.44 111.472 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.578 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 93.7 Cg_endo -79.33 167.58 21.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.688 2.925 . . . . 0.44 113.835 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.87 -5.24 50.38 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.311 -0.859 . . . . 0.44 114.881 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.02 159.16 23.95 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 117.498 0.649 . . . . 0.44 113.327 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 85.14 6.36 0.49 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.061 0.545 . . . . 0.44 111.996 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.634 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.6 pt -54.28 -27.04 16.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.632 0.73 . . . . 0.44 110.167 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.534 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.97 -66.92 0.32 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.491 -1.231 . . . . 0.44 111.035 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.503 ' C ' ' O ' ' A' ' 41' ' ' GLU . 5.4 mmt 14.65 -82.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.876 0.735 . . . . 0.44 112.409 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -177.52 33.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 0.44 112.59 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.6 mp0 -88.76 -172.97 3.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.861 0.362 . . . . 0.44 111.168 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.541 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.76 155.38 36.4 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.156 -0.475 . . . . 0.44 110.36 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.89 -25.46 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.817 2.345 . . . . 0.44 112.659 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.51 -41.6 5.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.492 -0.322 . . . . 0.44 111.386 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -80.28 -4.83 54.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.564 -0.289 . . . . 0.44 111.722 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.431 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -60.58 -55.41 33.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.44 110.896 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 2.7 m -78.19 -46.03 26.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.198 -0.455 . . . . 0.44 111.31 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 30.0 t -55.39 -41.13 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 116.125 -0.489 . . . . 0.44 111.368 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -77.98 -49.34 14.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.018 0.437 . . . . 0.44 110.451 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.46 ' HG3' ' OE1' ' A' ' 57' ' ' GLU . 14.9 tp10 -63.38 -20.0 65.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.898 -0.592 . . . . 0.44 110.504 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 1.4 tp -59.65 -44.46 93.54 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.44 110.303 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -30.16 70.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.952 -0.567 . . . . 0.44 109.827 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.5 tm-20 -77.27 -31.82 55.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.715 -0.675 . . . . 0.44 111.416 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.46 ' OE1' ' HG3' ' A' ' 53' ' ' GLU . 1.2 mp0 -108.68 6.14 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.703 0.631 . . . . 0.44 112.703 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.525 ' CG1' HG13 ' A' ' 60' ' ' ILE . 43.5 t -133.83 -44.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.161 0.505 . . . . 0.44 110.031 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.586 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.43 -39.82 0.28 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.52 -0.764 . . . . 0.44 113.966 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.525 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.52 -176.29 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 120.968 0.413 . . . . 0.44 110.841 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.22 89.1 11.53 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 115.762 -0.654 . . . . 0.44 110.468 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.651 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.9 Cg_endo -109.42 143.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.266 2.644 . . . . 0.44 114.243 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 34.5 mt-30 -74.7 80.03 2.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 105.437 -2.061 . . . . 0.44 105.437 175.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.643 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -120.92 134.53 55.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.102 -1.408 . . . . 0.44 111.418 -175.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 178.92 -139.9 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.686 -0.688 . . . . 0.44 110.089 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 56.46 156.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.206 0.527 . . . . 0.44 112.323 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.4 tt -120.1 109.44 15.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.632 -0.713 . . . . 0.44 110.562 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.74 -43.8 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.44 110.369 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.509 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.7 tt0 -171.25 163.32 7.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.834 -0.621 . . . . 0.44 110.311 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.436 ' CE ' ' CE2' ' A' ' 83' ' ' TRP . 1.1 ttpm? -143.15 132.04 22.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.81 0.338 . . . . 0.44 110.992 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 73' ' ' TYR . 4.6 tp -115.2 120.41 39.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.418 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -118.57 109.84 16.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.44 110.911 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.449 ' CE1' ' CD2' ' A' ' 71' ' ' LEU . 2.0 p90 -141.1 151.64 44.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.44 110.46 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.14 121.27 37.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 0.44 111.34 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.77 162.88 61.04 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.523 -0.762 . . . . 0.44 110.281 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -50.92 81.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.017 2.478 . . . . 0.44 112.097 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 t70 88.79 14.23 0.07 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.472 -0.785 . . . . 0.44 111.329 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -137.51 93.91 2.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.732 0.301 . . . . 0.44 110.805 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -75.76 97.57 3.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.899 0.38 . . . . 0.44 110.463 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.427 HG22 ' CE2' ' A' ' 73' ' ' TYR . 1.3 tt -100.84 112.9 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.281 -0.418 . . . . 0.44 111.405 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.48 119.66 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.44 110.279 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.42 HD21 ' CE1' ' A' ' 84' ' ' PHE . 12.7 tp -110.26 114.37 27.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.88 0.372 . . . . 0.44 111.334 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.436 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 10.9 m0 -109.47 122.89 48.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.44 111.178 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.42 ' CE1' HD21 ' A' ' 82' ' ' LEU . 5.3 m-30 -109.79 109.77 20.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.44 110.602 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 48.2 m95 -99.41 148.96 23.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.506 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.8 tp -98.5 102.84 14.7 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.427 0.632 . . . . 0.44 111.726 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.643 HG13 ' HA ' ' A' ' 64' ' ' HIS . 11.9 t -81.1 146.47 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-N 115.074 -0.966 . . . . 0.44 111.091 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -114.12 -25.68 8.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.267 1.21 . . . . 0.44 114.267 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.9 tpt180 -162.55 161.87 27.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.64 0.654 . . . . 0.44 111.583 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.651 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -155.61 123.46 5.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.132 -0.485 . . . . 0.44 111.316 178.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -72.05 143.94 48.93 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 116.123 -0.49 . . . . 0.44 111.019 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.2 -129.67 46.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.867 -0.682 . . . . 0.44 112.558 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -121.0 144.0 38.23 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.599 0.238 . . . . 0.44 110.76 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.455 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 3.5 Cg_exo -76.32 128.89 10.76 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.788 2.325 . . . . 0.44 111.031 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.586 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 47.0 p-90 -132.28 -63.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.496 0.554 . . . . 0.44 112.496 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.506 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.49 -99.87 0.02 OUTLIER Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.612 -0.804 . . . . 0.44 112.517 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.3 mtpp 164.77 42.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.83 0.348 . . . . 0.44 110.874 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -58.59 -31.99 68.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.524 -0.307 . . . . 0.44 110.939 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.42 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 129.93 -37.84 2.09 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.589 -0.815 . . . . 0.44 113.368 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -129.49 105.71 17.42 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.44 111.86 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -43.76 146.31 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.079 2.52 . . . . 0.44 112.661 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.45 177.18 18.74 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.743 -0.741 . . . . 0.44 112.745 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -131.65 157.38 43.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.506 0.194 . . . . 0.44 110.596 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.483 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -75.82 106.51 7.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.866 0.365 . . . . 0.44 110.203 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.0 ptm -120.16 161.32 21.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.44 110.981 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.9 p -76.86 114.98 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.44 110.712 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 tp -77.32 -18.94 57.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.44 111.303 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.3 p -51.0 -24.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.455 -0.338 . . . . 0.44 111.328 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.54 44.37 1.24 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.662 -0.78 . . . . 0.44 112.561 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.4 tt -62.78 150.35 41.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.577 0.227 . . . . 0.44 110.419 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.71 130.12 56.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.44 112.325 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.544 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.21 -14.8 61.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.481 -0.782 . . . . 0.44 110.55 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.43 -49.13 14.04 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.364 -0.38 . . . . 0.44 111.483 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -34.69 77.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.779 0.323 . . . . 0.44 111.054 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.47 174.34 6.21 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 0.44 110.172 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 40.1 Cg_endo -67.71 127.81 16.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 121.926 1.751 . . . . 0.44 111.928 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.85 -21.12 58.06 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.606 2.204 . . . . 0.44 112.693 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.29 -9.6 58.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.378 -0.374 . . . . 0.44 111.719 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.74 23.22 13.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.488 -0.323 . . . . 0.44 111.506 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -66.59 -36.46 12.15 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.283 0.475 . . . . 0.44 112.283 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 73.8 Cg_exo -51.13 -47.74 24.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.952 1.768 . . . . 0.44 112.84 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.419 HG13 ' CD2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -77.68 -51.21 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.936 0.398 . . . . 0.44 111.191 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.516 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -62.1 -32.84 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.858 -0.61 . . . . 0.44 111.227 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 120' ' ' GLU . . . -54.92 -36.99 65.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.972 0.415 . . . . 0.44 110.374 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -62.92 -46.51 87.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.793 -0.64 . . . . 0.44 110.519 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 13.6 tp -78.13 -27.81 48.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.074 -0.512 . . . . 0.44 111.032 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -58.99 -42.67 90.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.44 110.973 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -76.73 -3.29 37.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.44 110.111 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.231 0.126 0 CA-C-N 116.082 -0.508 . . . . 0.44 111.132 179.769 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.807 0.337 . . . . 0.44 110.874 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 8.8 ttmt -136.25 136.71 40.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.44 110.785 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 3.1 pp -146.04 137.76 24.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.44 110.667 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -109.24 147.53 32.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.331 0.586 . . . . 0.44 111.804 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.404 ' CD1' ' CD1' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -136.91 128.49 42.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.258 -0.883 . . . . 0.44 110.014 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.614 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -125.14 124.83 42.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.709 -0.223 . . . . 0.44 110.518 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.467 HG22 ' CD1' ' A' ' 35' ' ' PHE . 1.9 m -124.11 162.35 25.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.033 0.444 . . . . 0.44 111.062 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.69 116.12 0.75 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.656 -0.783 . . . . 0.44 112.688 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.506 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 2.4 mp -70.58 104.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.199 -0.667 . . . . 0.44 109.199 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.509 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -70.97 120.52 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.21 0.529 . . . . 0.44 112.311 -177.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.52 119.65 24.5 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.636 -0.711 . . . . 0.44 111.56 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.573 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 25.8 t-20 -78.24 179.93 6.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.92 -1.036 . . . . 0.44 111.434 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.573 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 22.0 tt0 -76.1 1.26 16.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.893 -1.048 . . . . 0.44 111.97 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -139.87 52.57 1.69 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.814 0.34 . . . . 0.44 111.522 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 45.53 27.12 0.37 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.147 -0.479 . . . . 0.44 111.725 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 11.5 pt-20 -117.45 160.6 20.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.041 -0.725 . . . . 0.44 109.041 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.509 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 2.8 mp -136.82 142.31 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.24 -0.584 . . . . 0.44 112.205 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -91.7 118.19 30.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.318 -0.855 . . . . 0.44 110.281 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.62 138.44 38.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.826 -0.435 . . . . 0.44 109.826 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 34' ' ' GLU . 4.2 p -83.1 111.38 18.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.922 0.391 . . . . 0.44 110.745 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.433 . . . . 0.44 111.169 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 111.612 0.227 . . . . 0.44 111.612 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -114.24 25.95 10.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.965 0.412 . . . . 0.44 111.441 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -53.45 89.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.681 -0.69 . . . . 0.44 110.216 179.344 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 21' ' ' THR . 3.1 tt0 -112.87 -168.19 1.29 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.29 0.566 . . . . 0.44 112.143 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.467 ' CD1' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.33 166.3 15.69 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.506 -0.77 . . . . 0.44 111.305 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 38.2 Cg_endo -63.93 168.6 11.8 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.334 2.689 . . . . 0.44 111.208 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.9 60.11 0.73 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 119.514 -1.327 . . . . 0.44 114.228 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.63 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.21 110.91 0.86 Allowed Glycine 0 C--N 1.314 -0.67 0 CA-C-N 114.581 -0.809 . . . . 0.44 111.732 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.63 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 126.98 -8.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.521 0.728 . . . . 0.44 110.873 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -42.2 -48.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.293 0.568 . . . . 0.44 111.57 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -31.8 -81.16 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.63 -1.168 . . . . 0.44 111.941 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.9 mmm 43.02 -92.82 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.635 -0.257 . . . . 0.44 111.557 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.71 23.8 0.09 OUTLIER Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.54 -0.838 . . . . 0.44 113.215 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -82.44 -162.95 0.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.546 0.213 . . . . 0.44 110.934 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.55 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -107.76 156.07 38.69 Favored Pre-proline 0 C--N 1.333 -0.13 0 N-CA-C 110.178 -0.305 . . . . 0.44 110.178 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.85 -24.71 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.703 2.269 . . . . 0.44 112.456 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -95.36 -54.03 3.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.976 0.362 . . . . 0.44 111.976 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -80.44 -5.26 56.28 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.052 0.39 . . . . 0.44 112.052 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.447 ' HB2' HG13 ' A' ' 40' ' ' ILE . . . -64.99 -57.44 8.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.685 0.278 . . . . 0.44 110.811 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.466 ' N ' HD11 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -79.02 -45.95 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.431 -0.35 . . . . 0.44 110.701 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.3 t -50.87 -37.76 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.335 -0.393 . . . . 0.44 111.033 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -48.68 14.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.68 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 40' ' ' ILE . 12.8 tp10 -63.92 -25.67 68.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.017 -0.538 . . . . 0.44 110.639 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.422 ' CD2' ' NE2' ' A' ' 64' ' ' HIS . 1.7 tp -55.3 -44.31 75.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.44 110.6 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -32.1 71.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.303 -0.628 . . . . 0.44 109.303 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.1 tm-20 -77.37 -25.49 51.0 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.426 -0.806 . . . . 0.44 110.848 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.413 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 5.3 mm-40 -108.38 5.18 25.19 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.104 0.409 . . . . 0.44 112.104 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.522 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 31.3 t -134.82 -44.62 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.11 0.481 . . . . 0.44 110.144 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.525 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.51 -40.25 0.23 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.482 -0.781 . . . . 0.44 113.893 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.497 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.65 -177.57 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.001 0.429 . . . . 0.44 111.227 -179.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.62 88.54 13.76 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.525 -0.761 . . . . 0.44 109.798 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.7 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 1.4 Cg_endo -112.55 147.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 123.322 2.681 . . . . 0.44 114.167 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 22.8 mt-30 -74.7 80.02 2.04 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.915 -1.883 . . . . 0.44 105.915 175.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.578 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.4 128.12 50.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.005 -1.452 . . . . 0.44 110.74 -176.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.7 t80 179.72 175.33 0.77 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.44 111.481 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 t 78.79 162.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.077 -0.51 . . . . 0.44 111.077 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -123.45 129.28 51.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.44 111.367 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.77 -44.24 33.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.292 0.568 . . . . 0.44 109.767 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.3 mt-10 -171.45 131.66 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.337 -0.847 . . . . 0.44 109.845 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.5 132.16 54.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.88 0.372 . . . . 0.44 111.286 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 tp -109.43 137.56 47.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.44 110.626 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -133.56 109.97 9.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.44 110.895 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.423 ' CZ ' HG23 ' A' ' 80' ' ' ILE . 2.3 p90 -141.22 146.28 36.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.44 110.584 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.16 133.96 55.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.105 0.478 . . . . 0.44 111.306 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -93.91 163.15 24.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.44 110.375 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.8 Cg_endo -54.15 82.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.823 2.349 . . . . 0.44 112.317 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 10.9 t0 93.49 8.53 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.435 -0.802 . . . . 0.44 111.547 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.34 93.92 2.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.774 0.321 . . . . 0.44 110.769 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.402 ' CD2' ' HG3' ' A' ' 3' ' ' LYS . 1.9 t60 -82.09 96.98 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.44 110.773 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.423 HG23 ' CZ ' ' A' ' 73' ' ' TYR . 5.0 tt -98.77 111.7 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.306 -0.406 . . . . 0.44 110.985 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.06 118.71 34.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.44 110.115 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.5 mt -106.19 114.47 28.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.963 0.411 . . . . 0.44 111.689 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 12.2 m0 -106.74 122.17 45.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.44 109.599 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.2 m-85 -112.95 109.78 19.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.44 110.196 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.739 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 15.9 m95 -94.77 148.46 22.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.277 -0.42 . . . . 0.44 111.595 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.613 ' O ' ' O ' ' A' ' 65' ' ' PHE . 59.2 tp -100.09 102.98 14.46 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.037 0.446 . . . . 0.44 111.568 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 64' ' ' HIS . 25.0 t -83.29 145.83 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 CA-C-N 115.777 -0.647 . . . . 0.44 111.159 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -113.5 -23.53 9.76 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.202 1.186 . . . . 0.44 114.202 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 2.9 ttt-85 -162.91 162.95 26.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.688 0.677 . . . . 0.44 111.287 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.7 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -157.25 125.18 5.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.44 111.674 179.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -76.07 151.9 36.97 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.285 -0.416 . . . . 0.44 111.136 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.21 -132.94 42.2 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.888 -0.672 . . . . 0.44 112.654 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 19.6 tt0 -119.69 146.94 42.75 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.6 0.238 . . . . 0.44 110.721 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.2 Cg_exo -76.69 128.85 10.44 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.904 2.403 . . . . 0.44 111.383 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.525 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 64.9 p-90 -137.08 -59.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.298 -0.561 . . . . 0.44 112.179 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.522 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 49.17 -94.63 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.617 -0.802 . . . . 0.44 112.813 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.1 mmtm 165.81 34.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.692 0.282 . . . . 0.44 111.114 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.33 -34.66 78.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.44 110.415 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.6 21.19 32.24 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.923 -0.656 . . . . 0.44 113.159 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.414 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 2.6 mp0 -140.21 92.08 9.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.972 0.415 . . . . 0.44 111.3 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -43.73 131.84 7.71 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.804 2.336 . . . . 0.44 112.374 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.0 177.04 19.42 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.511 -0.852 . . . . 0.44 112.858 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -145.2 157.25 44.12 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.298 -0.26 . . . . 0.44 110.298 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.19 106.61 3.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.851 0.357 . . . . 0.44 110.216 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.407 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -119.97 163.21 17.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.44 110.948 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.7 t -77.72 114.83 16.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.786 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.424 ' HG ' HG21 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -80.08 -19.96 46.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.44 111.255 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.9 p -52.97 -20.53 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.384 -0.371 . . . . 0.44 111.538 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.06 44.27 1.25 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.531 -0.842 . . . . 0.44 112.85 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 111' ' ' ASN . 8.5 tt -62.64 150.13 41.64 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.061 -0.348 . . . . 0.44 110.061 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.405 ' N ' HD22 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -122.49 130.52 53.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.838 0.681 . . . . 0.44 112.838 -178.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.16 61.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.318 -0.856 . . . . 0.44 110.402 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.6 -49.26 13.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.239 -0.437 . . . . 0.44 111.749 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -37.43 84.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.786 0.327 . . . . 0.44 111.001 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.565 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -80.77 173.98 6.87 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.256 -0.429 . . . . 0.44 110.146 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.8 Cg_endo -71.23 127.74 13.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.071 1.847 . . . . 0.44 111.659 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.38 -14.97 45.44 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.512 2.141 . . . . 0.44 113.18 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.55 58.65 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.049 0.388 . . . . 0.44 112.049 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -120.23 31.57 6.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.456 -0.338 . . . . 0.44 111.274 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -75.28 -45.07 4.58 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.448 0.536 . . . . 0.44 112.448 -179.073 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 85.9 Cg_exo -44.74 -36.27 10.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.242 1.961 . . . . 0.44 112.619 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.448 HG13 ' CG ' ' A' ' 84' ' ' PHE . 5.3 t -77.42 -44.6 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.047 0.451 . . . . 0.44 110.113 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.549 HG13 ' CE2' ' A' ' 115' ' ' PHE . 8.0 mm -68.27 -31.67 52.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 115.693 -0.685 . . . . 0.44 110.919 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.58 -27.59 40.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.44 110.133 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -49.5 11.67 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.842 -0.617 . . . . 0.44 111.634 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.479 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 6.8 tp -78.09 -30.75 49.76 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.895 0.378 . . . . 0.44 111.609 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 123' ' ' ILE . 14.3 ttpt -53.91 -42.62 68.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.102 -0.499 . . . . 0.44 110.949 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -70.5 -7.69 45.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.673 -0.694 . . . . 0.44 109.831 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.334 -0.105 0 CA-C-N 116.023 -0.535 . . . . 0.44 111.298 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.79 0.329 . . . . 0.44 110.91 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -140.01 129.15 23.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.44 110.866 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.1 pp -146.16 119.84 9.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.44 110.613 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 6.6 mt-30 -101.89 157.45 16.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.096 0.474 . . . . 0.44 112.022 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.463 HG22 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -142.96 138.99 27.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.512 -0.767 . . . . 0.44 110.46 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.707 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.97 125.68 44.29 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.393 -0.367 . . . . 0.44 110.469 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.468 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -135.81 156.02 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.169 0.509 . . . . 0.44 111.573 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -151.37 126.08 2.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.489 -0.778 . . . . 0.44 111.799 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.518 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.87 110.63 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.653 -0.499 . . . . 0.44 109.653 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.457 HG23 ' CE3' ' A' ' 90' ' ' TRP . 1.2 mt -71.43 120.27 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.96 0.41 . . . . 0.44 111.4 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -83.15 124.42 30.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.776 -0.647 . . . . 0.44 111.512 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.481 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 4.8 t-20 -70.33 -172.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.979 0.895 . . . . 0.44 112.587 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -64.15 -12.0 35.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.781 -1.554 . . . . 0.44 113.079 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -129.05 -82.26 0.57 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.815 -0.354 . . . . 0.44 111.669 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -153.81 14.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.464 -0.335 . . . . 0.44 111.543 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -100.98 160.32 14.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.228 -0.656 . . . . 0.44 109.228 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.417 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 11.3 mt -135.94 142.18 39.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.007 0.432 . . . . 0.44 111.501 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.441 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -93.02 129.46 38.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.827 -0.624 . . . . 0.44 110.992 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 ' HB ' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.83 140.88 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.44 109.957 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.438 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 6.4 p -71.55 111.8 7.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.807 0.336 . . . . 0.44 111.089 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.399 . . . . 0.44 111.073 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.161 0 N-CA-C 111.681 0.252 . . . . 0.44 111.681 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -114.28 26.21 10.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.994 0.426 . . . . 0.44 111.339 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -45.7 100.3 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.44 110.485 179.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.9 -174.18 2.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.245 0.545 . . . . 0.44 112.226 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.77 168.33 10.46 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.41 -0.814 . . . . 0.44 111.336 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.407 ' HA ' ' CD ' ' A' ' 98' ' ' GLU . 89.2 Cg_endo -75.41 168.8 23.79 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.6 2.867 . . . . 0.44 112.102 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.707 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.9 59.63 0.73 Allowed Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.19 -1.005 . . . . 0.44 114.213 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -121.42 138.82 12.69 Favored Glycine 0 C--N 1.315 -0.586 0 CA-C-N 114.614 -0.793 . . . . 0.44 112.206 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.62 -4.79 0.13 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.082 0.553 . . . . 0.44 111.901 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.497 HD11 ' HB ' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -43.89 -47.56 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.421 0.629 . . . . 0.44 111.099 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -30.95 -77.57 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.468 -1.242 . . . . 0.44 111.813 -179.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.5 mtp 39.42 -93.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.444 -0.344 . . . . 0.44 111.83 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.63 22.92 0.08 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.546 -0.835 . . . . 0.44 113.49 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.476 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.68 -158.21 0.11 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.339 0.114 . . . . 0.44 110.876 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.51 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -106.02 153.06 40.43 Favored Pre-proline 0 N--CA 1.455 -0.196 0 N-CA-C 110.226 -0.287 . . . . 0.44 110.226 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.51 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.99 -24.76 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.624 2.216 . . . . 0.44 112.373 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -101.61 -47.3 4.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.428 -0.351 . . . . 0.44 111.924 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -80.66 -5.2 56.62 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.799 0.296 . . . . 0.44 111.799 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 44' ' ' GLU . . . -64.82 -57.46 8.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.573 0.225 . . . . 0.44 110.719 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.497 ' HB ' HD11 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -79.17 -45.55 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.94 -0.304 . . . . 0.44 111.135 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.8 t -50.58 -38.45 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 0.44 111.146 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -78.64 -51.97 9.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.341 -0.39 . . . . 0.44 111.004 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.423 ' CG ' ' OE2' ' A' ' 57' ' ' GLU . 1.3 tp10 -63.68 -23.9 67.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.44 111.005 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 3.2 tp -53.95 -44.33 70.62 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.886 0.374 . . . . 0.44 110.054 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -60.81 -32.72 72.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.147 -0.686 . . . . 0.44 109.147 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -77.4 -23.95 50.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.375 -0.829 . . . . 0.44 110.733 179.024 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.423 ' OE2' ' CG ' ' A' ' 53' ' ' GLU . 5.7 mp0 -108.15 5.36 25.81 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.892 0.331 . . . . 0.44 111.892 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.511 ' CG1' HG13 ' A' ' 60' ' ' ILE . 25.3 t -134.63 -44.43 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.44 109.935 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.58 -40.17 0.23 Allowed Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.46 -0.791 . . . . 0.44 113.787 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.511 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.72 -177.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.06 0.457 . . . . 0.44 111.059 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.05 88.41 14.64 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 115.615 -0.721 . . . . 0.44 109.942 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.57 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.6 Cg_endo -111.1 148.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.446 2.764 . . . . 0.44 113.848 -177.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -74.67 79.73 2.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.738 -1.949 . . . . 0.44 105.738 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.608 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -122.72 126.96 48.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.495 -1.229 . . . . 0.44 110.885 -176.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.2 t80 -179.62 167.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.44 111.676 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.5 t 79.54 177.4 0.12 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.973 -0.558 . . . . 0.44 111.395 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.833 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -135.61 130.78 34.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.068 -0.515 . . . . 0.44 111.458 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.3 OUTLIER -76.86 -41.6 43.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.218 0.533 . . . . 0.44 109.696 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.687 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.9 mt-10 -171.39 131.35 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.371 -0.831 . . . . 0.44 109.786 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 132.16 56.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.836 0.351 . . . . 0.44 111.554 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.421 HD23 ' CE1' ' A' ' 73' ' ' TYR . 14.7 tp -112.04 132.81 54.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.44 110.472 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -123.9 110.96 15.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.328 -0.396 . . . . 0.44 110.817 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.421 ' CE1' HD23 ' A' ' 71' ' ' LEU . 2.0 p90 -141.01 153.07 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.44 110.764 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' OE1' ' CE1' ' A' ' 79' ' ' HIS . 8.0 pt-20 -116.27 138.35 51.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.185 0.516 . . . . 0.44 111.289 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -93.21 163.22 25.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.4 -0.818 . . . . 0.44 110.339 179.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -52.49 82.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.935 2.423 . . . . 0.44 112.168 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.5 t0 88.74 13.29 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.463 -0.789 . . . . 0.44 111.355 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -137.36 96.18 3.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.548 -0.296 . . . . 0.44 110.759 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.403 ' CE1' ' OE1' ' A' ' 74' ' ' GLU . 2.4 t60 -80.38 117.66 21.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.599 -0.273 . . . . 0.44 110.582 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 7.9 pt -125.32 128.31 72.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.172 0.51 . . . . 0.44 111.931 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -98.32 118.58 35.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.557 -0.747 . . . . 0.44 109.815 179.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.412 HD22 ' CE1' ' A' ' 84' ' ' PHE . 1.1 mt -101.57 113.61 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.908 0.385 . . . . 0.44 111.416 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 10.0 m0 -116.25 122.6 45.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.849 -0.614 . . . . 0.44 110.741 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.687 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.2 m-85 -110.84 111.36 22.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.981 -0.554 . . . . 0.44 109.924 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.833 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 24.4 m95 -94.29 136.55 34.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.983 0.42 . . . . 0.44 111.376 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 55.2 tp -88.37 102.93 15.35 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 116.01 -0.541 . . . . 0.44 111.232 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 64' ' ' HIS . 37.0 t -83.08 145.52 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-N 115.754 -0.657 . . . . 0.44 111.122 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -110.24 -25.73 9.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.811 1.041 . . . . 0.44 113.811 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.81 163.33 26.64 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.706 0.684 . . . . 0.44 111.408 -179.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.57 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -157.27 120.69 4.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.967 0.413 . . . . 0.44 111.324 178.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -77.5 153.47 33.42 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.979 -0.555 . . . . 0.44 111.067 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.46 -121.04 21.15 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.811 -0.709 . . . . 0.44 112.528 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.2 tt0 -134.96 147.6 63.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.547 0.213 . . . . 0.44 110.752 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.474 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.57 128.76 10.47 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.859 2.373 . . . . 0.44 111.241 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.551 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 57.7 p-90 -137.42 -60.24 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.354 -0.539 . . . . 0.44 112.161 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.496 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 53.93 -97.64 0.03 OUTLIER Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.578 -0.82 . . . . 0.44 112.688 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 178.06 22.94 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.32 0.489 . . . . 0.44 112.32 -179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.416 ' OE2' ' N ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -67.96 -32.9 73.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.934 0.397 . . . . 0.44 110.682 179.52 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.61 35.12 29.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.82 -0.705 . . . . 0.44 112.779 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.438 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 66.0 mt-30 -140.11 91.9 9.88 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.022 0.439 . . . . 0.44 111.178 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -43.69 137.38 6.27 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.025 2.483 . . . . 0.44 112.758 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.22 177.01 19.48 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.75 . . . . 0.44 112.596 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.8 157.0 44.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.576 0.227 . . . . 0.44 110.641 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -78.15 107.18 10.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.95 0.405 . . . . 0.44 110.509 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.4 ptm -119.61 163.23 17.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.032 -0.531 . . . . 0.44 110.908 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p -77.98 114.97 17.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.44 110.661 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.404 ' CB ' HD13 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -73.54 -28.14 61.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.44 111.02 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 p -53.01 -22.7 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.266 -0.424 . . . . 0.44 111.315 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.3 42.69 1.59 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.724 -0.75 . . . . 0.44 112.337 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.9 tp -62.66 147.22 50.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.351 -0.24 . . . . 0.44 110.351 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.11 132.1 53.95 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.454 0.538 . . . . 0.44 112.454 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.591 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.35 -15.2 61.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.399 -0.819 . . . . 0.44 110.498 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.67 -49.31 13.38 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.395 -0.366 . . . . 0.44 111.574 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -32.88 74.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.835 0.35 . . . . 0.44 111.086 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -87.97 173.14 6.73 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.176 -0.466 . . . . 0.44 110.408 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.497 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.2 Cg_endo -72.19 127.72 13.05 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.122 1.881 . . . . 0.44 111.701 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.44 -14.96 45.51 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.568 2.179 . . . . 0.44 113.125 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.49 58.57 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.037 0.384 . . . . 0.44 112.037 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.35 32.17 6.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.729 0.3 . . . . 0.44 111.278 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -75.93 -36.1 1.86 Allowed Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.876 0.695 . . . . 0.44 112.876 -179.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 71.4 Cg_exo -49.56 -43.19 40.21 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 121.971 1.78 . . . . 0.44 112.918 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.448 HG23 ' CE1' ' A' ' 84' ' ' PHE . 1.8 t -77.36 -51.25 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.105 0.479 . . . . 0.44 111.099 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.498 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.1 mm -63.65 -32.58 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.714 -0.676 . . . . 0.44 111.273 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.9 -31.26 59.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.038 0.447 . . . . 0.44 110.477 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -72.78 -52.54 14.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.44 111.617 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.432 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 1.8 tp -78.19 -33.01 50.34 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.771 0.286 . . . . 0.44 111.771 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -53.73 -42.61 68.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.44 111.067 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -67.85 -9.46 44.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 0.44 109.792 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--N 1.333 -0.112 0 CA-C-N 116.016 -0.538 . . . . 0.44 110.888 179.816 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.807 0.337 . . . . 0.44 110.933 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.99 126.54 20.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.44 110.901 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.4 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -133.51 140.33 47.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.469 . . . . 0.44 110.771 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -106.61 150.43 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.279 0.561 . . . . 0.44 111.915 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -140.7 139.09 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.329 -0.851 . . . . 0.44 110.41 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.659 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.47 140.63 52.77 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 110.134 -0.321 . . . . 0.44 110.134 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.437 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -144.56 151.24 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.242 0.544 . . . . 0.44 111.327 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.56 130.67 3.21 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.423 -0.808 . . . . 0.44 112.17 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.462 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -88.43 108.0 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.402 -0.592 . . . . 0.44 109.402 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.517 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.1 mt -71.28 124.99 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.133 0.492 . . . . 0.44 111.479 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -87.06 127.12 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.495 -0.775 . . . . 0.44 110.969 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.465 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 14.8 t30 -81.95 -172.29 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.858 0.837 . . . . 0.44 112.012 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.407 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -81.82 3.59 25.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.227 -1.351 . . . . 0.44 112.261 -179.225 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -139.2 51.88 1.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 0.44 111.425 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.7 p30 45.3 26.29 0.26 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.158 -0.474 . . . . 0.44 111.421 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 8.1 pt-20 -118.81 144.08 46.55 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.157 -0.683 . . . . 0.44 109.157 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' A' ' 105' ' ' MET . 10.1 mt -114.22 142.86 25.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.162 0.506 . . . . 0.44 111.459 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -95.92 128.4 42.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.503 -0.771 . . . . 0.44 110.671 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.65 162.14 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.44 110.489 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.423 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 38.2 p -91.99 111.97 23.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.404 -0.362 . . . . 0.44 110.755 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.488 -0.324 . . . . 0.44 110.219 179.812 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.575 0.226 . . . . 0.44 111.517 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 26.26 10.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.859 0.362 . . . . 0.44 111.532 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -48.61 95.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.944 -0.571 . . . . 0.44 110.508 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.7 tt0 -113.11 -179.14 3.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.196 0.522 . . . . 0.44 111.64 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.95 162.05 35.21 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.721 -0.672 . . . . 0.44 111.517 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.29 168.76 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.569 2.846 . . . . 0.44 111.526 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.04 59.69 0.73 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.757 -1.211 . . . . 0.44 113.86 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -138.3 117.73 1.49 Allowed Glycine 0 C--N 1.313 -0.71 0 CA-C-N 114.548 -0.826 . . . . 0.44 111.91 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.82 -6.9 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.307 0.643 . . . . 0.44 111.215 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.51 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -43.62 -62.65 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.258 0.551 . . . . 0.44 111.375 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -16.77 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.5 -1.227 . . . . 0.44 112.425 -179.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.5 mmt 43.14 -94.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.42 -0.354 . . . . 0.44 111.511 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.83 17.82 0.09 OUTLIER Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.505 -0.855 . . . . 0.44 113.598 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.74 -161.66 0.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.532 0.206 . . . . 0.44 110.742 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.66 154.4 39.26 Favored Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 110.158 -0.312 . . . . 0.44 110.158 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.9 Cg_endo -44.0 -24.87 0.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.694 2.263 . . . . 0.44 112.406 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.48 -50.38 4.31 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.341 -0.391 . . . . 0.44 111.985 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -80.45 -4.99 55.86 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.936 0.346 . . . . 0.44 111.936 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -65.49 -57.5 8.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.574 0.226 . . . . 0.44 110.819 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.509 ' HB ' HD11 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -78.68 -43.32 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.838 -0.345 . . . . 0.44 111.029 179.279 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.9 t -50.63 -36.45 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.344 . . . . 0.44 110.721 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.67 -48.47 14.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.143 -0.481 . . . . 0.44 110.747 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -67.03 -20.0 65.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.44 111.03 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 50' ' ' VAL . 3.3 tp -57.47 -44.82 85.18 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.44 110.477 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -32.28 73.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.207 -0.664 . . . . 0.44 109.207 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 97' ' ' LYS . 5.7 tm-20 -77.37 -25.48 51.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.339 -0.846 . . . . 0.44 110.92 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -108.15 5.36 25.81 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.956 0.354 . . . . 0.44 111.956 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.556 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 30.0 t -134.33 -44.31 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.139 0.495 . . . . 0.44 109.94 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.57 -41.62 0.31 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.463 -0.789 . . . . 0.44 113.715 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.501 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.64 -177.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 120.975 0.417 . . . . 0.44 111.107 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.36 88.41 15.46 Favored Pre-proline 0 N--CA 1.441 -0.897 0 CA-C-N 115.694 -0.685 . . . . 0.44 109.969 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.503 ' HB3' ' HB2' ' A' ' 90' ' ' TRP . 9.1 Cg_endo -109.69 150.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.393 2.729 . . . . 0.44 113.659 -177.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.639 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -77.02 80.72 3.55 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 105.112 -2.181 . . . . 0.44 105.112 175.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.564 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.65 128.0 50.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.029 -1.441 . . . . 0.44 110.298 -176.054 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.5 t80 -179.35 168.54 1.48 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.593 -0.443 . . . . 0.44 112.106 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.411 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 0.3 OUTLIER 77.26 -166.93 0.05 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.926 -0.579 . . . . 0.44 111.453 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -151.8 133.42 14.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.04 -0.527 . . . . 0.44 111.056 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 69' ' ' GLU . 15.7 p90 -76.7 -41.78 43.98 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.469 -0.567 . . . . 0.44 109.469 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.3 mt-10 -171.6 131.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.271 -0.877 . . . . 0.44 109.083 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.7 132.42 42.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.759 0.314 . . . . 0.44 111.643 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.405 ' CD2' ' CG2' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -112.31 156.52 22.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.302 -0.408 . . . . 0.44 110.791 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -137.12 110.0 7.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.44 110.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -128.84 153.12 47.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.44 110.757 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -121.05 119.4 32.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.44 111.212 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -73.97 163.07 71.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.693 -0.685 . . . . 0.44 110.52 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.4 Cg_endo -53.79 82.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.92 2.413 . . . . 0.44 112.087 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.9 t70 91.86 11.08 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.381 -0.827 . . . . 0.44 111.373 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -137.29 93.81 2.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 0.44 110.846 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.21 103.11 6.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.402 -0.363 . . . . 0.44 110.821 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 tt -106.17 111.75 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.44 111.015 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.411 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -94.36 118.47 31.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.44 109.77 179.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.4 mt -107.35 114.03 27.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.44 111.612 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CZ3' ' O ' ' A' ' 46' ' ' PRO . 11.2 m0 -108.62 122.47 47.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.935 -0.575 . . . . 0.44 110.139 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 6.3 m-85 -112.67 112.25 23.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.233 -0.44 . . . . 0.44 110.4 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.67 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 30.1 m95 -94.75 148.21 22.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.44 111.57 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 65' ' ' PHE . 47.2 tp -100.76 102.96 14.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.057 0.456 . . . . 0.44 110.809 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 64' ' ' HIS . 33.4 t -84.81 145.35 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.878 -0.601 . . . . 0.44 111.733 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 3.9 mt-10 -106.36 -33.47 7.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.851 1.056 . . . . 0.44 113.851 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.08 165.4 24.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.927 0.785 . . . . 0.44 111.813 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 62' ' ' PRO . 1.2 p90 -151.56 127.52 10.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.382 . . . . 0.44 111.53 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -76.89 147.76 36.84 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.082 -0.508 . . . . 0.44 110.869 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.11 -121.2 25.93 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.44 112.438 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -133.99 148.09 66.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.631 0.253 . . . . 0.44 110.82 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.501 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.65 128.71 10.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.948 2.432 . . . . 0.44 111.566 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.526 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 62.1 p-90 -136.16 -58.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.486 -0.486 . . . . 0.44 111.716 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.1 -95.72 0.01 OUTLIER Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.872 -0.68 . . . . 0.44 113.01 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' GLU . 2.8 tttp 174.25 37.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.44 110.938 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -66.94 -30.63 70.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.391 -0.368 . . . . 0.44 110.512 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 10.3 79.39 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.924 -0.655 . . . . 0.44 113.391 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.423 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 4.7 mt-30 -140.24 91.88 9.73 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.44 111.356 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -43.72 138.48 5.74 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 123.054 2.503 . . . . 0.44 112.643 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.07 19.43 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.752 -0.737 . . . . 0.44 112.747 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -136.4 157.17 47.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.567 0.222 . . . . 0.44 110.577 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -72.98 107.16 5.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.88 0.372 . . . . 0.44 110.278 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.455 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -119.63 163.04 17.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.44 111.053 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.97 114.85 18.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.234 -0.439 . . . . 0.44 110.92 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.27 -18.73 61.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.44 111.087 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -62.52 -10.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.296 -0.411 . . . . 0.44 111.446 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.25 50.48 0.89 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.942 -0.646 . . . . 0.44 111.63 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -62.09 138.86 58.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.678 0.275 . . . . 0.44 110.538 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.425 ' N ' HD11 ' A' ' 110' ' ' LEU . 1.1 m-80 -116.87 121.75 42.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.169 0.509 . . . . 0.44 111.885 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.642 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.1 -15.13 62.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.634 -0.712 . . . . 0.44 110.977 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -78.33 -49.46 13.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.924 0.342 . . . . 0.44 111.924 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -70.64 -22.54 62.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.546 0.212 . . . . 0.44 111.367 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.642 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -100.35 170.81 6.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 110.371 -0.233 . . . . 0.44 110.371 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.5 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 43.7 Cg_endo -68.09 127.67 16.34 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.234 1.956 . . . . 0.44 111.898 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.38 -19.65 61.54 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.577 2.184 . . . . 0.44 113.001 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.93 -9.37 58.25 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.008 0.373 . . . . 0.44 112.008 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.72 29.54 7.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.779 0.323 . . . . 0.44 111.408 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.3 mt-10 -76.24 -31.87 1.03 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.845 0.683 . . . . 0.44 112.845 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.3 Cg_exo -48.52 -45.44 27.14 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 121.869 1.712 . . . . 0.44 113.04 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.429 HG11 ' CD2' ' A' ' 84' ' ' PHE . 1.4 t -77.41 -51.4 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.07 0.462 . . . . 0.44 111.205 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.471 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -62.42 -36.89 77.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.44 111.612 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.62 -29.77 52.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.905 0.384 . . . . 0.44 110.852 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -79.74 -48.47 13.58 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.126 -0.488 . . . . 0.44 111.593 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.42 HD12 ' CD1' ' A' ' 68' ' ' PHE . 3.4 tp -78.09 -46.6 20.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.852 0.358 . . . . 0.44 111.269 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.461 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 8.2 ttpp -51.95 -42.24 62.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.44 110.879 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -63.96 -7.08 7.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.63 . . . . 0.44 110.142 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 C--O 1.231 0.119 0 CA-C-N 116.143 -0.481 . . . . 0.44 110.881 179.821 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.806 0.336 . . . . 0.44 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.415 ' HG2' ' CG ' ' A' ' 79' ' ' HIS . 23.1 mtpt -140.0 135.02 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.44 110.918 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.04 141.08 27.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.44 110.768 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -106.16 149.9 26.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.405 0.622 . . . . 0.44 112.316 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -146.31 116.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.029 -0.987 . . . . 0.44 109.611 178.667 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.98 135.81 53.15 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 121.019 -0.272 . . . . 0.44 110.352 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.552 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 0.9 OUTLIER -144.54 163.1 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.98 0.419 . . . . 0.44 111.19 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.25 130.35 4.41 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.726 -0.75 . . . . 0.44 112.091 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.483 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.0 108.45 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.799 -0.445 . . . . 0.44 109.799 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.495 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.5 mt -70.97 125.98 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.466 -0.334 . . . . 0.44 111.623 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.519 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -87.7 127.25 35.3 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.894 -0.593 . . . . 0.44 111.62 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.536 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 6.1 t-20 -69.93 -172.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.793 -1.094 . . . . 0.44 112.458 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.04 -10.7 31.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.77 -1.559 . . . . 0.44 112.895 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -133.82 -82.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.838 -0.345 . . . . 0.44 111.785 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -149.97 16.21 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 0.44 111.613 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -100.61 160.56 14.25 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.648 -0.871 . . . . 0.44 108.648 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.519 HG13 ' HA ' ' A' ' 12' ' ' ARG . 1.8 mp -130.64 138.14 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.094 0.473 . . . . 0.44 111.482 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.447 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.5 OUTLIER -85.96 116.02 23.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.695 -0.684 . . . . 0.44 110.332 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.505 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.05 120.11 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.385 -0.37 . . . . 0.44 110.745 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -70.73 115.97 10.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.458 . . . . 0.44 110.575 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.43 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 19.6 ptt-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.44 110.88 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.744 0.307 . . . . 0.44 111.144 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -114.22 26.2 10.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.018 0.437 . . . . 0.44 111.191 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -45.47 114.12 0.7 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.672 -0.695 . . . . 0.44 110.619 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' ' CD ' ' A' ' 116' ' ' PRO . 0.5 OUTLIER -124.85 -171.66 2.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.195 0.521 . . . . 0.44 112.094 -179.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.538 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.55 168.59 9.79 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.507 -0.769 . . . . 0.44 111.146 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.552 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 87.5 Cg_endo -81.74 167.29 16.79 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.628 2.885 . . . . 0.44 113.799 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.39 -5.44 52.05 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.371 -0.831 . . . . 0.44 114.988 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -59.25 171.68 4.97 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.5 0.65 . . . . 0.44 113.214 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 76.58 7.03 3.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.517 0.327 . . . . 0.44 111.811 179.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.624 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.3 pt -55.44 -26.84 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.673 0.749 . . . . 0.44 110.032 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.532 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -42.98 -60.17 1.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.323 -1.308 . . . . 0.44 110.692 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER 5.37 -79.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.404 -0.816 . . . . 0.44 112.471 179.283 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.54 33.63 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.897 -0.668 . . . . 0.44 112.643 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.4 mp0 -88.95 -174.82 4.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.821 0.343 . . . . 0.44 111.09 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.518 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.5 154.14 38.09 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.279 -0.418 . . . . 0.44 110.322 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.518 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.97 -25.25 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.872 2.381 . . . . 0.44 112.448 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -104.02 -40.4 6.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.491 -0.322 . . . . 0.44 111.405 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.402 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 34.4 mt-30 -80.29 -4.91 55.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.645 -0.252 . . . . 0.44 111.654 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.438 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -60.89 -57.11 14.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.409 . . . . 0.44 110.667 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.489 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 2.5 m -78.64 -45.99 25.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.44 111.48 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.489 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 29.0 t -56.33 -36.66 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.319 -0.401 . . . . 0.44 111.141 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -77.95 -49.78 13.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.983 0.42 . . . . 0.44 110.193 179.428 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.48 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.5 mm-40 -65.56 -19.89 66.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.004 -0.543 . . . . 0.44 110.334 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.477 ' CD1' ' CD2' ' A' ' 64' ' ' HIS . 8.6 tp -56.55 -44.49 80.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 0.44 110.527 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -31.81 69.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 0.44 110.075 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.45 -31.09 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.599 -0.728 . . . . 0.44 111.572 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.433 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 4.0 mp0 -108.06 5.37 25.99 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.453 0.538 . . . . 0.44 112.453 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.566 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 16.0 t -134.39 -43.96 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.104 0.478 . . . . 0.44 110.067 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.86 -38.32 0.29 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.614 -0.721 . . . . 0.44 114.207 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.535 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -77.71 -178.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 110.529 -0.174 . . . . 0.44 110.529 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.64 88.98 6.97 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 110.023 -0.362 . . . . 0.44 110.023 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.575 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 10.6 Cg_endo -108.28 144.07 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.475 2.783 . . . . 0.44 113.987 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -74.81 79.44 2.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.802 -1.925 . . . . 0.44 105.802 176.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.608 ' HA ' HG12 ' A' ' 87' ' ' VAL . 1.1 t-80 -123.23 122.36 38.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.65 -1.613 . . . . 0.44 109.895 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 6.5 t80 -179.41 161.07 1.04 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.456 -0.498 . . . . 0.44 112.177 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 9.3 t 77.01 166.93 0.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.701 -0.682 . . . . 0.44 110.783 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.777 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -119.54 130.08 54.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.922 0.341 . . . . 0.44 111.922 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 69' ' ' GLU . 7.1 p90 -78.2 -41.33 34.84 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.762 -0.459 . . . . 0.44 109.762 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.584 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -171.31 131.75 0.77 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.627 -0.715 . . . . 0.44 109.328 178.037 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -139.39 132.75 30.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.787 0.327 . . . . 0.44 111.483 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.451 ' CD1' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -123.43 151.38 42.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.952 0.406 . . . . 0.44 110.996 179.455 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -121.59 133.91 55.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.44 110.757 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.406 ' CE2' HG22 ' A' ' 80' ' ' ILE . 2.5 p90 -141.03 145.81 36.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.44 110.568 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.08 126.35 49.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.095 0.474 . . . . 0.44 111.365 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.453 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -86.4 163.1 43.51 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.533 -0.758 . . . . 0.44 110.319 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.6 Cg_endo -53.97 82.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.825 2.35 . . . . 0.44 112.166 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.7 t70 93.25 9.67 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.36 -0.836 . . . . 0.44 111.52 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 -137.34 93.78 2.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.299 . . . . 0.44 110.759 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.415 ' CG ' ' HG2' ' A' ' 3' ' ' LYS . 1.1 m-70 -82.3 102.28 11.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.379 -0.373 . . . . 0.44 110.921 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.406 HG22 ' CE2' ' A' ' 73' ' ' TYR . 2.0 tt -106.32 111.73 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.273 -0.421 . . . . 0.44 111.025 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.408 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -92.54 118.45 31.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.44 110.015 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.409 HD21 HD11 ' A' ' 71' ' ' LEU . 14.8 tp -108.0 114.09 27.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.44 111.577 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -112.22 122.2 47.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.44 110.46 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 5.8 m-30 -109.84 109.63 20.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.956 -0.565 . . . . 0.44 109.911 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.777 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 32.5 m95 -95.79 148.65 22.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.868 -0.605 . . . . 0.44 112.622 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.0 pp -87.29 138.12 31.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.661 -0.699 . . . . 0.44 110.433 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 64' ' ' HIS . 17.5 t -123.65 145.52 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-N 116.251 -0.431 . . . . 0.44 111.018 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.87 -30.68 8.01 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.46 1.282 . . . . 0.44 114.46 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.28 165.01 24.71 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.221 0.919 . . . . 0.44 112.111 -178.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.558 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -154.64 130.15 9.86 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.085 -0.507 . . . . 0.44 111.133 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.23 132.71 47.62 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.21 -0.45 . . . . 0.44 111.055 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 48.79 -105.23 0.12 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.704 -0.76 . . . . 0.44 112.416 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 26.5 tt0 -134.32 137.65 28.46 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.812 -0.194 . . . . 0.44 110.759 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 4.7 Cg_exo -74.13 128.9 12.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.596 2.197 . . . . 0.44 110.682 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.563 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 21.5 p-90 -118.15 -63.95 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.545 0.572 . . . . 0.44 112.545 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.566 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.43 -100.16 0.02 OUTLIER Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.822 -0.626 . . . . 0.44 112.853 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER 160.56 74.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.584 0.354 . . . . 0.44 110.774 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HG2' ' CG2' ' A' ' 21' ' ' THR . 0.9 OUTLIER -88.6 -33.2 17.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.501 -0.318 . . . . 0.44 110.803 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 142.44 -38.5 1.45 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.506 -0.854 . . . . 0.44 113.323 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.01 110.76 7.22 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.018 0.437 . . . . 0.44 111.885 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -43.84 146.39 1.58 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.121 2.547 . . . . 0.44 112.55 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.19 177.29 17.48 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.678 -0.773 . . . . 0.44 113.001 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -128.85 157.23 42.11 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.414 -0.217 . . . . 0.44 110.414 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -77.99 106.83 10.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.917 0.389 . . . . 0.44 110.556 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.4 ptp -119.99 163.08 18.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.44 110.924 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 95.8 p -75.04 114.98 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.452 -0.34 . . . . 0.44 110.859 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -78.97 -18.92 52.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.44 111.306 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.0 t -54.28 -18.52 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.437 -0.347 . . . . 0.44 111.424 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.39 55.1 0.57 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.838 -0.696 . . . . 0.44 112.268 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 tt -62.15 150.43 38.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.269 -0.271 . . . . 0.44 110.269 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -107.87 126.01 52.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.334 0.588 . . . . 0.44 112.428 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.636 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -15.2 61.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.207 -0.906 . . . . 0.44 110.791 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -78.11 -49.14 14.46 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.429 -0.351 . . . . 0.44 111.654 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -26.33 65.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.79 0.329 . . . . 0.44 110.8 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.636 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -98.36 166.96 12.33 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.17 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.6 Cg_endo -72.61 127.81 12.81 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.393 2.062 . . . . 0.44 111.937 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.54 -14.92 42.55 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.595 2.197 . . . . 0.44 113.05 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.69 -9.51 57.3 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.995 0.368 . . . . 0.44 111.995 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.72 31.17 6.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.827 0.346 . . . . 0.44 111.277 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.2 -34.13 1.37 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 113.021 0.749 . . . . 0.44 113.021 -179.162 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 93.1 Cg_exo -44.73 -46.28 12.69 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.21 1.94 . . . . 0.44 113.193 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.481 HG11 ' CE1' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -77.14 -33.98 20.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.029 0.442 . . . . 0.44 110.048 179.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.567 HG13 ' CE2' ' A' ' 115' ' ' PHE . 7.8 mm -68.18 -39.79 81.77 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.658 -0.701 . . . . 0.44 110.839 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.55 -29.44 50.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.436 . . . . 0.44 110.371 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -80.27 -53.21 6.86 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.888 -0.597 . . . . 0.44 111.782 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 1.7 tp -78.3 -19.79 52.84 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.142 0.423 . . . . 0.44 112.142 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 54.6 tttm -78.21 -42.71 30.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.081 0.467 . . . . 0.44 110.745 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -69.65 -7.03 35.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.593 -0.731 . . . . 0.44 109.905 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.421 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.123 0 CA-C-N 116.16 -0.473 . . . . 0.44 110.683 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.4 tttt . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.831 0.348 . . . . 0.44 110.887 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -128.62 134.72 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.44 110.912 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.13 143.03 38.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.44 110.969 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 30.9 mt-30 -102.61 153.1 20.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.335 0.588 . . . . 0.44 112.02 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.9 mp -146.2 127.93 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.108 -0.951 . . . . 0.44 109.743 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.602 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.58 124.56 42.5 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 110.163 -0.31 . . . . 0.44 110.163 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.543 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 2.0 m -116.53 162.23 14.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.345 0.593 . . . . 0.44 111.912 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.25 109.57 0.56 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.207 -0.906 . . . . 0.44 111.848 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -70.53 98.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.926 -0.398 . . . . 0.44 109.926 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.455 HG22 ' CE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.14 123.72 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 121.21 0.529 . . . . 0.44 112.121 -178.352 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -96.23 127.19 42.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.431 -0.804 . . . . 0.44 111.363 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.536 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -79.58 -172.63 3.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.268 -0.878 . . . . 0.44 112.113 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.502 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 14.9 tp10 -80.48 -2.72 47.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.265 -1.334 . . . . 0.44 112.299 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -134.16 49.61 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.879 0.371 . . . . 0.44 111.229 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 48.04 22.62 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.44 111.448 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 18.4 pt-20 -110.44 141.08 44.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.875 -0.787 . . . . 0.44 108.875 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.53 HG22 HG13 ' A' ' 10' ' ' ILE . 2.6 mt -110.82 151.44 12.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.284 0.564 . . . . 0.44 112.296 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -101.01 99.96 10.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.206 -0.906 . . . . 0.44 109.517 178.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.81 120.1 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.44 110.569 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.43 ' O ' ' O ' ' A' ' 34' ' ' GLU . 18.2 p -71.08 111.85 6.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.44 110.998 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.419 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 2.5 ptm180 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.403 -0.362 . . . . 0.44 110.451 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.587 0.232 . . . . 0.44 111.468 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 26.26 10.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.44 111.501 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -46.8 120.21 2.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.808 -0.633 . . . . 0.44 110.696 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 21' ' ' THR . 7.8 mt-10 -137.19 -174.11 3.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.045 0.45 . . . . 0.44 111.473 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.461 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.03 161.17 39.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.003 -0.544 . . . . 0.44 111.23 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.65 167.76 1.34 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.374 2.716 . . . . 0.44 111.715 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.61 59.56 0.75 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.068 -1.063 . . . . 0.44 113.768 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -124.96 132.15 8.01 Favored Glycine 0 C--N 1.311 -0.818 0 CA-C-N 114.406 -0.897 . . . . 0.44 111.78 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.41 5.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.936 0.494 . . . . 0.44 112.297 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.568 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.27 -28.11 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.601 0.715 . . . . 0.44 110.279 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.98 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.551 -1.204 . . . . 0.44 110.787 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.5 mmm 31.77 -86.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.52 0.513 . . . . 0.44 111.827 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -158.96 24.38 0.33 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.886 -0.673 . . . . 0.44 112.605 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -102.64 -179.51 3.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.892 0.377 . . . . 0.44 111.051 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.566 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.55 158.52 34.46 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.44 109.929 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.86 -24.7 0.85 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.726 2.284 . . . . 0.44 112.473 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.24 -61.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.182 0.438 . . . . 0.44 112.182 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -80.4 -20.13 44.69 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.175 0.435 . . . . 0.44 112.175 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.4 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . . . -56.87 -48.43 78.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.734 0.302 . . . . 0.44 111.093 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -78.11 -47.29 25.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.29 -0.414 . . . . 0.44 110.549 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 41.7 t -57.4 -38.49 63.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.547 . . . . 0.44 110.624 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -78.44 -46.54 19.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.44 110.989 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -69.79 -21.66 63.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 0.44 111.344 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.481 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -57.39 -44.68 84.71 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.777 0.322 . . . . 0.44 110.565 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -30.9 71.94 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.918 -0.771 . . . . 0.44 108.918 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.1 tm-20 -77.63 -29.05 51.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.058 -0.974 . . . . 0.44 111.104 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.425 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.68 5.85 25.23 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.777 0.658 . . . . 0.44 112.777 -178.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.529 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 21.3 t -134.04 -44.3 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.956 0.408 . . . . 0.44 109.989 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.585 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.68 -41.33 0.31 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.648 -0.705 . . . . 0.44 113.488 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.518 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.55 -176.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.936 0.398 . . . . 0.44 111.07 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -113.06 89.1 13.24 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 115.726 -0.67 . . . . 0.44 110.306 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 7.9 Cg_endo -108.79 148.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 123.205 2.604 . . . . 0.44 114.139 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -74.76 79.8 2.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.937 -1.875 . . . . 0.44 105.937 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.546 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -123.11 125.55 45.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.327 -1.306 . . . . 0.44 110.374 -176.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.6 t80 -177.77 159.12 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.578 -0.449 . . . . 0.44 112.128 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER 84.21 -170.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.81 -0.632 . . . . 0.44 111.298 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.5 pp -145.02 130.58 18.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.154 -0.475 . . . . 0.44 111.056 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 1.3 p90 -76.67 -35.18 58.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.212 0.529 . . . . 0.44 109.678 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.7 OUTLIER -171.2 163.53 7.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.42 -0.809 . . . . 0.44 109.504 179.038 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.53 132.41 22.74 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.762 -0.375 . . . . 0.44 111.684 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.406 HD21 ' CD1' ' A' ' 73' ' ' TYR . 9.0 tp -119.25 142.45 48.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.173 -0.467 . . . . 0.44 110.727 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -140.0 111.02 6.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.44 110.505 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.406 ' CD1' HD21 ' A' ' 71' ' ' LEU . 8.8 p90 -138.67 153.27 48.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.44 110.767 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.06 140.02 52.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.176 0.512 . . . . 0.44 111.214 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -89.2 163.18 35.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.391 -0.822 . . . . 0.44 110.545 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.3 Cg_endo -51.9 83.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.103 2.536 . . . . 0.44 112.036 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 8.1 m-20 93.96 16.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.229 -0.896 . . . . 0.44 111.142 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -137.32 150.13 47.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.44 110.489 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.83 99.72 6.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.763 0.316 . . . . 0.44 110.719 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 tt -104.35 111.75 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 120.956 0.408 . . . . 0.44 110.96 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.88 118.99 38.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.974 -0.557 . . . . 0.44 110.235 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.3 mt -118.86 114.35 22.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.877 0.37 . . . . 0.44 111.615 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.436 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.8 m0 -106.29 122.37 46.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.44 110.142 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.555 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 2.2 m-85 -98.94 110.39 23.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.842 -0.617 . . . . 0.44 110.71 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 31.9 m95 -94.85 148.77 21.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.44 111.822 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.1 tm? -94.17 137.36 33.44 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.805 -0.634 . . . . 0.44 111.356 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 64' ' ' HIS . 41.1 t -124.14 145.01 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-N 116.106 -0.497 . . . . 0.44 110.499 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.59 -27.68 8.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.73 1.011 . . . . 0.44 113.73 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.1 165.2 24.93 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.716 0.689 . . . . 0.44 111.766 -179.26 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -155.72 122.36 5.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.293 178.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.24 145.25 49.72 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.001 -0.545 . . . . 0.44 111.069 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.49 -116.82 6.9 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.867 -0.682 . . . . 0.44 112.582 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.6 tt0 -134.47 145.77 56.53 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.591 0.234 . . . . 0.44 110.819 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.465 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 3.4 Cg_exo -76.5 128.78 10.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.913 2.408 . . . . 0.44 111.135 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.585 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 47.5 p-90 -130.84 -62.54 0.9 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.512 0.56 . . . . 0.44 112.512 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.529 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.37 -97.5 0.01 OUTLIER Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.641 -0.79 . . . . 0.44 112.613 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.6 tptp 178.77 35.49 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.636 0.255 . . . . 0.44 111.389 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.35 -46.21 89.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.44 110.334 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.34 14.91 46.15 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.889 -0.672 . . . . 0.44 113.353 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.416 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 49.9 mt-30 -140.31 92.91 9.18 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.44 111.539 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -43.78 138.42 5.93 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.901 2.401 . . . . 0.44 112.534 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.18 177.13 19.39 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.628 -0.796 . . . . 0.44 112.645 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.07 157.09 45.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.641 0.258 . . . . 0.44 110.785 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.464 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.45 107.13 6.4 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.876 0.37 . . . . 0.44 110.391 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -119.67 163.42 17.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.057 -0.519 . . . . 0.44 110.871 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 p -82.0 114.94 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.394 -0.366 . . . . 0.44 110.851 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -18.79 62.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.288 -0.414 . . . . 0.44 111.112 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.9 p -57.29 -11.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.522 -0.308 . . . . 0.44 111.632 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.2 51.42 0.84 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.747 -0.739 . . . . 0.44 112.157 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.92 134.59 56.87 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.095 -0.335 . . . . 0.44 110.095 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -111.2 121.58 45.66 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.507 0.558 . . . . 0.44 112.507 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.669 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.42 -14.72 61.77 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.355 -0.839 . . . . 0.44 110.801 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -76.41 -49.05 17.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.464 -0.335 . . . . 0.44 111.483 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -27.19 64.47 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.671 -0.24 . . . . 0.44 111.085 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.669 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -93.78 169.8 9.48 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.48 -0.327 . . . . 0.44 110.249 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.524 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 40.3 Cg_endo -67.33 127.58 16.85 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.216 1.944 . . . . 0.44 111.837 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.86 -15.01 47.29 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.588 2.192 . . . . 0.44 113.151 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.3 -9.19 59.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.009 0.374 . . . . 0.44 112.009 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -114.96 28.58 8.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.429 -0.35 . . . . 0.44 111.579 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -69.26 -34.48 4.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 112.947 0.721 . . . . 0.44 112.947 -179.259 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 61.8 Cg_exo -51.82 -45.87 35.7 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 121.962 1.775 . . . . 0.44 113.218 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.448 HG11 ' CD1' ' A' ' 84' ' ' PHE . 2.1 t -77.44 -51.34 18.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.328 . . . . 0.44 111.314 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.505 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -64.95 -29.81 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.44 111.064 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.38 -33.03 63.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.031 0.443 . . . . 0.44 110.257 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -78.3 -47.51 17.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.755 -0.657 . . . . 0.44 111.556 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 2.8 tp -78.17 -19.75 53.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.451 -0.34 . . . . 0.44 111.651 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 123' ' ' ILE . 15.8 ttpp -83.64 -42.39 16.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.131 0.491 . . . . 0.44 110.524 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -63.91 -10.37 20.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.573 -0.739 . . . . 0.44 109.824 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.213 0 CA-C-N 116.183 -0.462 . . . . 0.44 111.006 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 pttt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.893 0.378 . . . . 0.44 110.922 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HG2' ' CG ' ' A' ' 79' ' ' HIS . 7.6 mtmt -132.53 148.98 52.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.44 110.68 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.5 pp -146.07 132.45 19.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.382 -0.372 . . . . 0.44 111.283 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 42.3 mt-30 -102.78 153.6 20.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.353 0.597 . . . . 0.44 111.756 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 81' ' ' THR . 10.4 mm -146.46 130.22 10.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.246 -0.888 . . . . 0.44 110.085 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.603 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.84 124.21 41.61 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.918 -0.401 . . . . 0.44 109.918 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.446 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.6 m -120.01 162.23 18.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.06 0.457 . . . . 0.44 111.564 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.93 109.4 0.48 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.724 -0.751 . . . . 0.44 112.81 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.598 HG13 HG21 ' A' ' 18' ' ' ILE . 1.1 tp -70.47 99.46 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.811 -0.811 . . . . 0.44 108.811 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.554 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -71.2 119.79 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 112.55 0.574 . . . . 0.44 112.55 -177.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -82.54 124.02 29.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.367 -0.833 . . . . 0.44 111.06 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.546 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 19.1 t-20 -69.63 177.6 2.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.999 -1.0 . . . . 0.44 111.851 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.546 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -54.59 -20.08 7.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.289 -1.323 . . . . 0.44 112.261 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -119.54 -82.46 0.64 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.67 0.271 . . . . 0.44 111.408 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.11 14.1 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.869 0.322 . . . . 0.44 111.869 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 17.2 pt-20 -100.89 160.15 14.61 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 109.64 -0.504 . . . . 0.44 109.64 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.598 HG21 HG13 ' A' ' 10' ' ' ILE . 3.4 mt -138.29 140.88 39.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.899 0.381 . . . . 0.44 111.895 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -86.15 113.08 21.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.25 -0.648 . . . . 0.44 109.25 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.495 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.81 119.53 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.517 -0.765 . . . . 0.44 110.168 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.99 111.8 10.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.95 0.405 . . . . 0.44 110.666 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.424 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 2.2 ptt180 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.872 -0.604 . . . . 0.44 110.742 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 111.751 0.278 . . . . 0.44 111.751 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.26 26.23 10.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.083 0.468 . . . . 0.44 111.371 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.424 ' HG ' ' HB3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -47.48 122.22 4.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.723 -0.672 . . . . 0.44 110.705 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -138.41 -167.25 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.005 0.431 . . . . 0.44 111.653 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.505 ' CE1' ' CE2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -119.15 155.2 53.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.837 -0.62 . . . . 0.44 111.499 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 10.2 Cg_endo -52.9 167.67 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.324 2.683 . . . . 0.44 111.341 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.53 59.71 0.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 119.852 -1.166 . . . . 0.44 114.318 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -123.62 136.47 10.38 Favored Glycine 0 C--N 1.31 -0.863 0 CA-C-N 114.919 -0.64 . . . . 0.44 111.971 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.2 ttpt 91.27 4.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.006 0.522 . . . . 0.44 112.305 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.585 HG13 ' N ' ' A' ' 41' ' ' GLU . 1.1 pt -50.51 -29.14 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.639 0.733 . . . . 0.44 110.364 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.585 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.17 -79.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.481 -1.236 . . . . 0.44 110.966 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 37.45 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.445 0.466 . . . . 0.44 111.634 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -161.93 26.14 0.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.957 -0.639 . . . . 0.44 112.691 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.451 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -99.45 -176.51 3.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.863 0.363 . . . . 0.44 111.125 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.606 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.93 162.92 18.66 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.44 110.405 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.606 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 9.3 Cg_endo -49.14 -24.53 8.03 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.639 2.226 . . . . 0.44 112.425 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -98.91 -48.04 5.05 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.144 0.424 . . . . 0.44 112.144 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -77.17 -26.61 53.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.66 0.266 . . . . 0.44 111.615 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.451 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -57.79 -45.31 86.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.799 0.333 . . . . 0.44 110.915 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -78.24 -46.63 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.44 110.516 179.585 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.483 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 46.4 t -60.03 -39.48 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.44 111.077 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -78.23 -45.77 22.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.176 -0.466 . . . . 0.44 110.963 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.68 -22.12 62.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.44 110.912 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 1.2 tp -53.87 -44.59 70.54 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.836 0.35 . . . . 0.44 110.082 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -59.54 -33.68 71.71 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.451 -0.574 . . . . 0.44 109.451 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.41 -26.25 51.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.411 -0.813 . . . . 0.44 110.994 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.426 ' HG2' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -108.02 6.04 26.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.102 0.408 . . . . 0.44 112.102 -178.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.577 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 10.3 t -134.32 -44.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.214 0.53 . . . . 0.44 109.876 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.549 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.44 -43.43 0.57 Allowed Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.476 -0.784 . . . . 0.44 113.866 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.5 OUTLIER -84.36 -175.08 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.079 0.466 . . . . 0.44 111.292 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 p -112.64 89.09 12.32 Favored Pre-proline 0 N--CA 1.442 -0.875 0 CA-C-N 115.629 -0.714 . . . . 0.44 110.554 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.642 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.9 Cg_endo -107.62 152.46 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.96 2.44 . . . . 0.44 114.203 -177.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -74.85 79.9 2.12 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.061 -1.829 . . . . 0.44 106.061 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.595 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.65 126.13 44.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.615 -1.175 . . . . 0.44 110.738 -176.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.9 t80 -179.35 165.66 1.43 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.9 0.381 . . . . 0.44 111.93 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 83.1 160.33 0.13 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.824 -0.626 . . . . 0.44 110.762 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -113.77 131.97 56.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.44 111.363 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -88.61 -33.91 17.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.039 -0.528 . . . . 0.44 110.102 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.1 tt0 -171.56 149.93 2.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.705 -0.679 . . . . 0.44 110.471 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.1 108.16 4.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.74 0.305 . . . . 0.44 110.689 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.85 140.55 51.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.44 110.794 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.14 139.47 35.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.964 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.406 ' O ' HG21 ' A' ' 80' ' ' ILE . 69.9 t80 -141.05 100.98 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.549 . . . . 0.44 110.4 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -64.76 136.88 57.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.159 0.504 . . . . 0.44 111.41 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.468 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -101.54 162.89 19.04 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.603 -0.726 . . . . 0.44 110.434 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.579 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.4 Cg_endo -53.06 81.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.019 2.479 . . . . 0.44 112.353 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 13.3 t70 102.23 -24.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.44 -0.8 . . . . 0.44 111.267 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -109.65 95.19 5.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.712 0.292 . . . . 0.44 111.09 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.416 ' CG ' ' HG2' ' A' ' 3' ' ' LYS . 18.9 m170 -77.85 93.87 4.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 0.44 110.542 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.406 HG21 ' O ' ' A' ' 73' ' ' TYR . 2.4 tt -85.78 131.8 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.44 111.475 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -134.06 118.63 17.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.44 110.178 179.668 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.475 ' CD1' ' CE1' ' A' ' 84' ' ' PHE . 1.6 pp -126.35 117.09 22.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.44 111.343 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -102.82 122.86 45.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.458 . . . . 0.44 110.966 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.505 ' CE2' ' CE1' ' A' ' 35' ' ' PHE . 3.5 m-30 -95.08 109.89 21.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.44 110.311 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 21.3 m95 -95.58 148.6 22.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.137 -0.483 . . . . 0.44 112.166 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 65' ' ' PHE . 12.2 tp -92.62 138.1 31.79 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.795 -0.639 . . . . 0.44 111.567 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.595 HG12 ' HA ' ' A' ' 64' ' ' HIS . 38.0 t -124.33 145.71 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-N 115.61 -0.723 . . . . 0.44 110.67 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -111.27 -30.57 7.38 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.589 1.329 . . . . 0.44 114.589 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.4 165.24 24.15 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.925 0.784 . . . . 0.44 111.688 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.642 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.8 p90 -148.23 130.25 15.36 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.317 -0.401 . . . . 0.44 111.538 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -78.06 145.08 36.06 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.271 -0.422 . . . . 0.44 110.935 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.14 -116.29 8.16 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.739 . . . . 0.44 112.383 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 7.0 mt-10 -135.05 139.29 31.56 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.458 0.171 . . . . 0.44 110.848 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.481 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 2.7 Cg_exo -76.35 128.6 10.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.812 2.341 . . . . 0.44 111.537 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.549 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.5 p-90 -132.32 -60.22 0.9 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.56 -0.456 . . . . 0.44 111.879 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.577 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.28 -107.31 0.1 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.908 -0.663 . . . . 0.44 113.248 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 1.3 tptt 178.1 72.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.755 0.312 . . . . 0.44 110.728 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.78 -30.66 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.39 . . . . 0.44 110.911 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.11 -66.23 0.4 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.578 -0.82 . . . . 0.44 112.885 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.1 104.97 36.12 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.002 0.43 . . . . 0.44 111.384 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -43.64 144.77 2.04 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.912 2.408 . . . . 0.44 112.748 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.489 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.08 177.12 19.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 0.44 112.393 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -133.14 153.6 51.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.644 0.259 . . . . 0.44 110.922 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 1.1 m0 -63.03 107.22 0.97 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.815 0.34 . . . . 0.44 110.357 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.4 ptm -119.44 140.5 50.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.457 . . . . 0.44 111.08 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.1 p -63.19 114.89 4.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.44 111.087 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 12.4 tp -64.6 -18.76 65.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.44 111.073 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.8 t -55.73 -15.13 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.333 -0.394 . . . . 0.44 111.6 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.18 42.16 1.88 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.715 -0.755 . . . . 0.44 112.371 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.3 128.47 36.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.187 -0.301 . . . . 0.44 110.187 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -119.66 129.38 54.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.158 0.504 . . . . 0.44 112.241 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.634 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -15.17 61.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.815 . . . . 0.44 110.817 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -78.35 -48.97 14.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.368 -0.378 . . . . 0.44 111.581 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -29.86 68.18 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.659 0.266 . . . . 0.44 111.246 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.634 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -91.41 171.9 7.36 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.467 -0.333 . . . . 0.44 110.183 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.5 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.6 Cg_endo -70.86 127.67 14.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.13 1.886 . . . . 0.44 111.714 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.61 -14.94 45.69 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.586 2.191 . . . . 0.44 113.095 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.5 -9.29 58.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.147 0.425 . . . . 0.44 112.147 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -119.76 31.31 6.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.546 -0.297 . . . . 0.44 111.698 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -70.19 -37.24 7.02 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.392 0.515 . . . . 0.44 112.392 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 64.6 Cg_exo -51.81 -43.44 51.51 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.09 1.86 . . . . 0.44 113.081 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.48 -51.27 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.962 0.411 . . . . 0.44 111.364 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.511 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -66.34 -32.13 56.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.91 -0.586 . . . . 0.44 111.343 -179.341 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.55 -29.67 59.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.847 0.356 . . . . 0.44 110.713 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -73.56 -53.24 11.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.44 111.74 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -36.22 46.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.552 -0.295 . . . . 0.44 111.48 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.4 ' HB2' HG23 ' A' ' 123' ' ' ILE . 3.1 ttpm? -53.13 -42.51 66.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.084 0.469 . . . . 0.44 111.15 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -63.99 -11.63 30.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.44 109.684 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 C--O 1.231 0.102 0 CA-C-N 115.948 -0.569 . . . . 0.44 111.089 179.563 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.849 0.357 . . . . 0.44 110.832 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -137.64 138.72 39.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.44 110.839 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 pp -144.01 139.82 29.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.44 110.966 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.401 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.1 mt-30 -102.7 153.83 19.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.4 0.619 . . . . 0.44 112.032 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mp -146.02 128.42 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.062 -0.972 . . . . 0.44 109.9 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.67 124.56 42.44 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 120.792 -0.363 . . . . 0.44 110.163 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.532 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.6 m -117.9 158.41 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.362 0.601 . . . . 0.44 111.713 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.08 108.66 0.54 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.074 -0.966 . . . . 0.44 111.345 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.595 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -70.69 96.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.358 0.599 . . . . 0.44 110.051 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.602 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 1.4 tt -71.44 121.34 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.464 0.913 . . . . 0.44 113.464 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.509 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -94.93 144.83 25.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.531 -0.758 . . . . 0.44 111.695 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.944 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.7 p-10 -102.67 -173.28 2.29 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.595 0.712 . . . . 0.44 112.164 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.3 tm-20 -71.85 1.48 6.97 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.792 -1.094 . . . . 0.44 113.425 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -124.05 43.25 3.04 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.099 -0.376 . . . . 0.44 111.695 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 45.87 27.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.098 0.475 . . . . 0.44 111.163 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 6.3 mt-10 -114.83 161.4 18.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.77 -0.65 . . . . 0.44 109.794 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.578 HD13 HG12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -125.72 132.63 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.792 0.33 . . . . 0.44 111.347 -178.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -85.26 125.72 33.11 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.021 0.439 . . . . 0.44 110.629 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.431 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -122.19 122.81 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.723 -0.671 . . . . 0.44 110.08 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 100' ' ' GLN . 19.7 p -71.01 111.96 6.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.818 0.342 . . . . 0.44 111.165 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.44 110.334 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.544 0.211 . . . . 0.44 111.485 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.35 26.23 10.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.377 . . . . 0.44 111.671 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 5.5 tt -42.79 121.64 2.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.802 -0.635 . . . . 0.44 110.751 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -140.69 -176.03 4.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.145 0.497 . . . . 0.44 111.972 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.92 163.32 28.55 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.737 -0.665 . . . . 0.44 111.557 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 19.3 Cg_endo -57.22 168.08 2.97 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.508 2.805 . . . . 0.44 111.801 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.22 59.67 0.76 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.01 -1.091 . . . . 0.44 113.788 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.27 126.07 5.27 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 114.556 -0.822 . . . . 0.44 112.19 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER 103.46 2.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.248 0.619 . . . . 0.44 112.305 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -51.5 -27.82 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.511 0.672 . . . . 0.44 110.754 179.401 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.557 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.44 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.844 -1.071 . . . . 0.44 111.016 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.4 mmm 33.75 -86.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.538 0.524 . . . . 0.44 111.841 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -164.3 27.57 0.21 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.876 -0.678 . . . . 0.44 112.565 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -95.62 -176.23 3.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.852 0.358 . . . . 0.44 111.138 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.537 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.81 155.75 38.49 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.45 . . . . 0.44 110.235 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 3.0 Cg_endo -44.74 -24.71 1.26 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.736 2.29 . . . . 0.44 112.608 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.21 -49.63 5.41 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.247 0.462 . . . . 0.44 112.247 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -80.08 -24.15 40.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.719 0.295 . . . . 0.44 111.741 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -55.43 -47.41 76.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.436 -0.347 . . . . 0.44 111.001 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.51 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -78.17 -47.89 23.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.321 -0.4 . . . . 0.44 110.823 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.51 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 44.7 t -56.76 -36.5 49.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.44 111.103 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -78.18 -50.66 11.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 0.44 111.086 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.483 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.9 mm-40 -66.9 -24.46 66.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.44 111.113 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.467 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 1.2 tp -51.8 -44.22 63.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.886 0.374 . . . . 0.44 110.272 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -33.93 75.01 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.19 -0.67 . . . . 0.44 109.19 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.58 -26.33 50.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.318 -0.855 . . . . 0.44 111.249 179.405 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mt-10 -108.14 5.17 25.65 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.15 0.426 . . . . 0.44 112.15 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.575 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 17.7 t -134.6 -43.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.191 0.52 . . . . 0.44 109.741 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.574 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.52 -43.94 0.59 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.464 -0.789 . . . . 0.44 113.215 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.511 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.57 -177.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.094 0.473 . . . . 0.44 111.175 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -111.29 89.22 9.87 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.411 -0.813 . . . . 0.44 109.368 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.561 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 1.4 Cg_endo -108.7 156.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.864 2.376 . . . . 0.44 115.211 -176.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' CB ' ' A' ' 89' ' ' ARG . 75.8 mt-30 -77.93 80.17 4.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.088 -1.819 . . . . 0.44 106.088 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.62 ' HA ' HG11 ' A' ' 87' ' ' VAL . 1.9 t-160 -127.07 124.24 38.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.753 -1.112 . . . . 0.44 110.669 -176.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.6 t80 -179.06 162.73 1.26 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.44 111.677 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER 83.84 155.77 0.1 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.055 -0.521 . . . . 0.44 110.943 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.7 pp -113.66 126.21 55.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.44 111.317 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -78.18 -36.75 47.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.44 110.253 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.06 162.03 7.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.44 110.469 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -143.08 132.14 23.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.889 0.376 . . . . 0.44 111.155 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.6 tp -119.01 121.98 41.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.648 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -120.91 109.95 15.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.44 110.685 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -141.04 150.85 43.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.649 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.19 122.28 39.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.097 0.475 . . . . 0.44 111.354 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.88 163.09 63.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.568 -0.742 . . . . 0.44 110.457 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.67 82.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.056 2.504 . . . . 0.44 112.149 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 14.3 t0 95.94 16.64 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.36 -0.836 . . . . 0.44 111.202 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.31 145.92 44.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.44 110.615 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -118.29 94.0 4.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.44 110.547 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 tt -103.08 111.8 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.241 -0.436 . . . . 0.44 111.195 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.85 122.44 46.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 0.44 110.377 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.3 mt -122.27 114.71 21.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.875 0.369 . . . . 0.44 111.367 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.433 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.9 m0 -104.89 122.51 45.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.438 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 2.9 m-85 -98.64 110.12 22.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.938 -0.574 . . . . 0.44 110.387 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.649 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 25.0 m95 -94.65 148.54 22.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.44 111.583 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.6 tm? -100.36 103.85 15.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.047 -0.524 . . . . 0.44 112.116 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.62 HG11 ' HA ' ' A' ' 64' ' ' HIS . 43.1 t -91.82 145.47 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-N 115.675 -0.693 . . . . 0.44 110.382 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -111.52 -29.52 7.73 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 115.107 1.521 . . . . 0.44 115.107 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.16 165.5 24.44 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.182 0.901 . . . . 0.44 111.824 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.944 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.6 p90 -149.4 132.67 16.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.44 111.667 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -81.23 128.38 33.73 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.172 -0.467 . . . . 0.44 110.749 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.2 -116.05 4.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.661 -0.781 . . . . 0.44 112.442 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 33.0 mt-10 -135.06 141.04 36.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.556 0.217 . . . . 0.44 110.93 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.506 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 4.1 Cg_exo -76.51 128.88 10.61 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.894 2.396 . . . . 0.44 111.199 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.574 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.6 p-90 -136.8 -64.81 0.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.846 -0.742 . . . . 0.44 112.811 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.575 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 49.21 -100.36 0.03 OUTLIER Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.588 -0.815 . . . . 0.44 112.65 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER 175.71 42.2 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.709 0.29 . . . . 0.44 111.091 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.53 -52.34 65.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.498 -0.319 . . . . 0.44 110.39 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 123.79 -11.06 8.38 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.478 -0.868 . . . . 0.44 113.723 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.441 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -140.17 98.94 7.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 117.38 0.59 . . . . 0.44 111.995 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -44.06 140.21 5.41 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.751 2.301 . . . . 0.44 112.269 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.51 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.18 177.28 19.27 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.499 -0.858 . . . . 0.44 112.897 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -129.75 157.29 42.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.693 0.283 . . . . 0.44 110.624 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.87 106.42 6.39 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.867 0.365 . . . . 0.44 110.178 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.5 ptp -120.2 149.76 41.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.44 111.075 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.68 114.9 5.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.44 110.626 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 1.1 tm? -69.95 -18.92 63.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.44 111.321 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.9 p -56.1 -17.86 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.48 -0.327 . . . . 0.44 111.519 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.34 45.39 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.637 -0.792 . . . . 0.44 112.619 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tt -62.65 150.49 40.74 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.272 -0.269 . . . . 0.44 110.272 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -119.26 127.43 53.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.58 0.585 . . . . 0.44 112.58 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.621 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -14.89 61.88 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.196 -0.911 . . . . 0.44 110.496 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -48.97 15.21 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.349 -0.387 . . . . 0.44 111.397 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -35.21 79.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.847 0.356 . . . . 0.44 110.701 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.621 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -85.41 168.16 21.6 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.44 110.27 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.513 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.2 Cg_endo -67.54 127.71 16.89 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.263 1.976 . . . . 0.44 111.918 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.02 -19.17 63.64 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.539 2.159 . . . . 0.44 112.892 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.64 -9.33 58.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.024 0.379 . . . . 0.44 112.024 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -116.2 29.43 7.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.485 -0.325 . . . . 0.44 111.463 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.4 pt-20 -71.86 -31.92 1.94 Allowed Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.879 0.696 . . . . 0.44 112.879 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 50.9 Cg_exo -53.89 -37.31 85.35 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 121.875 1.716 . . . . 0.44 112.567 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.448 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 22.7 t -77.35 -48.42 24.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.183 -0.462 . . . . 0.44 110.507 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.578 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.4 mm -67.44 -30.25 48.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.739 -0.664 . . . . 0.44 110.897 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.65 -28.33 46.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 0.44 110.317 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -48.26 16.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.82 -0.627 . . . . 0.44 111.428 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.405 HD23 ' CE2' ' A' ' 68' ' ' PHE . 7.8 tp -78.2 -30.42 48.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 0.44 111.499 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -54.61 -42.55 71.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.21 -0.45 . . . . 0.44 110.967 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -72.96 -5.69 40.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 0.44 110.005 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 CA--C 1.528 0.127 0 CA-C-N 116.057 -0.52 . . . . 0.44 111.284 179.797 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.034 0 CA-C-O 120.872 0.368 . . . . 0.44 110.912 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.94 143.38 49.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.44 110.878 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.84 137.0 31.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.873 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.402 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 42.8 mt-30 -102.62 151.74 21.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.446 0.641 . . . . 0.44 112.392 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -142.38 128.19 17.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.926 -1.034 . . . . 0.44 109.476 179.026 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.584 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.55 125.06 43.57 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 121.026 -0.27 . . . . 0.44 110.323 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.3 m -120.7 162.37 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.424 0.63 . . . . 0.44 112.167 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.06 113.47 0.59 Allowed Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.918 -1.037 . . . . 0.44 111.587 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.5 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -70.86 101.66 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.998 -0.371 . . . . 0.44 109.998 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.477 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -71.38 119.84 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.405 -0.361 . . . . 0.44 111.932 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.435 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -101.74 150.88 22.69 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.407 -0.815 . . . . 0.44 111.236 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.66 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 8.4 p-10 -121.34 -173.97 2.74 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.118 0.785 . . . . 0.44 113.118 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -56.45 -25.93 52.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.506 -1.224 . . . . 0.44 113.867 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -98.27 31.52 2.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.523 -0.308 . . . . 0.44 111.158 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 p30 49.12 23.21 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.182 0.515 . . . . 0.44 110.508 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -101.02 160.77 14.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.52 -0.764 . . . . 0.44 109.037 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -124.78 118.96 54.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.245 0.545 . . . . 0.44 111.943 -178.68 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.449 ' CE2' ' CA ' ' A' ' 102' ' ' GLY . 15.2 t80 -66.96 100.66 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.742 -0.663 . . . . 0.44 110.527 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 ' HB ' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -109.0 123.01 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.44 110.538 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.43 ' CG2' ' HG3' ' A' ' 98' ' ' GLU . 24.0 p -70.99 111.83 6.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.293 -0.412 . . . . 0.44 111.036 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.406 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 109.737 -0.468 . . . . 0.44 109.737 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.611 0.243 . . . . 0.44 111.43 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.52 26.5 10.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.922 0.392 . . . . 0.44 111.7 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.41 HD22 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -47.55 113.51 0.71 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.962 -0.563 . . . . 0.44 111.0 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.77 177.04 8.03 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.152 0.501 . . . . 0.44 111.779 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.483 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -119.9 162.02 35.27 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.865 -0.607 . . . . 0.44 111.941 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.5 Cg_endo -48.16 167.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.812 3.008 . . . . 0.44 112.177 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 101.89 59.71 0.77 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.051 -1.071 . . . . 0.44 114.186 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.531 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -131.76 130.24 5.9 Favored Glycine 0 C--N 1.312 -0.798 0 CA-C-N 114.724 -0.738 . . . . 0.44 111.952 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.43 6.64 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.986 0.515 . . . . 0.44 112.037 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.584 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.53 -28.09 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.667 0.746 . . . . 0.44 110.192 179.202 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.57 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.61 -73.57 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.552 -1.203 . . . . 0.44 111.13 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 41' ' ' GLU . 1.0 OUTLIER 26.85 -85.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.562 0.539 . . . . 0.44 112.119 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.28 28.36 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.735 -0.745 . . . . 0.44 112.676 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.461 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.3 mp0 -97.44 -175.13 3.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.713 0.292 . . . . 0.44 111.192 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.592 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.23 160.74 25.48 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.41 -0.359 . . . . 0.44 110.358 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.592 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 9.7 Cg_endo -49.3 -24.63 8.7 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.623 2.215 . . . . 0.44 112.316 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.14 -45.66 5.83 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.187 0.439 . . . . 0.44 112.187 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -80.05 -23.81 41.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.667 0.27 . . . . 0.44 111.624 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.461 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -56.79 -47.56 79.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.506 -0.316 . . . . 0.44 111.021 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -78.25 -46.07 26.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.359 -0.382 . . . . 0.44 110.768 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.487 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 46.1 t -59.39 -36.81 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.047 -0.524 . . . . 0.44 111.174 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -78.15 -47.15 18.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.292 -0.413 . . . . 0.44 110.742 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.444 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.3 mt-10 -70.09 -20.83 63.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.4 -0.364 . . . . 0.44 110.736 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.48 ' CD1' ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -51.36 -44.45 62.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.229 0.538 . . . . 0.44 109.602 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -32.21 73.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.36 -0.836 . . . . 0.44 109.937 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.48 -32.43 54.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.653 -0.703 . . . . 0.44 111.767 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.14 5.07 25.57 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.225 0.454 . . . . 0.44 112.225 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.573 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 21.8 t -134.65 -44.23 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.44 . . . . 0.44 110.146 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.586 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.75 -45.32 0.39 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.694 -0.685 . . . . 0.44 113.449 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.77 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -77.97 152.34 5.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 110.049 -0.352 . . . . 0.44 110.049 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.89 96.71 0.43 Allowed Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.44 110.49 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.77 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 19.7 Cg_endo -113.72 148.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.699 0 C-N-CA 123.443 2.762 . . . . 0.44 114.163 -177.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -74.8 79.58 2.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.794 -1.928 . . . . 0.44 105.794 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.586 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -124.92 121.18 33.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.329 -1.305 . . . . 0.44 110.274 -176.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.1 t80 -178.64 169.08 1.73 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.096 0.474 . . . . 0.44 112.142 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.449 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 82.7 162.36 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.428 -0.806 . . . . 0.44 111.383 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 8.0 tt -105.47 131.84 52.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 0.44 111.611 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -98.59 -32.28 11.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 0.44 109.916 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.487 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -171.61 159.96 5.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.48 -0.782 . . . . 0.44 109.945 179.491 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -143.48 132.08 22.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.726 0.298 . . . . 0.44 110.936 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.5 tp -118.9 120.41 37.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.44 110.639 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -115.97 109.82 18.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.44 110.697 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.42 ' CE2' HG22 ' A' ' 80' ' ' ILE . 2.1 p90 -141.14 145.85 36.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.44 110.612 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.11 121.7 38.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.132 0.492 . . . . 0.44 111.203 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -70.0 163.07 64.38 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.604 -0.725 . . . . 0.44 110.506 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.8 Cg_endo -51.85 83.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.063 2.509 . . . . 0.44 112.078 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 27.8 m-20 95.56 15.33 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.176 -0.92 . . . . 0.44 111.295 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.35 149.84 47.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.427 -0.351 . . . . 0.44 110.566 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -124.17 106.1 10.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.44 110.899 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.42 HG22 ' CE2' ' A' ' 73' ' ' TYR . 1.1 tt -111.35 112.33 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.44 110.951 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.414 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -98.42 118.64 35.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.44 110.415 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 6.7 mt -115.32 114.48 25.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.987 0.422 . . . . 0.44 111.764 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -108.99 122.56 47.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.986 -0.552 . . . . 0.44 110.315 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.519 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 2.6 m-85 -100.47 125.79 46.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.657 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 15.6 m95 -107.19 148.66 28.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.314 -0.403 . . . . 0.44 112.014 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.484 ' HB3' ' CB ' ' A' ' 68' ' ' PHE . 2.0 pp -97.69 103.85 15.82 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.306 0.574 . . . . 0.44 111.446 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 64' ' ' HIS . 41.2 t -84.83 144.76 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 115.672 -0.695 . . . . 0.44 111.229 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -32.24 7.88 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.812 1.042 . . . . 0.44 113.812 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.73 165.02 26.08 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.006 -0.678 . . . . 0.44 111.56 -179.189 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.66 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.4 p90 -149.64 136.61 19.59 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.264 -0.425 . . . . 0.44 111.331 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.403 ' HB2' HD11 ' A' ' 60' ' ' ILE . 1.5 mt-10 -73.77 134.04 43.37 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.269 -0.423 . . . . 0.44 110.735 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 51.13 -107.85 0.46 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.364 -0.922 . . . . 0.44 111.86 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 21.8 mt-10 -135.56 142.11 39.82 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.49 0.186 . . . . 0.44 111.038 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.516 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 3.3 Cg_exo -76.05 128.57 10.77 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.459 2.106 . . . . 0.44 110.672 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.586 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 35.8 p-90 -124.6 -59.05 1.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.966 0.412 . . . . 0.44 111.861 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.573 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.01 -95.75 0.01 OUTLIER Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.595 -0.729 . . . . 0.44 112.875 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.71 37.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.72 0.295 . . . . 0.44 110.895 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -64.54 -44.88 89.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.371 -0.377 . . . . 0.44 111.189 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.77 -98.76 0.23 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.366 -0.921 . . . . 0.44 113.44 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.92 114.41 36.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.077 0.465 . . . . 0.44 112.248 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -43.9 146.44 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.179 2.586 . . . . 0.44 112.648 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.449 ' CA ' ' CE2' ' A' ' 19' ' ' PHE . . . -123.37 177.07 16.68 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.731 -0.747 . . . . 0.44 112.966 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -138.98 157.53 45.83 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.427 -0.212 . . . . 0.44 110.427 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.49 ' CD1' ' HZ2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -72.24 105.99 4.24 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.928 0.394 . . . . 0.44 110.085 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.29 140.0 51.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.44 110.714 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.2 p -58.89 114.55 2.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.782 0.325 . . . . 0.44 110.44 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.41 HD21 ' CG2' ' A' ' 18' ' ' ILE . 1.8 tm? -61.67 -18.84 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.409 . . . . 0.44 111.311 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.9 t -59.75 -12.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.502 -0.317 . . . . 0.44 111.331 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.11 37.63 3.68 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.952 -0.642 . . . . 0.44 112.284 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.405 ' CD2' HD22 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -62.11 123.63 18.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.142 -0.318 . . . . 0.44 110.142 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.07 128.65 50.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.251 0.548 . . . . 0.44 112.412 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.619 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.26 -14.91 61.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.233 -0.894 . . . . 0.44 110.399 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.36 -49.41 13.63 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.333 -0.394 . . . . 0.44 111.737 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -31.0 70.94 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.838 0.351 . . . . 0.44 110.877 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.619 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -90.5 172.28 7.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.095 179.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.504 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.7 Cg_endo -71.45 127.64 13.52 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.12 1.88 . . . . 0.44 111.666 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.8 -14.95 46.05 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.63 2.22 . . . . 0.44 113.153 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.56 -9.58 58.75 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.986 0.365 . . . . 0.44 111.986 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.84 33.78 5.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.44 111.439 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.49 -34.95 2.01 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.714 0.635 . . . . 0.44 112.714 -179.308 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 74.2 Cg_exo -49.69 -45.57 31.01 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 121.87 1.713 . . . . 0.44 113.056 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.414 HG13 ' CG ' ' A' ' 84' ' ' PHE . 1.6 t -77.6 -51.31 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.987 0.422 . . . . 0.44 111.428 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.479 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -64.89 -34.07 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.621 . . . . 0.44 111.634 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.93 -31.19 60.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.861 0.362 . . . . 0.44 110.79 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.05 -53.63 16.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 0.44 111.564 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.72 -30.02 45.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.726 0.298 . . . . 0.44 111.394 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -54.65 -42.51 71.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.025 0.44 . . . . 0.44 110.741 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -66.14 -10.51 41.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.759 -0.655 . . . . 0.44 109.624 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-N 115.943 -0.572 . . . . 0.44 111.221 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.878 0.37 . . . . 0.44 111.191 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -74.0 124.24 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.44 110.871 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -133.65 143.52 48.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.44 110.895 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.425 HD12 " C3'" ' A' ' 131' ' ' 8OG . 3.3 pp -145.94 127.93 15.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.44 110.947 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.447 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 41.4 mt-30 -102.65 154.07 19.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.337 0.589 . . . . 0.44 112.282 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.437 HG13 " C2'" ' A' ' 131' ' ' 8OG . 27.2 mm -146.55 132.72 13.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.106 -0.952 . . . . 0.44 109.675 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.45 124.59 42.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.205 -0.294 . . . . 0.44 110.205 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.486 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.1 m -121.0 162.51 19.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.3 0.571 . . . . 0.44 111.994 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.2 113.05 0.56 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.15 -0.932 . . . . 0.44 111.738 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.468 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.78 107.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.775 -0.454 . . . . 0.44 109.775 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.455 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.2 mt -71.43 124.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.049 0.452 . . . . 0.44 111.68 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.76 124.01 32.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.773 -0.649 . . . . 0.44 111.43 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.52 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -79.19 -172.7 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.295 -0.866 . . . . 0.44 111.805 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.507 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.3 tp10 -82.62 2.9 31.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.469 -1.241 . . . . 0.44 112.084 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -135.95 50.32 2.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.797 0.332 . . . . 0.44 111.227 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 p30 45.5 26.68 0.33 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.111 -0.495 . . . . 0.44 111.385 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 13.6 pt-20 -120.39 141.7 49.86 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.388 -0.597 . . . . 0.44 109.388 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' A' ' 105' ' ' MET . 17.6 mt -110.88 140.31 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.154 0.502 . . . . 0.44 111.716 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -89.42 122.6 32.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.515 -0.766 . . . . 0.44 110.689 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.04 162.25 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.44 110.262 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.43 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 3.7 p -95.67 111.8 23.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.348 -0.387 . . . . 0.44 110.57 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -91.67 83.68 5.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.404 -0.362 . . . . 0.44 110.996 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 40.62 33.0 0.17 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.885 -0.598 . . . . 0.44 111.716 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.23 -79.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.44 111.113 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.08 -46.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 0.44 110.947 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.7 -83.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.44 110.794 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 46.6 38.8 6.03 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.787 0.327 . . . . 0.44 111.454 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 61.57 154.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.74 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 60.27 59.82 2.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.44 110.752 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.42 -8.67 52.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.44 111.811 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 29.81 0.91 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.556 0.217 . . . . 0.44 111.557 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 26.29 10.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.44 111.381 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.9 tt -46.84 96.11 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.786 -0.643 . . . . 0.44 110.855 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -114.49 -178.74 3.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.16 0.505 . . . . 0.44 111.711 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.465 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.6 164.23 22.98 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.593 -0.73 . . . . 0.44 111.432 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 19.8 Cg_endo -56.84 167.89 2.75 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.472 2.781 . . . . 0.44 112.012 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.18 59.47 0.76 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.257 -0.973 . . . . 0.44 113.613 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.17 126.79 5.12 Favored Glycine 0 C--N 1.313 -0.742 0 CA-C-N 114.581 -0.81 . . . . 0.44 112.101 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER 109.42 4.55 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.153 0.581 . . . . 0.44 112.125 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -58.65 -24.35 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.428 0.632 . . . . 0.44 110.791 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -49.83 -71.82 0.06 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.971 -1.013 . . . . 0.44 111.094 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.441 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER 23.54 -86.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.611 0.569 . . . . 0.44 112.252 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -159.7 23.82 0.29 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.771 -0.728 . . . . 0.44 112.787 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.24 -177.13 3.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.87 0.367 . . . . 0.44 111.026 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.56 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.68 157.47 38.31 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.44 109.872 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.79 -24.69 0.82 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.717 2.278 . . . . 0.44 112.413 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.57 -60.67 1.96 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.222 0.453 . . . . 0.44 112.222 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -80.43 -21.49 42.11 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.165 0.432 . . . . 0.44 112.165 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.73 -48.83 76.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.784 0.326 . . . . 0.44 111.095 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -78.4 -46.39 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.44 110.875 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 44.6 t -57.12 -36.56 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.44 110.902 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -78.29 -49.19 14.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.123 -0.49 . . . . 0.44 110.747 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.2 mm-40 -67.61 -20.0 65.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.44 110.992 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.449 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 1.3 tp -57.17 -44.64 83.72 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.866 0.365 . . . . 0.44 110.529 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -34.68 78.43 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.088 -0.708 . . . . 0.44 109.088 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.2 tm-20 -77.46 -24.09 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.226 -0.897 . . . . 0.44 110.873 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -108.47 5.15 25.0 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.926 0.343 . . . . 0.44 111.926 -179.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.539 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 38.5 t -134.65 -44.39 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.142 0.496 . . . . 0.44 109.836 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.541 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.99 -40.09 0.26 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.443 -0.798 . . . . 0.44 113.893 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.513 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.68 -176.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.009 0.433 . . . . 0.44 111.089 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.33 88.81 13.45 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.66 -0.7 . . . . 0.44 110.006 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.627 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.3 Cg_endo -110.57 145.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.362 2.708 . . . . 0.44 113.981 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 39.4 mt-30 -74.78 79.78 2.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 105.521 -2.029 . . . . 0.44 105.521 175.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.572 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.81 128.22 52.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.235 -1.348 . . . . 0.44 110.952 -176.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.4 t80 -179.34 167.89 1.49 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.44 111.76 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 14.6 m 84.51 149.14 0.07 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.71 -0.677 . . . . 0.44 110.544 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 pp -107.1 128.46 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.44 111.298 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -78.84 -41.29 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.955 -0.566 . . . . 0.44 110.252 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.502 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 10.3 tt0 -171.38 167.07 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.871 -0.604 . . . . 0.44 110.474 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.03 132.11 23.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.44 111.087 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.419 HD23 ' CG2' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -116.18 122.3 44.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.44 111.001 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -120.62 109.78 15.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.44 110.549 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -141.13 149.26 41.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.44 110.674 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 3.8 pt-20 -121.23 120.52 35.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.125 0.488 . . . . 0.44 111.198 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -69.98 163.74 58.24 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.597 -0.729 . . . . 0.44 110.354 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -50.94 83.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.221 2.614 . . . . 0.44 112.39 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.7 t70 94.74 16.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.333 -0.849 . . . . 0.44 111.357 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.449 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 27.1 ttt180 -137.38 146.44 44.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.44 110.641 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 9.4 t-160 -119.68 99.43 6.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.44 110.623 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 tt -106.79 121.08 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.44 111.093 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.76 122.82 48.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.44 110.424 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.409 HD13 ' N3 ' ' A' ' 131' ' ' 8OG . 8.1 mt -126.04 114.97 19.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.44 111.347 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.431 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.6 m0 -107.82 122.52 46.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.44 110.796 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.451 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 4.4 m-30 -93.37 109.61 21.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.87 -0.605 . . . . 0.44 109.817 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 28.2 m95 -96.82 148.75 22.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.025 0.441 . . . . 0.44 112.083 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 65' ' ' PHE . 7.1 tp -97.58 138.22 35.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.713 -0.676 . . . . 0.44 111.542 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.572 HG13 ' HA ' ' A' ' 64' ' ' HIS . 39.4 t -124.02 146.04 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-N 115.447 -0.797 . . . . 0.44 110.37 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -110.52 -26.34 9.54 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.098 1.147 . . . . 0.44 114.098 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.81 164.5 26.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.572 0.624 . . . . 0.44 111.548 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.627 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -157.37 123.48 4.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.272 -0.422 . . . . 0.44 111.381 178.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -73.88 147.2 43.45 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.199 -0.455 . . . . 0.44 111.141 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.67 -127.87 43.49 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.819 -0.705 . . . . 0.44 112.58 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 17.1 mt-10 -125.22 146.19 53.17 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.53 0.205 . . . . 0.44 110.727 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.47 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.58 128.74 10.46 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.827 2.351 . . . . 0.44 111.471 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.541 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.3 p-90 -132.58 -58.19 0.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.62 -0.432 . . . . 0.44 111.669 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.539 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.11 -97.11 0.01 OUTLIER Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.874 -0.679 . . . . 0.44 112.923 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.99 31.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.693 0.282 . . . . 0.44 111.172 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -40.78 95.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.78 0.324 . . . . 0.44 110.477 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.85 13.56 60.69 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.863 -0.684 . . . . 0.44 113.8 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.43 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 2.6 mp0 -140.31 92.02 9.58 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 117.18 0.49 . . . . 0.44 111.509 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -43.63 132.76 7.54 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.982 2.454 . . . . 0.44 112.688 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.25 177.1 19.42 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.787 -0.721 . . . . 0.44 112.856 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -134.22 157.29 46.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.641 0.257 . . . . 0.44 110.624 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.2 106.97 3.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.844 0.354 . . . . 0.44 110.323 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 18' ' ' ILE . 3.6 ptp -119.95 147.33 44.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.216 -0.447 . . . . 0.44 111.171 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t -66.63 114.87 5.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.44 110.734 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.97 -28.71 64.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.399 . . . . 0.44 110.914 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -53.25 -23.94 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.44 111.06 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.33 42.31 1.62 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.843 -0.694 . . . . 0.44 112.404 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.4 tt -62.56 150.16 41.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.209 -0.293 . . . . 0.44 110.209 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.22 127.67 54.96 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.656 0.613 . . . . 0.44 112.656 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -14.98 61.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.267 -0.879 . . . . 0.44 110.512 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.44 -49.31 13.69 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.363 -0.38 . . . . 0.44 111.78 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -38.84 87.21 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.885 0.374 . . . . 0.44 110.904 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.585 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.84 173.02 8.38 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.105 -0.498 . . . . 0.44 109.973 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 36.2 Cg_endo -65.7 127.79 18.67 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.087 1.858 . . . . 0.44 111.973 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.48 -21.18 53.59 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.576 2.184 . . . . 0.44 112.956 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.66 -9.59 57.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 0.44 111.85 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.77 34.26 5.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 0.44 111.179 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -75.15 -43.69 4.55 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 112.439 0.533 . . . . 0.44 112.439 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 85.8 Cg_exo -44.77 -33.16 6.82 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.184 1.923 . . . . 0.44 112.567 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.451 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 49.4 t -77.62 -51.08 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.44 110.419 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.585 HG13 ' CE2' ' A' ' 115' ' ' PHE . 12.4 mm -66.25 -30.45 49.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.744 -0.662 . . . . 0.44 110.979 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.73 -27.18 38.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.945 0.403 . . . . 0.44 110.485 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -80.18 -51.34 9.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.963 -0.562 . . . . 0.44 111.69 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.426 HD21 ' CE2' ' A' ' 68' ' ' PHE . 13.0 tp -78.09 -34.61 50.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.818 0.342 . . . . 0.44 111.599 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.4 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 42.6 tttp -53.19 -42.72 66.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.08 0.467 . . . . 0.44 111.137 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -73.02 -4.17 30.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.667 -0.697 . . . . 0.44 110.05 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.4 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-N 116.003 -0.544 . . . . 0.44 111.039 179.812 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.489 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 5011 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 5012 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 5013 ' ' HOH . . . . . 0.533 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 5014 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ttm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.844 0.354 . . . . 0.44 111.2 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.29 128.19 54.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.44 110.951 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.85 126.33 20.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.865 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -130.41 136.65 49.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 0.44 110.707 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 27.8 mt-30 -102.95 153.29 20.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.335 0.588 . . . . 0.44 112.146 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -146.04 124.64 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.44 109.795 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.74 125.26 43.77 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.827 -0.349 . . . . 0.44 110.743 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.549 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.5 m -115.77 162.09 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.426 0.631 . . . . 0.44 111.867 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.13 111.57 0.58 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.006 -0.997 . . . . 0.44 111.27 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.585 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.85 102.31 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.011 -0.366 . . . . 0.44 110.011 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.469 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -71.2 121.46 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 121.125 0.488 . . . . 0.44 111.659 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.441 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -91.29 132.81 35.9 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.436 -0.802 . . . . 0.44 111.629 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.66 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 2.4 p30 -89.04 -173.24 3.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.256 -0.884 . . . . 0.44 111.473 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 8.2 tt0 -79.61 8.93 5.59 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.395 -0.82 . . . . 0.44 112.686 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -132.25 47.17 2.55 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.141 -0.35 . . . . 0.44 111.691 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.1 p30 45.06 25.94 0.19 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.087 0.47 . . . . 0.44 111.507 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.561 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 25.9 mt-10 -116.87 161.19 19.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.043 -0.725 . . . . 0.44 109.043 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -118.8 135.68 58.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.052 0.453 . . . . 0.44 111.74 -178.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -85.78 109.86 18.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.788 -0.642 . . . . 0.44 110.994 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.436 ' HB ' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -119.5 140.18 44.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.44 110.106 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.401 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 16.3 p -73.58 111.67 8.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.44 111.195 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.12 83.71 6.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.44 110.756 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 43.82 46.23 6.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.089 -0.505 . . . . 0.44 111.387 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 64.97 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.44 111.138 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.14 -80.58 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.258 -0.428 . . . . 0.44 111.198 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -177.25 37.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.44 110.976 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.68 -164.46 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.44 110.918 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.02 148.51 7.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.37 -0.377 . . . . 0.44 110.953 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.9 mtp 60.53 53.55 4.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.44 110.554 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.09 -8.82 48.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.44 111.904 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.05 30.9 0.9 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.613 0.244 . . . . 0.44 111.437 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -114.41 26.41 10.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.886 0.374 . . . . 0.44 111.43 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -43.89 94.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.734 -0.666 . . . . 0.44 110.787 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -109.37 172.38 6.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.208 0.527 . . . . 0.44 112.076 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.475 ' CZ ' ' CZ ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -119.63 163.58 26.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.637 -0.71 . . . . 0.44 111.57 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.08 167.71 8.64 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.508 2.805 . . . . 0.44 112.03 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 101.99 59.53 0.77 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.215 -0.993 . . . . 0.44 113.73 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.619 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.15 118.66 2.46 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 114.552 -0.824 . . . . 0.44 111.999 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.619 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.31 2.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.185 0.594 . . . . 0.44 111.682 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.609 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -50.48 -28.92 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.57 0.7 . . . . 0.44 110.568 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.58 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.51 -79.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.613 -1.176 . . . . 0.44 110.964 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp 36.18 -85.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.5 0.5 . . . . 0.44 111.597 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.18 29.67 0.17 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.07 -0.586 . . . . 0.44 112.354 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 25.7 mp0 -97.32 -178.35 4.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.855 0.359 . . . . 0.44 111.155 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.564 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.33 159.34 32.46 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.44 109.995 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.564 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.87 -24.71 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.784 2.322 . . . . 0.44 112.479 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.1 -61.22 1.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.042 0.386 . . . . 0.44 112.042 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -80.54 -6.01 57.58 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.322 0.49 . . . . 0.44 112.322 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 40' ' ' ILE . . . -62.82 -55.13 29.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.44 110.884 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.489 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.5 m -78.22 -45.19 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 0.44 110.871 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.489 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 40.3 t -56.49 -41.47 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.44 111.128 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.32 -46.84 19.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.372 -0.376 . . . . 0.44 110.988 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -69.32 -21.66 63.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.197 -0.456 . . . . 0.44 111.034 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -55.43 -44.24 76.09 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.823 0.344 . . . . 0.44 110.12 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -34.86 73.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.893 -0.78 . . . . 0.44 108.893 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.8 -26.64 49.75 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.165 -0.925 . . . . 0.44 111.394 179.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.03 5.25 25.95 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.228 0.455 . . . . 0.44 112.228 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.573 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 19.9 t -134.79 -44.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.244 0.545 . . . . 0.44 110.053 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.549 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.13 -41.27 0.35 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.419 -0.81 . . . . 0.44 113.602 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.5 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.7 -176.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 120.977 0.418 . . . . 0.44 111.038 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.66 88.82 14.33 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-N 115.646 -0.707 . . . . 0.44 109.885 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.656 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.2 Cg_endo -110.74 146.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 123.276 2.651 . . . . 0.44 114.35 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 15.9 mt-30 -74.69 80.03 2.04 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 105.375 -2.083 . . . . 0.44 105.375 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.569 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.55 131.9 54.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.272 -1.331 . . . . 0.44 111.549 -175.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.515 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -176.22 -136.97 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.44 110.391 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 51.76 172.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.213 0.53 . . . . 0.44 112.258 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.6 tt -136.97 115.89 12.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.523 -0.762 . . . . 0.44 110.454 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.69 -56.3 4.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.44 109.982 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.647 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 mt-10 -171.46 131.51 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.44 110.138 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.445 ' NZ ' ' CH2' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -125.5 132.1 52.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.716 0.293 . . . . 0.44 110.679 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.403 ' O ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -124.22 168.29 13.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.44 110.857 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -140.16 123.62 17.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.44 110.72 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.468 ' CZ ' ' CG2' ' A' ' 80' ' ' ILE . 1.9 p90 -141.02 148.61 40.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.957 -0.565 . . . . 0.44 110.279 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -120.98 128.39 52.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.207 0.527 . . . . 0.44 111.487 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -86.48 162.86 44.12 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.426 -0.806 . . . . 0.44 110.193 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.5 Cg_endo -50.11 81.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.0 2.466 . . . . 0.44 112.31 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.4 t70 89.09 12.15 0.07 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.411 -0.813 . . . . 0.44 111.529 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -137.26 93.92 2.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.655 0.264 . . . . 0.44 110.938 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -77.15 108.73 10.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.44 110.854 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 2.7 tt -110.8 112.75 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.317 -0.401 . . . . 0.44 111.31 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.62 118.85 33.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.44 110.115 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.6 mt -112.01 114.15 26.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.888 0.375 . . . . 0.44 111.9 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.446 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 8.9 m0 -115.73 122.22 44.85 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.44 110.252 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.647 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 7.2 m-30 -106.15 123.08 47.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.731 -0.668 . . . . 0.44 110.97 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 31.5 m95 -105.13 149.0 26.25 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.078 -0.51 . . . . 0.44 110.611 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.515 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.3 tm? -98.7 103.47 15.42 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.597 0.713 . . . . 0.44 112.332 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.585 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 20.9 t -82.76 145.85 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 114.926 -1.034 . . . . 0.44 110.899 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -114.01 -25.38 8.58 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.006 1.113 . . . . 0.44 114.006 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -162.27 160.16 26.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.522 0.601 . . . . 0.44 111.49 -179.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.66 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -153.27 124.3 7.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.116 -0.493 . . . . 0.44 111.364 178.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -74.28 146.69 42.99 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 116.166 -0.47 . . . . 0.44 111.064 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.74 -130.99 51.3 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.716 -0.754 . . . . 0.44 112.559 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -121.32 144.79 40.74 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.572 0.225 . . . . 0.44 110.715 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.485 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.1 Cg_exo -76.66 128.74 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.934 2.422 . . . . 0.44 111.474 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.549 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.5 p-90 -135.23 -57.96 0.8 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.56 -0.456 . . . . 0.44 111.715 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.573 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.13 -94.56 0.01 OUTLIER Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.022 -0.609 . . . . 0.44 113.005 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 56' ' ' GLU . 4.7 tmtt? -177.23 32.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.767 0.317 . . . . 0.44 111.01 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.78 -38.65 73.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.44 110.342 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.81 21.25 63.96 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.975 -0.631 . . . . 0.44 113.337 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.401 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 1.5 mt-30 -140.23 91.85 9.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.022 0.439 . . . . 0.44 111.448 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -44.02 137.03 7.31 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.975 2.45 . . . . 0.44 112.626 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.16 177.05 19.44 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.735 -0.745 . . . . 0.44 112.874 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -145.07 157.38 44.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.583 0.23 . . . . 0.44 110.538 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.44 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.6 m0 -62.15 106.62 0.75 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.332 . . . . 0.44 110.474 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.439 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.05 147.34 44.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.193 -0.458 . . . . 0.44 110.67 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.04 114.7 12.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 0.44 110.801 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 30.1 tp -80.15 -18.92 48.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.239 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.0 t -50.59 -23.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.517 -0.31 . . . . 0.44 111.535 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.61 48.04 0.98 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.709 -0.757 . . . . 0.44 112.481 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.62 150.22 41.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.63 0.253 . . . . 0.44 110.47 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.02 135.19 54.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.169 0.509 . . . . 0.44 112.163 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.537 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.08 -15.25 62.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.622 -0.717 . . . . 0.44 110.493 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.98 -49.24 13.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.512 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -33.73 76.12 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.47 -0.332 . . . . 0.44 111.262 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.537 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -84.94 174.05 6.31 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.358 -0.383 . . . . 0.44 110.316 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.474 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.6 Cg_endo -71.05 127.8 14.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.05 1.833 . . . . 0.44 111.764 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.91 -15.02 46.68 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.606 2.204 . . . . 0.44 113.226 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.75 -9.63 58.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.025 0.38 . . . . 0.44 112.025 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.08 32.72 5.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.7 0.286 . . . . 0.44 111.303 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.523 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -76.18 -39.19 2.57 Favored Pre-proline 0 C--O 1.223 -0.305 0 N-CA-C 112.825 0.676 . . . . 0.44 112.825 -179.049 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 89.4 Cg_exo -44.9 -39.94 14.53 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 121.924 1.749 . . . . 0.44 113.024 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.422 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.4 t -77.53 -51.03 19.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.999 0.428 . . . . 0.44 110.924 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.532 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.0 mm -64.89 -32.13 56.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.803 -0.635 . . . . 0.44 111.405 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.74 -29.89 54.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.034 0.445 . . . . 0.44 110.497 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -76.49 -49.57 16.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.788 -0.642 . . . . 0.44 111.494 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -78.18 -31.37 49.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.47 -0.332 . . . . 0.44 111.672 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -54.07 -42.62 69.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.028 0.442 . . . . 0.44 111.01 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -69.99 -7.88 44.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.79 -0.641 . . . . 0.44 109.911 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-N 115.977 -0.556 . . . . 0.44 111.219 179.802 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.5 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 5023 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 5024 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 5025 ' ' HOH . . . . . 0.488 ' H1 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 5026 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.824 0.345 . . . . 0.44 111.229 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.41 107.52 17.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.44 110.911 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 146.76 28.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.44 110.884 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.445 HD13 " C3'" ' A' ' 131' ' ' 8OG . 1.7 pp -145.97 134.85 22.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.232 -0.44 . . . . 0.44 111.024 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -102.85 151.67 22.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.92 -0.582 . . . . 0.44 112.306 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.468 HG13 " C2'" ' A' ' 131' ' ' 8OG . 21.3 mm -146.64 129.39 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.165 -0.925 . . . . 0.44 109.981 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.68 125.05 43.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 121.037 -0.265 . . . . 0.44 110.556 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.547 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.5 m -118.07 161.45 16.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.249 0.547 . . . . 0.44 111.788 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.3 112.1 0.53 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.247 -0.888 . . . . 0.44 111.853 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.46 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.45 105.48 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.085 -0.339 . . . . 0.44 110.085 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.462 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.1 mt -71.74 124.83 29.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.12 0.486 . . . . 0.44 112.018 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.453 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -93.72 135.57 34.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.63 -0.714 . . . . 0.44 111.22 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.649 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.5 p30 -92.74 -173.45 3.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.457 -0.792 . . . . 0.44 111.905 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -75.31 -1.22 22.63 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.206 -0.907 . . . . 0.44 112.83 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -119.5 41.24 3.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.959 -0.296 . . . . 0.44 111.442 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p30 46.9 25.16 0.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.082 0.468 . . . . 0.44 111.201 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.545 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 25.1 mt-10 -114.44 160.94 18.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.966 -0.753 . . . . 0.44 108.966 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -116.85 138.64 46.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.078 0.466 . . . . 0.44 112.019 -178.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.476 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -82.27 99.84 9.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.788 -0.642 . . . . 0.44 110.79 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.474 ' CG2' ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -116.52 115.41 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.499 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 t -76.45 123.43 26.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.848 0.356 . . . . 0.44 111.009 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -86.21 83.82 7.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.44 110.624 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 46.17 49.53 12.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.173 0.511 . . . . 0.44 110.954 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 67.45 -86.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.792 -0.64 . . . . 0.44 111.199 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 179.22 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.74 0.305 . . . . 0.44 111.26 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -70.04 65.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.44 110.938 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 51.14 -92.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.44 111.341 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 m80 44.8 48.78 9.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.811 0.339 . . . . 0.44 111.22 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 mtt 63.09 92.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.44 110.654 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.05 -12.16 47.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.44 111.755 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.52 13.3 10.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 111.618 0.229 . . . . 0.44 111.618 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.6 26.3 10.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.941 0.401 . . . . 0.44 111.698 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -48.28 117.86 2.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.02 -0.536 . . . . 0.44 110.856 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -145.06 171.55 14.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.44 110.953 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.42 167.85 11.26 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 121.004 0.431 . . . . 0.44 111.934 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.4 Cg_endo -47.46 168.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.862 3.041 . . . . 0.44 112.694 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.07 59.99 0.72 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.549 -0.834 . . . . 0.44 113.851 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -131.83 132.62 6.8 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 114.391 -0.905 . . . . 0.44 112.14 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.8 ttmm 92.3 10.47 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.023 0.529 . . . . 0.44 112.388 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.587 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -56.79 -28.27 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.673 0.749 . . . . 0.44 109.993 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.575 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.83 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.341 -1.3 . . . . 0.44 110.896 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.98 -84.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.516 0.51 . . . . 0.44 111.709 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.44 32.74 0.1 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.904 -0.665 . . . . 0.44 112.57 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.479 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.3 mt-10 -93.21 -173.72 3.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.698 0.285 . . . . 0.44 111.194 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.521 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.19 154.02 37.85 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.313 -0.403 . . . . 0.44 110.316 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.99 -24.87 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.819 2.346 . . . . 0.44 112.494 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.62 -41.76 5.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.513 -0.312 . . . . 0.44 111.828 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -80.3 -13.6 59.06 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.706 0.262 . . . . 0.44 111.706 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.479 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -61.05 -52.95 62.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.752 0.31 . . . . 0.44 111.094 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -78.28 -44.64 27.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.434 -0.348 . . . . 0.44 110.921 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.466 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 45.2 t -55.87 -42.71 71.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.538 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -78.3 -49.94 12.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.916 0.388 . . . . 0.44 111.269 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.557 ' HG3' ' H1 ' ' A' 5037 ' ' HOH . 0.0 OUTLIER -68.4 -20.01 64.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.44 111.254 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -56.71 -45.06 82.07 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.44 110.103 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -31.88 71.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.431 -0.581 . . . . 0.44 109.431 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -76.75 -25.35 53.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.6 -0.727 . . . . 0.44 109.981 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -106.42 6.59 30.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.44 111.544 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.569 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 0.5 OUTLIER -133.45 -44.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.135 0.493 . . . . 0.44 109.793 179.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.524 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.67 -37.17 0.17 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.553 -0.749 . . . . 0.44 114.65 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 58' ' ' VAL . 0.6 OUTLIER -85.06 -174.32 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.889 0.376 . . . . 0.44 110.796 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.11 88.59 12.52 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-N 115.926 -0.579 . . . . 0.44 110.469 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.623 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.7 Cg_endo -111.13 145.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.471 2.78 . . . . 0.44 113.886 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 11.5 mt-30 -74.86 79.82 2.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.63 -1.989 . . . . 0.44 105.63 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.568 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.07 127.43 51.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.095 -1.411 . . . . 0.44 110.596 -176.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 86' ' ' LEU . 17.4 t80 179.85 168.15 1.22 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.27 0.47 . . . . 0.44 112.27 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 82.28 149.83 0.09 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.666 -0.697 . . . . 0.44 110.696 179.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -105.69 128.76 53.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.44 111.077 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -80.5 -38.36 29.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.44 110.426 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 2.0 tt0 -171.29 160.65 6.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.44 110.336 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -143.25 132.2 22.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.968 0.414 . . . . 0.44 111.233 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.11 130.2 56.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.058 -0.519 . . . . 0.44 110.431 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -123.15 109.97 14.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.44 110.562 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -141.17 150.58 42.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.44 110.731 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.26 123.09 41.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.125 0.488 . . . . 0.44 111.121 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.99 163.15 63.61 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.578 -0.737 . . . . 0.44 110.46 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.8 Cg_endo -52.36 82.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.028 2.485 . . . . 0.44 112.097 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 8.8 t70 96.19 15.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.345 -0.843 . . . . 0.44 111.152 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -137.35 149.91 47.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.44 110.635 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -120.35 93.98 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.478 -0.328 . . . . 0.44 110.453 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.422 ' CD1' " H2'" ' A' ' 131' ' ' 8OG . 4.6 tt -100.56 111.94 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.44 111.23 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.3 118.73 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.44 110.24 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.43 HD23 ' CE1' ' A' ' 84' ' ' PHE . 5.5 tp -110.84 114.25 27.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.44 111.336 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -110.34 122.49 47.82 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.081 -0.509 . . . . 0.44 110.547 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.43 ' CE1' HD23 ' A' ' 82' ' ' LEU . 2.8 m-30 -105.37 109.82 21.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.952 -0.567 . . . . 0.44 110.174 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.596 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 35.0 m95 -99.39 148.67 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.512 . . . . 0.44 112.013 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 65' ' ' PHE . 31.2 tp -96.54 138.6 33.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.571 -0.741 . . . . 0.44 111.571 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.568 HG13 ' HA ' ' A' ' 64' ' ' HIS . 35.1 t -123.61 145.35 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-N 115.55 -0.75 . . . . 0.44 110.237 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.66 -24.48 9.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.252 1.204 . . . . 0.44 114.252 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.8 tpt180 -162.86 162.39 26.39 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.183 -0.607 . . . . 0.44 111.574 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.649 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -157.09 123.92 5.09 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.228 -0.442 . . . . 0.44 111.214 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.45 146.17 40.91 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.149 -0.478 . . . . 0.44 111.251 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.3 -126.73 43.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.876 -0.678 . . . . 0.44 112.723 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 60' ' ' ILE . 22.7 mt-10 -125.15 143.74 45.19 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 110.486 -0.19 . . . . 0.44 110.486 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.406 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 3.9 Cg_exo -76.48 128.64 10.48 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.713 2.275 . . . . 0.44 111.434 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.524 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 64.3 p-90 -131.93 -56.69 0.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.522 -0.471 . . . . 0.44 111.787 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.569 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.92 -95.04 0.01 OUTLIER Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.89 -0.672 . . . . 0.44 113.111 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -179.1 33.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.653 0.263 . . . . 0.44 111.196 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -76.8 -37.1 56.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.98 0.419 . . . . 0.44 110.243 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.13 30.1 51.85 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.018 -0.61 . . . . 0.44 113.101 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -140.35 91.63 9.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.055 0.455 . . . . 0.44 111.503 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -47.59 133.55 21.21 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.096 2.531 . . . . 0.44 112.428 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.07 177.09 19.4 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.504 -0.855 . . . . 0.44 112.914 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 105' ' ' MET . 2.6 mt-10 -142.5 157.81 44.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.539 0.209 . . . . 0.44 110.491 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.485 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.3 m0 -66.63 106.59 1.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.684 0.278 . . . . 0.44 110.537 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 2.9 mmm -119.89 148.19 43.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.404 -0.362 . . . . 0.44 110.944 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.04 114.78 8.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.476 . . . . 0.44 110.8 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.0 -28.28 68.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.44 110.919 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.49 -22.79 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.121 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -109.84 34.38 5.49 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.741 -0.742 . . . . 0.44 112.497 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.78 139.52 58.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.153 -0.314 . . . . 0.44 110.153 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.03 131.26 53.63 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.735 0.643 . . . . 0.44 112.735 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.59 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.4 -15.14 61.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.342 -0.845 . . . . 0.44 110.547 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -78.62 -49.44 13.21 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.402 -0.363 . . . . 0.44 111.703 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -35.75 79.74 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.791 0.329 . . . . 0.44 111.225 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.92 174.13 6.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.302 -0.408 . . . . 0.44 110.127 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.499 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 53.7 Cg_endo -70.11 127.75 14.75 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.026 1.818 . . . . 0.44 111.705 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.93 -15.04 46.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.6 2.2 . . . . 0.44 113.085 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.19 -9.46 58.74 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.029 0.381 . . . . 0.44 112.029 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.438 ' ND2' ' N1 ' ' A' ' 131' ' ' 8OG . 1.0 OUTLIER -120.37 31.91 6.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.747 0.308 . . . . 0.44 111.426 -178.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -73.14 -36.28 3.19 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 112.546 0.573 . . . . 0.44 112.546 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 70.4 Cg_exo -50.98 -44.97 39.04 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 121.92 1.747 . . . . 0.44 112.699 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.41 -51.21 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.413 . . . . 0.44 111.097 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.571 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.8 mm -62.83 -32.9 57.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.895 -0.593 . . . . 0.44 111.232 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.02 -33.72 62.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.08 0.467 . . . . 0.44 110.553 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -66.84 -49.65 65.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.44 110.843 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.14 -26.07 47.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.44 111.144 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -58.21 -42.6 86.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.002 0.43 . . . . 0.44 110.778 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.6 ttm-85 -73.86 -5.32 40.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.726 -0.67 . . . . 0.44 109.953 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.461 0.095 0 CA-C-N 116.002 -0.544 . . . . 0.44 111.325 179.769 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.488 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 5035 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 5036 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 5037 ' ' HOH . . . . . 0.557 ' H1 ' ' HG3' ' A' ' 53' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 5038 ' ' HOH . . . . . 0.446 ' H1 ' ' HG2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mtt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.808 0.337 . . . . 0.44 111.183 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -89.54 138.52 31.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.44 110.97 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.27 37.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.44 110.903 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.445 ' CD1' " O3'" ' A' ' 131' ' ' 8OG . 3.9 pp -145.98 122.53 11.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.44 111.022 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -102.69 148.38 25.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.347 0.594 . . . . 0.44 111.888 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.437 HG13 " C2'" ' A' ' 131' ' ' 8OG . 31.5 mm -146.48 130.77 10.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.091 -0.959 . . . . 0.44 109.833 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.43 124.46 42.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.322 -0.251 . . . . 0.44 110.322 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.521 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -118.63 162.94 16.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.235 0.54 . . . . 0.44 111.933 -179.387 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.0 112.83 0.55 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.378 -0.828 . . . . 0.44 112.402 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.49 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -70.79 105.68 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.371 -0.603 . . . . 0.44 109.371 179.389 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 1.2 mt -71.54 124.0 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 112.635 0.606 . . . . 0.44 112.635 -177.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.28 126.86 34.04 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.695 -0.684 . . . . 0.44 111.456 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.557 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 24.8 t-20 -70.43 177.37 3.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.212 -0.904 . . . . 0.44 112.119 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.557 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 8.8 tt0 -56.62 -18.58 12.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.358 -1.292 . . . . 0.44 112.404 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -120.55 -82.74 0.65 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.615 0.245 . . . . 0.44 111.243 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.73 15.54 0.36 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.547 -0.297 . . . . 0.44 111.616 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 3.6 mt-10 -100.93 160.39 14.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.462 -0.57 . . . . 0.44 109.462 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 3.4 mt -138.12 140.72 39.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.014 0.435 . . . . 0.44 111.609 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.438 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -89.75 116.46 27.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.44 110.375 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.456 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.36 125.59 70.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.239 -0.437 . . . . 0.44 110.419 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 34' ' ' GLU . 15.0 p -75.46 111.85 11.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.82 0.343 . . . . 0.44 110.495 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' ALA . 45.3 ttp180 -96.86 170.36 9.22 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.925 -0.398 . . . . 0.44 109.925 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -69.84 59.96 0.16 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.165 0.507 . . . . 0.44 109.95 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . 58.32 -171.32 0.11 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.72 -0.673 . . . . 0.44 111.278 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.03 -71.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.44 111.145 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -160.49 155.35 24.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.44 110.975 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -175.52 -76.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.44 111.084 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -145.39 -62.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.44 110.763 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.6 ptp -94.32 52.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.44 110.735 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.05 -8.65 56.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.44 111.654 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -92.32 29.37 1.69 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.563 0.221 . . . . 0.44 111.476 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -114.54 26.32 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.44 111.585 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.7 tt -45.42 122.71 3.67 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.934 -0.576 . . . . 0.44 110.812 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 21' ' ' THR . 53.6 mt-10 -145.96 -175.32 4.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.894 0.378 . . . . 0.44 111.443 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.07 162.09 35.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.44 111.239 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 10.3 Cg_endo -50.09 167.91 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.387 2.725 . . . . 0.44 111.715 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.23 59.47 0.76 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 119.921 -1.133 . . . . 0.44 113.825 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.615 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.54 120.01 2.74 Favored Glycine 0 C--N 1.312 -0.78 0 CA-C-N 114.791 -0.705 . . . . 0.44 112.023 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.733 ' CG ' ' H2 ' ' A' 5049 ' ' HOH . 0.0 OUTLIER 114.09 3.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.313 0.645 . . . . 0.44 111.937 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.2 pt -53.64 -26.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.43 0.633 . . . . 0.44 110.569 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.538 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.12 -82.62 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.769 -1.105 . . . . 0.44 111.143 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 34.87 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.39 0.432 . . . . 0.44 111.886 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.89 31.24 0.14 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.819 -0.705 . . . . 0.44 112.623 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -91.24 -174.38 3.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.75 0.31 . . . . 0.44 111.189 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.533 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.68 154.85 36.94 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.44 110.352 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.8 Cg_endo -44.53 -24.86 1.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.735 2.29 . . . . 0.44 112.603 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -102.2 -42.91 5.88 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.964 0.357 . . . . 0.44 111.964 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -80.22 -16.07 55.6 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 111.638 0.236 . . . . 0.44 111.638 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.454 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -60.08 -50.49 73.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.562 -0.29 . . . . 0.44 111.146 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.467 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -78.1 -45.11 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.798 0.332 . . . . 0.44 110.884 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.467 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 45.2 t -53.71 -37.92 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.219 -0.446 . . . . 0.44 110.92 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -51.99 9.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.987 -0.551 . . . . 0.44 111.018 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.8 mm-40 -63.97 -22.07 66.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.44 110.907 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.468 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 1.0 OUTLIER -56.47 -44.62 80.75 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.979 0.419 . . . . 0.44 110.409 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -62.96 -34.64 77.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.272 -0.64 . . . . 0.44 109.272 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.6 tm-20 -77.47 -25.0 50.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.221 -0.9 . . . . 0.44 111.14 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 69.2 mm-40 -108.15 5.36 25.82 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.889 0.329 . . . . 0.44 111.889 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.513 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 31.4 t -134.71 -44.26 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.183 0.516 . . . . 0.44 109.793 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.543 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.83 -41.1 0.32 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.308 -0.86 . . . . 0.44 113.711 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.501 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.66 -176.53 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.016 0.436 . . . . 0.44 111.057 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.04 88.87 12.76 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 115.575 -0.739 . . . . 0.44 109.991 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.644 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.1 Cg_endo -109.48 145.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.287 2.658 . . . . 0.44 113.917 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 11.8 mt-30 -74.78 79.76 2.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 105.54 -2.022 . . . . 0.44 105.54 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.578 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.81 128.06 52.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.137 -1.392 . . . . 0.44 110.926 -176.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.7 t80 -179.22 168.46 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.44 111.991 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.3 p 83.07 158.0 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.765 -0.652 . . . . 0.44 110.827 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -110.83 137.9 47.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.0 0.429 . . . . 0.44 111.381 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -94.92 -32.46 13.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.964 -0.562 . . . . 0.44 110.264 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.491 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 17.8 tt0 -171.38 155.57 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.766 -0.652 . . . . 0.44 110.393 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.51 132.03 22.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.711 0.291 . . . . 0.44 110.95 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.402 HD22 ' CB ' ' A' ' 82' ' ' LEU . 2.5 pt? -129.19 132.36 47.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.44 110.851 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -127.28 109.93 12.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.44 110.558 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.425 ' CE2' HG22 ' A' ' 80' ' ' ILE . 3.0 p90 -132.24 153.04 51.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.44 110.491 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.422 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 5.4 pt-20 -118.74 138.61 52.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.158 0.504 . . . . 0.44 111.406 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -98.81 163.06 19.59 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.498 -0.774 . . . . 0.44 110.209 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 6.0 Cg_endo -48.09 81.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.11 2.54 . . . . 0.44 112.342 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 m-20 85.61 13.55 0.18 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.413 -0.812 . . . . 0.44 111.586 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -137.44 93.83 2.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 0.44 110.998 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 64.4 t-80 -75.02 112.47 11.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.44 110.573 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.425 HG22 ' CE2' ' A' ' 73' ' ' TYR . 3.7 tt -109.7 112.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.44 111.325 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.11 124.03 47.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.033 -0.53 . . . . 0.44 110.241 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.538 ' CD2' ' N3 ' ' A' ' 131' ' ' 8OG . 20.6 mt -126.02 114.93 19.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.863 0.364 . . . . 0.44 111.607 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -106.48 122.48 46.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.44 110.523 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.3 m-85 -99.07 109.66 22.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.204 -0.453 . . . . 0.44 110.211 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 25.5 m95 -97.24 148.66 22.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.19 0.519 . . . . 0.44 112.358 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 65' ' ' PHE . 25.0 tp -95.94 138.68 33.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.454 -0.793 . . . . 0.44 111.132 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.578 HG13 ' HA ' ' A' ' 64' ' ' HIS . 33.2 t -123.47 145.88 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.848 -0.614 . . . . 0.44 110.459 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.3 -24.59 9.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.151 1.167 . . . . 0.44 114.151 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.511 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 5.4 tpt180 -162.64 162.43 27.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.548 0.613 . . . . 0.44 111.544 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.644 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -155.08 124.91 6.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.195 -0.457 . . . . 0.44 111.24 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.43 148.32 39.22 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.134 -0.485 . . . . 0.44 111.156 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.33 -129.27 43.21 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.887 -0.673 . . . . 0.44 112.54 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -122.73 144.16 41.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.573 0.225 . . . . 0.44 110.678 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.479 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.43 128.72 10.57 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.778 2.319 . . . . 0.44 111.493 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.543 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -132.41 -58.02 0.94 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.59 -0.444 . . . . 0.44 111.649 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.513 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.72 -99.61 0.02 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.658 -0.782 . . . . 0.44 112.924 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 175.0 38.49 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.6 0.238 . . . . 0.44 111.209 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -70.53 -11.73 61.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.714 0.292 . . . . 0.44 111.253 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.74 20.17 68.03 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.026 -0.607 . . . . 0.44 113.378 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -140.48 97.51 7.48 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.84 0.352 . . . . 0.44 111.384 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.62 132.71 7.53 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.836 2.357 . . . . 0.44 112.51 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.05 177.12 19.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.569 -0.824 . . . . 0.44 112.823 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -149.49 157.27 43.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.529 0.204 . . . . 0.44 110.516 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -71.24 106.78 3.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.824 0.345 . . . . 0.44 110.116 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.3 ptp -119.86 152.06 37.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.44 110.998 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.2 p -75.26 114.89 14.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.44 110.606 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.422 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -57.92 -20.56 38.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.44 111.24 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.67 -21.24 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.466 -0.334 . . . . 0.44 111.48 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.36 31.92 8.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.772 -0.728 . . . . 0.44 112.678 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.458 HD11 ' CG2' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -62.51 126.97 29.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.64 0.257 . . . . 0.44 110.324 179.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.417 ' N ' HD12 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -123.33 130.63 52.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.5 0.556 . . . . 0.44 112.5 -179.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.623 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.17 -14.7 61.88 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.463 -0.79 . . . . 0.44 110.146 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -78.31 -49.01 14.43 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.191 -0.459 . . . . 0.44 111.617 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -39.8 88.33 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.75 0.309 . . . . 0.44 110.913 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.623 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -79.06 172.1 10.78 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.283 -0.417 . . . . 0.44 109.995 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.534 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.7 Cg_endo -70.77 127.33 13.65 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 121.976 1.784 . . . . 0.44 111.404 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.57 -14.84 42.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.617 2.212 . . . . 0.44 113.275 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.65 -9.32 58.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.286 0.476 . . . . 0.44 112.286 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.98 36.7 4.55 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.942 0.349 . . . . 0.44 111.942 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -69.75 -41.03 14.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 112.111 0.412 . . . . 0.44 112.111 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.2 Cg_exo -55.23 -40.58 84.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.052 1.835 . . . . 0.44 112.625 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.44 -51.26 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.548 . . . . 0.44 110.793 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.52 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -66.12 -29.87 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.402 -0.817 . . . . 0.44 111.187 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.85 -31.97 60.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.049 0.452 . . . . 0.44 110.226 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -52.35 57.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.667 -0.697 . . . . 0.44 110.886 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tp -78.12 -29.81 49.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.44 111.24 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -55.98 -42.56 76.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.44 111.128 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -74.22 -4.78 38.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 0.44 110.115 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 116.031 -0.531 . . . . 0.44 111.189 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.538 ' N3 ' ' CD2' ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 5047 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 5048 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 5049 ' ' HOH . . . . . 0.733 ' H2 ' ' CG ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 5050 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 mtt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.774 0.321 . . . . 0.44 111.189 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -79.93 133.34 36.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.44 110.925 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.03 131.91 27.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.44 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.714 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 3.0 pp -146.17 118.98 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.44 110.602 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 28.7 mt-30 -101.91 156.76 17.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.265 0.555 . . . . 0.44 112.219 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.454 HG12 H2'' ' A' ' 131' ' ' 8OG . 1.7 mp -146.19 130.76 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.434 -0.803 . . . . 0.44 110.575 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.585 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.44 124.43 42.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.928 -0.397 . . . . 0.44 109.928 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.457 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -127.99 158.36 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.915 0.388 . . . . 0.44 111.724 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.404 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.25 137.5 6.06 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.603 -0.726 . . . . 0.44 111.966 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.447 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.22 111.97 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.179 -0.304 . . . . 0.44 110.179 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 90' ' ' TRP . 1.5 mt -71.68 123.74 26.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.44 111.54 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -84.32 122.77 29.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.871 -0.604 . . . . 0.44 111.484 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.515 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.0 t-20 -79.65 -172.69 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.11 -0.95 . . . . 0.44 111.855 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.502 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -82.74 0.61 42.75 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.366 -1.288 . . . . 0.44 111.935 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -136.98 50.58 2.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.911 0.386 . . . . 0.44 111.241 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.51 26.38 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.163 -0.471 . . . . 0.44 111.263 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 13' ' ' ASN . 16.1 pt-20 -116.82 153.25 32.8 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.452 -0.573 . . . . 0.44 109.452 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 11' ' ' ILE . 5.2 mt -130.36 142.17 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 0.44 111.588 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.91 123.16 35.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.44 110.854 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.503 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -113.69 124.77 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.386 -0.37 . . . . 0.44 110.531 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 t -72.44 111.71 7.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 0.44 110.718 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.4 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 20.3 ptt180 -95.45 172.07 8.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.44 110.859 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.87 -12.2 23.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.44 111.102 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 78.5 0.57 2.58 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.082 -0.508 . . . . 0.44 111.813 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 50.03 29.69 3.64 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.785 0.326 . . . . 0.44 111.433 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -87.84 75.25 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.44 110.949 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 57.18 31.31 19.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.44 111.178 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -141.3 178.65 7.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.44 110.822 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.6 mtt -59.97 91.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.44 110.867 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.35 -8.91 56.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.44 111.641 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -93.19 23.4 4.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.575 0.226 . . . . 0.44 111.458 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.33 26.2 10.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.44 111.394 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -43.35 116.55 0.95 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.838 -0.619 . . . . 0.44 110.403 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -170.85 2.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.24 0.543 . . . . 0.44 112.056 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.503 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.77 165.69 16.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.44 111.097 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 47.5 Cg_endo -67.7 167.51 20.91 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.087 2.525 . . . . 0.44 111.533 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.09 59.13 0.77 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.806 -1.188 . . . . 0.44 113.914 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -123.39 127.32 6.56 Favored Glycine 0 C--N 1.311 -0.828 0 CA-C-N 114.841 -0.68 . . . . 0.44 112.021 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER 100.39 6.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.142 0.577 . . . . 0.44 112.211 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.585 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.1 pt -50.34 -29.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.744 0.783 . . . . 0.44 110.118 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.557 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.86 -81.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.32 -1.309 . . . . 0.44 111.22 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.6 mmt 40.16 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.269 0.356 . . . . 0.44 111.548 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.0 29.83 0.14 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.815 -0.707 . . . . 0.44 112.669 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -95.07 -173.31 2.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.736 0.303 . . . . 0.44 111.122 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.555 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.95 158.01 34.12 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.42 -0.355 . . . . 0.44 110.37 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 5.9 Cg_endo -46.74 -24.71 3.14 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.668 2.245 . . . . 0.44 112.375 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.54 -44.19 5.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.296 -0.411 . . . . 0.44 111.888 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -80.19 -12.63 59.62 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.72 0.267 . . . . 0.44 111.72 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.482 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -60.54 -54.02 50.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 0.44 110.925 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -78.14 -44.21 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.075 -0.511 . . . . 0.44 111.587 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -50.52 -37.77 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.37 . . . . 0.44 110.805 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -78.6 -49.49 13.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.47 . . . . 0.44 110.791 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.0 -19.83 66.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 0.44 111.036 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' VAL . 2.7 tp -59.53 -44.71 93.11 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.788 0.328 . . . . 0.44 110.629 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.18 -34.21 77.55 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.079 -0.711 . . . . 0.44 109.079 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 97' ' ' LYS . 5.5 tm-20 -77.35 -24.13 50.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.35 -0.841 . . . . 0.44 110.832 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.482 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 50.3 mm-40 -108.29 5.66 25.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.483 -0.326 . . . . 0.44 111.768 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.567 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 41.7 t -134.2 -44.27 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.166 0.508 . . . . 0.44 109.656 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.529 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.89 -39.74 0.25 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.397 -0.819 . . . . 0.44 113.994 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.495 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.7 -177.43 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.018 0.437 . . . . 0.44 111.026 -179.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.83 88.54 14.31 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 115.695 -0.684 . . . . 0.44 109.807 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.618 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.0 Cg_endo -111.71 145.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 123.406 2.737 . . . . 0.44 113.994 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 36.7 mt-30 -74.86 79.63 2.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.604 -1.999 . . . . 0.44 105.604 175.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.559 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -120.11 128.67 53.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.145 -1.389 . . . . 0.44 110.832 -176.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.8 t80 -179.51 168.71 1.42 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.44 111.981 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER 83.91 155.66 0.1 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.742 -0.663 . . . . 0.44 110.675 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -113.84 123.11 49.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.44 111.212 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.83 -38.19 54.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 0.44 110.074 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -171.3 141.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.63 -0.714 . . . . 0.44 110.349 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.46 132.18 22.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.671 0.272 . . . . 0.44 110.939 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.426 ' CD2' ' CG2' ' A' ' 122' ' ' VAL . 4.4 pp -124.46 164.69 19.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.315 . . . . 0.44 110.954 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -139.77 116.91 11.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.44 110.733 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -141.15 153.07 45.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.44 110.654 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -118.34 124.28 47.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.44 111.319 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.0 163.22 61.32 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.581 -0.736 . . . . 0.44 110.477 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.487 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -52.8 82.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.989 2.459 . . . . 0.44 112.19 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 7.7 t0 90.92 10.73 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.425 -0.807 . . . . 0.44 111.479 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -137.36 95.89 3.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.294 . . . . 0.44 110.809 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -80.4 106.58 12.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.523 -0.308 . . . . 0.44 110.263 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 3.6 pt -120.39 127.09 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.131 0.491 . . . . 0.44 112.119 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.26 118.68 34.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.712 -0.676 . . . . 0.44 110.041 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.557 HD12 ' N2 ' ' A' ' 131' ' ' 8OG . 4.4 tp -104.78 113.7 27.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.44 110.965 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.402 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 9.6 m0 -115.58 122.52 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.574 . . . . 0.44 111.053 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.1 m-30 -105.32 109.68 21.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.951 -0.568 . . . . 0.44 109.702 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 66.0 m95 -94.85 148.67 22.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.882 -0.599 . . . . 0.44 112.307 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 65' ' ' PHE . 65.6 tp -94.52 138.28 32.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.621 -0.718 . . . . 0.44 110.917 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 64' ' ' HIS . 27.0 t -123.96 145.81 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 CA-C-N 115.894 -0.593 . . . . 0.44 110.418 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -112.82 -24.57 9.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.215 1.191 . . . . 0.44 114.215 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -162.79 160.73 25.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.595 0.634 . . . . 0.44 111.484 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.618 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -157.19 121.66 4.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.181 -0.463 . . . . 0.44 111.164 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -77.21 155.31 32.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.064 -0.516 . . . . 0.44 111.214 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.37 -132.78 46.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.901 -0.666 . . . . 0.44 112.619 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.2 mt-10 -122.2 147.06 48.44 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.577 0.227 . . . . 0.44 110.694 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.48 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.62 128.64 10.36 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.85 2.367 . . . . 0.44 111.353 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.529 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 63.4 p-90 -136.59 -58.84 0.73 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.462 -0.495 . . . . 0.44 111.892 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.567 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.49 -96.4 0.01 OUTLIER Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.765 -0.731 . . . . 0.44 112.939 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.7 tmtt? 177.67 33.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.584 0.231 . . . . 0.44 111.173 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -29.01 68.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.7 0.286 . . . . 0.44 110.679 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.91 -2.12 71.91 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.717 -0.754 . . . . 0.44 113.719 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -140.12 95.46 8.43 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.259 0.529 . . . . 0.44 111.556 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -43.71 141.04 4.19 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.909 2.406 . . . . 0.44 112.497 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.23 171.56 22.14 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.578 -0.82 . . . . 0.44 112.871 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.55 157.17 39.5 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.387 -0.227 . . . . 0.44 110.387 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.53 106.44 6.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.898 0.38 . . . . 0.44 110.523 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.405 ' HG2' ' CD1' ' A' ' 20' ' ' ILE . 5.1 ppp? -120.28 155.87 32.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.44 111.041 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.2 t -70.3 114.93 8.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.375 . . . . 0.44 110.579 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -18.98 60.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.44 111.341 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 t -57.45 -16.88 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.36 . . . . 0.44 111.458 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.06 43.54 1.43 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.842 -0.694 . . . . 0.44 112.432 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.7 tp -62.4 146.98 49.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.185 -0.302 . . . . 0.44 110.185 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.11 126.81 47.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.574 0.583 . . . . 0.44 112.574 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.58 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.33 -15.16 61.88 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.166 -0.925 . . . . 0.44 110.733 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -78.28 -49.39 13.77 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.864 0.32 . . . . 0.44 111.864 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -39.03 87.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.982 0.42 . . . . 0.44 110.857 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.58 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -80.11 173.82 7.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.946 -0.57 . . . . 0.44 110.341 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.2 Cg_endo -72.26 127.76 13.04 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.162 1.908 . . . . 0.44 111.697 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.89 -14.95 44.24 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.693 2.262 . . . . 0.44 113.061 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.42 58.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.033 0.382 . . . . 0.44 112.033 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -121.67 32.6 5.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.695 0.283 . . . . 0.44 111.488 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.454 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.3 mt-10 -73.77 -46.88 6.98 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 112.158 0.429 . . . . 0.44 112.158 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 80.9 Cg_exo -44.8 -35.05 9.19 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.33 2.02 . . . . 0.44 112.525 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.458 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 12.5 t -77.35 -43.39 30.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.066 0.46 . . . . 0.44 110.127 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.542 HG13 ' CE2' ' A' ' 115' ' ' PHE . 15.5 mm -67.65 -34.41 67.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 CA-C-N 115.685 -0.688 . . . . 0.44 110.888 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.4 -26.61 31.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.983 0.421 . . . . 0.44 110.465 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.13 -52.72 7.44 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.928 -0.578 . . . . 0.44 111.712 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -33.48 50.25 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.725 0.298 . . . . 0.44 111.519 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 6.0 ttpm? -53.57 -42.67 67.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.969 0.414 . . . . 0.44 111.058 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -69.37 -7.92 41.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.44 109.87 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-N 115.957 -0.565 . . . . 0.44 111.33 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.557 ' N2 ' HD12 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 5059 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 5060 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 5061 ' ' HOH . . . . . 0.429 ' H2 ' ' HE2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 5062 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 mtm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.795 0.331 . . . . 0.44 111.194 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.22 131.53 41.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.44 110.768 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -140.08 131.65 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.44 110.935 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 pp -126.02 127.53 46.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.44 110.837 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -102.96 152.2 21.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.182 0.515 . . . . 0.44 111.255 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.526 HG12 H2'' ' A' ' 131' ' ' 8OG . 2.7 mp -143.9 139.02 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.608 -0.724 . . . . 0.44 110.355 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.766 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -125.16 125.46 43.73 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 110.153 -0.314 . . . . 0.44 110.153 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.452 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -134.53 151.43 31.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.363 0.602 . . . . 0.44 111.833 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.46 122.11 1.3 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.162 -0.926 . . . . 0.44 111.907 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.556 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.56 114.26 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.787 -0.449 . . . . 0.44 109.787 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.467 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -71.31 121.7 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.024 0.44 . . . . 0.44 111.553 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.7 119.41 24.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.783 -0.644 . . . . 0.44 111.5 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.546 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.1 t-20 -79.04 -172.64 3.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.275 -0.875 . . . . 0.44 111.967 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.522 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 1.1 tm-20 -81.43 0.91 35.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.446 -1.252 . . . . 0.44 112.118 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -139.47 52.28 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.44 111.27 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.8 p30 45.61 26.59 0.34 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.099 -0.501 . . . . 0.44 111.358 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 16.4 pt-20 -117.23 151.41 36.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.433 -0.58 . . . . 0.44 109.433 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 105' ' ' MET . 4.3 mt -127.93 146.78 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.034 0.445 . . . . 0.44 111.655 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.427 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -97.24 121.76 39.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.676 -0.693 . . . . 0.44 110.855 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.71 141.19 35.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.379 -0.373 . . . . 0.44 110.17 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 p -80.2 125.45 29.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.44 110.778 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 31.1 ttt180 -112.9 167.66 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.405 . . . . 0.44 110.621 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.96 62.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.028 0.442 . . . . 0.44 110.431 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 45.98 -165.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.957 -0.565 . . . . 0.44 111.433 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.8 -29.29 8.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.44 111.246 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -106.34 129.72 54.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.44 110.986 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.55 -174.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.44 111.252 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 62.77 147.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.44 110.918 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.4 mtm -59.45 95.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.44 110.94 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.28 -10.47 54.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.44 111.76 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.58 16.95 8.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.71 -0.223 . . . . 0.44 111.525 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -114.23 26.0 10.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.44 111.472 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -46.13 101.63 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.44 110.585 179.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -110.26 -169.34 1.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.03 0.443 . . . . 0.44 111.451 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.75 162.59 32.07 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.9 -0.591 . . . . 0.44 111.58 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.59 168.08 13.9 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.559 2.839 . . . . 0.44 111.989 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.766 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.41 59.17 0.76 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.263 -0.97 . . . . 0.44 113.872 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.611 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -127.64 127.73 5.89 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 114.242 -0.979 . . . . 0.44 111.688 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 111.7 -10.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.317 0.647 . . . . 0.44 110.974 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.532 ' O ' ' C ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -43.67 -74.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.848 0.356 . . . . 0.44 110.804 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER 6.31 -82.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.974 -1.012 . . . . 0.44 112.107 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 36.32 -141.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.105 -0.498 . . . . 0.44 111.373 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.9 11.27 9.44 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.558 -0.829 . . . . 0.44 113.077 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -169.08 0.29 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.585 0.231 . . . . 0.44 110.683 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.532 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.17 155.33 38.72 Favored Pre-proline 0 N--CA 1.454 -0.25 0 N-CA-C 109.865 -0.42 . . . . 0.44 109.865 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.74 -24.59 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.584 2.19 . . . . 0.44 112.226 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.6 -59.85 2.1 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.234 -0.439 . . . . 0.44 112.127 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -80.85 -4.84 56.19 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.293 0.479 . . . . 0.44 112.293 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.53 ' CB ' HD11 ' A' ' 40' ' ' ILE . . . -66.04 -57.26 8.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.638 0.256 . . . . 0.44 111.178 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.447 ' HB ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.55 -41.16 24.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.59 -0.277 . . . . 0.44 111.158 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.6 t -50.42 -35.62 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.44 110.811 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -78.35 -52.05 9.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 0.44 111.053 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.18 -23.37 66.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.44 110.763 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.439 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 2.2 tp -57.45 -44.66 84.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.307 -0.406 . . . . 0.44 110.782 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -62.74 -27.9 69.59 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.354 -0.61 . . . . 0.44 109.354 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.25 -27.03 53.13 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.481 -0.781 . . . . 0.44 111.001 179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -108.69 6.15 25.49 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.381 0.511 . . . . 0.44 112.381 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.542 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 25.4 t -133.51 -44.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.017 0.437 . . . . 0.44 109.928 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.95 -39.02 0.19 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.636 -0.711 . . . . 0.44 114.018 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.508 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.58 -176.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.979 0.419 . . . . 0.44 110.984 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.25 88.72 13.09 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 115.748 -0.66 . . . . 0.44 110.117 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.632 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.4 Cg_endo -111.41 144.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.426 2.75 . . . . 0.44 114.146 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.46 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 35.1 mt-30 -74.82 79.93 2.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.241 -2.133 . . . . 0.44 105.241 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.608 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.49 129.09 53.7 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.133 -1.394 . . . . 0.44 111.654 -175.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -177.77 -138.25 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.755 -0.657 . . . . 0.44 110.503 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.73 163.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.162 0.506 . . . . 0.44 112.045 179.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.1 tt -124.55 109.82 13.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.64 -0.709 . . . . 0.44 110.749 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.87 -43.43 35.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.44 110.164 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.4 tt0 -171.63 163.66 6.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.776 -0.647 . . . . 0.44 110.429 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.33 114.19 7.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.476 -0.329 . . . . 0.44 110.88 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -102.73 121.93 43.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 0.44 110.811 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -124.54 109.79 13.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.44 110.744 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.426 ' CZ ' HG22 ' A' ' 80' ' ' ILE . 2.5 p90 -141.09 152.1 44.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.44 110.635 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -121.17 118.82 30.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.047 0.451 . . . . 0.44 111.332 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -69.9 163.64 58.81 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.736 -0.666 . . . . 0.44 110.281 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -52.37 83.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.066 2.511 . . . . 0.44 112.362 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 4.6 t70 98.02 14.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.271 -0.877 . . . . 0.44 111.387 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.449 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -137.36 147.14 45.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.439 -0.346 . . . . 0.44 110.67 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.25 96.06 4.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.44 110.54 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.426 HG22 ' CZ ' ' A' ' 73' ' ' TYR . 1.1 tt -102.81 115.37 44.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 0.44 111.196 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.14 118.92 37.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.89 -0.596 . . . . 0.44 110.22 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.6 mt -118.69 114.57 22.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.44 111.489 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -104.81 122.51 45.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.057 -0.52 . . . . 0.44 110.217 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.428 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 4.4 m-30 -103.54 109.84 21.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.44 111.016 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 44.6 m95 -94.84 148.58 22.15 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.675 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.528 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.9 tm? -101.28 102.92 13.88 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.399 0.619 . . . . 0.44 111.75 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 64' ' ' HIS . 15.0 t -79.39 145.71 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-N 115.045 -0.98 . . . . 0.44 110.691 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -115.19 -23.02 9.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 114.214 1.19 . . . . 0.44 114.214 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -162.37 160.22 26.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.6 0.637 . . . . 0.44 111.556 -179.029 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.632 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -157.08 121.47 4.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.44 111.124 178.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.56 148.78 42.67 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.0 -0.545 . . . . 0.44 111.198 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.53 -128.93 47.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.804 -0.712 . . . . 0.44 112.589 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.0 mt-10 -123.57 147.57 53.35 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.615 0.245 . . . . 0.44 110.641 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.427 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 4.3 Cg_exo -76.47 128.71 10.53 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.793 2.329 . . . . 0.44 111.105 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.558 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.2 p-90 -135.5 -62.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.122 -0.631 . . . . 0.44 112.546 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.542 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.06 -97.75 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.64 -0.79 . . . . 0.44 112.614 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.9 tttp 171.32 34.98 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.578 0.228 . . . . 0.44 111.344 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -29.21 64.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.74 0.305 . . . . 0.44 110.568 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.44 64.72 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.777 -0.725 . . . . 0.44 113.374 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -140.18 94.78 8.6 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.007 0.432 . . . . 0.44 111.441 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.61 138.67 5.36 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.996 2.464 . . . . 0.44 112.398 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.4 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.19 177.07 19.43 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.628 -0.796 . . . . 0.44 112.915 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -142.06 157.31 45.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.58 0.229 . . . . 0.44 110.447 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -69.38 106.99 3.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.881 0.372 . . . . 0.44 110.332 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtt -119.68 163.13 17.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.134 -0.484 . . . . 0.44 110.837 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 p -80.36 114.75 19.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.405 -0.361 . . . . 0.44 110.925 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.23 -27.09 38.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.44 111.149 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -51.96 -23.46 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.44 111.493 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.21 44.62 1.22 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.677 -0.773 . . . . 0.44 112.591 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.57 150.24 41.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.588 0.232 . . . . 0.44 110.387 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.95 133.4 56.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.21 0.528 . . . . 0.44 112.344 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.588 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.15 -15.39 61.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.461 -0.79 . . . . 0.44 110.567 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.59 -49.13 13.8 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.208 -0.451 . . . . 0.44 111.538 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -33.8 76.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.849 0.357 . . . . 0.44 111.002 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -86.91 173.44 6.66 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.916 -0.402 . . . . 0.44 109.916 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.458 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.4 Cg_endo -67.7 127.69 16.71 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 121.947 1.765 . . . . 0.44 111.967 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.87 -20.56 58.24 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.519 2.146 . . . . 0.44 112.922 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.83 -9.49 58.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.883 0.327 . . . . 0.44 111.883 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.92 30.38 7.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.797 0.332 . . . . 0.44 111.397 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.611 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -76.23 -32.01 1.05 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.63 0.604 . . . . 0.44 112.63 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.3 Cg_exo -49.22 -43.52 36.9 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 121.957 1.771 . . . . 0.44 113.088 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.7 t -77.56 -51.32 18.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.44 111.542 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.462 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -65.95 -34.75 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.852 -0.613 . . . . 0.44 111.541 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -28.76 50.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.82 0.343 . . . . 0.44 110.95 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -74.81 -53.26 9.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.44 111.629 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tp -78.57 -32.97 48.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.472 -0.331 . . . . 0.44 111.638 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -53.85 -42.65 68.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.967 0.413 . . . . 0.44 111.019 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -65.94 -10.79 42.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.829 -0.623 . . . . 0.44 109.731 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--O 1.231 0.111 0 CA-C-N 115.99 -0.55 . . . . 0.44 111.048 179.709 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.526 H2'' HG12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 5071 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 5072 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 5073 ' ' HOH . . . . . 0.411 ' H2 ' ' HG2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 5074 ' ' HOH . . . . . 0.51 ' H2 ' ' CD ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.823 0.344 . . . . 0.44 111.173 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.03 147.03 43.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.44 110.922 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -137.64 143.14 41.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.44 110.867 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.763 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.9 pp -146.14 120.09 9.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.44 110.757 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 7.8 mt-30 -102.12 155.48 18.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.371 0.605 . . . . 0.44 111.918 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.417 HG21 H2'' ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -146.24 121.73 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.211 -0.904 . . . . 0.44 109.855 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.612 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -122.19 124.78 44.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.558 -0.292 . . . . 0.44 110.469 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.511 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -121.36 162.92 19.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.325 0.583 . . . . 0.44 111.952 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.99 120.66 1.35 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.255 -0.884 . . . . 0.44 111.987 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.51 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.81 105.52 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.812 -0.44 . . . . 0.44 109.812 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.451 HG21 ' CE3' ' A' ' 90' ' ' TRP . 1.5 mt -71.37 121.81 22.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 0.44 111.668 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.31 127.64 34.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.884 -0.598 . . . . 0.44 111.77 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.527 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.0 t-20 -83.63 -172.53 4.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.171 -0.922 . . . . 0.44 111.636 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.511 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 28.1 tt0 -83.95 5.66 24.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.589 -1.187 . . . . 0.44 112.141 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -141.25 52.66 1.56 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.44 111.367 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.0 p30 45.46 25.15 0.21 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.159 -0.473 . . . . 0.44 111.57 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 16.4 pt-20 -117.69 144.95 44.76 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 108.877 -0.786 . . . . 0.44 108.877 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 105' ' ' MET . 9.8 mt -115.13 135.94 53.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.248 0.546 . . . . 0.44 111.978 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.479 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -80.8 116.55 20.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.313 -0.858 . . . . 0.44 109.943 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.505 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -116.94 131.14 70.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.202 -0.454 . . . . 0.44 110.851 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 34' ' ' GLU . 62.9 p -71.92 111.87 7.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.181 -0.463 . . . . 0.44 111.07 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -91.09 172.27 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.44 110.146 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.11 28.5 0.12 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.791 0.329 . . . . 0.44 110.733 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.483 ' H ' ' C ' ' A' ' 22' ' ' ARG . . . 56.36 20.96 5.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.122 -0.49 . . . . 0.44 111.62 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.98 25.08 3.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.499 -0.319 . . . . 0.44 111.478 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 p30 178.83 89.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.383 -0.371 . . . . 0.44 111.011 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -175.56 76.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.44 111.134 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.12 -79.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.44 110.883 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.16 100.31 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 0.44 110.836 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.54 -8.82 56.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.44 111.741 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -93.46 31.2 1.56 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.703 0.287 . . . . 0.44 111.395 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -113.92 26.27 10.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.094 0.473 . . . . 0.44 111.401 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.2 tt -47.45 127.88 11.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.617 -0.719 . . . . 0.44 110.772 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -156.53 -173.91 4.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.44 111.496 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.511 ' CD1' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.94 162.71 31.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.44 111.469 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 10.6 Cg_endo -51.55 168.72 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.534 2.823 . . . . 0.44 111.657 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 7' ' ' ALA . . . 102.94 59.41 0.74 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.137 -1.03 . . . . 0.44 113.923 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.05 116.28 2.04 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.53 -0.835 . . . . 0.44 111.683 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.727 ' CG ' ' H2 ' ' A' 5085 ' ' HOH . 0.0 OUTLIER 113.69 5.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.224 0.61 . . . . 0.44 111.682 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.612 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.2 pt -50.71 -28.92 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.572 0.701 . . . . 0.44 110.275 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.564 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.94 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.479 -1.237 . . . . 0.44 111.151 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' GLU . 56.6 mmm 30.83 -86.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.566 0.541 . . . . 0.44 112.054 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.84 32.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.745 -0.74 . . . . 0.44 112.524 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.2 mp0 -87.16 -174.8 5.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.827 0.346 . . . . 0.44 111.161 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.517 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.69 154.08 37.62 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.284 -0.416 . . . . 0.44 110.353 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.517 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.82 -26.33 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.835 2.357 . . . . 0.44 112.548 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -104.2 -38.72 6.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.44 111.746 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -80.29 -11.72 59.69 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.803 0.297 . . . . 0.44 111.803 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.447 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -60.01 -53.02 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.44 111.072 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.7 m -78.23 -45.87 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.197 -0.456 . . . . 0.44 111.038 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.488 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 38.9 t -56.04 -37.94 51.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.113 -0.494 . . . . 0.44 111.04 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -78.28 -47.2 18.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 0.44 110.629 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.66 -21.57 65.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.998 -0.547 . . . . 0.44 110.804 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.443 HD21 ' CG ' ' A' ' 64' ' ' HIS . 1.9 tp -55.64 -44.55 77.26 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.871 0.367 . . . . 0.44 110.534 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -34.07 77.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.368 -0.605 . . . . 0.44 109.368 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -77.39 -25.82 51.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.323 -0.853 . . . . 0.44 111.072 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.447 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 31.0 mm-40 -108.54 5.52 25.2 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.189 0.44 . . . . 0.44 112.189 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.547 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 25.8 t -134.34 -44.18 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.117 0.484 . . . . 0.44 109.96 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.99 -41.07 0.33 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.512 -0.767 . . . . 0.44 113.696 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.523 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.54 -175.52 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.983 0.421 . . . . 0.44 110.965 -179.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.3 89.0 11.48 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.683 -0.689 . . . . 0.44 110.29 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.631 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.8 Cg_endo -108.78 143.59 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.172 2.581 . . . . 0.44 114.008 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 38.4 mt-30 -74.9 79.87 2.14 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.717 -1.957 . . . . 0.44 105.717 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.596 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -119.28 129.6 54.99 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.114 -1.403 . . . . 0.44 110.682 -176.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.4 t80 178.79 167.41 0.9 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.44 111.749 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 87.06 155.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.735 -0.666 . . . . 0.44 110.476 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -102.22 156.44 17.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.05 0.453 . . . . 0.44 110.729 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -116.99 -42.81 2.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.834 -0.621 . . . . 0.44 109.866 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.6 tt0 -171.76 162.1 6.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.592 -0.731 . . . . 0.44 110.186 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -143.36 132.08 22.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.75 0.309 . . . . 0.44 110.71 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.475 ' CD2' ' CE1' ' A' ' 73' ' ' TYR . 4.4 tp -124.08 125.8 45.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.352 -0.386 . . . . 0.44 110.597 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -118.05 112.51 20.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.44 111.015 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.475 ' CE1' ' CD2' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -141.08 153.13 45.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.987 -0.551 . . . . 0.44 110.403 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -117.5 140.05 50.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.263 0.554 . . . . 0.44 111.54 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.481 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.8 m-85 -90.22 162.42 34.81 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.374 -0.83 . . . . 0.44 110.347 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 11.2 Cg_endo -54.53 82.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.884 2.389 . . . . 0.44 112.062 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 13.0 m-20 90.36 12.4 0.05 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.359 -0.837 . . . . 0.44 111.45 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -137.33 98.82 3.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.474 -0.33 . . . . 0.44 110.396 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -78.56 115.67 18.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.561 -0.29 . . . . 0.44 110.883 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.763 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 7.2 pt -118.94 154.27 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.106 0.479 . . . . 0.44 111.7 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.44 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -128.67 118.74 23.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.79 -0.641 . . . . 0.44 110.208 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.455 HD23 ' CE1' ' A' ' 84' ' ' PHE . 5.9 tp -106.28 114.31 28.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.44 111.592 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.436 ' CH2' ' HA ' ' A' ' 46' ' ' PRO . 6.7 m0 -112.11 122.63 48.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.101 -0.499 . . . . 0.44 110.088 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.455 ' CE1' HD23 ' A' ' 82' ' ' LEU . 5.1 m-30 -108.43 109.62 20.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.881 0.372 . . . . 0.44 110.433 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.458 ' CD2' HG23 ' A' ' 50' ' ' VAL . 40.8 m95 -99.96 149.08 23.8 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.1 -0.5 . . . . 0.44 112.013 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 65' ' ' PHE . 52.6 tp -92.07 138.56 31.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.749 -0.66 . . . . 0.44 111.885 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.596 HG11 ' HA ' ' A' ' 64' ' ' HIS . 21.6 t -123.75 145.97 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-N 115.394 -0.821 . . . . 0.44 110.322 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -112.8 -26.02 8.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.206 1.187 . . . . 0.44 114.206 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.471 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.47 159.69 25.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.725 0.693 . . . . 0.44 111.678 -179.012 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.631 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -152.78 123.62 7.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.102 -0.499 . . . . 0.44 111.254 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -73.17 145.63 46.17 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 116.198 -0.456 . . . . 0.44 111.101 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.8 -129.17 44.55 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.844 -0.693 . . . . 0.44 112.617 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 57.3 tt0 -122.19 142.38 36.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.521 0.2 . . . . 0.44 110.731 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.479 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.44 128.75 10.58 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.833 2.355 . . . . 0.44 111.376 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.1 p-90 -131.36 -58.59 0.99 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.592 -0.443 . . . . 0.44 111.845 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.547 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.17 -94.87 0.01 OUTLIER Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.878 -0.677 . . . . 0.44 112.909 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.37 33.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.44 110.99 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.53 -23.66 65.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.377 -0.374 . . . . 0.44 110.629 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.3 74.95 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.119 -0.563 . . . . 0.44 113.584 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.443 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 15.0 mt-30 -140.35 93.27 9.0 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.016 0.436 . . . . 0.44 111.362 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.65 134.14 7.4 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.969 2.446 . . . . 0.44 112.575 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.16 177.11 19.4 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.641 -0.79 . . . . 0.44 112.823 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -142.48 157.25 44.95 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.479 -0.193 . . . . 0.44 110.479 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -69.44 106.7 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.34 . . . . 0.44 110.219 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 18' ' ' ILE . 9.0 ptm -119.92 153.95 35.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.44 111.082 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.1 p -74.99 114.78 13.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.423 -0.353 . . . . 0.44 110.686 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -23.16 62.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.44 111.089 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.48 -19.02 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.44 111.306 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.13 44.19 1.29 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.84 -0.695 . . . . 0.44 112.393 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.64 149.4 43.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.395 -0.224 . . . . 0.44 110.395 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.2 127.07 48.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.782 0.66 . . . . 0.44 112.782 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.563 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.43 -14.58 61.73 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.267 -0.878 . . . . 0.44 110.557 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.21 -49.33 13.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.438 -0.346 . . . . 0.44 111.602 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -39.01 87.33 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.915 0.388 . . . . 0.44 110.736 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.579 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -78.9 173.93 6.91 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.972 -0.558 . . . . 0.44 110.169 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 63.7 Cg_endo -73.4 127.66 12.06 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.121 1.881 . . . . 0.44 111.606 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.14 -14.93 40.79 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.587 2.191 . . . . 0.44 113.203 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.0 -9.5 58.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.18 0.437 . . . . 0.44 112.18 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.12 31.98 5.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.68 0.276 . . . . 0.44 111.427 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.3 mt-10 -72.95 -36.0 3.16 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.475 0.546 . . . . 0.44 112.475 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 69.3 Cg_exo -51.15 -45.87 34.34 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 121.981 1.787 . . . . 0.44 112.854 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.407 ' CG2' ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -77.36 -51.29 18.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 0.44 110.926 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.567 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.7 mm -62.23 -32.27 54.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.624 -0.716 . . . . 0.44 111.255 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.86 -35.33 63.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.011 0.434 . . . . 0.44 110.419 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -65.36 -53.09 48.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.767 -0.652 . . . . 0.44 111.087 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 0.4 OUTLIER -78.35 -20.04 52.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.44 111.639 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 123' ' ' ILE . 31.5 tttp -74.55 -42.59 58.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.19 0.519 . . . . 0.44 110.599 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -66.98 -10.29 47.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.54 -0.755 . . . . 0.44 109.912 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.128 0 CA-C-N 116.337 -0.392 . . . . 0.44 110.611 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.417 H2'' HG21 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 5083 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 5084 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 5085 ' ' HOH . . . . . 0.727 ' H2 ' ' CG ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 5086 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.1 mtp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.911 0.386 . . . . 0.44 111.168 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.33 140.22 38.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.44 110.893 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.24 122.05 27.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.44 110.88 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.406 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 2.0 pp -131.33 140.95 49.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.529 . . . . 0.44 110.798 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -102.92 151.49 22.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.38 0.61 . . . . 0.44 112.05 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.491 HG23 ' N3 ' ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -144.97 116.61 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.137 -0.938 . . . . 0.44 109.659 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.618 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.76 152.27 44.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 110.089 -0.337 . . . . 0.44 110.089 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -145.08 162.6 13.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.339 0.59 . . . . 0.44 111.883 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.0 110.07 0.85 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.054 -0.975 . . . . 0.44 111.274 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.542 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -70.88 96.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.115 -0.328 . . . . 0.44 110.115 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.569 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -71.46 125.04 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 121.179 0.514 . . . . 0.44 112.052 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -93.64 142.61 27.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.533 -0.758 . . . . 0.44 110.857 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.663 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 5.1 p30 -99.08 -173.33 2.47 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.519 -0.764 . . . . 0.44 112.111 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -74.87 0.2 16.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.867 -1.06 . . . . 0.44 112.89 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -123.48 42.93 3.09 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.181 -0.324 . . . . 0.44 111.597 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 46.11 24.9 0.29 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.046 0.45 . . . . 0.44 111.263 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.521 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 24.4 mt-10 -113.83 160.88 18.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.878 -0.786 . . . . 0.44 108.878 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.479 HG13 ' HA ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -119.33 131.99 70.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.134 0.492 . . . . 0.44 112.294 -178.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.471 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -85.06 116.01 23.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.615 -0.72 . . . . 0.44 110.26 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.96 140.16 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.44 110.682 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.406 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 45.7 p -76.48 120.2 21.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.44 110.593 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 35.4 ptt180 -107.19 167.96 9.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.467 -0.333 . . . . 0.44 110.512 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -72.5 57.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.997 0.427 . . . . 0.44 110.268 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 49.23 -174.98 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.863 -0.608 . . . . 0.44 111.36 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.03 14.63 31.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.44 111.455 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 176.67 40.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.793 0.33 . . . . 0.44 110.824 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.92 -78.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.44 111.217 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -148.6 -74.4 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 0.44 110.974 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.85 100.61 9.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.44 110.906 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.95 -8.92 57.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.44 111.579 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.74 16.89 8.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.758 -0.201 . . . . 0.44 111.533 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -114.25 26.23 10.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.045 0.45 . . . . 0.44 111.353 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -48.81 103.19 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.715 -0.675 . . . . 0.44 110.656 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' OE2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.3 OUTLIER -109.26 -170.61 1.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.988 0.423 . . . . 0.44 111.731 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.484 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.53 168.29 10.41 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.44 111.392 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.546 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 89.2 Cg_endo -83.13 167.12 14.2 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.643 2.895 . . . . 0.44 112.981 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.7 -5.1 50.75 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.954 -0.566 . . . . 0.44 114.496 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -62.71 167.7 19.74 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.136 -0.554 . . . . 0.44 112.864 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.598 ' HD2' ' H2 ' ' A' 5098 ' ' HOH . 0.0 OUTLIER 80.16 8.43 1.46 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 122.618 0.367 . . . . 0.44 111.759 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.618 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 2.1 pt -57.88 -26.94 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.651 0.739 . . . . 0.44 110.052 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -42.43 -69.27 0.14 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.391 -1.277 . . . . 0.44 111.121 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.478 ' C ' ' O ' ' A' ' 41' ' ' GLU . 44.0 mmm 19.73 -86.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.731 0.644 . . . . 0.44 112.467 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.46 30.02 0.11 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.762 -0.732 . . . . 0.44 112.856 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.402 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -88.2 -170.38 2.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.783 0.325 . . . . 0.44 111.124 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.544 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.11 156.1 35.66 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.324 -0.398 . . . . 0.44 110.385 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 5.0 Cg_endo -46.04 -24.88 2.51 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.781 2.321 . . . . 0.44 112.475 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -104.11 -39.96 6.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.433 -0.349 . . . . 0.44 111.526 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 6.0 mt-30 -80.1 -12.78 59.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.664 -0.244 . . . . 0.44 111.615 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -58.48 -52.78 64.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.869 0.366 . . . . 0.44 110.885 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.484 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 3.4 m -78.32 -45.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.44 111.373 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.484 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 33.4 t -61.17 -41.93 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.44 111.314 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 3.7 tpt180 -78.02 -37.69 46.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.889 0.376 . . . . 0.44 110.625 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' GLU . 7.9 tp10 -75.57 -19.93 58.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.046 -0.525 . . . . 0.44 110.627 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 3.8 tp -57.53 -44.37 85.07 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.442 -0.345 . . . . 0.44 110.575 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.89 -36.3 82.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.096 -0.705 . . . . 0.44 109.096 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.7 tm-20 -77.52 -24.49 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.315 -0.857 . . . . 0.44 111.042 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 53' ' ' GLU . 12.7 mm-40 -108.2 5.09 25.47 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.084 0.402 . . . . 0.44 112.084 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.565 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 39.5 t -134.79 -44.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.226 0.536 . . . . 0.44 109.756 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.554 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.29 -40.79 0.36 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.336 -0.847 . . . . 0.44 113.892 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.51 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.85 -176.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.983 0.42 . . . . 0.44 111.171 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.83 88.89 12.37 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.679 -0.691 . . . . 0.44 109.948 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.549 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.4 Cg_endo -109.45 154.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.399 2.733 . . . . 0.44 114.367 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.625 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -83.39 80.79 8.98 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 105.199 -2.149 . . . . 0.44 105.199 175.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.591 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -122.22 127.69 50.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.0 -1.455 . . . . 0.44 110.462 -175.534 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.513 ' O ' ' O ' ' A' ' 86' ' ' LEU . 6.1 t80 -179.11 163.41 1.31 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.928 0.394 . . . . 0.44 112.051 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER 85.72 153.33 0.08 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.68 -0.691 . . . . 0.44 110.725 179.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -112.14 129.4 56.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.44 110.925 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CE1' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.87 -51.09 11.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.44 110.152 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.636 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.4 mt-10 -171.26 131.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.44 110.425 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -111.95 131.97 55.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.725 0.298 . . . . 0.44 111.099 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.407 HD21 ' CE1' ' A' ' 73' ' ' TYR . 4.1 tp -110.28 131.14 55.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.44 110.649 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -121.1 109.89 15.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.44 110.617 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.407 ' CE1' HD21 ' A' ' 71' ' ' LEU . 35.3 p90 -141.1 146.32 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.44 110.843 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -121.15 140.03 52.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.151 0.501 . . . . 0.44 111.192 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.458 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -88.81 163.64 34.49 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.545 -0.752 . . . . 0.44 110.55 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -52.29 84.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.025 2.483 . . . . 0.44 112.205 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 20.5 m-20 93.68 15.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.162 -0.926 . . . . 0.44 111.235 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 30.7 ttt180 -137.37 150.09 47.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 0.44 110.452 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -126.18 101.97 7.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.44 110.979 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.5 tt -109.87 111.92 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.44 110.944 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.439 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -94.83 118.47 31.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.44 110.283 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.46 ' CD1' ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -108.45 114.32 28.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.44 111.421 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -113.14 122.71 48.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.089 -0.505 . . . . 0.44 111.042 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.636 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -106.86 109.71 21.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.766 -0.652 . . . . 0.44 109.449 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 47.2 m95 -97.99 148.5 23.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.44 112.173 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 65' ' ' PHE . 58.8 tp -92.9 134.74 34.8 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.721 -0.672 . . . . 0.44 111.436 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.591 HG13 ' HA ' ' A' ' 64' ' ' HIS . 20.7 t -124.7 146.13 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 115.584 -0.734 . . . . 0.44 111.03 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 4.8 tp10 -106.69 -35.3 7.05 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.561 1.319 . . . . 0.44 114.561 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.22 165.63 24.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.141 0.882 . . . . 0.44 111.945 -179.018 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.663 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.3 p90 -151.29 129.17 11.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 0.44 111.41 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -76.42 136.1 39.44 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.203 -0.453 . . . . 0.44 110.95 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.66 -126.78 24.95 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.777 -0.725 . . . . 0.44 112.556 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -125.85 143.44 45.28 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.549 0.214 . . . . 0.44 110.714 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.477 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.67 128.71 10.36 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.858 2.372 . . . . 0.44 111.489 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.554 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.9 p-90 -131.98 -58.8 0.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.592 -0.443 . . . . 0.44 111.726 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.565 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.94 -97.35 0.01 OUTLIER Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.771 -0.728 . . . . 0.44 112.968 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -179.97 33.88 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.685 0.279 . . . . 0.44 111.355 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -27.69 69.15 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.826 0.346 . . . . 0.44 110.432 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.8 12.45 84.44 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.005 -0.617 . . . . 0.44 113.425 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.406 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 41.7 mt-30 -140.35 98.15 7.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 117.075 0.438 . . . . 0.44 111.53 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -43.71 141.46 3.94 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.835 2.357 . . . . 0.44 112.461 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.15 177.18 19.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.591 -0.814 . . . . 0.44 112.949 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -147.64 157.4 43.54 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.275 -0.269 . . . . 0.44 110.275 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.46 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.7 OUTLIER -68.89 106.14 2.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.867 0.365 . . . . 0.44 110.495 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.472 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 3.1 mmm -120.24 151.93 38.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.125 -0.489 . . . . 0.44 110.838 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.32 114.79 13.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.44 110.572 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 25.9 tp -79.72 -18.95 50.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.44 111.269 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.97 -20.67 9.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.813 0.339 . . . . 0.44 111.176 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.12 49.74 0.88 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.831 -0.7 . . . . 0.44 112.255 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.45 150.22 40.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.701 0.286 . . . . 0.44 110.411 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -115.26 132.19 56.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.166 0.508 . . . . 0.44 112.184 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.62 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.25 -15.3 61.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.433 -0.803 . . . . 0.44 110.736 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -78.43 -49.19 13.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.391 -0.368 . . . . 0.44 111.325 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -27.67 67.4 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.77 0.319 . . . . 0.44 111.054 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.62 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -96.19 169.36 9.11 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.375 -0.375 . . . . 0.44 110.442 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.511 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 39.2 Cg_endo -67.07 127.71 17.3 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.353 2.036 . . . . 0.44 111.948 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.87 -19.88 58.44 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.535 2.157 . . . . 0.44 113.048 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.51 58.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.975 0.361 . . . . 0.44 111.975 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.33 32.4 6.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.789 0.328 . . . . 0.44 111.417 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.07 -40.21 2.92 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.571 0.582 . . . . 0.44 112.571 -179.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 86.4 Cg_exo -44.86 -36.61 11.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.135 1.89 . . . . 0.44 112.682 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 84' ' ' PHE . 7.0 t -77.57 -42.39 29.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.069 0.461 . . . . 0.44 110.339 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.556 HG13 ' CE2' ' A' ' 115' ' ' PHE . 6.0 mm -69.17 -34.14 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.44 110.954 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.62 -27.04 36.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.945 0.402 . . . . 0.44 110.416 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -50.76 9.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.921 -0.581 . . . . 0.44 111.693 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.474 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 7.1 tp -78.07 -32.05 50.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.781 0.324 . . . . 0.44 111.613 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 123' ' ' ILE . 5.9 ttpm? -53.81 -42.52 68.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.057 0.456 . . . . 0.44 111.002 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -71.87 -6.11 39.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.44 109.998 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-N 116.033 -0.531 . . . . 0.44 111.203 179.804 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.504 ' N1 ' ' OE2' ' A' ' 34' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 5095 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 5096 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 5097 ' ' HOH . . . . . 0.591 ' H1 ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 5098 ' ' HOH . . . . . 0.598 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.888 0.375 . . . . 0.44 111.161 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -110.08 103.01 11.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.44 110.85 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 132.82 46.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.44 110.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.401 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 2.7 pp -130.41 140.49 50.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.44 110.89 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 10.9 mt-30 -107.37 149.45 27.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.276 0.56 . . . . 0.44 111.838 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.523 HG21 ' N3 ' ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -142.92 123.55 10.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.201 -0.909 . . . . 0.44 110.037 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.51 124.53 42.47 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 110.171 -0.307 . . . . 0.44 110.171 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -116.99 155.75 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.45 0.643 . . . . 0.44 112.019 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -138.59 109.27 0.66 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.923 -1.035 . . . . 0.44 111.177 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.491 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -70.85 101.38 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.149 -0.315 . . . . 0.44 110.149 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.45 HG22 ' CE3' ' A' ' 90' ' ' TRP . 1.1 mt -71.58 124.49 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.124 0.488 . . . . 0.44 111.958 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.46 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -96.41 137.71 35.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.558 -0.746 . . . . 0.44 111.065 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.678 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.8 p30 -94.84 -173.43 2.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.556 -0.747 . . . . 0.44 112.222 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.69 -2.17 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.972 -1.013 . . . . 0.44 113.071 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -120.61 41.39 3.27 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.971 -0.291 . . . . 0.44 111.556 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p30 47.44 23.58 0.39 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.949 0.404 . . . . 0.44 111.18 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.584 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 20.2 mt-10 -111.41 160.94 16.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.716 -0.846 . . . . 0.44 108.716 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.46 HG13 ' HA ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -117.49 142.29 32.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.115 0.483 . . . . 0.44 112.137 -178.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -98.0 115.95 29.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.601 -0.727 . . . . 0.44 110.58 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.436 ' CD1' ' HG2' ' A' ' 105' ' ' MET . 0.2 OUTLIER -121.57 150.49 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.44 110.461 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.478 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 47.1 p -81.97 111.81 18.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.176 -0.465 . . . . 0.44 110.543 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.427 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -102.98 169.07 8.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.506 -0.315 . . . . 0.44 110.582 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -72.73 55.9 0.39 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.042 0.449 . . . . 0.44 110.398 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 46.79 27.75 0.73 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.902 -0.59 . . . . 0.44 111.669 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 47.95 28.7 1.48 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.388 -0.369 . . . . 0.44 111.437 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -81.95 -177.94 6.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.44 110.985 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.46 29.27 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.44 111.158 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -106.5 -31.67 8.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.44 110.796 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.74 43.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.44 110.738 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.66 -14.18 28.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 0.44 111.698 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.35 11.36 8.56 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.674 0.25 . . . . 0.44 111.674 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -114.16 26.02 10.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.063 0.459 . . . . 0.44 111.41 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -47.77 99.9 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.692 -0.685 . . . . 0.44 110.44 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.8 tt0 -106.68 -177.5 3.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.168 0.509 . . . . 0.44 111.919 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.87 166.37 15.13 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.742 -0.663 . . . . 0.44 111.347 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 56.3 Cg_endo -69.83 167.76 23.6 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.351 2.7 . . . . 0.44 111.887 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.3 59.65 0.76 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.194 -1.003 . . . . 0.44 114.062 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.544 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -123.01 132.51 8.65 Favored Glycine 0 C--N 1.311 -0.829 0 CA-C-N 114.679 -0.76 . . . . 0.44 112.055 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.611 ' HE2' ' H2 ' ' A' 5109 ' ' HOH . 1.0 OUTLIER 92.93 7.7 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.043 0.537 . . . . 0.44 112.377 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.587 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.1 pt -51.2 -29.23 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.706 0.765 . . . . 0.44 110.087 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.583 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.17 -80.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.425 -1.262 . . . . 0.44 110.876 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.2 mmm 37.13 -84.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.588 0.555 . . . . 0.44 111.605 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.57 31.37 0.13 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.971 -0.633 . . . . 0.44 112.456 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.456 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -90.94 -176.56 4.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.822 0.344 . . . . 0.44 111.287 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.521 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.4 153.9 37.55 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.44 110.325 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.93 -25.03 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.83 2.353 . . . . 0.44 112.589 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.02 -40.14 6.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.507 -0.315 . . . . 0.44 111.675 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -80.11 -13.92 58.9 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.652 0.242 . . . . 0.44 111.652 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -59.6 -51.13 71.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.719 0.295 . . . . 0.44 111.098 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.9 m -77.99 -45.48 27.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.418 -0.356 . . . . 0.44 111.037 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.494 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 40.1 t -57.73 -43.54 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.943 -0.571 . . . . 0.44 111.329 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -44.52 25.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 0.44 111.082 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.4 tm-20 -68.39 -25.52 65.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.855 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -53.7 -44.46 69.79 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.914 0.387 . . . . 0.44 110.385 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -60.42 -35.9 76.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.302 -0.629 . . . . 0.44 109.302 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.66 -26.61 50.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.391 -0.822 . . . . 0.44 111.487 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' CA ' ' OE1' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -108.11 6.17 26.64 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.197 0.444 . . . . 0.44 112.197 -178.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.592 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 48.3 t -134.02 -44.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.527 -0.546 . . . . 0.44 109.527 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.51 -40.24 0.29 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.442 -0.799 . . . . 0.44 114.065 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.51 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.84 -177.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.114 0.483 . . . . 0.44 111.092 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.38 88.81 13.58 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.512 -0.767 . . . . 0.44 109.821 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.678 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.2 Cg_endo -111.07 146.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 123.287 2.658 . . . . 0.44 114.159 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 38.6 mt-30 -74.84 79.71 2.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.585 -2.005 . . . . 0.44 105.585 175.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.551 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.82 127.46 50.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.102 -1.408 . . . . 0.44 110.562 -176.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.514 ' O ' ' O ' ' A' ' 86' ' ' LEU . 12.4 t80 -179.29 168.22 1.5 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.042 0.386 . . . . 0.44 112.042 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.5 m 84.43 154.73 0.09 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.733 -0.667 . . . . 0.44 110.742 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 pp -111.9 123.6 50.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.44 111.132 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.83 -38.69 53.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.198 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.2 mt-10 -171.29 148.33 2.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.716 -0.674 . . . . 0.44 110.342 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.4 132.15 22.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.633 0.254 . . . . 0.44 110.916 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.3 166.66 21.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.44 110.894 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -137.68 126.06 23.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.665 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.429 ' CE1' HG12 ' A' ' 80' ' ' ILE . 1.9 p90 -141.14 147.0 37.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.44 110.451 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -121.15 139.96 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.213 0.53 . . . . 0.44 111.424 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -88.28 163.26 37.42 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.382 -0.826 . . . . 0.44 110.353 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.6 Cg_endo -50.6 83.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.029 2.486 . . . . 0.44 112.126 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.5 m-20 93.15 18.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.3 -0.864 . . . . 0.44 111.215 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -137.45 150.08 47.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.44 110.515 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -123.11 106.59 10.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.412 -0.358 . . . . 0.44 110.774 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.429 HG12 ' CE1' ' A' ' 73' ' ' TYR . 3.6 tt -113.44 112.03 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.44 111.232 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.43 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -91.36 118.61 30.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.44 110.101 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.2 mt -109.19 114.26 27.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.997 0.427 . . . . 0.44 111.801 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -112.28 122.13 46.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.046 -0.524 . . . . 0.44 110.101 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.499 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.3 m-85 -106.63 109.79 21.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.128 -0.487 . . . . 0.44 110.244 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 39.4 m95 -98.38 148.7 23.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.44 112.081 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.514 ' O ' ' O ' ' A' ' 65' ' ' PHE . 18.7 tp -94.19 138.44 32.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.617 -0.719 . . . . 0.44 111.402 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 64' ' ' HIS . 34.5 t -123.66 145.41 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-N 115.737 -0.665 . . . . 0.44 110.439 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -111.87 -25.59 9.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.066 1.136 . . . . 0.44 114.066 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.528 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 5.8 tpt180 -162.79 163.54 26.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.511 0.596 . . . . 0.44 111.354 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.678 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -156.38 123.57 5.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.341 -0.391 . . . . 0.44 111.29 178.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -74.78 149.52 39.68 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.168 -0.469 . . . . 0.44 111.105 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.96 -131.76 48.08 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.863 -0.684 . . . . 0.44 112.596 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -121.4 145.05 41.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.44 0.162 . . . . 0.44 110.747 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.489 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.57 128.66 10.41 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.817 2.345 . . . . 0.44 111.386 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.54 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 59.5 p-90 -135.05 -58.27 0.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.502 -0.479 . . . . 0.44 111.921 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.592 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.79 -95.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.978 -0.629 . . . . 0.44 112.982 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -176.02 33.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.728 0.299 . . . . 0.44 111.234 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -26.21 60.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.421 -0.354 . . . . 0.44 110.41 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.99 16.8 73.03 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.057 -0.592 . . . . 0.44 113.632 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.478 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 48.8 mt-30 -140.28 92.08 9.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.129 0.49 . . . . 0.44 111.46 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -43.84 146.1 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.155 2.57 . . . . 0.44 112.935 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.45 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.1 177.11 19.38 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.882 -0.675 . . . . 0.44 112.576 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -142.26 157.28 45.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.569 0.223 . . . . 0.44 110.975 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.53 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -74.71 106.02 6.07 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.747 0.308 . . . . 0.44 110.503 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 4.7 ppp? -120.74 147.64 45.03 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.336 -0.393 . . . . 0.44 111.361 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.5 114.85 3.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.379 . . . . 0.44 110.823 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -80.13 -18.94 48.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.44 111.383 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.1 t -58.32 -15.13 4.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.493 -0.322 . . . . 0.44 111.586 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.07 51.92 0.78 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.729 -0.748 . . . . 0.44 112.315 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.32 149.75 41.29 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.403 -0.221 . . . . 0.44 110.403 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.23 132.21 53.95 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.786 0.662 . . . . 0.44 112.786 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.645 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.36 -15.32 61.86 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.439 -0.801 . . . . 0.44 110.497 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -78.56 -49.29 13.57 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.732 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -32.35 73.58 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.755 0.312 . . . . 0.44 111.031 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.645 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.68 170.74 10.48 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.187 -0.461 . . . . 0.44 110.312 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.538 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 55.5 Cg_endo -69.78 127.47 14.63 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.093 1.862 . . . . 0.44 111.669 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.57 -14.9 45.36 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.631 2.22 . . . . 0.44 113.385 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.64 -9.56 58.8 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.257 0.465 . . . . 0.44 112.257 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.61 34.3 5.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.762 0.315 . . . . 0.44 111.465 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -76.04 -31.87 1.06 Allowed Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.085 0.772 . . . . 0.44 113.085 -179.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 72.1 Cg_exo -49.06 -46.51 25.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 121.79 1.66 . . . . 0.44 112.817 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.418 HG12 ' CD2' ' A' ' 84' ' ' PHE . 1.5 t -77.41 -50.61 20.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.033 0.444 . . . . 0.44 110.622 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.586 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.4 mm -59.33 -35.06 56.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.701 -0.681 . . . . 0.44 111.248 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.73 -34.82 62.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.999 0.428 . . . . 0.44 110.489 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.75 -53.01 30.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.805 -0.634 . . . . 0.44 111.342 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.536 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -78.35 -19.74 52.79 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.311 -0.404 . . . . 0.44 111.699 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 123' ' ' ILE . 10.1 ttpp -66.24 -42.5 88.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.202 0.525 . . . . 0.44 110.334 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -70.03 -9.07 54.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.514 -0.766 . . . . 0.44 110.186 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.536 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.858 0.361 . . . . 0.44 110.652 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.523 ' N3 ' HG21 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 5107 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 5108 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 5109 ' ' HOH . . . . . 0.611 ' H2 ' ' HE2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 5110 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.817 0.341 . . . . 0.44 111.234 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.21 147.02 26.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.44 110.9 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -137.52 144.26 42.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.44 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.66 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 1.9 pp -146.14 119.15 8.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.44 110.724 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' HG2' ' OG1' ' A' ' 81' ' ' THR . 16.7 mt-30 -102.01 152.33 21.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.505 0.669 . . . . 0.44 112.341 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -146.54 131.25 11.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.012 -0.995 . . . . 0.44 110.323 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.589 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.35 125.09 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.207 -0.294 . . . . 0.44 110.207 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.543 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 m -115.6 162.49 13.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.618 0.723 . . . . 0.44 112.714 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.86 112.93 0.66 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.682 -1.145 . . . . 0.44 111.251 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.512 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -70.93 96.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.212 -0.292 . . . . 0.44 110.212 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.52 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.7 tt -71.64 117.54 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.205 0.526 . . . . 0.44 112.318 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -94.92 147.38 23.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.943 -0.571 . . . . 0.44 111.88 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.823 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 9.7 p-10 -103.78 -173.05 2.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.512 0.672 . . . . 0.44 112.225 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.7 tm-20 -71.8 1.6 6.7 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.779 -1.1 . . . . 0.44 113.455 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -124.64 44.59 2.73 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.751 -0.38 . . . . 0.44 111.597 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.9 p30 44.98 28.1 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.44 111.303 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 106' ' ' SER . 3.2 mt-10 -114.96 161.19 18.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.814 -0.63 . . . . 0.44 109.635 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -124.58 128.39 73.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.913 0.387 . . . . 0.44 111.937 -178.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -76.33 113.31 13.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.182 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.43 ' HB ' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.13 126.17 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 0.44 109.957 179.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 3.7 p -71.03 112.15 6.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.854 0.359 . . . . 0.44 110.987 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -86.15 83.44 7.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.44 110.582 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 44.67 46.94 8.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.026 -0.533 . . . . 0.44 111.643 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 65.39 17.12 10.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.398 -0.364 . . . . 0.44 111.768 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.81 48.62 19.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.44 111.196 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -114.19 -177.1 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.44 110.981 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.75 30.07 6.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.44 111.113 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.9 124.84 13.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.44 110.779 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 64.28 46.24 3.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.991 0.424 . . . . 0.44 110.756 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.39 -8.8 53.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.44 111.824 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -85.0 14.81 4.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.752 0.278 . . . . 0.44 111.752 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.18 26.25 10.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.115 0.483 . . . . 0.44 111.274 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.6 tt -45.77 100.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.633 -0.712 . . . . 0.44 110.657 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' OE1' ' N2 ' ' A' ' 131' ' ' 8OG . 14.6 mm-40 -125.12 179.08 5.21 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.227 0.537 . . . . 0.44 112.231 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.92 163.69 26.44 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.443 -0.799 . . . . 0.44 111.866 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 9.6 Cg_endo -51.49 168.61 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.884 3.056 . . . . 0.44 112.158 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.87 59.5 0.74 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.22 -0.99 . . . . 0.44 113.978 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.618 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.57 123.63 4.19 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 114.519 -0.84 . . . . 0.44 112.234 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.659 ' HB2' ' H2 ' ' A' 5121 ' ' HOH . 0.0 OUTLIER 112.47 1.01 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.558 0.577 . . . . 0.44 112.558 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.589 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.1 pt -52.8 -27.07 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.627 0.727 . . . . 0.44 110.577 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.524 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -44.32 -60.72 1.79 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.586 -1.188 . . . . 0.44 111.233 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.511 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.3 ttp 11.02 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.936 0.773 . . . . 0.44 112.574 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.89 34.76 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.787 -0.72 . . . . 0.44 112.503 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -90.19 -174.73 4.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.935 0.398 . . . . 0.44 111.118 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.527 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.33 154.44 38.05 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.088 -0.506 . . . . 0.44 110.432 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.527 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.89 -25.6 1.09 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.818 2.345 . . . . 0.44 112.515 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.04 -38.91 6.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 0.44 111.446 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -80.1 -11.81 59.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.623 -0.262 . . . . 0.44 111.614 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.421 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -59.77 -52.9 63.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 0.44 110.815 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.507 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.4 m -78.16 -47.27 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 0.44 111.089 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.507 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 38.6 t -54.88 -37.27 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.177 -0.465 . . . . 0.44 111.159 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.26 -51.74 9.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.132 -0.485 . . . . 0.44 111.125 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.425 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.9 mm-40 -66.01 -23.48 66.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.44 111.009 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.2 tp -52.69 -44.67 66.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.744 0.307 . . . . 0.44 110.193 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -34.92 76.07 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.268 -0.641 . . . . 0.44 109.268 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.8 tt0 -77.43 -24.05 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.464 -0.789 . . . . 0.44 110.797 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.465 ' HG2' ' HA2' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -108.59 6.01 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.407 -0.361 . . . . 0.44 111.899 -179.172 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.576 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 16.1 t -133.97 -44.72 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 0.44 110.02 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.13 -39.42 0.2 Allowed Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.628 -0.715 . . . . 0.44 114.0 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.483 HG22 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -88.26 -174.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.018 0.437 . . . . 0.44 111.085 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -111.98 88.87 10.69 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.596 -0.729 . . . . 0.44 110.259 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.62 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -108.63 154.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.915 2.41 . . . . 0.44 114.658 -177.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 89' ' ' ARG . 81.3 mt-30 -75.02 79.72 2.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.067 -1.827 . . . . 0.44 106.067 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.617 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -126.37 121.28 32.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.961 -1.018 . . . . 0.44 111.07 -176.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.9 t80 179.43 171.27 0.98 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.44 111.436 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.3 t 92.79 147.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.792 -0.64 . . . . 0.44 110.814 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.421 HD23 ' CE3' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -96.12 126.7 41.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.44 111.406 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -92.13 -51.77 5.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.44 110.08 179.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 9.4 tt0 -171.63 163.75 6.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.724 -0.671 . . . . 0.44 110.31 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -143.34 132.1 22.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.773 0.321 . . . . 0.44 110.901 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.414 ' CD2' ' CD1' ' A' ' 73' ' ' TYR . 2.6 tp -122.71 128.52 50.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.44 110.658 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -117.2 110.72 18.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.44 110.734 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.419 ' CE2' HD13 ' A' ' 80' ' ' ILE . 11.8 p90 -140.97 146.04 36.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.44 110.699 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.37 131.81 54.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.134 0.492 . . . . 0.44 111.241 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -82.04 163.22 54.14 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.44 110.489 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.1 Cg_endo -53.36 82.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.895 2.397 . . . . 0.44 112.152 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 17.6 t0 90.96 11.5 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.421 -0.809 . . . . 0.44 111.36 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -137.35 94.25 2.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.584 -0.28 . . . . 0.44 110.711 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -76.24 119.79 20.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.564 -0.289 . . . . 0.44 110.422 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.66 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 5.0 pt -127.52 146.99 32.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.065 0.459 . . . . 0.44 112.179 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.443 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -113.52 118.82 35.52 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.44 109.704 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.474 HD13 ' N2 ' ' A' ' 131' ' ' 8OG . 14.8 tp -106.42 114.0 27.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.854 0.359 . . . . 0.44 111.279 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.407 ' CZ3' ' O ' ' A' ' 46' ' ' PRO . 9.5 m0 -112.52 122.49 47.86 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.992 -0.549 . . . . 0.44 110.555 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.434 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 4.8 m-30 -106.54 109.87 21.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.869 -0.605 . . . . 0.44 110.591 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.45 ' CD2' HG23 ' A' ' 50' ' ' VAL . 34.9 m95 -101.32 148.48 25.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.169 -0.469 . . . . 0.44 111.455 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 65' ' ' PHE . 22.4 tp -91.69 138.35 31.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.324 0.583 . . . . 0.44 112.05 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 64' ' ' HIS . 38.3 t -124.44 145.37 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.299 -0.864 . . . . 0.44 110.264 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -112.49 -32.34 6.51 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.412 1.264 . . . . 0.44 114.412 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.434 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -163.18 165.62 24.27 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.711 0.687 . . . . 0.44 111.645 -178.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.823 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.9 p90 -148.17 133.06 18.06 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.363 -0.38 . . . . 0.44 111.793 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -80.18 144.41 33.01 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.357 -0.383 . . . . 0.44 110.691 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.13 -115.23 7.32 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.636 -0.792 . . . . 0.44 112.45 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 43.2 mt-10 -134.92 138.6 29.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.468 0.175 . . . . 0.44 110.82 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.484 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 3.4 Cg_exo -76.62 128.89 10.52 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.786 2.324 . . . . 0.44 111.12 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.571 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 62.4 p-90 -137.08 -60.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.942 -0.703 . . . . 0.44 112.633 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.576 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 52.51 -94.2 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.56 -0.828 . . . . 0.44 112.693 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.1 tttp 179.02 30.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.565 0.221 . . . . 0.44 111.549 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.69 -32.4 70.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.027 0.441 . . . . 0.44 110.143 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.91 32.29 69.96 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.813 -0.631 . . . . 0.44 113.73 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.459 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 76.7 mt-30 -140.56 91.64 9.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.973 0.416 . . . . 0.44 111.527 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -44.7 126.53 7.28 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.197 2.598 . . . . 0.44 112.959 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.467 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.47 177.31 19.31 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.736 -0.745 . . . . 0.44 112.823 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.16 157.13 46.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.626 0.25 . . . . 0.44 110.699 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.44 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -68.47 106.71 2.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.887 0.375 . . . . 0.44 110.156 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.5 ptp -119.87 148.52 43.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.44 111.159 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.415 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 95.0 p -65.85 114.57 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.3 -0.409 . . . . 0.44 110.593 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 33.5 tp -78.11 -18.87 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.44 111.309 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.91 -20.13 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.491 -0.322 . . . . 0.44 111.442 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.99 45.2 1.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.649 -0.786 . . . . 0.44 112.698 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.9 tt -62.79 150.57 41.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.627 0.251 . . . . 0.44 110.49 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.91 129.61 56.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.201 0.524 . . . . 0.44 112.377 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.556 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.23 -14.98 61.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.445 -0.798 . . . . 0.44 110.666 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -78.36 -49.17 14.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.386 -0.37 . . . . 0.44 111.578 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -34.93 78.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.91 0.386 . . . . 0.44 110.876 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.556 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -84.74 173.23 7.47 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.111 -0.495 . . . . 0.44 110.345 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.3 Cg_endo -70.68 127.69 14.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.162 1.908 . . . . 0.44 111.857 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.41 -17.57 60.08 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.53 2.154 . . . . 0.44 113.023 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.25 -9.36 58.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.464 -0.334 . . . . 0.44 111.875 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.51 29.5 7.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.609 -0.269 . . . . 0.44 111.42 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.05 -43.17 3.65 Favored Pre-proline 0 C--O 1.224 -0.25 0 N-CA-C 112.203 0.446 . . . . 0.44 112.203 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 92.4 Cg_exo -44.89 -39.0 13.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.18 1.92 . . . . 0.44 112.971 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.21 -51.14 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.189 0.518 . . . . 0.44 110.77 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.516 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.2 mm -64.84 -31.23 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 0.44 111.197 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.82 -30.88 58.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.003 0.43 . . . . 0.44 110.477 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.9 -53.27 18.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.857 -0.61 . . . . 0.44 111.469 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.33 -33.07 49.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.479 -0.328 . . . . 0.44 111.565 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -53.15 -42.64 66.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.44 111.148 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -67.2 -10.59 52.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.804 -0.634 . . . . 0.44 109.688 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.232 0.155 0 CA-C-N 116.015 -0.539 . . . . 0.44 111.058 179.752 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.496 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 5119 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 5120 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 5121 ' ' HOH . . . . . 0.659 ' H2 ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 5122 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ptt? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.862 0.363 . . . . 0.44 111.152 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -73.99 139.33 44.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.44 110.944 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -140.06 137.87 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.955 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.44 ' CD1' " O3'" ' A' ' 131' ' ' 8OG . 1.0 OUTLIER -146.07 131.95 19.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 0.44 110.736 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -102.84 155.43 18.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.44 111.666 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.459 HG12 H2'' ' A' ' 131' ' ' 8OG . 5.3 mp -144.52 137.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.44 110.35 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.607 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -125.41 125.3 43.17 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.292 -0.413 . . . . 0.44 110.329 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.463 HG22 ' CE1' ' A' ' 35' ' ' PHE . 1.9 m -128.63 155.79 40.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.064 0.459 . . . . 0.44 111.283 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.7 127.09 2.21 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.591 -0.731 . . . . 0.44 112.106 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.493 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -80.99 107.65 13.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.49 -0.559 . . . . 0.44 109.49 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.613 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.17 123.33 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.975 0.417 . . . . 0.44 111.31 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.9 119.04 23.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.607 -0.724 . . . . 0.44 111.359 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 21.9 t-20 -74.77 -172.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.082 -0.963 . . . . 0.44 111.927 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.49 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 32.1 tt0 -82.57 4.11 25.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.236 -1.347 . . . . 0.44 112.151 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -140.08 52.2 1.68 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.44 111.454 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.64 25.21 0.24 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.235 -0.439 . . . . 0.44 111.552 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 5.3 pt-20 -120.32 149.88 41.61 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.916 -0.772 . . . . 0.44 108.916 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 18' ' ' ILE . 1.3 mp -113.36 140.76 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.149 0.5 . . . . 0.44 111.665 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -91.16 103.58 16.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.569 -0.741 . . . . 0.44 110.048 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.9 162.12 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.738 -0.665 . . . . 0.44 110.186 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.401 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 73.7 p -92.61 111.71 23.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.787 0.327 . . . . 0.44 110.873 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -91.69 83.5 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.44 110.85 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 33.0 48.22 0.13 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.953 -0.567 . . . . 0.44 111.927 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 65.65 -77.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.44 111.146 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -175.41 -78.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.362 -0.381 . . . . 0.44 111.248 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -96.75 128.67 43.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.44 111.006 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -176.28 178.48 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.44 111.051 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -98.6 30.53 3.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.44 110.924 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.14 63.86 0.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.149 -0.478 . . . . 0.44 110.695 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.09 -8.72 56.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 0.44 111.723 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.85 23.21 2.09 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.744 0.276 . . . . 0.44 111.744 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.27 26.34 10.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.44 111.465 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -46.05 97.44 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.768 -0.651 . . . . 0.44 110.67 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.78 176.94 4.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.168 0.509 . . . . 0.44 111.715 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.484 ' CE1' ' CZ ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -119.76 161.44 37.95 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.747 -0.66 . . . . 0.44 111.904 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -55.66 168.54 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.671 2.914 . . . . 0.44 111.611 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.67 59.49 0.74 Allowed Glycine 0 C--N 1.33 0.242 0 C-N-CA 119.826 -1.178 . . . . 0.44 113.965 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.604 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.15 121.7 2.64 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 114.576 -0.812 . . . . 0.44 112.086 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.689 ' HD2' ' H1 ' ' A' 5133 ' ' HOH . 0.0 OUTLIER 112.49 -6.62 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.339 0.656 . . . . 0.44 111.565 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.507 HD13 ' CB ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -43.17 -57.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.303 0.573 . . . . 0.44 111.251 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -19.36 -78.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.335 -1.302 . . . . 0.44 112.305 -179.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.3 mmt 40.2 -93.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.423 -0.353 . . . . 0.44 111.774 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.47 22.06 0.08 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.488 -0.863 . . . . 0.44 113.359 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.45 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -78.84 -159.99 0.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.544 0.211 . . . . 0.44 110.863 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.535 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.14 154.7 38.63 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 110.323 -0.251 . . . . 0.44 110.323 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.2 Cg_endo -44.07 -24.91 0.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.777 2.318 . . . . 0.44 112.456 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -99.89 -48.77 4.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.371 -0.377 . . . . 0.44 111.919 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -80.5 -4.89 55.59 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 111.782 0.29 . . . . 0.44 111.782 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.507 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -65.49 -57.49 8.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.54 0.21 . . . . 0.44 110.955 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.465 HG13 ' CE2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.79 -44.01 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.821 -0.351 . . . . 0.44 110.706 179.163 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.9 t -50.61 -36.06 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.959 0.409 . . . . 0.44 110.73 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -78.59 -49.1 13.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.04 -0.527 . . . . 0.44 110.817 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -65.66 -23.75 66.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.44 110.932 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.431 HD23 ' CD2' ' A' ' 64' ' ' HIS . 2.5 tp -54.81 -44.56 73.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.393 -0.367 . . . . 0.44 110.467 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -31.29 71.13 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.337 -0.616 . . . . 0.44 109.337 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.3 tm-20 -77.44 -23.95 50.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.442 -0.799 . . . . 0.44 110.957 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.425 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 45.3 mm-40 -107.07 3.54 25.98 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.938 0.347 . . . . 0.44 111.938 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.516 ' CG1' HG13 ' A' ' 60' ' ' ILE . 21.9 t -134.91 -44.21 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.277 0.56 . . . . 0.44 109.847 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.57 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.2 -43.91 0.69 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.254 -0.885 . . . . 0.44 113.321 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.516 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.61 -175.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.105 0.478 . . . . 0.44 111.255 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.36 89.14 11.86 Favored Pre-proline 0 N--CA 1.442 -0.852 0 CA-C-N 115.521 -0.763 . . . . 0.44 110.196 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.645 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.8 Cg_endo -108.47 148.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.078 2.519 . . . . 0.44 114.133 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 21.3 mt-30 -74.64 79.95 2.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.939 -1.875 . . . . 0.44 105.939 175.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.596 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.76 127.52 48.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.989 -1.459 . . . . 0.44 110.675 -176.484 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.628 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.1 t80 -179.83 171.0 1.2 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.246 -0.433 . . . . 0.44 111.518 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 80.57 156.13 0.14 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.177 -0.465 . . . . 0.44 110.749 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.771 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.4 pp -117.09 129.28 55.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.237 -0.438 . . . . 0.44 111.436 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.8 -48.36 18.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.986 -0.552 . . . . 0.44 109.744 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -171.56 131.73 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.505 -0.77 . . . . 0.44 110.184 179.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 132.21 53.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.742 0.305 . . . . 0.44 110.719 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.68 162.25 26.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.44 111.185 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -140.14 128.28 22.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.44 110.656 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.408 ' O ' ' CG ' ' A' ' 73' ' ' TYR . 1.9 p90 -141.07 100.87 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.456 . . . . 0.44 110.643 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.8 pt-20 -74.83 122.42 23.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.44 111.446 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.99 162.89 60.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 0.44 110.303 179.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.0 Cg_endo -51.0 81.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.025 2.484 . . . . 0.44 112.287 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.4 t70 91.37 10.12 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.486 -0.779 . . . . 0.44 111.57 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -137.34 93.95 2.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.646 0.26 . . . . 0.44 110.854 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 52.7 t-80 -74.88 102.1 4.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.819 0.342 . . . . 0.44 110.703 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.6 tt -106.52 111.94 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.881 0.372 . . . . 0.44 111.071 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -103.28 128.55 50.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.44 110.413 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mt -126.25 114.54 18.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.98 0.419 . . . . 0.44 111.497 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -108.12 122.33 46.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.089 -0.505 . . . . 0.44 110.38 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.551 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 5.4 m-30 -100.5 113.77 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.344 -0.389 . . . . 0.44 110.754 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.771 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 35.8 m95 -94.29 148.74 21.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.288 -0.415 . . . . 0.44 111.258 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 65' ' ' PHE . 31.1 tp -98.35 103.43 15.38 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 121.159 0.504 . . . . 0.44 111.61 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.613 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 25.2 t -87.62 145.79 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-N 115.622 -0.717 . . . . 0.44 111.184 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -112.15 -26.74 8.67 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.542 1.312 . . . . 0.44 114.542 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.86 165.11 25.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.796 0.726 . . . . 0.44 111.796 -178.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.645 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.2 p90 -152.72 130.04 11.31 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.25 -0.432 . . . . 0.44 111.511 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -75.84 139.93 41.98 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.332 -0.395 . . . . 0.44 110.694 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.3 -117.82 12.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.44 112.347 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 8.0 mt-10 -135.05 140.12 33.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.414 0.149 . . . . 0.44 110.875 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.47 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 7.8 Cg_exo -75.5 128.58 11.2 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.943 2.429 . . . . 0.44 111.438 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.57 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 45.1 p-90 -128.45 -58.54 1.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.993 0.425 . . . . 0.44 111.383 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.489 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.77 -100.07 0.02 OUTLIER Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.62 -0.718 . . . . 0.44 112.877 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 179.08 36.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.44 111.321 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.99 -47.6 80.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.411 -0.359 . . . . 0.44 110.564 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.59 12.08 51.86 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.746 -0.74 . . . . 0.44 113.927 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.401 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 24.3 mt-30 -140.36 91.79 9.61 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 117.24 0.52 . . . . 0.44 111.386 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -44.23 125.39 5.68 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.837 2.358 . . . . 0.44 112.739 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.78 177.59 19.16 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.005 -0.617 . . . . 0.44 112.469 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -129.28 157.1 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.672 0.273 . . . . 0.44 110.773 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.45 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.12 107.1 3.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.901 0.381 . . . . 0.44 110.435 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 18' ' ' ILE . 12.5 ptm -119.62 158.1 27.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 0.44 111.018 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 p -71.83 121.32 18.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.44 111.094 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -80.11 -28.97 38.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.44 111.011 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 p -50.72 -24.58 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 0.44 111.232 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.7 43.34 1.4 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.875 -0.678 . . . . 0.44 112.382 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tt -62.55 150.14 41.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.256 -0.275 . . . . 0.44 110.256 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.97 132.91 56.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.178 0.513 . . . . 0.44 112.302 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.611 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.42 61.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.455 -0.793 . . . . 0.44 110.48 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -78.77 -49.27 13.31 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.321 -0.4 . . . . 0.44 111.755 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -32.77 74.26 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.799 0.333 . . . . 0.44 111.013 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.611 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -89.16 172.62 7.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 0.44 110.029 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.489 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.8 Cg_endo -67.51 127.58 16.69 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.032 1.822 . . . . 0.44 111.832 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.38 -18.64 60.67 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.552 2.168 . . . . 0.44 113.064 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.87 -9.38 58.24 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.915 0.339 . . . . 0.44 111.915 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.465 ' ND2' ' C6 ' ' A' ' 131' ' ' 8OG . 0.9 OUTLIER -119.36 34.31 5.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.767 0.318 . . . . 0.44 111.464 -178.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -75.6 -44.06 4.16 Favored Pre-proline 0 N--CA 1.463 0.217 0 N-CA-C 112.325 0.491 . . . . 0.44 112.325 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.6 Cg_exo -44.76 -35.38 9.43 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.224 1.949 . . . . 0.44 112.61 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.479 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 11.8 t -77.43 -41.05 29.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.136 0.493 . . . . 0.44 110.144 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.557 HG13 ' CE2' ' A' ' 115' ' ' PHE . 17.9 mm -70.28 -32.28 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.696 -0.684 . . . . 0.44 110.707 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.46 -26.96 34.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.086 0.47 . . . . 0.44 110.228 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.09 -50.89 9.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.807 -0.633 . . . . 0.44 111.669 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.475 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 8.1 tp -78.09 -33.5 50.69 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.856 0.36 . . . . 0.44 111.693 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -53.27 -42.53 66.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.135 -0.484 . . . . 0.44 111.133 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -71.71 -6.09 38.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.886 -0.597 . . . . 0.44 109.975 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-N 115.989 -0.55 . . . . 0.44 111.189 179.763 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.498 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 5131 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 5132 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 5133 ' ' HOH . . . . . 0.689 ' H1 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 5134 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 mmt . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.785 0.326 . . . . 0.44 111.223 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -104.23 136.73 43.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.44 110.896 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -140.02 137.53 34.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.44 110.854 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.423 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.7 pp -146.0 135.37 22.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.44 110.77 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -102.7 149.19 24.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.388 0.613 . . . . 0.44 112.107 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.495 HG12 H2'' ' A' ' 131' ' ' 8OG . 3.4 mp -146.22 120.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.017 -0.992 . . . . 0.44 109.866 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.634 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.66 143.34 50.79 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 121.01 -0.276 . . . . 0.44 110.314 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.578 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -144.6 162.52 14.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.112 0.482 . . . . 0.44 111.487 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.02 123.4 2.01 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.481 -0.781 . . . . 0.44 112.037 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.625 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.75 108.91 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.158 -0.682 . . . . 0.44 109.158 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.486 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -70.83 120.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.224 0.535 . . . . 0.44 112.252 -178.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.95 122.7 28.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.55 -0.75 . . . . 0.44 111.615 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.557 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -81.62 -172.58 3.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.979 -1.01 . . . . 0.44 111.887 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.52 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -82.38 -0.95 48.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.406 -1.27 . . . . 0.44 112.112 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -135.69 49.58 2.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 0.44 111.331 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.27 23.7 0.59 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.233 -0.439 . . . . 0.44 111.183 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 13' ' ' ASN . 16.2 pt-20 -114.23 153.97 28.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.103 -0.703 . . . . 0.44 109.103 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.457 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 5.2 mt -128.44 143.32 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.44 112.04 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.455 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.18 122.74 34.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.496 -0.775 . . . . 0.44 110.324 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.444 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -118.69 133.36 65.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.359 -0.382 . . . . 0.44 110.274 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.4 p -70.82 115.94 10.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.325 -0.398 . . . . 0.44 111.082 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.414 ' HA ' HD22 ' A' ' 33' ' ' LEU . 18.3 ptt85 -114.51 172.06 7.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.44 110.704 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -70.79 60.57 0.24 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 0.44 110.884 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 44.82 -92.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.212 -0.449 . . . . 0.44 111.567 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -178.18 34.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.782 0.325 . . . . 0.44 111.098 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 172.82 93.23 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.292 -0.413 . . . . 0.44 110.731 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -162.77 171.87 16.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.44 111.144 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -60.61 -68.77 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.44 110.893 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.8 mtm -93.35 68.94 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.871 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.51 -8.9 57.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.52 . . . . 0.44 111.614 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -92.15 31.18 1.31 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.713 -0.221 . . . . 0.44 111.354 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -114.23 25.65 10.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.428 . . . . 0.44 111.28 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -46.47 97.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.831 -0.622 . . . . 0.44 110.37 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -106.79 -170.35 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.18 0.514 . . . . 0.44 112.251 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.494 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.19 168.59 9.62 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.505 -0.77 . . . . 0.44 111.472 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.578 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 93.7 Cg_endo -79.33 167.58 21.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.688 2.925 . . . . 0.44 113.835 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.87 -5.24 50.38 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.311 -0.859 . . . . 0.44 114.881 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.02 159.16 23.95 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 117.498 0.649 . . . . 0.44 113.327 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 85.14 6.36 0.49 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.061 0.545 . . . . 0.44 111.996 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.634 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.6 pt -54.28 -27.04 16.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.632 0.73 . . . . 0.44 110.167 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.534 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.97 -66.92 0.32 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.491 -1.231 . . . . 0.44 111.035 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.503 ' C ' ' O ' ' A' ' 41' ' ' GLU . 5.4 mmt 14.65 -82.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.876 0.735 . . . . 0.44 112.409 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -177.52 33.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 0.44 112.59 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.6 mp0 -88.76 -172.97 3.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.861 0.362 . . . . 0.44 111.168 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.541 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.76 155.38 36.4 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.156 -0.475 . . . . 0.44 110.36 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.89 -25.46 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.817 2.345 . . . . 0.44 112.659 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.51 -41.6 5.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.492 -0.322 . . . . 0.44 111.386 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -80.28 -4.83 54.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.564 -0.289 . . . . 0.44 111.722 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.431 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -60.58 -55.41 33.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.44 110.896 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 2.7 m -78.19 -46.03 26.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.198 -0.455 . . . . 0.44 111.31 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 30.0 t -55.39 -41.13 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 116.125 -0.489 . . . . 0.44 111.368 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -77.98 -49.34 14.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.018 0.437 . . . . 0.44 110.451 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.46 ' HG3' ' OE1' ' A' ' 57' ' ' GLU . 14.9 tp10 -63.38 -20.0 65.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.898 -0.592 . . . . 0.44 110.504 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 1.4 tp -59.65 -44.46 93.54 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.44 110.303 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -30.16 70.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.952 -0.567 . . . . 0.44 109.827 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.5 tm-20 -77.27 -31.82 55.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.715 -0.675 . . . . 0.44 111.416 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.46 ' OE1' ' HG3' ' A' ' 53' ' ' GLU . 1.2 mp0 -108.68 6.14 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.703 0.631 . . . . 0.44 112.703 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.525 ' CG1' HG13 ' A' ' 60' ' ' ILE . 43.5 t -133.83 -44.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.161 0.505 . . . . 0.44 110.031 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.586 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.43 -39.82 0.28 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.52 -0.764 . . . . 0.44 113.966 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.525 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.52 -176.29 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 120.968 0.413 . . . . 0.44 110.841 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.22 89.1 11.53 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 115.762 -0.654 . . . . 0.44 110.468 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.651 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.9 Cg_endo -109.42 143.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.266 2.644 . . . . 0.44 114.243 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 34.5 mt-30 -74.7 80.03 2.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 105.437 -2.061 . . . . 0.44 105.437 175.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.643 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -120.92 134.53 55.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.102 -1.408 . . . . 0.44 111.418 -175.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 178.92 -139.9 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.686 -0.688 . . . . 0.44 110.089 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 56.46 156.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.206 0.527 . . . . 0.44 112.323 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.4 tt -120.1 109.44 15.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.632 -0.713 . . . . 0.44 110.562 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.74 -43.8 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.44 110.369 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.7 tt0 -171.25 163.32 7.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.834 -0.621 . . . . 0.44 110.311 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.436 ' CE ' ' CE2' ' A' ' 83' ' ' TRP . 1.1 ttpm? -143.15 132.04 22.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.81 0.338 . . . . 0.44 110.992 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 73' ' ' TYR . 4.6 tp -115.2 120.41 39.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.418 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -118.57 109.84 16.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.44 110.911 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.449 ' CE1' ' CD2' ' A' ' 71' ' ' LEU . 2.0 p90 -141.1 151.64 44.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.44 110.46 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.14 121.27 37.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 0.44 111.34 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.77 162.88 61.04 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.523 -0.762 . . . . 0.44 110.281 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -50.92 81.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.017 2.478 . . . . 0.44 112.097 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 t70 88.79 14.23 0.07 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.472 -0.785 . . . . 0.44 111.329 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.409 ' NH2' " H2'" ' A' ' 131' ' ' 8OG . 4.7 ttt180 -137.51 93.91 2.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.732 0.301 . . . . 0.44 110.805 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -75.76 97.57 3.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.899 0.38 . . . . 0.44 110.463 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.427 HG22 ' CE2' ' A' ' 73' ' ' TYR . 1.3 tt -100.84 112.9 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.281 -0.418 . . . . 0.44 111.405 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.48 119.66 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.44 110.279 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.553 ' CD1' ' N2 ' ' A' ' 131' ' ' 8OG . 12.7 tp -110.26 114.37 27.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.88 0.372 . . . . 0.44 111.334 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.436 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 10.9 m0 -109.47 122.89 48.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.44 111.178 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.42 ' CE1' HD21 ' A' ' 82' ' ' LEU . 5.3 m-30 -109.79 109.77 20.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.44 110.602 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 48.2 m95 -99.41 148.96 23.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.506 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.8 tp -98.5 102.84 14.7 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.427 0.632 . . . . 0.44 111.726 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.643 HG13 ' HA ' ' A' ' 64' ' ' HIS . 11.9 t -81.1 146.47 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-N 115.074 -0.966 . . . . 0.44 111.091 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -114.12 -25.68 8.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.267 1.21 . . . . 0.44 114.267 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.9 tpt180 -162.55 161.87 27.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.64 0.654 . . . . 0.44 111.583 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.651 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -155.61 123.46 5.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.132 -0.485 . . . . 0.44 111.316 178.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -72.05 143.94 48.93 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 116.123 -0.49 . . . . 0.44 111.019 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.2 -129.67 46.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.867 -0.682 . . . . 0.44 112.558 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -121.0 144.0 38.23 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.599 0.238 . . . . 0.44 110.76 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.455 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 3.5 Cg_exo -76.32 128.89 10.76 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.788 2.325 . . . . 0.44 111.031 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.586 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 47.0 p-90 -132.28 -63.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.496 0.554 . . . . 0.44 112.496 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.506 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.49 -99.87 0.02 OUTLIER Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.612 -0.804 . . . . 0.44 112.517 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.3 mtpp 164.77 42.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.83 0.348 . . . . 0.44 110.874 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -58.59 -31.99 68.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.524 -0.307 . . . . 0.44 110.939 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.42 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 129.93 -37.84 2.09 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.589 -0.815 . . . . 0.44 113.368 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -129.49 105.71 17.42 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.44 111.86 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -43.76 146.31 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.079 2.52 . . . . 0.44 112.661 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.45 177.18 18.74 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.743 -0.741 . . . . 0.44 112.745 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -131.65 157.38 43.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.506 0.194 . . . . 0.44 110.596 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.483 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -75.82 106.51 7.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.866 0.365 . . . . 0.44 110.203 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.0 ptm -120.16 161.32 21.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.44 110.981 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.9 p -76.86 114.98 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.44 110.712 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 tp -77.32 -18.94 57.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.44 111.303 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.3 p -51.0 -24.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.455 -0.338 . . . . 0.44 111.328 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.54 44.37 1.24 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.662 -0.78 . . . . 0.44 112.561 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.4 tt -62.78 150.35 41.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.577 0.227 . . . . 0.44 110.419 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.71 130.12 56.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.44 112.325 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.544 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.21 -14.8 61.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.481 -0.782 . . . . 0.44 110.55 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.43 -49.13 14.04 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.364 -0.38 . . . . 0.44 111.483 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -34.69 77.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.779 0.323 . . . . 0.44 111.054 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.47 174.34 6.21 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 0.44 110.172 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 40.1 Cg_endo -67.71 127.81 16.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 121.926 1.751 . . . . 0.44 111.928 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.85 -21.12 58.06 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.606 2.204 . . . . 0.44 112.693 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.29 -9.6 58.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.378 -0.374 . . . . 0.44 111.719 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.74 23.22 13.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.488 -0.323 . . . . 0.44 111.506 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -66.59 -36.46 12.15 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.283 0.475 . . . . 0.44 112.283 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 73.8 Cg_exo -51.13 -47.74 24.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.952 1.768 . . . . 0.44 112.84 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.419 HG13 ' CD2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -77.68 -51.21 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.936 0.398 . . . . 0.44 111.191 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.516 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -62.1 -32.84 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.858 -0.61 . . . . 0.44 111.227 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 120' ' ' GLU . . . -54.92 -36.99 65.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.972 0.415 . . . . 0.44 110.374 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -62.92 -46.51 87.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.793 -0.64 . . . . 0.44 110.519 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 13.6 tp -78.13 -27.81 48.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.074 -0.512 . . . . 0.44 111.032 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -58.99 -42.67 90.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.44 110.973 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -76.73 -3.29 37.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.44 110.111 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.231 0.126 0 CA-C-N 116.082 -0.508 . . . . 0.44 111.132 179.769 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.553 ' N2 ' ' CD1' ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 5143 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 5144 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 5145 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 5146 ' ' HOH . . . . . 0.431 ' H2 ' ' CG ' ' A' ' 57' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.86 0.362 . . . . 0.44 111.15 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.4 132.83 35.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.44 110.874 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 8.8 ttmt -136.25 136.71 40.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.44 110.785 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 3.1 pp -146.04 137.76 24.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.44 110.667 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -109.24 147.53 32.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.331 0.586 . . . . 0.44 111.804 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.529 HG23 ' N3 ' ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -136.91 128.49 42.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.258 -0.883 . . . . 0.44 110.014 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.614 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -125.14 124.83 42.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.709 -0.223 . . . . 0.44 110.518 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.467 HG22 ' CD1' ' A' ' 35' ' ' PHE . 1.9 m -124.11 162.35 25.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.033 0.444 . . . . 0.44 111.062 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.69 116.12 0.75 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.656 -0.783 . . . . 0.44 112.688 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.506 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 2.4 mp -70.58 104.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.199 -0.667 . . . . 0.44 109.199 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.509 ' O ' ' CG2' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -70.97 120.52 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.21 0.529 . . . . 0.44 112.311 -177.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.52 119.65 24.5 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.636 -0.711 . . . . 0.44 111.56 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.573 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 25.8 t-20 -78.24 179.93 6.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.92 -1.036 . . . . 0.44 111.434 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.573 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 22.0 tt0 -76.1 1.26 16.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.893 -1.048 . . . . 0.44 111.97 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -139.87 52.57 1.69 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.814 0.34 . . . . 0.44 111.522 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 45.53 27.12 0.37 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.147 -0.479 . . . . 0.44 111.725 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 11.5 pt-20 -117.45 160.6 20.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.041 -0.725 . . . . 0.44 109.041 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.509 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 2.8 mp -136.82 142.31 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.24 -0.584 . . . . 0.44 112.205 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -91.7 118.19 30.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.318 -0.855 . . . . 0.44 110.281 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.62 138.44 38.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.826 -0.435 . . . . 0.44 109.826 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 34' ' ' GLU . 4.2 p -83.1 111.38 18.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.922 0.391 . . . . 0.44 110.745 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -104.4 172.18 6.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.433 . . . . 0.44 111.169 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -67.0 -7.59 23.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 0.44 111.031 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 78.78 2.52 2.52 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.33 -0.395 . . . . 0.44 111.657 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 56.08 32.16 19.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.78 0.324 . . . . 0.44 111.287 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -148.26 70.05 1.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 0.44 110.891 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.04 -69.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.44 111.13 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -170.86 -42.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.44 110.956 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.3 mtt -121.44 87.89 2.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.44 110.864 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.55 -8.78 54.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.44 111.677 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.44 31.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.612 0.227 . . . . 0.44 111.612 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -114.24 25.95 10.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.965 0.412 . . . . 0.44 111.441 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -53.45 89.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.681 -0.69 . . . . 0.44 110.216 179.344 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 21' ' ' THR . 3.1 tt0 -112.87 -168.19 1.29 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.29 0.566 . . . . 0.44 112.143 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.467 ' CD1' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.33 166.3 15.69 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.506 -0.77 . . . . 0.44 111.305 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 38.2 Cg_endo -63.93 168.6 11.8 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.334 2.689 . . . . 0.44 111.208 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.9 60.11 0.73 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 119.514 -1.327 . . . . 0.44 114.228 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.63 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.21 110.91 0.86 Allowed Glycine 0 C--N 1.314 -0.67 0 CA-C-N 114.581 -0.809 . . . . 0.44 111.732 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.63 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 126.98 -8.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.521 0.728 . . . . 0.44 110.873 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -42.2 -48.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.293 0.568 . . . . 0.44 111.57 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -31.8 -81.16 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.63 -1.168 . . . . 0.44 111.941 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.9 mmm 43.02 -92.82 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.635 -0.257 . . . . 0.44 111.557 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.71 23.8 0.09 OUTLIER Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.54 -0.838 . . . . 0.44 113.215 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -82.44 -162.95 0.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.546 0.213 . . . . 0.44 110.934 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.55 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -107.76 156.07 38.69 Favored Pre-proline 0 C--N 1.333 -0.13 0 N-CA-C 110.178 -0.305 . . . . 0.44 110.178 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.85 -24.71 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.703 2.269 . . . . 0.44 112.456 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -95.36 -54.03 3.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.976 0.362 . . . . 0.44 111.976 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -80.44 -5.26 56.28 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.052 0.39 . . . . 0.44 112.052 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.447 ' HB2' HG13 ' A' ' 40' ' ' ILE . . . -64.99 -57.44 8.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.685 0.278 . . . . 0.44 110.811 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.466 ' N ' HD11 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -79.02 -45.95 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.431 -0.35 . . . . 0.44 110.701 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.3 t -50.87 -37.76 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.335 -0.393 . . . . 0.44 111.033 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -48.68 14.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.68 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 40' ' ' ILE . 12.8 tp10 -63.92 -25.67 68.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.017 -0.538 . . . . 0.44 110.639 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.422 ' CD2' ' NE2' ' A' ' 64' ' ' HIS . 1.7 tp -55.3 -44.31 75.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.44 110.6 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -32.1 71.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.303 -0.628 . . . . 0.44 109.303 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.1 tm-20 -77.37 -25.49 51.0 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.426 -0.806 . . . . 0.44 110.848 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.413 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 5.3 mm-40 -108.38 5.18 25.19 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.104 0.409 . . . . 0.44 112.104 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.522 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 31.3 t -134.82 -44.62 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.11 0.481 . . . . 0.44 110.144 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.525 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.51 -40.25 0.23 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.482 -0.781 . . . . 0.44 113.893 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.497 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.65 -177.57 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.001 0.429 . . . . 0.44 111.227 -179.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.62 88.54 13.76 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.525 -0.761 . . . . 0.44 109.798 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.7 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 1.4 Cg_endo -112.55 147.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 123.322 2.681 . . . . 0.44 114.167 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 22.8 mt-30 -74.7 80.02 2.04 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.915 -1.883 . . . . 0.44 105.915 175.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.578 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.4 128.12 50.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.005 -1.452 . . . . 0.44 110.74 -176.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.7 t80 179.72 175.33 0.77 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.44 111.481 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 t 78.79 162.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.077 -0.51 . . . . 0.44 111.077 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -123.45 129.28 51.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.44 111.367 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.77 -44.24 33.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.292 0.568 . . . . 0.44 109.767 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.3 mt-10 -171.45 131.66 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.337 -0.847 . . . . 0.44 109.845 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.5 132.16 54.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.88 0.372 . . . . 0.44 111.286 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 tp -109.43 137.56 47.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.44 110.626 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -133.56 109.97 9.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.44 110.895 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.423 ' CZ ' HG23 ' A' ' 80' ' ' ILE . 2.3 p90 -141.22 146.28 36.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.44 110.584 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.16 133.96 55.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.105 0.478 . . . . 0.44 111.306 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -93.91 163.15 24.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.44 110.375 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.8 Cg_endo -54.15 82.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.823 2.349 . . . . 0.44 112.317 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 10.9 t0 93.49 8.53 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.435 -0.802 . . . . 0.44 111.547 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.34 93.92 2.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.774 0.321 . . . . 0.44 110.769 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.402 ' CD2' ' HG3' ' A' ' 3' ' ' LYS . 1.9 t60 -82.09 96.98 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.44 110.773 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.423 HG23 ' CZ ' ' A' ' 73' ' ' TYR . 5.0 tt -98.77 111.7 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.306 -0.406 . . . . 0.44 110.985 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.06 118.71 34.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.44 110.115 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.5 mt -106.19 114.47 28.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.963 0.411 . . . . 0.44 111.689 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 12.2 m0 -106.74 122.17 45.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.44 109.599 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.2 m-85 -112.95 109.78 19.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.44 110.196 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.739 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 15.9 m95 -94.77 148.46 22.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.277 -0.42 . . . . 0.44 111.595 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.613 ' O ' ' O ' ' A' ' 65' ' ' PHE . 59.2 tp -100.09 102.98 14.46 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.037 0.446 . . . . 0.44 111.568 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 64' ' ' HIS . 25.0 t -83.29 145.83 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 CA-C-N 115.777 -0.647 . . . . 0.44 111.159 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -113.5 -23.53 9.76 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.202 1.186 . . . . 0.44 114.202 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 2.9 ttt-85 -162.91 162.95 26.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.688 0.677 . . . . 0.44 111.287 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.7 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -157.25 125.18 5.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.44 111.674 179.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -76.07 151.9 36.97 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.285 -0.416 . . . . 0.44 111.136 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.21 -132.94 42.2 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.888 -0.672 . . . . 0.44 112.654 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 19.6 tt0 -119.69 146.94 42.75 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.6 0.238 . . . . 0.44 110.721 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.2 Cg_exo -76.69 128.85 10.44 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.904 2.403 . . . . 0.44 111.383 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.525 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 64.9 p-90 -137.08 -59.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.298 -0.561 . . . . 0.44 112.179 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.522 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 49.17 -94.63 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.617 -0.802 . . . . 0.44 112.813 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.1 mmtm 165.81 34.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.692 0.282 . . . . 0.44 111.114 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.33 -34.66 78.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.44 110.415 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.6 21.19 32.24 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.923 -0.656 . . . . 0.44 113.159 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.414 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 2.6 mp0 -140.21 92.08 9.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.972 0.415 . . . . 0.44 111.3 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -43.73 131.84 7.71 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.804 2.336 . . . . 0.44 112.374 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.0 177.04 19.42 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.511 -0.852 . . . . 0.44 112.858 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -145.2 157.25 44.12 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.298 -0.26 . . . . 0.44 110.298 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.19 106.61 3.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.851 0.357 . . . . 0.44 110.216 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.407 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -119.97 163.21 17.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.44 110.948 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.7 t -77.72 114.83 16.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.786 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.424 ' HG ' HG21 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -80.08 -19.96 46.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.44 111.255 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.9 p -52.97 -20.53 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.384 -0.371 . . . . 0.44 111.538 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.06 44.27 1.25 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.531 -0.842 . . . . 0.44 112.85 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 111' ' ' ASN . 8.5 tt -62.64 150.13 41.64 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.061 -0.348 . . . . 0.44 110.061 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.405 ' N ' HD22 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -122.49 130.52 53.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.838 0.681 . . . . 0.44 112.838 -178.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.16 61.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.318 -0.856 . . . . 0.44 110.402 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.6 -49.26 13.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.239 -0.437 . . . . 0.44 111.749 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -37.43 84.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.786 0.327 . . . . 0.44 111.001 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.565 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -80.77 173.98 6.87 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.256 -0.429 . . . . 0.44 110.146 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.8 Cg_endo -71.23 127.74 13.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.071 1.847 . . . . 0.44 111.659 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.38 -14.97 45.44 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.512 2.141 . . . . 0.44 113.18 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.55 58.65 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.049 0.388 . . . . 0.44 112.049 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -120.23 31.57 6.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.456 -0.338 . . . . 0.44 111.274 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -75.28 -45.07 4.58 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.448 0.536 . . . . 0.44 112.448 -179.073 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 85.9 Cg_exo -44.74 -36.27 10.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.242 1.961 . . . . 0.44 112.619 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.448 HG13 ' CG ' ' A' ' 84' ' ' PHE . 5.3 t -77.42 -44.6 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.047 0.451 . . . . 0.44 110.113 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.549 HG13 ' CE2' ' A' ' 115' ' ' PHE . 8.0 mm -68.27 -31.67 52.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 115.693 -0.685 . . . . 0.44 110.919 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.58 -27.59 40.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.44 110.133 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -49.5 11.67 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.842 -0.617 . . . . 0.44 111.634 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.479 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 6.8 tp -78.09 -30.75 49.76 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.895 0.378 . . . . 0.44 111.609 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 123' ' ' ILE . 14.3 ttpt -53.91 -42.62 68.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.102 -0.499 . . . . 0.44 110.949 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -70.5 -7.69 45.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.673 -0.694 . . . . 0.44 109.831 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.334 -0.105 0 CA-C-N 116.023 -0.535 . . . . 0.44 111.298 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.529 ' N3 ' HG23 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 5155 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 5156 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 5157 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 5158 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.8 0.333 . . . . 0.44 111.224 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 134.45 42.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.91 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -140.01 129.15 23.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.44 110.866 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.1 pp -146.16 119.84 9.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.44 110.613 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 6.6 mt-30 -101.89 157.45 16.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.096 0.474 . . . . 0.44 112.022 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.463 HG22 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -142.96 138.99 27.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.512 -0.767 . . . . 0.44 110.46 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.707 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.97 125.68 44.29 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.393 -0.367 . . . . 0.44 110.469 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.468 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -135.81 156.02 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.169 0.509 . . . . 0.44 111.573 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -151.37 126.08 2.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.489 -0.778 . . . . 0.44 111.799 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.518 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.87 110.63 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.653 -0.499 . . . . 0.44 109.653 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.457 HG23 ' CE3' ' A' ' 90' ' ' TRP . 1.2 mt -71.43 120.27 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.96 0.41 . . . . 0.44 111.4 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -83.15 124.42 30.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.776 -0.647 . . . . 0.44 111.512 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.481 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 4.8 t-20 -70.33 -172.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.979 0.895 . . . . 0.44 112.587 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -64.15 -12.0 35.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.781 -1.554 . . . . 0.44 113.079 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -129.05 -82.26 0.57 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.815 -0.354 . . . . 0.44 111.669 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -153.81 14.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.464 -0.335 . . . . 0.44 111.543 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -100.98 160.32 14.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.228 -0.656 . . . . 0.44 109.228 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.417 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 11.3 mt -135.94 142.18 39.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.007 0.432 . . . . 0.44 111.501 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.441 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -93.02 129.46 38.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.827 -0.624 . . . . 0.44 110.992 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 ' HB ' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.83 140.88 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.44 109.957 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.438 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 6.4 p -71.55 111.8 7.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.807 0.336 . . . . 0.44 111.089 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -85.16 83.53 7.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.399 . . . . 0.44 111.073 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 43.64 30.77 0.38 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.053 -0.521 . . . . 0.44 111.965 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 65.22 24.4 12.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.473 -0.33 . . . . 0.44 111.534 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 50.07 49.23 20.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.44 111.334 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -96.87 22.98 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.44 111.17 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.66 -80.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.443 -0.344 . . . . 0.44 111.291 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -58.34 153.19 16.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.44 110.913 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 mtt 59.46 43.13 16.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.44 110.823 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.63 -8.79 57.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.44 111.681 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.16 13.47 11.27 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.681 0.252 . . . . 0.44 111.681 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -114.28 26.21 10.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.994 0.426 . . . . 0.44 111.339 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -45.7 100.3 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.44 110.485 179.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.9 -174.18 2.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.245 0.545 . . . . 0.44 112.226 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.77 168.33 10.46 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.41 -0.814 . . . . 0.44 111.336 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.407 ' HA ' ' CD ' ' A' ' 98' ' ' GLU . 89.2 Cg_endo -75.41 168.8 23.79 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.6 2.867 . . . . 0.44 112.102 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.707 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.9 59.63 0.73 Allowed Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.19 -1.005 . . . . 0.44 114.213 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -121.42 138.82 12.69 Favored Glycine 0 C--N 1.315 -0.586 0 CA-C-N 114.614 -0.793 . . . . 0.44 112.206 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.62 -4.79 0.13 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.082 0.553 . . . . 0.44 111.901 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.497 HD11 ' HB ' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -43.89 -47.56 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.421 0.629 . . . . 0.44 111.099 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -30.95 -77.57 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.468 -1.242 . . . . 0.44 111.813 -179.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.5 mtp 39.42 -93.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.444 -0.344 . . . . 0.44 111.83 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.63 22.92 0.08 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.546 -0.835 . . . . 0.44 113.49 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.476 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.68 -158.21 0.11 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.339 0.114 . . . . 0.44 110.876 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.51 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -106.02 153.06 40.43 Favored Pre-proline 0 N--CA 1.455 -0.196 0 N-CA-C 110.226 -0.287 . . . . 0.44 110.226 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.51 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.99 -24.76 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.624 2.216 . . . . 0.44 112.373 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -101.61 -47.3 4.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.428 -0.351 . . . . 0.44 111.924 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -80.66 -5.2 56.62 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.799 0.296 . . . . 0.44 111.799 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 44' ' ' GLU . . . -64.82 -57.46 8.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.573 0.225 . . . . 0.44 110.719 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.497 ' HB ' HD11 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -79.17 -45.55 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.94 -0.304 . . . . 0.44 111.135 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.8 t -50.58 -38.45 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 0.44 111.146 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -78.64 -51.97 9.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.341 -0.39 . . . . 0.44 111.004 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.423 ' CG ' ' OE2' ' A' ' 57' ' ' GLU . 1.3 tp10 -63.68 -23.9 67.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.44 111.005 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 3.2 tp -53.95 -44.33 70.62 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.886 0.374 . . . . 0.44 110.054 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -60.81 -32.72 72.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.147 -0.686 . . . . 0.44 109.147 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -77.4 -23.95 50.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.375 -0.829 . . . . 0.44 110.733 179.024 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.423 ' OE2' ' CG ' ' A' ' 53' ' ' GLU . 5.7 mp0 -108.15 5.36 25.81 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.892 0.331 . . . . 0.44 111.892 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.511 ' CG1' HG13 ' A' ' 60' ' ' ILE . 25.3 t -134.63 -44.43 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.44 109.935 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.58 -40.17 0.23 Allowed Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.46 -0.791 . . . . 0.44 113.787 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.511 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.72 -177.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.06 0.457 . . . . 0.44 111.059 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.05 88.41 14.64 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 115.615 -0.721 . . . . 0.44 109.942 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.57 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.6 Cg_endo -111.1 148.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.446 2.764 . . . . 0.44 113.848 -177.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -74.67 79.73 2.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.738 -1.949 . . . . 0.44 105.738 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.608 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -122.72 126.96 48.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.495 -1.229 . . . . 0.44 110.885 -176.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.2 t80 -179.62 167.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.44 111.676 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.5 t 79.54 177.4 0.12 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.973 -0.558 . . . . 0.44 111.395 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.833 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -135.61 130.78 34.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.068 -0.515 . . . . 0.44 111.458 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.3 OUTLIER -76.86 -41.6 43.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.218 0.533 . . . . 0.44 109.696 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.687 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.9 mt-10 -171.39 131.35 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.371 -0.831 . . . . 0.44 109.786 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 132.16 56.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.836 0.351 . . . . 0.44 111.554 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.421 HD23 ' CE1' ' A' ' 73' ' ' TYR . 14.7 tp -112.04 132.81 54.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.44 110.472 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -123.9 110.96 15.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.328 -0.396 . . . . 0.44 110.817 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.421 ' CE1' HD23 ' A' ' 71' ' ' LEU . 2.0 p90 -141.01 153.07 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.44 110.764 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' OE1' ' CE1' ' A' ' 79' ' ' HIS . 8.0 pt-20 -116.27 138.35 51.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.185 0.516 . . . . 0.44 111.289 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -93.21 163.22 25.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.4 -0.818 . . . . 0.44 110.339 179.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -52.49 82.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.935 2.423 . . . . 0.44 112.168 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.5 t0 88.74 13.29 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.463 -0.789 . . . . 0.44 111.355 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -137.36 96.18 3.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.548 -0.296 . . . . 0.44 110.759 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.403 ' CE1' ' OE1' ' A' ' 74' ' ' GLU . 2.4 t60 -80.38 117.66 21.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.599 -0.273 . . . . 0.44 110.582 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 7.9 pt -125.32 128.31 72.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.172 0.51 . . . . 0.44 111.931 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -98.32 118.58 35.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.557 -0.747 . . . . 0.44 109.815 179.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.412 HD22 ' CE1' ' A' ' 84' ' ' PHE . 1.1 mt -101.57 113.61 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.908 0.385 . . . . 0.44 111.416 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 10.0 m0 -116.25 122.6 45.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.849 -0.614 . . . . 0.44 110.741 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.687 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.2 m-85 -110.84 111.36 22.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.981 -0.554 . . . . 0.44 109.924 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.833 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 24.4 m95 -94.29 136.55 34.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.983 0.42 . . . . 0.44 111.376 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 55.2 tp -88.37 102.93 15.35 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 116.01 -0.541 . . . . 0.44 111.232 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 64' ' ' HIS . 37.0 t -83.08 145.52 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-N 115.754 -0.657 . . . . 0.44 111.122 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -110.24 -25.73 9.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.811 1.041 . . . . 0.44 113.811 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.81 163.33 26.64 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.706 0.684 . . . . 0.44 111.408 -179.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.57 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -157.27 120.69 4.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.967 0.413 . . . . 0.44 111.324 178.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -77.5 153.47 33.42 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.979 -0.555 . . . . 0.44 111.067 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.46 -121.04 21.15 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.811 -0.709 . . . . 0.44 112.528 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.2 tt0 -134.96 147.6 63.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.547 0.213 . . . . 0.44 110.752 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.474 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.57 128.76 10.47 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.859 2.373 . . . . 0.44 111.241 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.551 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 57.7 p-90 -137.42 -60.24 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.354 -0.539 . . . . 0.44 112.161 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.496 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 53.93 -97.64 0.03 OUTLIER Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.578 -0.82 . . . . 0.44 112.688 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 178.06 22.94 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.32 0.489 . . . . 0.44 112.32 -179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.416 ' OE2' ' N ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -67.96 -32.9 73.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.934 0.397 . . . . 0.44 110.682 179.52 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.61 35.12 29.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.82 -0.705 . . . . 0.44 112.779 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.438 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 66.0 mt-30 -140.11 91.9 9.88 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.022 0.439 . . . . 0.44 111.178 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -43.69 137.38 6.27 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.025 2.483 . . . . 0.44 112.758 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.22 177.01 19.48 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.75 . . . . 0.44 112.596 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.8 157.0 44.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.576 0.227 . . . . 0.44 110.641 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -78.15 107.18 10.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.95 0.405 . . . . 0.44 110.509 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.4 ptm -119.61 163.23 17.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.032 -0.531 . . . . 0.44 110.908 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p -77.98 114.97 17.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.44 110.661 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.404 ' CB ' HD13 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -73.54 -28.14 61.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.44 111.02 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 p -53.01 -22.7 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.266 -0.424 . . . . 0.44 111.315 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.3 42.69 1.59 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.724 -0.75 . . . . 0.44 112.337 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.9 tp -62.66 147.22 50.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.351 -0.24 . . . . 0.44 110.351 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.11 132.1 53.95 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.454 0.538 . . . . 0.44 112.454 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.591 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.35 -15.2 61.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.399 -0.819 . . . . 0.44 110.498 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.67 -49.31 13.38 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.395 -0.366 . . . . 0.44 111.574 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -32.88 74.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.835 0.35 . . . . 0.44 111.086 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -87.97 173.14 6.73 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.176 -0.466 . . . . 0.44 110.408 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.497 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.2 Cg_endo -72.19 127.72 13.05 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.122 1.881 . . . . 0.44 111.701 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.44 -14.96 45.51 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.568 2.179 . . . . 0.44 113.125 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.49 58.57 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.037 0.384 . . . . 0.44 112.037 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.35 32.17 6.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.729 0.3 . . . . 0.44 111.278 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -75.93 -36.1 1.86 Allowed Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.876 0.695 . . . . 0.44 112.876 -179.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 71.4 Cg_exo -49.56 -43.19 40.21 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 121.971 1.78 . . . . 0.44 112.918 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.448 HG23 ' CE1' ' A' ' 84' ' ' PHE . 1.8 t -77.36 -51.25 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.105 0.479 . . . . 0.44 111.099 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.498 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.1 mm -63.65 -32.58 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.714 -0.676 . . . . 0.44 111.273 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.9 -31.26 59.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.038 0.447 . . . . 0.44 110.477 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -72.78 -52.54 14.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.44 111.617 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.432 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 1.8 tp -78.19 -33.01 50.34 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.771 0.286 . . . . 0.44 111.771 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -53.73 -42.61 68.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.44 111.067 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -67.85 -9.46 44.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 0.44 109.792 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--N 1.333 -0.112 0 CA-C-N 116.016 -0.538 . . . . 0.44 110.888 179.816 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.504 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 5167 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 5168 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 5169 ' ' HOH . . . . . 0.485 ' H1 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 5170 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.85 0.357 . . . . 0.44 111.177 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.65 133.76 33.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.44 110.933 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.99 126.54 20.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.44 110.901 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.4 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -133.51 140.33 47.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.469 . . . . 0.44 110.771 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -106.61 150.43 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.279 0.561 . . . . 0.44 111.915 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.412 HD12 H2'' ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -140.7 139.09 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.329 -0.851 . . . . 0.44 110.41 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.659 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.47 140.63 52.77 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 110.134 -0.321 . . . . 0.44 110.134 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.437 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -144.56 151.24 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.242 0.544 . . . . 0.44 111.327 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.56 130.67 3.21 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.423 -0.808 . . . . 0.44 112.17 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.462 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -88.43 108.0 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.402 -0.592 . . . . 0.44 109.402 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.517 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.1 mt -71.28 124.99 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.133 0.492 . . . . 0.44 111.479 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -87.06 127.12 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.495 -0.775 . . . . 0.44 110.969 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.465 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 14.8 t30 -81.95 -172.29 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.858 0.837 . . . . 0.44 112.012 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.407 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -81.82 3.59 25.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.227 -1.351 . . . . 0.44 112.261 -179.225 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -139.2 51.88 1.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 0.44 111.425 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.7 p30 45.3 26.29 0.26 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.158 -0.474 . . . . 0.44 111.421 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 8.1 pt-20 -118.81 144.08 46.55 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.157 -0.683 . . . . 0.44 109.157 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' A' ' 105' ' ' MET . 10.1 mt -114.22 142.86 25.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.162 0.506 . . . . 0.44 111.459 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -95.92 128.4 42.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.503 -0.771 . . . . 0.44 110.671 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.65 162.14 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.44 110.489 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.423 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 38.2 p -91.99 111.97 23.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.404 -0.362 . . . . 0.44 110.755 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -101.15 165.9 11.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.488 -0.324 . . . . 0.44 110.219 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -71.45 55.86 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.958 0.408 . . . . 0.44 110.305 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 43.51 -164.63 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.919 -0.582 . . . . 0.44 111.489 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.78 47.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.382 . . . . 0.44 111.018 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -131.29 -174.48 3.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.44 110.992 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.29 -163.08 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.44 111.132 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.3 m80 64.33 99.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.383 -0.371 . . . . 0.44 110.95 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.3 mmt 57.51 52.04 8.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.44 110.931 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.0 -8.84 56.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.44 111.639 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.82 31.04 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.608 -0.269 . . . . 0.44 111.517 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 26.26 10.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.859 0.362 . . . . 0.44 111.532 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -48.61 95.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.944 -0.571 . . . . 0.44 110.508 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.7 tt0 -113.11 -179.14 3.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.196 0.522 . . . . 0.44 111.64 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.95 162.05 35.21 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.721 -0.672 . . . . 0.44 111.517 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.29 168.76 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.569 2.846 . . . . 0.44 111.526 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.04 59.69 0.73 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.757 -1.211 . . . . 0.44 113.86 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -138.3 117.73 1.49 Allowed Glycine 0 C--N 1.313 -0.71 0 CA-C-N 114.548 -0.826 . . . . 0.44 111.91 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.82 -6.9 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.307 0.643 . . . . 0.44 111.215 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.51 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -43.62 -62.65 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.258 0.551 . . . . 0.44 111.375 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -16.77 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.5 -1.227 . . . . 0.44 112.425 -179.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.5 mmt 43.14 -94.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.42 -0.354 . . . . 0.44 111.511 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.83 17.82 0.09 OUTLIER Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.505 -0.855 . . . . 0.44 113.598 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.74 -161.66 0.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.532 0.206 . . . . 0.44 110.742 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.66 154.4 39.26 Favored Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 110.158 -0.312 . . . . 0.44 110.158 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.9 Cg_endo -44.0 -24.87 0.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.694 2.263 . . . . 0.44 112.406 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.48 -50.38 4.31 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.341 -0.391 . . . . 0.44 111.985 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -80.45 -4.99 55.86 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.936 0.346 . . . . 0.44 111.936 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -65.49 -57.5 8.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.574 0.226 . . . . 0.44 110.819 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.509 ' HB ' HD11 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -78.68 -43.32 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.838 -0.345 . . . . 0.44 111.029 179.279 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.9 t -50.63 -36.45 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.344 . . . . 0.44 110.721 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.67 -48.47 14.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.143 -0.481 . . . . 0.44 110.747 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -67.03 -20.0 65.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.44 111.03 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 50' ' ' VAL . 3.3 tp -57.47 -44.82 85.18 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.44 110.477 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -32.28 73.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.207 -0.664 . . . . 0.44 109.207 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 97' ' ' LYS . 5.7 tm-20 -77.37 -25.48 51.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.339 -0.846 . . . . 0.44 110.92 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -108.15 5.36 25.81 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.956 0.354 . . . . 0.44 111.956 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.556 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 30.0 t -134.33 -44.31 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.139 0.495 . . . . 0.44 109.94 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.57 -41.62 0.31 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.463 -0.789 . . . . 0.44 113.715 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.501 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.64 -177.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 120.975 0.417 . . . . 0.44 111.107 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.36 88.41 15.46 Favored Pre-proline 0 N--CA 1.441 -0.897 0 CA-C-N 115.694 -0.685 . . . . 0.44 109.969 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.503 ' HB3' ' HB2' ' A' ' 90' ' ' TRP . 9.1 Cg_endo -109.69 150.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.393 2.729 . . . . 0.44 113.659 -177.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.639 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -77.02 80.72 3.55 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 105.112 -2.181 . . . . 0.44 105.112 175.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.564 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.65 128.0 50.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.029 -1.441 . . . . 0.44 110.298 -176.054 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.5 t80 -179.35 168.54 1.48 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.593 -0.443 . . . . 0.44 112.106 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.411 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 0.3 OUTLIER 77.26 -166.93 0.05 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.926 -0.579 . . . . 0.44 111.453 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -151.8 133.42 14.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.04 -0.527 . . . . 0.44 111.056 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 69' ' ' GLU . 15.7 p90 -76.7 -41.78 43.98 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.469 -0.567 . . . . 0.44 109.469 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.3 mt-10 -171.6 131.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.271 -0.877 . . . . 0.44 109.083 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.7 132.42 42.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.759 0.314 . . . . 0.44 111.643 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.405 ' CD2' ' CG2' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -112.31 156.52 22.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.302 -0.408 . . . . 0.44 110.791 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -137.12 110.0 7.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.44 110.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -128.84 153.12 47.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.44 110.757 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -121.05 119.4 32.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.44 111.212 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -73.97 163.07 71.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.693 -0.685 . . . . 0.44 110.52 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.4 Cg_endo -53.79 82.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.92 2.413 . . . . 0.44 112.087 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.9 t70 91.86 11.08 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.381 -0.827 . . . . 0.44 111.373 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -137.29 93.81 2.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 0.44 110.846 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.21 103.11 6.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.402 -0.363 . . . . 0.44 110.821 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 tt -106.17 111.75 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.44 111.015 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.411 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -94.36 118.47 31.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.44 109.77 179.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.4 mt -107.35 114.03 27.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.44 111.612 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CZ3' ' O ' ' A' ' 46' ' ' PRO . 11.2 m0 -108.62 122.47 47.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.935 -0.575 . . . . 0.44 110.139 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 6.3 m-85 -112.67 112.25 23.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.233 -0.44 . . . . 0.44 110.4 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.67 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 30.1 m95 -94.75 148.21 22.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.44 111.57 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 65' ' ' PHE . 47.2 tp -100.76 102.96 14.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.057 0.456 . . . . 0.44 110.809 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 64' ' ' HIS . 33.4 t -84.81 145.35 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.878 -0.601 . . . . 0.44 111.733 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 3.9 mt-10 -106.36 -33.47 7.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.851 1.056 . . . . 0.44 113.851 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.08 165.4 24.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.927 0.785 . . . . 0.44 111.813 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 62' ' ' PRO . 1.2 p90 -151.56 127.52 10.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.382 . . . . 0.44 111.53 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -76.89 147.76 36.84 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.082 -0.508 . . . . 0.44 110.869 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.11 -121.2 25.93 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.44 112.438 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -133.99 148.09 66.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.631 0.253 . . . . 0.44 110.82 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.501 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.65 128.71 10.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.948 2.432 . . . . 0.44 111.566 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.526 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 62.1 p-90 -136.16 -58.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.486 -0.486 . . . . 0.44 111.716 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.1 -95.72 0.01 OUTLIER Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.872 -0.68 . . . . 0.44 113.01 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' GLU . 2.8 tttp 174.25 37.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.44 110.938 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -66.94 -30.63 70.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.391 -0.368 . . . . 0.44 110.512 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 10.3 79.39 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.924 -0.655 . . . . 0.44 113.391 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.423 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 4.7 mt-30 -140.24 91.88 9.73 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.44 111.356 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -43.72 138.48 5.74 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 123.054 2.503 . . . . 0.44 112.643 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.07 19.43 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.752 -0.737 . . . . 0.44 112.747 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -136.4 157.17 47.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.567 0.222 . . . . 0.44 110.577 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -72.98 107.16 5.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.88 0.372 . . . . 0.44 110.278 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.455 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -119.63 163.04 17.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.44 111.053 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.97 114.85 18.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.234 -0.439 . . . . 0.44 110.92 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.27 -18.73 61.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.44 111.087 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -62.52 -10.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.296 -0.411 . . . . 0.44 111.446 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.25 50.48 0.89 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.942 -0.646 . . . . 0.44 111.63 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -62.09 138.86 58.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.678 0.275 . . . . 0.44 110.538 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.425 ' N ' HD11 ' A' ' 110' ' ' LEU . 1.1 m-80 -116.87 121.75 42.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.169 0.509 . . . . 0.44 111.885 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.642 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.1 -15.13 62.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.634 -0.712 . . . . 0.44 110.977 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -78.33 -49.46 13.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.924 0.342 . . . . 0.44 111.924 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -70.64 -22.54 62.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.546 0.212 . . . . 0.44 111.367 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.642 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -100.35 170.81 6.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 110.371 -0.233 . . . . 0.44 110.371 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.5 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 43.7 Cg_endo -68.09 127.67 16.34 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.234 1.956 . . . . 0.44 111.898 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.38 -19.65 61.54 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.577 2.184 . . . . 0.44 113.001 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.93 -9.37 58.25 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.008 0.373 . . . . 0.44 112.008 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.72 29.54 7.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.779 0.323 . . . . 0.44 111.408 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.3 mt-10 -76.24 -31.87 1.03 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.845 0.683 . . . . 0.44 112.845 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.3 Cg_exo -48.52 -45.44 27.14 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 121.869 1.712 . . . . 0.44 113.04 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.429 HG11 ' CD2' ' A' ' 84' ' ' PHE . 1.4 t -77.41 -51.4 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.07 0.462 . . . . 0.44 111.205 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.471 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -62.42 -36.89 77.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.44 111.612 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.62 -29.77 52.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.905 0.384 . . . . 0.44 110.852 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -79.74 -48.47 13.58 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.126 -0.488 . . . . 0.44 111.593 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.42 HD12 ' CD1' ' A' ' 68' ' ' PHE . 3.4 tp -78.09 -46.6 20.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.852 0.358 . . . . 0.44 111.269 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.461 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 8.2 ttpp -51.95 -42.24 62.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.44 110.879 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -63.96 -7.08 7.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.63 . . . . 0.44 110.142 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 C--O 1.231 0.119 0 CA-C-N 116.143 -0.481 . . . . 0.44 110.881 179.821 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.483 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 5179 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 5180 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 5181 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 5182 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.924 0.393 . . . . 0.44 111.126 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -74.96 134.16 41.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.44 110.891 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.415 ' HG2' ' CG ' ' A' ' 79' ' ' HIS . 23.1 mtpt -140.0 135.02 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.44 110.918 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.04 141.08 27.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.44 110.768 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -106.16 149.9 26.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.405 0.622 . . . . 0.44 112.316 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.449 HG22 " H1'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -146.31 116.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.029 -0.987 . . . . 0.44 109.611 178.667 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.98 135.81 53.15 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 121.019 -0.272 . . . . 0.44 110.352 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.552 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 0.9 OUTLIER -144.54 163.1 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.98 0.419 . . . . 0.44 111.19 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.25 130.35 4.41 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.726 -0.75 . . . . 0.44 112.091 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.483 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.0 108.45 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.799 -0.445 . . . . 0.44 109.799 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.495 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.5 mt -70.97 125.98 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.466 -0.334 . . . . 0.44 111.623 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -87.7 127.25 35.3 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.894 -0.593 . . . . 0.44 111.62 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.536 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 6.1 t-20 -69.93 -172.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.793 -1.094 . . . . 0.44 112.458 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.04 -10.7 31.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.77 -1.559 . . . . 0.44 112.895 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -133.82 -82.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.838 -0.345 . . . . 0.44 111.785 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -149.97 16.21 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 0.44 111.613 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -100.61 160.56 14.25 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.648 -0.871 . . . . 0.44 108.648 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.519 HG13 ' HA ' ' A' ' 12' ' ' ARG . 1.8 mp -130.64 138.14 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.094 0.473 . . . . 0.44 111.482 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.447 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.5 OUTLIER -85.96 116.02 23.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.695 -0.684 . . . . 0.44 110.332 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.505 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.05 120.11 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.385 -0.37 . . . . 0.44 110.745 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -70.73 115.97 10.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.458 . . . . 0.44 110.575 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.43 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 19.6 ptt-85 -106.89 172.33 6.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.44 110.88 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.66 62.03 0.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.44 110.496 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 46.23 -169.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.969 -0.56 . . . . 0.44 111.412 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.19 -33.68 38.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.44 111.069 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -159.42 138.01 10.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.44 110.907 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -171.18 -75.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.44 111.1 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -151.69 -66.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.44 110.953 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 tpt -106.4 79.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.44 110.788 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.93 -8.97 58.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.44 111.621 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -96.33 26.48 4.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.744 0.307 . . . . 0.44 111.144 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -114.22 26.2 10.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.018 0.437 . . . . 0.44 111.191 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -45.47 114.12 0.7 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.672 -0.695 . . . . 0.44 110.619 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' ' CD ' ' A' ' 116' ' ' PRO . 0.5 OUTLIER -124.85 -171.66 2.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.195 0.521 . . . . 0.44 112.094 -179.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.538 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.55 168.59 9.79 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.507 -0.769 . . . . 0.44 111.146 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.552 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 87.5 Cg_endo -81.74 167.29 16.79 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.628 2.885 . . . . 0.44 113.799 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.39 -5.44 52.05 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.371 -0.831 . . . . 0.44 114.988 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -59.25 171.68 4.97 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.5 0.65 . . . . 0.44 113.214 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.686 ' HD2' ' H2 ' ' A' 5193 ' ' HOH . 0.0 OUTLIER 76.58 7.03 3.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.517 0.327 . . . . 0.44 111.811 179.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.624 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.3 pt -55.44 -26.84 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.673 0.749 . . . . 0.44 110.032 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.532 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -42.98 -60.17 1.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.323 -1.308 . . . . 0.44 110.692 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER 5.37 -79.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.404 -0.816 . . . . 0.44 112.471 179.283 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.54 33.63 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.897 -0.668 . . . . 0.44 112.643 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.4 mp0 -88.95 -174.82 4.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.821 0.343 . . . . 0.44 111.09 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.518 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.5 154.14 38.09 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.279 -0.418 . . . . 0.44 110.322 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.518 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.97 -25.25 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.872 2.381 . . . . 0.44 112.448 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -104.02 -40.4 6.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.491 -0.322 . . . . 0.44 111.405 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.402 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 34.4 mt-30 -80.29 -4.91 55.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.645 -0.252 . . . . 0.44 111.654 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.438 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -60.89 -57.11 14.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.409 . . . . 0.44 110.667 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.489 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 2.5 m -78.64 -45.99 25.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.44 111.48 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.489 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 29.0 t -56.33 -36.66 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.319 -0.401 . . . . 0.44 111.141 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -77.95 -49.78 13.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.983 0.42 . . . . 0.44 110.193 179.428 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.48 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.5 mm-40 -65.56 -19.89 66.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.004 -0.543 . . . . 0.44 110.334 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.477 ' CD1' ' CD2' ' A' ' 64' ' ' HIS . 8.6 tp -56.55 -44.49 80.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 0.44 110.527 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -31.81 69.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 0.44 110.075 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.45 -31.09 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.599 -0.728 . . . . 0.44 111.572 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.433 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 4.0 mp0 -108.06 5.37 25.99 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.453 0.538 . . . . 0.44 112.453 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.566 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 16.0 t -134.39 -43.96 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.104 0.478 . . . . 0.44 110.067 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.86 -38.32 0.29 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.614 -0.721 . . . . 0.44 114.207 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.535 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -77.71 -178.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 110.529 -0.174 . . . . 0.44 110.529 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.64 88.98 6.97 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 110.023 -0.362 . . . . 0.44 110.023 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.575 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 10.6 Cg_endo -108.28 144.07 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.475 2.783 . . . . 0.44 113.987 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -74.81 79.44 2.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.802 -1.925 . . . . 0.44 105.802 176.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.608 ' HA ' HG12 ' A' ' 87' ' ' VAL . 1.1 t-80 -123.23 122.36 38.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.65 -1.613 . . . . 0.44 109.895 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 6.5 t80 -179.41 161.07 1.04 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.456 -0.498 . . . . 0.44 112.177 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 9.3 t 77.01 166.93 0.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.701 -0.682 . . . . 0.44 110.783 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.777 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -119.54 130.08 54.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.922 0.341 . . . . 0.44 111.922 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 69' ' ' GLU . 7.1 p90 -78.2 -41.33 34.84 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.762 -0.459 . . . . 0.44 109.762 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.584 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -171.31 131.75 0.77 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.627 -0.715 . . . . 0.44 109.328 178.037 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -139.39 132.75 30.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.787 0.327 . . . . 0.44 111.483 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.451 ' CD1' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -123.43 151.38 42.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.952 0.406 . . . . 0.44 110.996 179.455 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -121.59 133.91 55.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.44 110.757 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.406 ' CE2' HG22 ' A' ' 80' ' ' ILE . 2.5 p90 -141.03 145.81 36.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.44 110.568 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.08 126.35 49.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.095 0.474 . . . . 0.44 111.365 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.453 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -86.4 163.1 43.51 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.533 -0.758 . . . . 0.44 110.319 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.6 Cg_endo -53.97 82.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.825 2.35 . . . . 0.44 112.166 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.7 t70 93.25 9.67 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.36 -0.836 . . . . 0.44 111.52 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 -137.34 93.78 2.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.299 . . . . 0.44 110.759 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.415 ' CG ' ' HG2' ' A' ' 3' ' ' LYS . 1.1 m-70 -82.3 102.28 11.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.379 -0.373 . . . . 0.44 110.921 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.406 HG22 ' CE2' ' A' ' 73' ' ' TYR . 2.0 tt -106.32 111.73 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.273 -0.421 . . . . 0.44 111.025 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.408 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -92.54 118.45 31.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.44 110.015 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.409 HD21 HD11 ' A' ' 71' ' ' LEU . 14.8 tp -108.0 114.09 27.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.44 111.577 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -112.22 122.2 47.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.44 110.46 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 5.8 m-30 -109.84 109.63 20.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.956 -0.565 . . . . 0.44 109.911 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.777 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 32.5 m95 -95.79 148.65 22.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.868 -0.605 . . . . 0.44 112.622 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.0 pp -87.29 138.12 31.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.661 -0.699 . . . . 0.44 110.433 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 64' ' ' HIS . 17.5 t -123.65 145.52 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-N 116.251 -0.431 . . . . 0.44 111.018 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.87 -30.68 8.01 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.46 1.282 . . . . 0.44 114.46 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.575 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.28 165.01 24.71 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.221 0.919 . . . . 0.44 112.111 -178.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.558 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -154.64 130.15 9.86 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.085 -0.507 . . . . 0.44 111.133 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.23 132.71 47.62 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.21 -0.45 . . . . 0.44 111.055 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 48.79 -105.23 0.12 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.704 -0.76 . . . . 0.44 112.416 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 26.5 tt0 -134.32 137.65 28.46 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.812 -0.194 . . . . 0.44 110.759 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 4.7 Cg_exo -74.13 128.9 12.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.596 2.197 . . . . 0.44 110.682 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.563 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 21.5 p-90 -118.15 -63.95 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.545 0.572 . . . . 0.44 112.545 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.566 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.43 -100.16 0.02 OUTLIER Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.822 -0.626 . . . . 0.44 112.853 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER 160.56 74.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.584 0.354 . . . . 0.44 110.774 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HG2' ' CG2' ' A' ' 21' ' ' THR . 0.9 OUTLIER -88.6 -33.2 17.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.501 -0.318 . . . . 0.44 110.803 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 142.44 -38.5 1.45 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.506 -0.854 . . . . 0.44 113.323 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.01 110.76 7.22 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.018 0.437 . . . . 0.44 111.885 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -43.84 146.39 1.58 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.121 2.547 . . . . 0.44 112.55 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.19 177.29 17.48 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.678 -0.773 . . . . 0.44 113.001 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -128.85 157.23 42.11 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.414 -0.217 . . . . 0.44 110.414 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -77.99 106.83 10.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.917 0.389 . . . . 0.44 110.556 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.4 ptp -119.99 163.08 18.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.44 110.924 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 95.8 p -75.04 114.98 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.452 -0.34 . . . . 0.44 110.859 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -78.97 -18.92 52.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.44 111.306 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.0 t -54.28 -18.52 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.437 -0.347 . . . . 0.44 111.424 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.39 55.1 0.57 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.838 -0.696 . . . . 0.44 112.268 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 tt -62.15 150.43 38.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.269 -0.271 . . . . 0.44 110.269 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -107.87 126.01 52.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.334 0.588 . . . . 0.44 112.428 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.636 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -15.2 61.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.207 -0.906 . . . . 0.44 110.791 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -78.11 -49.14 14.46 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.429 -0.351 . . . . 0.44 111.654 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -26.33 65.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.79 0.329 . . . . 0.44 110.8 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.636 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -98.36 166.96 12.33 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.17 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.6 Cg_endo -72.61 127.81 12.81 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.393 2.062 . . . . 0.44 111.937 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.54 -14.92 42.55 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.595 2.197 . . . . 0.44 113.05 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.69 -9.51 57.3 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.995 0.368 . . . . 0.44 111.995 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.72 31.17 6.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.827 0.346 . . . . 0.44 111.277 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.2 -34.13 1.37 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 113.021 0.749 . . . . 0.44 113.021 -179.162 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 93.1 Cg_exo -44.73 -46.28 12.69 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.21 1.94 . . . . 0.44 113.193 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.481 HG11 ' CE1' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -77.14 -33.98 20.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.029 0.442 . . . . 0.44 110.048 179.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.567 HG13 ' CE2' ' A' ' 115' ' ' PHE . 7.8 mm -68.18 -39.79 81.77 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.658 -0.701 . . . . 0.44 110.839 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.55 -29.44 50.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.436 . . . . 0.44 110.371 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -80.27 -53.21 6.86 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.888 -0.597 . . . . 0.44 111.782 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 1.7 tp -78.3 -19.79 52.84 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.142 0.423 . . . . 0.44 112.142 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 54.6 tttm -78.21 -42.71 30.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.081 0.467 . . . . 0.44 110.745 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -69.65 -7.03 35.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.593 -0.731 . . . . 0.44 109.905 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.421 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.123 0 CA-C-N 116.16 -0.473 . . . . 0.44 110.683 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.506 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 5191 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 5192 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 5193 ' ' HOH . . . . . 0.686 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 5194 ' ' HOH . . . . . 0.465 ' H1 ' ' C ' ' A' ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.875 0.369 . . . . 0.44 111.138 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -109.75 121.5 45.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.44 110.887 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -128.62 134.72 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.44 110.912 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.13 143.03 38.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.44 110.969 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 30.9 mt-30 -102.61 153.1 20.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.335 0.588 . . . . 0.44 112.02 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.469 HG12 H2'' ' A' ' 131' ' ' 8OG . 4.9 mp -146.2 127.93 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.108 -0.951 . . . . 0.44 109.743 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.602 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.58 124.56 42.5 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 110.163 -0.31 . . . . 0.44 110.163 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.543 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 2.0 m -116.53 162.23 14.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.345 0.593 . . . . 0.44 111.912 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.25 109.57 0.56 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.207 -0.906 . . . . 0.44 111.848 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -70.53 98.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.926 -0.398 . . . . 0.44 109.926 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.455 HG22 ' CE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.14 123.72 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 121.21 0.529 . . . . 0.44 112.121 -178.352 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -96.23 127.19 42.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.431 -0.804 . . . . 0.44 111.363 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.536 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -79.58 -172.63 3.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.268 -0.878 . . . . 0.44 112.113 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.502 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 14.9 tp10 -80.48 -2.72 47.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.265 -1.334 . . . . 0.44 112.299 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -134.16 49.61 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.879 0.371 . . . . 0.44 111.229 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 48.04 22.62 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.44 111.448 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 18.4 pt-20 -110.44 141.08 44.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.875 -0.787 . . . . 0.44 108.875 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.53 HG22 HG13 ' A' ' 10' ' ' ILE . 2.6 mt -110.82 151.44 12.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.284 0.564 . . . . 0.44 112.296 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -101.01 99.96 10.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.206 -0.906 . . . . 0.44 109.517 178.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.81 120.1 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.44 110.569 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.43 ' O ' ' O ' ' A' ' 34' ' ' GLU . 18.2 p -71.08 111.85 6.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.44 110.998 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.419 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 2.5 ptm180 -98.71 172.09 7.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.403 -0.362 . . . . 0.44 110.451 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -72.06 58.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.967 0.413 . . . . 0.44 110.235 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 46.25 -169.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.907 -0.588 . . . . 0.44 111.419 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.22 27.31 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.44 111.133 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -180.0 38.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.44 110.895 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.78 -70.38 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.44 111.073 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -177.64 -68.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.44 110.889 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.21 85.27 3.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.44 110.942 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.01 -8.79 57.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.44 111.64 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.09 20.36 5.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.646 -0.252 . . . . 0.44 111.468 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 26.26 10.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.44 111.501 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -46.8 120.21 2.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.808 -0.633 . . . . 0.44 110.696 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HG2' ' N2 ' ' A' ' 131' ' ' 8OG . 7.8 mt-10 -137.19 -174.11 3.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.045 0.45 . . . . 0.44 111.473 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.461 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.03 161.17 39.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.003 -0.544 . . . . 0.44 111.23 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.65 167.76 1.34 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.374 2.716 . . . . 0.44 111.715 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.61 59.56 0.75 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.068 -1.063 . . . . 0.44 113.768 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -124.96 132.15 8.01 Favored Glycine 0 C--N 1.311 -0.818 0 CA-C-N 114.406 -0.897 . . . . 0.44 111.78 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.41 5.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.936 0.494 . . . . 0.44 112.297 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.568 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.27 -28.11 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.601 0.715 . . . . 0.44 110.279 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.98 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.551 -1.204 . . . . 0.44 110.787 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.5 mmm 31.77 -86.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.52 0.513 . . . . 0.44 111.827 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -158.96 24.38 0.33 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.886 -0.673 . . . . 0.44 112.605 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -102.64 -179.51 3.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.892 0.377 . . . . 0.44 111.051 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.566 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.55 158.52 34.46 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.44 109.929 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.86 -24.7 0.85 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.726 2.284 . . . . 0.44 112.473 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.24 -61.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.182 0.438 . . . . 0.44 112.182 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -80.4 -20.13 44.69 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.175 0.435 . . . . 0.44 112.175 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.4 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . . . -56.87 -48.43 78.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.734 0.302 . . . . 0.44 111.093 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -78.11 -47.29 25.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.29 -0.414 . . . . 0.44 110.549 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 41.7 t -57.4 -38.49 63.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.547 . . . . 0.44 110.624 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -78.44 -46.54 19.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.44 110.989 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -69.79 -21.66 63.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 0.44 111.344 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.481 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -57.39 -44.68 84.71 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.777 0.322 . . . . 0.44 110.565 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -30.9 71.94 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.918 -0.771 . . . . 0.44 108.918 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.1 tm-20 -77.63 -29.05 51.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.058 -0.974 . . . . 0.44 111.104 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.425 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.68 5.85 25.23 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.777 0.658 . . . . 0.44 112.777 -178.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.529 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 21.3 t -134.04 -44.3 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.956 0.408 . . . . 0.44 109.989 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.585 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.68 -41.33 0.31 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.648 -0.705 . . . . 0.44 113.488 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.518 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.55 -176.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.936 0.398 . . . . 0.44 111.07 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -113.06 89.1 13.24 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 115.726 -0.67 . . . . 0.44 110.306 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 7.9 Cg_endo -108.79 148.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 123.205 2.604 . . . . 0.44 114.139 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -74.76 79.8 2.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.937 -1.875 . . . . 0.44 105.937 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.546 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -123.11 125.55 45.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.327 -1.306 . . . . 0.44 110.374 -176.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.6 t80 -177.77 159.12 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.578 -0.449 . . . . 0.44 112.128 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER 84.21 -170.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.81 -0.632 . . . . 0.44 111.298 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.5 pp -145.02 130.58 18.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.154 -0.475 . . . . 0.44 111.056 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 1.3 p90 -76.67 -35.18 58.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.212 0.529 . . . . 0.44 109.678 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.7 OUTLIER -171.2 163.53 7.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.42 -0.809 . . . . 0.44 109.504 179.038 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.53 132.41 22.74 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.762 -0.375 . . . . 0.44 111.684 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.406 HD21 ' CD1' ' A' ' 73' ' ' TYR . 9.0 tp -119.25 142.45 48.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.173 -0.467 . . . . 0.44 110.727 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -140.0 111.02 6.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.44 110.505 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.406 ' CD1' HD21 ' A' ' 71' ' ' LEU . 8.8 p90 -138.67 153.27 48.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.44 110.767 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.06 140.02 52.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.176 0.512 . . . . 0.44 111.214 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -89.2 163.18 35.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.391 -0.822 . . . . 0.44 110.545 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.3 Cg_endo -51.9 83.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.103 2.536 . . . . 0.44 112.036 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 8.1 m-20 93.96 16.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.229 -0.896 . . . . 0.44 111.142 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -137.32 150.13 47.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.44 110.489 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.83 99.72 6.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.763 0.316 . . . . 0.44 110.719 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 tt -104.35 111.75 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 120.956 0.408 . . . . 0.44 110.96 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.88 118.99 38.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.974 -0.557 . . . . 0.44 110.235 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.3 mt -118.86 114.35 22.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.877 0.37 . . . . 0.44 111.615 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.436 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.8 m0 -106.29 122.37 46.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.44 110.142 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.555 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 2.2 m-85 -98.94 110.39 23.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.842 -0.617 . . . . 0.44 110.71 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 31.9 m95 -94.85 148.77 21.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.44 111.822 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.1 tm? -94.17 137.36 33.44 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.805 -0.634 . . . . 0.44 111.356 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 64' ' ' HIS . 41.1 t -124.14 145.01 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-N 116.106 -0.497 . . . . 0.44 110.499 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.59 -27.68 8.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.73 1.011 . . . . 0.44 113.73 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.1 165.2 24.93 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.716 0.689 . . . . 0.44 111.766 -179.26 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -155.72 122.36 5.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.293 178.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.24 145.25 49.72 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.001 -0.545 . . . . 0.44 111.069 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.49 -116.82 6.9 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.867 -0.682 . . . . 0.44 112.582 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.6 tt0 -134.47 145.77 56.53 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.591 0.234 . . . . 0.44 110.819 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.465 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 3.4 Cg_exo -76.5 128.78 10.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.913 2.408 . . . . 0.44 111.135 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.585 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 47.5 p-90 -130.84 -62.54 0.9 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.512 0.56 . . . . 0.44 112.512 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.529 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.37 -97.5 0.01 OUTLIER Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.641 -0.79 . . . . 0.44 112.613 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.6 tptp 178.77 35.49 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.636 0.255 . . . . 0.44 111.389 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.35 -46.21 89.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.44 110.334 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.34 14.91 46.15 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.889 -0.672 . . . . 0.44 113.353 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.416 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 49.9 mt-30 -140.31 92.91 9.18 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.44 111.539 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -43.78 138.42 5.93 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.901 2.401 . . . . 0.44 112.534 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.18 177.13 19.39 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.628 -0.796 . . . . 0.44 112.645 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.07 157.09 45.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.641 0.258 . . . . 0.44 110.785 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.464 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.45 107.13 6.4 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.876 0.37 . . . . 0.44 110.391 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -119.67 163.42 17.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.057 -0.519 . . . . 0.44 110.871 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 p -82.0 114.94 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.394 -0.366 . . . . 0.44 110.851 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -18.79 62.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.288 -0.414 . . . . 0.44 111.112 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.9 p -57.29 -11.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.522 -0.308 . . . . 0.44 111.632 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.2 51.42 0.84 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.747 -0.739 . . . . 0.44 112.157 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.92 134.59 56.87 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.095 -0.335 . . . . 0.44 110.095 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -111.2 121.58 45.66 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.507 0.558 . . . . 0.44 112.507 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.669 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.42 -14.72 61.77 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.355 -0.839 . . . . 0.44 110.801 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -76.41 -49.05 17.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.464 -0.335 . . . . 0.44 111.483 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -27.19 64.47 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.671 -0.24 . . . . 0.44 111.085 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.669 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -93.78 169.8 9.48 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.48 -0.327 . . . . 0.44 110.249 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.524 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 40.3 Cg_endo -67.33 127.58 16.85 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.216 1.944 . . . . 0.44 111.837 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.86 -15.01 47.29 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.588 2.192 . . . . 0.44 113.151 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.3 -9.19 59.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.009 0.374 . . . . 0.44 112.009 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.416 ' ND2' ' N1 ' ' A' ' 131' ' ' 8OG . 1.6 m-80 -114.96 28.58 8.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.429 -0.35 . . . . 0.44 111.579 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -69.26 -34.48 4.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 112.947 0.721 . . . . 0.44 112.947 -179.259 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 61.8 Cg_exo -51.82 -45.87 35.7 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 121.962 1.775 . . . . 0.44 113.218 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.448 HG11 ' CD1' ' A' ' 84' ' ' PHE . 2.1 t -77.44 -51.34 18.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.328 . . . . 0.44 111.314 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.505 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -64.95 -29.81 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.44 111.064 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.38 -33.03 63.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.031 0.443 . . . . 0.44 110.257 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -78.3 -47.51 17.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.755 -0.657 . . . . 0.44 111.556 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 2.8 tp -78.17 -19.75 53.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.451 -0.34 . . . . 0.44 111.651 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 123' ' ' ILE . 15.8 ttpp -83.64 -42.39 16.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.131 0.491 . . . . 0.44 110.524 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -63.91 -10.37 20.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.573 -0.739 . . . . 0.44 109.824 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.213 0 CA-C-N 116.183 -0.462 . . . . 0.44 111.006 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.532 ' N2 ' ' HG2' ' A' ' 34' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 5203 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 5204 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 5205 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 5206 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.878 0.371 . . . . 0.44 111.178 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -110.0 147.05 34.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.44 110.922 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HG2' ' CG ' ' A' ' 79' ' ' HIS . 7.6 mtmt -132.53 148.98 52.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.44 110.68 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.464 ' CD1' " O3'" ' A' ' 131' ' ' 8OG . 4.5 pp -146.07 132.45 19.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.382 -0.372 . . . . 0.44 111.283 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 42.3 mt-30 -102.78 153.6 20.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.353 0.597 . . . . 0.44 111.756 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.501 HG13 " H1'" ' A' ' 131' ' ' 8OG . 10.4 mm -146.46 130.22 10.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.246 -0.888 . . . . 0.44 110.085 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.603 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.84 124.21 41.61 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.918 -0.401 . . . . 0.44 109.918 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.446 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.6 m -120.01 162.23 18.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.06 0.457 . . . . 0.44 111.564 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.93 109.4 0.48 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.724 -0.751 . . . . 0.44 112.81 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.598 HG13 HG21 ' A' ' 18' ' ' ILE . 1.1 tp -70.47 99.46 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.811 -0.811 . . . . 0.44 108.811 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.554 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -71.2 119.79 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 112.55 0.574 . . . . 0.44 112.55 -177.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -82.54 124.02 29.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.367 -0.833 . . . . 0.44 111.06 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.546 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 19.1 t-20 -69.63 177.6 2.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.999 -1.0 . . . . 0.44 111.851 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.546 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -54.59 -20.08 7.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.289 -1.323 . . . . 0.44 112.261 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -119.54 -82.46 0.64 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.67 0.271 . . . . 0.44 111.408 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.11 14.1 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.869 0.322 . . . . 0.44 111.869 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 17.2 pt-20 -100.89 160.15 14.61 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 109.64 -0.504 . . . . 0.44 109.64 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.598 HG21 HG13 ' A' ' 10' ' ' ILE . 3.4 mt -138.29 140.88 39.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.899 0.381 . . . . 0.44 111.895 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -86.15 113.08 21.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.25 -0.648 . . . . 0.44 109.25 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.495 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.81 119.53 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.517 -0.765 . . . . 0.44 110.168 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.99 111.8 10.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.95 0.405 . . . . 0.44 110.666 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.424 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 2.2 ptt180 -94.92 172.37 8.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.872 -0.604 . . . . 0.44 110.742 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.48 -18.66 4.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.294 -0.412 . . . . 0.44 111.265 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 67.81 -81.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.004 -0.544 . . . . 0.44 111.227 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -177.94 87.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.306 -0.407 . . . . 0.44 111.093 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -113.78 -36.89 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.44 110.832 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -171.37 52.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.44 110.953 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 61.25 30.74 19.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.44 110.881 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.89 40.8 1.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.882 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.06 -8.72 55.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.507 . . . . 0.44 111.773 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.63 16.39 5.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.751 0.278 . . . . 0.44 111.751 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.26 26.23 10.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.083 0.468 . . . . 0.44 111.371 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.424 ' HG ' ' HB3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -47.48 122.22 4.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.723 -0.672 . . . . 0.44 110.705 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -138.41 -167.25 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.005 0.431 . . . . 0.44 111.653 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.505 ' CE1' ' CE2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -119.15 155.2 53.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.837 -0.62 . . . . 0.44 111.499 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 10.2 Cg_endo -52.9 167.67 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.324 2.683 . . . . 0.44 111.341 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.53 59.71 0.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 119.852 -1.166 . . . . 0.44 114.318 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -123.62 136.47 10.38 Favored Glycine 0 C--N 1.31 -0.863 0 CA-C-N 114.919 -0.64 . . . . 0.44 111.971 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.2 ttpt 91.27 4.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.006 0.522 . . . . 0.44 112.305 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.585 HG13 ' N ' ' A' ' 41' ' ' GLU . 1.1 pt -50.51 -29.14 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.639 0.733 . . . . 0.44 110.364 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.585 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.17 -79.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.481 -1.236 . . . . 0.44 110.966 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 37.45 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.445 0.466 . . . . 0.44 111.634 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -161.93 26.14 0.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.957 -0.639 . . . . 0.44 112.691 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.451 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -99.45 -176.51 3.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.863 0.363 . . . . 0.44 111.125 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.606 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.93 162.92 18.66 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.44 110.405 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.606 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 9.3 Cg_endo -49.14 -24.53 8.03 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.639 2.226 . . . . 0.44 112.425 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -98.91 -48.04 5.05 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.144 0.424 . . . . 0.44 112.144 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -77.17 -26.61 53.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.66 0.266 . . . . 0.44 111.615 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.451 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -57.79 -45.31 86.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.799 0.333 . . . . 0.44 110.915 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -78.24 -46.63 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.44 110.516 179.585 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.483 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 46.4 t -60.03 -39.48 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.44 111.077 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -78.23 -45.77 22.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.176 -0.466 . . . . 0.44 110.963 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.68 -22.12 62.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.44 110.912 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 1.2 tp -53.87 -44.59 70.54 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.836 0.35 . . . . 0.44 110.082 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -59.54 -33.68 71.71 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.451 -0.574 . . . . 0.44 109.451 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.41 -26.25 51.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.411 -0.813 . . . . 0.44 110.994 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.426 ' HG2' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -108.02 6.04 26.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.102 0.408 . . . . 0.44 112.102 -178.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.577 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 10.3 t -134.32 -44.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.214 0.53 . . . . 0.44 109.876 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.549 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.44 -43.43 0.57 Allowed Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.476 -0.784 . . . . 0.44 113.866 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.5 OUTLIER -84.36 -175.08 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.079 0.466 . . . . 0.44 111.292 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 p -112.64 89.09 12.32 Favored Pre-proline 0 N--CA 1.442 -0.875 0 CA-C-N 115.629 -0.714 . . . . 0.44 110.554 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.642 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.9 Cg_endo -107.62 152.46 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.96 2.44 . . . . 0.44 114.203 -177.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -74.85 79.9 2.12 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.061 -1.829 . . . . 0.44 106.061 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.595 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.65 126.13 44.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.615 -1.175 . . . . 0.44 110.738 -176.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.9 t80 -179.35 165.66 1.43 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.9 0.381 . . . . 0.44 111.93 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 83.1 160.33 0.13 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.824 -0.626 . . . . 0.44 110.762 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -113.77 131.97 56.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.44 111.363 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -88.61 -33.91 17.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.039 -0.528 . . . . 0.44 110.102 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.1 tt0 -171.56 149.93 2.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.705 -0.679 . . . . 0.44 110.471 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.1 108.16 4.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.74 0.305 . . . . 0.44 110.689 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.85 140.55 51.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.44 110.794 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.14 139.47 35.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.964 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.406 ' O ' HG21 ' A' ' 80' ' ' ILE . 69.9 t80 -141.05 100.98 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.549 . . . . 0.44 110.4 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -64.76 136.88 57.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.159 0.504 . . . . 0.44 111.41 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.468 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -101.54 162.89 19.04 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.603 -0.726 . . . . 0.44 110.434 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.579 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.4 Cg_endo -53.06 81.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.019 2.479 . . . . 0.44 112.353 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 13.3 t70 102.23 -24.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.44 -0.8 . . . . 0.44 111.267 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -109.65 95.19 5.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.712 0.292 . . . . 0.44 111.09 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.416 ' CG ' ' HG2' ' A' ' 3' ' ' LYS . 18.9 m170 -77.85 93.87 4.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 0.44 110.542 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.406 HG21 ' O ' ' A' ' 73' ' ' TYR . 2.4 tt -85.78 131.8 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.44 111.475 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -134.06 118.63 17.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.44 110.178 179.668 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.475 ' CD1' ' CE1' ' A' ' 84' ' ' PHE . 1.6 pp -126.35 117.09 22.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.44 111.343 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -102.82 122.86 45.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.458 . . . . 0.44 110.966 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.505 ' CE2' ' CE1' ' A' ' 35' ' ' PHE . 3.5 m-30 -95.08 109.89 21.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.44 110.311 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 21.3 m95 -95.58 148.6 22.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.137 -0.483 . . . . 0.44 112.166 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 65' ' ' PHE . 12.2 tp -92.62 138.1 31.79 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.795 -0.639 . . . . 0.44 111.567 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.595 HG12 ' HA ' ' A' ' 64' ' ' HIS . 38.0 t -124.33 145.71 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-N 115.61 -0.723 . . . . 0.44 110.67 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -111.27 -30.57 7.38 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.589 1.329 . . . . 0.44 114.589 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.4 165.24 24.15 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.925 0.784 . . . . 0.44 111.688 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.642 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.8 p90 -148.23 130.25 15.36 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.317 -0.401 . . . . 0.44 111.538 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -78.06 145.08 36.06 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.271 -0.422 . . . . 0.44 110.935 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.14 -116.29 8.16 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.739 . . . . 0.44 112.383 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 7.0 mt-10 -135.05 139.29 31.56 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.458 0.171 . . . . 0.44 110.848 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.481 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 2.7 Cg_exo -76.35 128.6 10.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.812 2.341 . . . . 0.44 111.537 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.549 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.5 p-90 -132.32 -60.22 0.9 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.56 -0.456 . . . . 0.44 111.879 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.577 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.28 -107.31 0.1 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.908 -0.663 . . . . 0.44 113.248 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 1.3 tptt 178.1 72.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.755 0.312 . . . . 0.44 110.728 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.78 -30.66 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.39 . . . . 0.44 110.911 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.11 -66.23 0.4 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.578 -0.82 . . . . 0.44 112.885 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.1 104.97 36.12 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.002 0.43 . . . . 0.44 111.384 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -43.64 144.77 2.04 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.912 2.408 . . . . 0.44 112.748 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.489 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.08 177.12 19.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 0.44 112.393 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -133.14 153.6 51.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.644 0.259 . . . . 0.44 110.922 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 1.1 m0 -63.03 107.22 0.97 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.815 0.34 . . . . 0.44 110.357 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.4 ptm -119.44 140.5 50.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.457 . . . . 0.44 111.08 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.1 p -63.19 114.89 4.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.44 111.087 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 12.4 tp -64.6 -18.76 65.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.44 111.073 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.8 t -55.73 -15.13 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.333 -0.394 . . . . 0.44 111.6 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.18 42.16 1.88 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.715 -0.755 . . . . 0.44 112.371 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.3 128.47 36.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.187 -0.301 . . . . 0.44 110.187 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -119.66 129.38 54.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.158 0.504 . . . . 0.44 112.241 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.634 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -15.17 61.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.815 . . . . 0.44 110.817 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -78.35 -48.97 14.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.368 -0.378 . . . . 0.44 111.581 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -29.86 68.18 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.659 0.266 . . . . 0.44 111.246 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.634 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -91.41 171.9 7.36 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.467 -0.333 . . . . 0.44 110.183 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.5 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.6 Cg_endo -70.86 127.67 14.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.13 1.886 . . . . 0.44 111.714 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.61 -14.94 45.69 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.586 2.191 . . . . 0.44 113.095 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.5 -9.29 58.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.147 0.425 . . . . 0.44 112.147 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -119.76 31.31 6.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.546 -0.297 . . . . 0.44 111.698 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -70.19 -37.24 7.02 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.392 0.515 . . . . 0.44 112.392 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 64.6 Cg_exo -51.81 -43.44 51.51 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.09 1.86 . . . . 0.44 113.081 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.48 -51.27 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.962 0.411 . . . . 0.44 111.364 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.511 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -66.34 -32.13 56.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.91 -0.586 . . . . 0.44 111.343 -179.341 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.55 -29.67 59.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.847 0.356 . . . . 0.44 110.713 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -73.56 -53.24 11.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.44 111.74 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -36.22 46.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.552 -0.295 . . . . 0.44 111.48 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.4 ' HB2' HG23 ' A' ' 123' ' ' ILE . 3.1 ttpm? -53.13 -42.51 66.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.084 0.469 . . . . 0.44 111.15 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -63.99 -11.63 30.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.44 109.684 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 C--O 1.231 0.102 0 CA-C-N 115.948 -0.569 . . . . 0.44 111.089 179.563 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.501 " H1'" HG13 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 5215 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 5216 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 5217 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 5218 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.777 0.322 . . . . 0.44 111.142 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.47 120.6 42.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.431 . . . . 0.44 110.832 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -137.64 138.72 39.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.44 110.839 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.403 HD12 " O3'" ' A' ' 131' ' ' 8OG . 1.4 pp -144.01 139.82 29.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.44 110.966 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.401 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.1 mt-30 -102.7 153.83 19.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.4 0.619 . . . . 0.44 112.032 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.44 HD12 H2'' ' A' ' 131' ' ' 8OG . 3.6 mp -146.02 128.42 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.062 -0.972 . . . . 0.44 109.9 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.67 124.56 42.44 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 120.792 -0.363 . . . . 0.44 110.163 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.532 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.6 m -117.9 158.41 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.362 0.601 . . . . 0.44 111.713 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.08 108.66 0.54 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.074 -0.966 . . . . 0.44 111.345 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.595 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -70.69 96.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.358 0.599 . . . . 0.44 110.051 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.602 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 1.4 tt -71.44 121.34 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.464 0.913 . . . . 0.44 113.464 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.509 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -94.93 144.83 25.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.531 -0.758 . . . . 0.44 111.695 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.944 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.7 p-10 -102.67 -173.28 2.29 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.595 0.712 . . . . 0.44 112.164 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.3 tm-20 -71.85 1.48 6.97 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.792 -1.094 . . . . 0.44 113.425 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -124.05 43.25 3.04 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.099 -0.376 . . . . 0.44 111.695 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 45.87 27.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.098 0.475 . . . . 0.44 111.163 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 6.3 mt-10 -114.83 161.4 18.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.77 -0.65 . . . . 0.44 109.794 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.578 HD13 HG12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -125.72 132.63 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.792 0.33 . . . . 0.44 111.347 -178.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -85.26 125.72 33.11 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.021 0.439 . . . . 0.44 110.629 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.431 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -122.19 122.81 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.723 -0.671 . . . . 0.44 110.08 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 100' ' ' GLN . 19.7 p -71.01 111.96 6.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.818 0.342 . . . . 0.44 111.165 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.0 172.14 7.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.44 110.334 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -64.03 -9.79 18.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.356 -0.384 . . . . 0.44 111.154 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 74.66 8.52 4.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.292 -0.413 . . . . 0.44 111.472 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 56.54 76.17 0.31 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.823 0.344 . . . . 0.44 111.261 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -178.88 60.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.44 110.886 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -177.5 -172.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.44 111.114 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -98.3 29.18 3.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.889 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.14 55.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.44 110.58 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.11 -8.77 56.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.974 -0.557 . . . . 0.44 111.788 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.42 31.03 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.666 -0.243 . . . . 0.44 111.485 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.35 26.23 10.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.377 . . . . 0.44 111.671 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 5.5 tt -42.79 121.64 2.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.802 -0.635 . . . . 0.44 110.751 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -140.69 -176.03 4.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.145 0.497 . . . . 0.44 111.972 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.92 163.32 28.55 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.737 -0.665 . . . . 0.44 111.557 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 19.3 Cg_endo -57.22 168.08 2.97 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.508 2.805 . . . . 0.44 111.801 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.22 59.67 0.76 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.01 -1.091 . . . . 0.44 113.788 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.27 126.07 5.27 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 114.556 -0.822 . . . . 0.44 112.19 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.681 ' HE2' ' H2 ' ' A' 5229 ' ' HOH . 0.5 OUTLIER 103.46 2.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.248 0.619 . . . . 0.44 112.305 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -51.5 -27.82 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.511 0.672 . . . . 0.44 110.754 179.401 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.557 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.44 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.844 -1.071 . . . . 0.44 111.016 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.4 mmm 33.75 -86.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.538 0.524 . . . . 0.44 111.841 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -164.3 27.57 0.21 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.876 -0.678 . . . . 0.44 112.565 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -95.62 -176.23 3.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.852 0.358 . . . . 0.44 111.138 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.537 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.81 155.75 38.49 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.45 . . . . 0.44 110.235 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 3.0 Cg_endo -44.74 -24.71 1.26 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.736 2.29 . . . . 0.44 112.608 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.21 -49.63 5.41 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.247 0.462 . . . . 0.44 112.247 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -80.08 -24.15 40.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.719 0.295 . . . . 0.44 111.741 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -55.43 -47.41 76.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.436 -0.347 . . . . 0.44 111.001 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.51 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -78.17 -47.89 23.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.321 -0.4 . . . . 0.44 110.823 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.51 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 44.7 t -56.76 -36.5 49.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.44 111.103 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -78.18 -50.66 11.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 0.44 111.086 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.483 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.9 mm-40 -66.9 -24.46 66.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.44 111.113 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.467 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 1.2 tp -51.8 -44.22 63.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.886 0.374 . . . . 0.44 110.272 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -33.93 75.01 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.19 -0.67 . . . . 0.44 109.19 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.58 -26.33 50.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.318 -0.855 . . . . 0.44 111.249 179.405 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mt-10 -108.14 5.17 25.65 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.15 0.426 . . . . 0.44 112.15 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.575 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 17.7 t -134.6 -43.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.191 0.52 . . . . 0.44 109.741 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.574 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.52 -43.94 0.59 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.464 -0.789 . . . . 0.44 113.215 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.511 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.57 -177.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.094 0.473 . . . . 0.44 111.175 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -111.29 89.22 9.87 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.411 -0.813 . . . . 0.44 109.368 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.561 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 1.4 Cg_endo -108.7 156.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.864 2.376 . . . . 0.44 115.211 -176.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' CB ' ' A' ' 89' ' ' ARG . 75.8 mt-30 -77.93 80.17 4.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.088 -1.819 . . . . 0.44 106.088 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.62 ' HA ' HG11 ' A' ' 87' ' ' VAL . 1.9 t-160 -127.07 124.24 38.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.753 -1.112 . . . . 0.44 110.669 -176.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.6 t80 -179.06 162.73 1.26 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.44 111.677 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER 83.84 155.77 0.1 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.055 -0.521 . . . . 0.44 110.943 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.7 pp -113.66 126.21 55.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.44 111.317 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -78.18 -36.75 47.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.44 110.253 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.06 162.03 7.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.44 110.469 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -143.08 132.14 23.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.889 0.376 . . . . 0.44 111.155 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.6 tp -119.01 121.98 41.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.648 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -120.91 109.95 15.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.44 110.685 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -141.04 150.85 43.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.649 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.19 122.28 39.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.097 0.475 . . . . 0.44 111.354 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.88 163.09 63.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.568 -0.742 . . . . 0.44 110.457 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.67 82.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.056 2.504 . . . . 0.44 112.149 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 14.3 t0 95.94 16.64 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.36 -0.836 . . . . 0.44 111.202 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.31 145.92 44.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.44 110.615 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -118.29 94.0 4.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.44 110.547 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 tt -103.08 111.8 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.241 -0.436 . . . . 0.44 111.195 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.85 122.44 46.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 0.44 110.377 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.463 HD22 ' N2 ' ' A' ' 131' ' ' 8OG . 32.3 mt -122.27 114.71 21.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.875 0.369 . . . . 0.44 111.367 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.433 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.9 m0 -104.89 122.51 45.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.438 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 2.9 m-85 -98.64 110.12 22.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.938 -0.574 . . . . 0.44 110.387 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.649 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 25.0 m95 -94.65 148.54 22.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.44 111.583 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.6 tm? -100.36 103.85 15.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.047 -0.524 . . . . 0.44 112.116 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.62 HG11 ' HA ' ' A' ' 64' ' ' HIS . 43.1 t -91.82 145.47 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-N 115.675 -0.693 . . . . 0.44 110.382 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -111.52 -29.52 7.73 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 115.107 1.521 . . . . 0.44 115.107 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.16 165.5 24.44 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.182 0.901 . . . . 0.44 111.824 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.944 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.6 p90 -149.4 132.67 16.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.44 111.667 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -81.23 128.38 33.73 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.172 -0.467 . . . . 0.44 110.749 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.2 -116.05 4.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.661 -0.781 . . . . 0.44 112.442 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 33.0 mt-10 -135.06 141.04 36.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.556 0.217 . . . . 0.44 110.93 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.506 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 4.1 Cg_exo -76.51 128.88 10.61 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.894 2.396 . . . . 0.44 111.199 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.574 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.6 p-90 -136.8 -64.81 0.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.846 -0.742 . . . . 0.44 112.811 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.575 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 49.21 -100.36 0.03 OUTLIER Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.588 -0.815 . . . . 0.44 112.65 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER 175.71 42.2 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.709 0.29 . . . . 0.44 111.091 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.53 -52.34 65.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.498 -0.319 . . . . 0.44 110.39 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 123.79 -11.06 8.38 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.478 -0.868 . . . . 0.44 113.723 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.441 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -140.17 98.94 7.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 117.38 0.59 . . . . 0.44 111.995 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -44.06 140.21 5.41 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.751 2.301 . . . . 0.44 112.269 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.51 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.18 177.28 19.27 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.499 -0.858 . . . . 0.44 112.897 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -129.75 157.29 42.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.693 0.283 . . . . 0.44 110.624 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.87 106.42 6.39 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.867 0.365 . . . . 0.44 110.178 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.5 ptp -120.2 149.76 41.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.44 111.075 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.68 114.9 5.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.44 110.626 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 1.1 tm? -69.95 -18.92 63.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.44 111.321 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.9 p -56.1 -17.86 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.48 -0.327 . . . . 0.44 111.519 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.34 45.39 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.637 -0.792 . . . . 0.44 112.619 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tt -62.65 150.49 40.74 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.272 -0.269 . . . . 0.44 110.272 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -119.26 127.43 53.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.58 0.585 . . . . 0.44 112.58 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.621 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -14.89 61.88 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.196 -0.911 . . . . 0.44 110.496 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -48.97 15.21 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.349 -0.387 . . . . 0.44 111.397 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -35.21 79.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.847 0.356 . . . . 0.44 110.701 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.621 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -85.41 168.16 21.6 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.44 110.27 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.513 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.2 Cg_endo -67.54 127.71 16.89 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.263 1.976 . . . . 0.44 111.918 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.02 -19.17 63.64 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.539 2.159 . . . . 0.44 112.892 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.64 -9.33 58.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.024 0.379 . . . . 0.44 112.024 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -116.2 29.43 7.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.485 -0.325 . . . . 0.44 111.463 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.4 pt-20 -71.86 -31.92 1.94 Allowed Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.879 0.696 . . . . 0.44 112.879 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 50.9 Cg_exo -53.89 -37.31 85.35 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 121.875 1.716 . . . . 0.44 112.567 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.448 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 22.7 t -77.35 -48.42 24.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.183 -0.462 . . . . 0.44 110.507 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.578 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.4 mm -67.44 -30.25 48.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.739 -0.664 . . . . 0.44 110.897 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.65 -28.33 46.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 0.44 110.317 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -48.26 16.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.82 -0.627 . . . . 0.44 111.428 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.405 HD23 ' CE2' ' A' ' 68' ' ' PHE . 7.8 tp -78.2 -30.42 48.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 0.44 111.499 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -54.61 -42.55 71.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.21 -0.45 . . . . 0.44 110.967 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -72.96 -5.69 40.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 0.44 110.005 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 CA--C 1.528 0.127 0 CA-C-N 116.057 -0.52 . . . . 0.44 111.284 179.797 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.498 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 5227 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 5228 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 5229 ' ' HOH . . . . . 0.681 ' H2 ' ' HE2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 5230 ' ' HOH . . . . . 0.475 ' H2 ' ' HZ2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.882 0.372 . . . . 0.44 111.192 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.08 103.25 15.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.44 110.912 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.94 143.38 49.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.44 110.878 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.84 137.0 31.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.873 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.402 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 42.8 mt-30 -102.62 151.74 21.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.446 0.641 . . . . 0.44 112.392 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.428 ' CD1' H2'' ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -142.38 128.19 17.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.926 -1.034 . . . . 0.44 109.476 179.026 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.584 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.55 125.06 43.57 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 121.026 -0.27 . . . . 0.44 110.323 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.3 m -120.7 162.37 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.424 0.63 . . . . 0.44 112.167 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.06 113.47 0.59 Allowed Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.918 -1.037 . . . . 0.44 111.587 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.5 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -70.86 101.66 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.998 -0.371 . . . . 0.44 109.998 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.477 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -71.38 119.84 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.405 -0.361 . . . . 0.44 111.932 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.435 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -101.74 150.88 22.69 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.407 -0.815 . . . . 0.44 111.236 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.66 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 8.4 p-10 -121.34 -173.97 2.74 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.118 0.785 . . . . 0.44 113.118 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -56.45 -25.93 52.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.506 -1.224 . . . . 0.44 113.867 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -98.27 31.52 2.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.523 -0.308 . . . . 0.44 111.158 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 p30 49.12 23.21 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.182 0.515 . . . . 0.44 110.508 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -101.02 160.77 14.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.52 -0.764 . . . . 0.44 109.037 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -124.78 118.96 54.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.245 0.545 . . . . 0.44 111.943 -178.68 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.449 ' CE2' ' CA ' ' A' ' 102' ' ' GLY . 15.2 t80 -66.96 100.66 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.742 -0.663 . . . . 0.44 110.527 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 ' HB ' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -109.0 123.01 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.44 110.538 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.43 ' CG2' ' HG3' ' A' ' 98' ' ' GLU . 24.0 p -70.99 111.83 6.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.293 -0.412 . . . . 0.44 111.036 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.406 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -96.98 166.49 11.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.737 -0.468 . . . . 0.44 109.737 179.52 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 30' ' ' ALA . 0.2 OUTLIER -70.74 56.5 0.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.102 0.477 . . . . 0.44 110.352 179.536 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 47.51 -172.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.866 -0.606 . . . . 0.44 111.411 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.33 -40.22 85.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.44 111.108 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -177.69 152.49 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.896 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -173.73 -70.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.44 111.112 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -140.73 -76.68 0.31 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.44 110.783 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.9 85.19 2.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.44 110.68 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 23' ' ' ARG . . . -71.52 -8.9 56.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.44 111.69 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -95.1 28.42 2.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.611 0.243 . . . . 0.44 111.43 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.52 26.5 10.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.922 0.392 . . . . 0.44 111.7 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.41 HD22 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -47.55 113.51 0.71 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.962 -0.563 . . . . 0.44 111.0 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.77 177.04 8.03 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.152 0.501 . . . . 0.44 111.779 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.483 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -119.9 162.02 35.27 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.865 -0.607 . . . . 0.44 111.941 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.5 Cg_endo -48.16 167.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.812 3.008 . . . . 0.44 112.177 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 101.89 59.71 0.77 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.051 -1.071 . . . . 0.44 114.186 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.531 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -131.76 130.24 5.9 Favored Glycine 0 C--N 1.312 -0.798 0 CA-C-N 114.724 -0.738 . . . . 0.44 111.952 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.43 6.64 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.986 0.515 . . . . 0.44 112.037 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.584 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.53 -28.09 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.667 0.746 . . . . 0.44 110.192 179.202 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.57 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.61 -73.57 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.552 -1.203 . . . . 0.44 111.13 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 41' ' ' GLU . 1.0 OUTLIER 26.85 -85.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.562 0.539 . . . . 0.44 112.119 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.28 28.36 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.735 -0.745 . . . . 0.44 112.676 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.461 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.3 mp0 -97.44 -175.13 3.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.713 0.292 . . . . 0.44 111.192 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.592 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.23 160.74 25.48 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.41 -0.359 . . . . 0.44 110.358 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.592 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 9.7 Cg_endo -49.3 -24.63 8.7 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.623 2.215 . . . . 0.44 112.316 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.14 -45.66 5.83 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.187 0.439 . . . . 0.44 112.187 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -80.05 -23.81 41.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.667 0.27 . . . . 0.44 111.624 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -56.79 -47.56 79.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.506 -0.316 . . . . 0.44 111.021 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -78.25 -46.07 26.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.359 -0.382 . . . . 0.44 110.768 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.487 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 46.1 t -59.39 -36.81 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.047 -0.524 . . . . 0.44 111.174 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -78.15 -47.15 18.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.292 -0.413 . . . . 0.44 110.742 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.444 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.3 mt-10 -70.09 -20.83 63.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.4 -0.364 . . . . 0.44 110.736 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.48 ' CD1' ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -51.36 -44.45 62.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.229 0.538 . . . . 0.44 109.602 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -32.21 73.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.36 -0.836 . . . . 0.44 109.937 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.48 -32.43 54.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.653 -0.703 . . . . 0.44 111.767 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.14 5.07 25.57 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.225 0.454 . . . . 0.44 112.225 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.573 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 21.8 t -134.65 -44.23 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.44 . . . . 0.44 110.146 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.586 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.75 -45.32 0.39 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.694 -0.685 . . . . 0.44 113.449 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.77 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -77.97 152.34 5.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 110.049 -0.352 . . . . 0.44 110.049 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.89 96.71 0.43 Allowed Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.44 110.49 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.77 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 19.7 Cg_endo -113.72 148.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.699 0 C-N-CA 123.443 2.762 . . . . 0.44 114.163 -177.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -74.8 79.58 2.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.794 -1.928 . . . . 0.44 105.794 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.586 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -124.92 121.18 33.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.329 -1.305 . . . . 0.44 110.274 -176.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.1 t80 -178.64 169.08 1.73 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.096 0.474 . . . . 0.44 112.142 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.449 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 82.7 162.36 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.428 -0.806 . . . . 0.44 111.383 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 8.0 tt -105.47 131.84 52.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 0.44 111.611 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -98.59 -32.28 11.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 0.44 109.916 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.487 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -171.61 159.96 5.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.48 -0.782 . . . . 0.44 109.945 179.491 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -143.48 132.08 22.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.726 0.298 . . . . 0.44 110.936 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.5 tp -118.9 120.41 37.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.44 110.639 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -115.97 109.82 18.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.44 110.697 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.42 ' CE2' HG22 ' A' ' 80' ' ' ILE . 2.1 p90 -141.14 145.85 36.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.44 110.612 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.11 121.7 38.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.132 0.492 . . . . 0.44 111.203 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -70.0 163.07 64.38 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.604 -0.725 . . . . 0.44 110.506 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.8 Cg_endo -51.85 83.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.063 2.509 . . . . 0.44 112.078 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 27.8 m-20 95.56 15.33 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.176 -0.92 . . . . 0.44 111.295 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.35 149.84 47.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.427 -0.351 . . . . 0.44 110.566 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -124.17 106.1 10.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.44 110.899 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.42 HG22 ' CE2' ' A' ' 73' ' ' TYR . 1.1 tt -111.35 112.33 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.44 110.951 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.414 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -98.42 118.64 35.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.44 110.415 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 6.7 mt -115.32 114.48 25.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.987 0.422 . . . . 0.44 111.764 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -108.99 122.56 47.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.986 -0.552 . . . . 0.44 110.315 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.519 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 2.6 m-85 -100.47 125.79 46.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.657 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 15.6 m95 -107.19 148.66 28.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.314 -0.403 . . . . 0.44 112.014 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.484 ' HB3' ' CB ' ' A' ' 68' ' ' PHE . 2.0 pp -97.69 103.85 15.82 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.306 0.574 . . . . 0.44 111.446 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 64' ' ' HIS . 41.2 t -84.83 144.76 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 115.672 -0.695 . . . . 0.44 111.229 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -32.24 7.88 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.812 1.042 . . . . 0.44 113.812 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.73 165.02 26.08 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.006 -0.678 . . . . 0.44 111.56 -179.189 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.66 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.4 p90 -149.64 136.61 19.59 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.264 -0.425 . . . . 0.44 111.331 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.403 ' HB2' HD11 ' A' ' 60' ' ' ILE . 1.5 mt-10 -73.77 134.04 43.37 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.269 -0.423 . . . . 0.44 110.735 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 51.13 -107.85 0.46 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.364 -0.922 . . . . 0.44 111.86 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 21.8 mt-10 -135.56 142.11 39.82 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.49 0.186 . . . . 0.44 111.038 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.516 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 3.3 Cg_exo -76.05 128.57 10.77 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.459 2.106 . . . . 0.44 110.672 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.586 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 35.8 p-90 -124.6 -59.05 1.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.966 0.412 . . . . 0.44 111.861 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.573 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.01 -95.75 0.01 OUTLIER Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.595 -0.729 . . . . 0.44 112.875 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.71 37.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.72 0.295 . . . . 0.44 110.895 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -64.54 -44.88 89.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.371 -0.377 . . . . 0.44 111.189 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.77 -98.76 0.23 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.366 -0.921 . . . . 0.44 113.44 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.92 114.41 36.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.077 0.465 . . . . 0.44 112.248 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -43.9 146.44 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.179 2.586 . . . . 0.44 112.648 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.449 ' CA ' ' CE2' ' A' ' 19' ' ' PHE . . . -123.37 177.07 16.68 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.731 -0.747 . . . . 0.44 112.966 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -138.98 157.53 45.83 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.427 -0.212 . . . . 0.44 110.427 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.49 ' CD1' ' HZ2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -72.24 105.99 4.24 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.928 0.394 . . . . 0.44 110.085 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.29 140.0 51.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.44 110.714 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.2 p -58.89 114.55 2.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.782 0.325 . . . . 0.44 110.44 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.41 HD21 ' CG2' ' A' ' 18' ' ' ILE . 1.8 tm? -61.67 -18.84 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.409 . . . . 0.44 111.311 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.9 t -59.75 -12.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.502 -0.317 . . . . 0.44 111.331 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.11 37.63 3.68 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.952 -0.642 . . . . 0.44 112.284 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.405 ' CD2' HD22 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -62.11 123.63 18.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.142 -0.318 . . . . 0.44 110.142 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.07 128.65 50.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.251 0.548 . . . . 0.44 112.412 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.619 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.26 -14.91 61.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.233 -0.894 . . . . 0.44 110.399 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.36 -49.41 13.63 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.333 -0.394 . . . . 0.44 111.737 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -31.0 70.94 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.838 0.351 . . . . 0.44 110.877 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.619 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -90.5 172.28 7.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.095 179.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.504 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.7 Cg_endo -71.45 127.64 13.52 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.12 1.88 . . . . 0.44 111.666 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.8 -14.95 46.05 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.63 2.22 . . . . 0.44 113.153 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.56 -9.58 58.75 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.986 0.365 . . . . 0.44 111.986 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.84 33.78 5.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.44 111.439 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.49 -34.95 2.01 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.714 0.635 . . . . 0.44 112.714 -179.308 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 74.2 Cg_exo -49.69 -45.57 31.01 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 121.87 1.713 . . . . 0.44 113.056 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.414 HG13 ' CG ' ' A' ' 84' ' ' PHE . 1.6 t -77.6 -51.31 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.987 0.422 . . . . 0.44 111.428 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.479 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -64.89 -34.07 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.621 . . . . 0.44 111.634 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.93 -31.19 60.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.861 0.362 . . . . 0.44 110.79 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.05 -53.63 16.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 0.44 111.564 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.72 -30.02 45.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.726 0.298 . . . . 0.44 111.394 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -54.65 -42.51 71.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.025 0.44 . . . . 0.44 110.741 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -66.14 -10.51 41.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.759 -0.655 . . . . 0.44 109.624 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-N 115.943 -0.572 . . . . 0.44 111.221 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.499 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 5239 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 5240 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 5241 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 5242 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.824 0.345 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -133.65 143.52 48.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.3 pp -145.94 127.93 15.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.565 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 41.4 mt-30 -102.65 154.07 19.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.337 0.589 . . . . 0.0 112.282 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 6' ' ' ILE . 27.2 mm -146.55 132.72 13.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.675 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.041 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.45 124.59 42.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.1 m -121.0 162.51 19.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.3 0.571 . . . . 0.0 111.994 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.422 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.2 113.05 0.56 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.738 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.064 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.78 107.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.714 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.2 mt -71.43 124.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.049 0.452 . . . . 0.0 111.68 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.76 124.01 32.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.43 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.488 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 52.0 t30 -79.19 -172.7 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.805 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.488 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.3 tp10 -82.62 2.9 31.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.469 -1.241 . . . . 0.0 112.084 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -135.95 50.32 2.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.797 0.332 . . . . 0.0 111.227 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 p30 45.5 26.68 0.33 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.385 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 13.6 pt-20 -120.39 141.7 49.86 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.064 HG21 HG22 ' A' ' 10' ' ' ILE . 17.6 mt -110.88 140.31 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.154 0.502 . . . . 0.0 111.716 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -89.42 122.6 32.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.689 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.602 HD13 HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -120.04 162.25 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.262 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.434 HG21 ' OE1' ' A' ' 98' ' ' GLU . 3.7 p -95.67 111.8 23.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.57 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 2.4 ptm180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.996 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.556 0.217 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 26.29 10.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.381 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.545 HD21 ' HB ' ' A' ' 20' ' ' ILE . 2.9 tt -46.84 96.11 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -114.49 -178.74 3.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.16 0.505 . . . . 0.0 111.711 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.546 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.6 164.23 22.98 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.432 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 19.8 Cg_endo -56.84 167.89 2.75 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.472 2.781 . . . . 0.0 112.012 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.18 59.47 0.76 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.613 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.17 126.79 5.12 Favored Glycine 0 C--N 1.313 -0.742 0 CA-C-N 114.581 -0.81 . . . . 0.0 112.101 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER 109.42 4.55 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.153 0.581 . . . . 0.0 112.125 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.041 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -58.65 -24.35 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.428 0.632 . . . . 0.0 110.791 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.565 ' HB3' ' H ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -49.83 -71.82 0.06 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.094 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.441 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER 23.54 -86.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.611 0.569 . . . . 0.0 112.252 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -159.7 23.82 0.29 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.787 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.24 -177.13 3.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.87 0.367 . . . . 0.0 111.026 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.891 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.68 157.47 38.31 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.872 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.891 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.79 -24.69 0.82 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.717 2.278 . . . . 0.0 112.413 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -85.57 -60.67 1.96 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.526 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -80.43 -21.49 42.11 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.84 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -56.73 -48.83 76.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.784 0.326 . . . . 0.0 111.095 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.736 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.4 -46.39 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.6 t -57.12 -36.56 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -78.29 -49.19 14.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.747 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.517 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.2 mm-40 -67.61 -20.0 65.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.992 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.797 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.3 tp -57.17 -44.64 83.72 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.866 0.365 . . . . 0.0 110.529 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -34.68 78.43 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.2 tm-20 -77.46 -24.09 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.873 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -108.47 5.15 25.0 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.096 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.949 HG12 HG13 ' A' ' 60' ' ' ILE . 38.5 t -134.65 -44.39 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.142 0.496 . . . . 0.0 109.836 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.99 -40.09 0.26 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.443 -0.798 . . . . 0.0 113.893 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.949 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.68 -176.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.009 0.433 . . . . 0.0 111.089 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.33 88.81 13.45 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.006 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.81 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.3 Cg_endo -110.57 145.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.362 2.708 . . . . 0.0 113.981 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 39.4 mt-30 -74.78 79.78 2.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.006 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.81 128.22 52.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.952 -176.252 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.4 t80 -179.34 167.89 1.49 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.76 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 14.6 m 84.51 149.14 0.07 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.544 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 pp -107.1 128.46 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.298 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.885 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -78.84 -41.29 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.252 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.502 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 10.3 tt0 -171.38 167.07 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.03 132.11 23.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 111.087 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.898 HD22 HG21 ' A' ' 122' ' ' VAL . 0.8 OUTLIER -116.18 122.3 44.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.001 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -120.62 109.78 15.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -141.13 149.26 41.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.674 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -121.23 120.52 35.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.125 0.488 . . . . 0.0 111.198 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.493 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -69.98 163.74 58.24 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.354 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -50.94 83.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.221 2.614 . . . . 0.0 112.39 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.7 t70 94.74 16.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.357 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 27.1 ttt180 -137.38 146.44 44.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.641 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -119.68 99.43 6.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.623 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 tt -106.79 121.08 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.093 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.454 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -109.76 122.82 48.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.424 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.438 HD13 ' OD1' ' A' ' 119' ' ' ASN . 8.1 mt -126.04 114.97 19.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 111.347 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.467 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.6 m0 -107.82 122.52 46.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.796 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.754 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.4 m-30 -93.37 109.61 21.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.817 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.705 ' CE2' HG11 ' A' ' 50' ' ' VAL . 28.2 m95 -96.82 148.75 22.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.025 0.441 . . . . 0.0 112.083 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 65' ' ' PHE . 7.1 tp -97.58 138.22 35.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.542 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.006 HG22 ' ND1' ' A' ' 64' ' ' HIS . 39.4 t -124.02 146.04 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.37 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -110.52 -26.34 9.54 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.81 164.5 26.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.572 0.624 . . . . 0.0 111.548 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.71 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -157.37 123.48 4.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.381 178.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -73.88 147.2 43.45 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.67 -127.87 43.49 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.58 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 17.1 mt-10 -125.22 146.19 53.17 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.53 0.205 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.58 128.74 10.46 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.827 2.351 . . . . 0.0 111.471 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.552 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.3 p-90 -132.58 -58.19 0.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.669 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.11 -97.11 0.01 OUTLIER Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.923 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.99 31.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.693 0.282 . . . . 0.0 111.172 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.434 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -61.49 -40.78 95.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.78 0.324 . . . . 0.0 110.477 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.85 13.56 60.69 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.8 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -140.31 92.02 9.58 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 117.18 0.49 . . . . 0.0 111.509 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -43.63 132.76 7.54 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.982 2.454 . . . . 0.0 112.688 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.25 177.1 19.42 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.856 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -134.22 157.29 46.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.641 0.257 . . . . 0.0 110.624 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.2 106.97 3.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.844 0.354 . . . . 0.0 110.323 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 18' ' ' ILE . 3.6 ptp -119.95 147.33 44.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.171 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t -66.63 114.87 5.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.66 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -70.97 -28.71 64.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.914 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.432 HG12 HD21 ' A' ' 129' ' ' LEU . 21.5 t -53.25 -23.94 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.06 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.33 42.31 1.62 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.404 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' ' 111' ' ' ASN . 10.4 tt -62.56 150.16 41.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.64 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -116.22 127.67 54.96 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.596 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -14.98 61.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.512 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.44 -49.31 13.69 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.78 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -38.84 87.21 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 110.904 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.611 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.84 173.02 8.38 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.973 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.469 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 36.2 Cg_endo -65.7 127.79 18.67 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.087 1.858 . . . . 0.0 111.973 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.48 -21.18 53.59 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.576 2.184 . . . . 0.0 112.956 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.66 -9.59 57.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.85 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.438 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -118.77 34.26 5.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.179 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -75.15 -43.69 4.55 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 85.8 Cg_exo -44.77 -33.16 6.82 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.184 1.923 . . . . 0.0 112.567 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.898 HG21 HD22 ' A' ' 71' ' ' LEU . 49.4 t -77.62 -51.08 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.419 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.837 HG22 ' HB2' ' A' ' 127' ' ' LYS . 12.4 mm -66.25 -30.45 49.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.979 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.73 -27.18 38.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.945 0.403 . . . . 0.0 110.485 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -80.18 -51.34 9.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.69 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.885 HD22 ' CE2' ' A' ' 68' ' ' PHE . 13.0 tp -78.09 -34.61 50.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.818 0.342 . . . . 0.0 111.599 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.837 ' HB2' HG22 ' A' ' 123' ' ' ILE . 42.6 tttp -53.19 -42.72 66.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.08 0.467 . . . . 0.0 111.137 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -73.02 -4.17 30.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.05 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 127' ' ' LYS . 4.4 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.039 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.824 0.345 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.85 126.33 20.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.761 HD12 ' CD1' ' A' ' 6' ' ' ILE . 0.8 OUTLIER -130.41 136.65 49.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.707 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.77 ' C ' HD13 ' A' ' 6' ' ' ILE . 27.8 mt-30 -102.95 153.29 20.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.335 0.588 . . . . 0.0 112.146 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.77 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -146.04 124.64 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.795 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.097 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.74 125.26 43.77 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.743 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.588 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.5 m -115.77 162.09 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.426 0.631 . . . . 0.0 111.867 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.13 111.57 0.58 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.27 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.682 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.85 102.31 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.735 HG22 ' CE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.2 121.46 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 121.125 0.488 . . . . 0.0 111.659 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.469 ' HG2' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -91.29 132.81 35.9 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.629 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.669 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 2.4 p30 -89.04 -173.24 3.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.473 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 8.2 tt0 -79.61 8.93 5.59 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.686 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -132.25 47.17 2.55 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.141 -0.35 . . . . 0.0 111.691 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 45.06 25.94 0.19 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.087 0.47 . . . . 0.0 111.507 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.574 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 25.9 mt-10 -116.87 161.19 19.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.842 HD13 HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -118.8 135.68 58.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.052 0.453 . . . . 0.0 111.74 -178.27 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -85.78 109.86 18.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.994 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.609 HG22 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.5 140.18 44.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.106 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.423 ' O ' HD23 ' A' ' 33' ' ' LEU . 16.3 p -73.58 111.67 8.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.0 111.195 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.406 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.756 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.613 0.244 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -114.41 26.41 10.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 111.43 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -43.89 94.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.787 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -109.37 172.38 6.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.208 0.527 . . . . 0.0 112.076 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.609 ' HB3' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -119.63 163.58 26.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.57 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.402 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 26.3 Cg_endo -61.08 167.71 8.64 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.508 2.805 . . . . 0.0 112.03 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 101.99 59.53 0.77 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.73 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.619 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.15 118.66 2.46 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 114.552 -0.824 . . . . 0.0 111.999 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.619 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.31 2.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.185 0.594 . . . . 0.0 111.682 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.097 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -50.48 -28.92 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.57 0.7 . . . . 0.0 110.568 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.595 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.51 -79.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.964 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp 36.18 -85.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.5 0.5 . . . . 0.0 111.597 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.18 29.67 0.17 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.354 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.426 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 25.7 mp0 -97.32 -178.35 4.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.931 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.33 159.34 32.46 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.995 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.931 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.87 -24.71 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.784 2.322 . . . . 0.0 112.479 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -88.1 -61.22 1.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -80.54 -6.01 57.58 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.912 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.82 -55.13 29.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 110.884 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.916 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.5 m -78.22 -45.19 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.871 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.3 t -56.49 -41.47 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.128 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.32 -46.84 19.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.988 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -69.32 -21.66 63.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.034 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.743 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -55.43 -44.24 76.09 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.823 0.344 . . . . 0.0 110.12 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -34.86 73.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.8 -26.64 49.75 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.394 179.26 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.03 5.25 25.95 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.942 HG12 HG13 ' A' ' 60' ' ' ILE . 19.9 t -134.79 -44.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.244 0.545 . . . . 0.0 110.053 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.13 -41.27 0.35 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.602 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.942 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.7 -176.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 120.977 0.418 . . . . 0.0 111.038 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.66 88.82 14.33 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.885 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.86 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.2 Cg_endo -110.74 146.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 123.276 2.651 . . . . 0.0 114.35 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 15.9 mt-30 -74.69 80.03 2.04 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.014 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.55 131.9 54.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.549 -175.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.515 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -176.22 -136.97 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.391 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 51.76 172.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.213 0.53 . . . . 0.0 112.258 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.668 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.6 tt -136.97 115.89 12.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.454 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.69 -56.3 4.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.982 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.662 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 mt-10 -171.46 131.51 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.138 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.668 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -125.5 132.1 52.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.716 0.293 . . . . 0.0 110.679 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.708 HD22 ' N ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -124.22 168.29 13.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 110.857 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.708 ' N ' HD22 ' A' ' 71' ' ' LEU . 5.0 tt0 -140.16 123.62 17.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.568 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.9 p90 -141.02 148.61 40.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.279 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -120.98 128.39 52.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 111.487 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -86.48 162.86 44.12 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.193 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.5 Cg_endo -50.11 81.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.0 2.466 . . . . 0.0 112.31 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.4 t70 89.09 12.15 0.07 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.529 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -137.26 93.92 2.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.655 0.264 . . . . 0.0 110.938 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -77.15 108.73 10.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.854 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 2.7 tt -110.8 112.75 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.31 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -96.62 118.85 33.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.115 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.568 HD12 ' CE1' ' A' ' 73' ' ' TYR . 20.6 mt -112.01 114.15 26.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.888 0.375 . . . . 0.0 111.9 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.477 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 8.9 m0 -115.73 122.22 44.85 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.252 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.662 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 7.2 m-30 -106.15 123.08 47.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.97 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.916 ' NE1' HG11 ' A' ' 50' ' ' VAL . 31.5 m95 -105.13 149.0 26.25 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.611 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 86' ' ' LEU . 2.3 tm? -98.7 103.47 15.42 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.597 0.713 . . . . 0.0 112.332 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.014 HG22 ' ND1' ' A' ' 64' ' ' HIS . 20.9 t -82.76 145.85 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.899 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -114.01 -25.38 8.58 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -162.27 160.16 26.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.522 0.601 . . . . 0.0 111.49 -179.011 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.735 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -153.27 124.3 7.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.364 178.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -74.28 146.69 42.99 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.74 -130.99 51.3 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 37.9 mt-10 -121.32 144.79 40.74 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.572 0.225 . . . . 0.0 110.715 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.513 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.1 Cg_exo -76.66 128.74 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.934 2.422 . . . . 0.0 111.474 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.559 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.5 p-90 -135.23 -57.96 0.8 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.715 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.595 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.13 -94.56 0.01 OUTLIER Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.005 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 56' ' ' GLU . 4.7 tmtt? -177.23 32.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.767 0.317 . . . . 0.0 111.01 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.448 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 8.4 pt-20 -70.78 -38.65 73.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.342 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.81 21.25 63.96 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.337 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.448 ' NE2' ' O ' ' A' ' 98' ' ' GLU . 2.8 mt-30 -140.23 91.85 9.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.022 0.439 . . . . 0.0 111.448 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -44.02 137.03 7.31 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.975 2.45 . . . . 0.0 112.626 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.16 177.05 19.44 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.874 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -145.07 157.38 44.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.583 0.23 . . . . 0.0 110.538 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.445 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.6 m0 -62.15 106.62 0.75 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.332 . . . . 0.0 110.474 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.445 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.05 147.34 44.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.67 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.04 114.7 12.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.801 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.842 HD22 HD13 ' A' ' 18' ' ' ILE . 30.1 tp -80.15 -18.92 48.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.0 t -50.59 -23.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.535 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.61 48.04 0.98 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.481 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.657 ' HB2' HD12 ' A' ' 107' ' ' LEU . 9.3 tt -62.62 150.22 41.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.63 0.253 . . . . 0.0 110.47 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.02 135.19 54.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.169 0.509 . . . . 0.0 112.163 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.553 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.08 -15.25 62.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.493 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.98 -49.24 13.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.512 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -33.73 76.12 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.262 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.553 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -84.94 174.05 6.31 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.316 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.474 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.6 Cg_endo -71.05 127.8 14.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.05 1.833 . . . . 0.0 111.764 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.91 -15.02 46.68 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.606 2.204 . . . . 0.0 113.226 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.75 -9.63 58.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.547 HD21 HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -122.08 32.72 5.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.7 0.286 . . . . 0.0 111.303 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.523 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -76.18 -39.19 2.57 Favored Pre-proline 0 C--O 1.223 -0.305 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.049 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 89.4 Cg_exo -44.9 -39.94 14.53 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 121.924 1.749 . . . . 0.0 113.024 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.626 HG22 ' CD1' ' A' ' 71' ' ' LEU . 2.4 t -77.53 -51.03 19.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.999 0.428 . . . . 0.0 110.924 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.547 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.0 mm -64.89 -32.13 56.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.405 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.74 -29.89 54.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.034 0.445 . . . . 0.0 110.497 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -76.49 -49.57 16.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.494 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 126' ' ' LEU . 2.6 tm? -78.18 -31.37 49.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.672 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 123' ' ' ILE . 2.9 ttpm? -54.07 -42.62 69.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.028 0.442 . . . . 0.0 111.01 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -69.99 -7.88 44.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.911 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 127' ' ' LYS . 1.6 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.219 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.792 0.329 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 146.76 28.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 4' ' ' LEU . 1.7 pp -145.97 134.85 22.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.024 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.449 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 26.1 mt-30 -102.85 151.67 22.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.306 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.3 mm -146.64 129.39 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.981 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.085 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.68 125.05 43.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.556 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.592 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.5 m -118.07 161.45 16.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.249 0.547 . . . . 0.0 111.788 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.3 112.1 0.53 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.853 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.475 ' CG2' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -74.45 105.48 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.706 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.1 mt -71.74 124.83 29.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.12 0.486 . . . . 0.0 112.018 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.461 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -93.72 135.57 34.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.22 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.657 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.5 p30 -92.74 -173.45 3.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.905 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -75.31 -1.22 22.63 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.83 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -119.5 41.24 3.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.442 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p30 46.9 25.16 0.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.082 0.468 . . . . 0.0 111.201 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.552 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 25.1 mt-10 -114.44 160.94 18.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.751 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -116.85 138.64 46.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.078 0.466 . . . . 0.0 112.019 -178.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.476 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -82.27 99.84 9.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.79 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -116.52 115.41 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.499 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.625 HG21 ' HB2' ' A' ' 100' ' ' GLN . 9.0 t -76.45 123.43 26.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.848 0.356 . . . . 0.0 111.009 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.624 179.748 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.25 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.6 26.3 10.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.941 0.401 . . . . 0.0 111.698 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -48.28 117.86 2.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.856 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.404 ' N ' HD23 ' A' ' 33' ' ' LEU . 32.7 mm-40 -145.06 171.55 14.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.953 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.762 ' CD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.42 167.85 11.26 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 121.004 0.431 . . . . 0.0 111.934 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.4 Cg_endo -47.46 168.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.862 3.041 . . . . 0.0 112.694 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.07 59.99 0.72 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.851 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -131.83 132.62 6.8 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 114.391 -0.905 . . . . 0.0 112.14 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.8 ttmm 92.3 10.47 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.023 0.529 . . . . 0.0 112.388 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.085 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -56.79 -28.27 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.673 0.749 . . . . 0.0 109.993 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.83 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.896 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.98 -84.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.516 0.51 . . . . 0.0 111.709 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.44 32.74 0.1 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.57 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.481 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.3 mt-10 -93.21 -173.72 3.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.698 0.285 . . . . 0.0 111.194 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.878 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.19 154.02 37.85 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.316 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.878 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.99 -24.87 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.819 2.346 . . . . 0.0 112.494 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -103.62 -41.76 5.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.828 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -80.3 -13.6 59.06 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.032 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.05 -52.95 62.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.752 0.31 . . . . 0.0 111.094 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.719 HG11 ' NE1' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -78.28 -44.64 27.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.921 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.2 t -55.87 -42.71 71.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.538 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -78.3 -49.94 12.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.916 0.388 . . . . 0.0 111.269 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -68.4 -20.01 64.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.254 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.67 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -56.71 -45.06 82.07 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 110.103 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -31.88 71.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -76.75 -25.35 53.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.981 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.447 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -106.42 6.59 30.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.544 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.967 HG13 HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -133.45 -44.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.135 0.493 . . . . 0.0 109.793 179.576 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.537 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.67 -37.17 0.17 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.553 -0.749 . . . . 0.0 114.65 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.967 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -85.06 -174.32 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.889 0.376 . . . . 0.0 110.796 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.11 88.59 12.52 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.469 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.642 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.7 Cg_endo -111.13 145.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.471 2.78 . . . . 0.0 113.886 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 11.5 mt-30 -74.86 79.82 2.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.013 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.07 127.43 51.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.596 -176.504 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 86' ' ' LEU . 17.4 t80 179.85 168.15 1.22 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 82.28 149.83 0.09 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.696 179.471 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -105.69 128.76 53.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 111.077 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' HE2' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -80.5 -38.36 29.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.426 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.498 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 2.0 tt0 -171.29 160.65 6.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.336 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -143.25 132.2 22.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.968 0.414 . . . . 0.0 111.233 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.672 ' HB2' HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -117.11 130.2 56.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.431 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -123.15 109.97 14.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.562 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -141.17 150.58 42.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.731 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.26 123.09 41.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.125 0.488 . . . . 0.0 111.121 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.473 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -69.99 163.15 63.61 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.46 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.8 Cg_endo -52.36 82.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.028 2.485 . . . . 0.0 112.097 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 8.8 t70 96.19 15.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.152 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -137.35 149.91 47.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.635 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -120.35 93.98 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.453 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.6 tt -100.56 111.94 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.23 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.3 118.73 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.24 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 122' ' ' VAL . 5.5 tp -110.84 114.25 27.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 111.336 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -110.34 122.49 47.82 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.547 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.42 ' HA ' HG22 ' A' ' 8' ' ' VAL . 2.8 m-30 -105.37 109.82 21.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.174 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.719 ' NE1' HG11 ' A' ' 50' ' ' VAL . 35.0 m95 -99.39 148.67 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.013 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 65' ' ' PHE . 31.2 tp -96.54 138.6 33.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.571 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.013 HG22 ' ND1' ' A' ' 64' ' ' HIS . 35.1 t -123.61 145.35 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.237 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.66 -24.48 9.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.8 tpt180 -162.86 162.39 26.39 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.574 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.706 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.09 123.92 5.09 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.214 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.45 146.17 40.91 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.251 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.3 -126.73 43.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.723 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' ILE . 22.7 mt-10 -125.15 143.74 45.19 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 110.486 -0.19 . . . . 0.0 110.486 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.425 ' HA ' ' CG1' ' A' ' 60' ' ' ILE . 3.9 Cg_exo -76.48 128.64 10.48 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.713 2.275 . . . . 0.0 111.434 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.537 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 64.3 p-90 -131.93 -56.69 0.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.787 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.593 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.92 -95.04 0.01 OUTLIER Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.111 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -179.1 33.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.653 0.263 . . . . 0.0 111.196 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -76.8 -37.1 56.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.98 0.419 . . . . 0.0 110.243 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.13 30.1 51.85 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.101 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.625 ' HB2' HG21 ' A' ' 21' ' ' THR . 5.0 mt-30 -140.35 91.63 9.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.055 0.455 . . . . 0.0 111.503 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -47.59 133.55 21.21 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.096 2.531 . . . . 0.0 112.428 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.07 177.09 19.4 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.914 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 105' ' ' MET . 2.6 mt-10 -142.5 157.81 44.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.539 0.209 . . . . 0.0 110.491 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.491 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.3 m0 -66.63 106.59 1.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 2.9 mmm -119.89 148.19 43.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.944 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.04 114.78 8.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.8 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.751 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -67.0 -28.28 68.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.828 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.1 p -55.49 -22.79 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -109.84 34.38 5.49 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.497 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.52 HD13 HD22 ' A' ' 107' ' ' LEU . 9.6 tp -62.78 139.52 58.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.03 131.26 53.63 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.4 -15.14 61.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.547 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -78.62 -49.44 13.21 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.703 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -35.75 79.74 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 111.225 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.92 174.13 6.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.127 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.499 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 53.7 Cg_endo -70.11 127.75 14.75 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.026 1.818 . . . . 0.0 111.705 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.93 -15.04 46.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.6 2.2 . . . . 0.0 113.085 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.19 -9.46 58.74 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.485 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -120.37 31.91 6.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.747 0.308 . . . . 0.0 111.426 -178.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -73.14 -36.28 3.19 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.621 ' HB2' HD13 ' A' ' 71' ' ' LEU . 70.4 Cg_exo -50.98 -44.97 39.04 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 121.92 1.747 . . . . 0.0 112.699 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.8 t -77.41 -51.21 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 111.097 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.587 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.8 mm -62.83 -32.9 57.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.232 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.02 -33.72 62.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.08 0.467 . . . . 0.0 110.553 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -66.84 -49.65 65.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.843 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 126' ' ' LEU . 0.7 OUTLIER -78.14 -26.07 47.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.144 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.455 ' O ' HD12 ' A' ' 129' ' ' LEU . 3.1 ttpm? -58.21 -42.6 86.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.002 0.43 . . . . 0.0 110.778 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.6 ttm-85 -73.86 -5.32 40.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.953 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.828 HD21 ' O ' ' A' ' 108' ' ' VAL . 1.7 mp . . . . . 0 N--CA 1.461 0.095 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.325 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.27 37.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.674 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.9 pp -145.98 122.53 11.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.7 mt-30 -102.69 148.38 25.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.347 0.594 . . . . 0.0 111.888 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.557 ' HB ' HD23 ' A' ' 82' ' ' LEU . 31.5 mm -146.48 130.77 10.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.833 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.093 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.43 124.46 42.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.608 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -118.63 162.94 16.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.235 0.54 . . . . 0.0 111.933 -179.387 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.0 112.83 0.55 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.402 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.976 ' CG2' HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -70.79 105.68 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.389 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.852 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.2 mt -71.54 124.0 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.438 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -85.28 126.86 34.04 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.456 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 24.8 t-20 -70.43 177.37 3.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.119 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.528 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 8.8 tt0 -56.62 -18.58 12.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.404 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -120.55 -82.74 0.65 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.615 0.245 . . . . 0.0 111.243 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.73 15.54 0.36 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.616 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 3.6 mt-10 -100.93 160.39 14.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.976 HG21 ' CG2' ' A' ' 10' ' ' ILE . 3.4 mt -138.12 140.72 39.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.014 0.435 . . . . 0.0 111.609 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -89.75 116.46 27.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.375 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.61 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -113.36 125.59 70.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.419 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.827 HG21 ' HG3' ' A' ' 98' ' ' GLU . 15.0 p -75.46 111.85 11.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.82 0.343 . . . . 0.0 110.495 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.563 0.221 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -114.54 26.32 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 111.585 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.61 HD21 ' HB ' ' A' ' 20' ' ' ILE . 2.7 tt -45.42 122.71 3.67 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.812 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.573 ' N ' HD23 ' A' ' 33' ' ' LEU . 53.6 mt-10 -145.96 -175.32 4.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.894 0.378 . . . . 0.0 111.443 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.608 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.07 162.09 35.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.239 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.685 ' HD3' HG23 ' A' ' 21' ' ' THR . 10.3 Cg_endo -50.09 167.91 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.387 2.725 . . . . 0.0 111.715 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.23 59.47 0.76 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.825 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.615 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.54 120.01 2.74 Favored Glycine 0 C--N 1.312 -0.78 0 CA-C-N 114.791 -0.705 . . . . 0.0 112.023 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.615 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 114.09 3.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.313 0.645 . . . . 0.0 111.937 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.093 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -53.64 -26.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.43 0.633 . . . . 0.0 110.569 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.12 -82.62 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.143 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 34.87 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.39 0.432 . . . . 0.0 111.886 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.89 31.24 0.14 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.623 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.455 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -91.24 -174.38 3.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.75 0.31 . . . . 0.0 111.189 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.888 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.68 154.85 36.94 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.352 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.888 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.8 Cg_endo -44.53 -24.86 1.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.735 2.29 . . . . 0.0 112.603 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.741 ' O ' HG23 ' A' ' 51' ' ' VAL . 11.6 mt-10 -102.2 -42.91 5.88 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -80.22 -16.07 55.6 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.916 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.08 -50.49 73.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.146 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.761 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -78.1 -45.11 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.798 0.332 . . . . 0.0 110.884 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.2 t -53.71 -37.92 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -51.99 9.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.018 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.8 mm-40 -63.97 -22.07 66.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.907 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.762 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.0 OUTLIER -56.47 -44.62 80.75 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.979 0.419 . . . . 0.0 110.409 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -62.96 -34.64 77.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.6 tm-20 -77.47 -25.0 50.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.14 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.453 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 69.2 mm-40 -108.15 5.36 25.82 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.953 HG12 HG13 ' A' ' 60' ' ' ILE . 31.4 t -134.71 -44.26 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.183 0.516 . . . . 0.0 109.793 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.83 -41.1 0.32 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.711 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.953 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.66 -176.53 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.016 0.436 . . . . 0.0 111.057 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.04 88.87 12.76 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.991 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.852 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.1 Cg_endo -109.48 145.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.287 2.658 . . . . 0.0 113.917 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 11.8 mt-30 -74.78 79.76 2.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.996 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.81 128.06 52.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.926 -176.222 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.7 t80 -179.22 168.46 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 111.991 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.3 p 83.07 158.0 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.827 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -110.83 137.9 47.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -94.92 -32.46 13.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.264 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.491 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 17.8 tt0 -171.38 155.57 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.51 132.03 22.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.711 0.291 . . . . 0.0 110.95 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.068 HD22 HG21 ' A' ' 122' ' ' VAL . 2.5 pt? -129.19 132.36 47.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.851 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -127.28 109.93 12.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.558 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.444 ' OH ' HD12 ' A' ' 82' ' ' LEU . 3.0 p90 -132.24 153.04 51.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.491 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -118.74 138.61 52.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.158 0.504 . . . . 0.0 111.406 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -98.81 163.06 19.59 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.209 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 6.0 Cg_endo -48.09 81.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.11 2.54 . . . . 0.0 112.342 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 m-20 85.61 13.55 0.18 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.586 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.564 ' NE ' HD21 ' A' ' 4' ' ' LEU . 8.9 ttt180 -137.44 93.83 2.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 0.0 110.998 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -75.02 112.47 11.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.573 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.428 HD13 ' OH ' ' A' ' 73' ' ' TYR . 3.7 tt -109.7 112.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.325 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.411 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -102.11 124.03 47.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.241 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.557 HD23 ' HB ' ' A' ' 6' ' ' ILE . 20.6 mt -126.02 114.93 19.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.863 0.364 . . . . 0.0 111.607 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.411 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.4 m0 -106.48 122.48 46.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.523 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.3 m-85 -99.07 109.66 22.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.211 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.68 ' NE1' HG11 ' A' ' 50' ' ' VAL . 25.5 m95 -97.24 148.66 22.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.19 0.519 . . . . 0.0 112.358 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 65' ' ' PHE . 25.0 tp -95.94 138.68 33.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.132 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.996 HG22 ' ND1' ' A' ' 64' ' ' HIS . 33.2 t -123.47 145.88 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.459 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.3 -24.59 9.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 5.4 tpt180 -162.64 162.43 27.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.548 0.613 . . . . 0.0 111.544 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.744 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -155.08 124.91 6.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.24 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.43 148.32 39.22 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.33 -129.27 43.21 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.54 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 49.3 mt-10 -122.73 144.16 41.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.573 0.225 . . . . 0.0 110.678 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.51 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.43 128.72 10.57 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.778 2.319 . . . . 0.0 111.493 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.555 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -132.41 -58.02 0.94 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.649 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.536 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.72 -99.61 0.02 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.924 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 175.0 38.49 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.6 0.238 . . . . 0.0 111.209 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.827 ' HG3' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -70.53 -11.73 61.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.714 0.292 . . . . 0.0 111.253 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.74 20.17 68.03 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.378 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.426 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 8.1 mm-40 -140.48 97.51 7.48 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.84 0.352 . . . . 0.0 111.384 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.62 132.71 7.53 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.836 2.357 . . . . 0.0 112.51 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.05 177.12 19.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.823 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -149.49 157.27 43.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.529 0.204 . . . . 0.0 110.516 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -71.24 106.78 3.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.824 0.345 . . . . 0.0 110.116 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.3 ptp -119.86 152.06 37.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.724 ' HB2' HG12 ' A' ' 108' ' ' VAL . 23.2 p -75.26 114.89 14.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.606 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.966 HD12 HD13 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -57.92 -20.56 38.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.24 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.724 HG12 ' HB2' ' A' ' 106' ' ' SER . 9.9 p -52.67 -21.24 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.48 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.36 31.92 8.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.678 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.96 HD23 ' CD2' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -62.51 126.97 29.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.64 0.257 . . . . 0.0 110.324 179.684 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.728 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -123.33 130.63 52.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.331 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.17 -14.7 61.88 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.146 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -78.31 -49.01 14.43 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.617 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -39.8 88.33 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.75 0.309 . . . . 0.0 110.913 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -79.06 172.1 10.78 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.995 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.534 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.7 Cg_endo -70.77 127.33 13.65 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 121.976 1.784 . . . . 0.0 111.404 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.57 -14.84 42.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.617 2.212 . . . . 0.0 113.275 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.65 -9.32 58.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.98 36.7 4.55 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -69.75 -41.03 14.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.2 Cg_exo -55.23 -40.58 84.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.052 1.835 . . . . 0.0 112.625 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 1.068 HG21 HD22 ' A' ' 71' ' ' LEU . 5.5 t -77.44 -51.26 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.548 . . . . 0.0 110.793 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.533 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -66.12 -29.87 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.187 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.85 -31.97 60.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.049 0.452 . . . . 0.0 110.226 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -52.35 57.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.886 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 68' ' ' PHE . 3.1 tp -78.12 -29.81 49.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.24 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -55.98 -42.56 76.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.831 ' O ' HD12 ' A' ' 129' ' ' LEU . 51.7 ttp180 -74.22 -4.78 38.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.115 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.189 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 tttp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.872 0.368 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.03 131.91 27.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.869 HD12 HD11 ' A' ' 6' ' ' ILE . 3.0 pp -146.17 118.98 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 28.7 mt-30 -101.91 156.76 17.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.265 0.555 . . . . 0.0 112.219 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.869 HD11 HD12 ' A' ' 4' ' ' LEU . 1.7 mp -146.19 130.76 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.575 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.027 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.44 124.43 42.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -127.99 158.36 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.915 0.388 . . . . 0.0 111.724 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.443 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.25 137.5 6.06 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.966 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.024 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -86.22 111.97 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.729 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.5 mt -71.68 123.74 26.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.54 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -84.32 122.77 29.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.484 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.482 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 50.3 t30 -79.65 -172.69 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.855 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.482 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -82.74 0.61 42.75 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.935 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -136.98 50.58 2.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.911 0.386 . . . . 0.0 111.241 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.51 26.38 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.263 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 16.1 pt-20 -116.82 153.25 32.8 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.024 HG21 HG22 ' A' ' 10' ' ' ILE . 5.2 mt -130.36 142.17 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 0.0 111.588 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.91 123.16 35.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.854 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.687 HD11 ' HG2' ' A' ' 105' ' ' MET . 0.5 OUTLIER -113.69 124.77 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.531 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 21' ' ' THR . 1.6 t -72.44 111.71 7.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 0.0 110.718 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.439 ' HA ' HD23 ' A' ' 33' ' ' LEU . 20.3 ptt180 . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.859 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 31' ' ' ASN . 2.7 t30 . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.575 0.226 . . . . 0.0 111.458 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.33 26.2 10.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 111.394 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.638 HD11 HD13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -43.35 116.55 0.95 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.403 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -170.85 2.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.24 0.543 . . . . 0.0 112.056 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.51 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.77 165.69 16.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.097 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 47.5 Cg_endo -67.7 167.51 20.91 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.087 2.525 . . . . 0.0 111.533 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.09 59.13 0.77 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.806 -1.188 . . . . 0.0 113.914 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -123.39 127.32 6.56 Favored Glycine 0 C--N 1.311 -0.828 0 CA-C-N 114.841 -0.68 . . . . 0.0 112.021 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER 100.39 6.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.142 0.577 . . . . 0.0 112.211 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.027 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -50.34 -29.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.744 0.783 . . . . 0.0 110.118 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.582 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.86 -81.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.22 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.6 mmt 40.16 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.269 0.356 . . . . 0.0 111.548 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.0 29.83 0.14 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.669 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -95.07 -173.31 2.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.736 0.303 . . . . 0.0 111.122 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.912 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.95 158.01 34.12 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.37 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.912 ' HD2' HG22 ' A' ' 45' ' ' THR . 5.9 Cg_endo -46.74 -24.71 3.14 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.668 2.245 . . . . 0.0 112.375 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.755 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mm-40 -101.54 -44.19 5.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.888 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -80.19 -12.63 59.62 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.951 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -60.54 -54.02 50.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 0.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.807 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.0 OUTLIER -78.14 -44.21 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.587 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.7 t -50.52 -37.77 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.37 . . . . 0.0 110.805 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -78.6 -49.49 13.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.791 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.0 -19.83 66.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.036 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.814 HD21 ' NE2' ' A' ' 64' ' ' HIS . 2.7 tp -59.53 -44.71 93.11 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.18 -34.21 77.55 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 97' ' ' LYS . 5.5 tm-20 -77.35 -24.13 50.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.832 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.484 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 50.3 mm-40 -108.29 5.66 25.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.911 HG12 HG13 ' A' ' 60' ' ' ILE . 41.7 t -134.2 -44.27 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.166 0.508 . . . . 0.0 109.656 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.541 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.89 -39.74 0.25 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.397 -0.819 . . . . 0.0 113.994 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.911 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.7 -177.43 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.018 0.437 . . . . 0.0 111.026 -179.449 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.83 88.54 14.31 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.807 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.758 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.0 Cg_endo -111.71 145.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 123.406 2.737 . . . . 0.0 113.994 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 36.7 mt-30 -74.86 79.63 2.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 175.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.994 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -120.11 128.67 53.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.832 -176.432 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.8 t80 -179.51 168.71 1.42 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.981 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER 83.91 155.66 0.1 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.675 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -113.84 123.11 49.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.212 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.83 -38.19 54.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.074 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -171.3 141.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.349 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.46 132.18 22.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.671 0.272 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.745 HD23 HG22 ' A' ' 122' ' ' VAL . 4.4 pp -124.46 164.69 19.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.315 . . . . 0.0 110.954 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -139.77 116.91 11.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.802 ' OH ' HD11 ' A' ' 80' ' ' ILE . 2.2 p90 -141.15 153.07 45.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 6.8 pt-20 -118.34 124.28 47.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 111.319 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.0 163.22 61.32 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.477 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.487 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -52.8 82.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.989 2.459 . . . . 0.0 112.19 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 7.7 t0 90.92 10.73 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.479 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.449 ' CD ' HD21 ' A' ' 4' ' ' LEU . 6.6 ttp180 -137.36 95.89 3.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.294 . . . . 0.0 110.809 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.414 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.8 t-80 -80.4 106.58 12.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.263 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.802 HD11 ' OH ' ' A' ' 73' ' ' TYR . 3.6 pt -120.39 127.09 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.131 0.491 . . . . 0.0 112.119 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.26 118.68 34.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.041 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.679 HD21 ' OD1' ' A' ' 119' ' ' ASN . 4.4 tp -104.78 113.7 27.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 110.965 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.402 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 9.6 m0 -115.58 122.52 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.053 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.705 ' CD2' HG11 ' A' ' 122' ' ' VAL . 3.1 m-30 -105.32 109.68 21.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.702 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.807 ' CE2' HG11 ' A' ' 50' ' ' VAL . 66.0 m95 -94.85 148.67 22.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.307 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 65' ' ' PHE . 65.6 tp -94.52 138.28 32.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.917 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.994 HG22 ' ND1' ' A' ' 64' ' ' HIS . 27.0 t -123.96 145.81 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.418 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -112.82 -24.57 9.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.477 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -162.79 160.73 25.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.595 0.634 . . . . 0.0 111.484 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.701 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.19 121.66 4.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.164 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -77.21 155.31 32.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.214 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.37 -132.78 46.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.619 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.2 mt-10 -122.2 147.06 48.44 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.577 0.227 . . . . 0.0 110.694 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.51 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.62 128.64 10.36 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.85 2.367 . . . . 0.0 111.353 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.541 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 63.4 p-90 -136.59 -58.84 0.73 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.892 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.59 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.49 -96.4 0.01 OUTLIER Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.939 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.7 tmtt? 177.67 33.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.584 0.231 . . . . 0.0 111.173 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -29.01 68.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.7 0.286 . . . . 0.0 110.679 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.91 -2.12 71.91 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.719 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -140.12 95.46 8.43 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.259 0.529 . . . . 0.0 111.556 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -43.71 141.04 4.19 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.909 2.406 . . . . 0.0 112.497 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.23 171.56 22.14 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.871 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.55 157.17 39.5 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.53 106.44 6.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.898 0.38 . . . . 0.0 110.523 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.687 ' HG2' HD11 ' A' ' 20' ' ' ILE . 5.1 ppp? -120.28 155.87 32.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.041 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.2 t -70.3 114.93 8.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.579 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.625 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.51 -18.98 60.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.341 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.651 ' O ' HD21 ' A' ' 129' ' ' LEU . 15.5 t -57.45 -16.88 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.458 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.06 43.54 1.43 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.432 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.601 HD22 HD11 ' A' ' 107' ' ' LEU . 12.7 tp -62.4 146.98 49.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.11 126.81 47.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.6 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.33 -15.16 61.88 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.733 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.456 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 5.9 t70 -78.28 -49.39 13.77 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -39.03 87.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.982 0.42 . . . . 0.0 110.857 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -80.11 173.82 7.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.341 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.476 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.2 Cg_endo -72.26 127.76 13.04 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.162 1.908 . . . . 0.0 111.697 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.89 -14.95 44.24 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 113.061 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.42 58.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.679 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.1 m-80 -121.67 32.6 5.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.695 0.283 . . . . 0.0 111.488 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.454 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.3 mt-10 -73.77 -46.88 6.98 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 80.9 Cg_exo -44.8 -35.05 9.19 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.33 2.02 . . . . 0.0 112.525 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.745 HG22 HD23 ' A' ' 71' ' ' LEU . 12.5 t -77.35 -43.39 30.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.066 0.46 . . . . 0.0 110.127 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.785 HG22 ' HB2' ' A' ' 127' ' ' LYS . 15.5 mm -67.65 -34.41 67.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.888 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.4 -26.61 31.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.983 0.421 . . . . 0.0 110.465 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.13 -52.72 7.44 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.712 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.16 -33.48 50.25 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.725 0.298 . . . . 0.0 111.519 -179.13 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.843 ' N ' HD23 ' A' ' 126' ' ' LEU . 6.0 ttpm? -53.57 -42.67 67.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.969 0.414 . . . . 0.0 111.058 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -69.37 -7.92 41.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.87 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.651 HD21 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.33 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.899 0.38 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -140.08 131.65 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.847 HD21 ' NE ' ' A' ' 78' ' ' ARG . 3.4 pp -126.02 127.53 46.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.837 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -102.96 152.2 21.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.182 0.515 . . . . 0.0 111.255 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.858 ' HB ' HD23 ' A' ' 82' ' ' LEU . 2.7 mp -143.9 139.02 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.355 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.978 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -125.16 125.46 43.73 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -134.53 151.43 31.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.363 0.602 . . . . 0.0 111.833 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.46 122.11 1.3 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.907 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.033 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -71.56 114.26 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.712 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.31 121.7 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.024 0.44 . . . . 0.0 111.553 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.418 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.7 119.41 24.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.5 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 54.9 t30 -79.04 -172.64 3.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.967 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.51 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 1.1 tm-20 -81.43 0.91 35.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.118 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -139.47 52.28 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 111.27 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.8 p30 45.61 26.59 0.34 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.358 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 16.4 pt-20 -117.23 151.41 36.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.033 HG21 HG22 ' A' ' 10' ' ' ILE . 4.3 mt -127.93 146.78 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.034 0.445 . . . . 0.0 111.655 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.454 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -97.24 121.76 39.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.855 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.954 HD13 HD11 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -116.71 141.19 35.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.17 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 p -80.2 125.45 29.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.778 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.473 ' CA ' HD23 ' A' ' 33' ' ' LEU . 31.1 ttt180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.621 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.156 0 N-CA-C 111.525 0.195 . . . . 0.0 111.525 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -114.23 26.0 10.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 111.472 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.954 HD11 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -46.13 101.63 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.585 179.648 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -110.26 -169.34 1.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.03 0.443 . . . . 0.0 111.451 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.75 162.59 32.07 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.58 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 36.8 Cg_endo -64.59 168.08 13.9 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.559 2.839 . . . . 0.0 111.989 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.784 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.41 59.17 0.76 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.872 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.611 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -127.64 127.73 5.89 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 114.242 -0.979 . . . . 0.0 111.688 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 111.7 -10.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.317 0.647 . . . . 0.0 110.974 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.978 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -43.67 -74.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.848 0.356 . . . . 0.0 110.804 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.548 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER 6.31 -82.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.107 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 36.32 -141.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.373 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.9 11.27 9.44 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.077 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -169.08 0.29 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.585 0.231 . . . . 0.0 110.683 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.879 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.17 155.33 38.72 Favored Pre-proline 0 N--CA 1.454 -0.25 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.879 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.74 -24.59 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.584 2.19 . . . . 0.0 112.226 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -89.6 -59.85 2.1 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.127 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -80.85 -4.84 56.19 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -66.04 -57.26 8.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.638 0.256 . . . . 0.0 111.178 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.705 HG23 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -78.55 -41.16 24.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.158 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 47' ' ' GLU . 73.6 t -50.42 -35.62 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.811 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -78.35 -52.05 9.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.053 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.44 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 1.1 tm-20 -62.18 -23.37 66.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.763 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.779 HD21 ' NE2' ' A' ' 64' ' ' HIS . 2.2 tp -57.45 -44.66 84.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.782 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -62.74 -27.9 69.59 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.25 -27.03 53.13 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.001 179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.433 ' HG2' ' H ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -108.69 6.15 25.49 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.943 HG12 HG13 ' A' ' 60' ' ' ILE . 25.4 t -133.51 -44.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.017 0.437 . . . . 0.0 109.928 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.95 -39.02 0.19 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.636 -0.711 . . . . 0.0 114.018 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.943 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.58 -176.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.979 0.419 . . . . 0.0 110.984 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.25 88.72 13.09 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.117 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.841 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.4 Cg_endo -111.41 144.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.426 2.75 . . . . 0.0 114.146 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 35.1 mt-30 -74.82 79.93 2.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.998 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.49 129.09 53.7 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.654 -175.596 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -177.77 -138.25 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.503 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.73 163.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.162 0.506 . . . . 0.0 112.045 179.159 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.1 tt -124.55 109.82 13.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.749 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.87 -43.43 35.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.164 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.4 tt0 -171.63 163.66 6.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.429 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.33 114.19 7.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.88 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.7 ' HB2' HG22 ' A' ' 122' ' ' VAL . 15.7 tp -102.73 121.93 43.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.811 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -124.54 109.79 13.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.596 ' HE1' HD12 ' A' ' 82' ' ' LEU . 2.5 p90 -141.09 152.1 44.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.635 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -121.17 118.82 30.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.047 0.451 . . . . 0.0 111.332 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -69.9 163.64 58.81 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.281 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -52.37 83.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.066 2.511 . . . . 0.0 112.362 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 4.6 t70 98.02 14.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.387 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.847 ' NE ' HD21 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -137.36 147.14 45.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.67 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.25 96.06 4.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.54 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.449 HD13 HH12 ' A' ' 78' ' ' ARG . 1.1 tt -102.81 115.37 44.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 0.0 111.196 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.14 118.92 37.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.22 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' A' ' 6' ' ' ILE . 16.6 mt -118.69 114.57 22.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 111.489 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -104.81 122.51 45.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.217 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.451 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 4.4 m-30 -103.54 109.84 21.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.016 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.599 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 44.6 m95 -94.84 148.58 22.15 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.675 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 86' ' ' LEU . 2.9 tm? -101.28 102.92 13.88 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.399 0.619 . . . . 0.0 111.75 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.998 HG22 ' ND1' ' A' ' 64' ' ' HIS . 15.0 t -79.39 145.71 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.691 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -115.19 -23.02 9.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.8 OUTLIER -162.37 160.22 26.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.6 0.637 . . . . 0.0 111.556 -179.029 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.712 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.08 121.47 4.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.124 178.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.56 148.78 42.67 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.198 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.53 -128.93 47.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.589 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.0 mt-10 -123.57 147.57 53.35 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.615 0.245 . . . . 0.0 110.641 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.47 128.71 10.53 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.793 2.329 . . . . 0.0 111.105 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.571 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.2 p-90 -135.5 -62.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.546 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.564 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.06 -97.75 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.614 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.9 tttp 171.32 34.98 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.578 0.228 . . . . 0.0 111.344 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -29.21 64.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.74 0.305 . . . . 0.0 110.568 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.44 64.72 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.374 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -140.18 94.78 8.6 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.007 0.432 . . . . 0.0 111.441 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.61 138.67 5.36 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.996 2.464 . . . . 0.0 112.398 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.07 19.43 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.915 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -142.06 157.31 45.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.58 0.229 . . . . 0.0 110.447 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -69.38 106.99 3.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.881 0.372 . . . . 0.0 110.332 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtt -119.68 163.13 17.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 p -80.36 114.75 19.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -80.23 -27.09 38.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.149 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -51.96 -23.46 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.493 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.21 44.62 1.22 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.591 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.57 150.24 41.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.588 0.232 . . . . 0.0 110.387 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.95 133.4 56.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.21 0.528 . . . . 0.0 112.344 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.15 -15.39 61.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.567 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.59 -49.13 13.8 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.538 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -33.8 76.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.849 0.357 . . . . 0.0 111.002 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -86.91 173.44 6.66 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.458 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.4 Cg_endo -67.7 127.69 16.71 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 121.947 1.765 . . . . 0.0 111.967 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.87 -20.56 58.24 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.519 2.146 . . . . 0.0 112.922 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.83 -9.49 58.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.92 30.38 7.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.797 0.332 . . . . 0.0 111.397 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.611 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -76.23 -32.01 1.05 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.3 Cg_exo -49.22 -43.52 36.9 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 121.957 1.771 . . . . 0.0 113.088 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.7 t -77.56 -51.32 18.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.0 111.542 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.569 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -65.95 -34.75 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.541 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -28.76 50.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -74.81 -53.26 9.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.629 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.78 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.2 tp -78.57 -32.97 48.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.638 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.569 ' HB2' HG22 ' A' ' 123' ' ' ILE . 4.0 tttm -53.85 -42.65 68.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.967 0.413 . . . . 0.0 111.019 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -65.94 -10.79 42.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.731 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.78 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.3 mp . . . . . 0 C--O 1.231 0.111 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.048 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.838 0.351 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -137.64 143.14 41.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.77 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.9 pp -146.14 120.09 9.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.757 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.763 ' C ' HD13 ' A' ' 6' ' ' ILE . 23.8 mt-30 -102.12 155.48 18.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.371 0.605 . . . . 0.0 111.918 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.763 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -146.24 121.73 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.855 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.012 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -122.19 124.78 44.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.469 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.694 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -121.36 162.92 19.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.325 0.583 . . . . 0.0 111.952 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -145.99 120.66 1.35 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.987 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.947 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.81 105.52 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.741 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.5 mt -71.37 121.81 22.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 0.0 111.668 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.31 127.64 34.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.77 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.492 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 51.8 t30 -83.63 -172.53 4.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.636 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.482 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 28.1 tt0 -83.95 5.66 24.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.141 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -141.25 52.66 1.56 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.0 111.367 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.0 p30 45.46 25.15 0.21 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.57 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 16.4 pt-20 -117.69 144.95 44.76 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.947 HG21 HG22 ' A' ' 10' ' ' ILE . 9.8 mt -115.13 135.94 53.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.248 0.546 . . . . 0.0 111.978 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -80.8 116.55 20.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.943 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.876 HG23 ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -116.94 131.14 70.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.754 HG23 ' HD3' ' A' ' 36' ' ' PRO . 62.9 p -71.92 111.87 7.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.408 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.146 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.703 0.287 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -113.92 26.27 10.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.094 0.473 . . . . 0.0 111.401 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 34' ' ' GLU . 1.2 tt -47.45 127.88 11.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.772 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.781 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -156.53 -173.91 4.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 111.496 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.876 ' CD2' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.94 162.71 31.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.469 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.754 ' HD3' HG23 ' A' ' 21' ' ' THR . 10.6 Cg_endo -51.55 168.72 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.534 2.823 . . . . 0.0 111.657 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 7' ' ' ALA . . . 102.94 59.41 0.74 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.923 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.05 116.28 2.04 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.53 -0.835 . . . . 0.0 111.683 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.69 5.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.224 0.61 . . . . 0.0 111.682 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.017 HD12 ' HB1' ' A' ' 49' ' ' ALA . 1.2 pt -50.71 -28.92 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.572 0.701 . . . . 0.0 110.275 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.583 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.94 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.151 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' GLU . 56.6 mmm 30.83 -86.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.566 0.541 . . . . 0.0 112.054 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.84 32.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.524 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.2 mp0 -87.16 -174.8 5.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.827 0.346 . . . . 0.0 111.161 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.857 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.69 154.08 37.62 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.353 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.857 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.82 -26.33 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.835 2.357 . . . . 0.0 112.548 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 51' ' ' VAL . 8.8 mt-10 -104.2 -38.72 6.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.746 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -80.29 -11.72 59.69 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.017 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.01 -53.02 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.0 111.072 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.905 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.7 m -78.23 -45.87 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.9 t -56.04 -37.94 51.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.04 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -78.28 -47.2 18.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.629 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.66 -21.57 65.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.804 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.833 HD21 ' CE1' ' A' ' 64' ' ' HIS . 1.9 tp -55.64 -44.55 77.26 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.871 0.367 . . . . 0.0 110.534 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -34.07 77.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -77.39 -25.82 51.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.072 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.456 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 31.0 mm-40 -108.54 5.52 25.2 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.963 HG12 HG13 ' A' ' 60' ' ' ILE . 25.8 t -134.34 -44.18 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.117 0.484 . . . . 0.0 109.96 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.99 -41.07 0.33 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.696 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.963 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.54 -175.52 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.983 0.421 . . . . 0.0 110.965 -179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.3 89.0 11.48 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.29 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.896 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.8 Cg_endo -108.78 143.59 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.172 2.581 . . . . 0.0 114.008 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 38.4 mt-30 -74.9 79.87 2.14 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.833 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -119.28 129.6 54.99 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.682 -176.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.4 t80 178.79 167.41 0.9 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.749 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 87.06 155.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.476 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.864 HD22 ' N ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -102.22 156.44 17.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.05 0.453 . . . . 0.0 110.729 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.864 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.99 -42.81 2.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.866 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.527 ' OE2' HG13 ' A' ' 122' ' ' VAL . 1.6 tt0 -171.76 162.1 6.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.186 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -143.36 132.08 22.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.75 0.309 . . . . 0.0 110.71 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.755 HD23 ' CE1' ' A' ' 73' ' ' TYR . 4.4 tp -124.08 125.8 45.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.597 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -118.05 112.51 20.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.015 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.998 ' CE2' HD11 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -141.08 153.13 45.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.403 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -117.5 140.05 50.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.263 0.554 . . . . 0.0 111.54 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.497 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.8 m-85 -90.22 162.42 34.81 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.347 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.497 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 11.2 Cg_endo -54.53 82.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.884 2.389 . . . . 0.0 112.062 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 13.0 m-20 90.36 12.4 0.05 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.45 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.433 ' CG ' HD23 ' A' ' 4' ' ' LEU . 22.0 ttp180 -137.33 98.82 3.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.396 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -78.56 115.67 18.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.883 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.998 HD11 ' CE2' ' A' ' 73' ' ' TYR . 7.2 pt -118.94 154.27 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.106 0.479 . . . . 0.0 111.7 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.44 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -128.67 118.74 23.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.208 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.519 HD21 ' CE1' ' A' ' 84' ' ' PHE . 5.9 tp -106.28 114.31 28.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.0 111.592 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.448 ' CH2' ' HA ' ' A' ' 46' ' ' PRO . 6.7 m0 -112.11 122.63 48.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.088 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.519 ' CE1' HD21 ' A' ' 82' ' ' LEU . 5.1 m-30 -108.43 109.62 20.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.881 0.372 . . . . 0.0 110.433 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.905 ' NE1' HG11 ' A' ' 50' ' ' VAL . 40.8 m95 -99.96 149.08 23.8 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.013 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 65' ' ' PHE . 52.6 tp -92.07 138.56 31.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.885 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.794 HG13 ' CB ' ' A' ' 64' ' ' HIS . 21.6 t -123.75 145.97 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.322 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -112.8 -26.02 8.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.47 159.69 25.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.725 0.693 . . . . 0.0 111.678 -179.012 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.741 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -152.78 123.62 7.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -73.17 145.63 46.17 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.101 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.8 -129.17 44.55 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.617 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 57.3 tt0 -122.19 142.38 36.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.521 0.2 . . . . 0.0 110.731 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.508 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -76.44 128.75 10.58 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.833 2.355 . . . . 0.0 111.376 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.581 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.1 p-90 -131.36 -58.59 0.99 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.845 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.567 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.17 -94.87 0.01 OUTLIER Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.909 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.37 33.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 110.99 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.53 -23.66 65.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.629 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.3 74.95 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.119 -0.563 . . . . 0.0 113.584 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.424 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 15.0 mt-30 -140.35 93.27 9.0 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.016 0.436 . . . . 0.0 111.362 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.65 134.14 7.4 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.969 2.446 . . . . 0.0 112.575 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.16 177.11 19.4 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.823 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -142.48 157.25 44.95 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -69.44 106.7 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.34 . . . . 0.0 110.219 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.515 ' SD ' HD12 ' A' ' 20' ' ' ILE . 9.0 ptm -119.92 153.95 35.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.409 ' HB2' HG12 ' A' ' 108' ' ' VAL . 87.1 p -74.99 114.78 13.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.686 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -70.59 -23.16 62.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.089 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 106' ' ' SER . 10.0 p -58.48 -19.02 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.306 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.13 44.19 1.29 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.393 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.474 HD13 HD22 ' A' ' 107' ' ' LEU . 8.4 tp -62.64 149.4 43.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.2 127.07 48.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.43 -14.58 61.73 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.557 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.21 -49.33 13.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.602 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -39.01 87.33 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.736 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.581 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.9 173.93 6.91 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.169 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 63.7 Cg_endo -73.4 127.66 12.06 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.121 1.881 . . . . 0.0 111.606 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.14 -14.93 40.79 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.587 2.191 . . . . 0.0 113.203 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.0 -9.5 58.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.12 31.98 5.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.68 0.276 . . . . 0.0 111.427 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.3 mt-10 -72.95 -36.0 3.16 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 69.3 Cg_exo -51.15 -45.87 34.34 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 121.981 1.787 . . . . 0.0 112.854 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -77.36 -51.29 18.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 0.0 110.926 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.581 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.7 mm -62.23 -32.27 54.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.255 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.86 -35.33 63.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.011 0.434 . . . . 0.0 110.419 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -65.36 -53.09 48.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.087 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.735 ' O ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -78.35 -20.04 52.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.639 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 123' ' ' ILE . 31.5 tttp -74.55 -42.59 58.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.19 0.519 . . . . 0.0 110.599 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -66.98 -10.29 47.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.912 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.735 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.128 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.611 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.785 0.326 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.24 122.05 27.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.709 HD12 HD11 ' A' ' 6' ' ' ILE . 2.0 pp -131.33 140.95 49.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.798 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.808 ' C ' HD13 ' A' ' 6' ' ' ILE . 33.9 mt-30 -102.92 151.49 22.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.38 0.61 . . . . 0.0 112.05 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.808 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -144.97 116.61 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.659 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.998 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.76 152.27 44.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -145.08 162.6 13.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.339 0.59 . . . . 0.0 111.883 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.0 110.07 0.85 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.274 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.61 HG22 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.88 96.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.755 HG23 HG11 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -71.46 125.04 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 121.179 0.514 . . . . 0.0 112.052 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -93.64 142.61 27.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.857 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.676 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 5.1 p30 -99.08 -173.33 2.47 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.111 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -74.87 0.2 16.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.89 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -123.48 42.93 3.09 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.181 -0.324 . . . . 0.0 111.597 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 46.11 24.9 0.29 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.046 0.45 . . . . 0.0 111.263 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.533 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 24.4 mt-10 -113.83 160.88 18.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.834 HD13 HD22 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -119.33 131.99 70.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.134 0.492 . . . . 0.0 112.294 -178.278 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.491 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -85.06 116.01 23.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.26 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -118.96 140.16 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.682 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.559 HG21 ' HG2' ' A' ' 98' ' ' GLU . 45.7 p -76.48 120.2 21.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.593 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 35.4 ptt180 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.512 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 113' ' ' ASP . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 111.533 0.198 . . . . 0.0 111.533 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -114.25 26.23 10.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.045 0.45 . . . . 0.0 111.353 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.52 HD11 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -48.81 103.19 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.656 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.26 -170.61 1.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.731 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.522 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.53 168.29 10.41 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.392 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.551 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 89.2 Cg_endo -83.13 167.12 14.2 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.643 2.895 . . . . 0.0 112.981 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.7 -5.1 50.75 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.496 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -62.71 167.7 19.74 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.864 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 80.16 8.43 1.46 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 122.618 0.367 . . . . 0.0 111.759 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.998 HG21 ' HB3' ' A' ' 7' ' ' ALA . 2.1 pt -57.88 -26.94 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.651 0.739 . . . . 0.0 110.052 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.496 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.43 -69.27 0.14 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.121 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.478 ' C ' ' O ' ' A' ' 41' ' ' GLU . 44.0 mmm 19.73 -86.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.731 0.644 . . . . 0.0 112.467 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.46 30.02 0.11 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.856 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -88.2 -170.38 2.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.783 0.325 . . . . 0.0 111.124 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.894 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.11 156.1 35.66 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.385 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.894 ' HD2' HG22 ' A' ' 45' ' ' THR . 5.0 Cg_endo -46.04 -24.88 2.51 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.781 2.321 . . . . 0.0 112.475 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 51' ' ' VAL . 8.3 mt-10 -104.11 -39.96 6.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.526 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 6.0 mt-30 -80.1 -12.78 59.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.615 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.869 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -58.48 -52.78 64.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.869 0.366 . . . . 0.0 110.885 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.931 HG11 ' NE1' ' A' ' 85' ' ' TRP . 3.4 m -78.32 -45.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 47' ' ' GLU . 33.4 t -61.17 -41.93 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.314 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 3.7 tpt180 -78.02 -37.69 46.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.889 0.376 . . . . 0.0 110.625 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' GLU . 7.9 tp10 -75.57 -19.93 58.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.627 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.899 HD21 ' CE1' ' A' ' 64' ' ' HIS . 3.8 tp -57.53 -44.37 85.07 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.575 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.89 -36.3 82.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.7 tm-20 -77.52 -24.49 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.042 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 53' ' ' GLU . 12.7 mm-40 -108.2 5.09 25.47 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.947 HG12 HG13 ' A' ' 60' ' ' ILE . 39.5 t -134.79 -44.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.226 0.536 . . . . 0.0 109.756 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.567 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.29 -40.79 0.36 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.336 -0.847 . . . . 0.0 113.892 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.947 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.85 -176.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.983 0.42 . . . . 0.0 111.171 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.83 88.89 12.37 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.948 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.843 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.4 Cg_endo -109.45 154.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.399 2.733 . . . . 0.0 114.367 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.625 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -83.39 80.79 8.98 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 175.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.899 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -122.22 127.69 50.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.462 -175.534 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.513 ' O ' ' O ' ' A' ' 86' ' ' LEU . 6.1 t80 -179.11 163.41 1.31 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.928 0.394 . . . . 0.0 112.051 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER 85.72 153.33 0.08 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.725 179.481 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -112.14 129.4 56.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.925 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.736 ' CE1' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.87 -51.09 11.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.152 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.4 mt-10 -171.26 131.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.425 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -111.95 131.97 55.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.725 0.298 . . . . 0.0 111.099 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.795 ' HB2' HG22 ' A' ' 122' ' ' VAL . 4.1 tp -110.28 131.14 55.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.649 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -121.1 109.89 15.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.617 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -141.1 146.32 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -121.15 140.03 52.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.151 0.501 . . . . 0.0 111.192 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -88.81 163.64 34.49 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.55 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 9.4 Cg_endo -52.29 84.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.025 2.483 . . . . 0.0 112.205 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 20.5 m-20 93.68 15.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.235 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 30.7 ttt180 -137.37 150.09 47.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.452 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -126.18 101.97 7.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.0 110.979 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.438 HG13 HD11 ' A' ' 6' ' ' ILE . 3.5 tt -109.87 111.92 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.453 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -94.83 118.47 31.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.283 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.902 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -108.45 114.32 28.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.0 111.421 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -113.14 122.71 48.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.042 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.902 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -106.86 109.71 21.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.449 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.931 ' NE1' HG11 ' A' ' 50' ' ' VAL . 47.2 m95 -97.99 148.5 23.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.0 112.173 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 65' ' ' PHE . 58.8 tp -92.9 134.74 34.8 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.436 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.803 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.7 t -124.7 146.13 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.03 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 4.8 tp10 -106.69 -35.3 7.05 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.22 165.63 24.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.141 0.882 . . . . 0.0 111.945 -179.018 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.734 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -151.29 129.17 11.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.41 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -76.42 136.1 39.44 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.66 -126.78 24.95 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.556 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -125.85 143.44 45.28 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.549 0.214 . . . . 0.0 110.714 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.67 128.71 10.36 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.858 2.372 . . . . 0.0 111.489 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.567 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.9 p-90 -131.98 -58.8 0.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.726 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.588 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.94 -97.35 0.01 OUTLIER Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.968 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -179.97 33.88 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.685 0.279 . . . . 0.0 111.355 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.559 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -64.49 -27.69 69.15 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.826 0.346 . . . . 0.0 110.432 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.8 12.45 84.44 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.425 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.448 ' O ' HG22 ' A' ' 21' ' ' THR . 41.7 mt-30 -140.35 98.15 7.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 117.075 0.438 . . . . 0.0 111.53 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -43.71 141.46 3.94 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.835 2.357 . . . . 0.0 112.461 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.15 177.18 19.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.949 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -147.64 157.4 43.54 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.468 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.7 OUTLIER -68.89 106.14 2.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.867 0.365 . . . . 0.0 110.495 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.478 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 3.1 mmm -120.24 151.93 38.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.838 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.32 114.79 13.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.572 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.834 HD22 HD13 ' A' ' 18' ' ' ILE . 25.9 tp -79.72 -18.95 50.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.269 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.578 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.5 p -55.97 -20.67 9.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.813 0.339 . . . . 0.0 111.176 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.12 49.74 0.88 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.255 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.548 HD22 HD12 ' A' ' 123' ' ' ILE . 6.7 tt -62.45 150.22 40.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.701 0.286 . . . . 0.0 110.411 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -115.26 132.19 56.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.166 0.508 . . . . 0.0 112.184 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.64 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.25 -15.3 61.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.736 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.453 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 3.2 t0 -78.43 -49.19 13.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.325 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -27.67 67.4 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.77 0.319 . . . . 0.0 111.054 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.64 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -96.19 169.36 9.11 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.442 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.511 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 39.2 Cg_endo -67.07 127.71 17.3 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.353 2.036 . . . . 0.0 111.948 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.87 -19.88 58.44 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.535 2.157 . . . . 0.0 113.048 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.51 58.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.33 32.4 6.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.789 0.328 . . . . 0.0 111.417 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.07 -40.21 2.92 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.18 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 86.4 Cg_exo -44.86 -36.61 11.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.135 1.89 . . . . 0.0 112.682 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.859 HG21 ' CE1' ' A' ' 84' ' ' PHE . 7.0 t -77.57 -42.39 29.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.069 0.461 . . . . 0.0 110.339 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.664 HG22 ' HB2' ' A' ' 127' ' ' LYS . 6.0 mm -69.17 -34.14 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.954 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.62 -27.04 36.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.945 0.402 . . . . 0.0 110.416 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -50.76 9.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.693 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.736 HD13 ' CE1' ' A' ' 68' ' ' PHE . 7.1 tp -78.07 -32.05 50.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.781 0.324 . . . . 0.0 111.613 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.664 ' HB2' HG22 ' A' ' 123' ' ' ILE . 5.9 ttpm? -53.81 -42.52 68.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.057 0.456 . . . . 0.0 111.002 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -71.87 -6.11 39.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.998 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 108' ' ' VAL . 2.3 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.203 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 tptm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.807 0.337 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 132.82 46.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.741 HD12 HD11 ' A' ' 6' ' ' ILE . 2.7 pp -130.41 140.49 50.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.818 ' C ' HD13 ' A' ' 6' ' ' ILE . 10.9 mt-30 -107.37 149.45 27.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.276 0.56 . . . . 0.0 111.838 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.818 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -142.92 123.55 10.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.037 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.093 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.51 124.53 42.47 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.487 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -116.99 155.75 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.45 0.643 . . . . 0.0 112.019 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -138.59 109.27 0.66 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.177 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.606 HG22 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.85 101.38 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.708 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.1 mt -71.58 124.49 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.124 0.488 . . . . 0.0 111.958 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.473 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -96.41 137.71 35.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.065 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.688 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.8 p30 -94.84 -173.43 2.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.222 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.69 -2.17 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.071 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -120.61 41.39 3.27 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.556 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 47.44 23.58 0.39 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.949 0.404 . . . . 0.0 111.18 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.596 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 20.2 mt-10 -111.41 160.94 16.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.606 ' CG2' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -117.49 142.29 32.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.115 0.483 . . . . 0.0 112.137 -178.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -98.0 115.95 29.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.58 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.76 HD11 ' HG2' ' A' ' 105' ' ' MET . 0.2 OUTLIER -121.57 150.49 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.461 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.463 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 47.1 p -81.97 111.81 18.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.543 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.456 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.582 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -114.16 26.02 10.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.063 0.459 . . . . 0.0 111.41 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.508 HD11 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -47.77 99.9 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.44 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.8 tt0 -106.68 -177.5 3.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.168 0.509 . . . . 0.0 111.919 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.611 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.87 166.37 15.13 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.347 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 56.3 Cg_endo -69.83 167.76 23.6 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.351 2.7 . . . . 0.0 111.887 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.3 59.65 0.76 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.194 -1.003 . . . . 0.0 114.062 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -123.01 132.51 8.65 Favored Glycine 0 C--N 1.311 -0.829 0 CA-C-N 114.679 -0.76 . . . . 0.0 112.055 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.0 OUTLIER 92.93 7.7 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.043 0.537 . . . . 0.0 112.377 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.093 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -51.2 -29.23 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.706 0.765 . . . . 0.0 110.087 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.596 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.17 -80.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.876 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.2 mmm 37.13 -84.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.588 0.555 . . . . 0.0 111.605 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.57 31.37 0.13 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.456 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -90.94 -176.56 4.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.822 0.344 . . . . 0.0 111.287 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.868 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.4 153.9 37.55 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.325 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.868 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.93 -25.03 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.83 2.353 . . . . 0.0 112.589 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -104.02 -40.14 6.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.675 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -80.11 -13.92 58.9 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.059 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -59.6 -51.13 71.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.719 0.295 . . . . 0.0 111.098 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.929 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.9 m -77.99 -45.48 27.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.037 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.1 t -57.73 -43.54 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.329 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -44.52 25.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.082 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.4 tm-20 -68.39 -25.52 65.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.808 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -53.7 -44.46 69.79 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.914 0.387 . . . . 0.0 110.385 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -60.42 -35.9 76.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.66 -26.61 50.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.487 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' CA ' ' OE1' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -108.11 6.17 26.64 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -178.533 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.902 HG12 HG13 ' A' ' 60' ' ' ILE . 48.3 t -134.02 -44.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.51 -40.24 0.29 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.442 -0.799 . . . . 0.0 114.065 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.902 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.84 -177.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.114 0.483 . . . . 0.0 111.092 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.38 88.81 13.58 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.821 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.735 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.2 Cg_endo -111.07 146.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 123.287 2.658 . . . . 0.0 114.159 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 38.6 mt-30 -74.84 79.71 2.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 175.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.003 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.82 127.46 50.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.562 -176.39 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.514 ' O ' ' O ' ' A' ' 86' ' ' LEU . 12.4 t80 -179.29 168.22 1.5 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.5 m 84.43 154.73 0.09 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.742 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 pp -111.9 123.6 50.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 111.132 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.83 -38.69 53.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.198 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.2 mt-10 -171.29 148.33 2.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.342 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.4 132.15 22.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.633 0.254 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.634 HD22 ' N ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -133.3 166.66 21.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 110.894 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.634 ' N ' HD22 ' A' ' 71' ' ' LEU . 16.2 tt0 -137.68 126.06 23.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.665 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.644 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.9 p90 -141.14 147.0 37.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.451 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -121.15 139.96 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.213 0.53 . . . . 0.0 111.424 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -88.28 163.26 37.42 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.353 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.6 Cg_endo -50.6 83.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.029 2.486 . . . . 0.0 112.126 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.5 m-20 93.15 18.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.215 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.594 ' CZ ' HD21 ' A' ' 4' ' ' LEU . 12.0 ttt180 -137.45 150.08 47.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.515 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -123.11 106.59 10.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.774 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.477 HD13 ' OH ' ' A' ' 73' ' ' TYR . 3.6 tt -113.44 112.03 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.232 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -91.36 118.61 30.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.101 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.644 HD12 ' CE1' ' A' ' 73' ' ' TYR . 10.2 mt -109.19 114.26 27.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.997 0.427 . . . . 0.0 111.801 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -112.28 122.13 46.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.101 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.6 ' HZ ' HD21 ' A' ' 119' ' ' ASN . 3.3 m-85 -106.63 109.79 21.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.244 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.929 ' NE1' HG11 ' A' ' 50' ' ' VAL . 39.4 m95 -98.38 148.7 23.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.081 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.514 ' O ' ' O ' ' A' ' 65' ' ' PHE . 18.7 tp -94.19 138.44 32.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.402 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.003 HG22 ' ND1' ' A' ' 64' ' ' HIS . 34.5 t -123.66 145.41 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.439 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -111.87 -25.59 9.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 5.8 tpt180 -162.79 163.54 26.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.511 0.596 . . . . 0.0 111.354 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.708 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -156.38 123.57 5.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.29 178.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -74.78 149.52 39.68 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.96 -131.76 48.08 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.596 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -121.4 145.05 41.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.44 0.162 . . . . 0.0 110.747 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.518 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.57 128.66 10.41 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.817 2.345 . . . . 0.0 111.386 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 59.5 p-90 -135.05 -58.27 0.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.921 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.616 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.79 -95.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.982 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -176.02 33.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.728 0.299 . . . . 0.0 111.234 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -26.21 60.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.41 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.99 16.8 73.03 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.632 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.463 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 48.8 mt-30 -140.28 92.08 9.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.129 0.49 . . . . 0.0 111.46 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -43.84 146.1 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.155 2.57 . . . . 0.0 112.935 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.448 ' CA ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.1 177.11 19.38 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.576 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -142.26 157.28 45.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.569 0.223 . . . . 0.0 110.975 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.535 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -74.71 106.02 6.07 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.747 0.308 . . . . 0.0 110.503 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.76 ' HG2' HD11 ' A' ' 20' ' ' ILE . 4.7 ppp? -120.74 147.64 45.03 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.361 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.5 114.85 3.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.823 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.962 HD11 HD11 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -80.13 -18.94 48.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.383 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.1 t -58.32 -15.13 4.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.586 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.07 51.92 0.78 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.315 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.736 HD13 HD22 ' A' ' 107' ' ' LEU . 11.5 tp -62.32 149.75 41.29 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.23 132.21 53.95 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.662 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.36 -15.32 61.86 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.497 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -78.56 -49.29 13.57 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.732 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -32.35 73.58 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.755 0.312 . . . . 0.0 111.031 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.662 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.68 170.74 10.48 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.312 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.538 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 55.5 Cg_endo -69.78 127.47 14.63 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.093 1.862 . . . . 0.0 111.669 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.57 -14.9 45.36 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.631 2.22 . . . . 0.0 113.385 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.64 -9.56 58.8 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.6 HD21 ' HZ ' ' A' ' 84' ' ' PHE . 1.7 m120 -121.61 34.3 5.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.762 0.315 . . . . 0.0 111.465 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -76.04 -31.87 1.06 Allowed Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.037 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 72.1 Cg_exo -49.06 -46.51 25.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 121.79 1.66 . . . . 0.0 112.817 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.445 HG22 ' CD1' ' A' ' 71' ' ' LEU . 1.5 t -77.41 -50.61 20.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.033 0.444 . . . . 0.0 110.622 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.599 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.4 mm -59.33 -35.06 56.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.248 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.73 -34.82 62.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.999 0.428 . . . . 0.0 110.489 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.75 -53.01 30.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.342 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.962 HD11 HD11 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -78.35 -19.74 52.79 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.699 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.66 ' N ' HD23 ' A' ' 126' ' ' LEU . 10.1 ttpp -66.24 -42.5 88.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.202 0.525 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -70.03 -9.07 54.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.186 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.858 0.361 . . . . 0.0 110.652 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.81 0.338 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -137.52 144.26 42.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.917 ' HG ' HG22 ' A' ' 80' ' ' ILE . 1.9 pp -146.14 119.15 8.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.724 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.518 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 16.7 mt-30 -102.01 152.33 21.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.505 0.669 . . . . 0.0 112.341 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.689 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -146.54 131.25 11.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.323 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.031 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.35 125.09 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 m -115.6 162.49 13.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.618 0.723 . . . . 0.0 112.714 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.422 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -145.86 112.93 0.66 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.251 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.718 HG22 HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.93 96.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.539 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.7 tt -71.64 117.54 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.205 0.526 . . . . 0.0 112.318 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.588 ' CG ' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -94.92 147.38 23.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.88 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.842 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 9.7 p-10 -103.78 -173.05 2.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.512 0.672 . . . . 0.0 112.225 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.7 tm-20 -71.8 1.6 6.7 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.455 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -124.64 44.59 2.73 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.597 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.9 p30 44.98 28.1 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.303 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 3.2 mt-10 -114.96 161.19 18.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.635 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.844 HD13 HD22 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -124.58 128.39 73.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.913 0.387 . . . . 0.0 111.937 -178.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -76.33 113.31 13.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.182 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.661 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.13 126.17 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.957 179.416 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.426 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 3.7 p -71.03 112.15 6.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.854 0.359 . . . . 0.0 110.987 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.582 179.904 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.18 26.25 10.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.115 0.483 . . . . 0.0 111.274 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.661 HD21 ' HB ' ' A' ' 20' ' ' ILE . 3.6 tt -45.77 100.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.657 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -125.12 179.08 5.21 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.227 0.537 . . . . 0.0 112.231 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.545 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.92 163.69 26.44 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.866 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 9.6 Cg_endo -51.49 168.61 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.884 3.056 . . . . 0.0 112.158 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.87 59.5 0.74 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.978 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.618 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.57 123.63 4.19 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 114.519 -0.84 . . . . 0.0 112.234 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.47 1.01 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.031 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -52.8 -27.07 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.627 0.727 . . . . 0.0 110.577 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.536 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -44.32 -60.72 1.79 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.233 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.511 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.3 ttp 11.02 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.936 0.773 . . . . 0.0 112.574 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.89 34.76 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.503 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -90.19 -174.73 4.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.935 0.398 . . . . 0.0 111.118 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.873 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.33 154.44 38.05 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.432 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.873 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.89 -25.6 1.09 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.818 2.345 . . . . 0.0 112.515 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.593 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -104.04 -38.91 6.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.446 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -80.1 -11.81 59.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.614 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.91 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -59.77 -52.9 63.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 0.0 110.815 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.918 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.4 m -78.16 -47.27 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.089 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.6 t -54.88 -37.27 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.26 -51.74 9.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.125 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.484 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.9 mm-40 -66.01 -23.48 66.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.764 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.2 tp -52.69 -44.67 66.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.744 0.307 . . . . 0.0 110.193 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -34.92 76.07 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.8 tt0 -77.43 -24.05 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.797 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.475 ' HG2' ' HA2' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -108.59 6.01 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.899 -179.172 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.645 HG11 ' HG3' ' A' ' 62' ' ' PRO . 16.1 t -133.97 -44.72 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 0.0 110.02 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.13 -39.42 0.2 Allowed Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.628 -0.715 . . . . 0.0 114.0 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.698 HG23 ' NE1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -88.26 -174.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.018 0.437 . . . . 0.0 111.085 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -111.98 88.87 10.69 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.259 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.645 ' HG3' HG11 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -108.63 154.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.915 2.41 . . . . 0.0 114.658 -177.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 89' ' ' ARG . 81.3 mt-30 -75.02 79.72 2.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.024 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -126.37 121.28 32.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.07 -176.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.9 t80 179.43 171.27 0.98 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.436 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.3 t 92.79 147.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.814 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.538 HD22 ' CD2' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -96.12 126.7 41.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.406 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -92.13 -51.77 5.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 179.491 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 9.4 tt0 -171.63 163.75 6.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.31 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -143.34 132.1 22.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.773 0.321 . . . . 0.0 110.901 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.768 ' HB2' HG22 ' A' ' 122' ' ' VAL . 2.6 tp -122.71 128.52 50.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.658 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -117.2 110.72 18.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.734 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.831 ' CE2' HD11 ' A' ' 80' ' ' ILE . 11.8 p90 -140.97 146.04 36.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.37 131.81 54.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.134 0.492 . . . . 0.0 111.241 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -82.04 163.22 54.14 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.489 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.1 Cg_endo -53.36 82.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.895 2.397 . . . . 0.0 112.152 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 17.6 t0 90.96 11.5 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.36 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.687 ' HG2' HD23 ' A' ' 4' ' ' LEU . 5.1 ttp180 -137.35 94.25 2.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.711 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -76.24 119.79 20.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.422 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.917 HG22 ' HG ' ' A' ' 4' ' ' LEU . 5.0 pt -127.52 146.99 32.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.065 0.459 . . . . 0.0 112.179 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -113.52 118.82 35.52 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.704 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.569 HD21 ' OD1' ' A' ' 119' ' ' ASN . 14.8 tp -106.42 114.0 27.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.854 0.359 . . . . 0.0 111.279 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.407 ' CZ3' ' O ' ' A' ' 46' ' ' PRO . 9.5 m0 -112.52 122.49 47.86 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.555 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.52 ' HE1' HD11 ' A' ' 82' ' ' LEU . 4.8 m-30 -106.54 109.87 21.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.591 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.918 ' NE1' HG11 ' A' ' 50' ' ' VAL . 34.9 m95 -101.32 148.48 25.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.455 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 65' ' ' PHE . 22.4 tp -91.69 138.35 31.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.324 0.583 . . . . 0.0 112.05 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.024 HG22 ' ND1' ' A' ' 64' ' ' HIS . 38.3 t -124.44 145.37 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.264 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -112.49 -32.34 6.51 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -163.18 165.62 24.27 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.711 0.687 . . . . 0.0 111.645 -178.427 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.842 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.9 p90 -148.17 133.06 18.06 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.793 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -80.18 144.41 33.01 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.691 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.13 -115.23 7.32 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.45 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 43.2 mt-10 -134.92 138.6 29.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.468 0.175 . . . . 0.0 110.82 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.512 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 3.4 Cg_exo -76.62 128.89 10.52 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.786 2.324 . . . . 0.0 111.12 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.698 ' NE1' HG23 ' A' ' 60' ' ' ILE . 62.4 p-90 -137.08 -60.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.633 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.602 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 52.51 -94.2 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.693 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.1 tttp 179.02 30.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.565 0.221 . . . . 0.0 111.549 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.69 -32.4 70.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.027 0.441 . . . . 0.0 110.143 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.91 32.29 69.96 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.73 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.426 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 76.7 mt-30 -140.56 91.64 9.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.973 0.416 . . . . 0.0 111.527 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -44.7 126.53 7.28 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.197 2.598 . . . . 0.0 112.959 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.471 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.47 177.31 19.31 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.823 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.16 157.13 46.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.626 0.25 . . . . 0.0 110.699 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.44 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -68.47 106.71 2.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.887 0.375 . . . . 0.0 110.156 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.5 ptp -119.87 148.52 43.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.159 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.427 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 95.0 p -65.85 114.57 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.593 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.844 HD22 HD13 ' A' ' 18' ' ' ILE . 33.5 tp -78.11 -18.87 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.309 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.91 -20.13 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.442 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.99 45.2 1.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.698 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.419 ' CD2' HD12 ' A' ' 123' ' ' ILE . 7.9 tt -62.79 150.57 41.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.627 0.251 . . . . 0.0 110.49 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.91 129.61 56.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.201 0.524 . . . . 0.0 112.377 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.573 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.23 -14.98 61.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.666 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -78.36 -49.17 14.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.578 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.48 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -66.82 -34.93 78.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.91 0.386 . . . . 0.0 110.876 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.573 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -84.74 173.23 7.47 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.345 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.3 Cg_endo -70.68 127.69 14.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.162 1.908 . . . . 0.0 111.857 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.41 -17.57 60.08 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.53 2.154 . . . . 0.0 113.023 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.25 -9.36 58.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.875 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.569 ' OD1' HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -118.51 29.5 7.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.42 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.05 -43.17 3.65 Favored Pre-proline 0 C--O 1.224 -0.25 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 92.4 Cg_exo -44.89 -39.0 13.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.18 1.92 . . . . 0.0 112.971 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.2 t -77.21 -51.14 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.189 0.518 . . . . 0.0 110.77 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.2 mm -64.84 -31.23 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.197 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.82 -30.88 58.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.003 0.43 . . . . 0.0 110.477 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.9 -53.27 18.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.469 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.789 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -78.33 -33.07 49.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.565 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.532 ' HB2' HG22 ' A' ' 123' ' ' ILE . 11.6 ttpp -53.15 -42.64 66.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 111.148 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -67.2 -10.59 52.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.688 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.8 mp . . . . . 0 C--O 1.232 0.155 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.058 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.1 tptm . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.835 0.35 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -140.06 137.87 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.972 HD12 HD11 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -146.07 131.95 19.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.736 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -102.84 155.43 18.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 111.666 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.972 HD11 HD12 ' A' ' 4' ' ' LEU . 5.3 mp -144.52 137.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.35 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.881 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -125.41 125.3 43.17 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.329 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.9 m -128.63 155.79 40.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.064 0.459 . . . . 0.0 111.283 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.7 127.09 2.21 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.106 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.09 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -80.99 107.65 13.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.795 HG22 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.17 123.33 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.975 0.417 . . . . 0.0 111.31 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.7 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.9 119.04 23.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.359 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.466 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 21.9 t-20 -74.77 -172.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.927 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 32.1 tt0 -82.57 4.11 25.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.151 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -140.08 52.2 1.68 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.0 111.454 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.64 25.21 0.24 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.552 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.702 ' C ' HD12 ' A' ' 18' ' ' ILE . 5.3 pt-20 -120.32 149.88 41.61 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.09 HG21 HG22 ' A' ' 10' ' ' ILE . 1.3 mp -113.36 140.76 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.149 0.5 . . . . 0.0 111.665 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -91.16 103.58 16.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.048 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.695 HG22 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.9 162.12 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.186 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 100' ' ' GLN . 73.7 p -92.61 111.71 23.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.787 0.327 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.85 179.975 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.27 26.34 10.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 111.465 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -46.05 97.44 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.67 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.78 176.94 4.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.168 0.509 . . . . 0.0 111.715 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.695 ' HB3' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.76 161.44 37.95 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.904 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -55.66 168.54 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.671 2.914 . . . . 0.0 111.611 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.67 59.49 0.74 Allowed Glycine 0 C--N 1.33 0.242 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.965 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.604 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.15 121.7 2.64 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 114.576 -0.812 . . . . 0.0 112.086 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.49 -6.62 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.339 0.656 . . . . 0.0 111.565 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.881 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.17 -57.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.303 0.573 . . . . 0.0 111.251 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -19.36 -78.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.305 -179.417 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.3 mmt 40.2 -93.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.774 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.47 22.06 0.08 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.359 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.45 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -78.84 -159.99 0.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.544 0.211 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.879 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.14 154.7 38.63 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.879 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.2 Cg_endo -44.07 -24.91 0.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.777 2.318 . . . . 0.0 112.456 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.9 mt-10 -99.89 -48.77 4.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.919 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -80.5 -4.89 55.59 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 44' ' ' GLU . . . -65.49 -57.49 8.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.54 0.21 . . . . 0.0 110.955 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.727 HG23 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -78.79 -44.01 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.706 179.163 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.9 t -50.61 -36.06 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 110.73 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -78.59 -49.1 13.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.817 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -65.66 -23.75 66.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.816 HD21 ' NE2' ' A' ' 64' ' ' HIS . 2.5 tp -54.81 -44.56 73.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.467 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -31.29 71.13 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.3 tm-20 -77.44 -23.95 50.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.957 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.433 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 45.3 mm-40 -107.07 3.54 25.98 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.972 HG12 HG13 ' A' ' 60' ' ' ILE . 21.9 t -134.91 -44.21 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.277 0.56 . . . . 0.0 109.847 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.582 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.2 -43.91 0.69 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.321 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.972 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.61 -175.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.105 0.478 . . . . 0.0 111.255 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.36 89.14 11.86 Favored Pre-proline 0 N--CA 1.442 -0.852 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.196 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.891 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.8 Cg_endo -108.47 148.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.078 2.519 . . . . 0.0 114.133 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 70.1 mt-30 -74.64 79.95 2.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 175.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.003 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.76 127.52 48.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.675 -176.484 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.628 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.1 t80 -179.83 171.0 1.2 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.518 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 80.57 156.13 0.14 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.749 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.4 pp -117.09 129.28 55.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.436 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.824 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.8 -48.36 18.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.744 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.567 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -171.56 131.73 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.184 179.428 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.653 ' HD2' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -123.56 132.21 53.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.742 0.305 . . . . 0.0 110.719 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.645 HD22 ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.68 162.25 26.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 111.185 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.533 ' N ' HD22 ' A' ' 71' ' ' LEU . 13.4 tt0 -140.14 128.28 22.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.656 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.478 ' HE1' HD12 ' A' ' 82' ' ' LEU . 1.9 p90 -141.07 100.87 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.643 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.8 pt-20 -74.83 122.42 23.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.446 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.99 162.89 60.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.303 179.364 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.0 Cg_endo -51.0 81.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.025 2.484 . . . . 0.0 112.287 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.4 t70 91.37 10.12 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.57 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -137.34 93.95 2.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.646 0.26 . . . . 0.0 110.854 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.555 ' HE1' HG23 ' A' ' 81' ' ' THR . 52.7 t-80 -74.88 102.1 4.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.819 0.342 . . . . 0.0 110.703 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.587 HG13 HD13 ' A' ' 6' ' ' ILE . 5.6 tt -106.52 111.94 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.555 HG23 ' HE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -103.28 128.55 50.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.413 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.478 HD12 ' HE1' ' A' ' 73' ' ' TYR . 1.6 mt -126.25 114.54 18.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.98 0.419 . . . . 0.0 111.497 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -108.12 122.33 46.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.38 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.746 ' CD2' HG11 ' A' ' 122' ' ' VAL . 5.4 m-30 -100.5 113.77 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.754 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.802 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 35.8 m95 -94.29 148.74 21.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.258 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 65' ' ' PHE . 31.1 tp -98.35 103.43 15.38 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 121.159 0.504 . . . . 0.0 111.61 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.003 HG22 ' ND1' ' A' ' 64' ' ' HIS . 25.2 t -87.62 145.79 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.184 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -112.15 -26.74 8.67 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.86 165.11 25.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.796 0.726 . . . . 0.0 111.796 -178.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.662 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.2 p90 -152.72 130.04 11.31 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.511 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -75.84 139.93 41.98 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.694 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.3 -117.82 12.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.347 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 8.0 mt-10 -135.05 140.12 33.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.414 0.149 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HA ' HD11 ' A' ' 60' ' ' ILE . 7.8 Cg_exo -75.5 128.58 11.2 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.943 2.429 . . . . 0.0 111.438 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.61 ' HE1' HG23 ' A' ' 60' ' ' ILE . 45.1 p-90 -128.45 -58.54 1.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.993 0.425 . . . . 0.0 111.383 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.77 -100.07 0.02 OUTLIER Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.877 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 179.08 36.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 111.321 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.99 -47.6 80.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.564 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.59 12.08 51.86 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.927 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.424 ' O ' HG22 ' A' ' 21' ' ' THR . 24.3 mt-30 -140.36 91.79 9.61 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 117.24 0.52 . . . . 0.0 111.386 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -44.23 125.39 5.68 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.837 2.358 . . . . 0.0 112.739 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.78 177.59 19.16 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.469 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -129.28 157.1 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.672 0.273 . . . . 0.0 110.773 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.45 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.12 107.1 3.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.901 0.381 . . . . 0.0 110.435 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 18' ' ' ILE . 12.5 ptm -119.62 158.1 27.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 p -71.83 121.32 18.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.764 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -80.11 -28.97 38.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.011 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.67 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.7 p -50.72 -24.58 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.232 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.7 43.34 1.4 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.382 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.573 HD22 HD12 ' A' ' 123' ' ' ILE . 9.5 tt -62.55 150.14 41.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.414 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -118.97 132.91 56.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.178 0.513 . . . . 0.0 112.302 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.629 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.42 61.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.48 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -78.77 -49.27 13.31 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.755 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -32.77 74.26 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.799 0.333 . . . . 0.0 111.013 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.629 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -89.16 172.62 7.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.029 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.489 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.8 Cg_endo -67.51 127.58 16.69 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.032 1.822 . . . . 0.0 111.832 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.38 -18.64 60.67 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.552 2.168 . . . . 0.0 113.064 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.87 -9.38 58.24 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.36 34.31 5.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.767 0.318 . . . . 0.0 111.464 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -75.6 -44.06 4.16 Favored Pre-proline 0 N--CA 1.463 0.217 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.6 Cg_exo -44.76 -35.38 9.43 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.224 1.949 . . . . 0.0 112.61 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.746 HG11 ' CD2' ' A' ' 84' ' ' PHE . 11.8 t -77.43 -41.05 29.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.136 0.493 . . . . 0.0 110.144 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.777 HG22 ' HB2' ' A' ' 127' ' ' LYS . 17.9 mm -70.28 -32.28 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.707 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.46 -26.96 34.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.086 0.47 . . . . 0.0 110.228 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.09 -50.89 9.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.669 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.824 HD13 ' CD2' ' A' ' 68' ' ' PHE . 8.1 tp -78.09 -33.5 50.69 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 111.693 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.777 ' HB2' HG22 ' A' ' 123' ' ' ILE . 17.7 ttpt -53.27 -42.53 66.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -71.71 -6.09 38.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.975 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.67 HD21 ' O ' ' A' ' 108' ' ' VAL . 2.9 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.189 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.837 0.351 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -140.02 137.53 34.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.936 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.7 pp -146.0 135.37 22.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.77 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -102.7 149.19 24.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.388 0.613 . . . . 0.0 112.107 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.936 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.4 mp -146.22 120.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.866 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.063 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.66 143.34 50.79 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.314 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -144.6 162.52 14.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.112 0.482 . . . . 0.0 111.487 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -144.02 123.4 2.01 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.037 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.004 HG22 ' CG2' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.75 108.91 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.765 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -70.83 120.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.224 0.535 . . . . 0.0 112.252 -178.118 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.95 122.7 28.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.615 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 56.1 t30 -81.62 -172.58 3.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.887 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.506 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -82.38 -0.95 48.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.112 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -135.69 49.58 2.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 0.0 111.331 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.27 23.7 0.59 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.183 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 16.2 pt-20 -114.23 153.97 28.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.004 ' CG2' HG22 ' A' ' 10' ' ' ILE . 5.2 mt -128.44 143.32 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.0 112.04 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.464 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.18 122.74 34.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.324 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.043 HD12 HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.69 133.36 65.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.274 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.658 HG21 ' HG2' ' A' ' 98' ' ' GLU . 21.4 p -70.82 115.94 10.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.082 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.515 ' CA ' HD23 ' A' ' 33' ' ' LEU . 18.3 ptt85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.704 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 CA--C 1.529 0.138 0 CA-C-O 120.561 0.22 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -114.23 25.65 10.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.428 . . . . 0.0 111.28 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.043 HD11 HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -46.47 97.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.37 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -106.79 -170.35 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.18 0.514 . . . . 0.0 112.251 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.19 168.59 9.62 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.472 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.586 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 93.7 Cg_endo -79.33 167.58 21.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.688 2.925 . . . . 0.0 113.835 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.87 -5.24 50.38 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.881 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.02 159.16 23.95 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 117.498 0.649 . . . . 0.0 113.327 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 85.14 6.36 0.49 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.061 0.545 . . . . 0.0 111.996 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.063 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.6 pt -54.28 -27.04 16.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.632 0.73 . . . . 0.0 110.167 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.554 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.97 -66.92 0.32 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.035 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.503 ' C ' ' O ' ' A' ' 41' ' ' GLU . 5.4 mmt 14.65 -82.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.876 0.735 . . . . 0.0 112.409 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -177.52 33.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.59 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.6 mp0 -88.76 -172.97 3.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.861 0.362 . . . . 0.0 111.168 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.868 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.76 155.38 36.4 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.36 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.868 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.89 -25.46 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.817 2.345 . . . . 0.0 112.659 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -103.51 -41.6 5.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.386 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 1.6 mm100 -80.28 -4.83 54.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.722 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.914 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.58 -55.41 33.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.9 HG11 ' NE1' ' A' ' 85' ' ' TRP . 2.7 m -78.19 -46.03 26.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.31 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 30.0 t -55.39 -41.13 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.368 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 3.6 tmm_? -77.98 -49.34 14.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.018 0.437 . . . . 0.0 110.451 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.469 ' HG3' ' OE1' ' A' ' 57' ' ' GLU . 14.9 tp10 -63.38 -20.0 65.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.504 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.87 HD21 ' CG ' ' A' ' 64' ' ' HIS . 1.4 tp -59.65 -44.46 93.54 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.303 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -30.16 70.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.827 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.5 tm-20 -77.27 -31.82 55.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.416 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.469 ' OE1' ' HG3' ' A' ' 53' ' ' GLU . 1.2 mp0 -108.68 6.14 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.932 HG12 HG13 ' A' ' 60' ' ' ILE . 43.5 t -133.83 -44.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.161 0.505 . . . . 0.0 110.031 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.599 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.43 -39.82 0.28 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.966 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.932 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.52 -176.29 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 120.968 0.413 . . . . 0.0 110.841 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.22 89.1 11.53 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.468 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.798 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.9 Cg_endo -109.42 143.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.266 2.644 . . . . 0.0 114.243 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 34.5 mt-30 -74.7 80.03 2.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 105.437 -2.061 . . . . 0.0 105.437 175.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.87 ' CG ' HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -120.92 134.53 55.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.418 -175.656 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 178.92 -139.9 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.089 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 56.46 156.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.206 0.527 . . . . 0.0 112.323 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.4 tt -120.1 109.44 15.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.562 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.74 -43.8 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.369 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.509 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.7 tt0 -171.25 163.32 7.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.311 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HE3' ' CZ2' ' A' ' 83' ' ' TRP . 1.1 ttpm? -143.15 132.04 22.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.81 0.338 . . . . 0.0 110.992 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.821 ' HB2' HG22 ' A' ' 122' ' ' VAL . 4.6 tp -115.2 120.41 39.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.418 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -118.57 109.84 16.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.476 ' CE1' HD23 ' A' ' 71' ' ' LEU . 2.0 p90 -141.1 151.64 44.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.46 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.14 121.27 37.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 0.0 111.34 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.77 162.88 61.04 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.281 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -50.92 81.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.017 2.478 . . . . 0.0 112.097 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 t70 88.79 14.23 0.07 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.329 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.659 ' HE ' HD21 ' A' ' 4' ' ' LEU . 4.7 ttt180 -137.51 93.91 2.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.732 0.301 . . . . 0.0 110.805 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -75.76 97.57 3.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.899 0.38 . . . . 0.0 110.463 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.692 HG13 HD13 ' A' ' 6' ' ' ILE . 1.3 tt -100.84 112.9 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.405 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.48 119.66 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.279 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.943 HD23 HG21 ' A' ' 122' ' ' VAL . 12.7 tp -110.26 114.37 27.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.88 0.372 . . . . 0.0 111.334 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.44 ' CZ2' ' HE3' ' A' ' 70' ' ' LYS . 10.9 m0 -109.47 122.89 48.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.178 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -109.79 109.77 20.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.602 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.9 ' NE1' HG11 ' A' ' 50' ' ' VAL . 48.2 m95 -99.41 148.96 23.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.506 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.8 tp -98.5 102.84 14.7 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.427 0.632 . . . . 0.0 111.726 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.781 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.9 t -81.1 146.47 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.091 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -114.12 -25.68 8.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.9 tpt180 -162.55 161.87 27.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.64 0.654 . . . . 0.0 111.583 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.738 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -155.61 123.46 5.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.316 178.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -72.05 143.94 48.93 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.019 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.2 -129.67 46.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.558 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -121.0 144.0 38.23 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.599 0.238 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.534 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.5 Cg_exo -76.32 128.89 10.76 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.788 2.325 . . . . 0.0 111.031 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.599 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 47.0 p-90 -132.28 -63.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.49 -99.87 0.02 OUTLIER Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.517 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.3 mtpp 164.77 42.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 110.874 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.658 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.4 OUTLIER -58.59 -31.99 68.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.939 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 129.93 -37.84 2.09 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.368 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -129.49 105.71 17.42 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.0 111.86 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -43.76 146.31 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.079 2.52 . . . . 0.0 112.661 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.45 177.18 18.74 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.745 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -131.65 157.38 43.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.506 0.194 . . . . 0.0 110.596 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.483 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -75.82 106.51 7.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.866 0.365 . . . . 0.0 110.203 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.0 ptm -120.16 161.32 21.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.981 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.9 p -76.86 114.98 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.712 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.721 HD22 HD13 ' A' ' 18' ' ' ILE . 2.6 tp -77.32 -18.94 57.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.449 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.3 p -51.0 -24.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.328 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.54 44.37 1.24 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.561 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.695 HD22 HD12 ' A' ' 123' ' ' ILE . 8.4 tt -62.78 150.35 41.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.577 0.227 . . . . 0.0 110.419 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.636 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -117.71 130.12 56.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 112.325 -178.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.56 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.21 -14.8 61.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.55 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.43 -49.13 14.04 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.483 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -34.69 77.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.779 0.323 . . . . 0.0 111.054 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.47 174.34 6.21 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.172 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 40.1 Cg_endo -67.71 127.81 16.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 121.926 1.751 . . . . 0.0 111.928 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.85 -21.12 58.06 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.606 2.204 . . . . 0.0 112.693 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.29 -9.6 58.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.719 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.535 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -113.74 23.22 13.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.506 -179.304 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -66.59 -36.46 12.15 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.578 ' HB2' HD13 ' A' ' 71' ' ' LEU . 73.8 Cg_exo -51.13 -47.74 24.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.952 1.768 . . . . 0.0 112.84 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.943 HG21 HD23 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -77.68 -51.21 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.936 0.398 . . . . 0.0 111.191 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.695 HD12 HD22 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -62.1 -32.84 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.227 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.92 -36.99 65.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.972 0.415 . . . . 0.0 110.374 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -62.92 -46.51 87.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.519 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 13.6 tp -78.13 -27.81 48.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.032 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.657 ' O ' HD12 ' A' ' 129' ' ' LEU . 14.8 tttp -58.99 -42.67 90.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -76.73 -3.29 37.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.111 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 127' ' ' LYS . 4.2 mp . . . . . 0 C--O 1.231 0.126 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.132 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.807 0.337 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 8.8 ttmt -136.25 136.71 40.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.785 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.831 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.1 pp -146.04 137.76 24.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.667 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.766 ' C ' HD13 ' A' ' 6' ' ' ILE . 5.8 mt-30 -109.24 147.53 32.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.331 0.586 . . . . 0.0 111.804 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.831 HD11 ' CD1' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -136.91 128.49 42.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.014 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.837 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -125.14 124.83 42.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.518 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.553 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.9 m -124.11 162.35 25.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.033 0.444 . . . . 0.0 111.062 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -150.69 116.12 0.75 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.688 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.966 HG22 HG21 ' A' ' 18' ' ' ILE . 2.4 mp -70.58 104.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.822 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -70.97 120.52 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.21 0.529 . . . . 0.0 112.311 -177.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.437 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.52 119.65 24.5 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.56 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.558 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 25.8 t-20 -78.24 179.93 6.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.434 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.548 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 22.0 tt0 -76.1 1.26 16.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.97 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -139.87 52.57 1.69 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.814 0.34 . . . . 0.0 111.522 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 45.53 27.12 0.37 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.725 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 11.5 pt-20 -117.45 160.6 20.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.966 HG21 HG22 ' A' ' 10' ' ' ILE . 2.8 mp -136.82 142.31 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.205 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.7 118.19 30.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.281 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.742 HD11 HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -110.62 138.44 38.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.714 HG23 ' HD3' ' A' ' 36' ' ' PRO . 4.2 p -83.1 111.38 18.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.922 0.391 . . . . 0.0 110.745 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.169 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -114.24 25.95 10.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.965 0.412 . . . . 0.0 111.441 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -53.45 89.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.216 179.344 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.677 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.1 tt0 -112.87 -168.19 1.29 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.29 0.566 . . . . 0.0 112.143 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.553 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.33 166.3 15.69 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.305 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.714 ' HD3' HG23 ' A' ' 21' ' ' THR . 38.2 Cg_endo -63.93 168.6 11.8 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.334 2.689 . . . . 0.0 111.208 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.9 60.11 0.73 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.228 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.63 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.21 110.91 0.86 Allowed Glycine 0 C--N 1.314 -0.67 0 CA-C-N 114.581 -0.809 . . . . 0.0 111.732 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.63 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 126.98 -8.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.521 0.728 . . . . 0.0 110.873 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.837 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -42.2 -48.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.293 0.568 . . . . 0.0 111.57 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -31.8 -81.16 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.941 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.9 mmm 43.02 -92.82 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.557 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.71 23.8 0.09 OUTLIER Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.215 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -82.44 -162.95 0.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.546 0.213 . . . . 0.0 110.934 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.858 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -107.76 156.07 38.69 Favored Pre-proline 0 C--N 1.333 -0.13 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.858 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.85 -24.71 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.703 2.269 . . . . 0.0 112.456 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.9 mm-40 -95.36 -54.03 3.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -80.44 -5.26 56.28 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -64.99 -57.44 8.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.685 0.278 . . . . 0.0 110.811 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.729 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -79.02 -45.95 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.701 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 47' ' ' GLU . 59.3 t -50.87 -37.76 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.033 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -48.68 14.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.68 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 40' ' ' ILE . 12.8 tp10 -63.92 -25.67 68.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.639 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.824 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.7 tp -55.3 -44.31 75.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -32.1 71.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.1 tm-20 -77.37 -25.49 51.0 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.848 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.422 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 5.3 mm-40 -108.38 5.18 25.19 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.933 HG12 HG13 ' A' ' 60' ' ' ILE . 31.3 t -134.82 -44.62 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.11 0.481 . . . . 0.0 110.144 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.51 -40.25 0.23 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.893 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.933 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.65 -177.57 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.001 0.429 . . . . 0.0 111.227 -179.507 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.62 88.54 13.76 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.798 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.786 ' HG3' HG11 ' A' ' 58' ' ' VAL . 1.4 Cg_endo -112.55 147.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 123.322 2.681 . . . . 0.0 114.167 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 72.9 mt-30 -74.7 80.02 2.04 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.007 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.4 128.12 50.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.74 -176.61 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.7 t80 179.72 175.33 0.77 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.481 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 t 78.79 162.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.077 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.771 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -123.45 129.28 51.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.367 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.963 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.77 -44.24 33.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.292 0.568 . . . . 0.0 109.767 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.3 mt-10 -171.45 131.66 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.845 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.5 132.16 54.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.88 0.372 . . . . 0.0 111.286 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.629 ' HB2' HG22 ' A' ' 122' ' ' VAL . 3.4 tp -109.43 137.56 47.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.626 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -133.56 109.97 9.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.895 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.412 ' CZ ' HG23 ' A' ' 80' ' ' ILE . 2.3 p90 -141.22 146.28 36.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.584 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.16 133.96 55.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.105 0.478 . . . . 0.0 111.306 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.471 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -93.91 163.15 24.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.375 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.8 Cg_endo -54.15 82.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.823 2.349 . . . . 0.0 112.317 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 10.9 t0 93.49 8.53 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.547 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' NH1' HD12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -137.34 93.92 2.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.774 0.321 . . . . 0.0 110.769 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' A' ' 3' ' ' LYS . 1.9 t60 -82.09 96.98 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.0 110.773 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.493 HD12 ' NH1' ' A' ' 78' ' ' ARG . 5.0 tt -98.77 111.7 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.985 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.06 118.71 34.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.115 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.579 HD23 ' HB ' ' A' ' 6' ' ' ILE . 38.5 mt -106.19 114.47 28.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.963 0.411 . . . . 0.0 111.689 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.622 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 12.2 m0 -106.74 122.17 45.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.599 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.698 ' CG ' HG11 ' A' ' 122' ' ' VAL . 3.2 m-85 -112.95 109.78 19.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.0 110.196 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.771 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 15.9 m95 -94.77 148.46 22.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.595 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.613 ' O ' ' O ' ' A' ' 65' ' ' PHE . 59.2 tp -100.09 102.98 14.46 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.037 0.446 . . . . 0.0 111.568 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.007 HG22 ' ND1' ' A' ' 64' ' ' HIS . 25.0 t -83.29 145.83 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.159 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -113.5 -23.53 9.76 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 2.9 ttt-85 -162.91 162.95 26.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.688 0.677 . . . . 0.0 111.287 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.714 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -157.25 125.18 5.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.0 111.674 179.223 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -76.07 151.9 36.97 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.136 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.21 -132.94 42.2 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.654 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 19.6 tt0 -119.69 146.94 42.75 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.6 0.238 . . . . 0.0 110.721 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.2 Cg_exo -76.69 128.85 10.44 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.904 2.403 . . . . 0.0 111.383 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.536 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 64.9 p-90 -137.08 -59.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.179 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.543 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 49.17 -94.63 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.813 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.1 mmtm 165.81 34.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.692 0.282 . . . . 0.0 111.114 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.33 -34.66 78.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.415 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.6 21.19 32.24 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.159 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.422 ' O ' ' HB ' ' A' ' 21' ' ' THR . 2.6 mp0 -140.21 92.08 9.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 111.3 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -43.73 131.84 7.71 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.804 2.336 . . . . 0.0 112.374 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.0 177.04 19.42 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.858 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -145.2 157.25 44.12 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.19 106.61 3.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.851 0.357 . . . . 0.0 110.216 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -119.97 163.21 17.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.948 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.516 ' OG ' HG12 ' A' ' 108' ' ' VAL . 1.7 t -77.72 114.83 16.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.786 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.8 OUTLIER -80.08 -19.96 46.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.255 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.516 HG12 ' OG ' ' A' ' 106' ' ' SER . 11.9 p -52.97 -20.53 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.538 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.06 44.27 1.25 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.85 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.651 HD12 HD21 ' A' ' 107' ' ' LEU . 8.5 tt -62.64 150.13 41.64 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.49 130.52 53.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.16 61.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.402 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.6 -49.26 13.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.749 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -37.43 84.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 111.001 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -80.77 173.98 6.87 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.146 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.8 Cg_endo -71.23 127.74 13.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.071 1.847 . . . . 0.0 111.659 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.38 -14.97 45.44 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.512 2.141 . . . . 0.0 113.18 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.55 58.65 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.511 ' ND2' HD11 ' A' ' 82' ' ' LEU . 1.1 m-80 -120.23 31.57 6.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.274 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -75.28 -45.07 4.58 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.073 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.521 ' HB2' HD13 ' A' ' 71' ' ' LEU . 85.9 Cg_exo -44.74 -36.27 10.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.242 1.961 . . . . 0.0 112.619 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.698 HG11 ' CG ' ' A' ' 84' ' ' PHE . 5.3 t -77.42 -44.6 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.047 0.451 . . . . 0.0 110.113 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.599 HG22 ' HB2' ' A' ' 127' ' ' LYS . 8.0 mm -68.27 -31.67 52.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.919 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.58 -27.59 40.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.133 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -49.5 11.67 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.634 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.963 HD13 ' CD2' ' A' ' 68' ' ' PHE . 6.8 tp -78.09 -30.75 49.76 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.895 0.378 . . . . 0.0 111.609 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.599 ' HB2' HG22 ' A' ' 123' ' ' ILE . 14.3 ttpt -53.91 -42.62 68.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.949 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -70.5 -7.69 45.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.831 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.334 -0.105 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.298 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.79 0.329 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 79' ' ' HIS . 4.9 mttt -140.01 129.15 23.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.812 ' HG ' HG22 ' A' ' 80' ' ' ILE . 2.1 pp -146.16 119.84 9.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.613 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.785 ' C ' HD13 ' A' ' 6' ' ' ILE . 6.6 mt-30 -101.89 157.45 16.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.096 0.474 . . . . 0.0 112.022 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.785 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -142.96 138.99 27.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.46 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.967 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.97 125.68 44.29 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.469 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.471 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -135.81 156.02 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.169 0.509 . . . . 0.0 111.573 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -151.37 126.08 2.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.799 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.024 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.87 110.63 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.756 HG22 ' CE3' ' A' ' 90' ' ' TRP . 1.2 mt -71.43 120.27 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.96 0.41 . . . . 0.0 111.4 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -83.15 124.42 30.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.512 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.506 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 4.8 t-20 -70.33 -172.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.979 0.895 . . . . 0.0 112.587 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -64.15 -12.0 35.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.781 -1.554 . . . . 0.0 113.079 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -129.05 -82.26 0.57 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.669 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -153.81 14.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.543 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 1.5 pt-20 -100.98 160.32 14.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.024 HG21 HG22 ' A' ' 10' ' ' ILE . 11.3 mt -135.94 142.18 39.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.007 0.432 . . . . 0.0 111.501 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -93.02 129.46 38.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.992 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' HB ' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.83 140.88 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.957 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.413 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 6.4 p -71.55 111.8 7.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.807 0.336 . . . . 0.0 111.089 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HA ' HD23 ' A' ' 33' ' ' LEU . 3.2 ttt-85 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.073 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.161 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -114.28 26.21 10.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.994 0.426 . . . . 0.0 111.339 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -45.7 100.3 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.485 179.543 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.9 -174.18 2.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.245 0.545 . . . . 0.0 112.226 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.77 168.33 10.46 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.336 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.439 ' HA ' ' CD ' ' A' ' 98' ' ' GLU . 89.2 Cg_endo -75.41 168.8 23.79 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.6 2.867 . . . . 0.0 112.102 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.723 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.9 59.63 0.73 Allowed Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.19 -1.005 . . . . 0.0 114.213 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -121.42 138.82 12.69 Favored Glycine 0 C--N 1.315 -0.586 0 CA-C-N 114.614 -0.793 . . . . 0.0 112.206 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.62 -4.79 0.13 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.082 0.553 . . . . 0.0 111.901 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.967 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.89 -47.56 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.421 0.629 . . . . 0.0 111.099 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -30.95 -77.57 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.813 -179.11 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.5 mtp 39.42 -93.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.83 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.63 22.92 0.08 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.49 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.68 -158.21 0.11 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.339 0.114 . . . . 0.0 110.876 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.83 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -106.02 153.06 40.43 Favored Pre-proline 0 N--CA 1.455 -0.196 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.83 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.99 -24.76 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.624 2.216 . . . . 0.0 112.373 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.623 ' O ' HG23 ' A' ' 51' ' ' VAL . 37.3 mm-40 -101.61 -47.3 4.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.924 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -80.66 -5.2 56.62 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 44' ' ' GLU . . . -64.82 -57.46 8.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.573 0.225 . . . . 0.0 110.719 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.712 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -79.17 -45.55 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.135 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.8 t -50.58 -38.45 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 0.0 111.146 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -78.64 -51.97 9.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.004 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.431 ' HG3' ' OE2' ' A' ' 57' ' ' GLU . 1.3 tp10 -63.68 -23.9 67.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.867 HD21 ' NE2' ' A' ' 64' ' ' HIS . 3.2 tp -53.95 -44.33 70.62 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.886 0.374 . . . . 0.0 110.054 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -60.81 -32.72 72.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -77.4 -23.95 50.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.733 179.024 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 37' ' ' GLY . 5.7 mp0 -108.15 5.36 25.81 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.968 HG12 HG13 ' A' ' 60' ' ' ILE . 25.3 t -134.63 -44.43 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 109.935 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.562 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.58 -40.17 0.23 Allowed Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.787 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.968 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.72 -177.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.06 0.457 . . . . 0.0 111.059 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.05 88.41 14.64 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.942 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.807 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.6 Cg_endo -111.1 148.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.446 2.764 . . . . 0.0 113.848 -177.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -74.67 79.73 2.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.006 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -122.72 126.96 48.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.885 -176.519 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.2 t80 -179.62 167.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.676 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.5 t 79.54 177.4 0.12 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.395 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.868 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -135.61 130.78 34.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.458 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.78 ' CD2' HD22 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -76.86 -41.6 43.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.218 0.533 . . . . 0.0 109.696 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.691 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.9 mt-10 -171.39 131.35 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.786 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 132.16 56.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.836 0.351 . . . . 0.0 111.554 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.777 HD22 ' HB2' ' A' ' 121' ' ' PRO . 14.7 tp -112.04 132.81 54.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.472 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -123.9 110.96 15.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.817 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.801 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.0 p90 -141.01 153.07 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.764 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' OE1' ' CE1' ' A' ' 79' ' ' HIS . 8.0 pt-20 -116.27 138.35 51.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.185 0.516 . . . . 0.0 111.289 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -93.21 163.22 25.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.339 179.716 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -52.49 82.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.935 2.423 . . . . 0.0 112.168 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.5 t0 88.74 13.29 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.355 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.451 ' NE ' HD21 ' A' ' 4' ' ' LEU . 7.1 ttp180 -137.36 96.18 3.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.759 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.403 ' CE1' ' OE1' ' A' ' 74' ' ' GLU . 2.4 t60 -80.38 117.66 21.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.582 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.812 HG22 ' HG ' ' A' ' 4' ' ' LEU . 7.9 pt -125.32 128.31 72.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.172 0.51 . . . . 0.0 111.931 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.32 118.58 35.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.815 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.849 HD22 ' CE1' ' A' ' 84' ' ' PHE . 1.1 mt -101.57 113.61 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.908 0.385 . . . . 0.0 111.416 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 10.0 m0 -116.25 122.6 45.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.741 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.898 ' CE1' HG21 ' A' ' 122' ' ' VAL . 1.2 m-85 -110.84 111.36 22.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.924 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.868 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 24.4 m95 -94.29 136.55 34.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.983 0.42 . . . . 0.0 111.376 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 55.2 tp -88.37 102.93 15.35 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.232 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.006 HG22 ' ND1' ' A' ' 64' ' ' HIS . 37.0 t -83.08 145.52 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.122 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -110.24 -25.73 9.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.81 163.33 26.64 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.706 0.684 . . . . 0.0 111.408 -179.428 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.756 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.27 120.69 4.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.967 0.413 . . . . 0.0 111.324 178.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -77.5 153.47 33.42 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.067 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.46 -121.04 21.15 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.528 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.2 tt0 -134.96 147.6 63.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.547 0.213 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.516 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.57 128.76 10.47 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.859 2.373 . . . . 0.0 111.241 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.562 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 57.7 p-90 -137.42 -60.24 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.161 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.518 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 53.93 -97.64 0.03 OUTLIER Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.688 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 178.06 22.94 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.439 ' CD ' ' HA ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -67.96 -32.9 73.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.934 0.397 . . . . 0.0 110.682 179.52 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.61 35.12 29.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.779 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.413 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 66.0 mt-30 -140.11 91.9 9.88 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.022 0.439 . . . . 0.0 111.178 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -43.69 137.38 6.27 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.025 2.483 . . . . 0.0 112.758 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.22 177.01 19.48 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.596 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.8 157.0 44.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.576 0.227 . . . . 0.0 110.641 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -78.15 107.18 10.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.95 0.405 . . . . 0.0 110.509 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.4 ptm -119.61 163.23 17.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.908 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p -77.98 114.97 17.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.661 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.755 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -73.54 -28.14 61.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 p -53.01 -22.7 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.315 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.3 42.69 1.59 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.337 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.511 HD13 HD22 ' A' ' 107' ' ' LEU . 10.9 tp -62.66 147.22 50.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.11 132.1 53.95 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.61 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.35 -15.2 61.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.498 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.67 -49.31 13.38 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.574 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -32.88 74.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.086 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.61 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -87.97 173.14 6.73 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.408 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.497 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.2 Cg_endo -72.19 127.72 13.05 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.122 1.881 . . . . 0.0 111.701 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.44 -14.96 45.51 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.568 2.179 . . . . 0.0 113.125 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.49 58.57 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.843 ' ND2' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -121.35 32.17 6.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.729 0.3 . . . . 0.0 111.278 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -75.93 -36.1 1.86 Allowed Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.251 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.777 ' HB2' HD22 ' A' ' 71' ' ' LEU . 71.4 Cg_exo -49.56 -43.19 40.21 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 121.971 1.78 . . . . 0.0 112.918 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.898 HG21 ' CE1' ' A' ' 84' ' ' PHE . 1.8 t -77.36 -51.25 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.105 0.479 . . . . 0.0 111.099 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.558 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.1 mm -63.65 -32.58 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.273 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.9 -31.26 59.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.038 0.447 . . . . 0.0 110.477 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -72.78 -52.54 14.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.617 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.78 HD22 ' CD2' ' A' ' 68' ' ' PHE . 1.8 tp -78.19 -33.01 50.34 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.558 ' HB2' HG22 ' A' ' 123' ' ' ILE . 3.2 ttpm? -53.73 -42.61 68.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.067 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -67.85 -9.46 44.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.792 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 126' ' ' LEU . 11.0 mp . . . . . 0 C--N 1.333 -0.112 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.888 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.807 0.337 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.99 126.54 20.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.829 HD12 ' CD1' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -133.51 140.33 47.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.771 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.747 ' C ' HD13 ' A' ' 6' ' ' ILE . 9.4 mt-30 -106.61 150.43 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.279 0.561 . . . . 0.0 111.915 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.829 ' CD1' HD12 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -140.7 139.09 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.41 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.941 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.47 140.63 52.77 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -144.56 151.24 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.242 0.544 . . . . 0.0 111.327 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.56 130.67 3.21 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.17 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.877 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -88.43 108.0 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.727 HG23 HG11 ' A' ' 87' ' ' VAL . 1.1 mt -71.28 124.99 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.133 0.492 . . . . 0.0 111.479 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -87.06 127.12 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.969 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.465 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 14.8 t30 -81.95 -172.29 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.858 0.837 . . . . 0.0 112.012 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -81.82 3.59 25.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.227 -1.351 . . . . 0.0 112.261 -179.225 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -139.2 51.88 1.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 0.0 111.425 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.7 p30 45.3 26.29 0.26 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.421 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 8.1 pt-20 -118.81 144.08 46.55 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.877 HG21 HG22 ' A' ' 10' ' ' ILE . 10.1 mt -114.22 142.86 25.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.162 0.506 . . . . 0.0 111.459 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -95.92 128.4 42.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.671 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.65 162.14 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.489 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.617 HG23 ' HD3' ' A' ' 36' ' ' PRO . 38.2 p -91.99 111.97 23.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.755 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.219 179.812 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.575 0.226 . . . . 0.0 111.517 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 26.26 10.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.859 0.362 . . . . 0.0 111.532 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -48.61 95.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.508 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.7 tt0 -113.11 -179.14 3.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.196 0.522 . . . . 0.0 111.64 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.95 162.05 35.21 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.517 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.617 ' HD3' HG23 ' A' ' 21' ' ' THR . 9.3 Cg_endo -50.29 168.76 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.569 2.846 . . . . 0.0 111.526 178.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.678 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.04 59.69 0.73 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.757 -1.211 . . . . 0.0 113.86 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -138.3 117.73 1.49 Allowed Glycine 0 C--N 1.313 -0.71 0 CA-C-N 114.548 -0.826 . . . . 0.0 111.91 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.82 -6.9 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.307 0.643 . . . . 0.0 111.215 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.941 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -43.62 -62.65 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.258 0.551 . . . . 0.0 111.375 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.499 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -16.77 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.425 -179.598 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.5 mmt 43.14 -94.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.511 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.83 17.82 0.09 OUTLIER Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.598 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.74 -161.66 0.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.532 0.206 . . . . 0.0 110.742 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.883 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.66 154.4 39.26 Favored Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.883 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -44.0 -24.87 0.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.694 2.263 . . . . 0.0 112.406 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.646 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -98.48 -50.38 4.31 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.985 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -80.45 -4.99 55.86 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -65.49 -57.5 8.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.574 0.226 . . . . 0.0 110.819 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.707 ' CG2' HD13 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -78.68 -43.32 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.029 179.279 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.9 t -50.63 -36.45 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.344 . . . . 0.0 110.721 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.67 -48.47 14.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.747 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -67.03 -20.0 65.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.03 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.707 HD13 ' CG2' ' A' ' 50' ' ' VAL . 3.3 tp -57.47 -44.82 85.18 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 110.477 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -32.28 73.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 97' ' ' LYS . 5.7 tm-20 -77.37 -25.48 51.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.92 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -108.15 5.36 25.81 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.93 HG12 HG13 ' A' ' 60' ' ' ILE . 30.0 t -134.33 -44.31 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.139 0.495 . . . . 0.0 109.94 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.535 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.57 -41.62 0.31 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.463 -0.789 . . . . 0.0 113.715 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.93 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.64 -177.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 120.975 0.417 . . . . 0.0 111.107 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.36 88.41 15.46 Favored Pre-proline 0 N--CA 1.441 -0.897 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.969 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.8 ' HG3' HG11 ' A' ' 58' ' ' VAL . 9.1 Cg_endo -109.69 150.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.393 2.729 . . . . 0.0 113.659 -177.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.66 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.02 80.72 3.55 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 175.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.996 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.65 128.0 50.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.298 -176.054 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.5 t80 -179.35 168.54 1.48 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.593 -0.443 . . . . 0.0 112.106 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.411 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 0.3 OUTLIER 77.26 -166.93 0.05 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.453 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -151.8 133.42 14.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.056 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.66 ' CE1' HG12 ' A' ' 122' ' ' VAL . 15.7 p90 -76.7 -41.78 43.98 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.663 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.3 mt-10 -171.6 131.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.083 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG2' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.7 132.42 42.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.759 0.314 . . . . 0.0 111.643 -179.082 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.846 HD22 HG22 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -112.31 156.52 22.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.791 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -137.12 110.0 7.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.658 ' HE1' HD12 ' A' ' 82' ' ' LEU . 7.2 p90 -128.84 153.12 47.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.757 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -121.05 119.4 32.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 111.212 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -73.97 163.07 71.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.52 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.4 Cg_endo -53.79 82.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.92 2.413 . . . . 0.0 112.087 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.9 t70 91.86 11.08 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.373 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.425 ' CG ' HD21 ' A' ' 4' ' ' LEU . 2.7 ttt180 -137.29 93.81 2.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 0.0 110.846 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.21 103.11 6.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 1.1 tt -106.17 111.75 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.015 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.428 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -94.36 118.47 31.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.77 179.272 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.658 HD12 ' HE1' ' A' ' 73' ' ' TYR . 10.4 mt -107.35 114.03 27.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 111.612 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.431 ' O ' HG13 ' A' ' 8' ' ' VAL . 11.2 m0 -108.62 122.47 47.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.139 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.663 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 6.3 m-85 -112.67 112.25 23.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.4 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.702 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 30.1 m95 -94.75 148.21 22.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.57 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 65' ' ' PHE . 47.2 tp -100.76 102.96 14.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.057 0.456 . . . . 0.0 110.809 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.996 HG22 ' ND1' ' A' ' 64' ' ' HIS . 33.4 t -84.81 145.35 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.733 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 3.9 mt-10 -106.36 -33.47 7.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.08 165.4 24.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.927 0.785 . . . . 0.0 111.813 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.703 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -151.56 127.52 10.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 111.53 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -76.89 147.76 36.84 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.11 -121.2 25.93 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.438 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -133.99 148.09 66.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.631 0.253 . . . . 0.0 110.82 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.49 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.65 128.71 10.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.948 2.432 . . . . 0.0 111.566 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.535 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 62.1 p-90 -136.16 -58.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.716 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.578 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.1 -95.72 0.01 OUTLIER Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.01 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' GLU . 2.8 tttp 174.25 37.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 110.938 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.459 ' OE2' HG22 ' A' ' 21' ' ' THR . 1.8 pt-20 -66.94 -30.63 70.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.512 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 10.3 79.39 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.391 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.406 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 4.7 mt-30 -140.24 91.88 9.73 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.356 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -43.72 138.48 5.74 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 123.054 2.503 . . . . 0.0 112.643 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.07 19.43 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.747 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -136.4 157.17 47.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.567 0.222 . . . . 0.0 110.577 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -72.98 107.16 5.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.88 0.372 . . . . 0.0 110.278 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.455 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -119.63 163.04 17.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.432 ' OG ' HG12 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -78.97 114.85 18.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.807 ' CD1' HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -72.27 -18.73 61.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.838 HG22 HD21 ' A' ' 129' ' ' LEU . 14.8 p -62.52 -10.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.446 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.25 50.48 0.89 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.63 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.807 HD23 ' CD1' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -62.09 138.86 58.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.678 0.275 . . . . 0.0 110.538 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.604 ' H ' HD13 ' A' ' 110' ' ' LEU . 1.1 m-80 -116.87 121.75 42.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.169 0.509 . . . . 0.0 111.885 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.663 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.1 -15.13 62.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.977 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -78.33 -49.46 13.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -70.64 -22.54 62.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.546 0.212 . . . . 0.0 111.367 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.663 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -100.35 170.81 6.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.5 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 43.7 Cg_endo -68.09 127.67 16.34 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.234 1.956 . . . . 0.0 111.898 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.38 -19.65 61.54 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.577 2.184 . . . . 0.0 113.001 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.93 -9.37 58.25 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.632 HD21 ' HZ ' ' A' ' 84' ' ' PHE . 1.6 m120 -117.72 29.54 7.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.779 0.323 . . . . 0.0 111.408 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.3 mt-10 -76.24 -31.87 1.03 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.789 ' HB2' HD13 ' A' ' 71' ' ' LEU . 82.3 Cg_exo -48.52 -45.44 27.14 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 121.869 1.712 . . . . 0.0 113.04 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.846 HG22 HD22 ' A' ' 71' ' ' LEU . 1.4 t -77.41 -51.4 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.07 0.462 . . . . 0.0 111.205 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.495 ' CG2' ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -62.42 -36.89 77.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.612 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.62 -29.77 52.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.905 0.384 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -79.74 -48.47 13.58 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.593 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.454 HD13 ' CD1' ' A' ' 68' ' ' PHE . 3.4 tp -78.09 -46.6 20.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.852 0.358 . . . . 0.0 111.269 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.571 ' O ' HD13 ' A' ' 129' ' ' LEU . 8.2 ttpp -51.95 -42.24 62.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.879 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -63.96 -7.08 7.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.142 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.838 HD21 HG22 ' A' ' 108' ' ' VAL . 8.1 mp . . . . . 0 C--O 1.231 0.119 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.806 0.336 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HG2' ' CG ' ' A' ' 79' ' ' HIS . 23.1 mtpt -140.0 135.02 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.766 HD12 ' CD1' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -146.04 141.08 27.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.768 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.753 ' C ' HD13 ' A' ' 6' ' ' ILE . 28.1 mt-30 -106.16 149.9 26.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.405 0.622 . . . . 0.0 112.316 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.766 ' CD1' HD12 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.31 116.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.611 178.667 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.969 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.98 135.81 53.15 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.352 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 0.9 OUTLIER -144.54 163.1 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.98 0.419 . . . . 0.0 111.19 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -141.25 130.35 4.41 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.091 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.964 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -72.0 108.45 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.74 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.5 mt -70.97 125.98 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.623 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.628 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -87.7 127.25 35.3 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.62 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.536 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 6.1 t-20 -69.93 -172.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.458 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.04 -10.7 31.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.895 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -133.82 -82.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.785 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -149.97 16.21 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 0.0 111.613 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.821 ' C ' HD12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -100.61 160.56 14.25 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.964 HG21 HG22 ' A' ' 10' ' ' ILE . 1.8 mp -130.64 138.14 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.094 0.473 . . . . 0.0 111.482 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.585 ' CZ ' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -85.96 116.02 23.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.332 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.505 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.05 120.11 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.745 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.86 HG21 ' HG2' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -70.73 115.97 10.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.575 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 19.6 ptt-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.744 0.307 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -114.22 26.2 10.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.018 0.437 . . . . 0.0 111.191 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.489 HD21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -45.47 114.12 0.7 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.619 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' ' CD ' ' A' ' 116' ' ' PRO . 0.5 OUTLIER -124.85 -171.66 2.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.195 0.521 . . . . 0.0 112.094 -179.17 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.611 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.55 168.59 9.79 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.146 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.562 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 87.5 Cg_endo -81.74 167.29 16.79 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.628 2.885 . . . . 0.0 113.799 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.39 -5.44 52.05 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.371 -0.831 . . . . 0.0 114.988 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -59.25 171.68 4.97 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.5 0.65 . . . . 0.0 113.214 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 76.58 7.03 3.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.517 0.327 . . . . 0.0 111.811 179.645 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.969 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.3 pt -55.44 -26.84 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.673 0.749 . . . . 0.0 110.032 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.542 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.98 -60.17 1.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.692 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER 5.37 -79.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.471 179.283 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.54 33.63 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.643 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.4 mp0 -88.95 -174.82 4.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.821 0.343 . . . . 0.0 111.09 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.852 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.5 154.14 38.09 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.322 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.852 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.97 -25.25 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.872 2.381 . . . . 0.0 112.448 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.8 mt-10 -104.02 -40.4 6.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.405 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.402 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 34.4 mt-30 -80.29 -4.91 55.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.654 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.919 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.89 -57.11 14.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.409 . . . . 0.0 110.667 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.803 HG11 ' NE1' ' A' ' 85' ' ' TRP . 2.5 m -78.64 -45.99 25.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.48 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.489 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 29.0 t -56.33 -36.66 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.141 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -77.95 -49.78 13.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.983 0.42 . . . . 0.0 110.193 179.428 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.53 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.5 mm-40 -65.56 -19.89 66.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.334 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.534 HD11 ' CD2' ' A' ' 64' ' ' HIS . 8.6 tp -56.55 -44.49 80.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -31.81 69.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.075 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.45 -31.09 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.572 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HA ' ' H ' ' A' ' 97' ' ' LYS . 4.0 mp0 -108.06 5.37 25.99 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.866 HG13 ' HB3' ' A' ' 94' ' ' PRO . 16.0 t -134.39 -43.96 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.104 0.478 . . . . 0.0 110.067 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.574 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.86 -38.32 0.29 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.614 -0.721 . . . . 0.0 114.207 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.845 HG22 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.71 -178.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.64 88.98 6.97 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.696 ' HG3' HG11 ' A' ' 58' ' ' VAL . 10.6 Cg_endo -108.28 144.07 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.475 2.783 . . . . 0.0 113.987 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.81 79.44 2.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.84 ' CB ' HG13 ' A' ' 87' ' ' VAL . 1.1 t-80 -123.23 122.36 38.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.65 -1.613 . . . . 0.0 109.895 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 6.5 t80 -179.41 161.07 1.04 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.177 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 9.3 t 77.01 166.93 0.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.783 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.797 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -119.54 130.08 54.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.873 ' CE2' HD11 ' A' ' 10' ' ' ILE . 7.1 p90 -78.2 -41.33 34.84 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.598 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -171.31 131.75 0.77 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.328 178.037 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.796 ' HG2' HD13 ' A' ' 67' ' ' LEU . 50.4 pttt -139.39 132.75 30.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 111.483 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.023 HD12 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -123.43 151.38 42.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.952 0.406 . . . . 0.0 110.996 179.455 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -121.59 133.91 55.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.757 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -141.03 145.81 36.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.568 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.08 126.35 49.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.095 0.474 . . . . 0.0 111.365 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -86.4 163.1 43.51 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.319 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.6 Cg_endo -53.97 82.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.825 2.35 . . . . 0.0 112.166 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.7 t70 93.25 9.67 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.52 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.482 ' CZ ' HD21 ' A' ' 4' ' ' LEU . 10.2 ttt85 -137.34 93.78 2.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.299 . . . . 0.0 110.759 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.416 ' CG ' ' HG2' ' A' ' 3' ' ' LYS . 1.1 m-70 -82.3 102.28 11.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.921 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 2.0 tt -106.32 111.73 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.025 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.422 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -92.54 118.45 31.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.015 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.531 HD23 HD11 ' A' ' 71' ' ' LEU . 14.8 tp -108.0 114.09 27.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 111.577 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.405 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 9.8 m0 -112.22 122.2 47.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.46 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 5.8 m-30 -109.84 109.63 20.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.911 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.803 ' NE1' HG11 ' A' ' 50' ' ' VAL . 32.5 m95 -95.79 148.65 22.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.622 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.0 pp -87.29 138.12 31.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.433 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.84 HG13 ' CB ' ' A' ' 64' ' ' HIS . 17.5 t -123.65 145.52 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.018 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.87 -30.68 8.01 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.572 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.28 165.01 24.71 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.221 0.919 . . . . 0.0 112.111 -178.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.74 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -154.64 130.15 9.86 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.133 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.23 132.71 47.62 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.055 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 48.79 -105.23 0.12 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.416 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 26.5 tt0 -134.32 137.65 28.46 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.812 -0.194 . . . . 0.0 110.759 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.866 ' HB3' HG13 ' A' ' 58' ' ' VAL . 4.7 Cg_exo -74.13 128.9 12.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.596 2.197 . . . . 0.0 110.682 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.574 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 21.5 p-90 -118.15 -63.95 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.583 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.43 -100.16 0.02 OUTLIER Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.853 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 160.56 74.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.584 0.354 . . . . 0.0 110.774 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.86 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.9 OUTLIER -88.6 -33.2 17.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.803 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 142.44 -38.5 1.45 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.323 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.487 ' O ' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -140.01 110.76 7.22 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.018 0.437 . . . . 0.0 111.885 -179.333 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -43.84 146.39 1.58 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.121 2.547 . . . . 0.0 112.55 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.19 177.29 17.48 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.001 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -128.85 157.23 42.11 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -77.99 106.83 10.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.4 ptp -119.99 163.08 18.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.924 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 95.8 p -75.04 114.98 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.859 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.69 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -78.97 -18.92 52.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.306 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.42 ' HA ' HD21 ' A' ' 129' ' ' LEU . 25.0 t -54.28 -18.52 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.424 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.39 55.1 0.57 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.268 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.533 HD22 HG23 ' A' ' 123' ' ' ILE . 5.6 tt -62.15 150.43 38.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -107.87 126.01 52.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.334 0.588 . . . . 0.0 112.428 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.656 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -15.2 61.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.791 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -78.11 -49.14 14.46 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.654 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -26.33 65.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.79 0.329 . . . . 0.0 110.8 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.656 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -98.36 166.96 12.33 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.17 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.6 Cg_endo -72.61 127.81 12.81 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.393 2.062 . . . . 0.0 111.937 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.54 -14.92 42.55 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.595 2.197 . . . . 0.0 113.05 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.69 -9.51 57.3 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.433 ' OD1' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -121.72 31.17 6.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.827 0.346 . . . . 0.0 111.277 -179.181 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.2 -34.13 1.37 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -179.162 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 93.1 Cg_exo -44.73 -46.28 12.69 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.21 1.94 . . . . 0.0 113.193 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 1.023 HG22 HD12 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -77.14 -33.98 20.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.029 0.442 . . . . 0.0 110.048 179.666 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.581 HG13 ' CE2' ' A' ' 115' ' ' PHE . 7.8 mm -68.18 -39.79 81.77 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.839 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.55 -29.44 50.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.436 . . . . 0.0 110.371 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -80.27 -53.21 6.86 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.782 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.69 ' CD2' HD12 ' A' ' 107' ' ' LEU . 1.7 tp -78.3 -19.79 52.84 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.513 ' HB2' HG22 ' A' ' 123' ' ' ILE . 54.6 tttm -78.21 -42.71 30.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.081 0.467 . . . . 0.0 110.745 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -69.65 -7.03 35.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.905 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.123 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.683 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.4 tttt . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.831 0.348 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -128.62 134.72 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.912 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.537 HD13 HD11 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -139.13 143.03 38.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.419 ' C ' HD12 ' A' ' 6' ' ' ILE . 30.9 mt-30 -102.61 153.1 20.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.335 0.588 . . . . 0.0 112.02 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.83 ' HB ' HD23 ' A' ' 82' ' ' LEU . 4.9 mp -146.2 127.93 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.743 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.063 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.58 124.56 42.5 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.581 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 2.0 m -116.53 162.23 14.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.345 0.593 . . . . 0.0 111.912 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -143.25 109.57 0.56 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.848 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -70.53 98.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.733 HG22 ' CE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.14 123.72 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 121.21 0.529 . . . . 0.0 112.121 -178.352 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.528 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -96.23 127.19 42.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.363 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.511 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 48.7 t30 -79.58 -172.63 3.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.113 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.483 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 14.9 tp10 -80.48 -2.72 47.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.299 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -134.16 49.61 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.879 0.371 . . . . 0.0 111.229 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 48.04 22.62 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.448 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 18.4 pt-20 -110.44 141.08 44.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.628 HG21 HG13 ' A' ' 10' ' ' ILE . 2.6 mt -110.82 151.44 12.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.284 0.564 . . . . 0.0 112.296 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -101.01 99.96 10.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.517 178.838 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.419 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.81 120.1 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.569 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.628 HG23 ' HD3' ' A' ' 36' ' ' PRO . 18.2 p -71.08 111.85 6.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.998 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 2.5 ptm180 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.451 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.587 0.232 . . . . 0.0 111.468 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 26.26 10.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 111.501 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -46.8 120.21 2.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.696 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 21' ' ' THR . 7.8 mt-10 -137.19 -174.11 3.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.045 0.45 . . . . 0.0 111.473 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.561 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.03 161.17 39.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.23 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.628 ' HD3' HG23 ' A' ' 21' ' ' THR . 12.2 Cg_endo -54.65 167.76 1.34 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.374 2.716 . . . . 0.0 111.715 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.61 59.56 0.75 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.768 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -124.96 132.15 8.01 Favored Glycine 0 C--N 1.311 -0.818 0 CA-C-N 114.406 -0.897 . . . . 0.0 111.78 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.41 5.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.936 0.494 . . . . 0.0 112.297 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.063 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.27 -28.11 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.601 0.715 . . . . 0.0 110.279 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.578 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.98 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.787 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.5 mmm 31.77 -86.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.52 0.513 . . . . 0.0 111.827 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -158.96 24.38 0.33 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.605 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -102.64 -179.51 3.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.892 0.377 . . . . 0.0 111.051 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.906 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.55 158.52 34.46 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.929 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.906 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.86 -24.7 0.85 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.726 2.284 . . . . 0.0 112.473 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -85.24 -61.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -80.4 -20.13 44.69 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.883 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -56.87 -48.43 78.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.734 0.302 . . . . 0.0 111.093 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.729 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.0 OUTLIER -78.11 -47.29 25.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.7 t -57.4 -38.49 63.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.624 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -78.44 -46.54 19.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.989 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -69.79 -21.66 63.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.344 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.678 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -57.39 -44.68 84.71 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.777 0.322 . . . . 0.0 110.565 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -30.9 71.94 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.1 tm-20 -77.63 -29.05 51.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.104 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.68 5.85 25.23 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.772 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.955 HG12 HG13 ' A' ' 60' ' ' ILE . 21.3 t -134.04 -44.3 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.956 0.408 . . . . 0.0 109.989 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.598 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.68 -41.33 0.31 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.648 -0.705 . . . . 0.0 113.488 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.955 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.55 -176.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -113.06 89.1 13.24 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.306 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.88 ' HG3' HG11 ' A' ' 58' ' ' VAL . 7.9 Cg_endo -108.79 148.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 123.205 2.604 . . . . 0.0 114.139 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' CG ' ' HG2' ' A' ' 89' ' ' ARG . 86.6 mt-30 -74.76 79.8 2.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.958 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -123.11 125.55 45.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.374 -176.822 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.6 t80 -177.77 159.12 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.128 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER 84.21 -170.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.298 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.689 HD13 ' HD3' ' A' ' 70' ' ' LYS . 3.5 pp -145.02 130.58 18.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.056 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.619 ' CE1' HG12 ' A' ' 122' ' ' VAL . 1.3 p90 -76.67 -35.18 58.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.212 0.529 . . . . 0.0 109.678 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.7 OUTLIER -171.2 163.53 7.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.504 179.038 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.689 ' HD3' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.53 132.41 22.74 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.684 -179.602 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.739 ' HB2' HG22 ' A' ' 122' ' ' VAL . 9.0 tp -119.25 142.45 48.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.727 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -140.0 111.02 6.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.505 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.579 ' HE1' HD12 ' A' ' 82' ' ' LEU . 8.8 p90 -138.67 153.27 48.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.767 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.06 140.02 52.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.176 0.512 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -89.2 163.18 35.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.545 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.3 Cg_endo -51.9 83.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.103 2.536 . . . . 0.0 112.036 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 8.1 m-20 93.96 16.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.142 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 35.1 ttt180 -137.32 150.13 47.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.489 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.83 99.72 6.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.763 0.316 . . . . 0.0 110.719 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.488 HG13 HD13 ' A' ' 6' ' ' ILE . 4.7 tt -104.35 111.75 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 120.956 0.408 . . . . 0.0 110.96 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.438 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -103.88 118.99 38.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.235 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.83 HD23 ' HB ' ' A' ' 6' ' ' ILE . 66.3 mt -118.86 114.35 22.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.877 0.37 . . . . 0.0 111.615 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.472 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.8 m0 -106.29 122.37 46.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.142 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.908 ' CG ' HG11 ' A' ' 122' ' ' VAL . 2.2 m-85 -98.94 110.39 23.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.71 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.729 ' NE1' HG11 ' A' ' 50' ' ' VAL . 31.9 m95 -94.85 148.77 21.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.822 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.746 HD13 ' N ' ' A' ' 87' ' ' VAL . 3.1 tm? -94.17 137.36 33.44 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.356 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.958 HG22 ' ND1' ' A' ' 64' ' ' HIS . 41.1 t -124.14 145.01 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.499 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.59 -27.68 8.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.1 165.2 24.93 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.716 0.689 . . . . 0.0 111.766 -179.26 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.733 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -155.72 122.36 5.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.293 178.611 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.24 145.25 49.72 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.069 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.49 -116.82 6.9 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.582 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.6 tt0 -134.47 145.77 56.53 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.591 0.234 . . . . 0.0 110.819 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.53 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.4 Cg_exo -76.5 128.78 10.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.913 2.408 . . . . 0.0 111.135 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.598 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 47.5 p-90 -130.84 -62.54 0.9 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.549 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.37 -97.5 0.01 OUTLIER Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.613 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.6 tptp 178.77 35.49 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.636 0.255 . . . . 0.0 111.389 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.523 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -62.35 -46.21 89.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.334 179.452 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.34 14.91 46.15 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.353 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.434 ' O ' ' HB ' ' A' ' 21' ' ' THR . 49.9 mt-30 -140.31 92.91 9.18 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 111.539 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -43.78 138.42 5.93 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.901 2.401 . . . . 0.0 112.534 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.457 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.18 177.13 19.39 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.645 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.07 157.09 45.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.641 0.258 . . . . 0.0 110.785 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.464 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.45 107.13 6.4 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.876 0.37 . . . . 0.0 110.391 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -119.67 163.42 17.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.871 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.603 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.2 p -82.0 114.94 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.851 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.625 ' CD2' HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -71.88 -18.79 62.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.112 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.912 ' HA ' HD21 ' A' ' 129' ' ' LEU . 10.9 p -57.29 -11.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.632 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.2 51.42 0.84 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.157 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.612 HD23 ' CD1' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -61.92 134.59 56.87 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.522 ' H ' HD13 ' A' ' 110' ' ' LEU . 1.6 m-20 -111.2 121.58 45.66 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.747 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . . . -72.42 -14.72 61.77 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.801 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -76.41 -49.05 17.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.483 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -27.19 64.47 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.085 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.689 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -93.78 169.8 9.48 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.249 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.524 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 40.3 Cg_endo -67.33 127.58 16.85 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.216 1.944 . . . . 0.0 111.837 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.86 -15.01 47.29 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.588 2.192 . . . . 0.0 113.151 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.3 -9.19 59.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.553 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.6 m-80 -114.96 28.58 8.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.579 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -69.26 -34.48 4.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.259 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 61.8 Cg_exo -51.82 -45.87 35.7 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 121.962 1.775 . . . . 0.0 113.218 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.908 HG11 ' CG ' ' A' ' 84' ' ' PHE . 2.1 t -77.44 -51.34 18.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.328 . . . . 0.0 111.314 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.509 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -64.95 -29.81 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.064 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.38 -33.03 63.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.031 0.443 . . . . 0.0 110.257 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -78.3 -47.51 17.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.556 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.594 HD13 ' CG ' ' A' ' 68' ' ' PHE . 2.8 tp -78.17 -19.75 53.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.651 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.747 ' HE2' ' HB2' ' A' ' 112' ' ' ALA . 15.8 ttpp -83.64 -42.39 16.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.131 0.491 . . . . 0.0 110.524 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -63.91 -10.37 20.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.824 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.912 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.213 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.006 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 pttt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.893 0.378 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HG2' ' CG ' ' A' ' 79' ' ' HIS . 7.6 mtmt -132.53 148.98 52.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.68 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.873 HD11 HG13 ' A' ' 80' ' ' ILE . 4.5 pp -146.07 132.45 19.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.283 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.465 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 42.3 mt-30 -102.78 153.6 20.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.353 0.597 . . . . 0.0 111.756 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 81' ' ' THR . 10.4 mm -146.46 130.22 10.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.085 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.021 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.84 124.21 41.61 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 9' ' ' GLY . 1.6 m -120.01 162.23 18.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.06 0.457 . . . . 0.0 111.564 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.93 109.4 0.48 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.81 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.74 HD11 HD13 ' A' ' 107' ' ' LEU . 1.1 tp -70.47 99.46 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.86 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -71.2 119.79 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -82.54 124.02 29.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.06 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.516 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 19.1 t-20 -69.63 177.6 2.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.851 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.516 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -54.59 -20.08 7.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.261 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -119.54 -82.46 0.64 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.67 0.271 . . . . 0.0 111.408 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.11 14.1 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 17.2 pt-20 -100.89 160.15 14.61 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.86 HG23 ' O ' ' A' ' 11' ' ' ILE . 3.4 mt -138.29 140.88 39.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.899 0.381 . . . . 0.0 111.895 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.724 ' CD2' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -86.15 113.08 21.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -111.81 119.53 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.168 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.731 HG22 ' HD3' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -74.99 111.8 10.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.95 0.405 . . . . 0.0 110.666 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.463 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 2.2 ptt180 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.742 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.26 26.23 10.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.083 0.468 . . . . 0.0 111.371 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.48 HD21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -47.48 122.22 4.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.705 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.825 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.4 tt0 -138.41 -167.25 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.005 0.431 . . . . 0.0 111.653 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.547 ' CD2' HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -119.15 155.2 53.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.499 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.731 ' HD3' HG22 ' A' ' 21' ' ' THR . 10.2 Cg_endo -52.9 167.67 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.324 2.683 . . . . 0.0 111.341 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.53 59.71 0.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 119.852 -1.166 . . . . 0.0 114.318 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -123.62 136.47 10.38 Favored Glycine 0 C--N 1.31 -0.863 0 CA-C-N 114.919 -0.64 . . . . 0.0 111.971 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.2 ttpt 91.27 4.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.006 0.522 . . . . 0.0 112.305 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.021 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -50.51 -29.14 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 110.364 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.17 -79.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.966 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 37.45 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.445 0.466 . . . . 0.0 111.634 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -161.93 26.14 0.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.691 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -99.45 -176.51 3.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.863 0.363 . . . . 0.0 111.125 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.917 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.93 162.92 18.66 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.405 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.917 ' HD2' HG22 ' A' ' 45' ' ' THR . 9.3 Cg_endo -49.14 -24.53 8.03 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.639 2.226 . . . . 0.0 112.425 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mm-40 -98.91 -48.04 5.05 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -77.17 -26.61 53.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.66 0.266 . . . . 0.0 111.615 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.967 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -57.79 -45.31 86.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.727 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.24 -46.63 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.516 179.585 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.4 t -60.03 -39.48 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.077 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -78.23 -45.77 22.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.963 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.68 -22.12 62.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.778 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.2 tp -53.87 -44.59 70.54 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.836 0.35 . . . . 0.0 110.082 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -59.54 -33.68 71.71 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.41 -26.25 51.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.994 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HG2' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -108.02 6.04 26.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.854 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.673 HG11 ' HG3' ' A' ' 62' ' ' PRO . 10.3 t -134.32 -44.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.214 0.53 . . . . 0.0 109.876 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.44 -43.43 0.57 Allowed Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.866 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.682 HG23 ' NE1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -84.36 -175.08 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.079 0.466 . . . . 0.0 111.292 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 p -112.64 89.09 12.32 Favored Pre-proline 0 N--CA 1.442 -0.875 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.554 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.673 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.9 Cg_endo -107.62 152.46 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.96 2.44 . . . . 0.0 114.203 -177.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -74.85 79.9 2.12 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.022 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.65 126.13 44.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.738 -176.704 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.9 t80 -179.35 165.66 1.43 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.9 0.381 . . . . 0.0 111.93 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 83.1 160.33 0.13 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.762 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -113.77 131.97 56.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 111.363 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -88.61 -33.91 17.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.102 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.1 tt0 -171.56 149.93 2.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.471 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.1 108.16 4.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.74 0.305 . . . . 0.0 110.689 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.723 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -120.85 140.55 51.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.794 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.475 ' CB ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER -140.14 139.47 35.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.964 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.591 ' O ' HG22 ' A' ' 80' ' ' ILE . 69.9 t80 -141.05 100.98 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.4 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 1.8 pm0 -64.76 136.88 57.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.159 0.504 . . . . 0.0 111.41 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.485 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -101.54 162.89 19.04 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.434 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.579 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.4 Cg_endo -53.06 81.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.019 2.479 . . . . 0.0 112.353 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 13.3 t70 102.23 -24.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.267 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.686 ' HE ' HD21 ' A' ' 4' ' ' LEU . 5.4 ttt180 -109.65 95.19 5.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.712 0.292 . . . . 0.0 111.09 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.413 ' CG ' ' HG2' ' A' ' 3' ' ' LYS . 18.9 m170 -77.85 93.87 4.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 0.0 110.542 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.873 HG13 HD11 ' A' ' 4' ' ' LEU . 2.4 tt -85.78 131.8 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.475 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.475 HG23 ' CB ' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -134.06 118.63 17.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.178 179.668 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.667 HD13 ' CE1' ' A' ' 84' ' ' PHE . 1.6 pp -126.35 117.09 22.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 111.343 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.416 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.9 m0 -102.82 122.86 45.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.667 ' CE1' HD13 ' A' ' 82' ' ' LEU . 3.5 m-30 -95.08 109.89 21.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.311 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.653 ' CE2' HG11 ' A' ' 50' ' ' VAL . 21.3 m95 -95.58 148.6 22.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.166 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 65' ' ' PHE . 12.2 tp -92.62 138.1 31.79 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.567 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.022 HG22 ' ND1' ' A' ' 64' ' ' HIS . 38.0 t -124.33 145.71 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.67 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -111.27 -30.57 7.38 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.4 165.24 24.15 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.925 0.784 . . . . 0.0 111.688 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.662 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.8 p90 -148.23 130.25 15.36 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.538 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -78.06 145.08 36.06 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.935 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.14 -116.29 8.16 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.383 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 7.0 mt-10 -135.05 139.29 31.56 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.458 0.171 . . . . 0.0 110.848 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.465 ' HA ' HG12 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -76.35 128.6 10.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.812 2.341 . . . . 0.0 111.537 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.682 ' NE1' HG23 ' A' ' 60' ' ' ILE . 55.5 p-90 -132.32 -60.22 0.9 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.879 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.597 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.28 -107.31 0.1 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.248 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 1.3 tptt 178.1 72.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.755 0.312 . . . . 0.0 110.728 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.524 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -89.78 -30.66 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.911 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.11 -66.23 0.4 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.885 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.1 104.97 36.12 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.002 0.43 . . . . 0.0 111.384 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -43.64 144.77 2.04 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.912 2.408 . . . . 0.0 112.748 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.482 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.08 177.12 19.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.393 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -133.14 153.6 51.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.644 0.259 . . . . 0.0 110.922 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 1.1 m0 -63.03 107.22 0.97 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.815 0.34 . . . . 0.0 110.357 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.4 ptm -119.44 140.5 50.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.08 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.1 p -63.19 114.89 4.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.087 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.74 HD13 HD11 ' A' ' 10' ' ' ILE . 12.4 tp -64.6 -18.76 65.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.073 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.8 t -55.73 -15.13 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.6 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.18 42.16 1.88 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.371 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.446 ' CD2' HD11 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -62.3 128.47 36.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -119.66 129.38 54.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.158 0.504 . . . . 0.0 112.241 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.654 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -15.17 61.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.817 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -78.35 -48.97 14.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.581 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -29.86 68.18 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.659 0.266 . . . . 0.0 111.246 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.654 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -91.41 171.9 7.36 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.183 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.5 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.6 Cg_endo -70.86 127.67 14.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.13 1.886 . . . . 0.0 111.714 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.61 -14.94 45.69 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.586 2.191 . . . . 0.0 113.095 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.5 -9.29 58.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -119.76 31.31 6.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.698 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -70.19 -37.24 7.02 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 64.6 Cg_exo -51.81 -43.44 51.51 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.09 1.86 . . . . 0.0 113.081 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 71' ' ' LEU . 2.4 t -77.48 -51.27 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.962 0.411 . . . . 0.0 111.364 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -66.34 -32.13 56.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.343 -179.341 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.55 -29.67 59.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.847 0.356 . . . . 0.0 110.713 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -73.56 -53.24 11.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.74 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.711 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -78.4 -36.22 46.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.48 -179.417 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.602 ' N ' HD23 ' A' ' 126' ' ' LEU . 3.1 ttpm? -53.13 -42.51 66.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.084 0.469 . . . . 0.0 111.15 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -63.99 -11.63 30.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.684 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 126' ' ' LEU . 3.8 mp . . . . . 0 C--O 1.231 0.102 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.089 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.849 0.357 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -137.64 138.72 39.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.839 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 4' ' ' LEU . 1.4 pp -144.01 139.82 29.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.966 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.515 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.1 mt-30 -102.7 153.83 19.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.032 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.738 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.6 mp -146.02 128.42 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.9 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.069 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 124.56 42.44 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.163 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.568 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.6 m -117.9 158.41 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.362 0.601 . . . . 0.0 111.713 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.08 108.66 0.54 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.345 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -70.69 96.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.358 0.599 . . . . 0.0 110.051 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.668 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 1.4 tt -71.44 121.34 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.592 ' CG ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -94.93 144.83 25.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.695 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.958 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.7 p-10 -102.67 -173.28 2.29 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.595 0.712 . . . . 0.0 112.164 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.3 tm-20 -71.85 1.48 6.97 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.425 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -124.05 43.25 3.04 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.099 -0.376 . . . . 0.0 111.695 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 45.87 27.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.098 0.475 . . . . 0.0 111.163 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 6.3 mt-10 -114.83 161.4 18.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.794 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.722 HG22 HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -125.72 132.63 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.792 0.33 . . . . 0.0 111.347 -178.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE1' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -85.26 125.72 33.11 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.021 0.439 . . . . 0.0 110.629 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.848 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -122.19 122.81 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.08 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.575 HG22 ' CE1' ' A' ' 19' ' ' PHE . 19.7 p -71.01 111.96 6.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.818 0.342 . . . . 0.0 111.165 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.334 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.544 0.211 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.35 26.23 10.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.377 . . . . 0.0 111.671 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.848 HD21 ' HB ' ' A' ' 20' ' ' ILE . 5.5 tt -42.79 121.64 2.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.751 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' N ' HD23 ' A' ' 33' ' ' LEU . 3.9 mt-10 -140.69 -176.03 4.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.145 0.497 . . . . 0.0 111.972 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.864 ' CD2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.92 163.32 28.55 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.557 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.461 ' HD3' HG23 ' A' ' 21' ' ' THR . 19.3 Cg_endo -57.22 168.08 2.97 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.508 2.805 . . . . 0.0 111.801 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.22 59.67 0.76 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.01 -1.091 . . . . 0.0 113.788 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.27 126.07 5.27 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 114.556 -0.822 . . . . 0.0 112.19 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER 103.46 2.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.248 0.619 . . . . 0.0 112.305 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.069 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -51.5 -27.82 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.511 0.672 . . . . 0.0 110.754 179.401 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.577 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.44 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.016 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.4 mmm 33.75 -86.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.538 0.524 . . . . 0.0 111.841 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -164.3 27.57 0.21 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.565 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -95.62 -176.23 3.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.852 0.358 . . . . 0.0 111.138 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.912 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.81 155.75 38.49 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.235 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.912 ' HD2' HG22 ' A' ' 45' ' ' THR . 3.0 Cg_endo -44.74 -24.71 1.26 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.736 2.29 . . . . 0.0 112.608 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -95.21 -49.63 5.41 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -80.08 -24.15 40.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.719 0.295 . . . . 0.0 111.741 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.876 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -55.43 -47.41 76.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.001 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.754 HG12 ' CB ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.17 -47.89 23.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.823 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.7 t -56.76 -36.5 49.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.103 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -78.18 -50.66 11.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.9 mm-40 -66.9 -24.46 66.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.797 HD21 ' CE1' ' A' ' 64' ' ' HIS . 1.2 tp -51.8 -44.22 63.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.886 0.374 . . . . 0.0 110.272 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -33.93 75.01 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.58 -26.33 50.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.249 179.405 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mt-10 -108.14 5.17 25.65 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.99 HG12 HG13 ' A' ' 60' ' ' ILE . 17.7 t -134.6 -43.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.191 0.52 . . . . 0.0 109.741 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.587 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.52 -43.94 0.59 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.215 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.99 HG13 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.57 -177.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.094 0.473 . . . . 0.0 111.175 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -111.29 89.22 9.87 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.368 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.926 ' HG3' HG11 ' A' ' 58' ' ' VAL . 1.4 Cg_endo -108.7 156.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.864 2.376 . . . . 0.0 115.211 -176.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.426 ' HB2' ' CB ' ' A' ' 89' ' ' ARG . 75.8 mt-30 -77.93 80.17 4.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.797 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -127.07 124.24 38.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.669 -176.514 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.6 t80 -179.06 162.73 1.26 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.677 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER 83.84 155.77 0.1 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.943 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.7 pp -113.66 126.21 55.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.317 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.692 ' CE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -78.18 -36.75 47.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.253 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.06 162.03 7.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.469 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -143.08 132.14 23.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.889 0.376 . . . . 0.0 111.155 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.725 ' HB2' HG22 ' A' ' 122' ' ' VAL . 22.6 tp -119.01 121.98 41.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.648 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -120.91 109.95 15.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.685 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.415 ' HE1' HD12 ' A' ' 82' ' ' LEU . 3.3 p90 -141.04 150.85 43.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.649 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.4 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 3.9 pt-20 -121.19 122.28 39.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.097 0.475 . . . . 0.0 111.354 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.88 163.09 63.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.457 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.67 82.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.056 2.504 . . . . 0.0 112.149 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 14.3 t0 95.94 16.64 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.202 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -137.31 145.92 44.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.615 179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.4 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 1.4 t-80 -118.29 94.0 4.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 110.547 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.449 HG13 HD13 ' A' ' 6' ' ' ILE . 2.6 tt -103.08 111.8 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.195 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.413 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -105.85 122.44 46.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.377 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.738 HD23 ' HB ' ' A' ' 6' ' ' ILE . 32.3 mt -122.27 114.71 21.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.875 0.369 . . . . 0.0 111.367 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.464 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.9 m0 -104.89 122.51 45.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.749 ' CD2' HG11 ' A' ' 122' ' ' VAL . 2.9 m-85 -98.64 110.12 22.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.387 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.741 ' CE2' HG11 ' A' ' 50' ' ' VAL . 25.0 m95 -94.65 148.54 22.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.583 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.634 HD12 ' OE2' ' A' ' 88' ' ' GLU . 1.6 tm? -100.36 103.85 15.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.116 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.786 HG22 ' ND1' ' A' ' 64' ' ' HIS . 43.1 t -91.82 145.47 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.382 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.634 ' OE2' HD12 ' A' ' 86' ' ' LEU . 3.2 mm-40 -111.52 -29.52 7.73 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.16 165.5 24.44 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.182 0.901 . . . . 0.0 111.824 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.958 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.6 p90 -149.4 132.67 16.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.667 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -81.23 128.38 33.73 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.749 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.2 -116.05 4.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.442 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 33.0 mt-10 -135.06 141.04 36.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.556 0.217 . . . . 0.0 110.93 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.568 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.1 Cg_exo -76.51 128.88 10.61 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.894 2.396 . . . . 0.0 111.199 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.657 ' HE1' HG23 ' A' ' 60' ' ' ILE . 55.6 p-90 -136.8 -64.81 0.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.846 -0.742 . . . . 0.0 112.811 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.599 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 49.21 -100.36 0.03 OUTLIER Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.65 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER 175.71 42.2 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.709 0.29 . . . . 0.0 111.091 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.405 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.8 OUTLIER -59.53 -52.34 65.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.39 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 123.79 -11.06 8.38 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.723 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.47 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.9 OUTLIER -140.17 98.94 7.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 117.38 0.59 . . . . 0.0 111.995 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -44.06 140.21 5.41 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.751 2.301 . . . . 0.0 112.269 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.515 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.18 177.28 19.27 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.897 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -129.75 157.29 42.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.693 0.283 . . . . 0.0 110.624 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.87 106.42 6.39 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.867 0.365 . . . . 0.0 110.178 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.5 ptp -120.2 149.76 41.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.075 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.505 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -66.68 114.9 5.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.626 179.611 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.1 tm? -69.95 -18.92 63.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.321 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.564 ' O ' HD21 ' A' ' 129' ' ' LEU . 12.9 p -56.1 -17.86 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.519 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.34 45.39 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.619 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.664 HD12 HD21 ' A' ' 107' ' ' LEU . 8.6 tt -62.65 150.49 40.74 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.422 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.2 m-20 -119.26 127.43 53.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.641 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -14.89 61.88 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.496 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -48.97 15.21 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.397 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -35.21 79.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.847 0.356 . . . . 0.0 110.701 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.641 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -85.41 168.16 21.6 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.27 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.513 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.2 Cg_endo -67.54 127.71 16.89 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.263 1.976 . . . . 0.0 111.918 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.02 -19.17 63.64 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.539 2.159 . . . . 0.0 112.892 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.64 -9.33 58.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.512 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.4 m-80 -116.2 29.43 7.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.463 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.4 pt-20 -71.86 -31.92 1.94 Allowed Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 50.9 Cg_exo -53.89 -37.31 85.35 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 121.875 1.716 . . . . 0.0 112.567 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.749 HG11 ' CD2' ' A' ' 84' ' ' PHE . 22.7 t -77.35 -48.42 24.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.507 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.598 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.4 mm -67.44 -30.25 48.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.897 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.65 -28.33 46.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 0.0 110.317 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -48.26 16.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.428 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.692 HD13 ' CE2' ' A' ' 68' ' ' PHE . 7.8 tp -78.2 -30.42 48.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 0.0 111.499 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.473 ' HB2' HG22 ' A' ' 123' ' ' ILE . 10.5 ttpp -54.61 -42.55 71.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -72.96 -5.69 40.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.005 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.564 HD21 ' O ' ' A' ' 108' ' ' VAL . 1.3 mp . . . . . 0 CA--C 1.528 0.127 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.284 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.034 0 CA-C-O 120.872 0.368 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.94 143.38 49.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.878 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 4' ' ' LEU . 1.6 pp -141.84 137.0 31.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.773 ' C ' HD13 ' A' ' 6' ' ' ILE . 42.8 mt-30 -102.62 151.74 21.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.446 0.641 . . . . 0.0 112.392 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.773 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -142.38 128.19 17.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.476 179.026 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.052 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.55 125.06 43.57 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.323 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.586 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.3 m -120.7 162.37 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.424 0.63 . . . . 0.0 112.167 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.421 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.06 113.47 0.59 Allowed Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.587 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.574 HG22 HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.86 101.66 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.809 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.38 119.84 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.932 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.501 ' CG ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -101.74 150.88 22.69 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.236 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.662 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 8.4 p-10 -121.34 -173.97 2.74 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -56.45 -25.93 52.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.506 -1.224 . . . . 0.0 113.867 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -98.27 31.52 2.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.158 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 p30 49.12 23.21 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.182 0.515 . . . . 0.0 110.508 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -101.02 160.77 14.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.037 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.769 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -124.78 118.96 54.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.245 0.545 . . . . 0.0 111.943 -178.68 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.456 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 15.2 t80 -66.96 100.66 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.527 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.553 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -109.0 123.01 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.538 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.752 HG21 ' HG3' ' A' ' 98' ' ' GLU . 24.0 p -70.99 111.83 6.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.036 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.611 0.243 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.52 26.5 10.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.922 0.392 . . . . 0.0 111.7 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -47.55 113.51 0.71 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.0 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.77 177.04 8.03 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.152 0.501 . . . . 0.0 111.779 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -119.9 162.02 35.27 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.941 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 21' ' ' THR . 6.5 Cg_endo -48.16 167.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.812 3.008 . . . . 0.0 112.177 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 101.89 59.71 0.77 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.051 -1.071 . . . . 0.0 114.186 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -131.76 130.24 5.9 Favored Glycine 0 C--N 1.312 -0.798 0 CA-C-N 114.724 -0.738 . . . . 0.0 111.952 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.43 6.64 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.986 0.515 . . . . 0.0 112.037 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.052 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.53 -28.09 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.667 0.746 . . . . 0.0 110.192 179.202 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.586 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.61 -73.57 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.552 -1.203 . . . . 0.0 111.13 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 41' ' ' GLU . 1.0 OUTLIER 26.85 -85.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.562 0.539 . . . . 0.0 112.119 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.28 28.36 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.676 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.3 mp0 -97.44 -175.13 3.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.713 0.292 . . . . 0.0 111.192 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.922 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.23 160.74 25.48 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.358 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.922 ' HD2' HG22 ' A' ' 45' ' ' THR . 9.7 Cg_endo -49.3 -24.63 8.7 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.623 2.215 . . . . 0.0 112.316 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.1 mt-10 -99.14 -45.66 5.83 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -80.05 -23.81 41.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.667 0.27 . . . . 0.0 111.624 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.872 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -56.79 -47.56 79.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.021 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.685 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -78.25 -46.07 26.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.768 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.1 t -59.39 -36.81 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.174 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -78.15 -47.15 18.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.742 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.3 mt-10 -70.09 -20.83 63.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.736 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.997 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -51.36 -44.45 62.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.229 0.538 . . . . 0.0 109.602 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -32.21 73.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.937 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.48 -32.43 54.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.767 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.14 5.07 25.57 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.754 HG11 ' HG3' ' A' ' 62' ' ' PRO . 21.8 t -134.65 -44.23 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.44 . . . . 0.0 110.146 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.599 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.75 -45.32 0.39 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.449 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.763 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -77.97 152.34 5.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.494 ' H ' HD13 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -84.89 96.71 0.43 Allowed Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.49 -179.52 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.763 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 19.7 Cg_endo -113.72 148.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.699 0 C-N-CA 123.443 2.762 . . . . 0.0 114.163 -177.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -74.8 79.58 2.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.997 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -124.92 121.18 33.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.274 -176.708 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.1 t80 -178.64 169.08 1.73 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.096 0.474 . . . . 0.0 112.142 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.461 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 82.7 162.36 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.383 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 8.0 tt -105.47 131.84 52.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.611 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -98.59 -32.28 11.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.916 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.487 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -171.61 159.96 5.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.945 179.491 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HB3' HD11 ' A' ' 67' ' ' LEU . 2.6 ptpp? -143.48 132.08 22.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.726 0.298 . . . . 0.0 110.936 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.79 ' HB2' HG22 ' A' ' 122' ' ' VAL . 37.5 tp -118.9 120.41 37.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.639 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -115.97 109.82 18.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.697 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.561 ' HE1' HD12 ' A' ' 82' ' ' LEU . 2.1 p90 -141.14 145.85 36.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.612 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.11 121.7 38.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.132 0.492 . . . . 0.0 111.203 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -70.0 163.07 64.38 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.506 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.8 Cg_endo -51.85 83.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.063 2.509 . . . . 0.0 112.078 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 27.8 m-20 95.56 15.33 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.295 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.547 ' HE ' HD21 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -137.35 149.84 47.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.566 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -124.17 106.1 10.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 tt -111.35 112.33 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.429 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -98.42 118.64 35.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.415 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.561 HD12 ' HE1' ' A' ' 73' ' ' TYR . 6.7 mt -115.32 114.48 25.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.987 0.422 . . . . 0.0 111.764 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -108.99 122.56 47.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.315 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.547 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 2.6 m-85 -100.47 125.79 46.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.657 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.685 ' CE2' HG11 ' A' ' 50' ' ' VAL . 15.6 m95 -107.19 148.66 28.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 112.014 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.527 ' O ' HD12 ' A' ' 86' ' ' LEU . 2.0 pp -97.69 103.85 15.82 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.306 0.574 . . . . 0.0 111.446 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.995 HG22 ' ND1' ' A' ' 64' ' ' HIS . 41.2 t -84.83 144.76 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.229 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -32.24 7.88 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.73 165.02 26.08 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.56 -179.189 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.809 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.4 p90 -149.64 136.61 19.59 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.331 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.683 ' CB ' HD12 ' A' ' 60' ' ' ILE . 1.5 mt-10 -73.77 134.04 43.37 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.735 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 51.13 -107.85 0.46 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.86 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 21.8 mt-10 -135.56 142.11 39.82 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.49 0.186 . . . . 0.0 111.038 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.548 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.3 Cg_exo -76.05 128.57 10.77 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.459 2.106 . . . . 0.0 110.672 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.599 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 35.8 p-90 -124.6 -59.05 1.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.966 0.412 . . . . 0.0 111.861 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.59 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.01 -95.75 0.01 OUTLIER Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.875 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.71 37.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.72 0.295 . . . . 0.0 110.895 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.752 ' HG3' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -64.54 -44.88 89.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.189 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.77 -98.76 0.23 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.44 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -75.92 114.41 36.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.077 0.465 . . . . 0.0 112.248 -178.832 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -43.9 146.44 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.179 2.586 . . . . 0.0 112.648 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.449 ' CA ' ' CE2' ' A' ' 19' ' ' PHE . . . -123.37 177.07 16.68 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.966 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -138.98 157.53 45.83 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.494 ' CD1' ' HZ2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -72.24 105.99 4.24 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.928 0.394 . . . . 0.0 110.085 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.29 140.0 51.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.714 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.2 p -58.89 114.55 2.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 110.44 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.815 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.8 tm? -61.67 -18.84 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.311 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 108' ' ' VAL . 27.9 t -59.75 -12.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.331 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.11 37.63 3.68 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.284 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.558 ' HG ' HD21 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -62.11 123.63 18.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.503 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -123.07 128.65 50.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.251 0.548 . . . . 0.0 112.412 -179.084 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.636 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.26 -14.91 61.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.399 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.36 -49.41 13.63 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.737 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -31.0 70.94 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.877 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.636 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -90.5 172.28 7.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.095 179.823 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.504 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.7 Cg_endo -71.45 127.64 13.52 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.12 1.88 . . . . 0.0 111.666 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.8 -14.95 46.05 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.63 2.22 . . . . 0.0 113.153 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.56 -9.58 58.75 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.84 33.78 5.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 111.439 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.49 -34.95 2.01 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.308 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 74.2 Cg_exo -49.69 -45.57 31.01 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 121.87 1.713 . . . . 0.0 113.056 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.6 t -77.6 -51.31 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.987 0.422 . . . . 0.0 111.428 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.617 ' O ' HD23 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -64.89 -34.07 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.634 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 120' ' ' GLU . . . -54.93 -31.19 60.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.861 0.362 . . . . 0.0 110.79 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.05 -53.63 16.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.564 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.793 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -78.72 -30.02 45.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.726 0.298 . . . . 0.0 111.394 -179.556 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.793 ' N ' HD23 ' A' ' 126' ' ' LEU . 5.4 ttpm? -54.65 -42.51 71.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.025 0.44 . . . . 0.0 110.741 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -66.14 -10.51 41.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.624 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.221 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.878 0.37 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -74.0 124.24 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -133.65 143.52 48.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.821 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.3 pp -145.94 127.93 15.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.565 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 41.4 mt-30 -102.65 154.07 19.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.337 0.589 . . . . 0.0 112.282 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.461 HG13 " C2'" ' A' ' 131' ' ' 8OG . 27.2 mm -146.55 132.72 13.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.675 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.041 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.45 124.59 42.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.1 m -121.0 162.51 19.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.3 0.571 . . . . 0.0 111.994 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.422 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.2 113.05 0.56 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.738 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.064 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.78 107.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.714 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.2 mt -71.43 124.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.049 0.452 . . . . 0.0 111.68 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.76 124.01 32.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.43 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.488 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 52.0 t30 -79.19 -172.7 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.805 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.488 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.3 tp10 -82.62 2.9 31.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.469 -1.241 . . . . 0.0 112.084 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -135.95 50.32 2.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.797 0.332 . . . . 0.0 111.227 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 p30 45.5 26.68 0.33 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.385 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 13.6 pt-20 -120.39 141.7 49.86 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.064 HG21 HG22 ' A' ' 10' ' ' ILE . 17.6 mt -110.88 140.31 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.154 0.502 . . . . 0.0 111.716 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -89.42 122.6 32.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.689 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.602 HD13 HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -120.04 162.25 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.262 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.434 HG21 ' OE1' ' A' ' 98' ' ' GLU . 3.7 p -95.67 111.8 23.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.57 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 2.4 ptm180 -91.67 83.68 5.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.996 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 40.62 33.0 0.17 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.716 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.23 -79.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.113 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.08 -46.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.947 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.7 -83.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.794 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 46.6 38.8 6.03 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.787 0.327 . . . . 0.0 111.454 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 61.57 154.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.74 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 60.27 59.82 2.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.752 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.42 -8.67 52.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.811 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 29.81 0.91 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.556 0.217 . . . . 0.0 111.557 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 26.29 10.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.381 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.545 HD21 ' HB ' ' A' ' 20' ' ' ILE . 2.9 tt -46.84 96.11 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -114.49 -178.74 3.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.16 0.505 . . . . 0.0 111.711 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.546 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.6 164.23 22.98 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.432 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 19.8 Cg_endo -56.84 167.89 2.75 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.472 2.781 . . . . 0.0 112.012 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.18 59.47 0.76 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.613 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.17 126.79 5.12 Favored Glycine 0 C--N 1.313 -0.742 0 CA-C-N 114.581 -0.81 . . . . 0.0 112.101 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER 109.42 4.55 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.153 0.581 . . . . 0.0 112.125 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.041 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -58.65 -24.35 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.428 0.632 . . . . 0.0 110.791 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.565 ' HB3' ' H ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -49.83 -71.82 0.06 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.094 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.441 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER 23.54 -86.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.611 0.569 . . . . 0.0 112.252 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -159.7 23.82 0.29 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.787 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.24 -177.13 3.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.87 0.367 . . . . 0.0 111.026 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.891 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.68 157.47 38.31 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.872 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.891 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.79 -24.69 0.82 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.717 2.278 . . . . 0.0 112.413 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -85.57 -60.67 1.96 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.526 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -80.43 -21.49 42.11 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.84 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -56.73 -48.83 76.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.784 0.326 . . . . 0.0 111.095 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.736 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.4 -46.39 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.6 t -57.12 -36.56 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -78.29 -49.19 14.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.747 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.517 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.2 mm-40 -67.61 -20.0 65.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.992 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.797 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.3 tp -57.17 -44.64 83.72 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.866 0.365 . . . . 0.0 110.529 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -34.68 78.43 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.2 tm-20 -77.46 -24.09 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.873 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -108.47 5.15 25.0 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.096 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.949 HG12 HG13 ' A' ' 60' ' ' ILE . 38.5 t -134.65 -44.39 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.142 0.496 . . . . 0.0 109.836 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.99 -40.09 0.26 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.443 -0.798 . . . . 0.0 113.893 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.949 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.68 -176.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.009 0.433 . . . . 0.0 111.089 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.33 88.81 13.45 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.006 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.81 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.3 Cg_endo -110.57 145.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.362 2.708 . . . . 0.0 113.981 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 39.4 mt-30 -74.78 79.78 2.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.006 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.81 128.22 52.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.952 -176.252 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.4 t80 -179.34 167.89 1.49 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.76 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 14.6 m 84.51 149.14 0.07 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.544 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 pp -107.1 128.46 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.298 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.885 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -78.84 -41.29 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.252 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.502 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 10.3 tt0 -171.38 167.07 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.03 132.11 23.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 111.087 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.898 HD22 HG21 ' A' ' 122' ' ' VAL . 0.8 OUTLIER -116.18 122.3 44.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.001 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -120.62 109.78 15.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -141.13 149.26 41.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.674 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -121.23 120.52 35.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.125 0.488 . . . . 0.0 111.198 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.493 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -69.98 163.74 58.24 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.354 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -50.94 83.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.221 2.614 . . . . 0.0 112.39 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.7 t70 94.74 16.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.357 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 27.1 ttt180 -137.38 146.44 44.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.641 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -119.68 99.43 6.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.623 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.529 HD12 H2'' ' A' ' 131' ' ' 8OG . 4.9 tt -106.79 121.08 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.093 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.454 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -109.76 122.82 48.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.424 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.673 HD11 ' N3 ' ' A' ' 131' ' ' 8OG . 8.1 mt -126.04 114.97 19.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 111.347 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.467 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.6 m0 -107.82 122.52 46.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.796 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.754 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.4 m-30 -93.37 109.61 21.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.817 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.705 ' CE2' HG11 ' A' ' 50' ' ' VAL . 28.2 m95 -96.82 148.75 22.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.025 0.441 . . . . 0.0 112.083 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 65' ' ' PHE . 7.1 tp -97.58 138.22 35.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.542 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.006 HG22 ' ND1' ' A' ' 64' ' ' HIS . 39.4 t -124.02 146.04 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.37 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -110.52 -26.34 9.54 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.81 164.5 26.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.572 0.624 . . . . 0.0 111.548 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.71 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -157.37 123.48 4.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.381 178.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -73.88 147.2 43.45 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.67 -127.87 43.49 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.58 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 17.1 mt-10 -125.22 146.19 53.17 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.53 0.205 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.58 128.74 10.46 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.827 2.351 . . . . 0.0 111.471 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.552 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.3 p-90 -132.58 -58.19 0.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.669 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.11 -97.11 0.01 OUTLIER Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.923 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.99 31.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.693 0.282 . . . . 0.0 111.172 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.434 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -61.49 -40.78 95.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.78 0.324 . . . . 0.0 110.477 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.85 13.56 60.69 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.8 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -140.31 92.02 9.58 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 117.18 0.49 . . . . 0.0 111.509 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -43.63 132.76 7.54 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.982 2.454 . . . . 0.0 112.688 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.25 177.1 19.42 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.856 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -134.22 157.29 46.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.641 0.257 . . . . 0.0 110.624 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.2 106.97 3.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.844 0.354 . . . . 0.0 110.323 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 18' ' ' ILE . 3.6 ptp -119.95 147.33 44.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.171 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t -66.63 114.87 5.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.66 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -70.97 -28.71 64.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.914 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.432 HG12 HD21 ' A' ' 129' ' ' LEU . 21.5 t -53.25 -23.94 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.06 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.33 42.31 1.62 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.404 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' ' 111' ' ' ASN . 10.4 tt -62.56 150.16 41.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.64 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -116.22 127.67 54.96 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.596 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -14.98 61.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.512 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.44 -49.31 13.69 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.78 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -38.84 87.21 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 110.904 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.611 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.84 173.02 8.38 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.973 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 36.2 Cg_endo -65.7 127.79 18.67 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.087 1.858 . . . . 0.0 111.973 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.48 -21.18 53.59 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.576 2.184 . . . . 0.0 112.956 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.66 -9.59 57.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.85 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.438 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -118.77 34.26 5.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.179 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -75.15 -43.69 4.55 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 85.8 Cg_exo -44.77 -33.16 6.82 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.184 1.923 . . . . 0.0 112.567 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.898 HG21 HD22 ' A' ' 71' ' ' LEU . 49.4 t -77.62 -51.08 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.419 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.837 HG22 ' HB2' ' A' ' 127' ' ' LYS . 12.4 mm -66.25 -30.45 49.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.979 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.73 -27.18 38.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.945 0.403 . . . . 0.0 110.485 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -80.18 -51.34 9.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.69 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.885 HD22 ' CE2' ' A' ' 68' ' ' PHE . 13.0 tp -78.09 -34.61 50.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.818 0.342 . . . . 0.0 111.599 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.837 ' HB2' HG22 ' A' ' 123' ' ' ILE . 42.6 tttp -53.19 -42.72 66.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.08 0.467 . . . . 0.0 111.137 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -73.02 -4.17 30.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.05 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 127' ' ' LYS . 4.4 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.039 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.821 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 5011 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 5012 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ttm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.844 0.354 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.29 128.19 54.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.85 126.33 20.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.761 HD12 ' CD1' ' A' ' 6' ' ' ILE . 0.8 OUTLIER -130.41 136.65 49.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.707 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.77 ' C ' HD13 ' A' ' 6' ' ' ILE . 27.8 mt-30 -102.95 153.29 20.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.335 0.588 . . . . 0.0 112.146 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.832 HD12 " H2'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -146.04 124.64 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.795 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.097 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.74 125.26 43.77 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.743 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.588 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.5 m -115.77 162.09 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.426 0.631 . . . . 0.0 111.867 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.13 111.57 0.58 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.27 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.682 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.85 102.31 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.735 HG22 ' CE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.2 121.46 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 121.125 0.488 . . . . 0.0 111.659 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.469 ' HG2' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -91.29 132.81 35.9 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.629 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.669 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 2.4 p30 -89.04 -173.24 3.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.473 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 8.2 tt0 -79.61 8.93 5.59 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.686 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -132.25 47.17 2.55 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.141 -0.35 . . . . 0.0 111.691 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 45.06 25.94 0.19 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.087 0.47 . . . . 0.0 111.507 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.574 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 25.9 mt-10 -116.87 161.19 19.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.842 HD13 HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -118.8 135.68 58.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.052 0.453 . . . . 0.0 111.74 -178.27 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -85.78 109.86 18.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.994 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.609 HG22 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.5 140.18 44.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.106 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.423 ' O ' HD23 ' A' ' 33' ' ' LEU . 16.3 p -73.58 111.67 8.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.0 111.195 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.406 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -90.12 83.71 6.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.756 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 43.82 46.23 6.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.387 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 64.97 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.138 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.14 -80.58 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.198 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -177.25 37.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.68 -164.46 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.918 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.02 148.51 7.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.953 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.9 mtp 60.53 53.55 4.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.0 110.554 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.09 -8.82 48.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.904 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.05 30.9 0.9 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.613 0.244 . . . . 0.0 111.437 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -114.41 26.41 10.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 111.43 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -43.89 94.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.787 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -109.37 172.38 6.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.208 0.527 . . . . 0.0 112.076 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.609 ' HB3' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -119.63 163.58 26.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.57 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.402 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 26.3 Cg_endo -61.08 167.71 8.64 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.508 2.805 . . . . 0.0 112.03 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 101.99 59.53 0.77 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.73 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.619 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.15 118.66 2.46 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 114.552 -0.824 . . . . 0.0 111.999 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.619 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.31 2.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.185 0.594 . . . . 0.0 111.682 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.097 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -50.48 -28.92 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.57 0.7 . . . . 0.0 110.568 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.595 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.51 -79.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.964 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp 36.18 -85.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.5 0.5 . . . . 0.0 111.597 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.18 29.67 0.17 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.354 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.426 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 25.7 mp0 -97.32 -178.35 4.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.931 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.33 159.34 32.46 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.995 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.931 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.87 -24.71 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.784 2.322 . . . . 0.0 112.479 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -88.1 -61.22 1.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -80.54 -6.01 57.58 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.912 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.82 -55.13 29.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 110.884 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.916 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.5 m -78.22 -45.19 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.871 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.3 t -56.49 -41.47 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.128 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.32 -46.84 19.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.988 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -69.32 -21.66 63.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.034 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.743 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -55.43 -44.24 76.09 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.823 0.344 . . . . 0.0 110.12 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -34.86 73.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.8 -26.64 49.75 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.394 179.26 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.03 5.25 25.95 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.942 HG12 HG13 ' A' ' 60' ' ' ILE . 19.9 t -134.79 -44.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.244 0.545 . . . . 0.0 110.053 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.13 -41.27 0.35 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.602 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.942 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.7 -176.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 120.977 0.418 . . . . 0.0 111.038 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.66 88.82 14.33 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.885 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.86 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.2 Cg_endo -110.74 146.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 123.276 2.651 . . . . 0.0 114.35 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 15.9 mt-30 -74.69 80.03 2.04 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.014 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.55 131.9 54.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.549 -175.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.515 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -176.22 -136.97 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.391 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 51.76 172.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.213 0.53 . . . . 0.0 112.258 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.668 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.6 tt -136.97 115.89 12.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.454 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.69 -56.3 4.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.982 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.662 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 mt-10 -171.46 131.51 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.138 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.668 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -125.5 132.1 52.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.716 0.293 . . . . 0.0 110.679 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.708 HD22 ' N ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -124.22 168.29 13.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 110.857 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.708 ' N ' HD22 ' A' ' 71' ' ' LEU . 5.0 tt0 -140.16 123.62 17.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.568 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.9 p90 -141.02 148.61 40.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.279 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -120.98 128.39 52.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 111.487 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -86.48 162.86 44.12 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.193 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.5 Cg_endo -50.11 81.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.0 2.466 . . . . 0.0 112.31 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.4 t70 89.09 12.15 0.07 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.529 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -137.26 93.92 2.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.655 0.264 . . . . 0.0 110.938 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -77.15 108.73 10.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.854 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 2.7 tt -110.8 112.75 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.31 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -96.62 118.85 33.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.115 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.568 HD12 ' CE1' ' A' ' 73' ' ' TYR . 20.6 mt -112.01 114.15 26.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.888 0.375 . . . . 0.0 111.9 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.477 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 8.9 m0 -115.73 122.22 44.85 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.252 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.662 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 7.2 m-30 -106.15 123.08 47.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.97 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.916 ' NE1' HG11 ' A' ' 50' ' ' VAL . 31.5 m95 -105.13 149.0 26.25 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.611 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 86' ' ' LEU . 2.3 tm? -98.7 103.47 15.42 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.597 0.713 . . . . 0.0 112.332 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.014 HG22 ' ND1' ' A' ' 64' ' ' HIS . 20.9 t -82.76 145.85 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.899 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -114.01 -25.38 8.58 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -162.27 160.16 26.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.522 0.601 . . . . 0.0 111.49 -179.011 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.735 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -153.27 124.3 7.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.364 178.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -74.28 146.69 42.99 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.74 -130.99 51.3 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 37.9 mt-10 -121.32 144.79 40.74 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.572 0.225 . . . . 0.0 110.715 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.513 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.1 Cg_exo -76.66 128.74 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.934 2.422 . . . . 0.0 111.474 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.559 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.5 p-90 -135.23 -57.96 0.8 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.715 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.595 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.13 -94.56 0.01 OUTLIER Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.005 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 56' ' ' GLU . 4.7 tmtt? -177.23 32.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.767 0.317 . . . . 0.0 111.01 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.448 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 8.4 pt-20 -70.78 -38.65 73.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.342 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.81 21.25 63.96 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.337 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.448 ' NE2' ' O ' ' A' ' 98' ' ' GLU . 2.8 mt-30 -140.23 91.85 9.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.022 0.439 . . . . 0.0 111.448 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -44.02 137.03 7.31 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.975 2.45 . . . . 0.0 112.626 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.16 177.05 19.44 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.874 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -145.07 157.38 44.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.583 0.23 . . . . 0.0 110.538 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.445 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.6 m0 -62.15 106.62 0.75 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.332 . . . . 0.0 110.474 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.445 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.05 147.34 44.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.67 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.04 114.7 12.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.801 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.842 HD22 HD13 ' A' ' 18' ' ' ILE . 30.1 tp -80.15 -18.92 48.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.0 t -50.59 -23.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.535 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.61 48.04 0.98 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.481 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.657 ' HB2' HD12 ' A' ' 107' ' ' LEU . 9.3 tt -62.62 150.22 41.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.63 0.253 . . . . 0.0 110.47 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.02 135.19 54.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.169 0.509 . . . . 0.0 112.163 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.553 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.08 -15.25 62.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.493 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.98 -49.24 13.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.512 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -33.73 76.12 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.262 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.553 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -84.94 174.05 6.31 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.316 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.474 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.6 Cg_endo -71.05 127.8 14.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.05 1.833 . . . . 0.0 111.764 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.91 -15.02 46.68 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.606 2.204 . . . . 0.0 113.226 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.75 -9.63 58.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.608 HD21 ' HZ ' ' A' ' 84' ' ' PHE . 1.5 m-20 -122.08 32.72 5.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.7 0.286 . . . . 0.0 111.303 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.523 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -76.18 -39.19 2.57 Favored Pre-proline 0 C--O 1.223 -0.305 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.049 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 89.4 Cg_exo -44.9 -39.94 14.53 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 121.924 1.749 . . . . 0.0 113.024 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.626 HG22 ' CD1' ' A' ' 71' ' ' LEU . 2.4 t -77.53 -51.03 19.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.999 0.428 . . . . 0.0 110.924 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.547 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.0 mm -64.89 -32.13 56.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.405 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.74 -29.89 54.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.034 0.445 . . . . 0.0 110.497 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -76.49 -49.57 16.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.494 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 126' ' ' LEU . 2.6 tm? -78.18 -31.37 49.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.672 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 123' ' ' ILE . 2.9 ttpm? -54.07 -42.62 69.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.028 0.442 . . . . 0.0 111.01 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -69.99 -7.88 44.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.911 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 127' ' ' LYS . 1.6 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.219 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.832 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 5023 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 5024 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.824 0.345 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.41 107.52 17.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 146.76 28.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.933 HD13 " O3'" ' A' ' 131' ' ' 8OG . 1.7 pp -145.97 134.85 22.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.024 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.449 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 26.1 mt-30 -102.85 151.67 22.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.306 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.495 HG13 " C2'" ' A' ' 131' ' ' 8OG . 21.3 mm -146.64 129.39 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.981 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.085 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.68 125.05 43.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.556 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.592 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.5 m -118.07 161.45 16.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.249 0.547 . . . . 0.0 111.788 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.3 112.1 0.53 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.853 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.475 ' CG2' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -74.45 105.48 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.706 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.1 mt -71.74 124.83 29.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.12 0.486 . . . . 0.0 112.018 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.461 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -93.72 135.57 34.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.22 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.657 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.5 p30 -92.74 -173.45 3.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.905 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -75.31 -1.22 22.63 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.83 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -119.5 41.24 3.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.442 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p30 46.9 25.16 0.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.082 0.468 . . . . 0.0 111.201 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.552 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 25.1 mt-10 -114.44 160.94 18.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.751 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -116.85 138.64 46.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.078 0.466 . . . . 0.0 112.019 -178.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.476 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -82.27 99.84 9.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.79 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -116.52 115.41 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.499 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.625 HG21 ' HB2' ' A' ' 100' ' ' GLN . 9.0 t -76.45 123.43 26.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.848 0.356 . . . . 0.0 111.009 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -86.21 83.82 7.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.624 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 46.17 49.53 12.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.173 0.511 . . . . 0.0 110.954 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . 67.45 -86.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.199 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 24' ' ' ALA . . . 179.22 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.74 0.305 . . . . 0.0 111.26 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -70.04 65.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.938 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 51.14 -92.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.341 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 m80 44.8 48.78 9.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.811 0.339 . . . . 0.0 111.22 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 mtt 63.09 92.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.654 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.05 -12.16 47.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.755 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.52 13.3 10.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.6 26.3 10.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.941 0.401 . . . . 0.0 111.698 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -48.28 117.86 2.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.856 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.404 ' N ' HD23 ' A' ' 33' ' ' LEU . 32.7 mm-40 -145.06 171.55 14.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.953 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.762 ' CD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.42 167.85 11.26 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 121.004 0.431 . . . . 0.0 111.934 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.4 Cg_endo -47.46 168.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.862 3.041 . . . . 0.0 112.694 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.07 59.99 0.72 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.851 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -131.83 132.62 6.8 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 114.391 -0.905 . . . . 0.0 112.14 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.8 ttmm 92.3 10.47 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.023 0.529 . . . . 0.0 112.388 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.085 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -56.79 -28.27 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.673 0.749 . . . . 0.0 109.993 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.83 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.896 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.98 -84.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.516 0.51 . . . . 0.0 111.709 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.44 32.74 0.1 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.57 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.481 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.3 mt-10 -93.21 -173.72 3.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.698 0.285 . . . . 0.0 111.194 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.878 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.19 154.02 37.85 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.316 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.878 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.99 -24.87 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.819 2.346 . . . . 0.0 112.494 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -103.62 -41.76 5.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.828 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -80.3 -13.6 59.06 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.032 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.05 -52.95 62.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.752 0.31 . . . . 0.0 111.094 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.719 HG11 ' NE1' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -78.28 -44.64 27.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.921 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.2 t -55.87 -42.71 71.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.538 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -78.3 -49.94 12.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.916 0.388 . . . . 0.0 111.269 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -68.4 -20.01 64.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.254 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.67 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -56.71 -45.06 82.07 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 110.103 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -31.88 71.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -76.75 -25.35 53.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.981 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.447 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -106.42 6.59 30.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.544 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.967 HG13 HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -133.45 -44.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.135 0.493 . . . . 0.0 109.793 179.576 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.537 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.67 -37.17 0.17 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.553 -0.749 . . . . 0.0 114.65 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.967 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -85.06 -174.32 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.889 0.376 . . . . 0.0 110.796 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.11 88.59 12.52 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.469 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.642 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.7 Cg_endo -111.13 145.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.471 2.78 . . . . 0.0 113.886 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 11.5 mt-30 -74.86 79.82 2.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.013 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.07 127.43 51.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.596 -176.504 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 86' ' ' LEU . 17.4 t80 179.85 168.15 1.22 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 82.28 149.83 0.09 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.696 179.471 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -105.69 128.76 53.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 111.077 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' HE2' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -80.5 -38.36 29.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.426 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 2.0 tt0 -171.29 160.65 6.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.336 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -143.25 132.2 22.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.968 0.414 . . . . 0.0 111.233 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.672 ' HB2' HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -117.11 130.2 56.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.431 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -123.15 109.97 14.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.562 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -141.17 150.58 42.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.731 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.26 123.09 41.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.125 0.488 . . . . 0.0 111.121 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.473 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -69.99 163.15 63.61 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.46 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.8 Cg_endo -52.36 82.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.028 2.485 . . . . 0.0 112.097 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 8.8 t70 96.19 15.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.152 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -137.35 149.91 47.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.635 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -120.35 93.98 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.453 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.527 HD12 H2'' ' A' ' 131' ' ' 8OG . 4.6 tt -100.56 111.94 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.23 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.3 118.73 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.24 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 122' ' ' VAL . 5.5 tp -110.84 114.25 27.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 111.336 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -110.34 122.49 47.82 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.547 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.42 ' HA ' HG22 ' A' ' 8' ' ' VAL . 2.8 m-30 -105.37 109.82 21.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.174 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.719 ' NE1' HG11 ' A' ' 50' ' ' VAL . 35.0 m95 -99.39 148.67 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.013 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 65' ' ' PHE . 31.2 tp -96.54 138.6 33.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.571 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.013 HG22 ' ND1' ' A' ' 64' ' ' HIS . 35.1 t -123.61 145.35 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.237 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.66 -24.48 9.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.8 tpt180 -162.86 162.39 26.39 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.574 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.706 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.09 123.92 5.09 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.214 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.45 146.17 40.91 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.251 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.3 -126.73 43.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.723 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' ILE . 22.7 mt-10 -125.15 143.74 45.19 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 110.486 -0.19 . . . . 0.0 110.486 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.425 ' HA ' ' CG1' ' A' ' 60' ' ' ILE . 3.9 Cg_exo -76.48 128.64 10.48 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.713 2.275 . . . . 0.0 111.434 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.537 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 64.3 p-90 -131.93 -56.69 0.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.787 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.593 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.92 -95.04 0.01 OUTLIER Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.111 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -179.1 33.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.653 0.263 . . . . 0.0 111.196 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -76.8 -37.1 56.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.98 0.419 . . . . 0.0 110.243 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.13 30.1 51.85 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.101 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.625 ' HB2' HG21 ' A' ' 21' ' ' THR . 5.0 mt-30 -140.35 91.63 9.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.055 0.455 . . . . 0.0 111.503 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -47.59 133.55 21.21 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.096 2.531 . . . . 0.0 112.428 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.07 177.09 19.4 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.914 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 105' ' ' MET . 2.6 mt-10 -142.5 157.81 44.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.539 0.209 . . . . 0.0 110.491 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.491 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.3 m0 -66.63 106.59 1.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 2.9 mmm -119.89 148.19 43.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.944 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.04 114.78 8.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.8 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.751 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -67.0 -28.28 68.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.828 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.1 p -55.49 -22.79 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -109.84 34.38 5.49 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.497 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.52 HD13 HD22 ' A' ' 107' ' ' LEU . 9.6 tp -62.78 139.52 58.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.03 131.26 53.63 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.4 -15.14 61.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.547 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -78.62 -49.44 13.21 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.703 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -35.75 79.74 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 111.225 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.92 174.13 6.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.127 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.499 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 53.7 Cg_endo -70.11 127.75 14.75 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.026 1.818 . . . . 0.0 111.705 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.93 -15.04 46.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.6 2.2 . . . . 0.0 113.085 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.19 -9.46 58.74 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.485 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -120.37 31.91 6.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.747 0.308 . . . . 0.0 111.426 -178.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -73.14 -36.28 3.19 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.621 ' HB2' HD13 ' A' ' 71' ' ' LEU . 70.4 Cg_exo -50.98 -44.97 39.04 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 121.92 1.747 . . . . 0.0 112.699 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.8 t -77.41 -51.21 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 111.097 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.587 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.8 mm -62.83 -32.9 57.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.232 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.02 -33.72 62.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.08 0.467 . . . . 0.0 110.553 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -66.84 -49.65 65.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.843 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 126' ' ' LEU . 0.7 OUTLIER -78.14 -26.07 47.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.144 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.455 ' O ' HD12 ' A' ' 129' ' ' LEU . 3.1 ttpm? -58.21 -42.6 86.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.002 0.43 . . . . 0.0 110.778 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.6 ttm-85 -73.86 -5.32 40.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.953 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.828 HD21 ' O ' ' A' ' 108' ' ' VAL . 1.7 mp . . . . . 0 N--CA 1.461 0.095 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.325 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.933 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 5035 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 5036 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mtt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.808 0.337 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -89.54 138.52 31.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.97 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.27 37.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.922 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.9 pp -145.98 122.53 11.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.7 mt-30 -102.69 148.38 25.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.347 0.594 . . . . 0.0 111.888 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.557 ' HB ' HD23 ' A' ' 82' ' ' LEU . 31.5 mm -146.48 130.77 10.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.833 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.093 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.43 124.46 42.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.608 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -118.63 162.94 16.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.235 0.54 . . . . 0.0 111.933 -179.387 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.0 112.83 0.55 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.402 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.976 ' CG2' HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -70.79 105.68 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.389 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.852 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.2 mt -71.54 124.0 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.438 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -85.28 126.86 34.04 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.456 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 24.8 t-20 -70.43 177.37 3.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.119 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.528 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 8.8 tt0 -56.62 -18.58 12.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.404 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -120.55 -82.74 0.65 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.615 0.245 . . . . 0.0 111.243 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.73 15.54 0.36 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.616 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 3.6 mt-10 -100.93 160.39 14.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.976 HG21 ' CG2' ' A' ' 10' ' ' ILE . 3.4 mt -138.12 140.72 39.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.014 0.435 . . . . 0.0 111.609 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -89.75 116.46 27.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.375 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.61 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -113.36 125.59 70.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.419 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.827 HG21 ' HG3' ' A' ' 98' ' ' GLU . 15.0 p -75.46 111.85 11.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.82 0.343 . . . . 0.0 110.495 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' ALA . 45.3 ttp180 -96.86 170.36 9.22 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 7.7 tpt180 -69.84 59.96 0.16 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.165 0.507 . . . . 0.0 109.95 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . 58.32 -171.32 0.11 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.278 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.03 -71.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.145 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -160.49 155.35 24.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.975 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -175.52 -76.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -145.39 -62.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.763 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.6 ptp -94.32 52.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.735 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . . . -73.05 -8.65 56.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.654 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -92.32 29.37 1.69 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.563 0.221 . . . . 0.0 111.476 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -114.54 26.32 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 111.585 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.61 HD21 ' HB ' ' A' ' 20' ' ' ILE . 2.7 tt -45.42 122.71 3.67 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.812 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.573 ' N ' HD23 ' A' ' 33' ' ' LEU . 53.6 mt-10 -145.96 -175.32 4.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.894 0.378 . . . . 0.0 111.443 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.608 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.07 162.09 35.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.239 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.685 ' HD3' HG23 ' A' ' 21' ' ' THR . 10.3 Cg_endo -50.09 167.91 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.387 2.725 . . . . 0.0 111.715 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.23 59.47 0.76 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.825 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.615 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.54 120.01 2.74 Favored Glycine 0 C--N 1.312 -0.78 0 CA-C-N 114.791 -0.705 . . . . 0.0 112.023 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.615 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 114.09 3.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.313 0.645 . . . . 0.0 111.937 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.093 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -53.64 -26.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.43 0.633 . . . . 0.0 110.569 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.12 -82.62 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.143 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 34.87 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.39 0.432 . . . . 0.0 111.886 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.89 31.24 0.14 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.623 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.455 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -91.24 -174.38 3.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.75 0.31 . . . . 0.0 111.189 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.888 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.68 154.85 36.94 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.352 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.888 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.8 Cg_endo -44.53 -24.86 1.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.735 2.29 . . . . 0.0 112.603 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.741 ' O ' HG23 ' A' ' 51' ' ' VAL . 11.6 mt-10 -102.2 -42.91 5.88 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -80.22 -16.07 55.6 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.916 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.08 -50.49 73.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.146 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.761 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -78.1 -45.11 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.798 0.332 . . . . 0.0 110.884 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.2 t -53.71 -37.92 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -51.99 9.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.018 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.8 mm-40 -63.97 -22.07 66.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.907 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.762 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.0 OUTLIER -56.47 -44.62 80.75 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.979 0.419 . . . . 0.0 110.409 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -62.96 -34.64 77.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.6 tm-20 -77.47 -25.0 50.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.14 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.453 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 69.2 mm-40 -108.15 5.36 25.82 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.953 HG12 HG13 ' A' ' 60' ' ' ILE . 31.4 t -134.71 -44.26 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.183 0.516 . . . . 0.0 109.793 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.83 -41.1 0.32 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.711 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.953 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.66 -176.53 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.016 0.436 . . . . 0.0 111.057 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.04 88.87 12.76 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.991 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.852 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.1 Cg_endo -109.48 145.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.287 2.658 . . . . 0.0 113.917 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 11.8 mt-30 -74.78 79.76 2.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.996 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.81 128.06 52.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.926 -176.222 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.7 t80 -179.22 168.46 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 111.991 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.3 p 83.07 158.0 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.827 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -110.83 137.9 47.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -94.92 -32.46 13.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.264 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.491 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 17.8 tt0 -171.38 155.57 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.51 132.03 22.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.711 0.291 . . . . 0.0 110.95 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.068 HD22 HG21 ' A' ' 122' ' ' VAL . 2.5 pt? -129.19 132.36 47.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.851 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -127.28 109.93 12.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.558 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.444 ' OH ' HD12 ' A' ' 82' ' ' LEU . 3.0 p90 -132.24 153.04 51.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.491 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -118.74 138.61 52.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.158 0.504 . . . . 0.0 111.406 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -98.81 163.06 19.59 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.209 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 6.0 Cg_endo -48.09 81.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.11 2.54 . . . . 0.0 112.342 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 m-20 85.61 13.55 0.18 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.586 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.564 ' NE ' HD21 ' A' ' 4' ' ' LEU . 8.9 ttt180 -137.44 93.83 2.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 0.0 110.998 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -75.02 112.47 11.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.573 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.428 HD13 ' OH ' ' A' ' 73' ' ' TYR . 3.7 tt -109.7 112.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.325 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.411 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -102.11 124.03 47.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.241 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.656 HD21 ' N3 ' ' A' ' 131' ' ' 8OG . 20.6 mt -126.02 114.93 19.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.863 0.364 . . . . 0.0 111.607 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.411 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.4 m0 -106.48 122.48 46.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.523 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.3 m-85 -99.07 109.66 22.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.211 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.68 ' NE1' HG11 ' A' ' 50' ' ' VAL . 25.5 m95 -97.24 148.66 22.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.19 0.519 . . . . 0.0 112.358 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 65' ' ' PHE . 25.0 tp -95.94 138.68 33.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.132 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.996 HG22 ' ND1' ' A' ' 64' ' ' HIS . 33.2 t -123.47 145.88 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.459 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.3 -24.59 9.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 5.4 tpt180 -162.64 162.43 27.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.548 0.613 . . . . 0.0 111.544 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.744 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -155.08 124.91 6.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.24 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.43 148.32 39.22 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.33 -129.27 43.21 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.54 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 49.3 mt-10 -122.73 144.16 41.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.573 0.225 . . . . 0.0 110.678 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.51 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.43 128.72 10.57 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.778 2.319 . . . . 0.0 111.493 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.555 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -132.41 -58.02 0.94 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.649 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.536 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.72 -99.61 0.02 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.924 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 175.0 38.49 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.6 0.238 . . . . 0.0 111.209 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.827 ' HG3' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -70.53 -11.73 61.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.714 0.292 . . . . 0.0 111.253 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.74 20.17 68.03 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.378 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.426 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 8.1 mm-40 -140.48 97.51 7.48 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.84 0.352 . . . . 0.0 111.384 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.62 132.71 7.53 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.836 2.357 . . . . 0.0 112.51 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.05 177.12 19.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.823 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -149.49 157.27 43.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.529 0.204 . . . . 0.0 110.516 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -71.24 106.78 3.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.824 0.345 . . . . 0.0 110.116 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.3 ptp -119.86 152.06 37.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.724 ' HB2' HG12 ' A' ' 108' ' ' VAL . 23.2 p -75.26 114.89 14.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.606 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.966 HD12 HD13 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -57.92 -20.56 38.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.24 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.724 HG12 ' HB2' ' A' ' 106' ' ' SER . 9.9 p -52.67 -21.24 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.48 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.36 31.92 8.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.678 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.96 HD23 ' CD2' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -62.51 126.97 29.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.64 0.257 . . . . 0.0 110.324 179.684 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.728 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -123.33 130.63 52.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.331 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.17 -14.7 61.88 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.146 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -78.31 -49.01 14.43 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.617 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -39.8 88.33 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.75 0.309 . . . . 0.0 110.913 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -79.06 172.1 10.78 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.995 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.534 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.7 Cg_endo -70.77 127.33 13.65 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 121.976 1.784 . . . . 0.0 111.404 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.57 -14.84 42.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.617 2.212 . . . . 0.0 113.275 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.65 -9.32 58.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.98 36.7 4.55 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -69.75 -41.03 14.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.2 Cg_exo -55.23 -40.58 84.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.052 1.835 . . . . 0.0 112.625 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 1.068 HG21 HD22 ' A' ' 71' ' ' LEU . 5.5 t -77.44 -51.26 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.548 . . . . 0.0 110.793 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.533 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -66.12 -29.87 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.187 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.85 -31.97 60.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.049 0.452 . . . . 0.0 110.226 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -52.35 57.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.886 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 68' ' ' PHE . 3.1 tp -78.12 -29.81 49.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.24 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -55.98 -42.56 76.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.831 ' O ' HD12 ' A' ' 129' ' ' LEU . 51.7 ttp180 -74.22 -4.78 38.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.115 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.189 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.922 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 5047 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 5048 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 mtt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.774 0.321 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -79.93 133.34 36.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.03 131.91 27.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.912 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.0 pp -146.17 118.98 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 28.7 mt-30 -101.91 156.76 17.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.265 0.555 . . . . 0.0 112.219 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.869 HD11 HD12 ' A' ' 4' ' ' LEU . 1.7 mp -146.19 130.76 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.575 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.027 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.44 124.43 42.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -127.99 158.36 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.915 0.388 . . . . 0.0 111.724 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.443 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.25 137.5 6.06 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.966 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.024 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -86.22 111.97 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.729 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.5 mt -71.68 123.74 26.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.54 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -84.32 122.77 29.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.484 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.482 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 50.3 t30 -79.65 -172.69 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.855 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.482 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -82.74 0.61 42.75 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.935 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -136.98 50.58 2.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.911 0.386 . . . . 0.0 111.241 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.51 26.38 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.263 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 16.1 pt-20 -116.82 153.25 32.8 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.024 HG21 HG22 ' A' ' 10' ' ' ILE . 5.2 mt -130.36 142.17 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 0.0 111.588 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.91 123.16 35.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.854 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.687 HD11 ' HG2' ' A' ' 105' ' ' MET . 0.5 OUTLIER -113.69 124.77 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.531 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 21' ' ' THR . 1.6 t -72.44 111.71 7.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 0.0 110.718 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.439 ' HA ' HD23 ' A' ' 33' ' ' LEU . 20.3 ptt180 -95.45 172.07 8.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.859 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.557 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -62.87 -12.2 23.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 78.5 0.57 2.58 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.813 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 30' ' ' ALA . . . 50.03 29.69 3.64 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.785 0.326 . . . . 0.0 111.433 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -87.84 75.25 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.949 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 57.18 31.31 19.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.178 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -141.3 178.65 7.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.6 mtt -59.97 91.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 25' ' ' ALA . . . -71.35 -8.91 56.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.641 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 31' ' ' ASN . 2.7 t30 -93.19 23.4 4.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.575 0.226 . . . . 0.0 111.458 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.33 26.2 10.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 111.394 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.638 HD11 HD13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -43.35 116.55 0.95 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.403 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -170.85 2.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.24 0.543 . . . . 0.0 112.056 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.51 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.77 165.69 16.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.097 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 47.5 Cg_endo -67.7 167.51 20.91 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.087 2.525 . . . . 0.0 111.533 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.09 59.13 0.77 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.806 -1.188 . . . . 0.0 113.914 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -123.39 127.32 6.56 Favored Glycine 0 C--N 1.311 -0.828 0 CA-C-N 114.841 -0.68 . . . . 0.0 112.021 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER 100.39 6.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.142 0.577 . . . . 0.0 112.211 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.027 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -50.34 -29.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.744 0.783 . . . . 0.0 110.118 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.582 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.86 -81.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.22 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.6 mmt 40.16 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.269 0.356 . . . . 0.0 111.548 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.0 29.83 0.14 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.669 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -95.07 -173.31 2.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.736 0.303 . . . . 0.0 111.122 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.912 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.95 158.01 34.12 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.37 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.912 ' HD2' HG22 ' A' ' 45' ' ' THR . 5.9 Cg_endo -46.74 -24.71 3.14 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.668 2.245 . . . . 0.0 112.375 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.755 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mm-40 -101.54 -44.19 5.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.888 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -80.19 -12.63 59.62 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.951 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -60.54 -54.02 50.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 0.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.807 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.0 OUTLIER -78.14 -44.21 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.587 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.7 t -50.52 -37.77 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.37 . . . . 0.0 110.805 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -78.6 -49.49 13.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.791 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.0 -19.83 66.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.036 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.814 HD21 ' NE2' ' A' ' 64' ' ' HIS . 2.7 tp -59.53 -44.71 93.11 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.18 -34.21 77.55 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 97' ' ' LYS . 5.5 tm-20 -77.35 -24.13 50.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.832 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.484 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 50.3 mm-40 -108.29 5.66 25.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.911 HG12 HG13 ' A' ' 60' ' ' ILE . 41.7 t -134.2 -44.27 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.166 0.508 . . . . 0.0 109.656 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.541 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.89 -39.74 0.25 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.397 -0.819 . . . . 0.0 113.994 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.911 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.7 -177.43 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.018 0.437 . . . . 0.0 111.026 -179.449 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.83 88.54 14.31 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.807 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.758 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.0 Cg_endo -111.71 145.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 123.406 2.737 . . . . 0.0 113.994 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 36.7 mt-30 -74.86 79.63 2.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 175.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.994 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -120.11 128.67 53.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.832 -176.432 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.8 t80 -179.51 168.71 1.42 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.981 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER 83.91 155.66 0.1 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.675 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -113.84 123.11 49.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.212 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.83 -38.19 54.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.074 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -171.3 141.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.349 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.46 132.18 22.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.671 0.272 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.745 HD23 HG22 ' A' ' 122' ' ' VAL . 4.4 pp -124.46 164.69 19.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.315 . . . . 0.0 110.954 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -139.77 116.91 11.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.802 ' OH ' HD11 ' A' ' 80' ' ' ILE . 2.2 p90 -141.15 153.07 45.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 6.8 pt-20 -118.34 124.28 47.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 111.319 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.0 163.22 61.32 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.477 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.487 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -52.8 82.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.989 2.459 . . . . 0.0 112.19 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 7.7 t0 90.92 10.73 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.479 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.449 ' CD ' HD21 ' A' ' 4' ' ' LEU . 6.6 ttp180 -137.36 95.89 3.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.294 . . . . 0.0 110.809 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.414 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.8 t-80 -80.4 106.58 12.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.263 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.802 HD11 ' OH ' ' A' ' 73' ' ' TYR . 3.6 pt -120.39 127.09 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.131 0.491 . . . . 0.0 112.119 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.26 118.68 34.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.041 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.679 HD21 ' OD1' ' A' ' 119' ' ' ASN . 4.4 tp -104.78 113.7 27.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 110.965 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.402 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 9.6 m0 -115.58 122.52 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.053 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.705 ' CD2' HG11 ' A' ' 122' ' ' VAL . 3.1 m-30 -105.32 109.68 21.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.702 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.807 ' CE2' HG11 ' A' ' 50' ' ' VAL . 66.0 m95 -94.85 148.67 22.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.307 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 65' ' ' PHE . 65.6 tp -94.52 138.28 32.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.917 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.994 HG22 ' ND1' ' A' ' 64' ' ' HIS . 27.0 t -123.96 145.81 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.418 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -112.82 -24.57 9.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.477 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -162.79 160.73 25.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.595 0.634 . . . . 0.0 111.484 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.701 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.19 121.66 4.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.164 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -77.21 155.31 32.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.214 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.37 -132.78 46.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.619 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.2 mt-10 -122.2 147.06 48.44 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.577 0.227 . . . . 0.0 110.694 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.51 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.62 128.64 10.36 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.85 2.367 . . . . 0.0 111.353 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.541 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 63.4 p-90 -136.59 -58.84 0.73 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.892 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.59 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.49 -96.4 0.01 OUTLIER Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.939 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.7 tmtt? 177.67 33.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.584 0.231 . . . . 0.0 111.173 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -29.01 68.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.7 0.286 . . . . 0.0 110.679 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.91 -2.12 71.91 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.719 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -140.12 95.46 8.43 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.259 0.529 . . . . 0.0 111.556 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -43.71 141.04 4.19 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.909 2.406 . . . . 0.0 112.497 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.23 171.56 22.14 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.871 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.55 157.17 39.5 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.53 106.44 6.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.898 0.38 . . . . 0.0 110.523 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.687 ' HG2' HD11 ' A' ' 20' ' ' ILE . 5.1 ppp? -120.28 155.87 32.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.041 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.2 t -70.3 114.93 8.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.579 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.625 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.51 -18.98 60.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.341 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.651 ' O ' HD21 ' A' ' 129' ' ' LEU . 15.5 t -57.45 -16.88 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.458 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.06 43.54 1.43 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.432 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.601 HD22 HD11 ' A' ' 107' ' ' LEU . 12.7 tp -62.4 146.98 49.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.11 126.81 47.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.6 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.33 -15.16 61.88 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.733 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.456 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 5.9 t70 -78.28 -49.39 13.77 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -39.03 87.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.982 0.42 . . . . 0.0 110.857 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -80.11 173.82 7.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.341 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.2 Cg_endo -72.26 127.76 13.04 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.162 1.908 . . . . 0.0 111.697 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.89 -14.95 44.24 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 113.061 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.42 58.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.679 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.1 m-80 -121.67 32.6 5.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.695 0.283 . . . . 0.0 111.488 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.454 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.3 mt-10 -73.77 -46.88 6.98 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 80.9 Cg_exo -44.8 -35.05 9.19 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.33 2.02 . . . . 0.0 112.525 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.745 HG22 HD23 ' A' ' 71' ' ' LEU . 12.5 t -77.35 -43.39 30.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.066 0.46 . . . . 0.0 110.127 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.785 HG22 ' HB2' ' A' ' 127' ' ' LYS . 15.5 mm -67.65 -34.41 67.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.888 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.4 -26.61 31.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.983 0.421 . . . . 0.0 110.465 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.13 -52.72 7.44 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.712 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.16 -33.48 50.25 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.725 0.298 . . . . 0.0 111.519 -179.13 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.843 ' N ' HD23 ' A' ' 126' ' ' LEU . 6.0 ttpm? -53.57 -42.67 67.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.969 0.414 . . . . 0.0 111.058 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -69.37 -7.92 41.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.87 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.651 HD21 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.33 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.912 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 5059 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 5060 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 mtm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.795 0.331 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.22 131.53 41.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.768 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -140.08 131.65 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.847 HD21 ' NE ' ' A' ' 78' ' ' ARG . 3.4 pp -126.02 127.53 46.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.837 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -102.96 152.2 21.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.182 0.515 . . . . 0.0 111.255 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.858 ' HB ' HD23 ' A' ' 82' ' ' LEU . 2.7 mp -143.9 139.02 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.355 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.978 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -125.16 125.46 43.73 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -134.53 151.43 31.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.363 0.602 . . . . 0.0 111.833 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.46 122.11 1.3 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.907 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.033 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -71.56 114.26 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.712 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.31 121.7 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.024 0.44 . . . . 0.0 111.553 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.418 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.7 119.41 24.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.5 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 54.9 t30 -79.04 -172.64 3.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.967 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.51 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 1.1 tm-20 -81.43 0.91 35.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.118 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -139.47 52.28 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 111.27 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.8 p30 45.61 26.59 0.34 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.358 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 16.4 pt-20 -117.23 151.41 36.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.033 HG21 HG22 ' A' ' 10' ' ' ILE . 4.3 mt -127.93 146.78 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.034 0.445 . . . . 0.0 111.655 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.454 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -97.24 121.76 39.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.855 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.954 HD13 HD11 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -116.71 141.19 35.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.17 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 p -80.2 125.45 29.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.778 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.473 ' CA ' HD23 ' A' ' 33' ' ' LEU . 31.1 ttt180 -112.9 167.66 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.621 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.96 62.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.028 0.442 . . . . 0.0 110.431 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 45.98 -165.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.433 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.8 -29.29 8.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.246 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -106.34 129.72 54.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.986 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.55 -174.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.252 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 62.77 147.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.4 mtm -59.45 95.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.28 -10.47 54.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.76 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.58 16.95 8.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.525 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -114.23 26.0 10.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 111.472 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.954 HD11 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -46.13 101.63 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.585 179.648 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -110.26 -169.34 1.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.03 0.443 . . . . 0.0 111.451 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.75 162.59 32.07 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.58 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 36.8 Cg_endo -64.59 168.08 13.9 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.559 2.839 . . . . 0.0 111.989 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.784 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.41 59.17 0.76 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.872 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.611 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -127.64 127.73 5.89 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 114.242 -0.979 . . . . 0.0 111.688 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 111.7 -10.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.317 0.647 . . . . 0.0 110.974 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.978 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -43.67 -74.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.848 0.356 . . . . 0.0 110.804 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.548 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER 6.31 -82.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.107 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 36.32 -141.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.373 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.9 11.27 9.44 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.077 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -169.08 0.29 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.585 0.231 . . . . 0.0 110.683 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.879 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.17 155.33 38.72 Favored Pre-proline 0 N--CA 1.454 -0.25 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.879 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.74 -24.59 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.584 2.19 . . . . 0.0 112.226 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -89.6 -59.85 2.1 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.127 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -80.85 -4.84 56.19 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -66.04 -57.26 8.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.638 0.256 . . . . 0.0 111.178 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.705 HG23 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -78.55 -41.16 24.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.158 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 47' ' ' GLU . 73.6 t -50.42 -35.62 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.811 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -78.35 -52.05 9.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.053 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.44 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 1.1 tm-20 -62.18 -23.37 66.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.763 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.779 HD21 ' NE2' ' A' ' 64' ' ' HIS . 2.2 tp -57.45 -44.66 84.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.782 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -62.74 -27.9 69.59 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.25 -27.03 53.13 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.001 179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.433 ' HG2' ' H ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -108.69 6.15 25.49 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.943 HG12 HG13 ' A' ' 60' ' ' ILE . 25.4 t -133.51 -44.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.017 0.437 . . . . 0.0 109.928 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.95 -39.02 0.19 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.636 -0.711 . . . . 0.0 114.018 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.943 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.58 -176.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.979 0.419 . . . . 0.0 110.984 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.25 88.72 13.09 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.117 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.841 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.4 Cg_endo -111.41 144.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.426 2.75 . . . . 0.0 114.146 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 35.1 mt-30 -74.82 79.93 2.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.998 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.49 129.09 53.7 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.654 -175.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -177.77 -138.25 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.503 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.73 163.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.162 0.506 . . . . 0.0 112.045 179.159 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.1 tt -124.55 109.82 13.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.749 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.87 -43.43 35.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.164 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.4 tt0 -171.63 163.66 6.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.429 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.33 114.19 7.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.88 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.7 ' HB2' HG22 ' A' ' 122' ' ' VAL . 15.7 tp -102.73 121.93 43.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.811 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -124.54 109.79 13.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.596 ' HE1' HD12 ' A' ' 82' ' ' LEU . 2.5 p90 -141.09 152.1 44.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.635 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -121.17 118.82 30.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.047 0.451 . . . . 0.0 111.332 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -69.9 163.64 58.81 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.281 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -52.37 83.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.066 2.511 . . . . 0.0 112.362 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 4.6 t70 98.02 14.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.387 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.847 ' NE ' HD21 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -137.36 147.14 45.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.67 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.25 96.06 4.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.54 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.449 HD13 HH12 ' A' ' 78' ' ' ARG . 1.1 tt -102.81 115.37 44.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 0.0 111.196 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.14 118.92 37.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.22 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' A' ' 6' ' ' ILE . 16.6 mt -118.69 114.57 22.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 111.489 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -104.81 122.51 45.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.217 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.451 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 4.4 m-30 -103.54 109.84 21.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.016 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.599 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 44.6 m95 -94.84 148.58 22.15 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.675 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 86' ' ' LEU . 2.9 tm? -101.28 102.92 13.88 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.399 0.619 . . . . 0.0 111.75 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.998 HG22 ' ND1' ' A' ' 64' ' ' HIS . 15.0 t -79.39 145.71 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.691 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -115.19 -23.02 9.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.8 OUTLIER -162.37 160.22 26.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.6 0.637 . . . . 0.0 111.556 -179.029 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.712 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.08 121.47 4.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.124 178.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.56 148.78 42.67 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.198 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.53 -128.93 47.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.589 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.0 mt-10 -123.57 147.57 53.35 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.615 0.245 . . . . 0.0 110.641 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.47 128.71 10.53 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.793 2.329 . . . . 0.0 111.105 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.571 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.2 p-90 -135.5 -62.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.546 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.564 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.06 -97.75 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.614 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.9 tttp 171.32 34.98 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.578 0.228 . . . . 0.0 111.344 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -29.21 64.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.74 0.305 . . . . 0.0 110.568 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.44 64.72 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.374 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -140.18 94.78 8.6 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.007 0.432 . . . . 0.0 111.441 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.61 138.67 5.36 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.996 2.464 . . . . 0.0 112.398 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.07 19.43 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.915 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -142.06 157.31 45.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.58 0.229 . . . . 0.0 110.447 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -69.38 106.99 3.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.881 0.372 . . . . 0.0 110.332 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtt -119.68 163.13 17.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 p -80.36 114.75 19.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -80.23 -27.09 38.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.149 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -51.96 -23.46 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.493 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.21 44.62 1.22 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.591 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.57 150.24 41.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.588 0.232 . . . . 0.0 110.387 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.95 133.4 56.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.21 0.528 . . . . 0.0 112.344 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.15 -15.39 61.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.567 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.59 -49.13 13.8 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.538 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -33.8 76.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.849 0.357 . . . . 0.0 111.002 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -86.91 173.44 6.66 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.458 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.4 Cg_endo -67.7 127.69 16.71 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 121.947 1.765 . . . . 0.0 111.967 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.87 -20.56 58.24 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.519 2.146 . . . . 0.0 112.922 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.83 -9.49 58.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.92 30.38 7.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.797 0.332 . . . . 0.0 111.397 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.611 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -76.23 -32.01 1.05 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.3 Cg_exo -49.22 -43.52 36.9 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 121.957 1.771 . . . . 0.0 113.088 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.7 t -77.56 -51.32 18.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.0 111.542 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.569 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -65.95 -34.75 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.541 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -28.76 50.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -74.81 -53.26 9.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.629 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.78 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.2 tp -78.57 -32.97 48.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.638 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.569 ' HB2' HG22 ' A' ' 123' ' ' ILE . 4.0 tttm -53.85 -42.65 68.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.967 0.413 . . . . 0.0 111.019 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -65.94 -10.79 42.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.731 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.78 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.3 mp . . . . . 0 C--O 1.231 0.111 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.048 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.643 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 5071 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 5072 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.823 0.344 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.03 147.03 43.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -137.64 143.14 41.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.77 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.9 pp -146.14 120.09 9.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.757 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.763 ' C ' HD13 ' A' ' 6' ' ' ILE . 23.8 mt-30 -102.12 155.48 18.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.371 0.605 . . . . 0.0 111.918 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.808 HD12 " H2'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -146.24 121.73 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.855 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.012 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -122.19 124.78 44.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.469 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.694 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -121.36 162.92 19.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.325 0.583 . . . . 0.0 111.952 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -145.99 120.66 1.35 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.987 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.947 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.81 105.52 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.741 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.5 mt -71.37 121.81 22.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 0.0 111.668 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.31 127.64 34.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.77 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.492 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 51.8 t30 -83.63 -172.53 4.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.636 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.482 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 28.1 tt0 -83.95 5.66 24.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.141 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -141.25 52.66 1.56 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.0 111.367 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.0 p30 45.46 25.15 0.21 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.57 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 16.4 pt-20 -117.69 144.95 44.76 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.947 HG21 HG22 ' A' ' 10' ' ' ILE . 9.8 mt -115.13 135.94 53.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.248 0.546 . . . . 0.0 111.978 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -80.8 116.55 20.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.943 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.876 HG23 ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -116.94 131.14 70.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.754 HG23 ' HD3' ' A' ' 36' ' ' PRO . 62.9 p -71.92 111.87 7.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' C ' ' H ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -91.09 172.27 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.146 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.11 28.5 0.12 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.791 0.329 . . . . 0.0 110.733 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 22' ' ' ARG . . . 56.36 20.96 5.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.62 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.98 25.08 3.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.478 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 p30 178.83 89.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.011 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -175.56 76.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.134 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.12 -79.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.16 100.31 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.836 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.54 -8.82 56.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.741 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -93.46 31.2 1.56 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.703 0.287 . . . . 0.0 111.395 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -113.92 26.27 10.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.094 0.473 . . . . 0.0 111.401 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 34' ' ' GLU . 1.2 tt -47.45 127.88 11.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.772 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.781 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -156.53 -173.91 4.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 111.496 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.876 ' CD2' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.94 162.71 31.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.469 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.754 ' HD3' HG23 ' A' ' 21' ' ' THR . 10.6 Cg_endo -51.55 168.72 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.534 2.823 . . . . 0.0 111.657 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 7' ' ' ALA . . . 102.94 59.41 0.74 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.923 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.05 116.28 2.04 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.53 -0.835 . . . . 0.0 111.683 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.69 5.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.224 0.61 . . . . 0.0 111.682 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.017 HD12 ' HB1' ' A' ' 49' ' ' ALA . 1.2 pt -50.71 -28.92 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.572 0.701 . . . . 0.0 110.275 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.583 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.94 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.151 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' GLU . 56.6 mmm 30.83 -86.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.566 0.541 . . . . 0.0 112.054 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.84 32.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.524 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.2 mp0 -87.16 -174.8 5.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.827 0.346 . . . . 0.0 111.161 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.857 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.69 154.08 37.62 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.353 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.857 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.82 -26.33 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.835 2.357 . . . . 0.0 112.548 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 51' ' ' VAL . 8.8 mt-10 -104.2 -38.72 6.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.746 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -80.29 -11.72 59.69 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.017 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.01 -53.02 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.0 111.072 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.905 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.7 m -78.23 -45.87 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.9 t -56.04 -37.94 51.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.04 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -78.28 -47.2 18.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.629 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.66 -21.57 65.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.804 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.833 HD21 ' CE1' ' A' ' 64' ' ' HIS . 1.9 tp -55.64 -44.55 77.26 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.871 0.367 . . . . 0.0 110.534 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -34.07 77.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -77.39 -25.82 51.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.072 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.456 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 31.0 mm-40 -108.54 5.52 25.2 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.963 HG12 HG13 ' A' ' 60' ' ' ILE . 25.8 t -134.34 -44.18 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.117 0.484 . . . . 0.0 109.96 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.99 -41.07 0.33 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.696 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.963 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.54 -175.52 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.983 0.421 . . . . 0.0 110.965 -179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.3 89.0 11.48 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.29 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.896 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.8 Cg_endo -108.78 143.59 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.172 2.581 . . . . 0.0 114.008 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 38.4 mt-30 -74.9 79.87 2.14 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.833 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -119.28 129.6 54.99 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.682 -176.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.4 t80 178.79 167.41 0.9 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.749 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 87.06 155.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.476 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.864 HD22 ' N ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -102.22 156.44 17.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.05 0.453 . . . . 0.0 110.729 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.864 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.99 -42.81 2.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.866 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' OE2' HG13 ' A' ' 122' ' ' VAL . 1.6 tt0 -171.76 162.1 6.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.186 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -143.36 132.08 22.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.75 0.309 . . . . 0.0 110.71 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.755 HD23 ' CE1' ' A' ' 73' ' ' TYR . 4.4 tp -124.08 125.8 45.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.597 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -118.05 112.51 20.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.015 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.998 ' CE2' HD11 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -141.08 153.13 45.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.403 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -117.5 140.05 50.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.263 0.554 . . . . 0.0 111.54 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.497 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.8 m-85 -90.22 162.42 34.81 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.347 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.497 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 11.2 Cg_endo -54.53 82.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.884 2.389 . . . . 0.0 112.062 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 13.0 m-20 90.36 12.4 0.05 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.45 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.433 ' CG ' HD23 ' A' ' 4' ' ' LEU . 22.0 ttp180 -137.33 98.82 3.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.396 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -78.56 115.67 18.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.883 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.998 HD11 ' CE2' ' A' ' 73' ' ' TYR . 7.2 pt -118.94 154.27 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.106 0.479 . . . . 0.0 111.7 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.44 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -128.67 118.74 23.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.208 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.519 HD21 ' CE1' ' A' ' 84' ' ' PHE . 5.9 tp -106.28 114.31 28.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.0 111.592 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.448 ' CH2' ' HA ' ' A' ' 46' ' ' PRO . 6.7 m0 -112.11 122.63 48.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.088 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.519 ' CE1' HD21 ' A' ' 82' ' ' LEU . 5.1 m-30 -108.43 109.62 20.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.881 0.372 . . . . 0.0 110.433 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.905 ' NE1' HG11 ' A' ' 50' ' ' VAL . 40.8 m95 -99.96 149.08 23.8 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.013 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 65' ' ' PHE . 52.6 tp -92.07 138.56 31.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.885 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.794 HG13 ' CB ' ' A' ' 64' ' ' HIS . 21.6 t -123.75 145.97 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.322 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -112.8 -26.02 8.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.47 159.69 25.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.725 0.693 . . . . 0.0 111.678 -179.012 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.741 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -152.78 123.62 7.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -73.17 145.63 46.17 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.101 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.8 -129.17 44.55 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.617 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 57.3 tt0 -122.19 142.38 36.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.521 0.2 . . . . 0.0 110.731 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.508 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -76.44 128.75 10.58 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.833 2.355 . . . . 0.0 111.376 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.581 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.1 p-90 -131.36 -58.59 0.99 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.845 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.567 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.17 -94.87 0.01 OUTLIER Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.909 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.37 33.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 110.99 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.53 -23.66 65.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.629 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.3 74.95 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.119 -0.563 . . . . 0.0 113.584 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.424 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 15.0 mt-30 -140.35 93.27 9.0 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.016 0.436 . . . . 0.0 111.362 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.65 134.14 7.4 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.969 2.446 . . . . 0.0 112.575 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.16 177.11 19.4 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.823 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -142.48 157.25 44.95 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -69.44 106.7 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.34 . . . . 0.0 110.219 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.515 ' SD ' HD12 ' A' ' 20' ' ' ILE . 9.0 ptm -119.92 153.95 35.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.409 ' HB2' HG12 ' A' ' 108' ' ' VAL . 87.1 p -74.99 114.78 13.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.686 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -70.59 -23.16 62.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.089 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 106' ' ' SER . 10.0 p -58.48 -19.02 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.306 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.13 44.19 1.29 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.393 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.474 HD13 HD22 ' A' ' 107' ' ' LEU . 8.4 tp -62.64 149.4 43.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.2 127.07 48.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.43 -14.58 61.73 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.557 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.21 -49.33 13.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.602 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -39.01 87.33 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.736 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.581 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.9 173.93 6.91 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.169 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 63.7 Cg_endo -73.4 127.66 12.06 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.121 1.881 . . . . 0.0 111.606 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.14 -14.93 40.79 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.587 2.191 . . . . 0.0 113.203 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.0 -9.5 58.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.12 31.98 5.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.68 0.276 . . . . 0.0 111.427 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.3 mt-10 -72.95 -36.0 3.16 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 69.3 Cg_exo -51.15 -45.87 34.34 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 121.981 1.787 . . . . 0.0 112.854 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -77.36 -51.29 18.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 0.0 110.926 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.581 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.7 mm -62.23 -32.27 54.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.255 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.86 -35.33 63.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.011 0.434 . . . . 0.0 110.419 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -65.36 -53.09 48.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.087 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.735 ' O ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -78.35 -20.04 52.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.639 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 123' ' ' ILE . 31.5 tttp -74.55 -42.59 58.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.19 0.519 . . . . 0.0 110.599 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -66.98 -10.29 47.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.912 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.735 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.128 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.611 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.808 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 5083 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 5084 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.1 mtp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.911 0.386 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.33 140.22 38.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.24 122.05 27.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.709 HD12 HD11 ' A' ' 6' ' ' ILE . 2.0 pp -131.33 140.95 49.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.798 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.808 ' C ' HD13 ' A' ' 6' ' ' ILE . 33.9 mt-30 -102.92 151.49 22.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.38 0.61 . . . . 0.0 112.05 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.808 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -144.97 116.61 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.659 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.998 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.76 152.27 44.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -145.08 162.6 13.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.339 0.59 . . . . 0.0 111.883 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.0 110.07 0.85 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.274 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.61 HG22 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.88 96.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.755 HG23 HG11 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -71.46 125.04 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 121.179 0.514 . . . . 0.0 112.052 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -93.64 142.61 27.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.857 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.676 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 5.1 p30 -99.08 -173.33 2.47 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.111 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -74.87 0.2 16.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.89 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -123.48 42.93 3.09 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.181 -0.324 . . . . 0.0 111.597 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 46.11 24.9 0.29 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.046 0.45 . . . . 0.0 111.263 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.533 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 24.4 mt-10 -113.83 160.88 18.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.834 HD13 HD22 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -119.33 131.99 70.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.134 0.492 . . . . 0.0 112.294 -178.278 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.491 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -85.06 116.01 23.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.26 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -118.96 140.16 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.682 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.559 HG21 ' HG2' ' A' ' 98' ' ' GLU . 45.7 p -76.48 120.2 21.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.593 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 35.4 ptt180 -107.19 167.96 9.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.512 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -72.5 57.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.997 0.427 . . . . 0.0 110.268 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . . . 49.23 -174.98 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.36 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.03 14.63 31.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.455 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 176.67 40.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.793 0.33 . . . . 0.0 110.824 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -86.92 -78.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.217 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -148.6 -74.4 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.974 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.85 100.61 9.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.95 -8.92 57.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.579 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 113' ' ' ASP . 0.9 OUTLIER -90.74 16.89 8.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.533 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -114.25 26.23 10.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.045 0.45 . . . . 0.0 111.353 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.52 HD11 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -48.81 103.19 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.656 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' OE2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.3 OUTLIER -109.26 -170.61 1.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.731 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.522 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.53 168.29 10.41 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.392 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.551 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 89.2 Cg_endo -83.13 167.12 14.2 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.643 2.895 . . . . 0.0 112.981 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.7 -5.1 50.75 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.496 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -62.71 167.7 19.74 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.864 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 80.16 8.43 1.46 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 122.618 0.367 . . . . 0.0 111.759 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.998 HG21 ' HB3' ' A' ' 7' ' ' ALA . 2.1 pt -57.88 -26.94 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.651 0.739 . . . . 0.0 110.052 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.496 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.43 -69.27 0.14 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.121 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.478 ' C ' ' O ' ' A' ' 41' ' ' GLU . 44.0 mmm 19.73 -86.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.731 0.644 . . . . 0.0 112.467 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.46 30.02 0.11 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.856 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -88.2 -170.38 2.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.783 0.325 . . . . 0.0 111.124 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.894 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.11 156.1 35.66 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.385 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.894 ' HD2' HG22 ' A' ' 45' ' ' THR . 5.0 Cg_endo -46.04 -24.88 2.51 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.781 2.321 . . . . 0.0 112.475 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 51' ' ' VAL . 8.3 mt-10 -104.11 -39.96 6.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.526 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 6.0 mt-30 -80.1 -12.78 59.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.615 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.869 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -58.48 -52.78 64.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.869 0.366 . . . . 0.0 110.885 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.931 HG11 ' NE1' ' A' ' 85' ' ' TRP . 3.4 m -78.32 -45.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 47' ' ' GLU . 33.4 t -61.17 -41.93 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.314 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 3.7 tpt180 -78.02 -37.69 46.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.889 0.376 . . . . 0.0 110.625 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' GLU . 7.9 tp10 -75.57 -19.93 58.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.627 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.899 HD21 ' CE1' ' A' ' 64' ' ' HIS . 3.8 tp -57.53 -44.37 85.07 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.575 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.89 -36.3 82.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.7 tm-20 -77.52 -24.49 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.042 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 53' ' ' GLU . 12.7 mm-40 -108.2 5.09 25.47 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.947 HG12 HG13 ' A' ' 60' ' ' ILE . 39.5 t -134.79 -44.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.226 0.536 . . . . 0.0 109.756 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.567 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.29 -40.79 0.36 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.336 -0.847 . . . . 0.0 113.892 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.947 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.85 -176.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.983 0.42 . . . . 0.0 111.171 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.83 88.89 12.37 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.948 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.843 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.4 Cg_endo -109.45 154.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.399 2.733 . . . . 0.0 114.367 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.625 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -83.39 80.79 8.98 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 175.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.899 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -122.22 127.69 50.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.462 -175.534 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.513 ' O ' ' O ' ' A' ' 86' ' ' LEU . 6.1 t80 -179.11 163.41 1.31 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.928 0.394 . . . . 0.0 112.051 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER 85.72 153.33 0.08 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.725 179.481 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -112.14 129.4 56.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.925 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.736 ' CE1' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.87 -51.09 11.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.152 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.4 mt-10 -171.26 131.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.425 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -111.95 131.97 55.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.725 0.298 . . . . 0.0 111.099 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.795 ' HB2' HG22 ' A' ' 122' ' ' VAL . 4.1 tp -110.28 131.14 55.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.649 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -121.1 109.89 15.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.617 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -141.1 146.32 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -121.15 140.03 52.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.151 0.501 . . . . 0.0 111.192 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -88.81 163.64 34.49 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.55 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 9.4 Cg_endo -52.29 84.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.025 2.483 . . . . 0.0 112.205 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 20.5 m-20 93.68 15.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.235 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 30.7 ttt180 -137.37 150.09 47.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.452 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -126.18 101.97 7.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.0 110.979 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.438 HG13 HD11 ' A' ' 6' ' ' ILE . 3.5 tt -109.87 111.92 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.453 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -94.83 118.47 31.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.283 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.902 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -108.45 114.32 28.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.0 111.421 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -113.14 122.71 48.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.042 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.902 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -106.86 109.71 21.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.449 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.931 ' NE1' HG11 ' A' ' 50' ' ' VAL . 47.2 m95 -97.99 148.5 23.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.0 112.173 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 65' ' ' PHE . 58.8 tp -92.9 134.74 34.8 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.436 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.803 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.7 t -124.7 146.13 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.03 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 4.8 tp10 -106.69 -35.3 7.05 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.22 165.63 24.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.141 0.882 . . . . 0.0 111.945 -179.018 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.734 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -151.29 129.17 11.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.41 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -76.42 136.1 39.44 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.66 -126.78 24.95 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.556 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -125.85 143.44 45.28 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.549 0.214 . . . . 0.0 110.714 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.67 128.71 10.36 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.858 2.372 . . . . 0.0 111.489 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.567 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.9 p-90 -131.98 -58.8 0.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.726 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.588 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.94 -97.35 0.01 OUTLIER Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.968 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -179.97 33.88 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.685 0.279 . . . . 0.0 111.355 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.559 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -64.49 -27.69 69.15 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.826 0.346 . . . . 0.0 110.432 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.8 12.45 84.44 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.425 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.448 ' O ' HG22 ' A' ' 21' ' ' THR . 41.7 mt-30 -140.35 98.15 7.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 117.075 0.438 . . . . 0.0 111.53 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -43.71 141.46 3.94 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.835 2.357 . . . . 0.0 112.461 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.15 177.18 19.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.949 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -147.64 157.4 43.54 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.468 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.7 OUTLIER -68.89 106.14 2.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.867 0.365 . . . . 0.0 110.495 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.478 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 3.1 mmm -120.24 151.93 38.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.838 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.32 114.79 13.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.572 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.834 HD22 HD13 ' A' ' 18' ' ' ILE . 25.9 tp -79.72 -18.95 50.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.269 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.578 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.5 p -55.97 -20.67 9.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.813 0.339 . . . . 0.0 111.176 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.12 49.74 0.88 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.255 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.548 HD22 HD12 ' A' ' 123' ' ' ILE . 6.7 tt -62.45 150.22 40.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.701 0.286 . . . . 0.0 110.411 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -115.26 132.19 56.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.166 0.508 . . . . 0.0 112.184 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.64 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.25 -15.3 61.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.736 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.453 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 3.2 t0 -78.43 -49.19 13.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.325 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -27.67 67.4 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.77 0.319 . . . . 0.0 111.054 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.64 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -96.19 169.36 9.11 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.442 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.511 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 39.2 Cg_endo -67.07 127.71 17.3 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.353 2.036 . . . . 0.0 111.948 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.87 -19.88 58.44 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.535 2.157 . . . . 0.0 113.048 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.51 58.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.33 32.4 6.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.789 0.328 . . . . 0.0 111.417 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.07 -40.21 2.92 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.18 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 86.4 Cg_exo -44.86 -36.61 11.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.135 1.89 . . . . 0.0 112.682 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.859 HG21 ' CE1' ' A' ' 84' ' ' PHE . 7.0 t -77.57 -42.39 29.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.069 0.461 . . . . 0.0 110.339 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.664 HG22 ' HB2' ' A' ' 127' ' ' LYS . 6.0 mm -69.17 -34.14 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.954 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.62 -27.04 36.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.945 0.402 . . . . 0.0 110.416 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -50.76 9.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.693 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.736 HD13 ' CE1' ' A' ' 68' ' ' PHE . 7.1 tp -78.07 -32.05 50.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.781 0.324 . . . . 0.0 111.613 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.664 ' HB2' HG22 ' A' ' 123' ' ' ILE . 5.9 ttpm? -53.81 -42.52 68.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.057 0.456 . . . . 0.0 111.002 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -71.87 -6.11 39.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.998 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 108' ' ' VAL . 2.3 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.203 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.742 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 5095 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 5096 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.888 0.375 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -110.08 103.01 11.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 132.82 46.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.741 HD12 HD11 ' A' ' 6' ' ' ILE . 2.7 pp -130.41 140.49 50.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.818 ' C ' HD13 ' A' ' 6' ' ' ILE . 10.9 mt-30 -107.37 149.45 27.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.276 0.56 . . . . 0.0 111.838 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.957 HD12 " H2'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -142.92 123.55 10.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.037 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.093 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.51 124.53 42.47 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.487 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -116.99 155.75 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.45 0.643 . . . . 0.0 112.019 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -138.59 109.27 0.66 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.177 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.606 HG22 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.85 101.38 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.708 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.1 mt -71.58 124.49 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.124 0.488 . . . . 0.0 111.958 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.473 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -96.41 137.71 35.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.065 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.688 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.8 p30 -94.84 -173.43 2.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.222 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.69 -2.17 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.071 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -120.61 41.39 3.27 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.556 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 47.44 23.58 0.39 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.949 0.404 . . . . 0.0 111.18 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.596 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 20.2 mt-10 -111.41 160.94 16.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.606 ' CG2' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -117.49 142.29 32.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.115 0.483 . . . . 0.0 112.137 -178.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -98.0 115.95 29.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.58 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.76 HD11 ' HG2' ' A' ' 105' ' ' MET . 0.2 OUTLIER -121.57 150.49 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.461 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.463 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 47.1 p -81.97 111.81 18.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.543 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.647 ' HD2' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -102.98 169.07 8.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.582 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -72.73 55.9 0.39 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.042 0.449 . . . . 0.0 110.398 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 46.79 27.75 0.73 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.669 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.647 ' HB2' ' HD2' ' A' ' 22' ' ' ARG . . . 47.95 28.7 1.48 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.437 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 57.8 p-10 -81.95 -177.94 6.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.985 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.46 29.27 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -106.5 -31.67 8.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.796 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.74 43.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.738 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 26' ' ' ASP . . . -61.66 -14.18 28.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.698 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.35 11.36 8.56 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -114.16 26.02 10.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.063 0.459 . . . . 0.0 111.41 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.508 HD11 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -47.77 99.9 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.44 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.8 tt0 -106.68 -177.5 3.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.168 0.509 . . . . 0.0 111.919 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.611 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.87 166.37 15.13 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.347 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 56.3 Cg_endo -69.83 167.76 23.6 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.351 2.7 . . . . 0.0 111.887 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.3 59.65 0.76 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.194 -1.003 . . . . 0.0 114.062 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -123.01 132.51 8.65 Favored Glycine 0 C--N 1.311 -0.829 0 CA-C-N 114.679 -0.76 . . . . 0.0 112.055 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.0 OUTLIER 92.93 7.7 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.043 0.537 . . . . 0.0 112.377 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.093 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -51.2 -29.23 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.706 0.765 . . . . 0.0 110.087 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.596 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.17 -80.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.876 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.2 mmm 37.13 -84.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.588 0.555 . . . . 0.0 111.605 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.57 31.37 0.13 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.456 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -90.94 -176.56 4.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.822 0.344 . . . . 0.0 111.287 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.868 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.4 153.9 37.55 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.325 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.868 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.93 -25.03 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.83 2.353 . . . . 0.0 112.589 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -104.02 -40.14 6.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.675 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -80.11 -13.92 58.9 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.059 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -59.6 -51.13 71.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.719 0.295 . . . . 0.0 111.098 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.929 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.9 m -77.99 -45.48 27.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.037 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.1 t -57.73 -43.54 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.329 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -44.52 25.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.082 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.4 tm-20 -68.39 -25.52 65.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.808 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -53.7 -44.46 69.79 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.914 0.387 . . . . 0.0 110.385 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -60.42 -35.9 76.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.66 -26.61 50.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.487 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' CA ' ' OE1' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -108.11 6.17 26.64 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -178.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.902 HG12 HG13 ' A' ' 60' ' ' ILE . 48.3 t -134.02 -44.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.51 -40.24 0.29 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.442 -0.799 . . . . 0.0 114.065 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.902 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.84 -177.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.114 0.483 . . . . 0.0 111.092 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.38 88.81 13.58 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.821 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.735 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.2 Cg_endo -111.07 146.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 123.287 2.658 . . . . 0.0 114.159 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 38.6 mt-30 -74.84 79.71 2.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 175.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.003 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.82 127.46 50.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.562 -176.39 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.514 ' O ' ' O ' ' A' ' 86' ' ' LEU . 12.4 t80 -179.29 168.22 1.5 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.5 m 84.43 154.73 0.09 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.742 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 pp -111.9 123.6 50.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 111.132 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.83 -38.69 53.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.198 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.2 mt-10 -171.29 148.33 2.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.342 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.4 132.15 22.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.633 0.254 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.634 HD22 ' N ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -133.3 166.66 21.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 110.894 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.634 ' N ' HD22 ' A' ' 71' ' ' LEU . 16.2 tt0 -137.68 126.06 23.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.665 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.644 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.9 p90 -141.14 147.0 37.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.451 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -121.15 139.96 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.213 0.53 . . . . 0.0 111.424 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -88.28 163.26 37.42 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.353 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.6 Cg_endo -50.6 83.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.029 2.486 . . . . 0.0 112.126 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.5 m-20 93.15 18.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.215 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.594 ' CZ ' HD21 ' A' ' 4' ' ' LEU . 12.0 ttt180 -137.45 150.08 47.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.515 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -123.11 106.59 10.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.774 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.477 HD13 ' OH ' ' A' ' 73' ' ' TYR . 3.6 tt -113.44 112.03 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.232 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -91.36 118.61 30.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.101 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.644 HD12 ' CE1' ' A' ' 73' ' ' TYR . 10.2 mt -109.19 114.26 27.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.997 0.427 . . . . 0.0 111.801 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -112.28 122.13 46.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.101 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.6 ' HZ ' HD21 ' A' ' 119' ' ' ASN . 3.3 m-85 -106.63 109.79 21.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.244 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.929 ' NE1' HG11 ' A' ' 50' ' ' VAL . 39.4 m95 -98.38 148.7 23.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.081 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.514 ' O ' ' O ' ' A' ' 65' ' ' PHE . 18.7 tp -94.19 138.44 32.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.402 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.003 HG22 ' ND1' ' A' ' 64' ' ' HIS . 34.5 t -123.66 145.41 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.439 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -111.87 -25.59 9.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 5.8 tpt180 -162.79 163.54 26.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.511 0.596 . . . . 0.0 111.354 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.708 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -156.38 123.57 5.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.29 178.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -74.78 149.52 39.68 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.96 -131.76 48.08 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.596 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -121.4 145.05 41.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.44 0.162 . . . . 0.0 110.747 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.518 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.57 128.66 10.41 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.817 2.345 . . . . 0.0 111.386 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 59.5 p-90 -135.05 -58.27 0.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.921 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.616 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.79 -95.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.982 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -176.02 33.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.728 0.299 . . . . 0.0 111.234 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -26.21 60.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.41 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.99 16.8 73.03 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.632 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.463 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 48.8 mt-30 -140.28 92.08 9.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.129 0.49 . . . . 0.0 111.46 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -43.84 146.1 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.155 2.57 . . . . 0.0 112.935 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.448 ' CA ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.1 177.11 19.38 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.576 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -142.26 157.28 45.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.569 0.223 . . . . 0.0 110.975 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.535 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -74.71 106.02 6.07 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.747 0.308 . . . . 0.0 110.503 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.76 ' HG2' HD11 ' A' ' 20' ' ' ILE . 4.7 ppp? -120.74 147.64 45.03 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.361 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.5 114.85 3.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.823 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.962 HD11 HD11 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -80.13 -18.94 48.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.383 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.1 t -58.32 -15.13 4.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.586 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.07 51.92 0.78 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.315 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.736 HD13 HD22 ' A' ' 107' ' ' LEU . 11.5 tp -62.32 149.75 41.29 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.23 132.21 53.95 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.662 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.36 -15.32 61.86 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.497 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -78.56 -49.29 13.57 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.732 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -32.35 73.58 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.755 0.312 . . . . 0.0 111.031 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.662 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.68 170.74 10.48 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.312 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.538 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 55.5 Cg_endo -69.78 127.47 14.63 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.093 1.862 . . . . 0.0 111.669 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.57 -14.9 45.36 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.631 2.22 . . . . 0.0 113.385 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.64 -9.56 58.8 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.6 HD21 ' HZ ' ' A' ' 84' ' ' PHE . 1.7 m120 -121.61 34.3 5.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.762 0.315 . . . . 0.0 111.465 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -76.04 -31.87 1.06 Allowed Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.037 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 72.1 Cg_exo -49.06 -46.51 25.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 121.79 1.66 . . . . 0.0 112.817 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.445 HG22 ' CD1' ' A' ' 71' ' ' LEU . 1.5 t -77.41 -50.61 20.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.033 0.444 . . . . 0.0 110.622 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.599 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.4 mm -59.33 -35.06 56.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.248 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.73 -34.82 62.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.999 0.428 . . . . 0.0 110.489 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.75 -53.01 30.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.342 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.962 HD11 HD11 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -78.35 -19.74 52.79 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.699 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.66 ' N ' HD23 ' A' ' 126' ' ' LEU . 10.1 ttpp -66.24 -42.5 88.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.202 0.525 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -70.03 -9.07 54.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.186 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.858 0.361 . . . . 0.0 110.652 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.957 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 5107 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 5108 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.817 0.341 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.21 147.02 26.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -137.52 144.26 42.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.917 ' HG ' HG22 ' A' ' 80' ' ' ILE . 1.9 pp -146.14 119.15 8.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.724 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.518 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 16.7 mt-30 -102.01 152.33 21.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.505 0.669 . . . . 0.0 112.341 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.733 HD12 " H2'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -146.54 131.25 11.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.323 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.031 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.35 125.09 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 m -115.6 162.49 13.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.618 0.723 . . . . 0.0 112.714 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.422 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -145.86 112.93 0.66 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.251 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.718 HG22 HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.93 96.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.539 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.7 tt -71.64 117.54 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.205 0.526 . . . . 0.0 112.318 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.588 ' CG ' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -94.92 147.38 23.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.88 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.842 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 9.7 p-10 -103.78 -173.05 2.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.512 0.672 . . . . 0.0 112.225 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.7 tm-20 -71.8 1.6 6.7 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.455 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -124.64 44.59 2.73 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.597 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.9 p30 44.98 28.1 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.303 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 3.2 mt-10 -114.96 161.19 18.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.635 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.844 HD13 HD22 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -124.58 128.39 73.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.913 0.387 . . . . 0.0 111.937 -178.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -76.33 113.31 13.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.182 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.661 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.13 126.17 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.957 179.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.426 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 3.7 p -71.03 112.15 6.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.854 0.359 . . . . 0.0 110.987 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -86.15 83.44 7.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.582 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 0.1 OUTLIER 44.67 46.94 8.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.643 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 65.39 17.12 10.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.768 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.81 48.62 19.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.196 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -114.19 -177.1 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.981 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.75 30.07 6.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.113 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.9 124.84 13.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.779 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 64.28 46.24 3.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.991 0.424 . . . . 0.0 110.756 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.39 -8.8 53.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.824 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -85.0 14.81 4.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.18 26.25 10.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.115 0.483 . . . . 0.0 111.274 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.661 HD21 ' HB ' ' A' ' 20' ' ' ILE . 3.6 tt -45.77 100.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.657 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' OE1' ' N2 ' ' A' ' 131' ' ' 8OG . 14.6 mm-40 -125.12 179.08 5.21 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.227 0.537 . . . . 0.0 112.231 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.545 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.92 163.69 26.44 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.866 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 9.6 Cg_endo -51.49 168.61 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.884 3.056 . . . . 0.0 112.158 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.87 59.5 0.74 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.978 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.618 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.57 123.63 4.19 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 114.519 -0.84 . . . . 0.0 112.234 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.47 1.01 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.031 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -52.8 -27.07 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.627 0.727 . . . . 0.0 110.577 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.536 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -44.32 -60.72 1.79 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.233 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.511 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.3 ttp 11.02 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.936 0.773 . . . . 0.0 112.574 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.89 34.76 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.503 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -90.19 -174.73 4.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.935 0.398 . . . . 0.0 111.118 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.873 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.33 154.44 38.05 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.432 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.873 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.89 -25.6 1.09 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.818 2.345 . . . . 0.0 112.515 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.593 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -104.04 -38.91 6.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.446 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -80.1 -11.81 59.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.614 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.91 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -59.77 -52.9 63.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 0.0 110.815 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.918 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.4 m -78.16 -47.27 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.089 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.6 t -54.88 -37.27 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.26 -51.74 9.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.125 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.484 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.9 mm-40 -66.01 -23.48 66.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.764 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.2 tp -52.69 -44.67 66.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.744 0.307 . . . . 0.0 110.193 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -34.92 76.07 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.8 tt0 -77.43 -24.05 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.797 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.475 ' HG2' ' HA2' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -108.59 6.01 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.899 -179.172 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.645 HG11 ' HG3' ' A' ' 62' ' ' PRO . 16.1 t -133.97 -44.72 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 0.0 110.02 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.13 -39.42 0.2 Allowed Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.628 -0.715 . . . . 0.0 114.0 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.698 HG23 ' NE1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -88.26 -174.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.018 0.437 . . . . 0.0 111.085 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -111.98 88.87 10.69 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.259 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.645 ' HG3' HG11 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -108.63 154.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.915 2.41 . . . . 0.0 114.658 -177.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 89' ' ' ARG . 81.3 mt-30 -75.02 79.72 2.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.024 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -126.37 121.28 32.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.07 -176.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.9 t80 179.43 171.27 0.98 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.436 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.3 t 92.79 147.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.814 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.538 HD22 ' CD2' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -96.12 126.7 41.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.406 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -92.13 -51.77 5.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 179.491 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 9.4 tt0 -171.63 163.75 6.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.31 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -143.34 132.1 22.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.773 0.321 . . . . 0.0 110.901 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.768 ' HB2' HG22 ' A' ' 122' ' ' VAL . 2.6 tp -122.71 128.52 50.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.658 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -117.2 110.72 18.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.734 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.831 ' CE2' HD11 ' A' ' 80' ' ' ILE . 11.8 p90 -140.97 146.04 36.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.37 131.81 54.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.134 0.492 . . . . 0.0 111.241 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -82.04 163.22 54.14 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.489 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.1 Cg_endo -53.36 82.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.895 2.397 . . . . 0.0 112.152 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 17.6 t0 90.96 11.5 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.36 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.687 ' HG2' HD23 ' A' ' 4' ' ' LEU . 5.1 ttp180 -137.35 94.25 2.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.711 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -76.24 119.79 20.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.422 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.917 HG22 ' HG ' ' A' ' 4' ' ' LEU . 5.0 pt -127.52 146.99 32.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.065 0.459 . . . . 0.0 112.179 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -113.52 118.82 35.52 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.704 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.569 HD21 ' OD1' ' A' ' 119' ' ' ASN . 14.8 tp -106.42 114.0 27.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.854 0.359 . . . . 0.0 111.279 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.407 ' CZ3' ' O ' ' A' ' 46' ' ' PRO . 9.5 m0 -112.52 122.49 47.86 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.555 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.52 ' HE1' HD11 ' A' ' 82' ' ' LEU . 4.8 m-30 -106.54 109.87 21.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.591 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.918 ' NE1' HG11 ' A' ' 50' ' ' VAL . 34.9 m95 -101.32 148.48 25.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.455 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 65' ' ' PHE . 22.4 tp -91.69 138.35 31.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.324 0.583 . . . . 0.0 112.05 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.024 HG22 ' ND1' ' A' ' 64' ' ' HIS . 38.3 t -124.44 145.37 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.264 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -112.49 -32.34 6.51 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -163.18 165.62 24.27 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.711 0.687 . . . . 0.0 111.645 -178.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.842 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.9 p90 -148.17 133.06 18.06 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.793 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -80.18 144.41 33.01 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.691 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.13 -115.23 7.32 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.45 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 43.2 mt-10 -134.92 138.6 29.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.468 0.175 . . . . 0.0 110.82 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.512 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 3.4 Cg_exo -76.62 128.89 10.52 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.786 2.324 . . . . 0.0 111.12 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.698 ' NE1' HG23 ' A' ' 60' ' ' ILE . 62.4 p-90 -137.08 -60.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.633 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.602 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 52.51 -94.2 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.693 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.1 tttp 179.02 30.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.565 0.221 . . . . 0.0 111.549 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.69 -32.4 70.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.027 0.441 . . . . 0.0 110.143 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.91 32.29 69.96 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.73 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.426 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 76.7 mt-30 -140.56 91.64 9.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.973 0.416 . . . . 0.0 111.527 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -44.7 126.53 7.28 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.197 2.598 . . . . 0.0 112.959 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.471 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.47 177.31 19.31 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.823 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.16 157.13 46.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.626 0.25 . . . . 0.0 110.699 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.44 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -68.47 106.71 2.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.887 0.375 . . . . 0.0 110.156 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.5 ptp -119.87 148.52 43.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.159 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.427 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 95.0 p -65.85 114.57 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.593 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.844 HD22 HD13 ' A' ' 18' ' ' ILE . 33.5 tp -78.11 -18.87 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.309 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.91 -20.13 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.442 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.99 45.2 1.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.698 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.419 ' CD2' HD12 ' A' ' 123' ' ' ILE . 7.9 tt -62.79 150.57 41.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.627 0.251 . . . . 0.0 110.49 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.91 129.61 56.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.201 0.524 . . . . 0.0 112.377 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.573 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.23 -14.98 61.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.666 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -78.36 -49.17 14.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.578 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.48 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -66.82 -34.93 78.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.91 0.386 . . . . 0.0 110.876 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.573 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -84.74 173.23 7.47 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.345 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.3 Cg_endo -70.68 127.69 14.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.162 1.908 . . . . 0.0 111.857 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.41 -17.57 60.08 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.53 2.154 . . . . 0.0 113.023 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.25 -9.36 58.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.875 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.569 ' OD1' HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -118.51 29.5 7.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.42 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.05 -43.17 3.65 Favored Pre-proline 0 C--O 1.224 -0.25 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 92.4 Cg_exo -44.89 -39.0 13.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.18 1.92 . . . . 0.0 112.971 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.2 t -77.21 -51.14 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.189 0.518 . . . . 0.0 110.77 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.2 mm -64.84 -31.23 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.197 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.82 -30.88 58.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.003 0.43 . . . . 0.0 110.477 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.9 -53.27 18.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.469 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.789 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -78.33 -33.07 49.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.565 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.532 ' HB2' HG22 ' A' ' 123' ' ' ILE . 11.6 ttpp -53.15 -42.64 66.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 111.148 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -67.2 -10.59 52.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.688 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.8 mp . . . . . 0 C--O 1.232 0.155 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.058 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.864 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 5119 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 5120 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ptt? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.862 0.363 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -73.99 139.33 44.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -140.06 137.87 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.972 HD12 HD11 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -146.07 131.95 19.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.736 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -102.84 155.43 18.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 111.666 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.972 HD11 HD12 ' A' ' 4' ' ' LEU . 5.3 mp -144.52 137.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.35 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.881 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -125.41 125.3 43.17 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.329 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.9 m -128.63 155.79 40.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.064 0.459 . . . . 0.0 111.283 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.7 127.09 2.21 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.106 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.09 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -80.99 107.65 13.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.795 HG22 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.17 123.33 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.975 0.417 . . . . 0.0 111.31 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.7 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.9 119.04 23.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.359 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 21.9 t-20 -74.77 -172.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.927 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 32.1 tt0 -82.57 4.11 25.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.151 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -140.08 52.2 1.68 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.0 111.454 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.64 25.21 0.24 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.552 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.702 ' C ' HD12 ' A' ' 18' ' ' ILE . 5.3 pt-20 -120.32 149.88 41.61 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.09 HG21 HG22 ' A' ' 10' ' ' ILE . 1.3 mp -113.36 140.76 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.149 0.5 . . . . 0.0 111.665 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -91.16 103.58 16.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.048 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.695 HG22 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.9 162.12 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.186 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 100' ' ' GLN . 73.7 p -92.61 111.71 23.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.787 0.327 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -91.69 83.5 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.45 ' NH2' ' HB1' ' A' ' 27' ' ' ALA . 11.3 mmm180 33.0 48.22 0.13 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.927 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 65.65 -77.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -175.41 -78.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.248 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -96.75 128.67 43.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.006 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' HB1' ' NH2' ' A' ' 23' ' ' ARG . . . -176.28 178.48 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -98.6 30.53 3.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.14 63.86 0.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.695 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.09 -8.72 56.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.723 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.85 23.21 2.09 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.27 26.34 10.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 111.465 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -46.05 97.44 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.67 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.78 176.94 4.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.168 0.509 . . . . 0.0 111.715 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.695 ' HB3' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.76 161.44 37.95 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.904 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -55.66 168.54 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.671 2.914 . . . . 0.0 111.611 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.67 59.49 0.74 Allowed Glycine 0 C--N 1.33 0.242 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.965 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.604 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.15 121.7 2.64 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 114.576 -0.812 . . . . 0.0 112.086 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.49 -6.62 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.339 0.656 . . . . 0.0 111.565 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.881 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.17 -57.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.303 0.573 . . . . 0.0 111.251 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -19.36 -78.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.305 -179.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.3 mmt 40.2 -93.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.774 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.47 22.06 0.08 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.359 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.45 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -78.84 -159.99 0.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.544 0.211 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.879 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.14 154.7 38.63 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.879 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.2 Cg_endo -44.07 -24.91 0.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.777 2.318 . . . . 0.0 112.456 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.9 mt-10 -99.89 -48.77 4.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.919 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -80.5 -4.89 55.59 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 44' ' ' GLU . . . -65.49 -57.49 8.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.54 0.21 . . . . 0.0 110.955 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.727 HG23 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -78.79 -44.01 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.706 179.163 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.9 t -50.61 -36.06 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 110.73 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -78.59 -49.1 13.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.817 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -65.66 -23.75 66.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.816 HD21 ' NE2' ' A' ' 64' ' ' HIS . 2.5 tp -54.81 -44.56 73.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.467 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -31.29 71.13 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.3 tm-20 -77.44 -23.95 50.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.957 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.433 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 45.3 mm-40 -107.07 3.54 25.98 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.972 HG12 HG13 ' A' ' 60' ' ' ILE . 21.9 t -134.91 -44.21 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.277 0.56 . . . . 0.0 109.847 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.582 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.2 -43.91 0.69 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.321 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.972 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.61 -175.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.105 0.478 . . . . 0.0 111.255 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.36 89.14 11.86 Favored Pre-proline 0 N--CA 1.442 -0.852 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.196 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.891 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.8 Cg_endo -108.47 148.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.078 2.519 . . . . 0.0 114.133 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 70.1 mt-30 -74.64 79.95 2.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 175.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.003 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.76 127.52 48.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.675 -176.484 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.628 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.1 t80 -179.83 171.0 1.2 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.518 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 80.57 156.13 0.14 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.749 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.4 pp -117.09 129.28 55.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.436 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.824 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.8 -48.36 18.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.744 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.567 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -171.56 131.73 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.184 179.428 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.653 ' HD2' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -123.56 132.21 53.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.742 0.305 . . . . 0.0 110.719 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.645 HD22 ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.68 162.25 26.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 111.185 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' N ' HD22 ' A' ' 71' ' ' LEU . 13.4 tt0 -140.14 128.28 22.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.656 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.478 ' HE1' HD12 ' A' ' 82' ' ' LEU . 1.9 p90 -141.07 100.87 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.643 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.8 pt-20 -74.83 122.42 23.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.446 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.99 162.89 60.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.303 179.364 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.0 Cg_endo -51.0 81.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.025 2.484 . . . . 0.0 112.287 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.4 t70 91.37 10.12 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.57 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -137.34 93.95 2.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.646 0.26 . . . . 0.0 110.854 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.555 ' HE1' HG23 ' A' ' 81' ' ' THR . 52.7 t-80 -74.88 102.1 4.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.819 0.342 . . . . 0.0 110.703 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.587 HG13 HD13 ' A' ' 6' ' ' ILE . 5.6 tt -106.52 111.94 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.555 HG23 ' HE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -103.28 128.55 50.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.413 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.478 HD12 ' HE1' ' A' ' 73' ' ' TYR . 1.6 mt -126.25 114.54 18.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.98 0.419 . . . . 0.0 111.497 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -108.12 122.33 46.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.38 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.746 ' CD2' HG11 ' A' ' 122' ' ' VAL . 5.4 m-30 -100.5 113.77 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.754 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.802 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 35.8 m95 -94.29 148.74 21.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.258 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 65' ' ' PHE . 31.1 tp -98.35 103.43 15.38 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 121.159 0.504 . . . . 0.0 111.61 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.003 HG22 ' ND1' ' A' ' 64' ' ' HIS . 25.2 t -87.62 145.79 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.184 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -112.15 -26.74 8.67 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.86 165.11 25.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.796 0.726 . . . . 0.0 111.796 -178.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.662 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.2 p90 -152.72 130.04 11.31 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.511 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -75.84 139.93 41.98 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.694 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.3 -117.82 12.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.347 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 8.0 mt-10 -135.05 140.12 33.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.414 0.149 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HA ' HD11 ' A' ' 60' ' ' ILE . 7.8 Cg_exo -75.5 128.58 11.2 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.943 2.429 . . . . 0.0 111.438 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.61 ' HE1' HG23 ' A' ' 60' ' ' ILE . 45.1 p-90 -128.45 -58.54 1.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.993 0.425 . . . . 0.0 111.383 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.77 -100.07 0.02 OUTLIER Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.877 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 179.08 36.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 111.321 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.99 -47.6 80.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.564 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.59 12.08 51.86 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.927 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.424 ' O ' HG22 ' A' ' 21' ' ' THR . 24.3 mt-30 -140.36 91.79 9.61 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 117.24 0.52 . . . . 0.0 111.386 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -44.23 125.39 5.68 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.837 2.358 . . . . 0.0 112.739 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.78 177.59 19.16 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.469 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -129.28 157.1 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.672 0.273 . . . . 0.0 110.773 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.45 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.12 107.1 3.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.901 0.381 . . . . 0.0 110.435 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 18' ' ' ILE . 12.5 ptm -119.62 158.1 27.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 p -71.83 121.32 18.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.764 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -80.11 -28.97 38.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.011 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.67 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.7 p -50.72 -24.58 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.232 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.7 43.34 1.4 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.382 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.573 HD22 HD12 ' A' ' 123' ' ' ILE . 9.5 tt -62.55 150.14 41.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.414 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -118.97 132.91 56.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.178 0.513 . . . . 0.0 112.302 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.629 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.42 61.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.48 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -78.77 -49.27 13.31 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.755 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -32.77 74.26 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.799 0.333 . . . . 0.0 111.013 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.629 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -89.16 172.62 7.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.029 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.489 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.8 Cg_endo -67.51 127.58 16.69 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.032 1.822 . . . . 0.0 111.832 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.38 -18.64 60.67 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.552 2.168 . . . . 0.0 113.064 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.87 -9.38 58.24 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.465 ' ND2' ' C6 ' ' A' ' 131' ' ' 8OG . 0.9 OUTLIER -119.36 34.31 5.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.767 0.318 . . . . 0.0 111.464 -178.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -75.6 -44.06 4.16 Favored Pre-proline 0 N--CA 1.463 0.217 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.6 Cg_exo -44.76 -35.38 9.43 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.224 1.949 . . . . 0.0 112.61 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.746 HG11 ' CD2' ' A' ' 84' ' ' PHE . 11.8 t -77.43 -41.05 29.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.136 0.493 . . . . 0.0 110.144 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.777 HG22 ' HB2' ' A' ' 127' ' ' LYS . 17.9 mm -70.28 -32.28 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.707 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.46 -26.96 34.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.086 0.47 . . . . 0.0 110.228 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.09 -50.89 9.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.669 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.824 HD13 ' CD2' ' A' ' 68' ' ' PHE . 8.1 tp -78.09 -33.5 50.69 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 111.693 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.777 ' HB2' HG22 ' A' ' 123' ' ' ILE . 17.7 ttpt -53.27 -42.53 66.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -71.71 -6.09 38.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.975 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.67 HD21 ' O ' ' A' ' 108' ' ' VAL . 2.9 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.189 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.63 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 5131 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 5132 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 mmt . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.785 0.326 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -104.23 136.73 43.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -140.02 137.53 34.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.936 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.7 pp -146.0 135.37 22.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.77 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -102.7 149.19 24.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.388 0.613 . . . . 0.0 112.107 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.936 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.4 mp -146.22 120.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.866 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.063 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.66 143.34 50.79 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.314 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -144.6 162.52 14.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.112 0.482 . . . . 0.0 111.487 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -144.02 123.4 2.01 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.037 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.004 HG22 ' CG2' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.75 108.91 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.765 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -70.83 120.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.224 0.535 . . . . 0.0 112.252 -178.118 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.95 122.7 28.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.615 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 56.1 t30 -81.62 -172.58 3.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.887 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.506 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -82.38 -0.95 48.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.112 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -135.69 49.58 2.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 0.0 111.331 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.27 23.7 0.59 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.183 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 16.2 pt-20 -114.23 153.97 28.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.004 ' CG2' HG22 ' A' ' 10' ' ' ILE . 5.2 mt -128.44 143.32 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.0 112.04 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.464 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.18 122.74 34.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.324 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.043 HD12 HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.69 133.36 65.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.274 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.658 HG21 ' HG2' ' A' ' 98' ' ' GLU . 21.4 p -70.82 115.94 10.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.082 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.515 ' CA ' HD23 ' A' ' 33' ' ' LEU . 18.3 ptt85 -114.51 172.06 7.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.704 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.433 ' HD3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -70.79 60.57 0.24 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 44.82 -92.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.567 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -178.18 34.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.782 0.325 . . . . 0.0 111.098 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 172.82 93.23 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.731 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 23' ' ' ARG . . . -162.77 171.87 16.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.144 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -60.61 -68.77 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.8 mtm -93.35 68.94 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.51 -8.9 57.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.614 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -92.15 31.18 1.31 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.354 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -114.23 25.65 10.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.428 . . . . 0.0 111.28 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.043 HD11 HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -46.47 97.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.37 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -106.79 -170.35 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.18 0.514 . . . . 0.0 112.251 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.19 168.59 9.62 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.472 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.586 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 93.7 Cg_endo -79.33 167.58 21.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.688 2.925 . . . . 0.0 113.835 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.87 -5.24 50.38 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.881 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.02 159.16 23.95 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 117.498 0.649 . . . . 0.0 113.327 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 85.14 6.36 0.49 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.061 0.545 . . . . 0.0 111.996 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.063 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.6 pt -54.28 -27.04 16.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.632 0.73 . . . . 0.0 110.167 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.554 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.97 -66.92 0.32 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.035 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.503 ' C ' ' O ' ' A' ' 41' ' ' GLU . 5.4 mmt 14.65 -82.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.876 0.735 . . . . 0.0 112.409 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -177.52 33.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.59 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.6 mp0 -88.76 -172.97 3.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.861 0.362 . . . . 0.0 111.168 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.868 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.76 155.38 36.4 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.36 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.868 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.89 -25.46 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.817 2.345 . . . . 0.0 112.659 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -103.51 -41.6 5.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.386 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 1.6 mm100 -80.28 -4.83 54.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.722 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.914 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.58 -55.41 33.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.9 HG11 ' NE1' ' A' ' 85' ' ' TRP . 2.7 m -78.19 -46.03 26.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.31 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 30.0 t -55.39 -41.13 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.368 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 3.6 tmm_? -77.98 -49.34 14.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.018 0.437 . . . . 0.0 110.451 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.469 ' HG3' ' OE1' ' A' ' 57' ' ' GLU . 14.9 tp10 -63.38 -20.0 65.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.504 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.87 HD21 ' CG ' ' A' ' 64' ' ' HIS . 1.4 tp -59.65 -44.46 93.54 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.303 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -30.16 70.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.827 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.5 tm-20 -77.27 -31.82 55.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.416 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.469 ' OE1' ' HG3' ' A' ' 53' ' ' GLU . 1.2 mp0 -108.68 6.14 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.932 HG12 HG13 ' A' ' 60' ' ' ILE . 43.5 t -133.83 -44.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.161 0.505 . . . . 0.0 110.031 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.599 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.43 -39.82 0.28 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.966 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.932 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.52 -176.29 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 120.968 0.413 . . . . 0.0 110.841 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.22 89.1 11.53 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.468 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.798 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.9 Cg_endo -109.42 143.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.266 2.644 . . . . 0.0 114.243 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 34.5 mt-30 -74.7 80.03 2.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 105.437 -2.061 . . . . 0.0 105.437 175.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.87 ' CG ' HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -120.92 134.53 55.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.418 -175.656 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 178.92 -139.9 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.089 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 56.46 156.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.206 0.527 . . . . 0.0 112.323 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.4 tt -120.1 109.44 15.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.562 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.74 -43.8 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.369 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.7 tt0 -171.25 163.32 7.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.311 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HE3' ' CZ2' ' A' ' 83' ' ' TRP . 1.1 ttpm? -143.15 132.04 22.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.81 0.338 . . . . 0.0 110.992 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.821 ' HB2' HG22 ' A' ' 122' ' ' VAL . 4.6 tp -115.2 120.41 39.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.418 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -118.57 109.84 16.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.476 ' CE1' HD23 ' A' ' 71' ' ' LEU . 2.0 p90 -141.1 151.64 44.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.46 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.14 121.27 37.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 0.0 111.34 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.77 162.88 61.04 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.281 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -50.92 81.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.017 2.478 . . . . 0.0 112.097 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 t70 88.79 14.23 0.07 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.329 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.659 ' HE ' HD21 ' A' ' 4' ' ' LEU . 4.7 ttt180 -137.51 93.91 2.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.732 0.301 . . . . 0.0 110.805 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -75.76 97.57 3.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.899 0.38 . . . . 0.0 110.463 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.692 HG13 HD13 ' A' ' 6' ' ' ILE . 1.3 tt -100.84 112.9 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.405 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.48 119.66 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.279 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.943 HD23 HG21 ' A' ' 122' ' ' VAL . 12.7 tp -110.26 114.37 27.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.88 0.372 . . . . 0.0 111.334 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.44 ' CZ2' ' HE3' ' A' ' 70' ' ' LYS . 10.9 m0 -109.47 122.89 48.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.178 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -109.79 109.77 20.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.602 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.9 ' NE1' HG11 ' A' ' 50' ' ' VAL . 48.2 m95 -99.41 148.96 23.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.506 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.8 tp -98.5 102.84 14.7 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.427 0.632 . . . . 0.0 111.726 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.781 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.9 t -81.1 146.47 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.091 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -114.12 -25.68 8.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.9 tpt180 -162.55 161.87 27.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.64 0.654 . . . . 0.0 111.583 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.738 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -155.61 123.46 5.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.316 178.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -72.05 143.94 48.93 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.019 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.2 -129.67 46.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.558 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -121.0 144.0 38.23 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.599 0.238 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.534 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.5 Cg_exo -76.32 128.89 10.76 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.788 2.325 . . . . 0.0 111.031 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.599 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 47.0 p-90 -132.28 -63.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.49 -99.87 0.02 OUTLIER Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.517 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.3 mtpp 164.77 42.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 110.874 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.658 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.4 OUTLIER -58.59 -31.99 68.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.939 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 129.93 -37.84 2.09 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.368 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -129.49 105.71 17.42 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.0 111.86 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -43.76 146.31 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.079 2.52 . . . . 0.0 112.661 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.45 177.18 18.74 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.745 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -131.65 157.38 43.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.506 0.194 . . . . 0.0 110.596 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.483 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -75.82 106.51 7.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.866 0.365 . . . . 0.0 110.203 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.0 ptm -120.16 161.32 21.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.981 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.9 p -76.86 114.98 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.712 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.721 HD22 HD13 ' A' ' 18' ' ' ILE . 2.6 tp -77.32 -18.94 57.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.449 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.3 p -51.0 -24.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.328 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.54 44.37 1.24 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.561 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.695 HD22 HD12 ' A' ' 123' ' ' ILE . 8.4 tt -62.78 150.35 41.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.577 0.227 . . . . 0.0 110.419 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.636 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -117.71 130.12 56.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 112.325 -178.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.56 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.21 -14.8 61.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.55 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.43 -49.13 14.04 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.483 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -34.69 77.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.779 0.323 . . . . 0.0 111.054 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.47 174.34 6.21 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.172 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 40.1 Cg_endo -67.71 127.81 16.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 121.926 1.751 . . . . 0.0 111.928 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.85 -21.12 58.06 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.606 2.204 . . . . 0.0 112.693 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.29 -9.6 58.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.719 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.535 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -113.74 23.22 13.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.506 -179.304 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -66.59 -36.46 12.15 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.578 ' HB2' HD13 ' A' ' 71' ' ' LEU . 73.8 Cg_exo -51.13 -47.74 24.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.952 1.768 . . . . 0.0 112.84 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.943 HG21 HD23 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -77.68 -51.21 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.936 0.398 . . . . 0.0 111.191 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.695 HD12 HD22 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -62.1 -32.84 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.227 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.92 -36.99 65.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.972 0.415 . . . . 0.0 110.374 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -62.92 -46.51 87.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.519 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 13.6 tp -78.13 -27.81 48.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.032 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.657 ' O ' HD12 ' A' ' 129' ' ' LEU . 14.8 tttp -58.99 -42.67 90.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -76.73 -3.29 37.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.111 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 127' ' ' LYS . 4.2 mp . . . . . 0 C--O 1.231 0.126 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.132 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.696 ' N2 ' HD11 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 5143 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 5144 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.4 132.83 35.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 8.8 ttmt -136.25 136.71 40.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.785 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.831 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.1 pp -146.04 137.76 24.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.667 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.766 ' C ' HD13 ' A' ' 6' ' ' ILE . 5.8 mt-30 -109.24 147.53 32.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.331 0.586 . . . . 0.0 111.804 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.915 HD12 " H2'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -136.91 128.49 42.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.014 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.837 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -125.14 124.83 42.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.518 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.553 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.9 m -124.11 162.35 25.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.033 0.444 . . . . 0.0 111.062 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -150.69 116.12 0.75 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.688 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.966 HG22 HG21 ' A' ' 18' ' ' ILE . 2.4 mp -70.58 104.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.822 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -70.97 120.52 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.21 0.529 . . . . 0.0 112.311 -177.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.437 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.52 119.65 24.5 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.56 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.558 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 25.8 t-20 -78.24 179.93 6.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.434 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.548 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 22.0 tt0 -76.1 1.26 16.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.97 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -139.87 52.57 1.69 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.814 0.34 . . . . 0.0 111.522 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 45.53 27.12 0.37 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.725 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 11.5 pt-20 -117.45 160.6 20.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.966 HG21 HG22 ' A' ' 10' ' ' ILE . 2.8 mp -136.82 142.31 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.205 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.7 118.19 30.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.281 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.742 HD11 HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -110.62 138.44 38.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.714 HG23 ' HD3' ' A' ' 36' ' ' PRO . 4.2 p -83.1 111.38 18.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.922 0.391 . . . . 0.0 110.745 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -104.4 172.18 6.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.169 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.555 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 17.1 mmt180 -67.0 -7.59 23.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.031 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 78.78 2.52 2.52 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.657 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 56.08 32.16 19.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.78 0.324 . . . . 0.0 111.287 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -148.26 70.05 1.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.04 -69.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.13 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -170.86 -42.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.3 mtt -121.44 87.89 2.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.55 -8.78 54.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.677 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.44 31.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.414 ' CB ' ' HG2' ' A' ' 23' ' ' ARG . 4.2 mttm -114.24 25.95 10.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.965 0.412 . . . . 0.0 111.441 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -53.45 89.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.216 179.344 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.677 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.1 tt0 -112.87 -168.19 1.29 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.29 0.566 . . . . 0.0 112.143 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.553 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.33 166.3 15.69 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.305 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.714 ' HD3' HG23 ' A' ' 21' ' ' THR . 38.2 Cg_endo -63.93 168.6 11.8 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.334 2.689 . . . . 0.0 111.208 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.9 60.11 0.73 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.228 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.63 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.21 110.91 0.86 Allowed Glycine 0 C--N 1.314 -0.67 0 CA-C-N 114.581 -0.809 . . . . 0.0 111.732 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.63 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 126.98 -8.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.521 0.728 . . . . 0.0 110.873 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.837 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -42.2 -48.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.293 0.568 . . . . 0.0 111.57 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -31.8 -81.16 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.941 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.9 mmm 43.02 -92.82 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.557 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.71 23.8 0.09 OUTLIER Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.215 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -82.44 -162.95 0.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.546 0.213 . . . . 0.0 110.934 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.858 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -107.76 156.07 38.69 Favored Pre-proline 0 C--N 1.333 -0.13 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.858 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.85 -24.71 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.703 2.269 . . . . 0.0 112.456 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.9 mm-40 -95.36 -54.03 3.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -80.44 -5.26 56.28 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -64.99 -57.44 8.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.685 0.278 . . . . 0.0 110.811 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.729 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -79.02 -45.95 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.701 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 47' ' ' GLU . 59.3 t -50.87 -37.76 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.033 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -48.68 14.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.68 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 40' ' ' ILE . 12.8 tp10 -63.92 -25.67 68.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.639 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.824 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.7 tp -55.3 -44.31 75.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -32.1 71.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.1 tm-20 -77.37 -25.49 51.0 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.848 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.422 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 5.3 mm-40 -108.38 5.18 25.19 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.933 HG12 HG13 ' A' ' 60' ' ' ILE . 31.3 t -134.82 -44.62 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.11 0.481 . . . . 0.0 110.144 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.51 -40.25 0.23 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.893 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.933 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.65 -177.57 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.001 0.429 . . . . 0.0 111.227 -179.507 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.62 88.54 13.76 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.798 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.786 ' HG3' HG11 ' A' ' 58' ' ' VAL . 1.4 Cg_endo -112.55 147.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 123.322 2.681 . . . . 0.0 114.167 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 72.9 mt-30 -74.7 80.02 2.04 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.007 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.4 128.12 50.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.74 -176.61 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.7 t80 179.72 175.33 0.77 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.481 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 t 78.79 162.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.077 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.771 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -123.45 129.28 51.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.367 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.963 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.77 -44.24 33.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.292 0.568 . . . . 0.0 109.767 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.3 mt-10 -171.45 131.66 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.845 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.5 132.16 54.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.88 0.372 . . . . 0.0 111.286 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.629 ' HB2' HG22 ' A' ' 122' ' ' VAL . 3.4 tp -109.43 137.56 47.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.626 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -133.56 109.97 9.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.895 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.412 ' CZ ' HG23 ' A' ' 80' ' ' ILE . 2.3 p90 -141.22 146.28 36.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.584 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.16 133.96 55.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.105 0.478 . . . . 0.0 111.306 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.471 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -93.91 163.15 24.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.375 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.8 Cg_endo -54.15 82.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.823 2.349 . . . . 0.0 112.317 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 10.9 t0 93.49 8.53 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.547 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' NH1' HD12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -137.34 93.92 2.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.774 0.321 . . . . 0.0 110.769 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' A' ' 3' ' ' LYS . 1.9 t60 -82.09 96.98 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.0 110.773 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.493 HD12 ' NH1' ' A' ' 78' ' ' ARG . 5.0 tt -98.77 111.7 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.985 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.06 118.71 34.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.115 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.579 HD23 ' HB ' ' A' ' 6' ' ' ILE . 38.5 mt -106.19 114.47 28.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.963 0.411 . . . . 0.0 111.689 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.622 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 12.2 m0 -106.74 122.17 45.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.599 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.731 ' HZ ' HD21 ' A' ' 119' ' ' ASN . 3.2 m-85 -112.95 109.78 19.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.0 110.196 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.771 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 15.9 m95 -94.77 148.46 22.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.595 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.613 ' O ' ' O ' ' A' ' 65' ' ' PHE . 59.2 tp -100.09 102.98 14.46 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.037 0.446 . . . . 0.0 111.568 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.007 HG22 ' ND1' ' A' ' 64' ' ' HIS . 25.0 t -83.29 145.83 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.159 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -113.5 -23.53 9.76 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 2.9 ttt-85 -162.91 162.95 26.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.688 0.677 . . . . 0.0 111.287 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.714 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -157.25 125.18 5.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.0 111.674 179.223 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -76.07 151.9 36.97 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.136 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.21 -132.94 42.2 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.654 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 19.6 tt0 -119.69 146.94 42.75 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.6 0.238 . . . . 0.0 110.721 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.2 Cg_exo -76.69 128.85 10.44 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.904 2.403 . . . . 0.0 111.383 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.536 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 64.9 p-90 -137.08 -59.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.179 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.543 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 49.17 -94.63 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.813 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.1 mmtm 165.81 34.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.692 0.282 . . . . 0.0 111.114 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.33 -34.66 78.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.415 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.6 21.19 32.24 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.159 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.422 ' O ' ' HB ' ' A' ' 21' ' ' THR . 2.6 mp0 -140.21 92.08 9.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 111.3 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -43.73 131.84 7.71 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.804 2.336 . . . . 0.0 112.374 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.0 177.04 19.42 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.858 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -145.2 157.25 44.12 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.19 106.61 3.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.851 0.357 . . . . 0.0 110.216 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -119.97 163.21 17.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.948 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.516 ' OG ' HG12 ' A' ' 108' ' ' VAL . 1.7 t -77.72 114.83 16.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.786 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.8 OUTLIER -80.08 -19.96 46.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.255 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.516 HG12 ' OG ' ' A' ' 106' ' ' SER . 11.9 p -52.97 -20.53 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.538 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.06 44.27 1.25 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.85 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.651 HD12 HD21 ' A' ' 107' ' ' LEU . 8.5 tt -62.64 150.13 41.64 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.49 130.52 53.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.16 61.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.402 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.6 -49.26 13.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.749 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -37.43 84.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 111.001 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -80.77 173.98 6.87 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.146 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.8 Cg_endo -71.23 127.74 13.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.071 1.847 . . . . 0.0 111.659 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.38 -14.97 45.44 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.512 2.141 . . . . 0.0 113.18 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.55 58.65 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.731 HD21 ' HZ ' ' A' ' 84' ' ' PHE . 1.9 m120 -120.23 31.57 6.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.274 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -75.28 -45.07 4.58 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.073 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.521 ' HB2' HD13 ' A' ' 71' ' ' LEU . 85.9 Cg_exo -44.74 -36.27 10.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.242 1.961 . . . . 0.0 112.619 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.698 HG11 ' CG ' ' A' ' 84' ' ' PHE . 5.3 t -77.42 -44.6 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.047 0.451 . . . . 0.0 110.113 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.599 HG22 ' HB2' ' A' ' 127' ' ' LYS . 8.0 mm -68.27 -31.67 52.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.919 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.58 -27.59 40.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.133 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -49.5 11.67 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.634 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.963 HD13 ' CD2' ' A' ' 68' ' ' PHE . 6.8 tp -78.09 -30.75 49.76 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.895 0.378 . . . . 0.0 111.609 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.599 ' HB2' HG22 ' A' ' 123' ' ' ILE . 14.3 ttpt -53.91 -42.62 68.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.949 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -70.5 -7.69 45.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.831 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.334 -0.105 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.298 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.915 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 5155 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 5156 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.8 0.333 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 134.45 42.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 79' ' ' HIS . 4.9 mttt -140.01 129.15 23.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.812 ' HG ' HG22 ' A' ' 80' ' ' ILE . 2.1 pp -146.16 119.84 9.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.613 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.785 ' C ' HD13 ' A' ' 6' ' ' ILE . 6.6 mt-30 -101.89 157.45 16.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.096 0.474 . . . . 0.0 112.022 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.785 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -142.96 138.99 27.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.46 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.967 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.97 125.68 44.29 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.469 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.471 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -135.81 156.02 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.169 0.509 . . . . 0.0 111.573 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -151.37 126.08 2.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.799 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.024 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.87 110.63 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.756 HG22 ' CE3' ' A' ' 90' ' ' TRP . 1.2 mt -71.43 120.27 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.96 0.41 . . . . 0.0 111.4 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -83.15 124.42 30.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.512 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.506 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 4.8 t-20 -70.33 -172.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.979 0.895 . . . . 0.0 112.587 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -64.15 -12.0 35.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.781 -1.554 . . . . 0.0 113.079 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -129.05 -82.26 0.57 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.669 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -153.81 14.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.543 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 1.5 pt-20 -100.98 160.32 14.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.024 HG21 HG22 ' A' ' 10' ' ' ILE . 11.3 mt -135.94 142.18 39.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.007 0.432 . . . . 0.0 111.501 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -93.02 129.46 38.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.992 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' HB ' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.83 140.88 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.957 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.413 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 6.4 p -71.55 111.8 7.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.807 0.336 . . . . 0.0 111.089 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HA ' HD23 ' A' ' 33' ' ' LEU . 3.2 ttt-85 -85.16 83.53 7.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.073 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 43.64 30.77 0.38 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.965 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.927 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . . . 65.22 24.4 12.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.534 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 50.07 49.23 20.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.0 111.334 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -96.87 22.98 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.17 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.66 -80.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.291 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -58.34 153.19 16.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.913 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 mtt 59.46 43.13 16.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.823 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.63 -8.79 57.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.681 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.16 13.47 11.27 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -114.28 26.21 10.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.994 0.426 . . . . 0.0 111.339 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -45.7 100.3 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.485 179.543 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.9 -174.18 2.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.245 0.545 . . . . 0.0 112.226 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.77 168.33 10.46 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.336 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.439 ' HA ' ' CD ' ' A' ' 98' ' ' GLU . 89.2 Cg_endo -75.41 168.8 23.79 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.6 2.867 . . . . 0.0 112.102 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.723 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.9 59.63 0.73 Allowed Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.19 -1.005 . . . . 0.0 114.213 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -121.42 138.82 12.69 Favored Glycine 0 C--N 1.315 -0.586 0 CA-C-N 114.614 -0.793 . . . . 0.0 112.206 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.62 -4.79 0.13 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.082 0.553 . . . . 0.0 111.901 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.967 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.89 -47.56 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.421 0.629 . . . . 0.0 111.099 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -30.95 -77.57 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.813 -179.11 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.5 mtp 39.42 -93.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.83 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.63 22.92 0.08 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.49 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.68 -158.21 0.11 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.339 0.114 . . . . 0.0 110.876 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.83 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -106.02 153.06 40.43 Favored Pre-proline 0 N--CA 1.455 -0.196 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.83 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.99 -24.76 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.624 2.216 . . . . 0.0 112.373 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.623 ' O ' HG23 ' A' ' 51' ' ' VAL . 37.3 mm-40 -101.61 -47.3 4.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.924 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -80.66 -5.2 56.62 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 44' ' ' GLU . . . -64.82 -57.46 8.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.573 0.225 . . . . 0.0 110.719 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.712 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -79.17 -45.55 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.135 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.8 t -50.58 -38.45 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 0.0 111.146 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -78.64 -51.97 9.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.004 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.431 ' HG3' ' OE2' ' A' ' 57' ' ' GLU . 1.3 tp10 -63.68 -23.9 67.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.867 HD21 ' NE2' ' A' ' 64' ' ' HIS . 3.2 tp -53.95 -44.33 70.62 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.886 0.374 . . . . 0.0 110.054 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -60.81 -32.72 72.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -77.4 -23.95 50.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.733 179.024 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 37' ' ' GLY . 5.7 mp0 -108.15 5.36 25.81 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.968 HG12 HG13 ' A' ' 60' ' ' ILE . 25.3 t -134.63 -44.43 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 109.935 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.562 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.58 -40.17 0.23 Allowed Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.787 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.968 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.72 -177.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.06 0.457 . . . . 0.0 111.059 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.05 88.41 14.64 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.942 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.807 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.6 Cg_endo -111.1 148.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.446 2.764 . . . . 0.0 113.848 -177.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -74.67 79.73 2.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.006 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -122.72 126.96 48.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.885 -176.519 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.2 t80 -179.62 167.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.676 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.5 t 79.54 177.4 0.12 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.395 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.868 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -135.61 130.78 34.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.458 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.78 ' CD2' HD22 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -76.86 -41.6 43.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.218 0.533 . . . . 0.0 109.696 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.691 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.9 mt-10 -171.39 131.35 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.786 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 132.16 56.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.836 0.351 . . . . 0.0 111.554 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.777 HD22 ' HB2' ' A' ' 121' ' ' PRO . 14.7 tp -112.04 132.81 54.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.472 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -123.9 110.96 15.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.817 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.801 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.0 p90 -141.01 153.07 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.764 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' OE1' ' CE1' ' A' ' 79' ' ' HIS . 8.0 pt-20 -116.27 138.35 51.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.185 0.516 . . . . 0.0 111.289 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -93.21 163.22 25.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.339 179.716 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -52.49 82.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.935 2.423 . . . . 0.0 112.168 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.5 t0 88.74 13.29 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.355 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.451 ' NE ' HD21 ' A' ' 4' ' ' LEU . 7.1 ttp180 -137.36 96.18 3.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.759 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.403 ' CE1' ' OE1' ' A' ' 74' ' ' GLU . 2.4 t60 -80.38 117.66 21.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.582 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.812 HG22 ' HG ' ' A' ' 4' ' ' LEU . 7.9 pt -125.32 128.31 72.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.172 0.51 . . . . 0.0 111.931 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.32 118.58 35.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.815 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.849 HD22 ' CE1' ' A' ' 84' ' ' PHE . 1.1 mt -101.57 113.61 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.908 0.385 . . . . 0.0 111.416 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 10.0 m0 -116.25 122.6 45.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.741 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.898 ' CE1' HG21 ' A' ' 122' ' ' VAL . 1.2 m-85 -110.84 111.36 22.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.924 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.868 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 24.4 m95 -94.29 136.55 34.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.983 0.42 . . . . 0.0 111.376 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 55.2 tp -88.37 102.93 15.35 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.232 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.006 HG22 ' ND1' ' A' ' 64' ' ' HIS . 37.0 t -83.08 145.52 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.122 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -110.24 -25.73 9.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.81 163.33 26.64 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.706 0.684 . . . . 0.0 111.408 -179.428 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.756 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.27 120.69 4.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.967 0.413 . . . . 0.0 111.324 178.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -77.5 153.47 33.42 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.067 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.46 -121.04 21.15 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.528 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.2 tt0 -134.96 147.6 63.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.547 0.213 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.516 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.57 128.76 10.47 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.859 2.373 . . . . 0.0 111.241 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.562 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 57.7 p-90 -137.42 -60.24 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.161 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.518 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 53.93 -97.64 0.03 OUTLIER Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.688 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 178.06 22.94 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.439 ' CD ' ' HA ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -67.96 -32.9 73.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.934 0.397 . . . . 0.0 110.682 179.52 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.61 35.12 29.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.779 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.927 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 66.0 mt-30 -140.11 91.9 9.88 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.022 0.439 . . . . 0.0 111.178 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -43.69 137.38 6.27 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.025 2.483 . . . . 0.0 112.758 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.22 177.01 19.48 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.596 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.8 157.0 44.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.576 0.227 . . . . 0.0 110.641 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -78.15 107.18 10.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.95 0.405 . . . . 0.0 110.509 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.4 ptm -119.61 163.23 17.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.908 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p -77.98 114.97 17.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.661 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.755 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -73.54 -28.14 61.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 p -53.01 -22.7 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.315 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.3 42.69 1.59 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.337 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.511 HD13 HD22 ' A' ' 107' ' ' LEU . 10.9 tp -62.66 147.22 50.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.11 132.1 53.95 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.61 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.35 -15.2 61.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.498 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.67 -49.31 13.38 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.574 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -32.88 74.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.086 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.61 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -87.97 173.14 6.73 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.408 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.497 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.2 Cg_endo -72.19 127.72 13.05 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.122 1.881 . . . . 0.0 111.701 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.44 -14.96 45.51 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.568 2.179 . . . . 0.0 113.125 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.49 58.57 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.843 ' ND2' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -121.35 32.17 6.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.729 0.3 . . . . 0.0 111.278 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -75.93 -36.1 1.86 Allowed Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.251 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.777 ' HB2' HD22 ' A' ' 71' ' ' LEU . 71.4 Cg_exo -49.56 -43.19 40.21 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 121.971 1.78 . . . . 0.0 112.918 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.898 HG21 ' CE1' ' A' ' 84' ' ' PHE . 1.8 t -77.36 -51.25 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.105 0.479 . . . . 0.0 111.099 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.558 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.1 mm -63.65 -32.58 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.273 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.9 -31.26 59.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.038 0.447 . . . . 0.0 110.477 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -72.78 -52.54 14.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.617 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.78 HD22 ' CD2' ' A' ' 68' ' ' PHE . 1.8 tp -78.19 -33.01 50.34 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.558 ' HB2' HG22 ' A' ' 123' ' ' ILE . 3.2 ttpm? -53.73 -42.61 68.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.067 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -67.85 -9.46 44.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.792 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 126' ' ' LEU . 11.0 mp . . . . . 0 C--N 1.333 -0.112 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.888 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.748 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 5167 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 5168 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.85 0.357 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.65 133.76 33.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.99 126.54 20.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.829 HD12 ' CD1' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -133.51 140.33 47.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.771 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.747 ' C ' HD13 ' A' ' 6' ' ' ILE . 9.4 mt-30 -106.61 150.43 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.279 0.561 . . . . 0.0 111.915 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.829 ' CD1' HD12 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -140.7 139.09 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.41 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.941 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.47 140.63 52.77 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -144.56 151.24 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.242 0.544 . . . . 0.0 111.327 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.56 130.67 3.21 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.17 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.877 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -88.43 108.0 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.727 HG23 HG11 ' A' ' 87' ' ' VAL . 1.1 mt -71.28 124.99 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.133 0.492 . . . . 0.0 111.479 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -87.06 127.12 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.969 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.465 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 14.8 t30 -81.95 -172.29 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.858 0.837 . . . . 0.0 112.012 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -81.82 3.59 25.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.227 -1.351 . . . . 0.0 112.261 -179.225 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -139.2 51.88 1.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 0.0 111.425 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.7 p30 45.3 26.29 0.26 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.421 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 8.1 pt-20 -118.81 144.08 46.55 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.877 HG21 HG22 ' A' ' 10' ' ' ILE . 10.1 mt -114.22 142.86 25.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.162 0.506 . . . . 0.0 111.459 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -95.92 128.4 42.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.671 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.65 162.14 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.489 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.617 HG23 ' HD3' ' A' ' 36' ' ' PRO . 38.2 p -91.99 111.97 23.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.755 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -101.15 165.9 11.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.219 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -71.45 55.86 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.958 0.408 . . . . 0.0 110.305 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 43.51 -164.63 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.489 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.78 47.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.018 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -131.29 -174.48 3.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.992 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.29 -163.08 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.3 m80 64.33 99.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.95 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.3 mmt 57.51 52.04 8.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.0 -8.84 56.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.639 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.82 31.04 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.517 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 26.26 10.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.859 0.362 . . . . 0.0 111.532 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -48.61 95.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.508 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.7 tt0 -113.11 -179.14 3.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.196 0.522 . . . . 0.0 111.64 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.95 162.05 35.21 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.517 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.617 ' HD3' HG23 ' A' ' 21' ' ' THR . 9.3 Cg_endo -50.29 168.76 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.569 2.846 . . . . 0.0 111.526 178.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.678 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.04 59.69 0.73 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.757 -1.211 . . . . 0.0 113.86 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -138.3 117.73 1.49 Allowed Glycine 0 C--N 1.313 -0.71 0 CA-C-N 114.548 -0.826 . . . . 0.0 111.91 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.82 -6.9 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.307 0.643 . . . . 0.0 111.215 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.941 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -43.62 -62.65 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.258 0.551 . . . . 0.0 111.375 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.499 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -16.77 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.425 -179.598 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.5 mmt 43.14 -94.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.511 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.83 17.82 0.09 OUTLIER Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.598 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.74 -161.66 0.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.532 0.206 . . . . 0.0 110.742 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.883 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.66 154.4 39.26 Favored Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.883 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -44.0 -24.87 0.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.694 2.263 . . . . 0.0 112.406 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.646 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -98.48 -50.38 4.31 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.985 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -80.45 -4.99 55.86 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -65.49 -57.5 8.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.574 0.226 . . . . 0.0 110.819 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.707 ' CG2' HD13 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -78.68 -43.32 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.029 179.279 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.9 t -50.63 -36.45 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.344 . . . . 0.0 110.721 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.67 -48.47 14.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.747 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -67.03 -20.0 65.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.03 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.707 HD13 ' CG2' ' A' ' 50' ' ' VAL . 3.3 tp -57.47 -44.82 85.18 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 110.477 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -32.28 73.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 97' ' ' LYS . 5.7 tm-20 -77.37 -25.48 51.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.92 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -108.15 5.36 25.81 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.93 HG12 HG13 ' A' ' 60' ' ' ILE . 30.0 t -134.33 -44.31 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.139 0.495 . . . . 0.0 109.94 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.535 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.57 -41.62 0.31 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.463 -0.789 . . . . 0.0 113.715 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.93 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.64 -177.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 120.975 0.417 . . . . 0.0 111.107 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.36 88.41 15.46 Favored Pre-proline 0 N--CA 1.441 -0.897 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.969 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.8 ' HG3' HG11 ' A' ' 58' ' ' VAL . 9.1 Cg_endo -109.69 150.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.393 2.729 . . . . 0.0 113.659 -177.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.66 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.02 80.72 3.55 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 175.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.996 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.65 128.0 50.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.298 -176.054 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.5 t80 -179.35 168.54 1.48 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.593 -0.443 . . . . 0.0 112.106 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.411 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 0.3 OUTLIER 77.26 -166.93 0.05 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.453 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -151.8 133.42 14.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.056 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.66 ' CE1' HG12 ' A' ' 122' ' ' VAL . 15.7 p90 -76.7 -41.78 43.98 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.663 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.3 mt-10 -171.6 131.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.083 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG2' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.7 132.42 42.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.759 0.314 . . . . 0.0 111.643 -179.082 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.846 HD22 HG22 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -112.31 156.52 22.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.791 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -137.12 110.0 7.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.658 ' HE1' HD12 ' A' ' 82' ' ' LEU . 7.2 p90 -128.84 153.12 47.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.757 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -121.05 119.4 32.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 111.212 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -73.97 163.07 71.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.52 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.4 Cg_endo -53.79 82.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.92 2.413 . . . . 0.0 112.087 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.9 t70 91.86 11.08 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.373 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.425 ' CG ' HD21 ' A' ' 4' ' ' LEU . 2.7 ttt180 -137.29 93.81 2.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 0.0 110.846 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.21 103.11 6.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 1.1 tt -106.17 111.75 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.015 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.428 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -94.36 118.47 31.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.77 179.272 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.658 HD12 ' HE1' ' A' ' 73' ' ' TYR . 10.4 mt -107.35 114.03 27.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 111.612 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.431 ' O ' HG13 ' A' ' 8' ' ' VAL . 11.2 m0 -108.62 122.47 47.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.139 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.663 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 6.3 m-85 -112.67 112.25 23.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.4 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.702 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 30.1 m95 -94.75 148.21 22.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.57 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 65' ' ' PHE . 47.2 tp -100.76 102.96 14.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.057 0.456 . . . . 0.0 110.809 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.996 HG22 ' ND1' ' A' ' 64' ' ' HIS . 33.4 t -84.81 145.35 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.733 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 3.9 mt-10 -106.36 -33.47 7.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.08 165.4 24.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.927 0.785 . . . . 0.0 111.813 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.703 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -151.56 127.52 10.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 111.53 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -76.89 147.76 36.84 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.11 -121.2 25.93 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.438 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -133.99 148.09 66.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.631 0.253 . . . . 0.0 110.82 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.49 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.65 128.71 10.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.948 2.432 . . . . 0.0 111.566 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.535 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 62.1 p-90 -136.16 -58.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.716 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.578 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.1 -95.72 0.01 OUTLIER Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.01 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' GLU . 2.8 tttp 174.25 37.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 110.938 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.459 ' OE2' HG22 ' A' ' 21' ' ' THR . 1.8 pt-20 -66.94 -30.63 70.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.512 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 10.3 79.39 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.391 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.406 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 4.7 mt-30 -140.24 91.88 9.73 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.356 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -43.72 138.48 5.74 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 123.054 2.503 . . . . 0.0 112.643 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.07 19.43 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.747 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -136.4 157.17 47.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.567 0.222 . . . . 0.0 110.577 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -72.98 107.16 5.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.88 0.372 . . . . 0.0 110.278 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.455 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -119.63 163.04 17.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.432 ' OG ' HG12 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -78.97 114.85 18.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.807 ' CD1' HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -72.27 -18.73 61.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.838 HG22 HD21 ' A' ' 129' ' ' LEU . 14.8 p -62.52 -10.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.446 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.25 50.48 0.89 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.63 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.807 HD23 ' CD1' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -62.09 138.86 58.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.678 0.275 . . . . 0.0 110.538 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.604 ' H ' HD13 ' A' ' 110' ' ' LEU . 1.1 m-80 -116.87 121.75 42.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.169 0.509 . . . . 0.0 111.885 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.663 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.1 -15.13 62.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.977 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -78.33 -49.46 13.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -70.64 -22.54 62.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.546 0.212 . . . . 0.0 111.367 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.663 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -100.35 170.81 6.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.5 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 43.7 Cg_endo -68.09 127.67 16.34 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.234 1.956 . . . . 0.0 111.898 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.38 -19.65 61.54 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.577 2.184 . . . . 0.0 113.001 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.93 -9.37 58.25 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.632 HD21 ' HZ ' ' A' ' 84' ' ' PHE . 1.6 m120 -117.72 29.54 7.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.779 0.323 . . . . 0.0 111.408 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.3 mt-10 -76.24 -31.87 1.03 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.789 ' HB2' HD13 ' A' ' 71' ' ' LEU . 82.3 Cg_exo -48.52 -45.44 27.14 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 121.869 1.712 . . . . 0.0 113.04 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.846 HG22 HD22 ' A' ' 71' ' ' LEU . 1.4 t -77.41 -51.4 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.07 0.462 . . . . 0.0 111.205 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.495 ' CG2' ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -62.42 -36.89 77.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.612 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.62 -29.77 52.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.905 0.384 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -79.74 -48.47 13.58 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.593 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.454 HD13 ' CD1' ' A' ' 68' ' ' PHE . 3.4 tp -78.09 -46.6 20.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.852 0.358 . . . . 0.0 111.269 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.571 ' O ' HD13 ' A' ' 129' ' ' LEU . 8.2 ttpp -51.95 -42.24 62.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.879 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -63.96 -7.08 7.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.142 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.838 HD21 HG22 ' A' ' 108' ' ' VAL . 8.1 mp . . . . . 0 C--O 1.231 0.119 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.813 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 5179 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 5180 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.924 0.393 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -74.96 134.16 41.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HG2' ' CG ' ' A' ' 79' ' ' HIS . 23.1 mtpt -140.0 135.02 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.766 HD12 ' CD1' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -146.04 141.08 27.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.768 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.753 ' C ' HD13 ' A' ' 6' ' ' ILE . 28.1 mt-30 -106.16 149.9 26.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.405 0.622 . . . . 0.0 112.316 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.766 ' CD1' HD12 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.31 116.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.611 178.667 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.969 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.98 135.81 53.15 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.352 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 0.9 OUTLIER -144.54 163.1 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.98 0.419 . . . . 0.0 111.19 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -141.25 130.35 4.41 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.091 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.964 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -72.0 108.45 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.74 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.5 mt -70.97 125.98 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.623 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.628 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -87.7 127.25 35.3 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.62 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.536 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 6.1 t-20 -69.93 -172.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.458 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.04 -10.7 31.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.895 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -133.82 -82.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.785 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -149.97 16.21 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 0.0 111.613 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.821 ' C ' HD12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -100.61 160.56 14.25 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.964 HG21 HG22 ' A' ' 10' ' ' ILE . 1.8 mp -130.64 138.14 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.094 0.473 . . . . 0.0 111.482 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.585 ' CZ ' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -85.96 116.02 23.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.332 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.505 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.05 120.11 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.745 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.86 HG21 ' HG2' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -70.73 115.97 10.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.575 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 19.6 ptt-85 -106.89 172.33 6.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.66 62.03 0.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.496 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 46.23 -169.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.412 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.19 -33.68 38.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.069 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -159.42 138.01 10.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -171.18 -75.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -151.69 -66.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 tpt -106.4 79.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.788 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.93 -8.97 58.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.621 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -96.33 26.48 4.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.744 0.307 . . . . 0.0 111.144 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -114.22 26.2 10.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.018 0.437 . . . . 0.0 111.191 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.489 HD21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -45.47 114.12 0.7 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.619 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' ' CD ' ' A' ' 116' ' ' PRO . 0.5 OUTLIER -124.85 -171.66 2.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.195 0.521 . . . . 0.0 112.094 -179.17 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.611 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.55 168.59 9.79 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.146 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.562 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 87.5 Cg_endo -81.74 167.29 16.79 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.628 2.885 . . . . 0.0 113.799 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.39 -5.44 52.05 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.371 -0.831 . . . . 0.0 114.988 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -59.25 171.68 4.97 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.5 0.65 . . . . 0.0 113.214 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 76.58 7.03 3.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.517 0.327 . . . . 0.0 111.811 179.645 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.969 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.3 pt -55.44 -26.84 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.673 0.749 . . . . 0.0 110.032 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.542 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.98 -60.17 1.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.692 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER 5.37 -79.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.471 179.283 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.54 33.63 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.643 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.4 mp0 -88.95 -174.82 4.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.821 0.343 . . . . 0.0 111.09 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.852 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.5 154.14 38.09 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.322 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.852 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.97 -25.25 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.872 2.381 . . . . 0.0 112.448 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.8 mt-10 -104.02 -40.4 6.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.405 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.402 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 34.4 mt-30 -80.29 -4.91 55.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.654 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.919 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.89 -57.11 14.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.409 . . . . 0.0 110.667 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.803 HG11 ' NE1' ' A' ' 85' ' ' TRP . 2.5 m -78.64 -45.99 25.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.48 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.489 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 29.0 t -56.33 -36.66 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.141 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -77.95 -49.78 13.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.983 0.42 . . . . 0.0 110.193 179.428 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.53 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.5 mm-40 -65.56 -19.89 66.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.334 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.534 HD11 ' CD2' ' A' ' 64' ' ' HIS . 8.6 tp -56.55 -44.49 80.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -31.81 69.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.075 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.45 -31.09 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.572 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HA ' ' H ' ' A' ' 97' ' ' LYS . 4.0 mp0 -108.06 5.37 25.99 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.866 HG13 ' HB3' ' A' ' 94' ' ' PRO . 16.0 t -134.39 -43.96 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.104 0.478 . . . . 0.0 110.067 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.574 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.86 -38.32 0.29 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.614 -0.721 . . . . 0.0 114.207 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.845 HG22 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.71 -178.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.64 88.98 6.97 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.696 ' HG3' HG11 ' A' ' 58' ' ' VAL . 10.6 Cg_endo -108.28 144.07 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.475 2.783 . . . . 0.0 113.987 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.81 79.44 2.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.84 ' CB ' HG13 ' A' ' 87' ' ' VAL . 1.1 t-80 -123.23 122.36 38.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.65 -1.613 . . . . 0.0 109.895 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 6.5 t80 -179.41 161.07 1.04 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.177 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 9.3 t 77.01 166.93 0.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.783 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.797 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -119.54 130.08 54.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.873 ' CE2' HD11 ' A' ' 10' ' ' ILE . 7.1 p90 -78.2 -41.33 34.84 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.598 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -171.31 131.75 0.77 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.328 178.037 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.796 ' HG2' HD13 ' A' ' 67' ' ' LEU . 50.4 pttt -139.39 132.75 30.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 111.483 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.023 HD12 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -123.43 151.38 42.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.952 0.406 . . . . 0.0 110.996 179.455 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -121.59 133.91 55.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.757 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -141.03 145.81 36.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.568 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.08 126.35 49.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.095 0.474 . . . . 0.0 111.365 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -86.4 163.1 43.51 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.319 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.6 Cg_endo -53.97 82.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.825 2.35 . . . . 0.0 112.166 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.7 t70 93.25 9.67 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.52 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.482 ' CZ ' HD21 ' A' ' 4' ' ' LEU . 10.2 ttt85 -137.34 93.78 2.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.299 . . . . 0.0 110.759 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.416 ' CG ' ' HG2' ' A' ' 3' ' ' LYS . 1.1 m-70 -82.3 102.28 11.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.921 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 2.0 tt -106.32 111.73 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.025 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.422 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -92.54 118.45 31.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.015 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.531 HD23 HD11 ' A' ' 71' ' ' LEU . 14.8 tp -108.0 114.09 27.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 111.577 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.405 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 9.8 m0 -112.22 122.2 47.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.46 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 5.8 m-30 -109.84 109.63 20.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.911 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.803 ' NE1' HG11 ' A' ' 50' ' ' VAL . 32.5 m95 -95.79 148.65 22.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.622 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.0 pp -87.29 138.12 31.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.433 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.84 HG13 ' CB ' ' A' ' 64' ' ' HIS . 17.5 t -123.65 145.52 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.018 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.87 -30.68 8.01 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.572 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.28 165.01 24.71 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.221 0.919 . . . . 0.0 112.111 -178.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.74 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -154.64 130.15 9.86 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.133 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.23 132.71 47.62 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.055 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 48.79 -105.23 0.12 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.416 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 26.5 tt0 -134.32 137.65 28.46 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.812 -0.194 . . . . 0.0 110.759 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.866 ' HB3' HG13 ' A' ' 58' ' ' VAL . 4.7 Cg_exo -74.13 128.9 12.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.596 2.197 . . . . 0.0 110.682 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.574 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 21.5 p-90 -118.15 -63.95 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.583 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.43 -100.16 0.02 OUTLIER Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.853 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 160.56 74.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.584 0.354 . . . . 0.0 110.774 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.86 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.9 OUTLIER -88.6 -33.2 17.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.803 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 142.44 -38.5 1.45 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.323 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.487 ' O ' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -140.01 110.76 7.22 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.018 0.437 . . . . 0.0 111.885 -179.333 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -43.84 146.39 1.58 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.121 2.547 . . . . 0.0 112.55 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.19 177.29 17.48 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.001 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -128.85 157.23 42.11 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -77.99 106.83 10.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.4 ptp -119.99 163.08 18.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.924 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 95.8 p -75.04 114.98 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.859 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.69 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -78.97 -18.92 52.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.306 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.42 ' HA ' HD21 ' A' ' 129' ' ' LEU . 25.0 t -54.28 -18.52 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.424 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.39 55.1 0.57 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.268 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.533 HD22 HG23 ' A' ' 123' ' ' ILE . 5.6 tt -62.15 150.43 38.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -107.87 126.01 52.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.334 0.588 . . . . 0.0 112.428 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.656 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -15.2 61.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.791 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -78.11 -49.14 14.46 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.654 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -26.33 65.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.79 0.329 . . . . 0.0 110.8 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.656 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -98.36 166.96 12.33 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.17 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.6 Cg_endo -72.61 127.81 12.81 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.393 2.062 . . . . 0.0 111.937 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.54 -14.92 42.55 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.595 2.197 . . . . 0.0 113.05 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.69 -9.51 57.3 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.433 ' OD1' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -121.72 31.17 6.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.827 0.346 . . . . 0.0 111.277 -179.181 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.2 -34.13 1.37 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -179.162 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 93.1 Cg_exo -44.73 -46.28 12.69 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.21 1.94 . . . . 0.0 113.193 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 1.023 HG22 HD12 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -77.14 -33.98 20.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.029 0.442 . . . . 0.0 110.048 179.666 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.581 HG13 ' CE2' ' A' ' 115' ' ' PHE . 7.8 mm -68.18 -39.79 81.77 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.839 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.55 -29.44 50.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.436 . . . . 0.0 110.371 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -80.27 -53.21 6.86 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.782 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.69 ' CD2' HD12 ' A' ' 107' ' ' LEU . 1.7 tp -78.3 -19.79 52.84 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.513 ' HB2' HG22 ' A' ' 123' ' ' ILE . 54.6 tttm -78.21 -42.71 30.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.081 0.467 . . . . 0.0 110.745 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -69.65 -7.03 35.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.905 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.123 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.683 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.749 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 5191 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 5192 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.875 0.369 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -109.75 121.5 45.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -128.62 134.72 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.912 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.537 HD13 HD11 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -139.13 143.03 38.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.419 ' C ' HD12 ' A' ' 6' ' ' ILE . 30.9 mt-30 -102.61 153.1 20.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.335 0.588 . . . . 0.0 112.02 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.83 ' HB ' HD23 ' A' ' 82' ' ' LEU . 4.9 mp -146.2 127.93 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.743 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.063 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.58 124.56 42.5 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.581 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 2.0 m -116.53 162.23 14.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.345 0.593 . . . . 0.0 111.912 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -143.25 109.57 0.56 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.848 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -70.53 98.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.733 HG22 ' CE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.14 123.72 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 121.21 0.529 . . . . 0.0 112.121 -178.352 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.528 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -96.23 127.19 42.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.363 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.511 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 48.7 t30 -79.58 -172.63 3.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.113 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.483 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 14.9 tp10 -80.48 -2.72 47.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.299 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -134.16 49.61 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.879 0.371 . . . . 0.0 111.229 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 48.04 22.62 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.448 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 18.4 pt-20 -110.44 141.08 44.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.628 HG21 HG13 ' A' ' 10' ' ' ILE . 2.6 mt -110.82 151.44 12.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.284 0.564 . . . . 0.0 112.296 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -101.01 99.96 10.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.517 178.838 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.419 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.81 120.1 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.569 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.628 HG23 ' HD3' ' A' ' 36' ' ' PRO . 18.2 p -71.08 111.85 6.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.998 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 2.5 ptm180 -98.71 172.09 7.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.451 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -72.06 58.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.967 0.413 . . . . 0.0 110.235 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 46.25 -169.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.419 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.22 27.31 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -180.0 38.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.78 -70.38 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -177.64 -68.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.21 85.27 3.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.01 -8.79 57.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.64 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.09 20.36 5.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.468 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 26.26 10.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 111.501 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -46.8 120.21 2.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.696 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.533 ' HG2' ' N2 ' ' A' ' 131' ' ' 8OG . 7.8 mt-10 -137.19 -174.11 3.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.045 0.45 . . . . 0.0 111.473 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.561 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.03 161.17 39.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.23 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.628 ' HD3' HG23 ' A' ' 21' ' ' THR . 12.2 Cg_endo -54.65 167.76 1.34 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.374 2.716 . . . . 0.0 111.715 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.61 59.56 0.75 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.768 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -124.96 132.15 8.01 Favored Glycine 0 C--N 1.311 -0.818 0 CA-C-N 114.406 -0.897 . . . . 0.0 111.78 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.41 5.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.936 0.494 . . . . 0.0 112.297 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.063 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.27 -28.11 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.601 0.715 . . . . 0.0 110.279 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.578 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.98 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.787 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.5 mmm 31.77 -86.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.52 0.513 . . . . 0.0 111.827 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -158.96 24.38 0.33 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.605 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -102.64 -179.51 3.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.892 0.377 . . . . 0.0 111.051 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.906 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.55 158.52 34.46 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.929 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.906 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.86 -24.7 0.85 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.726 2.284 . . . . 0.0 112.473 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -85.24 -61.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -80.4 -20.13 44.69 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.883 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -56.87 -48.43 78.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.734 0.302 . . . . 0.0 111.093 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.729 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.0 OUTLIER -78.11 -47.29 25.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.7 t -57.4 -38.49 63.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.624 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -78.44 -46.54 19.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.989 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -69.79 -21.66 63.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.344 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.678 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -57.39 -44.68 84.71 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.777 0.322 . . . . 0.0 110.565 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -30.9 71.94 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.1 tm-20 -77.63 -29.05 51.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.104 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.68 5.85 25.23 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.955 HG12 HG13 ' A' ' 60' ' ' ILE . 21.3 t -134.04 -44.3 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.956 0.408 . . . . 0.0 109.989 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.598 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.68 -41.33 0.31 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.648 -0.705 . . . . 0.0 113.488 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.955 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.55 -176.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -113.06 89.1 13.24 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.306 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.88 ' HG3' HG11 ' A' ' 58' ' ' VAL . 7.9 Cg_endo -108.79 148.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 123.205 2.604 . . . . 0.0 114.139 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' CG ' ' HG2' ' A' ' 89' ' ' ARG . 86.6 mt-30 -74.76 79.8 2.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.958 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -123.11 125.55 45.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.374 -176.822 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.6 t80 -177.77 159.12 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.128 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER 84.21 -170.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.298 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.689 HD13 ' HD3' ' A' ' 70' ' ' LYS . 3.5 pp -145.02 130.58 18.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.056 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.619 ' CE1' HG12 ' A' ' 122' ' ' VAL . 1.3 p90 -76.67 -35.18 58.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.212 0.529 . . . . 0.0 109.678 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.7 OUTLIER -171.2 163.53 7.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.504 179.038 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.689 ' HD3' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.53 132.41 22.74 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.684 -179.602 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.739 ' HB2' HG22 ' A' ' 122' ' ' VAL . 9.0 tp -119.25 142.45 48.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.727 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -140.0 111.02 6.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.505 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.579 ' HE1' HD12 ' A' ' 82' ' ' LEU . 8.8 p90 -138.67 153.27 48.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.767 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.06 140.02 52.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.176 0.512 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -89.2 163.18 35.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.545 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.3 Cg_endo -51.9 83.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.103 2.536 . . . . 0.0 112.036 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 8.1 m-20 93.96 16.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.142 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 35.1 ttt180 -137.32 150.13 47.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.489 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.83 99.72 6.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.763 0.316 . . . . 0.0 110.719 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.506 HD12 H2'' ' A' ' 131' ' ' 8OG . 4.7 tt -104.35 111.75 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 120.956 0.408 . . . . 0.0 110.96 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.438 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -103.88 118.99 38.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.235 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.83 HD23 ' HB ' ' A' ' 6' ' ' ILE . 66.3 mt -118.86 114.35 22.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.877 0.37 . . . . 0.0 111.615 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.472 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.8 m0 -106.29 122.37 46.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.142 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.908 ' CG ' HG11 ' A' ' 122' ' ' VAL . 2.2 m-85 -98.94 110.39 23.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.71 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.729 ' NE1' HG11 ' A' ' 50' ' ' VAL . 31.9 m95 -94.85 148.77 21.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.822 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.746 HD13 ' N ' ' A' ' 87' ' ' VAL . 3.1 tm? -94.17 137.36 33.44 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.356 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.958 HG22 ' ND1' ' A' ' 64' ' ' HIS . 41.1 t -124.14 145.01 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.499 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.59 -27.68 8.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.1 165.2 24.93 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.716 0.689 . . . . 0.0 111.766 -179.26 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.733 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -155.72 122.36 5.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.293 178.611 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.24 145.25 49.72 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.069 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.49 -116.82 6.9 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.582 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.6 tt0 -134.47 145.77 56.53 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.591 0.234 . . . . 0.0 110.819 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.53 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.4 Cg_exo -76.5 128.78 10.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.913 2.408 . . . . 0.0 111.135 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.598 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 47.5 p-90 -130.84 -62.54 0.9 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.549 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.37 -97.5 0.01 OUTLIER Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.613 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.6 tptp 178.77 35.49 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.636 0.255 . . . . 0.0 111.389 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.523 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -62.35 -46.21 89.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.334 179.452 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.34 14.91 46.15 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.353 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.434 ' O ' ' HB ' ' A' ' 21' ' ' THR . 49.9 mt-30 -140.31 92.91 9.18 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 111.539 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -43.78 138.42 5.93 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.901 2.401 . . . . 0.0 112.534 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.457 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.18 177.13 19.39 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.645 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.07 157.09 45.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.641 0.258 . . . . 0.0 110.785 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.464 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.45 107.13 6.4 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.876 0.37 . . . . 0.0 110.391 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -119.67 163.42 17.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.871 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.603 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.2 p -82.0 114.94 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.851 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.625 ' CD2' HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -71.88 -18.79 62.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.112 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.912 ' HA ' HD21 ' A' ' 129' ' ' LEU . 10.9 p -57.29 -11.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.632 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.2 51.42 0.84 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.157 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.612 HD23 ' CD1' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -61.92 134.59 56.87 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.522 ' H ' HD13 ' A' ' 110' ' ' LEU . 1.6 m-20 -111.2 121.58 45.66 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.747 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . . . -72.42 -14.72 61.77 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.801 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -76.41 -49.05 17.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.483 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -27.19 64.47 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.085 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.689 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -93.78 169.8 9.48 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.249 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.524 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 40.3 Cg_endo -67.33 127.58 16.85 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.216 1.944 . . . . 0.0 111.837 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.86 -15.01 47.29 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.588 2.192 . . . . 0.0 113.151 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.3 -9.19 59.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.553 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.6 m-80 -114.96 28.58 8.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.579 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -69.26 -34.48 4.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.259 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 61.8 Cg_exo -51.82 -45.87 35.7 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 121.962 1.775 . . . . 0.0 113.218 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.908 HG11 ' CG ' ' A' ' 84' ' ' PHE . 2.1 t -77.44 -51.34 18.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.328 . . . . 0.0 111.314 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.509 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -64.95 -29.81 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.064 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.38 -33.03 63.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.031 0.443 . . . . 0.0 110.257 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -78.3 -47.51 17.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.556 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.594 HD13 ' CG ' ' A' ' 68' ' ' PHE . 2.8 tp -78.17 -19.75 53.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.651 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.747 ' HE2' ' HB2' ' A' ' 112' ' ' ALA . 15.8 ttpp -83.64 -42.39 16.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.131 0.491 . . . . 0.0 110.524 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -63.91 -10.37 20.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.824 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.912 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.213 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.006 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.627 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 5203 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 5204 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.878 0.371 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -110.0 147.05 34.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HG2' ' CG ' ' A' ' 79' ' ' HIS . 7.6 mtmt -132.53 148.98 52.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.68 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.978 HD13 " O3'" ' A' ' 131' ' ' 8OG . 4.5 pp -146.07 132.45 19.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.283 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.465 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 42.3 mt-30 -102.78 153.6 20.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.353 0.597 . . . . 0.0 111.756 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 81' ' ' THR . 10.4 mm -146.46 130.22 10.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.085 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.021 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.84 124.21 41.61 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 9' ' ' GLY . 1.6 m -120.01 162.23 18.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.06 0.457 . . . . 0.0 111.564 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.93 109.4 0.48 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.81 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.74 HD11 HD13 ' A' ' 107' ' ' LEU . 1.1 tp -70.47 99.46 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.86 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -71.2 119.79 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -82.54 124.02 29.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.06 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.516 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 19.1 t-20 -69.63 177.6 2.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.851 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -54.59 -20.08 7.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.261 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -119.54 -82.46 0.64 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.67 0.271 . . . . 0.0 111.408 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.11 14.1 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 17.2 pt-20 -100.89 160.15 14.61 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.86 HG23 ' O ' ' A' ' 11' ' ' ILE . 3.4 mt -138.29 140.88 39.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.899 0.381 . . . . 0.0 111.895 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.724 ' CD2' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -86.15 113.08 21.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -111.81 119.53 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.168 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.731 HG22 ' HD3' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -74.99 111.8 10.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.95 0.405 . . . . 0.0 110.666 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.463 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 2.2 ptt180 -94.92 172.37 8.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.742 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.48 -18.66 4.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.265 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 100' ' ' GLN . . . 67.81 -81.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.227 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -177.94 87.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.093 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -113.78 -36.89 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -171.37 52.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 61.25 30.74 19.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.89 40.8 1.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.06 -8.72 55.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.773 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.63 16.39 5.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.26 26.23 10.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.083 0.468 . . . . 0.0 111.371 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.48 HD21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -47.48 122.22 4.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.705 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.825 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.4 tt0 -138.41 -167.25 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.005 0.431 . . . . 0.0 111.653 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.547 ' CD2' HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -119.15 155.2 53.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.499 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.731 ' HD3' HG22 ' A' ' 21' ' ' THR . 10.2 Cg_endo -52.9 167.67 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.324 2.683 . . . . 0.0 111.341 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.53 59.71 0.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 119.852 -1.166 . . . . 0.0 114.318 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -123.62 136.47 10.38 Favored Glycine 0 C--N 1.31 -0.863 0 CA-C-N 114.919 -0.64 . . . . 0.0 111.971 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.2 ttpt 91.27 4.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.006 0.522 . . . . 0.0 112.305 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.021 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -50.51 -29.14 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 110.364 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.17 -79.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.966 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 37.45 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.445 0.466 . . . . 0.0 111.634 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -161.93 26.14 0.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.691 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -99.45 -176.51 3.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.863 0.363 . . . . 0.0 111.125 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.917 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.93 162.92 18.66 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.405 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.917 ' HD2' HG22 ' A' ' 45' ' ' THR . 9.3 Cg_endo -49.14 -24.53 8.03 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.639 2.226 . . . . 0.0 112.425 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mm-40 -98.91 -48.04 5.05 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -77.17 -26.61 53.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.66 0.266 . . . . 0.0 111.615 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.967 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -57.79 -45.31 86.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.727 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.24 -46.63 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.516 179.585 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.4 t -60.03 -39.48 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.077 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -78.23 -45.77 22.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.963 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.68 -22.12 62.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.778 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.2 tp -53.87 -44.59 70.54 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.836 0.35 . . . . 0.0 110.082 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -59.54 -33.68 71.71 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.41 -26.25 51.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.994 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HG2' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -108.02 6.04 26.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.673 HG11 ' HG3' ' A' ' 62' ' ' PRO . 10.3 t -134.32 -44.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.214 0.53 . . . . 0.0 109.876 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.44 -43.43 0.57 Allowed Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.866 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.682 HG23 ' NE1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -84.36 -175.08 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.079 0.466 . . . . 0.0 111.292 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 p -112.64 89.09 12.32 Favored Pre-proline 0 N--CA 1.442 -0.875 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.554 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.673 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.9 Cg_endo -107.62 152.46 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.96 2.44 . . . . 0.0 114.203 -177.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -74.85 79.9 2.12 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.022 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.65 126.13 44.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.738 -176.704 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.9 t80 -179.35 165.66 1.43 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.9 0.381 . . . . 0.0 111.93 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 83.1 160.33 0.13 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.762 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -113.77 131.97 56.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 111.363 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -88.61 -33.91 17.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.102 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.1 tt0 -171.56 149.93 2.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.471 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.1 108.16 4.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.74 0.305 . . . . 0.0 110.689 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.723 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -120.85 140.55 51.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.794 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.475 ' CB ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER -140.14 139.47 35.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.964 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.591 ' O ' HG22 ' A' ' 80' ' ' ILE . 69.9 t80 -141.05 100.98 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.4 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 1.8 pm0 -64.76 136.88 57.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.159 0.504 . . . . 0.0 111.41 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.485 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -101.54 162.89 19.04 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.434 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.579 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.4 Cg_endo -53.06 81.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.019 2.479 . . . . 0.0 112.353 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 13.3 t70 102.23 -24.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.267 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.686 ' HE ' HD21 ' A' ' 4' ' ' LEU . 5.4 ttt180 -109.65 95.19 5.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.712 0.292 . . . . 0.0 111.09 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.413 ' CG ' ' HG2' ' A' ' 3' ' ' LYS . 18.9 m170 -77.85 93.87 4.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 0.0 110.542 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.873 HG13 HD11 ' A' ' 4' ' ' LEU . 2.4 tt -85.78 131.8 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.475 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.475 HG23 ' CB ' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -134.06 118.63 17.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.178 179.668 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.667 HD13 ' CE1' ' A' ' 84' ' ' PHE . 1.6 pp -126.35 117.09 22.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 111.343 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.416 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.9 m0 -102.82 122.86 45.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.667 ' CE1' HD13 ' A' ' 82' ' ' LEU . 3.5 m-30 -95.08 109.89 21.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.311 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.653 ' CE2' HG11 ' A' ' 50' ' ' VAL . 21.3 m95 -95.58 148.6 22.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.166 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 65' ' ' PHE . 12.2 tp -92.62 138.1 31.79 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.567 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.022 HG22 ' ND1' ' A' ' 64' ' ' HIS . 38.0 t -124.33 145.71 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.67 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -111.27 -30.57 7.38 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.4 165.24 24.15 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.925 0.784 . . . . 0.0 111.688 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.662 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.8 p90 -148.23 130.25 15.36 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.538 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -78.06 145.08 36.06 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.935 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.14 -116.29 8.16 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.383 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 7.0 mt-10 -135.05 139.29 31.56 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.458 0.171 . . . . 0.0 110.848 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.465 ' HA ' HG12 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -76.35 128.6 10.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.812 2.341 . . . . 0.0 111.537 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.682 ' NE1' HG23 ' A' ' 60' ' ' ILE . 55.5 p-90 -132.32 -60.22 0.9 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.879 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.597 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.28 -107.31 0.1 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.248 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 1.3 tptt 178.1 72.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.755 0.312 . . . . 0.0 110.728 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.524 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -89.78 -30.66 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.911 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.11 -66.23 0.4 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.885 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -101.1 104.97 36.12 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.002 0.43 . . . . 0.0 111.384 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -43.64 144.77 2.04 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.912 2.408 . . . . 0.0 112.748 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.482 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.08 177.12 19.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.393 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -133.14 153.6 51.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.644 0.259 . . . . 0.0 110.922 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 1.1 m0 -63.03 107.22 0.97 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.815 0.34 . . . . 0.0 110.357 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.4 ptm -119.44 140.5 50.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.08 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.1 p -63.19 114.89 4.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.087 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.74 HD13 HD11 ' A' ' 10' ' ' ILE . 12.4 tp -64.6 -18.76 65.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.073 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.8 t -55.73 -15.13 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.6 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.18 42.16 1.88 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.371 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.446 ' CD2' HD11 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -62.3 128.47 36.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -119.66 129.38 54.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.158 0.504 . . . . 0.0 112.241 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.654 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -15.17 61.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.817 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -78.35 -48.97 14.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.581 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -29.86 68.18 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.659 0.266 . . . . 0.0 111.246 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.654 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -91.41 171.9 7.36 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.183 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.5 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.6 Cg_endo -70.86 127.67 14.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.13 1.886 . . . . 0.0 111.714 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.61 -14.94 45.69 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.586 2.191 . . . . 0.0 113.095 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.5 -9.29 58.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -119.76 31.31 6.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.698 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -70.19 -37.24 7.02 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 64.6 Cg_exo -51.81 -43.44 51.51 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.09 1.86 . . . . 0.0 113.081 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 71' ' ' LEU . 2.4 t -77.48 -51.27 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.962 0.411 . . . . 0.0 111.364 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -66.34 -32.13 56.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.343 -179.341 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.55 -29.67 59.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.847 0.356 . . . . 0.0 110.713 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -73.56 -53.24 11.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.74 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.711 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -78.4 -36.22 46.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.48 -179.417 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.602 ' N ' HD23 ' A' ' 126' ' ' LEU . 3.1 ttpm? -53.13 -42.51 66.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.084 0.469 . . . . 0.0 111.15 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -63.99 -11.63 30.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.684 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 126' ' ' LEU . 3.8 mp . . . . . 0 C--O 1.231 0.102 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.089 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.978 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 5215 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 5216 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.777 0.322 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.47 120.6 42.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.832 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -137.64 138.72 39.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.839 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.612 HD13 " O3'" ' A' ' 131' ' ' 8OG . 1.4 pp -144.01 139.82 29.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.966 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.515 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.1 mt-30 -102.7 153.83 19.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.032 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.738 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.6 mp -146.02 128.42 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.9 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.069 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 124.56 42.44 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.163 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.568 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.6 m -117.9 158.41 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.362 0.601 . . . . 0.0 111.713 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.08 108.66 0.54 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.345 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -70.69 96.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.358 0.599 . . . . 0.0 110.051 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.668 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 1.4 tt -71.44 121.34 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.592 ' CG ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -94.93 144.83 25.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.695 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.958 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.7 p-10 -102.67 -173.28 2.29 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.595 0.712 . . . . 0.0 112.164 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.3 tm-20 -71.85 1.48 6.97 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.425 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -124.05 43.25 3.04 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.099 -0.376 . . . . 0.0 111.695 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 45.87 27.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.098 0.475 . . . . 0.0 111.163 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 6.3 mt-10 -114.83 161.4 18.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.794 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.722 HG22 HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -125.72 132.63 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.792 0.33 . . . . 0.0 111.347 -178.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE1' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -85.26 125.72 33.11 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.021 0.439 . . . . 0.0 110.629 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.848 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -122.19 122.81 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.08 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.575 HG22 ' CE1' ' A' ' 19' ' ' PHE . 19.7 p -71.01 111.96 6.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.818 0.342 . . . . 0.0 111.165 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.0 172.14 7.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.334 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.505 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 2.5 mmp_? -64.03 -9.79 18.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.154 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 74.66 8.52 4.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.472 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 56.54 76.17 0.31 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.823 0.344 . . . . 0.0 111.261 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -178.88 60.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.886 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -177.5 -172.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -98.3 29.18 3.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.14 55.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.58 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.11 -8.77 56.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.788 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.42 31.03 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.485 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.35 26.23 10.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.377 . . . . 0.0 111.671 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.848 HD21 ' HB ' ' A' ' 20' ' ' ILE . 5.5 tt -42.79 121.64 2.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.751 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' N ' HD23 ' A' ' 33' ' ' LEU . 3.9 mt-10 -140.69 -176.03 4.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.145 0.497 . . . . 0.0 111.972 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.864 ' CD2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.92 163.32 28.55 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.557 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.461 ' HD3' HG23 ' A' ' 21' ' ' THR . 19.3 Cg_endo -57.22 168.08 2.97 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.508 2.805 . . . . 0.0 111.801 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.22 59.67 0.76 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.01 -1.091 . . . . 0.0 113.788 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.27 126.07 5.27 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 114.556 -0.822 . . . . 0.0 112.19 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER 103.46 2.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.248 0.619 . . . . 0.0 112.305 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.069 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -51.5 -27.82 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.511 0.672 . . . . 0.0 110.754 179.401 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.577 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.44 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.016 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.4 mmm 33.75 -86.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.538 0.524 . . . . 0.0 111.841 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -164.3 27.57 0.21 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.565 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -95.62 -176.23 3.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.852 0.358 . . . . 0.0 111.138 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.912 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.81 155.75 38.49 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.235 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.912 ' HD2' HG22 ' A' ' 45' ' ' THR . 3.0 Cg_endo -44.74 -24.71 1.26 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.736 2.29 . . . . 0.0 112.608 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -95.21 -49.63 5.41 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -80.08 -24.15 40.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.719 0.295 . . . . 0.0 111.741 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.876 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -55.43 -47.41 76.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.001 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.754 HG12 ' CB ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.17 -47.89 23.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.823 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.7 t -56.76 -36.5 49.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.103 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -78.18 -50.66 11.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.9 mm-40 -66.9 -24.46 66.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.797 HD21 ' CE1' ' A' ' 64' ' ' HIS . 1.2 tp -51.8 -44.22 63.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.886 0.374 . . . . 0.0 110.272 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -33.93 75.01 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.58 -26.33 50.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.249 179.405 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mt-10 -108.14 5.17 25.65 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.99 HG12 HG13 ' A' ' 60' ' ' ILE . 17.7 t -134.6 -43.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.191 0.52 . . . . 0.0 109.741 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.587 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.52 -43.94 0.59 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.215 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.99 HG13 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.57 -177.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.094 0.473 . . . . 0.0 111.175 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -111.29 89.22 9.87 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.368 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.926 ' HG3' HG11 ' A' ' 58' ' ' VAL . 1.4 Cg_endo -108.7 156.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.864 2.376 . . . . 0.0 115.211 -176.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.426 ' HB2' ' CB ' ' A' ' 89' ' ' ARG . 75.8 mt-30 -77.93 80.17 4.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.797 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -127.07 124.24 38.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.669 -176.514 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.6 t80 -179.06 162.73 1.26 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.677 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER 83.84 155.77 0.1 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.943 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.7 pp -113.66 126.21 55.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.317 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.692 ' CE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -78.18 -36.75 47.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.253 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.06 162.03 7.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.469 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -143.08 132.14 23.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.889 0.376 . . . . 0.0 111.155 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.725 ' HB2' HG22 ' A' ' 122' ' ' VAL . 22.6 tp -119.01 121.98 41.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.648 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -120.91 109.95 15.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.685 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.415 ' HE1' HD12 ' A' ' 82' ' ' LEU . 3.3 p90 -141.04 150.85 43.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.649 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.4 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 3.9 pt-20 -121.19 122.28 39.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.097 0.475 . . . . 0.0 111.354 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.88 163.09 63.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.457 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.67 82.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.056 2.504 . . . . 0.0 112.149 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 14.3 t0 95.94 16.64 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.202 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -137.31 145.92 44.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.615 179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.4 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 1.4 t-80 -118.29 94.0 4.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 110.547 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.466 HD12 H2'' ' A' ' 131' ' ' 8OG . 2.6 tt -103.08 111.8 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.195 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.413 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -105.85 122.44 46.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.377 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.738 HD23 ' HB ' ' A' ' 6' ' ' ILE . 32.3 mt -122.27 114.71 21.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.875 0.369 . . . . 0.0 111.367 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.464 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.9 m0 -104.89 122.51 45.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.749 ' CD2' HG11 ' A' ' 122' ' ' VAL . 2.9 m-85 -98.64 110.12 22.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.387 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.741 ' CE2' HG11 ' A' ' 50' ' ' VAL . 25.0 m95 -94.65 148.54 22.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.583 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.634 HD12 ' OE2' ' A' ' 88' ' ' GLU . 1.6 tm? -100.36 103.85 15.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.116 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.786 HG22 ' ND1' ' A' ' 64' ' ' HIS . 43.1 t -91.82 145.47 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.382 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.634 ' OE2' HD12 ' A' ' 86' ' ' LEU . 3.2 mm-40 -111.52 -29.52 7.73 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.16 165.5 24.44 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.182 0.901 . . . . 0.0 111.824 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.958 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.6 p90 -149.4 132.67 16.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.667 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -81.23 128.38 33.73 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.749 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.2 -116.05 4.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.442 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 33.0 mt-10 -135.06 141.04 36.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.556 0.217 . . . . 0.0 110.93 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.568 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.1 Cg_exo -76.51 128.88 10.61 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.894 2.396 . . . . 0.0 111.199 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.657 ' HE1' HG23 ' A' ' 60' ' ' ILE . 55.6 p-90 -136.8 -64.81 0.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.846 -0.742 . . . . 0.0 112.811 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.599 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 49.21 -100.36 0.03 OUTLIER Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.65 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER 175.71 42.2 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.709 0.29 . . . . 0.0 111.091 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.405 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.8 OUTLIER -59.53 -52.34 65.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.39 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 123.79 -11.06 8.38 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.723 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.47 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.9 OUTLIER -140.17 98.94 7.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 117.38 0.59 . . . . 0.0 111.995 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -44.06 140.21 5.41 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.751 2.301 . . . . 0.0 112.269 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.515 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.18 177.28 19.27 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.897 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -129.75 157.29 42.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.693 0.283 . . . . 0.0 110.624 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.87 106.42 6.39 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.867 0.365 . . . . 0.0 110.178 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.5 ptp -120.2 149.76 41.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.075 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.505 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -66.68 114.9 5.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.626 179.611 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.1 tm? -69.95 -18.92 63.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.321 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.564 ' O ' HD21 ' A' ' 129' ' ' LEU . 12.9 p -56.1 -17.86 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.519 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.34 45.39 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.619 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.664 HD12 HD21 ' A' ' 107' ' ' LEU . 8.6 tt -62.65 150.49 40.74 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.422 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.2 m-20 -119.26 127.43 53.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.641 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -14.89 61.88 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.496 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -48.97 15.21 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.397 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -35.21 79.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.847 0.356 . . . . 0.0 110.701 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.641 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -85.41 168.16 21.6 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.27 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.513 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.2 Cg_endo -67.54 127.71 16.89 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.263 1.976 . . . . 0.0 111.918 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.02 -19.17 63.64 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.539 2.159 . . . . 0.0 112.892 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.64 -9.33 58.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.512 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.4 m-80 -116.2 29.43 7.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.463 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.4 pt-20 -71.86 -31.92 1.94 Allowed Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 50.9 Cg_exo -53.89 -37.31 85.35 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 121.875 1.716 . . . . 0.0 112.567 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.749 HG11 ' CD2' ' A' ' 84' ' ' PHE . 22.7 t -77.35 -48.42 24.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.507 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.598 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.4 mm -67.44 -30.25 48.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.897 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.65 -28.33 46.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 0.0 110.317 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -48.26 16.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.428 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.692 HD13 ' CE2' ' A' ' 68' ' ' PHE . 7.8 tp -78.2 -30.42 48.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 0.0 111.499 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.473 ' HB2' HG22 ' A' ' 123' ' ' ILE . 10.5 ttpp -54.61 -42.55 71.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -72.96 -5.69 40.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.005 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.564 HD21 ' O ' ' A' ' 108' ' ' VAL . 1.3 mp . . . . . 0 CA--C 1.528 0.127 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.284 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.631 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 5227 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 5228 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.882 0.372 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.08 103.25 15.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.94 143.38 49.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.878 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 4' ' ' LEU . 1.6 pp -141.84 137.0 31.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.773 ' C ' HD13 ' A' ' 6' ' ' ILE . 42.8 mt-30 -102.62 151.74 21.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.446 0.641 . . . . 0.0 112.392 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.95 HD12 " H2'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -142.38 128.19 17.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.476 179.026 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.052 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.55 125.06 43.57 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.323 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.586 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.3 m -120.7 162.37 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.424 0.63 . . . . 0.0 112.167 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.06 113.47 0.59 Allowed Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.587 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.574 HG22 HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.86 101.66 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.809 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.38 119.84 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.932 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.501 ' CG ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -101.74 150.88 22.69 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.236 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.662 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 8.4 p-10 -121.34 -173.97 2.74 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -56.45 -25.93 52.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.506 -1.224 . . . . 0.0 113.867 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -98.27 31.52 2.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.158 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 p30 49.12 23.21 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.182 0.515 . . . . 0.0 110.508 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -101.02 160.77 14.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.037 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.769 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -124.78 118.96 54.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.245 0.545 . . . . 0.0 111.943 -178.68 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.456 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 15.2 t80 -66.96 100.66 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.527 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.553 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -109.0 123.01 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.538 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.752 HG21 ' HG3' ' A' ' 98' ' ' GLU . 24.0 p -70.99 111.83 6.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.036 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -96.98 166.49 11.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.52 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 30' ' ' ALA . 0.2 OUTLIER -70.74 56.5 0.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.102 0.477 . . . . 0.0 110.352 179.536 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 47.51 -172.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.411 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.33 -40.22 85.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.108 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -177.69 152.49 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -173.73 -70.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.112 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -140.73 -76.68 0.31 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.783 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.9 85.19 2.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.68 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 23' ' ' ARG . . . -71.52 -8.9 56.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.69 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -95.1 28.42 2.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.611 0.243 . . . . 0.0 111.43 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.52 26.5 10.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.922 0.392 . . . . 0.0 111.7 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -47.55 113.51 0.71 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.0 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.77 177.04 8.03 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.152 0.501 . . . . 0.0 111.779 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -119.9 162.02 35.27 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.941 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 21' ' ' THR . 6.5 Cg_endo -48.16 167.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.812 3.008 . . . . 0.0 112.177 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 101.89 59.71 0.77 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.051 -1.071 . . . . 0.0 114.186 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -131.76 130.24 5.9 Favored Glycine 0 C--N 1.312 -0.798 0 CA-C-N 114.724 -0.738 . . . . 0.0 111.952 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.43 6.64 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.986 0.515 . . . . 0.0 112.037 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.052 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.53 -28.09 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.667 0.746 . . . . 0.0 110.192 179.202 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.586 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.61 -73.57 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.552 -1.203 . . . . 0.0 111.13 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 41' ' ' GLU . 1.0 OUTLIER 26.85 -85.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.562 0.539 . . . . 0.0 112.119 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.28 28.36 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.676 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.3 mp0 -97.44 -175.13 3.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.713 0.292 . . . . 0.0 111.192 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.922 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.23 160.74 25.48 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.358 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.922 ' HD2' HG22 ' A' ' 45' ' ' THR . 9.7 Cg_endo -49.3 -24.63 8.7 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.623 2.215 . . . . 0.0 112.316 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.1 mt-10 -99.14 -45.66 5.83 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -80.05 -23.81 41.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.667 0.27 . . . . 0.0 111.624 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.872 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -56.79 -47.56 79.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.021 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.685 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -78.25 -46.07 26.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.768 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.1 t -59.39 -36.81 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.174 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -78.15 -47.15 18.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.742 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.3 mt-10 -70.09 -20.83 63.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.736 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.997 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -51.36 -44.45 62.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.229 0.538 . . . . 0.0 109.602 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -32.21 73.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.937 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.48 -32.43 54.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.767 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.14 5.07 25.57 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.754 HG11 ' HG3' ' A' ' 62' ' ' PRO . 21.8 t -134.65 -44.23 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.44 . . . . 0.0 110.146 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.599 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.75 -45.32 0.39 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.449 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.763 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -77.97 152.34 5.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.494 ' H ' HD13 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -84.89 96.71 0.43 Allowed Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.49 -179.52 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.763 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 19.7 Cg_endo -113.72 148.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.699 0 C-N-CA 123.443 2.762 . . . . 0.0 114.163 -177.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -74.8 79.58 2.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.997 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -124.92 121.18 33.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.274 -176.708 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.1 t80 -178.64 169.08 1.73 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.096 0.474 . . . . 0.0 112.142 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.461 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 82.7 162.36 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.383 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 8.0 tt -105.47 131.84 52.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.611 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -98.59 -32.28 11.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.916 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.487 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -171.61 159.96 5.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.945 179.491 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HB3' HD11 ' A' ' 67' ' ' LEU . 2.6 ptpp? -143.48 132.08 22.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.726 0.298 . . . . 0.0 110.936 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.79 ' HB2' HG22 ' A' ' 122' ' ' VAL . 37.5 tp -118.9 120.41 37.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.639 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -115.97 109.82 18.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.697 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.561 ' HE1' HD12 ' A' ' 82' ' ' LEU . 2.1 p90 -141.14 145.85 36.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.612 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.11 121.7 38.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.132 0.492 . . . . 0.0 111.203 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -70.0 163.07 64.38 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.506 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.8 Cg_endo -51.85 83.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.063 2.509 . . . . 0.0 112.078 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 27.8 m-20 95.56 15.33 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.295 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.547 ' HE ' HD21 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -137.35 149.84 47.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.566 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -124.17 106.1 10.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 tt -111.35 112.33 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.429 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -98.42 118.64 35.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.415 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.561 HD12 ' HE1' ' A' ' 73' ' ' TYR . 6.7 mt -115.32 114.48 25.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.987 0.422 . . . . 0.0 111.764 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -108.99 122.56 47.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.315 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.547 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 2.6 m-85 -100.47 125.79 46.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.657 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.685 ' CE2' HG11 ' A' ' 50' ' ' VAL . 15.6 m95 -107.19 148.66 28.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 112.014 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.527 ' O ' HD12 ' A' ' 86' ' ' LEU . 2.0 pp -97.69 103.85 15.82 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.306 0.574 . . . . 0.0 111.446 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.995 HG22 ' ND1' ' A' ' 64' ' ' HIS . 41.2 t -84.83 144.76 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.229 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -32.24 7.88 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.73 165.02 26.08 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.56 -179.189 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.809 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.4 p90 -149.64 136.61 19.59 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.331 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.683 ' CB ' HD12 ' A' ' 60' ' ' ILE . 1.5 mt-10 -73.77 134.04 43.37 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.735 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 51.13 -107.85 0.46 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.86 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 21.8 mt-10 -135.56 142.11 39.82 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.49 0.186 . . . . 0.0 111.038 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.548 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.3 Cg_exo -76.05 128.57 10.77 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.459 2.106 . . . . 0.0 110.672 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.599 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 35.8 p-90 -124.6 -59.05 1.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.966 0.412 . . . . 0.0 111.861 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.59 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.01 -95.75 0.01 OUTLIER Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.875 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.71 37.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.72 0.295 . . . . 0.0 110.895 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.752 ' HG3' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -64.54 -44.88 89.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.189 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.77 -98.76 0.23 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.44 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -75.92 114.41 36.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.077 0.465 . . . . 0.0 112.248 -178.832 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -43.9 146.44 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.179 2.586 . . . . 0.0 112.648 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.449 ' CA ' ' CE2' ' A' ' 19' ' ' PHE . . . -123.37 177.07 16.68 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.966 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -138.98 157.53 45.83 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.494 ' CD1' ' HZ2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -72.24 105.99 4.24 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.928 0.394 . . . . 0.0 110.085 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.29 140.0 51.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.714 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.2 p -58.89 114.55 2.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 110.44 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.815 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.8 tm? -61.67 -18.84 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.311 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 108' ' ' VAL . 27.9 t -59.75 -12.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.331 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.11 37.63 3.68 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.284 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.558 ' HG ' HD21 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -62.11 123.63 18.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.503 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -123.07 128.65 50.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.251 0.548 . . . . 0.0 112.412 -179.084 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.636 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.26 -14.91 61.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.399 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.36 -49.41 13.63 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.737 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -31.0 70.94 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.877 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.636 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -90.5 172.28 7.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.095 179.823 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.504 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.7 Cg_endo -71.45 127.64 13.52 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.12 1.88 . . . . 0.0 111.666 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.8 -14.95 46.05 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.63 2.22 . . . . 0.0 113.153 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.56 -9.58 58.75 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.84 33.78 5.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 111.439 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.49 -34.95 2.01 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.308 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 74.2 Cg_exo -49.69 -45.57 31.01 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 121.87 1.713 . . . . 0.0 113.056 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.6 t -77.6 -51.31 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.987 0.422 . . . . 0.0 111.428 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.617 ' O ' HD23 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -64.89 -34.07 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.634 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 120' ' ' GLU . . . -54.93 -31.19 60.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.861 0.362 . . . . 0.0 110.79 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.05 -53.63 16.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.564 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.793 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -78.72 -30.02 45.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.726 0.298 . . . . 0.0 111.394 -179.556 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.793 ' N ' HD23 ' A' ' 126' ' ' LEU . 5.4 ttpm? -54.65 -42.51 71.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.025 0.44 . . . . 0.0 110.741 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -66.14 -10.51 41.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.624 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.221 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.95 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 5239 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 5240 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.824 0.345 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -133.65 143.52 48.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.756 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.3 pp -145.94 127.93 15.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.565 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 41.4 mt-30 -102.65 154.07 19.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.337 0.589 . . . . 0.0 112.282 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 6' ' ' ILE . 27.2 mm -146.55 132.72 13.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.675 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.041 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.45 124.59 42.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.1 m -121.0 162.51 19.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.3 0.571 . . . . 0.0 111.994 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.422 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.2 113.05 0.56 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.738 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.064 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.78 107.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.714 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.2 mt -71.43 124.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.049 0.452 . . . . 0.0 111.68 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.76 124.01 32.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.43 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.52 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -79.19 -172.7 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.805 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.488 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.3 tp10 -82.62 2.9 31.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.469 -1.241 . . . . 0.0 112.084 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -135.95 50.32 2.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.797 0.332 . . . . 0.0 111.227 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 p30 45.5 26.68 0.33 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.385 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 13.6 pt-20 -120.39 141.7 49.86 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.064 HG21 HG22 ' A' ' 10' ' ' ILE . 17.6 mt -110.88 140.31 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.154 0.502 . . . . 0.0 111.716 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -89.42 122.6 32.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.689 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.602 HD13 HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -120.04 162.25 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.262 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.434 HG21 ' OE1' ' A' ' 98' ' ' GLU . 3.7 p -95.67 111.8 23.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.57 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 2.4 ptm180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.996 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.556 0.217 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 26.29 10.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.381 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.545 HD21 ' HB ' ' A' ' 20' ' ' ILE . 2.9 tt -46.84 96.11 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -114.49 -178.74 3.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.16 0.505 . . . . 0.0 111.711 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.546 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.6 164.23 22.98 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.432 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 19.8 Cg_endo -56.84 167.89 2.75 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.472 2.781 . . . . 0.0 112.012 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.18 59.47 0.76 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.613 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.17 126.79 5.12 Favored Glycine 0 C--N 1.313 -0.742 0 CA-C-N 114.581 -0.81 . . . . 0.0 112.101 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER 109.42 4.55 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.153 0.581 . . . . 0.0 112.125 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.041 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -58.65 -24.35 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.428 0.632 . . . . 0.0 110.791 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.565 ' HB3' ' H ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -49.83 -71.82 0.06 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.094 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.441 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER 23.54 -86.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.611 0.569 . . . . 0.0 112.252 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -159.7 23.82 0.29 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.787 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.24 -177.13 3.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.87 0.367 . . . . 0.0 111.026 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.891 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.68 157.47 38.31 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.872 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.891 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.79 -24.69 0.82 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.717 2.278 . . . . 0.0 112.413 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -85.57 -60.67 1.96 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -80.43 -21.49 42.11 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.84 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -56.73 -48.83 76.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.784 0.326 . . . . 0.0 111.095 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.736 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.4 -46.39 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.6 t -57.12 -36.56 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -78.29 -49.19 14.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.747 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.517 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.2 mm-40 -67.61 -20.0 65.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.992 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.797 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.3 tp -57.17 -44.64 83.72 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.866 0.365 . . . . 0.0 110.529 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -34.68 78.43 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.2 tm-20 -77.46 -24.09 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.873 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -108.47 5.15 25.0 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.949 HG12 HG13 ' A' ' 60' ' ' ILE . 38.5 t -134.65 -44.39 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.142 0.496 . . . . 0.0 109.836 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.99 -40.09 0.26 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.443 -0.798 . . . . 0.0 113.893 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.949 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.68 -176.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.009 0.433 . . . . 0.0 111.089 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.33 88.81 13.45 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.006 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.81 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.3 Cg_endo -110.57 145.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.362 2.708 . . . . 0.0 113.981 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 39.4 mt-30 -74.78 79.78 2.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.006 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.81 128.22 52.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.952 -176.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.4 t80 -179.34 167.89 1.49 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.76 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 14.6 m 84.51 149.14 0.07 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.544 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 pp -107.1 128.46 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.298 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.885 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -78.84 -41.29 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.252 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.502 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 10.3 tt0 -171.38 167.07 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.03 132.11 23.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 111.087 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.898 HD22 HG21 ' A' ' 122' ' ' VAL . 0.8 OUTLIER -116.18 122.3 44.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.001 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -120.62 109.78 15.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -141.13 149.26 41.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.674 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.43 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 3.8 pt-20 -121.23 120.52 35.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.125 0.488 . . . . 0.0 111.198 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.493 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -69.98 163.74 58.24 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.354 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -50.94 83.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.221 2.614 . . . . 0.0 112.39 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.7 t70 94.74 16.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.357 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 27.1 ttt180 -137.38 146.44 44.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.641 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 9.4 t-160 -119.68 99.43 6.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.623 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 tt -106.79 121.08 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.093 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.454 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -109.76 122.82 48.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.424 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.438 HD13 ' OD1' ' A' ' 119' ' ' ASN . 8.1 mt -126.04 114.97 19.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 111.347 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.467 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.6 m0 -107.82 122.52 46.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.796 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.754 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.4 m-30 -93.37 109.61 21.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.817 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.705 ' CE2' HG11 ' A' ' 50' ' ' VAL . 28.2 m95 -96.82 148.75 22.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.025 0.441 . . . . 0.0 112.083 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 65' ' ' PHE . 7.1 tp -97.58 138.22 35.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.542 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.006 HG22 ' ND1' ' A' ' 64' ' ' HIS . 39.4 t -124.02 146.04 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.37 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -110.52 -26.34 9.54 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.81 164.5 26.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.572 0.624 . . . . 0.0 111.548 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.71 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -157.37 123.48 4.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.381 178.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -73.88 147.2 43.45 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.67 -127.87 43.49 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.58 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 17.1 mt-10 -125.22 146.19 53.17 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.53 0.205 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.58 128.74 10.46 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.827 2.351 . . . . 0.0 111.471 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.552 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.3 p-90 -132.58 -58.19 0.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.669 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.11 -97.11 0.01 OUTLIER Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.923 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.99 31.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.693 0.282 . . . . 0.0 111.172 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.434 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -61.49 -40.78 95.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.78 0.324 . . . . 0.0 110.477 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.85 13.56 60.69 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.8 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -140.31 92.02 9.58 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 117.18 0.49 . . . . 0.0 111.509 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -43.63 132.76 7.54 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.982 2.454 . . . . 0.0 112.688 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.25 177.1 19.42 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.856 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -134.22 157.29 46.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.641 0.257 . . . . 0.0 110.624 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.2 106.97 3.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.844 0.354 . . . . 0.0 110.323 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 18' ' ' ILE . 3.6 ptp -119.95 147.33 44.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.171 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t -66.63 114.87 5.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.66 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -70.97 -28.71 64.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.914 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.432 HG12 HD21 ' A' ' 129' ' ' LEU . 21.5 t -53.25 -23.94 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.06 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.33 42.31 1.62 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.404 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' ' 111' ' ' ASN . 10.4 tt -62.56 150.16 41.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.64 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -116.22 127.67 54.96 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.596 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -14.98 61.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.512 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.44 -49.31 13.69 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.78 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -38.84 87.21 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 110.904 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.611 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.84 173.02 8.38 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.973 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.469 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 36.2 Cg_endo -65.7 127.79 18.67 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.087 1.858 . . . . 0.0 111.973 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.48 -21.18 53.59 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.576 2.184 . . . . 0.0 112.956 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.66 -9.59 57.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.85 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.438 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -118.77 34.26 5.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.179 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -75.15 -43.69 4.55 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 85.8 Cg_exo -44.77 -33.16 6.82 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.184 1.923 . . . . 0.0 112.567 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.898 HG21 HD22 ' A' ' 71' ' ' LEU . 49.4 t -77.62 -51.08 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.419 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.837 HG22 ' HB2' ' A' ' 127' ' ' LYS . 12.4 mm -66.25 -30.45 49.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.979 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.73 -27.18 38.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.945 0.403 . . . . 0.0 110.485 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -80.18 -51.34 9.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.69 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.885 HD22 ' CE2' ' A' ' 68' ' ' PHE . 13.0 tp -78.09 -34.61 50.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.818 0.342 . . . . 0.0 111.599 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.837 ' HB2' HG22 ' A' ' 123' ' ' ILE . 42.6 tttp -53.19 -42.72 66.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.08 0.467 . . . . 0.0 111.137 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -73.02 -4.17 30.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.05 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 127' ' ' LYS . 4.4 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.039 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.824 0.345 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.85 126.33 20.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.761 HD12 ' CD1' ' A' ' 6' ' ' ILE . 0.8 OUTLIER -130.41 136.65 49.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.707 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.77 ' C ' HD13 ' A' ' 6' ' ' ILE . 27.8 mt-30 -102.95 153.29 20.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.335 0.588 . . . . 0.0 112.146 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.77 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -146.04 124.64 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.795 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.097 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.74 125.26 43.77 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.743 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.588 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.5 m -115.77 162.09 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.426 0.631 . . . . 0.0 111.867 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.13 111.57 0.58 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.27 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.682 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.85 102.31 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.735 HG22 ' CE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.2 121.46 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 121.125 0.488 . . . . 0.0 111.659 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.469 ' HG2' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -91.29 132.81 35.9 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.629 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.669 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 2.4 p30 -89.04 -173.24 3.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.473 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 8.2 tt0 -79.61 8.93 5.59 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.686 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -132.25 47.17 2.55 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.141 -0.35 . . . . 0.0 111.691 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.1 p30 45.06 25.94 0.19 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.087 0.47 . . . . 0.0 111.507 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.574 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 25.9 mt-10 -116.87 161.19 19.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.842 HD13 HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -118.8 135.68 58.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.052 0.453 . . . . 0.0 111.74 -178.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -85.78 109.86 18.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.994 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.609 HG22 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.5 140.18 44.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.106 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.423 ' O ' HD23 ' A' ' 33' ' ' LEU . 16.3 p -73.58 111.67 8.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.0 111.195 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.406 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.756 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.613 0.244 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -114.41 26.41 10.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 111.43 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -43.89 94.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.787 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -109.37 172.38 6.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.208 0.527 . . . . 0.0 112.076 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.609 ' HB3' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -119.63 163.58 26.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.57 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.402 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 26.3 Cg_endo -61.08 167.71 8.64 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.508 2.805 . . . . 0.0 112.03 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 101.99 59.53 0.77 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.73 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.619 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.15 118.66 2.46 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 114.552 -0.824 . . . . 0.0 111.999 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.619 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.31 2.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.185 0.594 . . . . 0.0 111.682 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.097 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -50.48 -28.92 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.57 0.7 . . . . 0.0 110.568 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.595 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.51 -79.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.964 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp 36.18 -85.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.5 0.5 . . . . 0.0 111.597 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.18 29.67 0.17 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.354 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.426 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 25.7 mp0 -97.32 -178.35 4.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.931 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.33 159.34 32.46 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.995 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.931 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.87 -24.71 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.784 2.322 . . . . 0.0 112.479 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -88.1 -61.22 1.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -80.54 -6.01 57.58 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.912 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.82 -55.13 29.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 110.884 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.916 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.5 m -78.22 -45.19 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.871 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.3 t -56.49 -41.47 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.128 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.32 -46.84 19.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.988 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -69.32 -21.66 63.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.034 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.743 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -55.43 -44.24 76.09 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.823 0.344 . . . . 0.0 110.12 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -34.86 73.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.8 -26.64 49.75 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.394 179.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.03 5.25 25.95 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.942 HG12 HG13 ' A' ' 60' ' ' ILE . 19.9 t -134.79 -44.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.244 0.545 . . . . 0.0 110.053 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.13 -41.27 0.35 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.602 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.942 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.7 -176.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 120.977 0.418 . . . . 0.0 111.038 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.66 88.82 14.33 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.885 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.86 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.2 Cg_endo -110.74 146.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 123.276 2.651 . . . . 0.0 114.35 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 15.9 mt-30 -74.69 80.03 2.04 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.014 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.55 131.9 54.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.549 -175.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.515 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -176.22 -136.97 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.391 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 51.76 172.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.213 0.53 . . . . 0.0 112.258 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.668 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.6 tt -136.97 115.89 12.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.454 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.69 -56.3 4.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.982 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.662 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 mt-10 -171.46 131.51 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.138 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.668 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -125.5 132.1 52.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.716 0.293 . . . . 0.0 110.679 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.708 HD22 ' N ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -124.22 168.29 13.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 110.857 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.708 ' N ' HD22 ' A' ' 71' ' ' LEU . 5.0 tt0 -140.16 123.62 17.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.568 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.9 p90 -141.02 148.61 40.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.279 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -120.98 128.39 52.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 111.487 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -86.48 162.86 44.12 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.193 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.5 Cg_endo -50.11 81.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.0 2.466 . . . . 0.0 112.31 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.4 t70 89.09 12.15 0.07 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.529 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -137.26 93.92 2.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.655 0.264 . . . . 0.0 110.938 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -77.15 108.73 10.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.854 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 2.7 tt -110.8 112.75 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.31 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -96.62 118.85 33.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.115 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.568 HD12 ' CE1' ' A' ' 73' ' ' TYR . 20.6 mt -112.01 114.15 26.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.888 0.375 . . . . 0.0 111.9 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.477 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 8.9 m0 -115.73 122.22 44.85 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.252 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.662 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 7.2 m-30 -106.15 123.08 47.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.97 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.916 ' NE1' HG11 ' A' ' 50' ' ' VAL . 31.5 m95 -105.13 149.0 26.25 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.611 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 86' ' ' LEU . 2.3 tm? -98.7 103.47 15.42 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.597 0.713 . . . . 0.0 112.332 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.014 HG22 ' ND1' ' A' ' 64' ' ' HIS . 20.9 t -82.76 145.85 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.899 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -114.01 -25.38 8.58 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -162.27 160.16 26.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.522 0.601 . . . . 0.0 111.49 -179.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.735 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -153.27 124.3 7.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.364 178.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -74.28 146.69 42.99 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.74 -130.99 51.3 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 37.9 mt-10 -121.32 144.79 40.74 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.572 0.225 . . . . 0.0 110.715 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.513 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.1 Cg_exo -76.66 128.74 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.934 2.422 . . . . 0.0 111.474 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.559 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.5 p-90 -135.23 -57.96 0.8 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.715 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.595 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.13 -94.56 0.01 OUTLIER Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.005 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 56' ' ' GLU . 4.7 tmtt? -177.23 32.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.767 0.317 . . . . 0.0 111.01 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.78 -38.65 73.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.342 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.81 21.25 63.96 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.337 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -140.23 91.85 9.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.022 0.439 . . . . 0.0 111.448 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -44.02 137.03 7.31 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.975 2.45 . . . . 0.0 112.626 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.16 177.05 19.44 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.874 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -145.07 157.38 44.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.583 0.23 . . . . 0.0 110.538 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.445 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.6 m0 -62.15 106.62 0.75 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.332 . . . . 0.0 110.474 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.445 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.05 147.34 44.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.67 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.04 114.7 12.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.801 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.842 HD22 HD13 ' A' ' 18' ' ' ILE . 30.1 tp -80.15 -18.92 48.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.0 t -50.59 -23.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.535 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.61 48.04 0.98 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.481 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.657 ' HB2' HD12 ' A' ' 107' ' ' LEU . 9.3 tt -62.62 150.22 41.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.63 0.253 . . . . 0.0 110.47 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.02 135.19 54.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.169 0.509 . . . . 0.0 112.163 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.553 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.08 -15.25 62.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.493 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.98 -49.24 13.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.512 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -33.73 76.12 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.262 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.553 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -84.94 174.05 6.31 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.316 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.474 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.6 Cg_endo -71.05 127.8 14.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.05 1.833 . . . . 0.0 111.764 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.91 -15.02 46.68 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.606 2.204 . . . . 0.0 113.226 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.75 -9.63 58.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.547 HD21 HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -122.08 32.72 5.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.7 0.286 . . . . 0.0 111.303 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.523 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -76.18 -39.19 2.57 Favored Pre-proline 0 C--O 1.223 -0.305 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.049 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 89.4 Cg_exo -44.9 -39.94 14.53 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 121.924 1.749 . . . . 0.0 113.024 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.626 HG22 ' CD1' ' A' ' 71' ' ' LEU . 2.4 t -77.53 -51.03 19.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.999 0.428 . . . . 0.0 110.924 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.547 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.0 mm -64.89 -32.13 56.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.405 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.74 -29.89 54.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.034 0.445 . . . . 0.0 110.497 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -76.49 -49.57 16.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.494 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 126' ' ' LEU . 2.6 tm? -78.18 -31.37 49.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.672 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 123' ' ' ILE . 2.9 ttpm? -54.07 -42.62 69.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.028 0.442 . . . . 0.0 111.01 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -69.99 -7.88 44.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.911 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 127' ' ' LYS . 1.6 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.219 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.792 0.329 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 146.76 28.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 4' ' ' LEU . 1.7 pp -145.97 134.85 22.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.024 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.449 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 26.1 mt-30 -102.85 151.67 22.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.306 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.3 mm -146.64 129.39 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.981 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.085 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.68 125.05 43.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.556 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.592 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.5 m -118.07 161.45 16.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.249 0.547 . . . . 0.0 111.788 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.3 112.1 0.53 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.853 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.475 ' CG2' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -74.45 105.48 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.706 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.1 mt -71.74 124.83 29.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.12 0.486 . . . . 0.0 112.018 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.461 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -93.72 135.57 34.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.22 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.657 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.5 p30 -92.74 -173.45 3.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.905 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -75.31 -1.22 22.63 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.83 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -119.5 41.24 3.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.442 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p30 46.9 25.16 0.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.082 0.468 . . . . 0.0 111.201 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.552 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 25.1 mt-10 -114.44 160.94 18.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.751 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -116.85 138.64 46.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.078 0.466 . . . . 0.0 112.019 -178.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.476 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -82.27 99.84 9.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.79 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -116.52 115.41 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.499 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.625 HG21 ' HB2' ' A' ' 100' ' ' GLN . 9.0 t -76.45 123.43 26.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.848 0.356 . . . . 0.0 111.009 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.624 179.748 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.25 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.6 26.3 10.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.941 0.401 . . . . 0.0 111.698 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -48.28 117.86 2.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.856 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.404 ' N ' HD23 ' A' ' 33' ' ' LEU . 32.7 mm-40 -145.06 171.55 14.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.953 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.762 ' CD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.42 167.85 11.26 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 121.004 0.431 . . . . 0.0 111.934 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.4 Cg_endo -47.46 168.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.862 3.041 . . . . 0.0 112.694 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.07 59.99 0.72 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.851 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -131.83 132.62 6.8 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 114.391 -0.905 . . . . 0.0 112.14 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.8 ttmm 92.3 10.47 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.023 0.529 . . . . 0.0 112.388 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.085 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -56.79 -28.27 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.673 0.749 . . . . 0.0 109.993 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.83 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.896 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.98 -84.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.516 0.51 . . . . 0.0 111.709 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.44 32.74 0.1 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.57 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.481 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.3 mt-10 -93.21 -173.72 3.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.698 0.285 . . . . 0.0 111.194 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.878 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.19 154.02 37.85 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.316 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.878 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.99 -24.87 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.819 2.346 . . . . 0.0 112.494 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -103.62 -41.76 5.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.828 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -80.3 -13.6 59.06 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.032 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.05 -52.95 62.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.752 0.31 . . . . 0.0 111.094 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.719 HG11 ' NE1' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -78.28 -44.64 27.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.921 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.2 t -55.87 -42.71 71.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.538 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -78.3 -49.94 12.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.916 0.388 . . . . 0.0 111.269 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -68.4 -20.01 64.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.254 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.67 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -56.71 -45.06 82.07 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 110.103 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -31.88 71.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -76.75 -25.35 53.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.981 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.447 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -106.42 6.59 30.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.544 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.967 HG13 HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -133.45 -44.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.135 0.493 . . . . 0.0 109.793 179.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.537 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.67 -37.17 0.17 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.553 -0.749 . . . . 0.0 114.65 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.967 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -85.06 -174.32 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.889 0.376 . . . . 0.0 110.796 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.11 88.59 12.52 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.469 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.642 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.7 Cg_endo -111.13 145.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.471 2.78 . . . . 0.0 113.886 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 11.5 mt-30 -74.86 79.82 2.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.013 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.07 127.43 51.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.596 -176.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 86' ' ' LEU . 17.4 t80 179.85 168.15 1.22 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 82.28 149.83 0.09 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.696 179.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -105.69 128.76 53.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 111.077 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' HE2' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -80.5 -38.36 29.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.426 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.498 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 2.0 tt0 -171.29 160.65 6.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.336 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -143.25 132.2 22.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.968 0.414 . . . . 0.0 111.233 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.672 ' HB2' HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -117.11 130.2 56.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.431 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -123.15 109.97 14.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.562 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -141.17 150.58 42.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.731 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.26 123.09 41.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.125 0.488 . . . . 0.0 111.121 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.473 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -69.99 163.15 63.61 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.46 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.8 Cg_endo -52.36 82.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.028 2.485 . . . . 0.0 112.097 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 8.8 t70 96.19 15.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.152 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -137.35 149.91 47.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.635 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -120.35 93.98 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.453 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.6 tt -100.56 111.94 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.23 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.3 118.73 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.24 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 122' ' ' VAL . 5.5 tp -110.84 114.25 27.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 111.336 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -110.34 122.49 47.82 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.547 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.42 ' HA ' HG22 ' A' ' 8' ' ' VAL . 2.8 m-30 -105.37 109.82 21.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.174 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.719 ' NE1' HG11 ' A' ' 50' ' ' VAL . 35.0 m95 -99.39 148.67 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.013 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 65' ' ' PHE . 31.2 tp -96.54 138.6 33.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.571 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.013 HG22 ' ND1' ' A' ' 64' ' ' HIS . 35.1 t -123.61 145.35 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.237 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.66 -24.48 9.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.8 tpt180 -162.86 162.39 26.39 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.574 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.706 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.09 123.92 5.09 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.214 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.45 146.17 40.91 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.251 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.3 -126.73 43.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.723 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' ILE . 22.7 mt-10 -125.15 143.74 45.19 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 110.486 -0.19 . . . . 0.0 110.486 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.425 ' HA ' ' CG1' ' A' ' 60' ' ' ILE . 3.9 Cg_exo -76.48 128.64 10.48 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.713 2.275 . . . . 0.0 111.434 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.537 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 64.3 p-90 -131.93 -56.69 0.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.787 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.593 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.92 -95.04 0.01 OUTLIER Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.111 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -179.1 33.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.653 0.263 . . . . 0.0 111.196 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -76.8 -37.1 56.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.98 0.419 . . . . 0.0 110.243 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.13 30.1 51.85 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.101 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.625 ' HB2' HG21 ' A' ' 21' ' ' THR . 5.0 mt-30 -140.35 91.63 9.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.055 0.455 . . . . 0.0 111.503 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -47.59 133.55 21.21 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.096 2.531 . . . . 0.0 112.428 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.07 177.09 19.4 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.914 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 105' ' ' MET . 2.6 mt-10 -142.5 157.81 44.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.539 0.209 . . . . 0.0 110.491 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.491 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.3 m0 -66.63 106.59 1.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 2.9 mmm -119.89 148.19 43.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.944 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.04 114.78 8.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.8 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.751 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -67.0 -28.28 68.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.828 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.1 p -55.49 -22.79 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -109.84 34.38 5.49 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.497 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.52 HD13 HD22 ' A' ' 107' ' ' LEU . 9.6 tp -62.78 139.52 58.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.03 131.26 53.63 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.4 -15.14 61.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.547 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -78.62 -49.44 13.21 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.703 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -35.75 79.74 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 111.225 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.92 174.13 6.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.127 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.499 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 53.7 Cg_endo -70.11 127.75 14.75 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.026 1.818 . . . . 0.0 111.705 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.93 -15.04 46.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.6 2.2 . . . . 0.0 113.085 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.19 -9.46 58.74 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.485 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -120.37 31.91 6.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.747 0.308 . . . . 0.0 111.426 -178.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -73.14 -36.28 3.19 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.621 ' HB2' HD13 ' A' ' 71' ' ' LEU . 70.4 Cg_exo -50.98 -44.97 39.04 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 121.92 1.747 . . . . 0.0 112.699 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.8 t -77.41 -51.21 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 111.097 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.587 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.8 mm -62.83 -32.9 57.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.232 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.02 -33.72 62.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.08 0.467 . . . . 0.0 110.553 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -66.84 -49.65 65.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.843 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 126' ' ' LEU . 0.7 OUTLIER -78.14 -26.07 47.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.144 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.455 ' O ' HD12 ' A' ' 129' ' ' LEU . 3.1 ttpm? -58.21 -42.6 86.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.002 0.43 . . . . 0.0 110.778 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.6 ttm-85 -73.86 -5.32 40.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.953 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.828 HD21 ' O ' ' A' ' 108' ' ' VAL . 1.7 mp . . . . . 0 N--CA 1.461 0.095 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.325 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.27 37.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.674 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.9 pp -145.98 122.53 11.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.7 mt-30 -102.69 148.38 25.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.347 0.594 . . . . 0.0 111.888 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.557 ' HB ' HD23 ' A' ' 82' ' ' LEU . 31.5 mm -146.48 130.77 10.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.833 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.093 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.43 124.46 42.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.608 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -118.63 162.94 16.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.235 0.54 . . . . 0.0 111.933 -179.387 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.0 112.83 0.55 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.402 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.976 ' CG2' HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -70.79 105.68 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.389 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.852 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.2 mt -71.54 124.0 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.438 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -85.28 126.86 34.04 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.456 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 24.8 t-20 -70.43 177.37 3.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.119 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.528 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 8.8 tt0 -56.62 -18.58 12.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.404 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -120.55 -82.74 0.65 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.615 0.245 . . . . 0.0 111.243 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.73 15.54 0.36 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.616 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 3.6 mt-10 -100.93 160.39 14.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.976 HG21 ' CG2' ' A' ' 10' ' ' ILE . 3.4 mt -138.12 140.72 39.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.014 0.435 . . . . 0.0 111.609 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -89.75 116.46 27.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.375 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.61 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -113.36 125.59 70.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.419 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.827 HG21 ' HG3' ' A' ' 98' ' ' GLU . 15.0 p -75.46 111.85 11.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.82 0.343 . . . . 0.0 110.495 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.563 0.221 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -114.54 26.32 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 111.585 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.61 HD21 ' HB ' ' A' ' 20' ' ' ILE . 2.7 tt -45.42 122.71 3.67 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.812 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.573 ' N ' HD23 ' A' ' 33' ' ' LEU . 53.6 mt-10 -145.96 -175.32 4.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.894 0.378 . . . . 0.0 111.443 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.608 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.07 162.09 35.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.239 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.685 ' HD3' HG23 ' A' ' 21' ' ' THR . 10.3 Cg_endo -50.09 167.91 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.387 2.725 . . . . 0.0 111.715 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.23 59.47 0.76 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.825 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.615 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.54 120.01 2.74 Favored Glycine 0 C--N 1.312 -0.78 0 CA-C-N 114.791 -0.705 . . . . 0.0 112.023 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.615 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 114.09 3.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.313 0.645 . . . . 0.0 111.937 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.093 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -53.64 -26.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.43 0.633 . . . . 0.0 110.569 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.12 -82.62 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.143 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 34.87 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.39 0.432 . . . . 0.0 111.886 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.89 31.24 0.14 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.623 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.455 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -91.24 -174.38 3.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.75 0.31 . . . . 0.0 111.189 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.888 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.68 154.85 36.94 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.352 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.888 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.8 Cg_endo -44.53 -24.86 1.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.735 2.29 . . . . 0.0 112.603 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.741 ' O ' HG23 ' A' ' 51' ' ' VAL . 11.6 mt-10 -102.2 -42.91 5.88 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -80.22 -16.07 55.6 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.916 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.08 -50.49 73.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.146 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.761 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -78.1 -45.11 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.798 0.332 . . . . 0.0 110.884 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.2 t -53.71 -37.92 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -51.99 9.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.018 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.8 mm-40 -63.97 -22.07 66.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.907 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.762 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.0 OUTLIER -56.47 -44.62 80.75 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.979 0.419 . . . . 0.0 110.409 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -62.96 -34.64 77.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.6 tm-20 -77.47 -25.0 50.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.14 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.453 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 69.2 mm-40 -108.15 5.36 25.82 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.953 HG12 HG13 ' A' ' 60' ' ' ILE . 31.4 t -134.71 -44.26 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.183 0.516 . . . . 0.0 109.793 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.83 -41.1 0.32 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.711 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.953 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.66 -176.53 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.016 0.436 . . . . 0.0 111.057 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.04 88.87 12.76 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.991 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.852 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.1 Cg_endo -109.48 145.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.287 2.658 . . . . 0.0 113.917 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 11.8 mt-30 -74.78 79.76 2.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.996 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.81 128.06 52.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.926 -176.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.7 t80 -179.22 168.46 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 111.991 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.3 p 83.07 158.0 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.827 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -110.83 137.9 47.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -94.92 -32.46 13.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.264 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.491 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 17.8 tt0 -171.38 155.57 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.51 132.03 22.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.711 0.291 . . . . 0.0 110.95 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.068 HD22 HG21 ' A' ' 122' ' ' VAL . 2.5 pt? -129.19 132.36 47.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.851 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -127.28 109.93 12.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.558 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.444 ' OH ' HD12 ' A' ' 82' ' ' LEU . 3.0 p90 -132.24 153.04 51.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.491 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 5.4 pt-20 -118.74 138.61 52.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.158 0.504 . . . . 0.0 111.406 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -98.81 163.06 19.59 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.209 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 6.0 Cg_endo -48.09 81.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.11 2.54 . . . . 0.0 112.342 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 m-20 85.61 13.55 0.18 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.586 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.564 ' NE ' HD21 ' A' ' 4' ' ' LEU . 8.9 ttt180 -137.44 93.83 2.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 0.0 110.998 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.434 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 64.4 t-80 -75.02 112.47 11.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.573 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.428 HD13 ' OH ' ' A' ' 73' ' ' TYR . 3.7 tt -109.7 112.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.325 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.411 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -102.11 124.03 47.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.241 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.557 HD23 ' HB ' ' A' ' 6' ' ' ILE . 20.6 mt -126.02 114.93 19.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.863 0.364 . . . . 0.0 111.607 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.411 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.4 m0 -106.48 122.48 46.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.523 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.3 m-85 -99.07 109.66 22.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.211 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.68 ' NE1' HG11 ' A' ' 50' ' ' VAL . 25.5 m95 -97.24 148.66 22.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.19 0.519 . . . . 0.0 112.358 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 65' ' ' PHE . 25.0 tp -95.94 138.68 33.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.132 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.996 HG22 ' ND1' ' A' ' 64' ' ' HIS . 33.2 t -123.47 145.88 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.459 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.3 -24.59 9.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 5.4 tpt180 -162.64 162.43 27.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.548 0.613 . . . . 0.0 111.544 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.744 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -155.08 124.91 6.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.24 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.43 148.32 39.22 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.33 -129.27 43.21 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.54 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 49.3 mt-10 -122.73 144.16 41.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.573 0.225 . . . . 0.0 110.678 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.51 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.43 128.72 10.57 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.778 2.319 . . . . 0.0 111.493 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.555 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -132.41 -58.02 0.94 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.649 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.536 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.72 -99.61 0.02 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.924 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 175.0 38.49 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.6 0.238 . . . . 0.0 111.209 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.827 ' HG3' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -70.53 -11.73 61.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.714 0.292 . . . . 0.0 111.253 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.74 20.17 68.03 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.378 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.426 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 8.1 mm-40 -140.48 97.51 7.48 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.84 0.352 . . . . 0.0 111.384 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.62 132.71 7.53 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.836 2.357 . . . . 0.0 112.51 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.05 177.12 19.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.823 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -149.49 157.27 43.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.529 0.204 . . . . 0.0 110.516 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -71.24 106.78 3.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.824 0.345 . . . . 0.0 110.116 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.3 ptp -119.86 152.06 37.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.724 ' HB2' HG12 ' A' ' 108' ' ' VAL . 23.2 p -75.26 114.89 14.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.606 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.966 HD12 HD13 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -57.92 -20.56 38.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.24 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.724 HG12 ' HB2' ' A' ' 106' ' ' SER . 9.9 p -52.67 -21.24 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.48 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.36 31.92 8.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.678 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.96 HD23 ' CD2' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -62.51 126.97 29.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.64 0.257 . . . . 0.0 110.324 179.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.728 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -123.33 130.63 52.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.17 -14.7 61.88 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.146 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -78.31 -49.01 14.43 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.617 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -39.8 88.33 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.75 0.309 . . . . 0.0 110.913 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -79.06 172.1 10.78 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.995 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.534 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.7 Cg_endo -70.77 127.33 13.65 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 121.976 1.784 . . . . 0.0 111.404 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.57 -14.84 42.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.617 2.212 . . . . 0.0 113.275 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.65 -9.32 58.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.98 36.7 4.55 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -69.75 -41.03 14.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.2 Cg_exo -55.23 -40.58 84.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.052 1.835 . . . . 0.0 112.625 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 1.068 HG21 HD22 ' A' ' 71' ' ' LEU . 5.5 t -77.44 -51.26 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.548 . . . . 0.0 110.793 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.533 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -66.12 -29.87 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.187 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.85 -31.97 60.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.049 0.452 . . . . 0.0 110.226 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -52.35 57.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.886 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 68' ' ' PHE . 3.1 tp -78.12 -29.81 49.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.24 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -55.98 -42.56 76.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.831 ' O ' HD12 ' A' ' 129' ' ' LEU . 51.7 ttp180 -74.22 -4.78 38.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.115 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.189 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 tttp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.872 0.368 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.03 131.91 27.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.869 HD12 HD11 ' A' ' 6' ' ' ILE . 3.0 pp -146.17 118.98 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 28.7 mt-30 -101.91 156.76 17.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.265 0.555 . . . . 0.0 112.219 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.869 HD11 HD12 ' A' ' 4' ' ' LEU . 1.7 mp -146.19 130.76 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.575 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.027 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.44 124.43 42.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -127.99 158.36 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.915 0.388 . . . . 0.0 111.724 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.443 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.25 137.5 6.06 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.966 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.024 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -86.22 111.97 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.729 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.5 mt -71.68 123.74 26.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.54 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -84.32 122.77 29.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.484 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.515 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.0 t-20 -79.65 -172.69 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.855 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.482 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -82.74 0.61 42.75 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.935 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -136.98 50.58 2.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.911 0.386 . . . . 0.0 111.241 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.51 26.38 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.263 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 16.1 pt-20 -116.82 153.25 32.8 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.024 HG21 HG22 ' A' ' 10' ' ' ILE . 5.2 mt -130.36 142.17 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 0.0 111.588 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.91 123.16 35.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.854 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.687 HD11 ' HG2' ' A' ' 105' ' ' MET . 0.5 OUTLIER -113.69 124.77 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.531 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 21' ' ' THR . 1.6 t -72.44 111.71 7.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 0.0 110.718 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.439 ' HA ' HD23 ' A' ' 33' ' ' LEU . 20.3 ptt180 . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.859 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.575 0.226 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.33 26.2 10.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 111.394 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.638 HD11 HD13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -43.35 116.55 0.95 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.403 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -170.85 2.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.24 0.543 . . . . 0.0 112.056 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.51 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.77 165.69 16.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.097 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 47.5 Cg_endo -67.7 167.51 20.91 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.087 2.525 . . . . 0.0 111.533 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.09 59.13 0.77 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.806 -1.188 . . . . 0.0 113.914 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -123.39 127.32 6.56 Favored Glycine 0 C--N 1.311 -0.828 0 CA-C-N 114.841 -0.68 . . . . 0.0 112.021 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER 100.39 6.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.142 0.577 . . . . 0.0 112.211 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.027 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -50.34 -29.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.744 0.783 . . . . 0.0 110.118 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.582 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.86 -81.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.22 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.6 mmt 40.16 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.269 0.356 . . . . 0.0 111.548 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.0 29.83 0.14 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.669 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -95.07 -173.31 2.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.736 0.303 . . . . 0.0 111.122 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.912 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.95 158.01 34.12 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.37 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.912 ' HD2' HG22 ' A' ' 45' ' ' THR . 5.9 Cg_endo -46.74 -24.71 3.14 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.668 2.245 . . . . 0.0 112.375 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.755 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mm-40 -101.54 -44.19 5.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.888 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -80.19 -12.63 59.62 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.951 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -60.54 -54.02 50.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 0.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.807 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.0 OUTLIER -78.14 -44.21 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.587 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.7 t -50.52 -37.77 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.37 . . . . 0.0 110.805 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -78.6 -49.49 13.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.791 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.0 -19.83 66.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.036 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.814 HD21 ' NE2' ' A' ' 64' ' ' HIS . 2.7 tp -59.53 -44.71 93.11 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.18 -34.21 77.55 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 97' ' ' LYS . 5.5 tm-20 -77.35 -24.13 50.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.832 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.484 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 50.3 mm-40 -108.29 5.66 25.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.911 HG12 HG13 ' A' ' 60' ' ' ILE . 41.7 t -134.2 -44.27 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.166 0.508 . . . . 0.0 109.656 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.541 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.89 -39.74 0.25 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.397 -0.819 . . . . 0.0 113.994 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.911 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.7 -177.43 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.018 0.437 . . . . 0.0 111.026 -179.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.83 88.54 14.31 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.807 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.758 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.0 Cg_endo -111.71 145.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 123.406 2.737 . . . . 0.0 113.994 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 36.7 mt-30 -74.86 79.63 2.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 175.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.994 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -120.11 128.67 53.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.832 -176.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.8 t80 -179.51 168.71 1.42 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.981 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER 83.91 155.66 0.1 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.675 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -113.84 123.11 49.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.212 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.83 -38.19 54.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.074 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -171.3 141.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.349 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.46 132.18 22.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.671 0.272 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.745 HD23 HG22 ' A' ' 122' ' ' VAL . 4.4 pp -124.46 164.69 19.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.315 . . . . 0.0 110.954 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -139.77 116.91 11.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.802 ' OH ' HD11 ' A' ' 80' ' ' ILE . 2.2 p90 -141.15 153.07 45.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 6.8 pt-20 -118.34 124.28 47.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 111.319 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.0 163.22 61.32 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.477 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.487 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -52.8 82.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.989 2.459 . . . . 0.0 112.19 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 7.7 t0 90.92 10.73 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.479 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.449 ' CD ' HD21 ' A' ' 4' ' ' LEU . 6.6 ttp180 -137.36 95.89 3.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.294 . . . . 0.0 110.809 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.414 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.8 t-80 -80.4 106.58 12.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.263 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.802 HD11 ' OH ' ' A' ' 73' ' ' TYR . 3.6 pt -120.39 127.09 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.131 0.491 . . . . 0.0 112.119 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.26 118.68 34.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.041 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.679 HD21 ' OD1' ' A' ' 119' ' ' ASN . 4.4 tp -104.78 113.7 27.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 110.965 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.402 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 9.6 m0 -115.58 122.52 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.053 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.705 ' CD2' HG11 ' A' ' 122' ' ' VAL . 3.1 m-30 -105.32 109.68 21.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.702 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.807 ' CE2' HG11 ' A' ' 50' ' ' VAL . 66.0 m95 -94.85 148.67 22.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.307 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 65' ' ' PHE . 65.6 tp -94.52 138.28 32.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.917 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.994 HG22 ' ND1' ' A' ' 64' ' ' HIS . 27.0 t -123.96 145.81 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.418 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -112.82 -24.57 9.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.477 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -162.79 160.73 25.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.595 0.634 . . . . 0.0 111.484 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.701 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.19 121.66 4.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.164 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -77.21 155.31 32.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.214 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.37 -132.78 46.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.619 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.2 mt-10 -122.2 147.06 48.44 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.577 0.227 . . . . 0.0 110.694 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.51 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.62 128.64 10.36 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.85 2.367 . . . . 0.0 111.353 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.541 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 63.4 p-90 -136.59 -58.84 0.73 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.892 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.59 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.49 -96.4 0.01 OUTLIER Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.939 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.7 tmtt? 177.67 33.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.584 0.231 . . . . 0.0 111.173 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -29.01 68.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.7 0.286 . . . . 0.0 110.679 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.91 -2.12 71.91 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.719 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -140.12 95.46 8.43 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.259 0.529 . . . . 0.0 111.556 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -43.71 141.04 4.19 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.909 2.406 . . . . 0.0 112.497 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.23 171.56 22.14 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.871 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.55 157.17 39.5 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.53 106.44 6.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.898 0.38 . . . . 0.0 110.523 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.687 ' HG2' HD11 ' A' ' 20' ' ' ILE . 5.1 ppp? -120.28 155.87 32.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.041 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.2 t -70.3 114.93 8.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.579 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.625 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.51 -18.98 60.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.341 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.651 ' O ' HD21 ' A' ' 129' ' ' LEU . 15.5 t -57.45 -16.88 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.458 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.06 43.54 1.43 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.432 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.601 HD22 HD11 ' A' ' 107' ' ' LEU . 12.7 tp -62.4 146.98 49.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.11 126.81 47.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.6 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.33 -15.16 61.88 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.733 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -78.28 -49.39 13.77 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -39.03 87.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.982 0.42 . . . . 0.0 110.857 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -80.11 173.82 7.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.341 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.476 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.2 Cg_endo -72.26 127.76 13.04 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.162 1.908 . . . . 0.0 111.697 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.89 -14.95 44.24 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 113.061 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.42 58.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.679 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.1 m-80 -121.67 32.6 5.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.695 0.283 . . . . 0.0 111.488 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.454 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.3 mt-10 -73.77 -46.88 6.98 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 80.9 Cg_exo -44.8 -35.05 9.19 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.33 2.02 . . . . 0.0 112.525 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.745 HG22 HD23 ' A' ' 71' ' ' LEU . 12.5 t -77.35 -43.39 30.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.066 0.46 . . . . 0.0 110.127 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.785 HG22 ' HB2' ' A' ' 127' ' ' LYS . 15.5 mm -67.65 -34.41 67.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.888 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.4 -26.61 31.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.983 0.421 . . . . 0.0 110.465 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.13 -52.72 7.44 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.712 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.16 -33.48 50.25 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.725 0.298 . . . . 0.0 111.519 -179.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.843 ' N ' HD23 ' A' ' 126' ' ' LEU . 6.0 ttpm? -53.57 -42.67 67.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.969 0.414 . . . . 0.0 111.058 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -69.37 -7.92 41.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.87 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.651 HD21 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.33 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.899 0.38 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -140.08 131.65 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.847 HD21 ' NE ' ' A' ' 78' ' ' ARG . 3.4 pp -126.02 127.53 46.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.837 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -102.96 152.2 21.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.182 0.515 . . . . 0.0 111.255 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.858 ' HB ' HD23 ' A' ' 82' ' ' LEU . 2.7 mp -143.9 139.02 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.355 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.978 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -125.16 125.46 43.73 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -134.53 151.43 31.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.363 0.602 . . . . 0.0 111.833 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.46 122.11 1.3 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.907 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.033 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -71.56 114.26 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.712 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.31 121.7 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.024 0.44 . . . . 0.0 111.553 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.418 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.7 119.41 24.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.5 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.546 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.1 t-20 -79.04 -172.64 3.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.967 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.51 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 1.1 tm-20 -81.43 0.91 35.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.118 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -139.47 52.28 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 111.27 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.8 p30 45.61 26.59 0.34 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.358 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 16.4 pt-20 -117.23 151.41 36.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.033 HG21 HG22 ' A' ' 10' ' ' ILE . 4.3 mt -127.93 146.78 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.034 0.445 . . . . 0.0 111.655 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.454 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -97.24 121.76 39.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.855 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.954 HD13 HD11 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -116.71 141.19 35.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.17 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 p -80.2 125.45 29.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.778 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.473 ' CA ' HD23 ' A' ' 33' ' ' LEU . 31.1 ttt180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.621 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.156 0 N-CA-C 111.525 0.195 . . . . 0.0 111.525 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -114.23 26.0 10.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 111.472 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.954 HD11 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -46.13 101.63 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.585 179.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -110.26 -169.34 1.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.03 0.443 . . . . 0.0 111.451 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.75 162.59 32.07 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.58 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 36.8 Cg_endo -64.59 168.08 13.9 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.559 2.839 . . . . 0.0 111.989 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.784 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.41 59.17 0.76 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.872 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.611 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -127.64 127.73 5.89 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 114.242 -0.979 . . . . 0.0 111.688 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 111.7 -10.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.317 0.647 . . . . 0.0 110.974 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.978 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -43.67 -74.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.848 0.356 . . . . 0.0 110.804 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.548 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER 6.31 -82.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.107 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 36.32 -141.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.373 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.9 11.27 9.44 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.077 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -169.08 0.29 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.585 0.231 . . . . 0.0 110.683 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.879 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.17 155.33 38.72 Favored Pre-proline 0 N--CA 1.454 -0.25 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.879 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.74 -24.59 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.584 2.19 . . . . 0.0 112.226 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -89.6 -59.85 2.1 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.127 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -80.85 -4.84 56.19 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -66.04 -57.26 8.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.638 0.256 . . . . 0.0 111.178 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.705 HG23 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -78.55 -41.16 24.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.158 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 47' ' ' GLU . 73.6 t -50.42 -35.62 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.811 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -78.35 -52.05 9.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.053 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.44 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 1.1 tm-20 -62.18 -23.37 66.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.763 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.779 HD21 ' NE2' ' A' ' 64' ' ' HIS . 2.2 tp -57.45 -44.66 84.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.782 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -62.74 -27.9 69.59 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.25 -27.03 53.13 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.001 179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.433 ' HG2' ' H ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -108.69 6.15 25.49 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.943 HG12 HG13 ' A' ' 60' ' ' ILE . 25.4 t -133.51 -44.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.017 0.437 . . . . 0.0 109.928 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.95 -39.02 0.19 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.636 -0.711 . . . . 0.0 114.018 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.943 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.58 -176.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.979 0.419 . . . . 0.0 110.984 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.25 88.72 13.09 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.117 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.841 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.4 Cg_endo -111.41 144.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.426 2.75 . . . . 0.0 114.146 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 35.1 mt-30 -74.82 79.93 2.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.998 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.49 129.09 53.7 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.654 -175.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -177.77 -138.25 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.503 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.73 163.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.162 0.506 . . . . 0.0 112.045 179.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.1 tt -124.55 109.82 13.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.749 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.87 -43.43 35.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.164 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.4 tt0 -171.63 163.66 6.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.429 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.33 114.19 7.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.88 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.7 ' HB2' HG22 ' A' ' 122' ' ' VAL . 15.7 tp -102.73 121.93 43.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.811 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -124.54 109.79 13.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.596 ' HE1' HD12 ' A' ' 82' ' ' LEU . 2.5 p90 -141.09 152.1 44.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.635 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -121.17 118.82 30.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.047 0.451 . . . . 0.0 111.332 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -69.9 163.64 58.81 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.281 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -52.37 83.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.066 2.511 . . . . 0.0 112.362 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 4.6 t70 98.02 14.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.387 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.847 ' NE ' HD21 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -137.36 147.14 45.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.67 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.25 96.06 4.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.54 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.449 HD13 HH12 ' A' ' 78' ' ' ARG . 1.1 tt -102.81 115.37 44.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 0.0 111.196 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.14 118.92 37.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.22 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' A' ' 6' ' ' ILE . 16.6 mt -118.69 114.57 22.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 111.489 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -104.81 122.51 45.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.217 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.451 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 4.4 m-30 -103.54 109.84 21.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.016 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.599 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 44.6 m95 -94.84 148.58 22.15 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.675 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 86' ' ' LEU . 2.9 tm? -101.28 102.92 13.88 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.399 0.619 . . . . 0.0 111.75 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.998 HG22 ' ND1' ' A' ' 64' ' ' HIS . 15.0 t -79.39 145.71 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.691 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -115.19 -23.02 9.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.8 OUTLIER -162.37 160.22 26.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.6 0.637 . . . . 0.0 111.556 -179.029 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.712 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.08 121.47 4.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.124 178.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.56 148.78 42.67 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.198 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.53 -128.93 47.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.589 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.0 mt-10 -123.57 147.57 53.35 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.615 0.245 . . . . 0.0 110.641 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.47 128.71 10.53 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.793 2.329 . . . . 0.0 111.105 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.571 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.2 p-90 -135.5 -62.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.546 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.564 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.06 -97.75 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.614 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.9 tttp 171.32 34.98 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.578 0.228 . . . . 0.0 111.344 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -29.21 64.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.74 0.305 . . . . 0.0 110.568 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.44 64.72 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.374 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -140.18 94.78 8.6 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.007 0.432 . . . . 0.0 111.441 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.61 138.67 5.36 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.996 2.464 . . . . 0.0 112.398 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.07 19.43 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.915 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -142.06 157.31 45.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.58 0.229 . . . . 0.0 110.447 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -69.38 106.99 3.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.881 0.372 . . . . 0.0 110.332 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtt -119.68 163.13 17.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 p -80.36 114.75 19.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -80.23 -27.09 38.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.149 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -51.96 -23.46 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.493 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.21 44.62 1.22 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.591 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.57 150.24 41.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.588 0.232 . . . . 0.0 110.387 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.95 133.4 56.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.21 0.528 . . . . 0.0 112.344 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.15 -15.39 61.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.567 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.59 -49.13 13.8 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.538 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -33.8 76.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.849 0.357 . . . . 0.0 111.002 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -86.91 173.44 6.66 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.458 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.4 Cg_endo -67.7 127.69 16.71 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 121.947 1.765 . . . . 0.0 111.967 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.87 -20.56 58.24 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.519 2.146 . . . . 0.0 112.922 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.83 -9.49 58.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.92 30.38 7.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.797 0.332 . . . . 0.0 111.397 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.611 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -76.23 -32.01 1.05 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.3 Cg_exo -49.22 -43.52 36.9 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 121.957 1.771 . . . . 0.0 113.088 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.7 t -77.56 -51.32 18.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.0 111.542 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.569 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -65.95 -34.75 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.541 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -28.76 50.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -74.81 -53.26 9.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.629 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.78 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.2 tp -78.57 -32.97 48.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.638 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.569 ' HB2' HG22 ' A' ' 123' ' ' ILE . 4.0 tttm -53.85 -42.65 68.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.967 0.413 . . . . 0.0 111.019 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -65.94 -10.79 42.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.731 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.78 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.3 mp . . . . . 0 C--O 1.231 0.111 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.048 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.838 0.351 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -137.64 143.14 41.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.77 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.9 pp -146.14 120.09 9.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.757 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.763 ' C ' HD13 ' A' ' 6' ' ' ILE . 7.8 mt-30 -102.12 155.48 18.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.371 0.605 . . . . 0.0 111.918 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.763 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -146.24 121.73 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.855 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.012 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -122.19 124.78 44.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.469 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.694 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -121.36 162.92 19.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.325 0.583 . . . . 0.0 111.952 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -145.99 120.66 1.35 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.987 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.947 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.81 105.52 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.741 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.5 mt -71.37 121.81 22.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 0.0 111.668 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.31 127.64 34.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.77 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.527 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.0 t-20 -83.63 -172.53 4.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.636 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.482 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 28.1 tt0 -83.95 5.66 24.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.141 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -141.25 52.66 1.56 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.0 111.367 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.0 p30 45.46 25.15 0.21 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.57 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 16.4 pt-20 -117.69 144.95 44.76 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.947 HG21 HG22 ' A' ' 10' ' ' ILE . 9.8 mt -115.13 135.94 53.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.248 0.546 . . . . 0.0 111.978 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -80.8 116.55 20.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.943 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.876 HG23 ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -116.94 131.14 70.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.754 HG23 ' HD3' ' A' ' 36' ' ' PRO . 62.9 p -71.92 111.87 7.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.408 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.146 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.703 0.287 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -113.92 26.27 10.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.094 0.473 . . . . 0.0 111.401 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 34' ' ' GLU . 1.2 tt -47.45 127.88 11.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.772 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.781 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -156.53 -173.91 4.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 111.496 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.876 ' CD2' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.94 162.71 31.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.469 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.754 ' HD3' HG23 ' A' ' 21' ' ' THR . 10.6 Cg_endo -51.55 168.72 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.534 2.823 . . . . 0.0 111.657 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 7' ' ' ALA . . . 102.94 59.41 0.74 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.923 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.05 116.28 2.04 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.53 -0.835 . . . . 0.0 111.683 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.69 5.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.224 0.61 . . . . 0.0 111.682 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.017 HD12 ' HB1' ' A' ' 49' ' ' ALA . 1.2 pt -50.71 -28.92 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.572 0.701 . . . . 0.0 110.275 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.583 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.94 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.151 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' GLU . 56.6 mmm 30.83 -86.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.566 0.541 . . . . 0.0 112.054 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.84 32.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.524 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.2 mp0 -87.16 -174.8 5.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.827 0.346 . . . . 0.0 111.161 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.857 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.69 154.08 37.62 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.353 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.857 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.82 -26.33 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.835 2.357 . . . . 0.0 112.548 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 51' ' ' VAL . 8.8 mt-10 -104.2 -38.72 6.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.746 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -80.29 -11.72 59.69 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.017 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.01 -53.02 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.0 111.072 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.905 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.7 m -78.23 -45.87 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.9 t -56.04 -37.94 51.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.04 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -78.28 -47.2 18.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.629 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.66 -21.57 65.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.804 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.911 HD21 ' CD2' ' A' ' 64' ' ' HIS . 1.9 tp -55.64 -44.55 77.26 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.871 0.367 . . . . 0.0 110.534 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -34.07 77.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -77.39 -25.82 51.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.072 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.456 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 31.0 mm-40 -108.54 5.52 25.2 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.963 HG12 HG13 ' A' ' 60' ' ' ILE . 25.8 t -134.34 -44.18 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.117 0.484 . . . . 0.0 109.96 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.99 -41.07 0.33 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.696 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.963 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.54 -175.52 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.983 0.421 . . . . 0.0 110.965 -179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.3 89.0 11.48 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.29 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.896 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.8 Cg_endo -108.78 143.59 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.172 2.581 . . . . 0.0 114.008 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 38.4 mt-30 -74.9 79.87 2.14 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.911 ' CD2' HD21 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -119.28 129.6 54.99 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.682 -176.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.4 t80 178.79 167.41 0.9 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.749 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 87.06 155.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.476 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.864 HD22 ' N ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -102.22 156.44 17.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.05 0.453 . . . . 0.0 110.729 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.864 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.99 -42.81 2.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.866 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.527 ' OE2' HG13 ' A' ' 122' ' ' VAL . 1.6 tt0 -171.76 162.1 6.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.186 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -143.36 132.08 22.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.75 0.309 . . . . 0.0 110.71 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.755 HD23 ' CE1' ' A' ' 73' ' ' TYR . 4.4 tp -124.08 125.8 45.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.597 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -118.05 112.51 20.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.015 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.998 ' CE2' HD11 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -141.08 153.13 45.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.403 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -117.5 140.05 50.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.263 0.554 . . . . 0.0 111.54 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.497 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.8 m-85 -90.22 162.42 34.81 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.347 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.497 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 11.2 Cg_endo -54.53 82.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.884 2.389 . . . . 0.0 112.062 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 13.0 m-20 90.36 12.4 0.05 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.45 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.433 ' CG ' HD23 ' A' ' 4' ' ' LEU . 22.0 ttp180 -137.33 98.82 3.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.396 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -78.56 115.67 18.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.883 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.998 HD11 ' CE2' ' A' ' 73' ' ' TYR . 7.2 pt -118.94 154.27 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.106 0.479 . . . . 0.0 111.7 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.44 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -128.67 118.74 23.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.208 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.519 HD21 ' CE1' ' A' ' 84' ' ' PHE . 5.9 tp -106.28 114.31 28.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.0 111.592 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.448 ' CH2' ' HA ' ' A' ' 46' ' ' PRO . 6.7 m0 -112.11 122.63 48.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.088 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.519 ' CE1' HD21 ' A' ' 82' ' ' LEU . 5.1 m-30 -108.43 109.62 20.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.881 0.372 . . . . 0.0 110.433 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.905 ' NE1' HG11 ' A' ' 50' ' ' VAL . 40.8 m95 -99.96 149.08 23.8 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.013 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 65' ' ' PHE . 52.6 tp -92.07 138.56 31.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.885 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.794 HG13 ' CB ' ' A' ' 64' ' ' HIS . 21.6 t -123.75 145.97 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.322 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -112.8 -26.02 8.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.47 159.69 25.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.725 0.693 . . . . 0.0 111.678 -179.012 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.741 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -152.78 123.62 7.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -73.17 145.63 46.17 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.101 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.8 -129.17 44.55 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.617 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 57.3 tt0 -122.19 142.38 36.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.521 0.2 . . . . 0.0 110.731 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.508 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -76.44 128.75 10.58 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.833 2.355 . . . . 0.0 111.376 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.581 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.1 p-90 -131.36 -58.59 0.99 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.845 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.567 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.17 -94.87 0.01 OUTLIER Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.909 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.37 33.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 110.99 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.53 -23.66 65.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.629 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.3 74.95 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.119 -0.563 . . . . 0.0 113.584 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.424 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 15.0 mt-30 -140.35 93.27 9.0 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.016 0.436 . . . . 0.0 111.362 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.65 134.14 7.4 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.969 2.446 . . . . 0.0 112.575 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.16 177.11 19.4 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.823 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -142.48 157.25 44.95 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -69.44 106.7 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.34 . . . . 0.0 110.219 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.515 ' SD ' HD12 ' A' ' 20' ' ' ILE . 9.0 ptm -119.92 153.95 35.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.409 ' HB2' HG12 ' A' ' 108' ' ' VAL . 87.1 p -74.99 114.78 13.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.686 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -70.59 -23.16 62.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.089 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 106' ' ' SER . 10.0 p -58.48 -19.02 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.306 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.13 44.19 1.29 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.393 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.474 HD13 HD22 ' A' ' 107' ' ' LEU . 8.4 tp -62.64 149.4 43.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.2 127.07 48.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.43 -14.58 61.73 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.557 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.21 -49.33 13.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.602 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -39.01 87.33 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.736 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.581 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.9 173.93 6.91 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.169 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 63.7 Cg_endo -73.4 127.66 12.06 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.121 1.881 . . . . 0.0 111.606 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.14 -14.93 40.79 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.587 2.191 . . . . 0.0 113.203 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.0 -9.5 58.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.12 31.98 5.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.68 0.276 . . . . 0.0 111.427 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.3 mt-10 -72.95 -36.0 3.16 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 69.3 Cg_exo -51.15 -45.87 34.34 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 121.981 1.787 . . . . 0.0 112.854 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -77.36 -51.29 18.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 0.0 110.926 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.581 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.7 mm -62.23 -32.27 54.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.255 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.86 -35.33 63.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.011 0.434 . . . . 0.0 110.419 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -65.36 -53.09 48.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.087 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.735 ' O ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -78.35 -20.04 52.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.639 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 123' ' ' ILE . 31.5 tttp -74.55 -42.59 58.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.19 0.519 . . . . 0.0 110.599 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -66.98 -10.29 47.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.912 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.735 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.128 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.611 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.785 0.326 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.24 122.05 27.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.709 HD12 HD11 ' A' ' 6' ' ' ILE . 2.0 pp -131.33 140.95 49.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.798 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.808 ' C ' HD13 ' A' ' 6' ' ' ILE . 33.9 mt-30 -102.92 151.49 22.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.38 0.61 . . . . 0.0 112.05 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.808 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -144.97 116.61 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.659 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.998 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.76 152.27 44.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -145.08 162.6 13.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.339 0.59 . . . . 0.0 111.883 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.0 110.07 0.85 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.274 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.61 HG22 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.88 96.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.755 HG23 HG11 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -71.46 125.04 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 121.179 0.514 . . . . 0.0 112.052 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -93.64 142.61 27.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.857 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.676 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 5.1 p30 -99.08 -173.33 2.47 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.111 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -74.87 0.2 16.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.89 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -123.48 42.93 3.09 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.181 -0.324 . . . . 0.0 111.597 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 46.11 24.9 0.29 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.046 0.45 . . . . 0.0 111.263 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.533 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 24.4 mt-10 -113.83 160.88 18.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.834 HD13 HD22 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -119.33 131.99 70.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.134 0.492 . . . . 0.0 112.294 -178.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.491 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -85.06 116.01 23.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.26 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -118.96 140.16 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.682 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.559 HG21 ' HG2' ' A' ' 98' ' ' GLU . 45.7 p -76.48 120.2 21.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.593 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 35.4 ptt180 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.512 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 111.533 0.198 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -114.25 26.23 10.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.045 0.45 . . . . 0.0 111.353 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.52 HD11 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -48.81 103.19 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.656 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.26 -170.61 1.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.731 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.522 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.53 168.29 10.41 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.392 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.551 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 89.2 Cg_endo -83.13 167.12 14.2 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.643 2.895 . . . . 0.0 112.981 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.7 -5.1 50.75 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.496 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -62.71 167.7 19.74 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.864 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 80.16 8.43 1.46 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 122.618 0.367 . . . . 0.0 111.759 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.998 HG21 ' HB3' ' A' ' 7' ' ' ALA . 2.1 pt -57.88 -26.94 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.651 0.739 . . . . 0.0 110.052 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.496 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.43 -69.27 0.14 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.121 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.478 ' C ' ' O ' ' A' ' 41' ' ' GLU . 44.0 mmm 19.73 -86.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.731 0.644 . . . . 0.0 112.467 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.46 30.02 0.11 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.856 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -88.2 -170.38 2.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.783 0.325 . . . . 0.0 111.124 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.894 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.11 156.1 35.66 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.385 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.894 ' HD2' HG22 ' A' ' 45' ' ' THR . 5.0 Cg_endo -46.04 -24.88 2.51 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.781 2.321 . . . . 0.0 112.475 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 51' ' ' VAL . 8.3 mt-10 -104.11 -39.96 6.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.526 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 6.0 mt-30 -80.1 -12.78 59.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.615 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.869 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -58.48 -52.78 64.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.869 0.366 . . . . 0.0 110.885 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.931 HG11 ' NE1' ' A' ' 85' ' ' TRP . 3.4 m -78.32 -45.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 47' ' ' GLU . 33.4 t -61.17 -41.93 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.314 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 3.7 tpt180 -78.02 -37.69 46.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.889 0.376 . . . . 0.0 110.625 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' GLU . 7.9 tp10 -75.57 -19.93 58.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.627 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.899 HD21 ' CE1' ' A' ' 64' ' ' HIS . 3.8 tp -57.53 -44.37 85.07 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.575 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.89 -36.3 82.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.7 tm-20 -77.52 -24.49 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.042 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 53' ' ' GLU . 12.7 mm-40 -108.2 5.09 25.47 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.947 HG12 HG13 ' A' ' 60' ' ' ILE . 39.5 t -134.79 -44.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.226 0.536 . . . . 0.0 109.756 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.567 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.29 -40.79 0.36 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.336 -0.847 . . . . 0.0 113.892 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.947 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.85 -176.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.983 0.42 . . . . 0.0 111.171 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.83 88.89 12.37 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.948 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.843 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.4 Cg_endo -109.45 154.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.399 2.733 . . . . 0.0 114.367 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.625 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -83.39 80.79 8.98 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 175.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.899 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -122.22 127.69 50.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.462 -175.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.513 ' O ' ' O ' ' A' ' 86' ' ' LEU . 6.1 t80 -179.11 163.41 1.31 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.928 0.394 . . . . 0.0 112.051 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER 85.72 153.33 0.08 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.725 179.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -112.14 129.4 56.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.925 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.736 ' CE1' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.87 -51.09 11.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.152 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.4 mt-10 -171.26 131.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.425 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -111.95 131.97 55.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.725 0.298 . . . . 0.0 111.099 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.795 ' HB2' HG22 ' A' ' 122' ' ' VAL . 4.1 tp -110.28 131.14 55.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.649 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -121.1 109.89 15.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.617 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -141.1 146.32 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -121.15 140.03 52.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.151 0.501 . . . . 0.0 111.192 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -88.81 163.64 34.49 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.55 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 9.4 Cg_endo -52.29 84.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.025 2.483 . . . . 0.0 112.205 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 20.5 m-20 93.68 15.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.235 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 30.7 ttt180 -137.37 150.09 47.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.452 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -126.18 101.97 7.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.0 110.979 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.438 HG13 HD11 ' A' ' 6' ' ' ILE . 3.5 tt -109.87 111.92 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.453 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -94.83 118.47 31.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.283 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.902 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -108.45 114.32 28.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.0 111.421 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -113.14 122.71 48.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.042 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.902 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -106.86 109.71 21.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.449 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.931 ' NE1' HG11 ' A' ' 50' ' ' VAL . 47.2 m95 -97.99 148.5 23.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.0 112.173 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 65' ' ' PHE . 58.8 tp -92.9 134.74 34.8 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.436 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.803 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.7 t -124.7 146.13 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.03 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 4.8 tp10 -106.69 -35.3 7.05 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.22 165.63 24.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.141 0.882 . . . . 0.0 111.945 -179.018 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.734 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -151.29 129.17 11.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.41 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -76.42 136.1 39.44 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.66 -126.78 24.95 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.556 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -125.85 143.44 45.28 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.549 0.214 . . . . 0.0 110.714 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.67 128.71 10.36 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.858 2.372 . . . . 0.0 111.489 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.567 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.9 p-90 -131.98 -58.8 0.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.726 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.588 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.94 -97.35 0.01 OUTLIER Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.968 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -179.97 33.88 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.685 0.279 . . . . 0.0 111.355 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.559 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -64.49 -27.69 69.15 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.826 0.346 . . . . 0.0 110.432 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.8 12.45 84.44 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.425 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.448 ' O ' HG22 ' A' ' 21' ' ' THR . 41.7 mt-30 -140.35 98.15 7.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 117.075 0.438 . . . . 0.0 111.53 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -43.71 141.46 3.94 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.835 2.357 . . . . 0.0 112.461 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.15 177.18 19.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.949 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -147.64 157.4 43.54 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.468 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.7 OUTLIER -68.89 106.14 2.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.867 0.365 . . . . 0.0 110.495 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.478 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 3.1 mmm -120.24 151.93 38.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.838 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.32 114.79 13.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.572 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.834 HD22 HD13 ' A' ' 18' ' ' ILE . 25.9 tp -79.72 -18.95 50.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.269 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.578 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.5 p -55.97 -20.67 9.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.813 0.339 . . . . 0.0 111.176 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.12 49.74 0.88 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.255 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.548 HD22 HD12 ' A' ' 123' ' ' ILE . 6.7 tt -62.45 150.22 40.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.701 0.286 . . . . 0.0 110.411 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -115.26 132.19 56.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.166 0.508 . . . . 0.0 112.184 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.64 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.25 -15.3 61.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.736 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -78.43 -49.19 13.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.325 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -27.67 67.4 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.77 0.319 . . . . 0.0 111.054 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.64 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -96.19 169.36 9.11 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.442 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.511 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 39.2 Cg_endo -67.07 127.71 17.3 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.353 2.036 . . . . 0.0 111.948 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.87 -19.88 58.44 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.535 2.157 . . . . 0.0 113.048 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.51 58.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.33 32.4 6.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.789 0.328 . . . . 0.0 111.417 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.07 -40.21 2.92 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 86.4 Cg_exo -44.86 -36.61 11.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.135 1.89 . . . . 0.0 112.682 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.859 HG21 ' CE1' ' A' ' 84' ' ' PHE . 7.0 t -77.57 -42.39 29.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.069 0.461 . . . . 0.0 110.339 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.664 HG22 ' HB2' ' A' ' 127' ' ' LYS . 6.0 mm -69.17 -34.14 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.954 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.62 -27.04 36.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.945 0.402 . . . . 0.0 110.416 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -50.76 9.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.693 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.736 HD13 ' CE1' ' A' ' 68' ' ' PHE . 7.1 tp -78.07 -32.05 50.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.781 0.324 . . . . 0.0 111.613 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.664 ' HB2' HG22 ' A' ' 123' ' ' ILE . 5.9 ttpm? -53.81 -42.52 68.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.057 0.456 . . . . 0.0 111.002 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -71.87 -6.11 39.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.998 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 108' ' ' VAL . 2.3 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.203 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 tptm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.807 0.337 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 132.82 46.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.741 HD12 HD11 ' A' ' 6' ' ' ILE . 2.7 pp -130.41 140.49 50.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.818 ' C ' HD13 ' A' ' 6' ' ' ILE . 10.9 mt-30 -107.37 149.45 27.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.276 0.56 . . . . 0.0 111.838 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.818 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -142.92 123.55 10.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.037 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.093 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.51 124.53 42.47 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.487 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -116.99 155.75 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.45 0.643 . . . . 0.0 112.019 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -138.59 109.27 0.66 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.177 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.606 HG22 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.85 101.38 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.708 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.1 mt -71.58 124.49 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.124 0.488 . . . . 0.0 111.958 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.473 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -96.41 137.71 35.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.065 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.688 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.8 p30 -94.84 -173.43 2.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.222 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.69 -2.17 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.071 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -120.61 41.39 3.27 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.556 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p30 47.44 23.58 0.39 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.949 0.404 . . . . 0.0 111.18 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.596 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 20.2 mt-10 -111.41 160.94 16.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.606 ' CG2' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -117.49 142.29 32.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.115 0.483 . . . . 0.0 112.137 -178.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -98.0 115.95 29.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.58 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.76 HD11 ' HG2' ' A' ' 105' ' ' MET . 0.2 OUTLIER -121.57 150.49 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.461 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.463 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 47.1 p -81.97 111.81 18.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.543 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.456 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.582 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -114.16 26.02 10.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.063 0.459 . . . . 0.0 111.41 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.508 HD11 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -47.77 99.9 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.44 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.8 tt0 -106.68 -177.5 3.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.168 0.509 . . . . 0.0 111.919 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.611 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.87 166.37 15.13 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.347 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 56.3 Cg_endo -69.83 167.76 23.6 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.351 2.7 . . . . 0.0 111.887 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.3 59.65 0.76 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.194 -1.003 . . . . 0.0 114.062 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -123.01 132.51 8.65 Favored Glycine 0 C--N 1.311 -0.829 0 CA-C-N 114.679 -0.76 . . . . 0.0 112.055 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.0 OUTLIER 92.93 7.7 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.043 0.537 . . . . 0.0 112.377 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.093 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -51.2 -29.23 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.706 0.765 . . . . 0.0 110.087 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.596 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.17 -80.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.876 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.2 mmm 37.13 -84.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.588 0.555 . . . . 0.0 111.605 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.57 31.37 0.13 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.456 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -90.94 -176.56 4.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.822 0.344 . . . . 0.0 111.287 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.868 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.4 153.9 37.55 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.325 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.868 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.93 -25.03 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.83 2.353 . . . . 0.0 112.589 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -104.02 -40.14 6.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.675 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -80.11 -13.92 58.9 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.059 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -59.6 -51.13 71.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.719 0.295 . . . . 0.0 111.098 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.929 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.9 m -77.99 -45.48 27.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.037 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.1 t -57.73 -43.54 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.329 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -44.52 25.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.082 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.4 tm-20 -68.39 -25.52 65.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.808 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -53.7 -44.46 69.79 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.914 0.387 . . . . 0.0 110.385 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -60.42 -35.9 76.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.66 -26.61 50.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.487 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' CA ' ' OE1' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -108.11 6.17 26.64 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -178.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.902 HG12 HG13 ' A' ' 60' ' ' ILE . 48.3 t -134.02 -44.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.51 -40.24 0.29 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.442 -0.799 . . . . 0.0 114.065 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.902 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.84 -177.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.114 0.483 . . . . 0.0 111.092 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.38 88.81 13.58 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.821 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.735 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.2 Cg_endo -111.07 146.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 123.287 2.658 . . . . 0.0 114.159 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 38.6 mt-30 -74.84 79.71 2.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 175.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.003 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.82 127.46 50.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.562 -176.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.514 ' O ' ' O ' ' A' ' 86' ' ' LEU . 12.4 t80 -179.29 168.22 1.5 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.5 m 84.43 154.73 0.09 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.742 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 pp -111.9 123.6 50.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 111.132 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.83 -38.69 53.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.198 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.2 mt-10 -171.29 148.33 2.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.342 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.4 132.15 22.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.633 0.254 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.634 HD22 ' N ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -133.3 166.66 21.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 110.894 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.634 ' N ' HD22 ' A' ' 71' ' ' LEU . 16.2 tt0 -137.68 126.06 23.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.665 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.644 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.9 p90 -141.14 147.0 37.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.451 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -121.15 139.96 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.213 0.53 . . . . 0.0 111.424 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -88.28 163.26 37.42 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.353 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.6 Cg_endo -50.6 83.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.029 2.486 . . . . 0.0 112.126 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.5 m-20 93.15 18.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.215 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.594 ' CZ ' HD21 ' A' ' 4' ' ' LEU . 12.0 ttt180 -137.45 150.08 47.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.515 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -123.11 106.59 10.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.774 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.477 HD13 ' OH ' ' A' ' 73' ' ' TYR . 3.6 tt -113.44 112.03 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.232 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -91.36 118.61 30.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.101 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.686 HD11 HD21 ' A' ' 119' ' ' ASN . 10.2 mt -109.19 114.26 27.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.997 0.427 . . . . 0.0 111.801 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -112.28 122.13 46.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.101 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.522 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.3 m-85 -106.63 109.79 21.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.244 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.929 ' NE1' HG11 ' A' ' 50' ' ' VAL . 39.4 m95 -98.38 148.7 23.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.081 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.514 ' O ' ' O ' ' A' ' 65' ' ' PHE . 18.7 tp -94.19 138.44 32.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.402 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.003 HG22 ' ND1' ' A' ' 64' ' ' HIS . 34.5 t -123.66 145.41 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.439 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -111.87 -25.59 9.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 5.8 tpt180 -162.79 163.54 26.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.511 0.596 . . . . 0.0 111.354 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.708 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -156.38 123.57 5.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.29 178.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -74.78 149.52 39.68 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.96 -131.76 48.08 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.596 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -121.4 145.05 41.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.44 0.162 . . . . 0.0 110.747 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.518 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.57 128.66 10.41 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.817 2.345 . . . . 0.0 111.386 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 59.5 p-90 -135.05 -58.27 0.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.921 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.616 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.79 -95.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.982 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -176.02 33.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.728 0.299 . . . . 0.0 111.234 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -26.21 60.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.41 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.99 16.8 73.03 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.632 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.463 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 48.8 mt-30 -140.28 92.08 9.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.129 0.49 . . . . 0.0 111.46 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -43.84 146.1 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.155 2.57 . . . . 0.0 112.935 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.448 ' CA ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.1 177.11 19.38 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.576 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -142.26 157.28 45.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.569 0.223 . . . . 0.0 110.975 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.535 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -74.71 106.02 6.07 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.747 0.308 . . . . 0.0 110.503 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.76 ' HG2' HD11 ' A' ' 20' ' ' ILE . 4.7 ppp? -120.74 147.64 45.03 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.361 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.5 114.85 3.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.823 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.962 HD11 HD11 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -80.13 -18.94 48.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.383 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.1 t -58.32 -15.13 4.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.586 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.07 51.92 0.78 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.315 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.736 HD13 HD22 ' A' ' 107' ' ' LEU . 11.5 tp -62.32 149.75 41.29 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.23 132.21 53.95 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.662 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.36 -15.32 61.86 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.497 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -78.56 -49.29 13.57 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.732 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -32.35 73.58 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.755 0.312 . . . . 0.0 111.031 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.662 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.68 170.74 10.48 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.312 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.538 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 55.5 Cg_endo -69.78 127.47 14.63 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.093 1.862 . . . . 0.0 111.669 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.57 -14.9 45.36 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.631 2.22 . . . . 0.0 113.385 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.64 -9.56 58.8 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.686 HD21 HD11 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -121.61 34.3 5.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.762 0.315 . . . . 0.0 111.465 -178.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -76.04 -31.87 1.06 Allowed Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 72.1 Cg_exo -49.06 -46.51 25.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 121.79 1.66 . . . . 0.0 112.817 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.445 HG22 ' CD1' ' A' ' 71' ' ' LEU . 1.5 t -77.41 -50.61 20.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.033 0.444 . . . . 0.0 110.622 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.599 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.4 mm -59.33 -35.06 56.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.248 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.73 -34.82 62.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.999 0.428 . . . . 0.0 110.489 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.75 -53.01 30.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.342 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.962 HD11 HD11 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -78.35 -19.74 52.79 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.699 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.66 ' N ' HD23 ' A' ' 126' ' ' LEU . 10.1 ttpp -66.24 -42.5 88.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.202 0.525 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -70.03 -9.07 54.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.186 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.858 0.361 . . . . 0.0 110.652 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.81 0.338 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -137.52 144.26 42.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.917 ' HG ' HG22 ' A' ' 80' ' ' ILE . 1.9 pp -146.14 119.15 8.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.724 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.518 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 16.7 mt-30 -102.01 152.33 21.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.505 0.669 . . . . 0.0 112.341 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.689 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -146.54 131.25 11.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.323 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.031 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.35 125.09 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 m -115.6 162.49 13.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.618 0.723 . . . . 0.0 112.714 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.422 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -145.86 112.93 0.66 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.251 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.718 HG22 HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.93 96.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.539 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.7 tt -71.64 117.54 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.205 0.526 . . . . 0.0 112.318 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.588 ' CG ' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -94.92 147.38 23.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.88 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.842 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 9.7 p-10 -103.78 -173.05 2.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.512 0.672 . . . . 0.0 112.225 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.7 tm-20 -71.8 1.6 6.7 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.455 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -124.64 44.59 2.73 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.597 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.9 p30 44.98 28.1 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.303 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 3.2 mt-10 -114.96 161.19 18.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.635 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.844 HD13 HD22 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -124.58 128.39 73.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.913 0.387 . . . . 0.0 111.937 -178.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -76.33 113.31 13.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.182 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.661 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.13 126.17 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.957 179.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.426 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 3.7 p -71.03 112.15 6.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.854 0.359 . . . . 0.0 110.987 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.582 179.904 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.18 26.25 10.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.115 0.483 . . . . 0.0 111.274 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.661 HD21 ' HB ' ' A' ' 20' ' ' ILE . 3.6 tt -45.77 100.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.657 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -125.12 179.08 5.21 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.227 0.537 . . . . 0.0 112.231 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.545 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.92 163.69 26.44 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.866 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 9.6 Cg_endo -51.49 168.61 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.884 3.056 . . . . 0.0 112.158 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.87 59.5 0.74 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.978 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.618 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.57 123.63 4.19 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 114.519 -0.84 . . . . 0.0 112.234 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.47 1.01 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.031 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -52.8 -27.07 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.627 0.727 . . . . 0.0 110.577 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.536 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -44.32 -60.72 1.79 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.233 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.511 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.3 ttp 11.02 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.936 0.773 . . . . 0.0 112.574 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.89 34.76 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.503 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -90.19 -174.73 4.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.935 0.398 . . . . 0.0 111.118 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.873 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.33 154.44 38.05 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.432 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.873 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.89 -25.6 1.09 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.818 2.345 . . . . 0.0 112.515 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.593 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -104.04 -38.91 6.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.446 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -80.1 -11.81 59.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.614 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.91 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -59.77 -52.9 63.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 0.0 110.815 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.918 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.4 m -78.16 -47.27 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.089 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.6 t -54.88 -37.27 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.26 -51.74 9.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.125 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.484 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.9 mm-40 -66.01 -23.48 66.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.764 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.2 tp -52.69 -44.67 66.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.744 0.307 . . . . 0.0 110.193 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -34.92 76.07 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.8 tt0 -77.43 -24.05 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.797 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.475 ' HG2' ' HA2' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -108.59 6.01 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.899 -179.172 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.645 HG11 ' HG3' ' A' ' 62' ' ' PRO . 16.1 t -133.97 -44.72 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 0.0 110.02 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.13 -39.42 0.2 Allowed Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.628 -0.715 . . . . 0.0 114.0 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.698 HG23 ' NE1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -88.26 -174.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.018 0.437 . . . . 0.0 111.085 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -111.98 88.87 10.69 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.259 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.645 ' HG3' HG11 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -108.63 154.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.915 2.41 . . . . 0.0 114.658 -177.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 89' ' ' ARG . 81.3 mt-30 -75.02 79.72 2.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.024 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -126.37 121.28 32.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.07 -176.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.9 t80 179.43 171.27 0.98 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.436 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.3 t 92.79 147.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.814 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.538 HD22 ' CD2' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -96.12 126.7 41.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.406 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -92.13 -51.77 5.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 179.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 9.4 tt0 -171.63 163.75 6.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.31 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -143.34 132.1 22.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.773 0.321 . . . . 0.0 110.901 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.768 ' HB2' HG22 ' A' ' 122' ' ' VAL . 2.6 tp -122.71 128.52 50.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.658 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -117.2 110.72 18.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.734 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.831 ' CE2' HD11 ' A' ' 80' ' ' ILE . 11.8 p90 -140.97 146.04 36.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.37 131.81 54.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.134 0.492 . . . . 0.0 111.241 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -82.04 163.22 54.14 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.489 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.1 Cg_endo -53.36 82.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.895 2.397 . . . . 0.0 112.152 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 17.6 t0 90.96 11.5 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.36 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.687 ' HG2' HD23 ' A' ' 4' ' ' LEU . 5.1 ttp180 -137.35 94.25 2.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.711 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -76.24 119.79 20.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.422 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.917 HG22 ' HG ' ' A' ' 4' ' ' LEU . 5.0 pt -127.52 146.99 32.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.065 0.459 . . . . 0.0 112.179 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -113.52 118.82 35.52 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.704 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.569 HD21 ' OD1' ' A' ' 119' ' ' ASN . 14.8 tp -106.42 114.0 27.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.854 0.359 . . . . 0.0 111.279 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.407 ' CZ3' ' O ' ' A' ' 46' ' ' PRO . 9.5 m0 -112.52 122.49 47.86 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.555 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.52 ' HE1' HD11 ' A' ' 82' ' ' LEU . 4.8 m-30 -106.54 109.87 21.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.591 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.918 ' NE1' HG11 ' A' ' 50' ' ' VAL . 34.9 m95 -101.32 148.48 25.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.455 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 65' ' ' PHE . 22.4 tp -91.69 138.35 31.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.324 0.583 . . . . 0.0 112.05 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.024 HG22 ' ND1' ' A' ' 64' ' ' HIS . 38.3 t -124.44 145.37 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.264 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -112.49 -32.34 6.51 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -163.18 165.62 24.27 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.711 0.687 . . . . 0.0 111.645 -178.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.842 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.9 p90 -148.17 133.06 18.06 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.793 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -80.18 144.41 33.01 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.691 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.13 -115.23 7.32 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.45 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 43.2 mt-10 -134.92 138.6 29.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.468 0.175 . . . . 0.0 110.82 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.512 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 3.4 Cg_exo -76.62 128.89 10.52 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.786 2.324 . . . . 0.0 111.12 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.698 ' NE1' HG23 ' A' ' 60' ' ' ILE . 62.4 p-90 -137.08 -60.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.633 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.602 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 52.51 -94.2 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.693 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.1 tttp 179.02 30.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.565 0.221 . . . . 0.0 111.549 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.69 -32.4 70.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.027 0.441 . . . . 0.0 110.143 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.91 32.29 69.96 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.73 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.426 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 76.7 mt-30 -140.56 91.64 9.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.973 0.416 . . . . 0.0 111.527 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -44.7 126.53 7.28 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.197 2.598 . . . . 0.0 112.959 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.471 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.47 177.31 19.31 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.823 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.16 157.13 46.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.626 0.25 . . . . 0.0 110.699 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.44 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -68.47 106.71 2.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.887 0.375 . . . . 0.0 110.156 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.5 ptp -119.87 148.52 43.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.159 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.427 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 95.0 p -65.85 114.57 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.593 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.844 HD22 HD13 ' A' ' 18' ' ' ILE . 33.5 tp -78.11 -18.87 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.309 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.91 -20.13 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.442 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.99 45.2 1.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.698 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.419 ' CD2' HD12 ' A' ' 123' ' ' ILE . 7.9 tt -62.79 150.57 41.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.627 0.251 . . . . 0.0 110.49 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.91 129.61 56.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.201 0.524 . . . . 0.0 112.377 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.573 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.23 -14.98 61.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.666 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -78.36 -49.17 14.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.578 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.48 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -66.82 -34.93 78.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.91 0.386 . . . . 0.0 110.876 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.573 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -84.74 173.23 7.47 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.345 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.3 Cg_endo -70.68 127.69 14.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.162 1.908 . . . . 0.0 111.857 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.41 -17.57 60.08 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.53 2.154 . . . . 0.0 113.023 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.25 -9.36 58.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.875 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.569 ' OD1' HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -118.51 29.5 7.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.42 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.05 -43.17 3.65 Favored Pre-proline 0 C--O 1.224 -0.25 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 92.4 Cg_exo -44.89 -39.0 13.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.18 1.92 . . . . 0.0 112.971 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.2 t -77.21 -51.14 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.189 0.518 . . . . 0.0 110.77 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.2 mm -64.84 -31.23 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.197 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.82 -30.88 58.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.003 0.43 . . . . 0.0 110.477 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.9 -53.27 18.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.469 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.789 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -78.33 -33.07 49.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.565 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.532 ' HB2' HG22 ' A' ' 123' ' ' ILE . 11.6 ttpp -53.15 -42.64 66.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 111.148 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -67.2 -10.59 52.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.688 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.8 mp . . . . . 0 C--O 1.232 0.155 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.058 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.1 tptm . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.835 0.35 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -140.06 137.87 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.972 HD12 HD11 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -146.07 131.95 19.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.736 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -102.84 155.43 18.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 111.666 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.972 HD11 HD12 ' A' ' 4' ' ' LEU . 5.3 mp -144.52 137.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.35 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.881 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -125.41 125.3 43.17 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.329 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.9 m -128.63 155.79 40.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.064 0.459 . . . . 0.0 111.283 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.7 127.09 2.21 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.106 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.09 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -80.99 107.65 13.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.795 HG22 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.17 123.33 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.975 0.417 . . . . 0.0 111.31 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.7 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.9 119.04 23.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.359 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.466 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 21.9 t-20 -74.77 -172.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.927 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 32.1 tt0 -82.57 4.11 25.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.151 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -140.08 52.2 1.68 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.0 111.454 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.64 25.21 0.24 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.552 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.702 ' C ' HD12 ' A' ' 18' ' ' ILE . 5.3 pt-20 -120.32 149.88 41.61 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.09 HG21 HG22 ' A' ' 10' ' ' ILE . 1.3 mp -113.36 140.76 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.149 0.5 . . . . 0.0 111.665 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -91.16 103.58 16.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.048 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.695 HG22 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.9 162.12 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.186 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 100' ' ' GLN . 73.7 p -92.61 111.71 23.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.787 0.327 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.85 179.975 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.27 26.34 10.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 111.465 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -46.05 97.44 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.67 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.78 176.94 4.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.168 0.509 . . . . 0.0 111.715 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.695 ' HB3' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.76 161.44 37.95 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.904 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -55.66 168.54 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.671 2.914 . . . . 0.0 111.611 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.67 59.49 0.74 Allowed Glycine 0 C--N 1.33 0.242 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.965 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.604 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.15 121.7 2.64 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 114.576 -0.812 . . . . 0.0 112.086 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.49 -6.62 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.339 0.656 . . . . 0.0 111.565 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.881 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.17 -57.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.303 0.573 . . . . 0.0 111.251 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -19.36 -78.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.305 -179.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.3 mmt 40.2 -93.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.774 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.47 22.06 0.08 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.359 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.45 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -78.84 -159.99 0.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.544 0.211 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.879 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.14 154.7 38.63 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.879 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.2 Cg_endo -44.07 -24.91 0.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.777 2.318 . . . . 0.0 112.456 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.9 mt-10 -99.89 -48.77 4.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.919 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -80.5 -4.89 55.59 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 44' ' ' GLU . . . -65.49 -57.49 8.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.54 0.21 . . . . 0.0 110.955 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.727 HG23 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -78.79 -44.01 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.706 179.163 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.9 t -50.61 -36.06 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 110.73 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -78.59 -49.1 13.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.817 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -65.66 -23.75 66.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.816 HD21 ' NE2' ' A' ' 64' ' ' HIS . 2.5 tp -54.81 -44.56 73.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.467 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -31.29 71.13 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.3 tm-20 -77.44 -23.95 50.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.957 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.433 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 45.3 mm-40 -107.07 3.54 25.98 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.972 HG12 HG13 ' A' ' 60' ' ' ILE . 21.9 t -134.91 -44.21 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.277 0.56 . . . . 0.0 109.847 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.582 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.2 -43.91 0.69 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.321 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.972 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.61 -175.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.105 0.478 . . . . 0.0 111.255 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.36 89.14 11.86 Favored Pre-proline 0 N--CA 1.442 -0.852 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.196 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.891 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.8 Cg_endo -108.47 148.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.078 2.519 . . . . 0.0 114.133 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 21.3 mt-30 -74.64 79.95 2.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 175.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.003 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.76 127.52 48.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.675 -176.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.628 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.1 t80 -179.83 171.0 1.2 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.518 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 80.57 156.13 0.14 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.749 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.4 pp -117.09 129.28 55.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.436 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.824 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.8 -48.36 18.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.744 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.567 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -171.56 131.73 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.184 179.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.653 ' HD2' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -123.56 132.21 53.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.742 0.305 . . . . 0.0 110.719 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.645 HD22 ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.68 162.25 26.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 111.185 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.533 ' N ' HD22 ' A' ' 71' ' ' LEU . 13.4 tt0 -140.14 128.28 22.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.656 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.478 ' HE1' HD12 ' A' ' 82' ' ' LEU . 1.9 p90 -141.07 100.87 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.643 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.8 pt-20 -74.83 122.42 23.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.446 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.99 162.89 60.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.303 179.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.0 Cg_endo -51.0 81.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.025 2.484 . . . . 0.0 112.287 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.4 t70 91.37 10.12 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.57 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -137.34 93.95 2.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.646 0.26 . . . . 0.0 110.854 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.555 ' HE1' HG23 ' A' ' 81' ' ' THR . 52.7 t-80 -74.88 102.1 4.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.819 0.342 . . . . 0.0 110.703 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.587 HG13 HD13 ' A' ' 6' ' ' ILE . 5.6 tt -106.52 111.94 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.555 HG23 ' HE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -103.28 128.55 50.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.413 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.478 HD12 ' HE1' ' A' ' 73' ' ' TYR . 1.6 mt -126.25 114.54 18.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.98 0.419 . . . . 0.0 111.497 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -108.12 122.33 46.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.38 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.746 ' CD2' HG11 ' A' ' 122' ' ' VAL . 5.4 m-30 -100.5 113.77 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.754 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.802 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 35.8 m95 -94.29 148.74 21.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.258 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 65' ' ' PHE . 31.1 tp -98.35 103.43 15.38 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 121.159 0.504 . . . . 0.0 111.61 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.003 HG22 ' ND1' ' A' ' 64' ' ' HIS . 25.2 t -87.62 145.79 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.184 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -112.15 -26.74 8.67 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.86 165.11 25.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.796 0.726 . . . . 0.0 111.796 -178.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.662 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.2 p90 -152.72 130.04 11.31 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.511 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -75.84 139.93 41.98 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.694 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.3 -117.82 12.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.347 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 8.0 mt-10 -135.05 140.12 33.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.414 0.149 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HA ' HD11 ' A' ' 60' ' ' ILE . 7.8 Cg_exo -75.5 128.58 11.2 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.943 2.429 . . . . 0.0 111.438 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.61 ' HE1' HG23 ' A' ' 60' ' ' ILE . 45.1 p-90 -128.45 -58.54 1.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.993 0.425 . . . . 0.0 111.383 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.77 -100.07 0.02 OUTLIER Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.877 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 179.08 36.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 111.321 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.99 -47.6 80.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.564 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.59 12.08 51.86 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.927 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.424 ' O ' HG22 ' A' ' 21' ' ' THR . 24.3 mt-30 -140.36 91.79 9.61 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 117.24 0.52 . . . . 0.0 111.386 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -44.23 125.39 5.68 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.837 2.358 . . . . 0.0 112.739 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.78 177.59 19.16 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.469 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -129.28 157.1 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.672 0.273 . . . . 0.0 110.773 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.45 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.12 107.1 3.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.901 0.381 . . . . 0.0 110.435 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 18' ' ' ILE . 12.5 ptm -119.62 158.1 27.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 p -71.83 121.32 18.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.764 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -80.11 -28.97 38.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.011 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.67 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.7 p -50.72 -24.58 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.232 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.7 43.34 1.4 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.382 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.573 HD22 HD12 ' A' ' 123' ' ' ILE . 9.5 tt -62.55 150.14 41.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.414 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -118.97 132.91 56.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.178 0.513 . . . . 0.0 112.302 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.629 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.42 61.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.48 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -78.77 -49.27 13.31 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.755 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -32.77 74.26 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.799 0.333 . . . . 0.0 111.013 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.629 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -89.16 172.62 7.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.029 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.489 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.8 Cg_endo -67.51 127.58 16.69 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.032 1.822 . . . . 0.0 111.832 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.38 -18.64 60.67 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.552 2.168 . . . . 0.0 113.064 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.87 -9.38 58.24 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.36 34.31 5.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.767 0.318 . . . . 0.0 111.464 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -75.6 -44.06 4.16 Favored Pre-proline 0 N--CA 1.463 0.217 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.6 Cg_exo -44.76 -35.38 9.43 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.224 1.949 . . . . 0.0 112.61 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.746 HG11 ' CD2' ' A' ' 84' ' ' PHE . 11.8 t -77.43 -41.05 29.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.136 0.493 . . . . 0.0 110.144 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.777 HG22 ' HB2' ' A' ' 127' ' ' LYS . 17.9 mm -70.28 -32.28 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.707 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.46 -26.96 34.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.086 0.47 . . . . 0.0 110.228 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.09 -50.89 9.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.669 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.824 HD13 ' CD2' ' A' ' 68' ' ' PHE . 8.1 tp -78.09 -33.5 50.69 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 111.693 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.777 ' HB2' HG22 ' A' ' 123' ' ' ILE . 17.7 ttpt -53.27 -42.53 66.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -71.71 -6.09 38.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.975 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.67 HD21 ' O ' ' A' ' 108' ' ' VAL . 2.9 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.189 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.837 0.351 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -140.02 137.53 34.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.936 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.7 pp -146.0 135.37 22.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.77 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -102.7 149.19 24.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.388 0.613 . . . . 0.0 112.107 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.936 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.4 mp -146.22 120.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.866 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.063 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.66 143.34 50.79 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.314 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -144.6 162.52 14.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.112 0.482 . . . . 0.0 111.487 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -144.02 123.4 2.01 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.037 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.004 HG22 ' CG2' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.75 108.91 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.765 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -70.83 120.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.224 0.535 . . . . 0.0 112.252 -178.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.95 122.7 28.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.615 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.557 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -81.62 -172.58 3.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.887 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.506 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -82.38 -0.95 48.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.112 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -135.69 49.58 2.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 0.0 111.331 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.27 23.7 0.59 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.183 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 16.2 pt-20 -114.23 153.97 28.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.004 ' CG2' HG22 ' A' ' 10' ' ' ILE . 5.2 mt -128.44 143.32 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.0 112.04 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.464 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.18 122.74 34.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.324 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.043 HD12 HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.69 133.36 65.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.274 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.658 HG21 ' HG2' ' A' ' 98' ' ' GLU . 21.4 p -70.82 115.94 10.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.082 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.515 ' CA ' HD23 ' A' ' 33' ' ' LEU . 18.3 ptt85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.704 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 CA--C 1.529 0.138 0 CA-C-O 120.561 0.22 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -114.23 25.65 10.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.428 . . . . 0.0 111.28 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.043 HD11 HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -46.47 97.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.37 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -106.79 -170.35 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.18 0.514 . . . . 0.0 112.251 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.19 168.59 9.62 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.472 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.586 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 93.7 Cg_endo -79.33 167.58 21.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.688 2.925 . . . . 0.0 113.835 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.87 -5.24 50.38 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.881 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.02 159.16 23.95 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 117.498 0.649 . . . . 0.0 113.327 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 85.14 6.36 0.49 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.061 0.545 . . . . 0.0 111.996 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.063 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.6 pt -54.28 -27.04 16.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.632 0.73 . . . . 0.0 110.167 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.554 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.97 -66.92 0.32 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.035 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.503 ' C ' ' O ' ' A' ' 41' ' ' GLU . 5.4 mmt 14.65 -82.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.876 0.735 . . . . 0.0 112.409 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -177.52 33.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.59 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.6 mp0 -88.76 -172.97 3.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.861 0.362 . . . . 0.0 111.168 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.868 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.76 155.38 36.4 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.36 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.868 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.89 -25.46 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.817 2.345 . . . . 0.0 112.659 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -103.51 -41.6 5.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.386 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 1.6 mm100 -80.28 -4.83 54.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.722 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.914 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.58 -55.41 33.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.9 HG11 ' NE1' ' A' ' 85' ' ' TRP . 2.7 m -78.19 -46.03 26.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.31 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 30.0 t -55.39 -41.13 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.368 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 3.6 tmm_? -77.98 -49.34 14.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.018 0.437 . . . . 0.0 110.451 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.469 ' HG3' ' OE1' ' A' ' 57' ' ' GLU . 14.9 tp10 -63.38 -20.0 65.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.504 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.87 HD21 ' CG ' ' A' ' 64' ' ' HIS . 1.4 tp -59.65 -44.46 93.54 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.303 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -30.16 70.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.827 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.5 tm-20 -77.27 -31.82 55.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.416 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.469 ' OE1' ' HG3' ' A' ' 53' ' ' GLU . 1.2 mp0 -108.68 6.14 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.932 HG12 HG13 ' A' ' 60' ' ' ILE . 43.5 t -133.83 -44.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.161 0.505 . . . . 0.0 110.031 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.599 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.43 -39.82 0.28 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.966 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.932 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.52 -176.29 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 120.968 0.413 . . . . 0.0 110.841 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.22 89.1 11.53 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.468 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.798 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.9 Cg_endo -109.42 143.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.266 2.644 . . . . 0.0 114.243 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 34.5 mt-30 -74.7 80.03 2.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 105.437 -2.061 . . . . 0.0 105.437 175.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.87 ' CG ' HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -120.92 134.53 55.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.418 -175.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 178.92 -139.9 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.089 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 56.46 156.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.206 0.527 . . . . 0.0 112.323 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.4 tt -120.1 109.44 15.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.562 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.74 -43.8 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.369 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.509 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.7 tt0 -171.25 163.32 7.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.311 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HE3' ' CZ2' ' A' ' 83' ' ' TRP . 1.1 ttpm? -143.15 132.04 22.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.81 0.338 . . . . 0.0 110.992 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.821 ' HB2' HG22 ' A' ' 122' ' ' VAL . 4.6 tp -115.2 120.41 39.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.418 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -118.57 109.84 16.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.476 ' CE1' HD23 ' A' ' 71' ' ' LEU . 2.0 p90 -141.1 151.64 44.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.46 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.14 121.27 37.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 0.0 111.34 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.77 162.88 61.04 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.281 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -50.92 81.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.017 2.478 . . . . 0.0 112.097 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 t70 88.79 14.23 0.07 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.329 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.659 ' HE ' HD21 ' A' ' 4' ' ' LEU . 4.7 ttt180 -137.51 93.91 2.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.732 0.301 . . . . 0.0 110.805 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -75.76 97.57 3.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.899 0.38 . . . . 0.0 110.463 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.692 HG13 HD13 ' A' ' 6' ' ' ILE . 1.3 tt -100.84 112.9 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.405 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.48 119.66 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.279 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.943 HD23 HG21 ' A' ' 122' ' ' VAL . 12.7 tp -110.26 114.37 27.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.88 0.372 . . . . 0.0 111.334 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.44 ' CZ2' ' HE3' ' A' ' 70' ' ' LYS . 10.9 m0 -109.47 122.89 48.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.178 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -109.79 109.77 20.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.602 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.9 ' NE1' HG11 ' A' ' 50' ' ' VAL . 48.2 m95 -99.41 148.96 23.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.506 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.8 tp -98.5 102.84 14.7 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.427 0.632 . . . . 0.0 111.726 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.781 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.9 t -81.1 146.47 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.091 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -114.12 -25.68 8.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.9 tpt180 -162.55 161.87 27.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.64 0.654 . . . . 0.0 111.583 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.738 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -155.61 123.46 5.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.316 178.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -72.05 143.94 48.93 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.019 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.2 -129.67 46.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.558 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -121.0 144.0 38.23 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.599 0.238 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.534 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.5 Cg_exo -76.32 128.89 10.76 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.788 2.325 . . . . 0.0 111.031 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.599 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 47.0 p-90 -132.28 -63.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.49 -99.87 0.02 OUTLIER Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.517 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.3 mtpp 164.77 42.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 110.874 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.658 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.4 OUTLIER -58.59 -31.99 68.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.939 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 129.93 -37.84 2.09 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.368 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -129.49 105.71 17.42 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.0 111.86 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -43.76 146.31 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.079 2.52 . . . . 0.0 112.661 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.45 177.18 18.74 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.745 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -131.65 157.38 43.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.506 0.194 . . . . 0.0 110.596 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.483 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -75.82 106.51 7.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.866 0.365 . . . . 0.0 110.203 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.0 ptm -120.16 161.32 21.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.981 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.9 p -76.86 114.98 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.712 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.721 HD22 HD13 ' A' ' 18' ' ' ILE . 2.6 tp -77.32 -18.94 57.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.449 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.3 p -51.0 -24.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.328 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.54 44.37 1.24 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.561 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.695 HD22 HD12 ' A' ' 123' ' ' ILE . 8.4 tt -62.78 150.35 41.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.577 0.227 . . . . 0.0 110.419 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.636 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -117.71 130.12 56.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 112.325 -178.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.56 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.21 -14.8 61.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.55 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.43 -49.13 14.04 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.483 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -34.69 77.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.779 0.323 . . . . 0.0 111.054 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.47 174.34 6.21 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.172 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 40.1 Cg_endo -67.71 127.81 16.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 121.926 1.751 . . . . 0.0 111.928 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.85 -21.12 58.06 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.606 2.204 . . . . 0.0 112.693 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.29 -9.6 58.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.719 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.535 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -113.74 23.22 13.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.506 -179.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -66.59 -36.46 12.15 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.578 ' HB2' HD13 ' A' ' 71' ' ' LEU . 73.8 Cg_exo -51.13 -47.74 24.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.952 1.768 . . . . 0.0 112.84 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.943 HG21 HD23 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -77.68 -51.21 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.936 0.398 . . . . 0.0 111.191 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.695 HD12 HD22 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -62.1 -32.84 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.227 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.92 -36.99 65.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.972 0.415 . . . . 0.0 110.374 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -62.92 -46.51 87.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.519 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 13.6 tp -78.13 -27.81 48.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.032 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.657 ' O ' HD12 ' A' ' 129' ' ' LEU . 14.8 tttp -58.99 -42.67 90.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -76.73 -3.29 37.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.111 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 127' ' ' LYS . 4.2 mp . . . . . 0 C--O 1.231 0.126 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.132 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.807 0.337 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 8.8 ttmt -136.25 136.71 40.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.785 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.831 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.1 pp -146.04 137.76 24.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.667 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.766 ' C ' HD13 ' A' ' 6' ' ' ILE . 5.8 mt-30 -109.24 147.53 32.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.331 0.586 . . . . 0.0 111.804 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.831 HD11 ' CD1' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -136.91 128.49 42.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.014 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.837 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -125.14 124.83 42.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.518 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.553 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.9 m -124.11 162.35 25.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.033 0.444 . . . . 0.0 111.062 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -150.69 116.12 0.75 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.688 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.966 HG22 HG21 ' A' ' 18' ' ' ILE . 2.4 mp -70.58 104.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.822 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -70.97 120.52 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.21 0.529 . . . . 0.0 112.311 -177.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.437 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.52 119.65 24.5 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.56 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.558 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 25.8 t-20 -78.24 179.93 6.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.434 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.548 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 22.0 tt0 -76.1 1.26 16.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.97 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -139.87 52.57 1.69 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.814 0.34 . . . . 0.0 111.522 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 45.53 27.12 0.37 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.725 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 11.5 pt-20 -117.45 160.6 20.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.966 HG21 HG22 ' A' ' 10' ' ' ILE . 2.8 mp -136.82 142.31 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.205 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.7 118.19 30.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.281 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.742 HD11 HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -110.62 138.44 38.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.714 HG23 ' HD3' ' A' ' 36' ' ' PRO . 4.2 p -83.1 111.38 18.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.922 0.391 . . . . 0.0 110.745 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.169 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -114.24 25.95 10.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.965 0.412 . . . . 0.0 111.441 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -53.45 89.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.216 179.344 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.677 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.1 tt0 -112.87 -168.19 1.29 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.29 0.566 . . . . 0.0 112.143 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.553 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.33 166.3 15.69 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.305 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.714 ' HD3' HG23 ' A' ' 21' ' ' THR . 38.2 Cg_endo -63.93 168.6 11.8 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.334 2.689 . . . . 0.0 111.208 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.9 60.11 0.73 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.228 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.63 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.21 110.91 0.86 Allowed Glycine 0 C--N 1.314 -0.67 0 CA-C-N 114.581 -0.809 . . . . 0.0 111.732 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.63 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 126.98 -8.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.521 0.728 . . . . 0.0 110.873 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.837 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -42.2 -48.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.293 0.568 . . . . 0.0 111.57 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -31.8 -81.16 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.941 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.9 mmm 43.02 -92.82 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.557 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.71 23.8 0.09 OUTLIER Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.215 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -82.44 -162.95 0.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.546 0.213 . . . . 0.0 110.934 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.858 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -107.76 156.07 38.69 Favored Pre-proline 0 C--N 1.333 -0.13 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.858 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.85 -24.71 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.703 2.269 . . . . 0.0 112.456 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.9 mm-40 -95.36 -54.03 3.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -80.44 -5.26 56.28 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -64.99 -57.44 8.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.685 0.278 . . . . 0.0 110.811 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.729 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -79.02 -45.95 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.701 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 47' ' ' GLU . 59.3 t -50.87 -37.76 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.033 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -48.68 14.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.68 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 40' ' ' ILE . 12.8 tp10 -63.92 -25.67 68.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.639 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.824 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.7 tp -55.3 -44.31 75.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -32.1 71.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.1 tm-20 -77.37 -25.49 51.0 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.848 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.422 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 5.3 mm-40 -108.38 5.18 25.19 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.933 HG12 HG13 ' A' ' 60' ' ' ILE . 31.3 t -134.82 -44.62 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.11 0.481 . . . . 0.0 110.144 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.51 -40.25 0.23 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.893 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.933 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.65 -177.57 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.001 0.429 . . . . 0.0 111.227 -179.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.62 88.54 13.76 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.798 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.786 ' HG3' HG11 ' A' ' 58' ' ' VAL . 1.4 Cg_endo -112.55 147.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 123.322 2.681 . . . . 0.0 114.167 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 22.8 mt-30 -74.7 80.02 2.04 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.007 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.4 128.12 50.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.74 -176.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.7 t80 179.72 175.33 0.77 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.481 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 t 78.79 162.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.077 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.771 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -123.45 129.28 51.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.367 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.963 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.77 -44.24 33.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.292 0.568 . . . . 0.0 109.767 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.3 mt-10 -171.45 131.66 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.845 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.5 132.16 54.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.88 0.372 . . . . 0.0 111.286 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.629 ' HB2' HG22 ' A' ' 122' ' ' VAL . 3.4 tp -109.43 137.56 47.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.626 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -133.56 109.97 9.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.895 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.412 ' CZ ' HG23 ' A' ' 80' ' ' ILE . 2.3 p90 -141.22 146.28 36.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.584 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.16 133.96 55.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.105 0.478 . . . . 0.0 111.306 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.471 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -93.91 163.15 24.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.375 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.8 Cg_endo -54.15 82.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.823 2.349 . . . . 0.0 112.317 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 10.9 t0 93.49 8.53 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.547 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' NH1' HD12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -137.34 93.92 2.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.774 0.321 . . . . 0.0 110.769 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' A' ' 3' ' ' LYS . 1.9 t60 -82.09 96.98 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.0 110.773 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.493 HD12 ' NH1' ' A' ' 78' ' ' ARG . 5.0 tt -98.77 111.7 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.985 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.06 118.71 34.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.115 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.579 HD23 ' HB ' ' A' ' 6' ' ' ILE . 38.5 mt -106.19 114.47 28.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.963 0.411 . . . . 0.0 111.689 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.622 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 12.2 m0 -106.74 122.17 45.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.599 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.698 ' CG ' HG11 ' A' ' 122' ' ' VAL . 3.2 m-85 -112.95 109.78 19.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.0 110.196 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.771 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 15.9 m95 -94.77 148.46 22.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.595 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.613 ' O ' ' O ' ' A' ' 65' ' ' PHE . 59.2 tp -100.09 102.98 14.46 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.037 0.446 . . . . 0.0 111.568 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.007 HG22 ' ND1' ' A' ' 64' ' ' HIS . 25.0 t -83.29 145.83 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.159 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -113.5 -23.53 9.76 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 2.9 ttt-85 -162.91 162.95 26.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.688 0.677 . . . . 0.0 111.287 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.714 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -157.25 125.18 5.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.0 111.674 179.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -76.07 151.9 36.97 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.136 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.21 -132.94 42.2 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.654 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 19.6 tt0 -119.69 146.94 42.75 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.6 0.238 . . . . 0.0 110.721 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.2 Cg_exo -76.69 128.85 10.44 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.904 2.403 . . . . 0.0 111.383 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.536 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 64.9 p-90 -137.08 -59.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.179 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.543 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 49.17 -94.63 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.813 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.1 mmtm 165.81 34.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.692 0.282 . . . . 0.0 111.114 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.33 -34.66 78.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.415 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.6 21.19 32.24 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.159 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.422 ' O ' ' HB ' ' A' ' 21' ' ' THR . 2.6 mp0 -140.21 92.08 9.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 111.3 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -43.73 131.84 7.71 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.804 2.336 . . . . 0.0 112.374 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.0 177.04 19.42 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.858 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -145.2 157.25 44.12 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.19 106.61 3.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.851 0.357 . . . . 0.0 110.216 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -119.97 163.21 17.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.948 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.516 ' OG ' HG12 ' A' ' 108' ' ' VAL . 1.7 t -77.72 114.83 16.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.786 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.8 OUTLIER -80.08 -19.96 46.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.255 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.516 HG12 ' OG ' ' A' ' 106' ' ' SER . 11.9 p -52.97 -20.53 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.538 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.06 44.27 1.25 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.85 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.651 HD12 HD21 ' A' ' 107' ' ' LEU . 8.5 tt -62.64 150.13 41.64 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.49 130.52 53.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.16 61.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.402 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.6 -49.26 13.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.749 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -37.43 84.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 111.001 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -80.77 173.98 6.87 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.146 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.8 Cg_endo -71.23 127.74 13.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.071 1.847 . . . . 0.0 111.659 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.38 -14.97 45.44 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.512 2.141 . . . . 0.0 113.18 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.55 58.65 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.511 ' ND2' HD11 ' A' ' 82' ' ' LEU . 1.1 m-80 -120.23 31.57 6.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.274 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -75.28 -45.07 4.58 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.073 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.521 ' HB2' HD13 ' A' ' 71' ' ' LEU . 85.9 Cg_exo -44.74 -36.27 10.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.242 1.961 . . . . 0.0 112.619 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.698 HG11 ' CG ' ' A' ' 84' ' ' PHE . 5.3 t -77.42 -44.6 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.047 0.451 . . . . 0.0 110.113 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.599 HG22 ' HB2' ' A' ' 127' ' ' LYS . 8.0 mm -68.27 -31.67 52.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.919 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.58 -27.59 40.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.133 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -49.5 11.67 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.634 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.963 HD13 ' CD2' ' A' ' 68' ' ' PHE . 6.8 tp -78.09 -30.75 49.76 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.895 0.378 . . . . 0.0 111.609 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.599 ' HB2' HG22 ' A' ' 123' ' ' ILE . 14.3 ttpt -53.91 -42.62 68.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.949 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -70.5 -7.69 45.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.831 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.334 -0.105 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.298 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.79 0.329 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 79' ' ' HIS . 4.9 mttt -140.01 129.15 23.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.812 ' HG ' HG22 ' A' ' 80' ' ' ILE . 2.1 pp -146.16 119.84 9.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.613 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.785 ' C ' HD13 ' A' ' 6' ' ' ILE . 6.6 mt-30 -101.89 157.45 16.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.096 0.474 . . . . 0.0 112.022 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.785 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -142.96 138.99 27.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.46 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.967 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.97 125.68 44.29 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.469 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.471 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -135.81 156.02 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.169 0.509 . . . . 0.0 111.573 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -151.37 126.08 2.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.799 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.024 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.87 110.63 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.756 HG22 ' CE3' ' A' ' 90' ' ' TRP . 1.2 mt -71.43 120.27 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.96 0.41 . . . . 0.0 111.4 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -83.15 124.42 30.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.512 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.506 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 4.8 t-20 -70.33 -172.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.979 0.895 . . . . 0.0 112.587 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -64.15 -12.0 35.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.781 -1.554 . . . . 0.0 113.079 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -129.05 -82.26 0.57 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.669 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -153.81 14.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.543 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 1.5 pt-20 -100.98 160.32 14.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.024 HG21 HG22 ' A' ' 10' ' ' ILE . 11.3 mt -135.94 142.18 39.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.007 0.432 . . . . 0.0 111.501 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -93.02 129.46 38.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.992 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' HB ' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.83 140.88 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.957 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.413 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 6.4 p -71.55 111.8 7.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.807 0.336 . . . . 0.0 111.089 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HA ' HD23 ' A' ' 33' ' ' LEU . 3.2 ttt-85 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.073 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.161 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -114.28 26.21 10.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.994 0.426 . . . . 0.0 111.339 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -45.7 100.3 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.485 179.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.9 -174.18 2.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.245 0.545 . . . . 0.0 112.226 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.77 168.33 10.46 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.336 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.439 ' HA ' ' CD ' ' A' ' 98' ' ' GLU . 89.2 Cg_endo -75.41 168.8 23.79 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.6 2.867 . . . . 0.0 112.102 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.723 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.9 59.63 0.73 Allowed Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.19 -1.005 . . . . 0.0 114.213 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -121.42 138.82 12.69 Favored Glycine 0 C--N 1.315 -0.586 0 CA-C-N 114.614 -0.793 . . . . 0.0 112.206 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.62 -4.79 0.13 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.082 0.553 . . . . 0.0 111.901 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.967 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.89 -47.56 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.421 0.629 . . . . 0.0 111.099 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -30.95 -77.57 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.813 -179.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.5 mtp 39.42 -93.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.83 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.63 22.92 0.08 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.49 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.68 -158.21 0.11 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.339 0.114 . . . . 0.0 110.876 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.83 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -106.02 153.06 40.43 Favored Pre-proline 0 N--CA 1.455 -0.196 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.83 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.99 -24.76 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.624 2.216 . . . . 0.0 112.373 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.623 ' O ' HG23 ' A' ' 51' ' ' VAL . 37.3 mm-40 -101.61 -47.3 4.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.924 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -80.66 -5.2 56.62 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 44' ' ' GLU . . . -64.82 -57.46 8.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.573 0.225 . . . . 0.0 110.719 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.712 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -79.17 -45.55 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.135 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.8 t -50.58 -38.45 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 0.0 111.146 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -78.64 -51.97 9.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.004 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.431 ' HG3' ' OE2' ' A' ' 57' ' ' GLU . 1.3 tp10 -63.68 -23.9 67.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.867 HD21 ' NE2' ' A' ' 64' ' ' HIS . 3.2 tp -53.95 -44.33 70.62 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.886 0.374 . . . . 0.0 110.054 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -60.81 -32.72 72.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -77.4 -23.95 50.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.733 179.024 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 37' ' ' GLY . 5.7 mp0 -108.15 5.36 25.81 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.968 HG12 HG13 ' A' ' 60' ' ' ILE . 25.3 t -134.63 -44.43 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 109.935 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.562 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.58 -40.17 0.23 Allowed Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.787 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.968 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.72 -177.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.06 0.457 . . . . 0.0 111.059 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.05 88.41 14.64 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.942 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.807 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.6 Cg_endo -111.1 148.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.446 2.764 . . . . 0.0 113.848 -177.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -74.67 79.73 2.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.006 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -122.72 126.96 48.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.885 -176.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.2 t80 -179.62 167.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.676 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.5 t 79.54 177.4 0.12 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.395 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.868 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -135.61 130.78 34.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.458 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.78 ' CD2' HD22 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -76.86 -41.6 43.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.218 0.533 . . . . 0.0 109.696 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.691 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.9 mt-10 -171.39 131.35 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.786 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 132.16 56.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.836 0.351 . . . . 0.0 111.554 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.777 HD22 ' HB2' ' A' ' 121' ' ' PRO . 14.7 tp -112.04 132.81 54.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.472 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -123.9 110.96 15.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.817 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.801 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.0 p90 -141.01 153.07 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.764 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' OE1' ' CE1' ' A' ' 79' ' ' HIS . 8.0 pt-20 -116.27 138.35 51.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.185 0.516 . . . . 0.0 111.289 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -93.21 163.22 25.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.339 179.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -52.49 82.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.935 2.423 . . . . 0.0 112.168 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.5 t0 88.74 13.29 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.355 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.451 ' NE ' HD21 ' A' ' 4' ' ' LEU . 7.1 ttp180 -137.36 96.18 3.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.759 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.403 ' CE1' ' OE1' ' A' ' 74' ' ' GLU . 2.4 t60 -80.38 117.66 21.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.582 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.812 HG22 ' HG ' ' A' ' 4' ' ' LEU . 7.9 pt -125.32 128.31 72.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.172 0.51 . . . . 0.0 111.931 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.32 118.58 35.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.815 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.849 HD22 ' CE1' ' A' ' 84' ' ' PHE . 1.1 mt -101.57 113.61 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.908 0.385 . . . . 0.0 111.416 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 10.0 m0 -116.25 122.6 45.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.741 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.898 ' CE1' HG21 ' A' ' 122' ' ' VAL . 1.2 m-85 -110.84 111.36 22.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.924 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.868 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 24.4 m95 -94.29 136.55 34.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.983 0.42 . . . . 0.0 111.376 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 55.2 tp -88.37 102.93 15.35 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.232 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.006 HG22 ' ND1' ' A' ' 64' ' ' HIS . 37.0 t -83.08 145.52 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.122 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -110.24 -25.73 9.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.81 163.33 26.64 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.706 0.684 . . . . 0.0 111.408 -179.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.756 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.27 120.69 4.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.967 0.413 . . . . 0.0 111.324 178.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -77.5 153.47 33.42 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.067 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.46 -121.04 21.15 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.528 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.2 tt0 -134.96 147.6 63.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.547 0.213 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.516 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.57 128.76 10.47 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.859 2.373 . . . . 0.0 111.241 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.562 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 57.7 p-90 -137.42 -60.24 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.161 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.518 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 53.93 -97.64 0.03 OUTLIER Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.688 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 178.06 22.94 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.439 ' CD ' ' HA ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -67.96 -32.9 73.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.934 0.397 . . . . 0.0 110.682 179.52 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.61 35.12 29.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.779 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.413 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 66.0 mt-30 -140.11 91.9 9.88 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.022 0.439 . . . . 0.0 111.178 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -43.69 137.38 6.27 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.025 2.483 . . . . 0.0 112.758 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.22 177.01 19.48 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.596 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.8 157.0 44.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.576 0.227 . . . . 0.0 110.641 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -78.15 107.18 10.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.95 0.405 . . . . 0.0 110.509 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.4 ptm -119.61 163.23 17.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.908 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p -77.98 114.97 17.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.661 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.755 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -73.54 -28.14 61.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 p -53.01 -22.7 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.315 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.3 42.69 1.59 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.337 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.511 HD13 HD22 ' A' ' 107' ' ' LEU . 10.9 tp -62.66 147.22 50.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.11 132.1 53.95 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.61 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.35 -15.2 61.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.498 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.67 -49.31 13.38 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.574 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -32.88 74.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.086 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.61 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -87.97 173.14 6.73 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.408 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.497 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.2 Cg_endo -72.19 127.72 13.05 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.122 1.881 . . . . 0.0 111.701 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.44 -14.96 45.51 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.568 2.179 . . . . 0.0 113.125 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.49 58.57 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.843 ' ND2' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -121.35 32.17 6.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.729 0.3 . . . . 0.0 111.278 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -75.93 -36.1 1.86 Allowed Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.777 ' HB2' HD22 ' A' ' 71' ' ' LEU . 71.4 Cg_exo -49.56 -43.19 40.21 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 121.971 1.78 . . . . 0.0 112.918 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.898 HG21 ' CE1' ' A' ' 84' ' ' PHE . 1.8 t -77.36 -51.25 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.105 0.479 . . . . 0.0 111.099 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.558 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.1 mm -63.65 -32.58 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.273 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.9 -31.26 59.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.038 0.447 . . . . 0.0 110.477 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -72.78 -52.54 14.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.617 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.78 HD22 ' CD2' ' A' ' 68' ' ' PHE . 1.8 tp -78.19 -33.01 50.34 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.558 ' HB2' HG22 ' A' ' 123' ' ' ILE . 3.2 ttpm? -53.73 -42.61 68.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.067 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -67.85 -9.46 44.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.792 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 126' ' ' LEU . 11.0 mp . . . . . 0 C--N 1.333 -0.112 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.888 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.807 0.337 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.99 126.54 20.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.829 HD12 ' CD1' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -133.51 140.33 47.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.771 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.747 ' C ' HD13 ' A' ' 6' ' ' ILE . 9.4 mt-30 -106.61 150.43 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.279 0.561 . . . . 0.0 111.915 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.829 ' CD1' HD12 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -140.7 139.09 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.41 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.941 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.47 140.63 52.77 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -144.56 151.24 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.242 0.544 . . . . 0.0 111.327 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.56 130.67 3.21 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.17 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.877 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -88.43 108.0 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.727 HG23 HG11 ' A' ' 87' ' ' VAL . 1.1 mt -71.28 124.99 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.133 0.492 . . . . 0.0 111.479 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -87.06 127.12 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.969 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.465 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 14.8 t30 -81.95 -172.29 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.858 0.837 . . . . 0.0 112.012 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -81.82 3.59 25.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.227 -1.351 . . . . 0.0 112.261 -179.225 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -139.2 51.88 1.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 0.0 111.425 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.7 p30 45.3 26.29 0.26 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.421 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 8.1 pt-20 -118.81 144.08 46.55 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.877 HG21 HG22 ' A' ' 10' ' ' ILE . 10.1 mt -114.22 142.86 25.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.162 0.506 . . . . 0.0 111.459 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -95.92 128.4 42.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.671 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.65 162.14 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.489 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.617 HG23 ' HD3' ' A' ' 36' ' ' PRO . 38.2 p -91.99 111.97 23.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.755 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.219 179.812 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.575 0.226 . . . . 0.0 111.517 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 26.26 10.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.859 0.362 . . . . 0.0 111.532 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -48.61 95.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.508 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.7 tt0 -113.11 -179.14 3.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.196 0.522 . . . . 0.0 111.64 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.95 162.05 35.21 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.517 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.617 ' HD3' HG23 ' A' ' 21' ' ' THR . 9.3 Cg_endo -50.29 168.76 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.569 2.846 . . . . 0.0 111.526 178.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.678 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.04 59.69 0.73 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.757 -1.211 . . . . 0.0 113.86 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -138.3 117.73 1.49 Allowed Glycine 0 C--N 1.313 -0.71 0 CA-C-N 114.548 -0.826 . . . . 0.0 111.91 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.82 -6.9 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.307 0.643 . . . . 0.0 111.215 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.941 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -43.62 -62.65 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.258 0.551 . . . . 0.0 111.375 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.499 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -16.77 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.425 -179.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.5 mmt 43.14 -94.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.511 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.83 17.82 0.09 OUTLIER Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.598 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.74 -161.66 0.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.532 0.206 . . . . 0.0 110.742 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.883 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.66 154.4 39.26 Favored Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.883 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -44.0 -24.87 0.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.694 2.263 . . . . 0.0 112.406 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.646 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -98.48 -50.38 4.31 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.985 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -80.45 -4.99 55.86 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -65.49 -57.5 8.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.574 0.226 . . . . 0.0 110.819 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.707 ' CG2' HD13 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -78.68 -43.32 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.029 179.279 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.9 t -50.63 -36.45 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.344 . . . . 0.0 110.721 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.67 -48.47 14.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.747 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -67.03 -20.0 65.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.03 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.707 HD13 ' CG2' ' A' ' 50' ' ' VAL . 3.3 tp -57.47 -44.82 85.18 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 110.477 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -32.28 73.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 97' ' ' LYS . 5.7 tm-20 -77.37 -25.48 51.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.92 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -108.15 5.36 25.81 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.93 HG12 HG13 ' A' ' 60' ' ' ILE . 30.0 t -134.33 -44.31 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.139 0.495 . . . . 0.0 109.94 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.535 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.57 -41.62 0.31 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.463 -0.789 . . . . 0.0 113.715 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.93 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.64 -177.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 120.975 0.417 . . . . 0.0 111.107 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.36 88.41 15.46 Favored Pre-proline 0 N--CA 1.441 -0.897 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.969 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.8 ' HG3' HG11 ' A' ' 58' ' ' VAL . 9.1 Cg_endo -109.69 150.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.393 2.729 . . . . 0.0 113.659 -177.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.66 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -77.02 80.72 3.55 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 175.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.996 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.65 128.0 50.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.298 -176.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.5 t80 -179.35 168.54 1.48 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.593 -0.443 . . . . 0.0 112.106 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.411 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 0.3 OUTLIER 77.26 -166.93 0.05 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.453 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -151.8 133.42 14.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.056 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.66 ' CE1' HG12 ' A' ' 122' ' ' VAL . 15.7 p90 -76.7 -41.78 43.98 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.663 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.3 mt-10 -171.6 131.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.083 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG2' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.7 132.42 42.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.759 0.314 . . . . 0.0 111.643 -179.082 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.846 HD22 HG22 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -112.31 156.52 22.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.791 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -137.12 110.0 7.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.658 ' HE1' HD12 ' A' ' 82' ' ' LEU . 7.2 p90 -128.84 153.12 47.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.757 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -121.05 119.4 32.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 111.212 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -73.97 163.07 71.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.52 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.4 Cg_endo -53.79 82.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.92 2.413 . . . . 0.0 112.087 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.9 t70 91.86 11.08 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.373 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.425 ' CG ' HD21 ' A' ' 4' ' ' LEU . 2.7 ttt180 -137.29 93.81 2.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 0.0 110.846 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.21 103.11 6.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 1.1 tt -106.17 111.75 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.015 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.428 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -94.36 118.47 31.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.77 179.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.668 HD11 HD21 ' A' ' 119' ' ' ASN . 10.4 mt -107.35 114.03 27.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 111.612 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.431 ' O ' HG13 ' A' ' 8' ' ' VAL . 11.2 m0 -108.62 122.47 47.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.139 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.663 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 6.3 m-85 -112.67 112.25 23.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.4 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.702 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 30.1 m95 -94.75 148.21 22.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.57 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 65' ' ' PHE . 47.2 tp -100.76 102.96 14.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.057 0.456 . . . . 0.0 110.809 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.996 HG22 ' ND1' ' A' ' 64' ' ' HIS . 33.4 t -84.81 145.35 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.733 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 3.9 mt-10 -106.36 -33.47 7.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.08 165.4 24.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.927 0.785 . . . . 0.0 111.813 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.703 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -151.56 127.52 10.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 111.53 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -76.89 147.76 36.84 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.11 -121.2 25.93 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.438 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -133.99 148.09 66.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.631 0.253 . . . . 0.0 110.82 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.49 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.65 128.71 10.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.948 2.432 . . . . 0.0 111.566 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.535 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 62.1 p-90 -136.16 -58.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.716 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.578 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.1 -95.72 0.01 OUTLIER Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.01 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' GLU . 2.8 tttp 174.25 37.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 110.938 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.459 ' OE2' HG22 ' A' ' 21' ' ' THR . 1.8 pt-20 -66.94 -30.63 70.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.512 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 10.3 79.39 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.391 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.406 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 4.7 mt-30 -140.24 91.88 9.73 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.356 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -43.72 138.48 5.74 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 123.054 2.503 . . . . 0.0 112.643 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.07 19.43 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.747 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -136.4 157.17 47.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.567 0.222 . . . . 0.0 110.577 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -72.98 107.16 5.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.88 0.372 . . . . 0.0 110.278 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.455 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -119.63 163.04 17.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.432 ' OG ' HG12 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -78.97 114.85 18.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.807 ' CD1' HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -72.27 -18.73 61.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.838 HG22 HD21 ' A' ' 129' ' ' LEU . 14.8 p -62.52 -10.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.446 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.25 50.48 0.89 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.63 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.807 HD23 ' CD1' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -62.09 138.86 58.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.678 0.275 . . . . 0.0 110.538 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.604 ' H ' HD13 ' A' ' 110' ' ' LEU . 1.1 m-80 -116.87 121.75 42.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.169 0.509 . . . . 0.0 111.885 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.663 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.1 -15.13 62.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.977 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -78.33 -49.46 13.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -70.64 -22.54 62.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.546 0.212 . . . . 0.0 111.367 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.663 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -100.35 170.81 6.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.5 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 43.7 Cg_endo -68.09 127.67 16.34 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.234 1.956 . . . . 0.0 111.898 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.38 -19.65 61.54 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.577 2.184 . . . . 0.0 113.001 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.93 -9.37 58.25 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.668 HD21 HD11 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -117.72 29.54 7.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.779 0.323 . . . . 0.0 111.408 -178.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.3 mt-10 -76.24 -31.87 1.03 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.789 ' HB2' HD13 ' A' ' 71' ' ' LEU . 82.3 Cg_exo -48.52 -45.44 27.14 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 121.869 1.712 . . . . 0.0 113.04 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.846 HG22 HD22 ' A' ' 71' ' ' LEU . 1.4 t -77.41 -51.4 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.07 0.462 . . . . 0.0 111.205 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.495 ' CG2' ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -62.42 -36.89 77.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.612 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.62 -29.77 52.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.905 0.384 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -79.74 -48.47 13.58 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.593 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.454 HD13 ' CD1' ' A' ' 68' ' ' PHE . 3.4 tp -78.09 -46.6 20.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.852 0.358 . . . . 0.0 111.269 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.571 ' O ' HD13 ' A' ' 129' ' ' LEU . 8.2 ttpp -51.95 -42.24 62.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.879 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -63.96 -7.08 7.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.142 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.838 HD21 HG22 ' A' ' 108' ' ' VAL . 8.1 mp . . . . . 0 C--O 1.231 0.119 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.806 0.336 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HG2' ' CG ' ' A' ' 79' ' ' HIS . 23.1 mtpt -140.0 135.02 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.766 HD12 ' CD1' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -146.04 141.08 27.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.768 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.753 ' C ' HD13 ' A' ' 6' ' ' ILE . 28.1 mt-30 -106.16 149.9 26.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.405 0.622 . . . . 0.0 112.316 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.766 ' CD1' HD12 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.31 116.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.611 178.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.969 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.98 135.81 53.15 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.352 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 0.9 OUTLIER -144.54 163.1 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.98 0.419 . . . . 0.0 111.19 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -141.25 130.35 4.41 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.091 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.964 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -72.0 108.45 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.74 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.5 mt -70.97 125.98 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.623 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.628 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -87.7 127.25 35.3 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.62 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.536 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 6.1 t-20 -69.93 -172.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.458 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.04 -10.7 31.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.895 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -133.82 -82.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.785 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -149.97 16.21 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 0.0 111.613 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.821 ' C ' HD12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -100.61 160.56 14.25 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.964 HG21 HG22 ' A' ' 10' ' ' ILE . 1.8 mp -130.64 138.14 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.094 0.473 . . . . 0.0 111.482 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.585 ' CZ ' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -85.96 116.02 23.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.332 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.505 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.05 120.11 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.745 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.86 HG21 ' HG2' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -70.73 115.97 10.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.575 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 19.6 ptt-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.744 0.307 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -114.22 26.2 10.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.018 0.437 . . . . 0.0 111.191 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.489 HD21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -45.47 114.12 0.7 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.619 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' ' CD ' ' A' ' 116' ' ' PRO . 0.5 OUTLIER -124.85 -171.66 2.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.195 0.521 . . . . 0.0 112.094 -179.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.611 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.55 168.59 9.79 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.146 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.562 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 87.5 Cg_endo -81.74 167.29 16.79 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.628 2.885 . . . . 0.0 113.799 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.39 -5.44 52.05 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.371 -0.831 . . . . 0.0 114.988 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -59.25 171.68 4.97 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.5 0.65 . . . . 0.0 113.214 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 76.58 7.03 3.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.517 0.327 . . . . 0.0 111.811 179.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.969 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.3 pt -55.44 -26.84 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.673 0.749 . . . . 0.0 110.032 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.542 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.98 -60.17 1.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.692 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER 5.37 -79.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.471 179.283 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.54 33.63 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.643 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.4 mp0 -88.95 -174.82 4.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.821 0.343 . . . . 0.0 111.09 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.852 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.5 154.14 38.09 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.322 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.852 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.97 -25.25 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.872 2.381 . . . . 0.0 112.448 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.8 mt-10 -104.02 -40.4 6.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.405 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.402 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 34.4 mt-30 -80.29 -4.91 55.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.654 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.919 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.89 -57.11 14.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.409 . . . . 0.0 110.667 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.803 HG11 ' NE1' ' A' ' 85' ' ' TRP . 2.5 m -78.64 -45.99 25.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.48 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.489 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 29.0 t -56.33 -36.66 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.141 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -77.95 -49.78 13.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.983 0.42 . . . . 0.0 110.193 179.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.53 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.5 mm-40 -65.56 -19.89 66.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.334 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.534 HD11 ' CD2' ' A' ' 64' ' ' HIS . 8.6 tp -56.55 -44.49 80.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -31.81 69.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.075 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.45 -31.09 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.572 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HA ' ' H ' ' A' ' 97' ' ' LYS . 4.0 mp0 -108.06 5.37 25.99 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.866 HG13 ' HB3' ' A' ' 94' ' ' PRO . 16.0 t -134.39 -43.96 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.104 0.478 . . . . 0.0 110.067 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.574 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.86 -38.32 0.29 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.614 -0.721 . . . . 0.0 114.207 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.845 HG22 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.71 -178.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.64 88.98 6.97 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.696 ' HG3' HG11 ' A' ' 58' ' ' VAL . 10.6 Cg_endo -108.28 144.07 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.475 2.783 . . . . 0.0 113.987 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -74.81 79.44 2.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.84 ' CB ' HG13 ' A' ' 87' ' ' VAL . 1.1 t-80 -123.23 122.36 38.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.65 -1.613 . . . . 0.0 109.895 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 6.5 t80 -179.41 161.07 1.04 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.177 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 9.3 t 77.01 166.93 0.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.783 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.797 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -119.54 130.08 54.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.873 ' CE2' HD11 ' A' ' 10' ' ' ILE . 7.1 p90 -78.2 -41.33 34.84 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.598 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -171.31 131.75 0.77 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.328 178.037 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.796 ' HG2' HD13 ' A' ' 67' ' ' LEU . 50.4 pttt -139.39 132.75 30.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 111.483 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.023 HD12 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -123.43 151.38 42.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.952 0.406 . . . . 0.0 110.996 179.455 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -121.59 133.91 55.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.757 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -141.03 145.81 36.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.568 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.08 126.35 49.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.095 0.474 . . . . 0.0 111.365 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -86.4 163.1 43.51 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.319 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.6 Cg_endo -53.97 82.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.825 2.35 . . . . 0.0 112.166 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.7 t70 93.25 9.67 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.52 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.482 ' CZ ' HD21 ' A' ' 4' ' ' LEU . 10.2 ttt85 -137.34 93.78 2.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.299 . . . . 0.0 110.759 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.416 ' CG ' ' HG2' ' A' ' 3' ' ' LYS . 1.1 m-70 -82.3 102.28 11.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.921 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 2.0 tt -106.32 111.73 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.025 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.422 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -92.54 118.45 31.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.015 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.531 HD23 HD11 ' A' ' 71' ' ' LEU . 14.8 tp -108.0 114.09 27.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 111.577 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.405 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 9.8 m0 -112.22 122.2 47.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.46 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 5.8 m-30 -109.84 109.63 20.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.911 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.803 ' NE1' HG11 ' A' ' 50' ' ' VAL . 32.5 m95 -95.79 148.65 22.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.622 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.0 pp -87.29 138.12 31.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.433 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.84 HG13 ' CB ' ' A' ' 64' ' ' HIS . 17.5 t -123.65 145.52 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.018 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.87 -30.68 8.01 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.572 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.28 165.01 24.71 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.221 0.919 . . . . 0.0 112.111 -178.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.74 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -154.64 130.15 9.86 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.133 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.23 132.71 47.62 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.055 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 48.79 -105.23 0.12 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.416 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 26.5 tt0 -134.32 137.65 28.46 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.812 -0.194 . . . . 0.0 110.759 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.866 ' HB3' HG13 ' A' ' 58' ' ' VAL . 4.7 Cg_exo -74.13 128.9 12.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.596 2.197 . . . . 0.0 110.682 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.574 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 21.5 p-90 -118.15 -63.95 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.583 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.43 -100.16 0.02 OUTLIER Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.853 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 160.56 74.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.584 0.354 . . . . 0.0 110.774 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.86 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.9 OUTLIER -88.6 -33.2 17.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.803 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 142.44 -38.5 1.45 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.323 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.487 ' O ' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -140.01 110.76 7.22 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.018 0.437 . . . . 0.0 111.885 -179.333 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -43.84 146.39 1.58 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.121 2.547 . . . . 0.0 112.55 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.19 177.29 17.48 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.001 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -128.85 157.23 42.11 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -77.99 106.83 10.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.4 ptp -119.99 163.08 18.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.924 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 95.8 p -75.04 114.98 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.859 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.69 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -78.97 -18.92 52.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.306 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.42 ' HA ' HD21 ' A' ' 129' ' ' LEU . 25.0 t -54.28 -18.52 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.424 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.39 55.1 0.57 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.268 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.533 HD22 HG23 ' A' ' 123' ' ' ILE . 5.6 tt -62.15 150.43 38.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -107.87 126.01 52.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.334 0.588 . . . . 0.0 112.428 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.656 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -15.2 61.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.791 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -78.11 -49.14 14.46 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.654 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -26.33 65.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.79 0.329 . . . . 0.0 110.8 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.656 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -98.36 166.96 12.33 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.17 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.6 Cg_endo -72.61 127.81 12.81 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.393 2.062 . . . . 0.0 111.937 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.54 -14.92 42.55 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.595 2.197 . . . . 0.0 113.05 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.69 -9.51 57.3 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.433 ' OD1' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -121.72 31.17 6.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.827 0.346 . . . . 0.0 111.277 -179.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.2 -34.13 1.37 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -179.162 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 93.1 Cg_exo -44.73 -46.28 12.69 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.21 1.94 . . . . 0.0 113.193 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 1.023 HG22 HD12 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -77.14 -33.98 20.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.029 0.442 . . . . 0.0 110.048 179.666 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.581 HG13 ' CE2' ' A' ' 115' ' ' PHE . 7.8 mm -68.18 -39.79 81.77 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.839 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.55 -29.44 50.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.436 . . . . 0.0 110.371 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -80.27 -53.21 6.86 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.782 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.69 ' CD2' HD12 ' A' ' 107' ' ' LEU . 1.7 tp -78.3 -19.79 52.84 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.513 ' HB2' HG22 ' A' ' 123' ' ' ILE . 54.6 tttm -78.21 -42.71 30.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.081 0.467 . . . . 0.0 110.745 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -69.65 -7.03 35.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.905 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.123 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.683 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.4 tttt . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.831 0.348 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -128.62 134.72 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.912 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.537 HD13 HD11 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -139.13 143.03 38.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.419 ' C ' HD12 ' A' ' 6' ' ' ILE . 30.9 mt-30 -102.61 153.1 20.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.335 0.588 . . . . 0.0 112.02 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.83 ' HB ' HD23 ' A' ' 82' ' ' LEU . 4.9 mp -146.2 127.93 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.743 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.063 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.58 124.56 42.5 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.581 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 2.0 m -116.53 162.23 14.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.345 0.593 . . . . 0.0 111.912 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -143.25 109.57 0.56 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.848 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -70.53 98.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.733 HG22 ' CE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.14 123.72 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 121.21 0.529 . . . . 0.0 112.121 -178.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.528 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -96.23 127.19 42.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.363 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.536 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -79.58 -172.63 3.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.113 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.483 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 14.9 tp10 -80.48 -2.72 47.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.299 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -134.16 49.61 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.879 0.371 . . . . 0.0 111.229 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 48.04 22.62 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.448 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 18.4 pt-20 -110.44 141.08 44.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.628 HG21 HG13 ' A' ' 10' ' ' ILE . 2.6 mt -110.82 151.44 12.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.284 0.564 . . . . 0.0 112.296 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -101.01 99.96 10.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.517 178.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.419 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.81 120.1 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.569 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.628 HG23 ' HD3' ' A' ' 36' ' ' PRO . 18.2 p -71.08 111.85 6.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.998 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 2.5 ptm180 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.451 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.587 0.232 . . . . 0.0 111.468 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 26.26 10.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 111.501 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -46.8 120.21 2.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.696 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 21' ' ' THR . 7.8 mt-10 -137.19 -174.11 3.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.045 0.45 . . . . 0.0 111.473 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.561 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.03 161.17 39.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.23 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.628 ' HD3' HG23 ' A' ' 21' ' ' THR . 12.2 Cg_endo -54.65 167.76 1.34 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.374 2.716 . . . . 0.0 111.715 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.61 59.56 0.75 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.768 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -124.96 132.15 8.01 Favored Glycine 0 C--N 1.311 -0.818 0 CA-C-N 114.406 -0.897 . . . . 0.0 111.78 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.41 5.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.936 0.494 . . . . 0.0 112.297 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.063 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.27 -28.11 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.601 0.715 . . . . 0.0 110.279 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.578 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.98 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.787 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.5 mmm 31.77 -86.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.52 0.513 . . . . 0.0 111.827 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -158.96 24.38 0.33 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.605 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -102.64 -179.51 3.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.892 0.377 . . . . 0.0 111.051 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.906 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.55 158.52 34.46 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.929 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.906 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.86 -24.7 0.85 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.726 2.284 . . . . 0.0 112.473 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -85.24 -61.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -80.4 -20.13 44.69 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.883 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -56.87 -48.43 78.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.734 0.302 . . . . 0.0 111.093 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.729 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.0 OUTLIER -78.11 -47.29 25.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.7 t -57.4 -38.49 63.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.624 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -78.44 -46.54 19.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.989 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -69.79 -21.66 63.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.344 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.678 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -57.39 -44.68 84.71 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.777 0.322 . . . . 0.0 110.565 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -30.9 71.94 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.1 tm-20 -77.63 -29.05 51.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.104 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.68 5.85 25.23 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.955 HG12 HG13 ' A' ' 60' ' ' ILE . 21.3 t -134.04 -44.3 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.956 0.408 . . . . 0.0 109.989 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.598 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.68 -41.33 0.31 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.648 -0.705 . . . . 0.0 113.488 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.955 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.55 -176.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -113.06 89.1 13.24 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.306 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.88 ' HG3' HG11 ' A' ' 58' ' ' VAL . 7.9 Cg_endo -108.79 148.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 123.205 2.604 . . . . 0.0 114.139 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' CG ' ' HG2' ' A' ' 89' ' ' ARG . 86.6 mt-30 -74.76 79.8 2.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.958 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -123.11 125.55 45.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.374 -176.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.6 t80 -177.77 159.12 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.128 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER 84.21 -170.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.298 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.689 HD13 ' HD3' ' A' ' 70' ' ' LYS . 3.5 pp -145.02 130.58 18.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.056 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.619 ' CE1' HG12 ' A' ' 122' ' ' VAL . 1.3 p90 -76.67 -35.18 58.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.212 0.529 . . . . 0.0 109.678 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.7 OUTLIER -171.2 163.53 7.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.504 179.038 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.689 ' HD3' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.53 132.41 22.74 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.684 -179.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.739 ' HB2' HG22 ' A' ' 122' ' ' VAL . 9.0 tp -119.25 142.45 48.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.727 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -140.0 111.02 6.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.505 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.579 ' HE1' HD12 ' A' ' 82' ' ' LEU . 8.8 p90 -138.67 153.27 48.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.767 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.06 140.02 52.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.176 0.512 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -89.2 163.18 35.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.545 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.3 Cg_endo -51.9 83.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.103 2.536 . . . . 0.0 112.036 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 8.1 m-20 93.96 16.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.142 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 35.1 ttt180 -137.32 150.13 47.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.489 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.83 99.72 6.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.763 0.316 . . . . 0.0 110.719 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.488 HG13 HD13 ' A' ' 6' ' ' ILE . 4.7 tt -104.35 111.75 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 120.956 0.408 . . . . 0.0 110.96 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.438 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -103.88 118.99 38.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.235 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.83 HD23 ' HB ' ' A' ' 6' ' ' ILE . 66.3 mt -118.86 114.35 22.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.877 0.37 . . . . 0.0 111.615 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.472 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.8 m0 -106.29 122.37 46.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.142 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.908 ' CG ' HG11 ' A' ' 122' ' ' VAL . 2.2 m-85 -98.94 110.39 23.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.71 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.729 ' NE1' HG11 ' A' ' 50' ' ' VAL . 31.9 m95 -94.85 148.77 21.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.822 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.746 HD13 ' N ' ' A' ' 87' ' ' VAL . 3.1 tm? -94.17 137.36 33.44 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.356 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.958 HG22 ' ND1' ' A' ' 64' ' ' HIS . 41.1 t -124.14 145.01 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.499 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.59 -27.68 8.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.1 165.2 24.93 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.716 0.689 . . . . 0.0 111.766 -179.26 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.733 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -155.72 122.36 5.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.293 178.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.24 145.25 49.72 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.069 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.49 -116.82 6.9 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.582 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.6 tt0 -134.47 145.77 56.53 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.591 0.234 . . . . 0.0 110.819 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.53 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.4 Cg_exo -76.5 128.78 10.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.913 2.408 . . . . 0.0 111.135 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.598 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 47.5 p-90 -130.84 -62.54 0.9 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.549 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.37 -97.5 0.01 OUTLIER Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.613 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.6 tptp 178.77 35.49 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.636 0.255 . . . . 0.0 111.389 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.523 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -62.35 -46.21 89.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.334 179.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.34 14.91 46.15 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.353 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.434 ' O ' ' HB ' ' A' ' 21' ' ' THR . 49.9 mt-30 -140.31 92.91 9.18 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 111.539 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -43.78 138.42 5.93 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.901 2.401 . . . . 0.0 112.534 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.457 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.18 177.13 19.39 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.645 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.07 157.09 45.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.641 0.258 . . . . 0.0 110.785 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.464 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.45 107.13 6.4 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.876 0.37 . . . . 0.0 110.391 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -119.67 163.42 17.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.871 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.603 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.2 p -82.0 114.94 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.851 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.625 ' CD2' HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -71.88 -18.79 62.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.112 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.912 ' HA ' HD21 ' A' ' 129' ' ' LEU . 10.9 p -57.29 -11.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.632 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.2 51.42 0.84 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.157 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.612 HD23 ' CD1' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -61.92 134.59 56.87 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.522 ' H ' HD13 ' A' ' 110' ' ' LEU . 1.6 m-20 -111.2 121.58 45.66 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.747 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . . . -72.42 -14.72 61.77 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.801 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -76.41 -49.05 17.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.483 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -27.19 64.47 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.085 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.689 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -93.78 169.8 9.48 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.249 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.524 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 40.3 Cg_endo -67.33 127.58 16.85 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.216 1.944 . . . . 0.0 111.837 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.86 -15.01 47.29 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.588 2.192 . . . . 0.0 113.151 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.3 -9.19 59.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.553 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.6 m-80 -114.96 28.58 8.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.579 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -69.26 -34.48 4.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.259 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 61.8 Cg_exo -51.82 -45.87 35.7 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 121.962 1.775 . . . . 0.0 113.218 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.908 HG11 ' CG ' ' A' ' 84' ' ' PHE . 2.1 t -77.44 -51.34 18.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.328 . . . . 0.0 111.314 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.509 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -64.95 -29.81 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.064 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.38 -33.03 63.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.031 0.443 . . . . 0.0 110.257 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -78.3 -47.51 17.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.556 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.594 HD13 ' CG ' ' A' ' 68' ' ' PHE . 2.8 tp -78.17 -19.75 53.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.651 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.747 ' HE2' ' HB2' ' A' ' 112' ' ' ALA . 15.8 ttpp -83.64 -42.39 16.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.131 0.491 . . . . 0.0 110.524 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -63.91 -10.37 20.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.824 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.912 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.213 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.006 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 pttt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.893 0.378 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HG2' ' CG ' ' A' ' 79' ' ' HIS . 7.6 mtmt -132.53 148.98 52.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.68 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.873 HD11 HG13 ' A' ' 80' ' ' ILE . 4.5 pp -146.07 132.45 19.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.283 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.465 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 42.3 mt-30 -102.78 153.6 20.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.353 0.597 . . . . 0.0 111.756 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 81' ' ' THR . 10.4 mm -146.46 130.22 10.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.085 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.021 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.84 124.21 41.61 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 9' ' ' GLY . 1.6 m -120.01 162.23 18.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.06 0.457 . . . . 0.0 111.564 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.93 109.4 0.48 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.81 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.74 HD11 HD13 ' A' ' 107' ' ' LEU . 1.1 tp -70.47 99.46 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.86 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -71.2 119.79 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -82.54 124.02 29.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.06 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.516 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 19.1 t-20 -69.63 177.6 2.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.851 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.516 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -54.59 -20.08 7.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.261 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -119.54 -82.46 0.64 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.67 0.271 . . . . 0.0 111.408 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.11 14.1 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 17.2 pt-20 -100.89 160.15 14.61 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.86 HG23 ' O ' ' A' ' 11' ' ' ILE . 3.4 mt -138.29 140.88 39.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.899 0.381 . . . . 0.0 111.895 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.724 ' CD2' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -86.15 113.08 21.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -111.81 119.53 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.168 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.731 HG22 ' HD3' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -74.99 111.8 10.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.95 0.405 . . . . 0.0 110.666 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.463 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 2.2 ptt180 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.742 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.26 26.23 10.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.083 0.468 . . . . 0.0 111.371 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.48 HD21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -47.48 122.22 4.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.705 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.825 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.4 tt0 -138.41 -167.25 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.005 0.431 . . . . 0.0 111.653 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.547 ' CD2' HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -119.15 155.2 53.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.499 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.731 ' HD3' HG22 ' A' ' 21' ' ' THR . 10.2 Cg_endo -52.9 167.67 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.324 2.683 . . . . 0.0 111.341 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.53 59.71 0.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 119.852 -1.166 . . . . 0.0 114.318 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -123.62 136.47 10.38 Favored Glycine 0 C--N 1.31 -0.863 0 CA-C-N 114.919 -0.64 . . . . 0.0 111.971 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.2 ttpt 91.27 4.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.006 0.522 . . . . 0.0 112.305 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.021 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -50.51 -29.14 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 110.364 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.17 -79.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.966 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 37.45 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.445 0.466 . . . . 0.0 111.634 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -161.93 26.14 0.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.691 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -99.45 -176.51 3.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.863 0.363 . . . . 0.0 111.125 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.917 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.93 162.92 18.66 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.405 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.917 ' HD2' HG22 ' A' ' 45' ' ' THR . 9.3 Cg_endo -49.14 -24.53 8.03 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.639 2.226 . . . . 0.0 112.425 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mm-40 -98.91 -48.04 5.05 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -77.17 -26.61 53.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.66 0.266 . . . . 0.0 111.615 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.967 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -57.79 -45.31 86.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.727 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.24 -46.63 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.516 179.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.4 t -60.03 -39.48 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.077 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -78.23 -45.77 22.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.963 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.68 -22.12 62.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.778 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.2 tp -53.87 -44.59 70.54 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.836 0.35 . . . . 0.0 110.082 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -59.54 -33.68 71.71 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.41 -26.25 51.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.994 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HG2' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -108.02 6.04 26.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.673 HG11 ' HG3' ' A' ' 62' ' ' PRO . 10.3 t -134.32 -44.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.214 0.53 . . . . 0.0 109.876 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.44 -43.43 0.57 Allowed Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.866 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.682 HG23 ' NE1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -84.36 -175.08 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.079 0.466 . . . . 0.0 111.292 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 p -112.64 89.09 12.32 Favored Pre-proline 0 N--CA 1.442 -0.875 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.554 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.673 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.9 Cg_endo -107.62 152.46 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.96 2.44 . . . . 0.0 114.203 -177.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -74.85 79.9 2.12 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.022 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.65 126.13 44.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.738 -176.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.9 t80 -179.35 165.66 1.43 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.9 0.381 . . . . 0.0 111.93 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 83.1 160.33 0.13 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.762 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -113.77 131.97 56.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 111.363 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -88.61 -33.91 17.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.102 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.1 tt0 -171.56 149.93 2.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.471 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.1 108.16 4.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.74 0.305 . . . . 0.0 110.689 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.723 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -120.85 140.55 51.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.794 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.475 ' CB ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER -140.14 139.47 35.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.964 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.591 ' O ' HG22 ' A' ' 80' ' ' ILE . 69.9 t80 -141.05 100.98 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.4 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 1.8 pm0 -64.76 136.88 57.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.159 0.504 . . . . 0.0 111.41 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.485 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -101.54 162.89 19.04 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.434 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.579 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.4 Cg_endo -53.06 81.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.019 2.479 . . . . 0.0 112.353 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 13.3 t70 102.23 -24.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.267 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.686 ' HE ' HD21 ' A' ' 4' ' ' LEU . 5.4 ttt180 -109.65 95.19 5.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.712 0.292 . . . . 0.0 111.09 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.413 ' CG ' ' HG2' ' A' ' 3' ' ' LYS . 18.9 m170 -77.85 93.87 4.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 0.0 110.542 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.873 HG13 HD11 ' A' ' 4' ' ' LEU . 2.4 tt -85.78 131.8 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.475 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.475 HG23 ' CB ' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -134.06 118.63 17.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.178 179.668 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.667 HD13 ' CE1' ' A' ' 84' ' ' PHE . 1.6 pp -126.35 117.09 22.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 111.343 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.416 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.9 m0 -102.82 122.86 45.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.667 ' CE1' HD13 ' A' ' 82' ' ' LEU . 3.5 m-30 -95.08 109.89 21.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.311 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.653 ' CE2' HG11 ' A' ' 50' ' ' VAL . 21.3 m95 -95.58 148.6 22.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.166 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 65' ' ' PHE . 12.2 tp -92.62 138.1 31.79 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.567 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.022 HG22 ' ND1' ' A' ' 64' ' ' HIS . 38.0 t -124.33 145.71 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.67 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -111.27 -30.57 7.38 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.4 165.24 24.15 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.925 0.784 . . . . 0.0 111.688 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.662 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.8 p90 -148.23 130.25 15.36 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.538 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -78.06 145.08 36.06 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.935 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.14 -116.29 8.16 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.383 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 7.0 mt-10 -135.05 139.29 31.56 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.458 0.171 . . . . 0.0 110.848 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.465 ' HA ' HG12 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -76.35 128.6 10.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.812 2.341 . . . . 0.0 111.537 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.682 ' NE1' HG23 ' A' ' 60' ' ' ILE . 55.5 p-90 -132.32 -60.22 0.9 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.879 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.597 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.28 -107.31 0.1 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.248 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 1.3 tptt 178.1 72.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.755 0.312 . . . . 0.0 110.728 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.524 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -89.78 -30.66 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.911 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.11 -66.23 0.4 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.885 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.1 104.97 36.12 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.002 0.43 . . . . 0.0 111.384 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -43.64 144.77 2.04 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.912 2.408 . . . . 0.0 112.748 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.482 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.08 177.12 19.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.393 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -133.14 153.6 51.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.644 0.259 . . . . 0.0 110.922 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 1.1 m0 -63.03 107.22 0.97 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.815 0.34 . . . . 0.0 110.357 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.4 ptm -119.44 140.5 50.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.08 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.1 p -63.19 114.89 4.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.087 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.74 HD13 HD11 ' A' ' 10' ' ' ILE . 12.4 tp -64.6 -18.76 65.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.073 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.8 t -55.73 -15.13 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.6 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.18 42.16 1.88 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.371 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.446 ' CD2' HD11 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -62.3 128.47 36.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -119.66 129.38 54.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.158 0.504 . . . . 0.0 112.241 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.654 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -15.17 61.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.817 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -78.35 -48.97 14.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.581 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -29.86 68.18 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.659 0.266 . . . . 0.0 111.246 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.654 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -91.41 171.9 7.36 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.183 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.5 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.6 Cg_endo -70.86 127.67 14.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.13 1.886 . . . . 0.0 111.714 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.61 -14.94 45.69 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.586 2.191 . . . . 0.0 113.095 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.5 -9.29 58.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -119.76 31.31 6.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.698 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -70.19 -37.24 7.02 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 64.6 Cg_exo -51.81 -43.44 51.51 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.09 1.86 . . . . 0.0 113.081 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 71' ' ' LEU . 2.4 t -77.48 -51.27 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.962 0.411 . . . . 0.0 111.364 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -66.34 -32.13 56.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.343 -179.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.55 -29.67 59.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.847 0.356 . . . . 0.0 110.713 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -73.56 -53.24 11.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.74 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.711 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -78.4 -36.22 46.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.48 -179.417 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.602 ' N ' HD23 ' A' ' 126' ' ' LEU . 3.1 ttpm? -53.13 -42.51 66.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.084 0.469 . . . . 0.0 111.15 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -63.99 -11.63 30.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.684 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 126' ' ' LEU . 3.8 mp . . . . . 0 C--O 1.231 0.102 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.089 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.849 0.357 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -137.64 138.72 39.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.839 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 4' ' ' LEU . 1.4 pp -144.01 139.82 29.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.966 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.515 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.1 mt-30 -102.7 153.83 19.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.032 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.738 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.6 mp -146.02 128.42 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.9 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.069 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 124.56 42.44 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.163 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.568 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.6 m -117.9 158.41 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.362 0.601 . . . . 0.0 111.713 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.08 108.66 0.54 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.345 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -70.69 96.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.358 0.599 . . . . 0.0 110.051 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.668 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 1.4 tt -71.44 121.34 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.592 ' CG ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -94.93 144.83 25.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.695 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.958 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.7 p-10 -102.67 -173.28 2.29 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.595 0.712 . . . . 0.0 112.164 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.3 tm-20 -71.85 1.48 6.97 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.425 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -124.05 43.25 3.04 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.099 -0.376 . . . . 0.0 111.695 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 45.87 27.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.098 0.475 . . . . 0.0 111.163 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 6.3 mt-10 -114.83 161.4 18.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.794 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.722 HG22 HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -125.72 132.63 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.792 0.33 . . . . 0.0 111.347 -178.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE1' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -85.26 125.72 33.11 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.021 0.439 . . . . 0.0 110.629 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.848 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -122.19 122.81 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.08 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.575 HG22 ' CE1' ' A' ' 19' ' ' PHE . 19.7 p -71.01 111.96 6.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.818 0.342 . . . . 0.0 111.165 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.334 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.544 0.211 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.35 26.23 10.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.377 . . . . 0.0 111.671 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.848 HD21 ' HB ' ' A' ' 20' ' ' ILE . 5.5 tt -42.79 121.64 2.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.751 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' N ' HD23 ' A' ' 33' ' ' LEU . 3.9 mt-10 -140.69 -176.03 4.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.145 0.497 . . . . 0.0 111.972 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.864 ' CD2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.92 163.32 28.55 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.557 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.461 ' HD3' HG23 ' A' ' 21' ' ' THR . 19.3 Cg_endo -57.22 168.08 2.97 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.508 2.805 . . . . 0.0 111.801 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.22 59.67 0.76 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.01 -1.091 . . . . 0.0 113.788 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.27 126.07 5.27 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 114.556 -0.822 . . . . 0.0 112.19 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER 103.46 2.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.248 0.619 . . . . 0.0 112.305 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.069 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -51.5 -27.82 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.511 0.672 . . . . 0.0 110.754 179.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.577 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.44 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.016 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.4 mmm 33.75 -86.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.538 0.524 . . . . 0.0 111.841 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -164.3 27.57 0.21 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.565 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -95.62 -176.23 3.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.852 0.358 . . . . 0.0 111.138 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.912 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.81 155.75 38.49 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.235 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.912 ' HD2' HG22 ' A' ' 45' ' ' THR . 3.0 Cg_endo -44.74 -24.71 1.26 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.736 2.29 . . . . 0.0 112.608 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -95.21 -49.63 5.41 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -80.08 -24.15 40.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.719 0.295 . . . . 0.0 111.741 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.876 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -55.43 -47.41 76.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.001 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.754 HG12 ' CB ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.17 -47.89 23.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.823 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.7 t -56.76 -36.5 49.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.103 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -78.18 -50.66 11.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.9 mm-40 -66.9 -24.46 66.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.748 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.2 tp -51.8 -44.22 63.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.886 0.374 . . . . 0.0 110.272 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -33.93 75.01 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.58 -26.33 50.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.249 179.405 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mt-10 -108.14 5.17 25.65 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.99 HG12 HG13 ' A' ' 60' ' ' ILE . 17.7 t -134.6 -43.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.191 0.52 . . . . 0.0 109.741 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.587 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.52 -43.94 0.59 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.215 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.99 HG13 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.57 -177.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.094 0.473 . . . . 0.0 111.175 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -111.29 89.22 9.87 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.368 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.926 ' HG3' HG11 ' A' ' 58' ' ' VAL . 1.4 Cg_endo -108.7 156.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.864 2.376 . . . . 0.0 115.211 -176.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.426 ' HB2' ' CB ' ' A' ' 89' ' ' ARG . 75.8 mt-30 -77.93 80.17 4.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.997 ' CD2' HG22 ' A' ' 87' ' ' VAL . 1.9 t-160 -127.07 124.24 38.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.669 -176.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.6 t80 -179.06 162.73 1.26 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.677 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER 83.84 155.77 0.1 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.943 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.7 pp -113.66 126.21 55.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.317 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.692 ' CE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -78.18 -36.75 47.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.253 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.06 162.03 7.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.469 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -143.08 132.14 23.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.889 0.376 . . . . 0.0 111.155 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.725 ' HB2' HG22 ' A' ' 122' ' ' VAL . 22.6 tp -119.01 121.98 41.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.648 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -120.91 109.95 15.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.685 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.415 ' HE1' HD12 ' A' ' 82' ' ' LEU . 3.3 p90 -141.04 150.85 43.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.649 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.19 122.28 39.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.097 0.475 . . . . 0.0 111.354 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.88 163.09 63.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.457 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.67 82.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.056 2.504 . . . . 0.0 112.149 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 14.3 t0 95.94 16.64 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.202 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -137.31 145.92 44.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.615 179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -118.29 94.0 4.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 110.547 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.449 HG13 HD13 ' A' ' 6' ' ' ILE . 2.6 tt -103.08 111.8 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.195 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.413 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -105.85 122.44 46.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.377 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.738 HD23 ' HB ' ' A' ' 6' ' ' ILE . 32.3 mt -122.27 114.71 21.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.875 0.369 . . . . 0.0 111.367 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.464 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.9 m0 -104.89 122.51 45.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.749 ' CD2' HG11 ' A' ' 122' ' ' VAL . 2.9 m-85 -98.64 110.12 22.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.387 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.741 ' CE2' HG11 ' A' ' 50' ' ' VAL . 25.0 m95 -94.65 148.54 22.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.583 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.634 HD12 ' OE2' ' A' ' 88' ' ' GLU . 1.6 tm? -100.36 103.85 15.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.116 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.997 HG22 ' CD2' ' A' ' 64' ' ' HIS . 43.1 t -91.82 145.47 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.382 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.634 ' OE2' HD12 ' A' ' 86' ' ' LEU . 3.2 mm-40 -111.52 -29.52 7.73 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.16 165.5 24.44 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.182 0.901 . . . . 0.0 111.824 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.958 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.6 p90 -149.4 132.67 16.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.667 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -81.23 128.38 33.73 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.749 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.2 -116.05 4.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.442 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 33.0 mt-10 -135.06 141.04 36.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.556 0.217 . . . . 0.0 110.93 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.568 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.1 Cg_exo -76.51 128.88 10.61 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.894 2.396 . . . . 0.0 111.199 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.657 ' HE1' HG23 ' A' ' 60' ' ' ILE . 55.6 p-90 -136.8 -64.81 0.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.846 -0.742 . . . . 0.0 112.811 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.599 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 49.21 -100.36 0.03 OUTLIER Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.65 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER 175.71 42.2 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.709 0.29 . . . . 0.0 111.091 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.405 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.8 OUTLIER -59.53 -52.34 65.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.39 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 123.79 -11.06 8.38 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.723 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.47 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -140.17 98.94 7.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 117.38 0.59 . . . . 0.0 111.995 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -44.06 140.21 5.41 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.751 2.301 . . . . 0.0 112.269 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.515 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.18 177.28 19.27 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.897 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -129.75 157.29 42.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.693 0.283 . . . . 0.0 110.624 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.87 106.42 6.39 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.867 0.365 . . . . 0.0 110.178 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.5 ptp -120.2 149.76 41.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.075 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.505 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -66.68 114.9 5.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.626 179.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.1 tm? -69.95 -18.92 63.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.321 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.564 ' O ' HD21 ' A' ' 129' ' ' LEU . 12.9 p -56.1 -17.86 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.519 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.34 45.39 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.619 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.664 HD12 HD21 ' A' ' 107' ' ' LEU . 8.6 tt -62.65 150.49 40.74 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.422 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.2 m-20 -119.26 127.43 53.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.641 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -14.89 61.88 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.496 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -48.97 15.21 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.397 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -35.21 79.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.847 0.356 . . . . 0.0 110.701 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.641 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -85.41 168.16 21.6 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.27 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.513 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.2 Cg_endo -67.54 127.71 16.89 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.263 1.976 . . . . 0.0 111.918 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.02 -19.17 63.64 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.539 2.159 . . . . 0.0 112.892 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.64 -9.33 58.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.512 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.4 m-80 -116.2 29.43 7.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.463 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.4 pt-20 -71.86 -31.92 1.94 Allowed Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 50.9 Cg_exo -53.89 -37.31 85.35 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 121.875 1.716 . . . . 0.0 112.567 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.749 HG11 ' CD2' ' A' ' 84' ' ' PHE . 22.7 t -77.35 -48.42 24.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.507 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.598 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.4 mm -67.44 -30.25 48.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.897 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.65 -28.33 46.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 0.0 110.317 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -48.26 16.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.428 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.692 HD13 ' CE2' ' A' ' 68' ' ' PHE . 7.8 tp -78.2 -30.42 48.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 0.0 111.499 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.473 ' HB2' HG22 ' A' ' 123' ' ' ILE . 10.5 ttpp -54.61 -42.55 71.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -72.96 -5.69 40.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.005 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.564 HD21 ' O ' ' A' ' 108' ' ' VAL . 1.3 mp . . . . . 0 CA--C 1.528 0.127 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.284 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.034 0 CA-C-O 120.872 0.368 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.94 143.38 49.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.878 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 4' ' ' LEU . 1.6 pp -141.84 137.0 31.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.773 ' C ' HD13 ' A' ' 6' ' ' ILE . 42.8 mt-30 -102.62 151.74 21.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.446 0.641 . . . . 0.0 112.392 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.773 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -142.38 128.19 17.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.476 179.026 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.052 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.55 125.06 43.57 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.323 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.586 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.3 m -120.7 162.37 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.424 0.63 . . . . 0.0 112.167 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.421 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.06 113.47 0.59 Allowed Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.587 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.574 HG22 HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.86 101.66 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.809 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.38 119.84 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.932 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.501 ' CG ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -101.74 150.88 22.69 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.236 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.662 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 8.4 p-10 -121.34 -173.97 2.74 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -56.45 -25.93 52.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.506 -1.224 . . . . 0.0 113.867 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -98.27 31.52 2.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.158 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 p30 49.12 23.21 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.182 0.515 . . . . 0.0 110.508 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -101.02 160.77 14.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.037 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.769 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -124.78 118.96 54.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.245 0.545 . . . . 0.0 111.943 -178.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.456 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 15.2 t80 -66.96 100.66 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.527 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.553 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -109.0 123.01 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.538 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.752 HG21 ' HG3' ' A' ' 98' ' ' GLU . 24.0 p -70.99 111.83 6.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.036 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.611 0.243 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.52 26.5 10.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.922 0.392 . . . . 0.0 111.7 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -47.55 113.51 0.71 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.0 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.77 177.04 8.03 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.152 0.501 . . . . 0.0 111.779 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -119.9 162.02 35.27 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.941 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 21' ' ' THR . 6.5 Cg_endo -48.16 167.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.812 3.008 . . . . 0.0 112.177 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 101.89 59.71 0.77 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.051 -1.071 . . . . 0.0 114.186 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -131.76 130.24 5.9 Favored Glycine 0 C--N 1.312 -0.798 0 CA-C-N 114.724 -0.738 . . . . 0.0 111.952 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.43 6.64 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.986 0.515 . . . . 0.0 112.037 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.052 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.53 -28.09 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.667 0.746 . . . . 0.0 110.192 179.202 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.586 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.61 -73.57 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.552 -1.203 . . . . 0.0 111.13 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 41' ' ' GLU . 1.0 OUTLIER 26.85 -85.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.562 0.539 . . . . 0.0 112.119 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.28 28.36 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.676 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.3 mp0 -97.44 -175.13 3.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.713 0.292 . . . . 0.0 111.192 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.922 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.23 160.74 25.48 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.358 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.922 ' HD2' HG22 ' A' ' 45' ' ' THR . 9.7 Cg_endo -49.3 -24.63 8.7 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.623 2.215 . . . . 0.0 112.316 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.1 mt-10 -99.14 -45.66 5.83 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -80.05 -23.81 41.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.667 0.27 . . . . 0.0 111.624 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.872 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -56.79 -47.56 79.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.021 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.685 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -78.25 -46.07 26.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.768 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.1 t -59.39 -36.81 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.174 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -78.15 -47.15 18.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.742 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.3 mt-10 -70.09 -20.83 63.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.736 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.997 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -51.36 -44.45 62.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.229 0.538 . . . . 0.0 109.602 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -32.21 73.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.937 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.48 -32.43 54.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.767 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.14 5.07 25.57 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.754 HG11 ' HG3' ' A' ' 62' ' ' PRO . 21.8 t -134.65 -44.23 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.44 . . . . 0.0 110.146 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.599 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.75 -45.32 0.39 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.449 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.763 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -77.97 152.34 5.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.494 ' H ' HD13 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -84.89 96.71 0.43 Allowed Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.49 -179.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.763 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 19.7 Cg_endo -113.72 148.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.699 0 C-N-CA 123.443 2.762 . . . . 0.0 114.163 -177.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -74.8 79.58 2.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.997 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -124.92 121.18 33.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.274 -176.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.1 t80 -178.64 169.08 1.73 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.096 0.474 . . . . 0.0 112.142 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.461 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 82.7 162.36 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.383 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 8.0 tt -105.47 131.84 52.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.611 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -98.59 -32.28 11.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.916 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.487 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -171.61 159.96 5.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.945 179.491 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HB3' HD11 ' A' ' 67' ' ' LEU . 2.6 ptpp? -143.48 132.08 22.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.726 0.298 . . . . 0.0 110.936 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.79 ' HB2' HG22 ' A' ' 122' ' ' VAL . 37.5 tp -118.9 120.41 37.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.639 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -115.97 109.82 18.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.697 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.561 ' HE1' HD12 ' A' ' 82' ' ' LEU . 2.1 p90 -141.14 145.85 36.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.612 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.11 121.7 38.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.132 0.492 . . . . 0.0 111.203 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -70.0 163.07 64.38 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.506 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.8 Cg_endo -51.85 83.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.063 2.509 . . . . 0.0 112.078 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 27.8 m-20 95.56 15.33 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.295 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.547 ' HE ' HD21 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -137.35 149.84 47.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.566 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -124.17 106.1 10.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 tt -111.35 112.33 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.429 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -98.42 118.64 35.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.415 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.561 HD12 ' HE1' ' A' ' 73' ' ' TYR . 6.7 mt -115.32 114.48 25.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.987 0.422 . . . . 0.0 111.764 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -108.99 122.56 47.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.315 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.547 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 2.6 m-85 -100.47 125.79 46.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.657 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.685 ' CE2' HG11 ' A' ' 50' ' ' VAL . 15.6 m95 -107.19 148.66 28.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 112.014 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.527 ' O ' HD12 ' A' ' 86' ' ' LEU . 2.0 pp -97.69 103.85 15.82 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.306 0.574 . . . . 0.0 111.446 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.995 HG22 ' ND1' ' A' ' 64' ' ' HIS . 41.2 t -84.83 144.76 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.229 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -32.24 7.88 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.73 165.02 26.08 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.56 -179.189 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.809 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.4 p90 -149.64 136.61 19.59 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.331 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.683 ' CB ' HD12 ' A' ' 60' ' ' ILE . 1.5 mt-10 -73.77 134.04 43.37 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.735 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 51.13 -107.85 0.46 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.86 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 21.8 mt-10 -135.56 142.11 39.82 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.49 0.186 . . . . 0.0 111.038 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.548 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.3 Cg_exo -76.05 128.57 10.77 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.459 2.106 . . . . 0.0 110.672 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.599 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 35.8 p-90 -124.6 -59.05 1.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.966 0.412 . . . . 0.0 111.861 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.59 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.01 -95.75 0.01 OUTLIER Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.875 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.71 37.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.72 0.295 . . . . 0.0 110.895 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.752 ' HG3' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -64.54 -44.88 89.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.189 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.77 -98.76 0.23 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.44 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -75.92 114.41 36.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.077 0.465 . . . . 0.0 112.248 -178.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -43.9 146.44 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.179 2.586 . . . . 0.0 112.648 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.449 ' CA ' ' CE2' ' A' ' 19' ' ' PHE . . . -123.37 177.07 16.68 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.966 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -138.98 157.53 45.83 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.494 ' CD1' ' HZ2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -72.24 105.99 4.24 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.928 0.394 . . . . 0.0 110.085 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.29 140.0 51.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.714 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.2 p -58.89 114.55 2.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 110.44 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.815 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.8 tm? -61.67 -18.84 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.311 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 108' ' ' VAL . 27.9 t -59.75 -12.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.331 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.11 37.63 3.68 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.284 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.558 ' HG ' HD21 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -62.11 123.63 18.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.503 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -123.07 128.65 50.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.251 0.548 . . . . 0.0 112.412 -179.084 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.636 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.26 -14.91 61.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.399 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.36 -49.41 13.63 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.737 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -31.0 70.94 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.877 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.636 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -90.5 172.28 7.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.095 179.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.504 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.7 Cg_endo -71.45 127.64 13.52 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.12 1.88 . . . . 0.0 111.666 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.8 -14.95 46.05 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.63 2.22 . . . . 0.0 113.153 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.56 -9.58 58.75 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.84 33.78 5.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 111.439 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.49 -34.95 2.01 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.308 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 74.2 Cg_exo -49.69 -45.57 31.01 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 121.87 1.713 . . . . 0.0 113.056 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.6 t -77.6 -51.31 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.987 0.422 . . . . 0.0 111.428 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.617 ' O ' HD23 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -64.89 -34.07 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.634 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 120' ' ' GLU . . . -54.93 -31.19 60.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.861 0.362 . . . . 0.0 110.79 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.05 -53.63 16.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.564 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.793 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -78.72 -30.02 45.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.726 0.298 . . . . 0.0 111.394 -179.556 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.793 ' N ' HD23 ' A' ' 126' ' ' LEU . 5.4 ttpm? -54.65 -42.51 71.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.025 0.44 . . . . 0.0 110.741 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -66.14 -10.51 41.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.624 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.221 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.878 0.37 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -74.0 124.24 25.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -133.65 143.52 48.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.821 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.3 pp -145.94 127.93 15.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.565 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 41.4 mt-30 -102.65 154.07 19.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.337 0.589 . . . . 0.0 112.282 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.461 HG13 " C2'" ' A' ' 131' ' ' 8OG . 27.2 mm -146.55 132.72 13.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.675 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.041 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.45 124.59 42.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.1 m -121.0 162.51 19.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.3 0.571 . . . . 0.0 111.994 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.422 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.2 113.05 0.56 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.738 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.064 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.78 107.95 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.714 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.2 mt -71.43 124.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.049 0.452 . . . . 0.0 111.68 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.76 124.01 32.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.43 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.52 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -79.19 -172.7 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.805 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.488 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.3 tp10 -82.62 2.9 31.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.469 -1.241 . . . . 0.0 112.084 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -135.95 50.32 2.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.797 0.332 . . . . 0.0 111.227 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 p30 45.5 26.68 0.33 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.385 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 13.6 pt-20 -120.39 141.7 49.86 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.064 HG21 HG22 ' A' ' 10' ' ' ILE . 17.6 mt -110.88 140.31 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.154 0.502 . . . . 0.0 111.716 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -89.42 122.6 32.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.689 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.602 HD13 HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -120.04 162.25 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.262 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.434 HG21 ' OE1' ' A' ' 98' ' ' GLU . 3.7 p -95.67 111.8 23.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.57 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 2.4 ptm180 -91.67 83.68 5.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.996 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 40.62 33.0 0.17 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.716 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.23 -79.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.113 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.08 -46.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.947 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -170.7 -83.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.794 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 46.6 38.8 6.03 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.787 0.327 . . . . 0.0 111.454 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 61.57 154.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.74 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 60.27 59.82 2.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.752 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.42 -8.67 52.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.811 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 29.81 0.91 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.556 0.217 . . . . 0.0 111.557 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 26.29 10.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.381 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.545 HD21 ' HB ' ' A' ' 20' ' ' ILE . 2.9 tt -46.84 96.11 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.855 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -114.49 -178.74 3.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.16 0.505 . . . . 0.0 111.711 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.546 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.6 164.23 22.98 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.432 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 19.8 Cg_endo -56.84 167.89 2.75 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.472 2.781 . . . . 0.0 112.012 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.18 59.47 0.76 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.613 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.17 126.79 5.12 Favored Glycine 0 C--N 1.313 -0.742 0 CA-C-N 114.581 -0.81 . . . . 0.0 112.101 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER 109.42 4.55 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.153 0.581 . . . . 0.0 112.125 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.041 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -58.65 -24.35 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.428 0.632 . . . . 0.0 110.791 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.565 ' HB3' ' H ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -49.83 -71.82 0.06 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.094 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.441 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER 23.54 -86.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.611 0.569 . . . . 0.0 112.252 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -159.7 23.82 0.29 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.787 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.24 -177.13 3.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.87 0.367 . . . . 0.0 111.026 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.891 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.68 157.47 38.31 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.872 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.891 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.79 -24.69 0.82 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.717 2.278 . . . . 0.0 112.413 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -85.57 -60.67 1.96 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -80.43 -21.49 42.11 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.84 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -56.73 -48.83 76.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.784 0.326 . . . . 0.0 111.095 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.736 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.4 -46.39 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.6 t -57.12 -36.56 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -78.29 -49.19 14.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.747 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.517 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.2 mm-40 -67.61 -20.0 65.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.992 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.797 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.3 tp -57.17 -44.64 83.72 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.866 0.365 . . . . 0.0 110.529 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -34.68 78.43 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.2 tm-20 -77.46 -24.09 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.873 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -108.47 5.15 25.0 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.949 HG12 HG13 ' A' ' 60' ' ' ILE . 38.5 t -134.65 -44.39 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.142 0.496 . . . . 0.0 109.836 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.99 -40.09 0.26 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.443 -0.798 . . . . 0.0 113.893 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.949 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.68 -176.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.009 0.433 . . . . 0.0 111.089 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.33 88.81 13.45 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.006 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.81 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.3 Cg_endo -110.57 145.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.362 2.708 . . . . 0.0 113.981 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 39.4 mt-30 -74.78 79.78 2.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.006 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.81 128.22 52.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.952 -176.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.4 t80 -179.34 167.89 1.49 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.76 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 14.6 m 84.51 149.14 0.07 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.544 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 pp -107.1 128.46 54.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.298 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.885 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -78.84 -41.29 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.252 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.502 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 10.3 tt0 -171.38 167.07 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.03 132.11 23.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 111.087 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.898 HD22 HG21 ' A' ' 122' ' ' VAL . 0.8 OUTLIER -116.18 122.3 44.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.001 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -120.62 109.78 15.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -141.13 149.26 41.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.674 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.43 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 3.8 pt-20 -121.23 120.52 35.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.125 0.488 . . . . 0.0 111.198 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.493 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -69.98 163.74 58.24 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.354 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -50.94 83.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.221 2.614 . . . . 0.0 112.39 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.7 t70 94.74 16.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.357 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 27.1 ttt180 -137.38 146.44 44.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.641 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 9.4 t-160 -119.68 99.43 6.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.623 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.529 HD12 H2'' ' A' ' 131' ' ' 8OG . 4.9 tt -106.79 121.08 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.093 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.454 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -109.76 122.82 48.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.424 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.673 HD11 ' N3 ' ' A' ' 131' ' ' 8OG . 8.1 mt -126.04 114.97 19.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 111.347 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.467 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.6 m0 -107.82 122.52 46.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.796 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.754 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.4 m-30 -93.37 109.61 21.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.817 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.705 ' CE2' HG11 ' A' ' 50' ' ' VAL . 28.2 m95 -96.82 148.75 22.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.025 0.441 . . . . 0.0 112.083 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 65' ' ' PHE . 7.1 tp -97.58 138.22 35.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.542 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.006 HG22 ' ND1' ' A' ' 64' ' ' HIS . 39.4 t -124.02 146.04 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.37 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -110.52 -26.34 9.54 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.81 164.5 26.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.572 0.624 . . . . 0.0 111.548 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.71 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -157.37 123.48 4.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.381 178.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -73.88 147.2 43.45 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.67 -127.87 43.49 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.58 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 17.1 mt-10 -125.22 146.19 53.17 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.53 0.205 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.58 128.74 10.46 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.827 2.351 . . . . 0.0 111.471 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.552 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.3 p-90 -132.58 -58.19 0.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.669 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.11 -97.11 0.01 OUTLIER Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.923 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.99 31.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.693 0.282 . . . . 0.0 111.172 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.434 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -61.49 -40.78 95.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.78 0.324 . . . . 0.0 110.477 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.85 13.56 60.69 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.8 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -140.31 92.02 9.58 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 117.18 0.49 . . . . 0.0 111.509 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -43.63 132.76 7.54 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.982 2.454 . . . . 0.0 112.688 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.25 177.1 19.42 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.856 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -134.22 157.29 46.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.641 0.257 . . . . 0.0 110.624 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.2 106.97 3.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.844 0.354 . . . . 0.0 110.323 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 18' ' ' ILE . 3.6 ptp -119.95 147.33 44.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.171 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.4 t -66.63 114.87 5.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.66 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -70.97 -28.71 64.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.914 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.432 HG12 HD21 ' A' ' 129' ' ' LEU . 21.5 t -53.25 -23.94 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.06 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.33 42.31 1.62 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.404 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' ' 111' ' ' ASN . 10.4 tt -62.56 150.16 41.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.64 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -116.22 127.67 54.96 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.596 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -14.98 61.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.512 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.44 -49.31 13.69 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.78 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -38.84 87.21 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 110.904 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.611 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.84 173.02 8.38 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.973 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 36.2 Cg_endo -65.7 127.79 18.67 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.087 1.858 . . . . 0.0 111.973 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.48 -21.18 53.59 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.576 2.184 . . . . 0.0 112.956 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.66 -9.59 57.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.85 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.438 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -118.77 34.26 5.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.179 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -75.15 -43.69 4.55 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 85.8 Cg_exo -44.77 -33.16 6.82 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.184 1.923 . . . . 0.0 112.567 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.898 HG21 HD22 ' A' ' 71' ' ' LEU . 49.4 t -77.62 -51.08 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.419 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.837 HG22 ' HB2' ' A' ' 127' ' ' LYS . 12.4 mm -66.25 -30.45 49.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.979 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.73 -27.18 38.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.945 0.403 . . . . 0.0 110.485 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -80.18 -51.34 9.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.69 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.885 HD22 ' CE2' ' A' ' 68' ' ' PHE . 13.0 tp -78.09 -34.61 50.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.818 0.342 . . . . 0.0 111.599 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.837 ' HB2' HG22 ' A' ' 123' ' ' ILE . 42.6 tttp -53.19 -42.72 66.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.08 0.467 . . . . 0.0 111.137 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -73.02 -4.17 30.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.05 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 127' ' ' LYS . 4.4 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.039 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.821 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 5011 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 5012 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ttm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.844 0.354 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.29 128.19 54.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.85 126.33 20.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.761 HD12 ' CD1' ' A' ' 6' ' ' ILE . 0.8 OUTLIER -130.41 136.65 49.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.707 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.77 ' C ' HD13 ' A' ' 6' ' ' ILE . 27.8 mt-30 -102.95 153.29 20.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.335 0.588 . . . . 0.0 112.146 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.832 HD12 " H2'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -146.04 124.64 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.795 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.097 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.74 125.26 43.77 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.743 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.588 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.5 m -115.77 162.09 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.426 0.631 . . . . 0.0 111.867 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.13 111.57 0.58 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.27 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.682 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.85 102.31 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.735 HG22 ' CE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.2 121.46 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 121.125 0.488 . . . . 0.0 111.659 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.469 ' HG2' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -91.29 132.81 35.9 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.629 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.669 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 2.4 p30 -89.04 -173.24 3.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.473 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 8.2 tt0 -79.61 8.93 5.59 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.686 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -132.25 47.17 2.55 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.141 -0.35 . . . . 0.0 111.691 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.1 p30 45.06 25.94 0.19 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.087 0.47 . . . . 0.0 111.507 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.574 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 25.9 mt-10 -116.87 161.19 19.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.842 HD13 HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -118.8 135.68 58.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.052 0.453 . . . . 0.0 111.74 -178.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.481 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -85.78 109.86 18.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.994 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.609 HG22 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.5 140.18 44.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.106 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.423 ' O ' HD23 ' A' ' 33' ' ' LEU . 16.3 p -73.58 111.67 8.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.0 111.195 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.406 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -90.12 83.71 6.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.756 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 43.82 46.23 6.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.387 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 64.97 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.138 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.14 -80.58 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.198 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -177.25 37.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.68 -164.46 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.918 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.02 148.51 7.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.953 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.9 mtp 60.53 53.55 4.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.0 110.554 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.09 -8.82 48.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.904 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.05 30.9 0.9 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.613 0.244 . . . . 0.0 111.437 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -114.41 26.41 10.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 111.43 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -43.89 94.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.787 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -109.37 172.38 6.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.208 0.527 . . . . 0.0 112.076 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.609 ' HB3' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -119.63 163.58 26.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.57 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.402 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 26.3 Cg_endo -61.08 167.71 8.64 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.508 2.805 . . . . 0.0 112.03 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 101.99 59.53 0.77 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.73 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.619 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.15 118.66 2.46 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 114.552 -0.824 . . . . 0.0 111.999 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.619 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.31 2.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.185 0.594 . . . . 0.0 111.682 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.097 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -50.48 -28.92 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.57 0.7 . . . . 0.0 110.568 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.595 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.51 -79.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.964 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp 36.18 -85.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.5 0.5 . . . . 0.0 111.597 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.18 29.67 0.17 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.354 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.426 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 25.7 mp0 -97.32 -178.35 4.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.931 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.33 159.34 32.46 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.995 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.931 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.87 -24.71 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.784 2.322 . . . . 0.0 112.479 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -88.1 -61.22 1.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -80.54 -6.01 57.58 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.912 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.82 -55.13 29.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 110.884 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.916 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.5 m -78.22 -45.19 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.871 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.3 t -56.49 -41.47 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.128 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.32 -46.84 19.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.988 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -69.32 -21.66 63.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.034 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.743 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -55.43 -44.24 76.09 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.823 0.344 . . . . 0.0 110.12 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -34.86 73.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.8 -26.64 49.75 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.394 179.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.03 5.25 25.95 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.942 HG12 HG13 ' A' ' 60' ' ' ILE . 19.9 t -134.79 -44.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.244 0.545 . . . . 0.0 110.053 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.13 -41.27 0.35 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.602 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.942 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.7 -176.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 120.977 0.418 . . . . 0.0 111.038 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.66 88.82 14.33 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.885 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.86 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.2 Cg_endo -110.74 146.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 123.276 2.651 . . . . 0.0 114.35 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 15.9 mt-30 -74.69 80.03 2.04 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.014 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.55 131.9 54.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.549 -175.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.515 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -176.22 -136.97 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.391 -179.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 51.76 172.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.213 0.53 . . . . 0.0 112.258 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.668 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.6 tt -136.97 115.89 12.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.454 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.69 -56.3 4.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.982 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.662 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 mt-10 -171.46 131.51 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.138 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.668 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -125.5 132.1 52.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.716 0.293 . . . . 0.0 110.679 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.708 HD22 ' N ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -124.22 168.29 13.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 110.857 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.708 ' N ' HD22 ' A' ' 71' ' ' LEU . 5.0 tt0 -140.16 123.62 17.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.568 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.9 p90 -141.02 148.61 40.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.279 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -120.98 128.39 52.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 111.487 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -86.48 162.86 44.12 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.193 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.5 Cg_endo -50.11 81.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.0 2.466 . . . . 0.0 112.31 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.4 t70 89.09 12.15 0.07 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.529 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.7 ttt-85 -137.26 93.92 2.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.655 0.264 . . . . 0.0 110.938 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -77.15 108.73 10.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.854 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 2.7 tt -110.8 112.75 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.31 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -96.62 118.85 33.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.115 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.568 HD12 ' CE1' ' A' ' 73' ' ' TYR . 20.6 mt -112.01 114.15 26.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.888 0.375 . . . . 0.0 111.9 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.477 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 8.9 m0 -115.73 122.22 44.85 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.252 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.662 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 7.2 m-30 -106.15 123.08 47.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.97 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.916 ' NE1' HG11 ' A' ' 50' ' ' VAL . 31.5 m95 -105.13 149.0 26.25 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.611 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 86' ' ' LEU . 2.3 tm? -98.7 103.47 15.42 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.597 0.713 . . . . 0.0 112.332 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.014 HG22 ' ND1' ' A' ' 64' ' ' HIS . 20.9 t -82.76 145.85 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.899 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -114.01 -25.38 8.58 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -162.27 160.16 26.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.522 0.601 . . . . 0.0 111.49 -179.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.735 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -153.27 124.3 7.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.364 178.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -74.28 146.69 42.99 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.74 -130.99 51.3 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 37.9 mt-10 -121.32 144.79 40.74 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.572 0.225 . . . . 0.0 110.715 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.513 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.1 Cg_exo -76.66 128.74 10.39 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.934 2.422 . . . . 0.0 111.474 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.559 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.5 p-90 -135.23 -57.96 0.8 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.715 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.595 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.13 -94.56 0.01 OUTLIER Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.005 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 56' ' ' GLU . 4.7 tmtt? -177.23 32.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.767 0.317 . . . . 0.0 111.01 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.78 -38.65 73.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.342 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.81 21.25 63.96 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.337 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -140.23 91.85 9.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.022 0.439 . . . . 0.0 111.448 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -44.02 137.03 7.31 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.975 2.45 . . . . 0.0 112.626 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.16 177.05 19.44 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.874 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -145.07 157.38 44.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.583 0.23 . . . . 0.0 110.538 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.445 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.6 m0 -62.15 106.62 0.75 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.332 . . . . 0.0 110.474 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.445 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.05 147.34 44.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.67 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.04 114.7 12.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.801 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.842 HD22 HD13 ' A' ' 18' ' ' ILE . 30.1 tp -80.15 -18.92 48.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.0 t -50.59 -23.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.535 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.61 48.04 0.98 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.481 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.657 ' HB2' HD12 ' A' ' 107' ' ' LEU . 9.3 tt -62.62 150.22 41.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.63 0.253 . . . . 0.0 110.47 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.02 135.19 54.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.169 0.509 . . . . 0.0 112.163 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.553 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.08 -15.25 62.01 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.493 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.98 -49.24 13.06 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.512 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -33.73 76.12 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.262 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.553 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -84.94 174.05 6.31 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.316 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.474 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.6 Cg_endo -71.05 127.8 14.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.05 1.833 . . . . 0.0 111.764 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.91 -15.02 46.68 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.606 2.204 . . . . 0.0 113.226 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.75 -9.63 58.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.547 HD21 HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -122.08 32.72 5.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.7 0.286 . . . . 0.0 111.303 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.523 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -76.18 -39.19 2.57 Favored Pre-proline 0 C--O 1.223 -0.305 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.049 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 89.4 Cg_exo -44.9 -39.94 14.53 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 121.924 1.749 . . . . 0.0 113.024 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.626 HG22 ' CD1' ' A' ' 71' ' ' LEU . 2.4 t -77.53 -51.03 19.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.999 0.428 . . . . 0.0 110.924 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.547 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.0 mm -64.89 -32.13 56.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.405 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.74 -29.89 54.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.034 0.445 . . . . 0.0 110.497 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -76.49 -49.57 16.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.494 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 126' ' ' LEU . 2.6 tm? -78.18 -31.37 49.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.672 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 123' ' ' ILE . 2.9 ttpm? -54.07 -42.62 69.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.028 0.442 . . . . 0.0 111.01 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -69.99 -7.88 44.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.911 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 127' ' ' LYS . 1.6 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.219 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.832 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 5023 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 5024 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.824 0.345 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.41 107.52 17.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 146.76 28.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.933 HD13 " O3'" ' A' ' 131' ' ' 8OG . 1.7 pp -145.97 134.85 22.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.024 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.449 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 26.1 mt-30 -102.85 151.67 22.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.306 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.495 HG13 " C2'" ' A' ' 131' ' ' 8OG . 21.3 mm -146.64 129.39 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.981 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.085 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.68 125.05 43.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.556 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.592 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.5 m -118.07 161.45 16.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.249 0.547 . . . . 0.0 111.788 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.3 112.1 0.53 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.853 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.475 ' CG2' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -74.45 105.48 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.706 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.1 mt -71.74 124.83 29.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.12 0.486 . . . . 0.0 112.018 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.461 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -93.72 135.57 34.88 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.22 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.657 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.5 p30 -92.74 -173.45 3.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.905 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -75.31 -1.22 22.63 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.83 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -119.5 41.24 3.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.442 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p30 46.9 25.16 0.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.082 0.468 . . . . 0.0 111.201 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.552 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 25.1 mt-10 -114.44 160.94 18.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.751 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -116.85 138.64 46.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.078 0.466 . . . . 0.0 112.019 -178.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.476 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -82.27 99.84 9.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.79 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -116.52 115.41 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.499 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.625 HG21 ' HB2' ' A' ' 100' ' ' GLN . 9.0 t -76.45 123.43 26.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.848 0.356 . . . . 0.0 111.009 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -86.21 83.82 7.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.624 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 46.17 49.53 12.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.173 0.511 . . . . 0.0 110.954 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . 67.45 -86.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.199 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 24' ' ' ALA . . . 179.22 -38.54 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.74 0.305 . . . . 0.0 111.26 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -70.04 65.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.938 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 51.14 -92.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.341 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 m80 44.8 48.78 9.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.811 0.339 . . . . 0.0 111.22 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 mtt 63.09 92.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.654 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.05 -12.16 47.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.755 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.52 13.3 10.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.6 26.3 10.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.941 0.401 . . . . 0.0 111.698 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -48.28 117.86 2.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.856 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.404 ' N ' HD23 ' A' ' 33' ' ' LEU . 32.7 mm-40 -145.06 171.55 14.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.953 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.762 ' CD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.42 167.85 11.26 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 121.004 0.431 . . . . 0.0 111.934 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.4 Cg_endo -47.46 168.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.862 3.041 . . . . 0.0 112.694 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.07 59.99 0.72 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.851 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -131.83 132.62 6.8 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 114.391 -0.905 . . . . 0.0 112.14 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.8 ttmm 92.3 10.47 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.023 0.529 . . . . 0.0 112.388 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.085 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -56.79 -28.27 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.673 0.749 . . . . 0.0 109.993 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.83 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.896 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.98 -84.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.516 0.51 . . . . 0.0 111.709 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.44 32.74 0.1 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.57 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.481 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.3 mt-10 -93.21 -173.72 3.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.698 0.285 . . . . 0.0 111.194 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.878 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.19 154.02 37.85 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.316 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.878 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.99 -24.87 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.819 2.346 . . . . 0.0 112.494 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -103.62 -41.76 5.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.828 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -80.3 -13.6 59.06 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.032 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.05 -52.95 62.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.752 0.31 . . . . 0.0 111.094 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.719 HG11 ' NE1' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -78.28 -44.64 27.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.921 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.2 t -55.87 -42.71 71.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.538 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -78.3 -49.94 12.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.916 0.388 . . . . 0.0 111.269 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -68.4 -20.01 64.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.254 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.67 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -56.71 -45.06 82.07 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 110.103 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -31.88 71.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -76.75 -25.35 53.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.981 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.447 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -106.42 6.59 30.48 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.544 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.967 HG13 HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -133.45 -44.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.135 0.493 . . . . 0.0 109.793 179.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.537 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.67 -37.17 0.17 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.553 -0.749 . . . . 0.0 114.65 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.967 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -85.06 -174.32 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.889 0.376 . . . . 0.0 110.796 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.11 88.59 12.52 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.469 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.642 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.7 Cg_endo -111.13 145.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.471 2.78 . . . . 0.0 113.886 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 11.5 mt-30 -74.86 79.82 2.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.013 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.07 127.43 51.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.596 -176.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 86' ' ' LEU . 17.4 t80 179.85 168.15 1.22 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 82.28 149.83 0.09 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.696 179.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -105.69 128.76 53.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 111.077 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' HE2' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -80.5 -38.36 29.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.426 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 2.0 tt0 -171.29 160.65 6.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.336 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -143.25 132.2 22.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.968 0.414 . . . . 0.0 111.233 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.672 ' HB2' HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -117.11 130.2 56.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.431 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -123.15 109.97 14.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.562 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -141.17 150.58 42.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.731 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.26 123.09 41.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.125 0.488 . . . . 0.0 111.121 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.473 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -69.99 163.15 63.61 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.46 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.8 Cg_endo -52.36 82.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.028 2.485 . . . . 0.0 112.097 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 8.8 t70 96.19 15.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.152 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -137.35 149.91 47.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.635 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -120.35 93.98 4.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.453 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.527 HD12 H2'' ' A' ' 131' ' ' 8OG . 4.6 tt -100.56 111.94 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.23 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.3 118.73 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.24 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 122' ' ' VAL . 5.5 tp -110.84 114.25 27.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 111.336 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -110.34 122.49 47.82 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.547 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.42 ' HA ' HG22 ' A' ' 8' ' ' VAL . 2.8 m-30 -105.37 109.82 21.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.174 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.719 ' NE1' HG11 ' A' ' 50' ' ' VAL . 35.0 m95 -99.39 148.67 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.013 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 65' ' ' PHE . 31.2 tp -96.54 138.6 33.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.571 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.013 HG22 ' ND1' ' A' ' 64' ' ' HIS . 35.1 t -123.61 145.35 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.237 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.66 -24.48 9.62 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.8 tpt180 -162.86 162.39 26.39 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.574 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.706 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.09 123.92 5.09 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.214 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.45 146.17 40.91 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.251 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.3 -126.73 43.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.723 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' ILE . 22.7 mt-10 -125.15 143.74 45.19 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 110.486 -0.19 . . . . 0.0 110.486 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.425 ' HA ' ' CG1' ' A' ' 60' ' ' ILE . 3.9 Cg_exo -76.48 128.64 10.48 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.713 2.275 . . . . 0.0 111.434 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.537 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 64.3 p-90 -131.93 -56.69 0.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.787 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.593 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.92 -95.04 0.01 OUTLIER Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.111 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -179.1 33.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.653 0.263 . . . . 0.0 111.196 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -76.8 -37.1 56.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.98 0.419 . . . . 0.0 110.243 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.13 30.1 51.85 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.101 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.625 ' HB2' HG21 ' A' ' 21' ' ' THR . 5.0 mt-30 -140.35 91.63 9.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.055 0.455 . . . . 0.0 111.503 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -47.59 133.55 21.21 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.096 2.531 . . . . 0.0 112.428 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.07 177.09 19.4 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.914 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 105' ' ' MET . 2.6 mt-10 -142.5 157.81 44.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.539 0.209 . . . . 0.0 110.491 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.491 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.3 m0 -66.63 106.59 1.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 2.9 mmm -119.89 148.19 43.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.944 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.04 114.78 8.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.8 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.751 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -67.0 -28.28 68.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.828 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.1 p -55.49 -22.79 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -109.84 34.38 5.49 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.497 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.52 HD13 HD22 ' A' ' 107' ' ' LEU . 9.6 tp -62.78 139.52 58.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.03 131.26 53.63 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.4 -15.14 61.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.547 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -78.62 -49.44 13.21 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.703 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -35.75 79.74 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 111.225 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.92 174.13 6.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.127 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.499 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 53.7 Cg_endo -70.11 127.75 14.75 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.026 1.818 . . . . 0.0 111.705 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.93 -15.04 46.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.6 2.2 . . . . 0.0 113.085 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.19 -9.46 58.74 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.485 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -120.37 31.91 6.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.747 0.308 . . . . 0.0 111.426 -178.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -73.14 -36.28 3.19 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.621 ' HB2' HD13 ' A' ' 71' ' ' LEU . 70.4 Cg_exo -50.98 -44.97 39.04 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 121.92 1.747 . . . . 0.0 112.699 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.8 t -77.41 -51.21 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 111.097 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.587 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.8 mm -62.83 -32.9 57.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.232 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.02 -33.72 62.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.08 0.467 . . . . 0.0 110.553 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -66.84 -49.65 65.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.843 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 126' ' ' LEU . 0.7 OUTLIER -78.14 -26.07 47.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.144 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.455 ' O ' HD12 ' A' ' 129' ' ' LEU . 3.1 ttpm? -58.21 -42.6 86.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.002 0.43 . . . . 0.0 110.778 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.6 ttm-85 -73.86 -5.32 40.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.953 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.828 HD21 ' O ' ' A' ' 108' ' ' VAL . 1.7 mp . . . . . 0 N--CA 1.461 0.095 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.325 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.933 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 5035 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 5036 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mtt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.808 0.337 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -89.54 138.52 31.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.97 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.27 37.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.922 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.9 pp -145.98 122.53 11.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.7 mt-30 -102.69 148.38 25.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.347 0.594 . . . . 0.0 111.888 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.557 ' HB ' HD23 ' A' ' 82' ' ' LEU . 31.5 mm -146.48 130.77 10.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.833 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.093 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.43 124.46 42.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.608 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -118.63 162.94 16.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.235 0.54 . . . . 0.0 111.933 -179.387 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.0 112.83 0.55 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.402 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.976 ' CG2' HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -70.79 105.68 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.389 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.852 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.2 mt -71.54 124.0 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.438 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -85.28 126.86 34.04 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.456 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 24.8 t-20 -70.43 177.37 3.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.119 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.528 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 8.8 tt0 -56.62 -18.58 12.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.404 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -120.55 -82.74 0.65 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.615 0.245 . . . . 0.0 111.243 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.73 15.54 0.36 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.616 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 3.6 mt-10 -100.93 160.39 14.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.976 HG21 ' CG2' ' A' ' 10' ' ' ILE . 3.4 mt -138.12 140.72 39.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.014 0.435 . . . . 0.0 111.609 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -89.75 116.46 27.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.375 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.61 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -113.36 125.59 70.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.419 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.827 HG21 ' HG3' ' A' ' 98' ' ' GLU . 15.0 p -75.46 111.85 11.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.82 0.343 . . . . 0.0 110.495 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' ALA . 45.3 ttp180 -96.86 170.36 9.22 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 7.7 tpt180 -69.84 59.96 0.16 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.165 0.507 . . . . 0.0 109.95 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . 58.32 -171.32 0.11 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.278 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.03 -71.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.145 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -160.49 155.35 24.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.975 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -175.52 -76.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -145.39 -62.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.763 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.6 ptp -94.32 52.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.735 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . . . -73.05 -8.65 56.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.654 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -92.32 29.37 1.69 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.563 0.221 . . . . 0.0 111.476 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -114.54 26.32 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 111.585 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.61 HD21 ' HB ' ' A' ' 20' ' ' ILE . 2.7 tt -45.42 122.71 3.67 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.812 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.573 ' N ' HD23 ' A' ' 33' ' ' LEU . 53.6 mt-10 -145.96 -175.32 4.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.894 0.378 . . . . 0.0 111.443 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.608 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.07 162.09 35.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.239 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.685 ' HD3' HG23 ' A' ' 21' ' ' THR . 10.3 Cg_endo -50.09 167.91 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.387 2.725 . . . . 0.0 111.715 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.23 59.47 0.76 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.825 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.615 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.54 120.01 2.74 Favored Glycine 0 C--N 1.312 -0.78 0 CA-C-N 114.791 -0.705 . . . . 0.0 112.023 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.615 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 114.09 3.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.313 0.645 . . . . 0.0 111.937 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.093 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -53.64 -26.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.43 0.633 . . . . 0.0 110.569 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.12 -82.62 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.143 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 34.87 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.39 0.432 . . . . 0.0 111.886 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.89 31.24 0.14 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.623 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.455 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -91.24 -174.38 3.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.75 0.31 . . . . 0.0 111.189 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.888 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.68 154.85 36.94 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.352 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.888 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.8 Cg_endo -44.53 -24.86 1.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.735 2.29 . . . . 0.0 112.603 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.741 ' O ' HG23 ' A' ' 51' ' ' VAL . 11.6 mt-10 -102.2 -42.91 5.88 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -80.22 -16.07 55.6 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.916 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.08 -50.49 73.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.146 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.761 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -78.1 -45.11 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.798 0.332 . . . . 0.0 110.884 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.2 t -53.71 -37.92 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -51.99 9.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.018 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.8 mm-40 -63.97 -22.07 66.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.907 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.762 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.0 OUTLIER -56.47 -44.62 80.75 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.979 0.419 . . . . 0.0 110.409 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -62.96 -34.64 77.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.6 tm-20 -77.47 -25.0 50.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.14 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.453 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 69.2 mm-40 -108.15 5.36 25.82 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.953 HG12 HG13 ' A' ' 60' ' ' ILE . 31.4 t -134.71 -44.26 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.183 0.516 . . . . 0.0 109.793 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.83 -41.1 0.32 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.711 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.953 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.66 -176.53 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.016 0.436 . . . . 0.0 111.057 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.04 88.87 12.76 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.991 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.852 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.1 Cg_endo -109.48 145.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.287 2.658 . . . . 0.0 113.917 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 11.8 mt-30 -74.78 79.76 2.08 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.996 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.81 128.06 52.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.926 -176.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.7 t80 -179.22 168.46 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 111.991 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 2.3 p 83.07 158.0 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.827 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -110.83 137.9 47.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -94.92 -32.46 13.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.264 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.491 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 17.8 tt0 -171.38 155.57 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.51 132.03 22.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.711 0.291 . . . . 0.0 110.95 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.068 HD22 HG21 ' A' ' 122' ' ' VAL . 2.5 pt? -129.19 132.36 47.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.851 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -127.28 109.93 12.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.558 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.444 ' OH ' HD12 ' A' ' 82' ' ' LEU . 3.0 p90 -132.24 153.04 51.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.491 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 5.4 pt-20 -118.74 138.61 52.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.158 0.504 . . . . 0.0 111.406 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -98.81 163.06 19.59 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.209 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 6.0 Cg_endo -48.09 81.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.11 2.54 . . . . 0.0 112.342 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 m-20 85.61 13.55 0.18 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.586 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.564 ' NE ' HD21 ' A' ' 4' ' ' LEU . 8.9 ttt180 -137.44 93.83 2.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 0.0 110.998 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.434 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 64.4 t-80 -75.02 112.47 11.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.573 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.428 HD13 ' OH ' ' A' ' 73' ' ' TYR . 3.7 tt -109.7 112.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.325 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.411 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -102.11 124.03 47.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.241 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.656 HD21 ' N3 ' ' A' ' 131' ' ' 8OG . 20.6 mt -126.02 114.93 19.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.863 0.364 . . . . 0.0 111.607 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.411 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.4 m0 -106.48 122.48 46.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.523 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.3 m-85 -99.07 109.66 22.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.211 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.68 ' NE1' HG11 ' A' ' 50' ' ' VAL . 25.5 m95 -97.24 148.66 22.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.19 0.519 . . . . 0.0 112.358 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 65' ' ' PHE . 25.0 tp -95.94 138.68 33.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.132 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.996 HG22 ' ND1' ' A' ' 64' ' ' HIS . 33.2 t -123.47 145.88 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.459 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.3 -24.59 9.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 5.4 tpt180 -162.64 162.43 27.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.548 0.613 . . . . 0.0 111.544 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.744 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -155.08 124.91 6.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.24 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.43 148.32 39.22 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.33 -129.27 43.21 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.54 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 49.3 mt-10 -122.73 144.16 41.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.573 0.225 . . . . 0.0 110.678 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.51 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.43 128.72 10.57 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.778 2.319 . . . . 0.0 111.493 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.555 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -132.41 -58.02 0.94 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.649 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.536 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.72 -99.61 0.02 OUTLIER Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.924 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 175.0 38.49 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.6 0.238 . . . . 0.0 111.209 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.827 ' HG3' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -70.53 -11.73 61.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.714 0.292 . . . . 0.0 111.253 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.74 20.17 68.03 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.378 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.426 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 8.1 mm-40 -140.48 97.51 7.48 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.84 0.352 . . . . 0.0 111.384 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.62 132.71 7.53 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.836 2.357 . . . . 0.0 112.51 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.05 177.12 19.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.823 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -149.49 157.27 43.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.529 0.204 . . . . 0.0 110.516 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -71.24 106.78 3.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.824 0.345 . . . . 0.0 110.116 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.3 ptp -119.86 152.06 37.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.724 ' HB2' HG12 ' A' ' 108' ' ' VAL . 23.2 p -75.26 114.89 14.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.606 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.966 HD12 HD13 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -57.92 -20.56 38.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.24 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.724 HG12 ' HB2' ' A' ' 106' ' ' SER . 9.9 p -52.67 -21.24 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.48 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.36 31.92 8.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.678 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.96 HD23 ' CD2' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -62.51 126.97 29.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.64 0.257 . . . . 0.0 110.324 179.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.728 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -123.33 130.63 52.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.17 -14.7 61.88 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.146 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -78.31 -49.01 14.43 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.617 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -39.8 88.33 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.75 0.309 . . . . 0.0 110.913 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -79.06 172.1 10.78 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.995 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.534 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.7 Cg_endo -70.77 127.33 13.65 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 121.976 1.784 . . . . 0.0 111.404 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.57 -14.84 42.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.617 2.212 . . . . 0.0 113.275 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.65 -9.32 58.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.98 36.7 4.55 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -69.75 -41.03 14.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 53.2 Cg_exo -55.23 -40.58 84.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.052 1.835 . . . . 0.0 112.625 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 1.068 HG21 HD22 ' A' ' 71' ' ' LEU . 5.5 t -77.44 -51.26 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.548 . . . . 0.0 110.793 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.533 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.8 OUTLIER -66.12 -29.87 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.187 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.85 -31.97 60.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.049 0.452 . . . . 0.0 110.226 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -52.35 57.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.886 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 68' ' ' PHE . 3.1 tp -78.12 -29.81 49.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.24 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -55.98 -42.56 76.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.831 ' O ' HD12 ' A' ' 129' ' ' LEU . 51.7 ttp180 -74.22 -4.78 38.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.115 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.189 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.922 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 5047 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 5048 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 mtt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.774 0.321 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -79.93 133.34 36.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.03 131.91 27.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.912 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.0 pp -146.17 118.98 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 28.7 mt-30 -101.91 156.76 17.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.265 0.555 . . . . 0.0 112.219 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.869 HD11 HD12 ' A' ' 4' ' ' LEU . 1.7 mp -146.19 130.76 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.575 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.027 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.44 124.43 42.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -127.99 158.36 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.915 0.388 . . . . 0.0 111.724 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.443 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.25 137.5 6.06 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.966 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.024 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -86.22 111.97 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.729 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.5 mt -71.68 123.74 26.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.54 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -84.32 122.77 29.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.484 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.515 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.0 t-20 -79.65 -172.69 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.855 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.482 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -82.74 0.61 42.75 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.935 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -136.98 50.58 2.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.911 0.386 . . . . 0.0 111.241 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.51 26.38 0.5 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.263 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 16.1 pt-20 -116.82 153.25 32.8 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.024 HG21 HG22 ' A' ' 10' ' ' ILE . 5.2 mt -130.36 142.17 44.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 0.0 111.588 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.91 123.16 35.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.854 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.687 HD11 ' HG2' ' A' ' 105' ' ' MET . 0.5 OUTLIER -113.69 124.77 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.531 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 21' ' ' THR . 1.6 t -72.44 111.71 7.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 0.0 110.718 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.439 ' HA ' HD23 ' A' ' 33' ' ' LEU . 20.3 ptt180 -95.45 172.07 8.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.859 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.557 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -62.87 -12.2 23.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 78.5 0.57 2.58 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.813 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 30' ' ' ALA . . . 50.03 29.69 3.64 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.785 0.326 . . . . 0.0 111.433 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -87.84 75.25 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.949 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 57.18 31.31 19.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.178 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -141.3 178.65 7.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.6 mtt -59.97 91.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 25' ' ' ALA . . . -71.35 -8.91 56.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.641 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -93.19 23.4 4.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.575 0.226 . . . . 0.0 111.458 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.33 26.2 10.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 111.394 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.638 HD11 HD13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -43.35 116.55 0.95 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.403 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -170.85 2.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.24 0.543 . . . . 0.0 112.056 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.51 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.77 165.69 16.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.097 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 47.5 Cg_endo -67.7 167.51 20.91 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.087 2.525 . . . . 0.0 111.533 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.09 59.13 0.77 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.806 -1.188 . . . . 0.0 113.914 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -123.39 127.32 6.56 Favored Glycine 0 C--N 1.311 -0.828 0 CA-C-N 114.841 -0.68 . . . . 0.0 112.021 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER 100.39 6.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.142 0.577 . . . . 0.0 112.211 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.027 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -50.34 -29.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.744 0.783 . . . . 0.0 110.118 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.582 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.86 -81.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.22 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.6 mmt 40.16 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.269 0.356 . . . . 0.0 111.548 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.0 29.83 0.14 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.669 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -95.07 -173.31 2.92 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.736 0.303 . . . . 0.0 111.122 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.912 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.95 158.01 34.12 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.37 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.912 ' HD2' HG22 ' A' ' 45' ' ' THR . 5.9 Cg_endo -46.74 -24.71 3.14 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.668 2.245 . . . . 0.0 112.375 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.755 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mm-40 -101.54 -44.19 5.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.888 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -80.19 -12.63 59.62 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.951 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -60.54 -54.02 50.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.898 0.38 . . . . 0.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.807 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.0 OUTLIER -78.14 -44.21 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.587 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.7 t -50.52 -37.77 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.37 . . . . 0.0 110.805 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -78.6 -49.49 13.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.791 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.0 -19.83 66.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.036 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.814 HD21 ' NE2' ' A' ' 64' ' ' HIS . 2.7 tp -59.53 -44.71 93.11 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.18 -34.21 77.55 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 97' ' ' LYS . 5.5 tm-20 -77.35 -24.13 50.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.832 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.484 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 50.3 mm-40 -108.29 5.66 25.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.911 HG12 HG13 ' A' ' 60' ' ' ILE . 41.7 t -134.2 -44.27 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.166 0.508 . . . . 0.0 109.656 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.541 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.89 -39.74 0.25 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.397 -0.819 . . . . 0.0 113.994 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.911 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.7 -177.43 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.018 0.437 . . . . 0.0 111.026 -179.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.83 88.54 14.31 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.807 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.758 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.0 Cg_endo -111.71 145.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 123.406 2.737 . . . . 0.0 113.994 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 36.7 mt-30 -74.86 79.63 2.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 175.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.994 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -120.11 128.67 53.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.832 -176.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.8 t80 -179.51 168.71 1.42 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.981 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER 83.91 155.66 0.1 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.675 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.0 pp -113.84 123.11 49.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.212 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.83 -38.19 54.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.074 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -171.3 141.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.349 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.46 132.18 22.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.671 0.272 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.745 HD23 HG22 ' A' ' 122' ' ' VAL . 4.4 pp -124.46 164.69 19.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.315 . . . . 0.0 110.954 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -139.77 116.91 11.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.802 ' OH ' HD11 ' A' ' 80' ' ' ILE . 2.2 p90 -141.15 153.07 45.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 6.8 pt-20 -118.34 124.28 47.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 111.319 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.0 163.22 61.32 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.477 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.487 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -52.8 82.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.989 2.459 . . . . 0.0 112.19 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 7.7 t0 90.92 10.73 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.479 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.449 ' CD ' HD21 ' A' ' 4' ' ' LEU . 6.6 ttp180 -137.36 95.89 3.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.294 . . . . 0.0 110.809 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.414 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.8 t-80 -80.4 106.58 12.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.263 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.802 HD11 ' OH ' ' A' ' 73' ' ' TYR . 3.6 pt -120.39 127.09 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.131 0.491 . . . . 0.0 112.119 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.26 118.68 34.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.041 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.679 HD21 ' OD1' ' A' ' 119' ' ' ASN . 4.4 tp -104.78 113.7 27.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 110.965 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.402 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 9.6 m0 -115.58 122.52 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.053 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.705 ' CD2' HG11 ' A' ' 122' ' ' VAL . 3.1 m-30 -105.32 109.68 21.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.702 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.807 ' CE2' HG11 ' A' ' 50' ' ' VAL . 66.0 m95 -94.85 148.67 22.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.307 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 65' ' ' PHE . 65.6 tp -94.52 138.28 32.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.917 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.994 HG22 ' ND1' ' A' ' 64' ' ' HIS . 27.0 t -123.96 145.81 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.418 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -112.82 -24.57 9.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.477 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -162.79 160.73 25.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.595 0.634 . . . . 0.0 111.484 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.701 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.19 121.66 4.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.164 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -77.21 155.31 32.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.214 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.37 -132.78 46.42 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.619 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.2 mt-10 -122.2 147.06 48.44 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.577 0.227 . . . . 0.0 110.694 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.51 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.62 128.64 10.36 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.85 2.367 . . . . 0.0 111.353 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.541 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 63.4 p-90 -136.59 -58.84 0.73 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.892 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.59 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.49 -96.4 0.01 OUTLIER Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.939 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.7 tmtt? 177.67 33.87 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.584 0.231 . . . . 0.0 111.173 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -29.01 68.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.7 0.286 . . . . 0.0 110.679 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.91 -2.12 71.91 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.719 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -140.12 95.46 8.43 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.259 0.529 . . . . 0.0 111.556 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -43.71 141.04 4.19 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.909 2.406 . . . . 0.0 112.497 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.23 171.56 22.14 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.871 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.55 157.17 39.5 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.53 106.44 6.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.898 0.38 . . . . 0.0 110.523 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.687 ' HG2' HD11 ' A' ' 20' ' ' ILE . 5.1 ppp? -120.28 155.87 32.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.041 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.2 t -70.3 114.93 8.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.579 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.625 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.51 -18.98 60.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.341 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.651 ' O ' HD21 ' A' ' 129' ' ' LEU . 15.5 t -57.45 -16.88 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.458 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -123.06 43.54 1.43 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.432 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.601 HD22 HD11 ' A' ' 107' ' ' LEU . 12.7 tp -62.4 146.98 49.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.11 126.81 47.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.6 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.33 -15.16 61.88 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.733 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -78.28 -49.39 13.77 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -39.03 87.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.982 0.42 . . . . 0.0 110.857 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -80.11 173.82 7.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.341 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.2 Cg_endo -72.26 127.76 13.04 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.162 1.908 . . . . 0.0 111.697 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.89 -14.95 44.24 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 113.061 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.42 58.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.679 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.1 m-80 -121.67 32.6 5.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.695 0.283 . . . . 0.0 111.488 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.454 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.3 mt-10 -73.77 -46.88 6.98 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 80.9 Cg_exo -44.8 -35.05 9.19 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.33 2.02 . . . . 0.0 112.525 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.745 HG22 HD23 ' A' ' 71' ' ' LEU . 12.5 t -77.35 -43.39 30.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.066 0.46 . . . . 0.0 110.127 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.785 HG22 ' HB2' ' A' ' 127' ' ' LYS . 15.5 mm -67.65 -34.41 67.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.888 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.4 -26.61 31.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.983 0.421 . . . . 0.0 110.465 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.13 -52.72 7.44 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.712 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.16 -33.48 50.25 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.725 0.298 . . . . 0.0 111.519 -179.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.843 ' N ' HD23 ' A' ' 126' ' ' LEU . 6.0 ttpm? -53.57 -42.67 67.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.969 0.414 . . . . 0.0 111.058 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -69.37 -7.92 41.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.87 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.651 HD21 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.33 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.912 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 5059 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 5060 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 mtm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.795 0.331 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.22 131.53 41.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.768 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -140.08 131.65 27.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.847 HD21 ' NE ' ' A' ' 78' ' ' ARG . 3.4 pp -126.02 127.53 46.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.837 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -102.96 152.2 21.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.182 0.515 . . . . 0.0 111.255 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.858 ' HB ' HD23 ' A' ' 82' ' ' LEU . 2.7 mp -143.9 139.02 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.355 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.978 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -125.16 125.46 43.73 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -134.53 151.43 31.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.363 0.602 . . . . 0.0 111.833 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.46 122.11 1.3 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.907 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.033 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -71.56 114.26 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.712 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.31 121.7 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.024 0.44 . . . . 0.0 111.553 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.418 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.7 119.41 24.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.5 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.546 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.1 t-20 -79.04 -172.64 3.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.967 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.51 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 1.1 tm-20 -81.43 0.91 35.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.118 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -139.47 52.28 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 111.27 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.8 p30 45.61 26.59 0.34 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.358 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 16.4 pt-20 -117.23 151.41 36.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.033 HG21 HG22 ' A' ' 10' ' ' ILE . 4.3 mt -127.93 146.78 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.034 0.445 . . . . 0.0 111.655 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.454 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -97.24 121.76 39.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.855 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.954 HD13 HD11 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -116.71 141.19 35.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.17 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 p -80.2 125.45 29.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.778 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.473 ' CA ' HD23 ' A' ' 33' ' ' LEU . 31.1 ttt180 -112.9 167.66 10.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.621 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.96 62.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.028 0.442 . . . . 0.0 110.431 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 45.98 -165.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.433 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.8 -29.29 8.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.246 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -106.34 129.72 54.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.986 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.55 -174.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.252 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 62.77 147.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.4 mtm -59.45 95.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.28 -10.47 54.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.76 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.58 16.95 8.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.525 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -114.23 26.0 10.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 111.472 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.954 HD11 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -46.13 101.63 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.585 179.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -110.26 -169.34 1.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.03 0.443 . . . . 0.0 111.451 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.75 162.59 32.07 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.58 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 36.8 Cg_endo -64.59 168.08 13.9 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.559 2.839 . . . . 0.0 111.989 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.784 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.41 59.17 0.76 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.872 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.611 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -127.64 127.73 5.89 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 114.242 -0.979 . . . . 0.0 111.688 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 111.7 -10.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.317 0.647 . . . . 0.0 110.974 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.978 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -43.67 -74.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.848 0.356 . . . . 0.0 110.804 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.548 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER 6.31 -82.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.107 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 36.32 -141.29 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.373 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.9 11.27 9.44 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.077 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -169.08 0.29 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.585 0.231 . . . . 0.0 110.683 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.879 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.17 155.33 38.72 Favored Pre-proline 0 N--CA 1.454 -0.25 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.879 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.74 -24.59 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.584 2.19 . . . . 0.0 112.226 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -89.6 -59.85 2.1 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.127 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -80.85 -4.84 56.19 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -66.04 -57.26 8.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.638 0.256 . . . . 0.0 111.178 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.705 HG23 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -78.55 -41.16 24.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.158 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 47' ' ' GLU . 73.6 t -50.42 -35.62 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 0.0 110.811 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -78.35 -52.05 9.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.053 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.44 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 1.1 tm-20 -62.18 -23.37 66.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.763 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.779 HD21 ' NE2' ' A' ' 64' ' ' HIS . 2.2 tp -57.45 -44.66 84.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.782 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -62.74 -27.9 69.59 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.25 -27.03 53.13 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.001 179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.433 ' HG2' ' H ' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -108.69 6.15 25.49 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.943 HG12 HG13 ' A' ' 60' ' ' ILE . 25.4 t -133.51 -44.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.017 0.437 . . . . 0.0 109.928 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.95 -39.02 0.19 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.636 -0.711 . . . . 0.0 114.018 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.943 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.58 -176.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.979 0.419 . . . . 0.0 110.984 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.25 88.72 13.09 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.117 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.841 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.4 Cg_endo -111.41 144.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.426 2.75 . . . . 0.0 114.146 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 35.1 mt-30 -74.82 79.93 2.1 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.998 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.49 129.09 53.7 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.654 -175.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -177.77 -138.25 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.503 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.73 163.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.162 0.506 . . . . 0.0 112.045 179.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.1 tt -124.55 109.82 13.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.749 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.87 -43.43 35.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.164 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.4 tt0 -171.63 163.66 6.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.429 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.33 114.19 7.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.88 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.7 ' HB2' HG22 ' A' ' 122' ' ' VAL . 15.7 tp -102.73 121.93 43.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.811 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -124.54 109.79 13.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.596 ' HE1' HD12 ' A' ' 82' ' ' LEU . 2.5 p90 -141.09 152.1 44.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.635 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -121.17 118.82 30.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.047 0.451 . . . . 0.0 111.332 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -69.9 163.64 58.81 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.281 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -52.37 83.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.066 2.511 . . . . 0.0 112.362 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 4.6 t70 98.02 14.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.387 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.847 ' NE ' HD21 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -137.36 147.14 45.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.67 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.25 96.06 4.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.54 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.449 HD13 HH12 ' A' ' 78' ' ' ARG . 1.1 tt -102.81 115.37 44.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 0.0 111.196 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.14 118.92 37.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.22 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' A' ' 6' ' ' ILE . 16.6 mt -118.69 114.57 22.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 111.489 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -104.81 122.51 45.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.217 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.451 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 4.4 m-30 -103.54 109.84 21.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.016 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.599 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 44.6 m95 -94.84 148.58 22.15 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.675 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 86' ' ' LEU . 2.9 tm? -101.28 102.92 13.88 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.399 0.619 . . . . 0.0 111.75 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.998 HG22 ' ND1' ' A' ' 64' ' ' HIS . 15.0 t -79.39 145.71 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.691 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -115.19 -23.02 9.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.8 OUTLIER -162.37 160.22 26.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.6 0.637 . . . . 0.0 111.556 -179.029 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.712 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.08 121.47 4.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.124 178.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.56 148.78 42.67 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.198 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.53 -128.93 47.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.589 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.0 mt-10 -123.57 147.57 53.35 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.615 0.245 . . . . 0.0 110.641 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.47 128.71 10.53 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.793 2.329 . . . . 0.0 111.105 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.571 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.2 p-90 -135.5 -62.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.546 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.564 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.06 -97.75 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.614 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.9 tttp 171.32 34.98 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.578 0.228 . . . . 0.0 111.344 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -29.21 64.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.74 0.305 . . . . 0.0 110.568 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.44 64.72 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.374 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -140.18 94.78 8.6 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.007 0.432 . . . . 0.0 111.441 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.61 138.67 5.36 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.996 2.464 . . . . 0.0 112.398 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.07 19.43 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.915 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -142.06 157.31 45.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.58 0.229 . . . . 0.0 110.447 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -69.38 106.99 3.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.881 0.372 . . . . 0.0 110.332 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtt -119.68 163.13 17.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 p -80.36 114.75 19.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -80.23 -27.09 38.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.149 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -51.96 -23.46 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.493 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.21 44.62 1.22 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.591 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.57 150.24 41.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.588 0.232 . . . . 0.0 110.387 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.95 133.4 56.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.21 0.528 . . . . 0.0 112.344 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.15 -15.39 61.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.567 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.59 -49.13 13.8 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.538 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -33.8 76.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.849 0.357 . . . . 0.0 111.002 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -86.91 173.44 6.66 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.458 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.4 Cg_endo -67.7 127.69 16.71 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 121.947 1.765 . . . . 0.0 111.967 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.87 -20.56 58.24 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.519 2.146 . . . . 0.0 112.922 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.83 -9.49 58.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.92 30.38 7.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.797 0.332 . . . . 0.0 111.397 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.611 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -76.23 -32.01 1.05 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.3 Cg_exo -49.22 -43.52 36.9 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 121.957 1.771 . . . . 0.0 113.088 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.7 t -77.56 -51.32 18.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.0 111.542 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.569 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -65.95 -34.75 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.541 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -28.76 50.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -74.81 -53.26 9.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.629 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.78 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.2 tp -78.57 -32.97 48.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.638 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.569 ' HB2' HG22 ' A' ' 123' ' ' ILE . 4.0 tttm -53.85 -42.65 68.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.967 0.413 . . . . 0.0 111.019 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -65.94 -10.79 42.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.731 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.78 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.3 mp . . . . . 0 C--O 1.231 0.111 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.048 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.643 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 5071 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 5072 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.823 0.344 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.03 147.03 43.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -137.64 143.14 41.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.77 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.9 pp -146.14 120.09 9.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.757 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.763 ' C ' HD13 ' A' ' 6' ' ' ILE . 7.8 mt-30 -102.12 155.48 18.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.371 0.605 . . . . 0.0 111.918 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.808 HD12 " H2'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -146.24 121.73 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.855 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.012 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -122.19 124.78 44.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.469 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.694 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -121.36 162.92 19.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.325 0.583 . . . . 0.0 111.952 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -145.99 120.66 1.35 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.987 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.947 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.81 105.52 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.741 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.5 mt -71.37 121.81 22.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 0.0 111.668 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.31 127.64 34.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.77 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.527 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.0 t-20 -83.63 -172.53 4.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.636 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.482 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 28.1 tt0 -83.95 5.66 24.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.141 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -141.25 52.66 1.56 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.0 111.367 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.0 p30 45.46 25.15 0.21 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.57 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 16.4 pt-20 -117.69 144.95 44.76 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.947 HG21 HG22 ' A' ' 10' ' ' ILE . 9.8 mt -115.13 135.94 53.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.248 0.546 . . . . 0.0 111.978 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -80.8 116.55 20.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.943 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.876 HG23 ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -116.94 131.14 70.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.754 HG23 ' HD3' ' A' ' 36' ' ' PRO . 62.9 p -71.92 111.87 7.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' C ' ' H ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -91.09 172.27 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.146 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.11 28.5 0.12 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.791 0.329 . . . . 0.0 110.733 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 22' ' ' ARG . . . 56.36 20.96 5.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.62 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.98 25.08 3.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.478 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 p30 178.83 89.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.011 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -175.56 76.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.134 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.12 -79.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.16 100.31 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.836 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.54 -8.82 56.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.741 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -93.46 31.2 1.56 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.703 0.287 . . . . 0.0 111.395 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -113.92 26.27 10.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.094 0.473 . . . . 0.0 111.401 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 34' ' ' GLU . 1.2 tt -47.45 127.88 11.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.772 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.781 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -156.53 -173.91 4.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 111.496 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.876 ' CD2' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.94 162.71 31.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.469 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.754 ' HD3' HG23 ' A' ' 21' ' ' THR . 10.6 Cg_endo -51.55 168.72 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.534 2.823 . . . . 0.0 111.657 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 7' ' ' ALA . . . 102.94 59.41 0.74 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.923 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.635 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -130.05 116.28 2.04 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.53 -0.835 . . . . 0.0 111.683 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.69 5.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.224 0.61 . . . . 0.0 111.682 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.017 HD12 ' HB1' ' A' ' 49' ' ' ALA . 1.2 pt -50.71 -28.92 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.572 0.701 . . . . 0.0 110.275 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.583 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.94 -79.42 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.151 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' GLU . 56.6 mmm 30.83 -86.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.566 0.541 . . . . 0.0 112.054 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.84 32.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.524 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.2 mp0 -87.16 -174.8 5.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.827 0.346 . . . . 0.0 111.161 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.857 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.69 154.08 37.62 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.353 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.857 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.82 -26.33 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.835 2.357 . . . . 0.0 112.548 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 51' ' ' VAL . 8.8 mt-10 -104.2 -38.72 6.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.746 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -80.29 -11.72 59.69 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.017 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.01 -53.02 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.0 111.072 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.905 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.7 m -78.23 -45.87 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.9 t -56.04 -37.94 51.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.04 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -78.28 -47.2 18.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.629 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.66 -21.57 65.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.804 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.911 HD21 ' CD2' ' A' ' 64' ' ' HIS . 1.9 tp -55.64 -44.55 77.26 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.871 0.367 . . . . 0.0 110.534 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -34.07 77.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -77.39 -25.82 51.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.072 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.456 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 31.0 mm-40 -108.54 5.52 25.2 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.963 HG12 HG13 ' A' ' 60' ' ' ILE . 25.8 t -134.34 -44.18 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.117 0.484 . . . . 0.0 109.96 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.99 -41.07 0.33 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.696 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.963 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.54 -175.52 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.983 0.421 . . . . 0.0 110.965 -179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.3 89.0 11.48 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.29 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.896 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.8 Cg_endo -108.78 143.59 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.172 2.581 . . . . 0.0 114.008 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 38.4 mt-30 -74.9 79.87 2.14 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.911 ' CD2' HD21 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -119.28 129.6 54.99 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.682 -176.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.4 t80 178.79 167.41 0.9 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.749 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 87.06 155.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.476 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.864 HD22 ' N ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -102.22 156.44 17.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.05 0.453 . . . . 0.0 110.729 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.864 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.99 -42.81 2.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.866 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' OE2' HG13 ' A' ' 122' ' ' VAL . 1.6 tt0 -171.76 162.1 6.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.186 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -143.36 132.08 22.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.75 0.309 . . . . 0.0 110.71 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.755 HD23 ' CE1' ' A' ' 73' ' ' TYR . 4.4 tp -124.08 125.8 45.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.597 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -118.05 112.51 20.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.015 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.998 ' CE2' HD11 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -141.08 153.13 45.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.403 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -117.5 140.05 50.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.263 0.554 . . . . 0.0 111.54 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.497 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.8 m-85 -90.22 162.42 34.81 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.347 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.497 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 11.2 Cg_endo -54.53 82.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.884 2.389 . . . . 0.0 112.062 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 13.0 m-20 90.36 12.4 0.05 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.45 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.433 ' CG ' HD23 ' A' ' 4' ' ' LEU . 22.0 ttp180 -137.33 98.82 3.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.396 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -78.56 115.67 18.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.883 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.998 HD11 ' CE2' ' A' ' 73' ' ' TYR . 7.2 pt -118.94 154.27 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.106 0.479 . . . . 0.0 111.7 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.44 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -128.67 118.74 23.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.208 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.519 HD21 ' CE1' ' A' ' 84' ' ' PHE . 5.9 tp -106.28 114.31 28.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.0 111.592 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.448 ' CH2' ' HA ' ' A' ' 46' ' ' PRO . 6.7 m0 -112.11 122.63 48.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.088 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.519 ' CE1' HD21 ' A' ' 82' ' ' LEU . 5.1 m-30 -108.43 109.62 20.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.881 0.372 . . . . 0.0 110.433 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.905 ' NE1' HG11 ' A' ' 50' ' ' VAL . 40.8 m95 -99.96 149.08 23.8 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.013 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 65' ' ' PHE . 52.6 tp -92.07 138.56 31.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.885 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.794 HG13 ' CB ' ' A' ' 64' ' ' HIS . 21.6 t -123.75 145.97 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.322 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -112.8 -26.02 8.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.47 159.69 25.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 118.725 0.693 . . . . 0.0 111.678 -179.012 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.741 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -152.78 123.62 7.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -73.17 145.63 46.17 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.101 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.8 -129.17 44.55 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.617 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 57.3 tt0 -122.19 142.38 36.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.521 0.2 . . . . 0.0 110.731 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.508 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -76.44 128.75 10.58 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.833 2.355 . . . . 0.0 111.376 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.581 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.1 p-90 -131.36 -58.59 0.99 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.845 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.567 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.17 -94.87 0.01 OUTLIER Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.909 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.37 33.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 110.99 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.53 -23.66 65.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.629 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.3 74.95 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.119 -0.563 . . . . 0.0 113.584 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.424 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 15.0 mt-30 -140.35 93.27 9.0 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.016 0.436 . . . . 0.0 111.362 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -43.65 134.14 7.4 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.969 2.446 . . . . 0.0 112.575 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.16 177.11 19.4 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.823 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -142.48 157.25 44.95 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -69.44 106.7 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.813 0.34 . . . . 0.0 110.219 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.515 ' SD ' HD12 ' A' ' 20' ' ' ILE . 9.0 ptm -119.92 153.95 35.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.409 ' HB2' HG12 ' A' ' 108' ' ' VAL . 87.1 p -74.99 114.78 13.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.686 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -70.59 -23.16 62.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.089 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 106' ' ' SER . 10.0 p -58.48 -19.02 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.306 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -125.13 44.19 1.29 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.393 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.474 HD13 HD22 ' A' ' 107' ' ' LEU . 8.4 tp -62.64 149.4 43.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.2 127.07 48.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.43 -14.58 61.73 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.557 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.21 -49.33 13.97 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.602 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -39.01 87.33 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.736 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.581 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.9 173.93 6.91 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.169 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 63.7 Cg_endo -73.4 127.66 12.06 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.121 1.881 . . . . 0.0 111.606 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.14 -14.93 40.79 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.587 2.191 . . . . 0.0 113.203 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.0 -9.5 58.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.12 31.98 5.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.68 0.276 . . . . 0.0 111.427 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.3 mt-10 -72.95 -36.0 3.16 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 69.3 Cg_exo -51.15 -45.87 34.34 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 121.981 1.787 . . . . 0.0 112.854 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -77.36 -51.29 18.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 0.0 110.926 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.581 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.7 mm -62.23 -32.27 54.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.255 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.86 -35.33 63.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.011 0.434 . . . . 0.0 110.419 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -65.36 -53.09 48.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.087 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.735 ' O ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -78.35 -20.04 52.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.639 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 123' ' ' ILE . 31.5 tttp -74.55 -42.59 58.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.19 0.519 . . . . 0.0 110.599 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -66.98 -10.29 47.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.912 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.735 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.128 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.611 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.808 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 5083 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 5084 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.1 mtp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.911 0.386 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.33 140.22 38.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.24 122.05 27.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.709 HD12 HD11 ' A' ' 6' ' ' ILE . 2.0 pp -131.33 140.95 49.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.798 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.808 ' C ' HD13 ' A' ' 6' ' ' ILE . 33.9 mt-30 -102.92 151.49 22.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.38 0.61 . . . . 0.0 112.05 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.808 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -144.97 116.61 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.659 178.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.998 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.76 152.27 44.04 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -145.08 162.6 13.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.339 0.59 . . . . 0.0 111.883 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.0 110.07 0.85 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.274 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.61 HG22 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.88 96.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.755 HG23 HG11 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -71.46 125.04 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 121.179 0.514 . . . . 0.0 112.052 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -93.64 142.61 27.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.857 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.676 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 5.1 p30 -99.08 -173.33 2.47 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.111 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -74.87 0.2 16.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.89 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -123.48 42.93 3.09 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.181 -0.324 . . . . 0.0 111.597 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 46.11 24.9 0.29 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.046 0.45 . . . . 0.0 111.263 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.533 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 24.4 mt-10 -113.83 160.88 18.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.834 HD13 HD22 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -119.33 131.99 70.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.134 0.492 . . . . 0.0 112.294 -178.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.491 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -85.06 116.01 23.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.26 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -118.96 140.16 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.682 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.559 HG21 ' HG2' ' A' ' 98' ' ' GLU . 45.7 p -76.48 120.2 21.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.593 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 35.4 ptt180 -107.19 167.96 9.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.512 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -72.5 57.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.997 0.427 . . . . 0.0 110.268 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . . . 49.23 -174.98 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.36 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.03 14.63 31.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.455 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 176.67 40.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.793 0.33 . . . . 0.0 110.824 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -86.92 -78.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.217 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -148.6 -74.4 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.974 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.85 100.61 9.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.95 -8.92 57.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.579 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.74 16.89 8.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.533 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -114.25 26.23 10.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.045 0.45 . . . . 0.0 111.353 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.52 HD11 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -48.81 103.19 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.656 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' OE2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.3 OUTLIER -109.26 -170.61 1.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.731 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.522 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.53 168.29 10.41 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.392 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.551 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 89.2 Cg_endo -83.13 167.12 14.2 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.643 2.895 . . . . 0.0 112.981 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.7 -5.1 50.75 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.496 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -62.71 167.7 19.74 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.864 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 80.16 8.43 1.46 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 122.618 0.367 . . . . 0.0 111.759 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.998 HG21 ' HB3' ' A' ' 7' ' ' ALA . 2.1 pt -57.88 -26.94 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.651 0.739 . . . . 0.0 110.052 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.496 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.43 -69.27 0.14 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.121 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.478 ' C ' ' O ' ' A' ' 41' ' ' GLU . 44.0 mmm 19.73 -86.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.731 0.644 . . . . 0.0 112.467 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.46 30.02 0.11 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.856 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -88.2 -170.38 2.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.783 0.325 . . . . 0.0 111.124 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.894 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.11 156.1 35.66 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.385 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.894 ' HD2' HG22 ' A' ' 45' ' ' THR . 5.0 Cg_endo -46.04 -24.88 2.51 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.781 2.321 . . . . 0.0 112.475 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 51' ' ' VAL . 8.3 mt-10 -104.11 -39.96 6.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.526 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 6.0 mt-30 -80.1 -12.78 59.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.615 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.869 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -58.48 -52.78 64.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.869 0.366 . . . . 0.0 110.885 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.931 HG11 ' NE1' ' A' ' 85' ' ' TRP . 3.4 m -78.32 -45.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 47' ' ' GLU . 33.4 t -61.17 -41.93 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.314 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 3.7 tpt180 -78.02 -37.69 46.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.889 0.376 . . . . 0.0 110.625 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' GLU . 7.9 tp10 -75.57 -19.93 58.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.627 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.899 HD21 ' CE1' ' A' ' 64' ' ' HIS . 3.8 tp -57.53 -44.37 85.07 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.575 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.89 -36.3 82.87 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.7 tm-20 -77.52 -24.49 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.042 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 53' ' ' GLU . 12.7 mm-40 -108.2 5.09 25.47 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.947 HG12 HG13 ' A' ' 60' ' ' ILE . 39.5 t -134.79 -44.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.226 0.536 . . . . 0.0 109.756 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.567 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.29 -40.79 0.36 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.336 -0.847 . . . . 0.0 113.892 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.947 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.85 -176.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.983 0.42 . . . . 0.0 111.171 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.83 88.89 12.37 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.948 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.843 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.4 Cg_endo -109.45 154.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.399 2.733 . . . . 0.0 114.367 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.625 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -83.39 80.79 8.98 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 175.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.899 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -122.22 127.69 50.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.462 -175.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.513 ' O ' ' O ' ' A' ' 86' ' ' LEU . 6.1 t80 -179.11 163.41 1.31 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.928 0.394 . . . . 0.0 112.051 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER 85.72 153.33 0.08 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.725 179.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -112.14 129.4 56.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.925 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.736 ' CE1' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.87 -51.09 11.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.152 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.4 mt-10 -171.26 131.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.425 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -111.95 131.97 55.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.725 0.298 . . . . 0.0 111.099 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.795 ' HB2' HG22 ' A' ' 122' ' ' VAL . 4.1 tp -110.28 131.14 55.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.649 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -121.1 109.89 15.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.617 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -141.1 146.32 36.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -121.15 140.03 52.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.151 0.501 . . . . 0.0 111.192 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -88.81 163.64 34.49 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.55 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 9.4 Cg_endo -52.29 84.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.025 2.483 . . . . 0.0 112.205 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 20.5 m-20 93.68 15.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.235 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 30.7 ttt180 -137.37 150.09 47.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.452 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -126.18 101.97 7.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.0 110.979 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.438 HG13 HD11 ' A' ' 6' ' ' ILE . 3.5 tt -109.87 111.92 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.453 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -94.83 118.47 31.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.283 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.902 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -108.45 114.32 28.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.0 111.421 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -113.14 122.71 48.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.042 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.902 ' CE1' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -106.86 109.71 21.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.449 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.931 ' NE1' HG11 ' A' ' 50' ' ' VAL . 47.2 m95 -97.99 148.5 23.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.0 112.173 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 65' ' ' PHE . 58.8 tp -92.9 134.74 34.8 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.436 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.803 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.7 t -124.7 146.13 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.03 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . 4.8 tp10 -106.69 -35.3 7.05 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.22 165.63 24.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.141 0.882 . . . . 0.0 111.945 -179.018 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.734 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.3 p90 -151.29 129.17 11.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.41 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -76.42 136.1 39.44 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.66 -126.78 24.95 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.556 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -125.85 143.44 45.28 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.549 0.214 . . . . 0.0 110.714 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.67 128.71 10.36 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.858 2.372 . . . . 0.0 111.489 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.567 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.9 p-90 -131.98 -58.8 0.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.726 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.588 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.94 -97.35 0.01 OUTLIER Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.968 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -179.97 33.88 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.685 0.279 . . . . 0.0 111.355 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.559 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -64.49 -27.69 69.15 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.826 0.346 . . . . 0.0 110.432 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.8 12.45 84.44 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.425 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.448 ' O ' HG22 ' A' ' 21' ' ' THR . 41.7 mt-30 -140.35 98.15 7.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 117.075 0.438 . . . . 0.0 111.53 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -43.71 141.46 3.94 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.835 2.357 . . . . 0.0 112.461 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.15 177.18 19.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.949 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -147.64 157.4 43.54 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.468 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.7 OUTLIER -68.89 106.14 2.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.867 0.365 . . . . 0.0 110.495 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.478 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 3.1 mmm -120.24 151.93 38.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.838 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.32 114.79 13.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.572 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.834 HD22 HD13 ' A' ' 18' ' ' ILE . 25.9 tp -79.72 -18.95 50.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.269 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.578 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.5 p -55.97 -20.67 9.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.813 0.339 . . . . 0.0 111.176 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.12 49.74 0.88 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.255 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.548 HD22 HD12 ' A' ' 123' ' ' ILE . 6.7 tt -62.45 150.22 40.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.701 0.286 . . . . 0.0 110.411 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -115.26 132.19 56.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.166 0.508 . . . . 0.0 112.184 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.64 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.25 -15.3 61.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.736 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -78.43 -49.19 13.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.325 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -27.67 67.4 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.77 0.319 . . . . 0.0 111.054 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.64 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -96.19 169.36 9.11 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.442 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.511 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 39.2 Cg_endo -67.07 127.71 17.3 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.353 2.036 . . . . 0.0 111.948 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.87 -19.88 58.44 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.535 2.157 . . . . 0.0 113.048 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.33 -9.51 58.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.33 32.4 6.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.789 0.328 . . . . 0.0 111.417 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.07 -40.21 2.92 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 86.4 Cg_exo -44.86 -36.61 11.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.135 1.89 . . . . 0.0 112.682 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.859 HG21 ' CE1' ' A' ' 84' ' ' PHE . 7.0 t -77.57 -42.39 29.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.069 0.461 . . . . 0.0 110.339 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.664 HG22 ' HB2' ' A' ' 127' ' ' LYS . 6.0 mm -69.17 -34.14 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.954 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.62 -27.04 36.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.945 0.402 . . . . 0.0 110.416 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -50.76 9.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.693 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.736 HD13 ' CE1' ' A' ' 68' ' ' PHE . 7.1 tp -78.07 -32.05 50.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.781 0.324 . . . . 0.0 111.613 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.664 ' HB2' HG22 ' A' ' 123' ' ' ILE . 5.9 ttpm? -53.81 -42.52 68.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.057 0.456 . . . . 0.0 111.002 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -71.87 -6.11 39.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.998 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 108' ' ' VAL . 2.3 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.203 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.742 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 5095 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 5096 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.888 0.375 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -110.08 103.01 11.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 132.82 46.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.741 HD12 HD11 ' A' ' 6' ' ' ILE . 2.7 pp -130.41 140.49 50.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.818 ' C ' HD13 ' A' ' 6' ' ' ILE . 10.9 mt-30 -107.37 149.45 27.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.276 0.56 . . . . 0.0 111.838 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.957 HD12 " H2'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -142.92 123.55 10.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.037 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.093 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.51 124.53 42.47 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.487 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -116.99 155.75 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.45 0.643 . . . . 0.0 112.019 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -138.59 109.27 0.66 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.177 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.606 HG22 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.85 101.38 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.708 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.1 mt -71.58 124.49 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.124 0.488 . . . . 0.0 111.958 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.473 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -96.41 137.71 35.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.065 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.688 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.8 p30 -94.84 -173.43 2.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.222 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.69 -2.17 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.071 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -120.61 41.39 3.27 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.556 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p30 47.44 23.58 0.39 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.949 0.404 . . . . 0.0 111.18 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.596 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 20.2 mt-10 -111.41 160.94 16.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.606 ' CG2' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -117.49 142.29 32.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.115 0.483 . . . . 0.0 112.137 -178.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -98.0 115.95 29.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.58 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.76 HD11 ' HG2' ' A' ' 105' ' ' MET . 0.2 OUTLIER -121.57 150.49 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.461 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.463 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 47.1 p -81.97 111.81 18.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.543 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.647 ' HD2' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -102.98 169.07 8.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.582 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -72.73 55.9 0.39 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.042 0.449 . . . . 0.0 110.398 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 46.79 27.75 0.73 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.669 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.647 ' HB2' ' HD2' ' A' ' 22' ' ' ARG . . . 47.95 28.7 1.48 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.437 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 57.8 p-10 -81.95 -177.94 6.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.985 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.46 29.27 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -106.5 -31.67 8.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.796 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.74 43.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.738 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 26' ' ' ASP . . . -61.66 -14.18 28.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.698 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.35 11.36 8.56 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -114.16 26.02 10.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.063 0.459 . . . . 0.0 111.41 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.508 HD11 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -47.77 99.9 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.44 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.8 tt0 -106.68 -177.5 3.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.168 0.509 . . . . 0.0 111.919 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.611 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.87 166.37 15.13 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.347 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 56.3 Cg_endo -69.83 167.76 23.6 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.351 2.7 . . . . 0.0 111.887 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.3 59.65 0.76 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.194 -1.003 . . . . 0.0 114.062 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -123.01 132.51 8.65 Favored Glycine 0 C--N 1.311 -0.829 0 CA-C-N 114.679 -0.76 . . . . 0.0 112.055 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.0 OUTLIER 92.93 7.7 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.043 0.537 . . . . 0.0 112.377 179.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.093 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -51.2 -29.23 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.706 0.765 . . . . 0.0 110.087 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.596 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.17 -80.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.876 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.2 mmm 37.13 -84.56 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.588 0.555 . . . . 0.0 111.605 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.57 31.37 0.13 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.456 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -90.94 -176.56 4.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.822 0.344 . . . . 0.0 111.287 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.868 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.4 153.9 37.55 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.325 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.868 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.93 -25.03 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.83 2.353 . . . . 0.0 112.589 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -104.02 -40.14 6.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.675 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -80.11 -13.92 58.9 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.059 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -59.6 -51.13 71.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.719 0.295 . . . . 0.0 111.098 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.929 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.9 m -77.99 -45.48 27.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.037 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.1 t -57.73 -43.54 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.329 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -44.52 25.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.082 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.4 tm-20 -68.39 -25.52 65.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.808 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -53.7 -44.46 69.79 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.914 0.387 . . . . 0.0 110.385 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -60.42 -35.9 76.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.66 -26.61 50.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.487 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' CA ' ' OE1' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -108.11 6.17 26.64 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -178.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.902 HG12 HG13 ' A' ' 60' ' ' ILE . 48.3 t -134.02 -44.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.51 -40.24 0.29 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.442 -0.799 . . . . 0.0 114.065 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.902 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.84 -177.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.114 0.483 . . . . 0.0 111.092 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.38 88.81 13.58 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.821 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.735 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.2 Cg_endo -111.07 146.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 123.287 2.658 . . . . 0.0 114.159 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 38.6 mt-30 -74.84 79.71 2.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 175.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.003 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.82 127.46 50.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.562 -176.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.514 ' O ' ' O ' ' A' ' 86' ' ' LEU . 12.4 t80 -179.29 168.22 1.5 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.5 m 84.43 154.73 0.09 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.742 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.5 pp -111.9 123.6 50.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 111.132 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.83 -38.69 53.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.198 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.2 mt-10 -171.29 148.33 2.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.342 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.4 132.15 22.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.633 0.254 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.634 HD22 ' N ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -133.3 166.66 21.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 110.894 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.634 ' N ' HD22 ' A' ' 71' ' ' LEU . 16.2 tt0 -137.68 126.06 23.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.665 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.644 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.9 p90 -141.14 147.0 37.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.451 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -121.15 139.96 52.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.213 0.53 . . . . 0.0 111.424 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -88.28 163.26 37.42 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.353 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.6 Cg_endo -50.6 83.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.029 2.486 . . . . 0.0 112.126 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.5 m-20 93.15 18.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.215 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.594 ' CZ ' HD21 ' A' ' 4' ' ' LEU . 12.0 ttt180 -137.45 150.08 47.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.515 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -123.11 106.59 10.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.774 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.477 HD13 ' OH ' ' A' ' 73' ' ' TYR . 3.6 tt -113.44 112.03 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.232 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -91.36 118.61 30.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.101 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.686 HD11 HD21 ' A' ' 119' ' ' ASN . 10.2 mt -109.19 114.26 27.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.997 0.427 . . . . 0.0 111.801 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -112.28 122.13 46.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.101 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.522 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.3 m-85 -106.63 109.79 21.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.244 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.929 ' NE1' HG11 ' A' ' 50' ' ' VAL . 39.4 m95 -98.38 148.7 23.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.081 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.514 ' O ' ' O ' ' A' ' 65' ' ' PHE . 18.7 tp -94.19 138.44 32.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.402 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.003 HG22 ' ND1' ' A' ' 64' ' ' HIS . 34.5 t -123.66 145.41 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.439 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -111.87 -25.59 9.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.52 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 5.8 tpt180 -162.79 163.54 26.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.511 0.596 . . . . 0.0 111.354 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.708 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -156.38 123.57 5.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.29 178.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -74.78 149.52 39.68 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.96 -131.76 48.08 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.596 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -121.4 145.05 41.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.44 0.162 . . . . 0.0 110.747 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.518 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.57 128.66 10.41 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.817 2.345 . . . . 0.0 111.386 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 59.5 p-90 -135.05 -58.27 0.8 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.921 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.616 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.79 -95.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.982 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -176.02 33.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.728 0.299 . . . . 0.0 111.234 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -26.21 60.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.41 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.99 16.8 73.03 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.632 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.463 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 48.8 mt-30 -140.28 92.08 9.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.129 0.49 . . . . 0.0 111.46 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -43.84 146.1 1.69 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.155 2.57 . . . . 0.0 112.935 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.448 ' CA ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.1 177.11 19.38 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.576 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -142.26 157.28 45.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.569 0.223 . . . . 0.0 110.975 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.535 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -74.71 106.02 6.07 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.747 0.308 . . . . 0.0 110.503 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.76 ' HG2' HD11 ' A' ' 20' ' ' ILE . 4.7 ppp? -120.74 147.64 45.03 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.361 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.5 114.85 3.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.823 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.962 HD11 HD11 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -80.13 -18.94 48.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.383 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.1 t -58.32 -15.13 4.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.586 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.07 51.92 0.78 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.315 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.736 HD13 HD22 ' A' ' 107' ' ' LEU . 11.5 tp -62.32 149.75 41.29 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.23 132.21 53.95 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.662 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.36 -15.32 61.86 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.497 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -78.56 -49.29 13.57 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.732 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -32.35 73.58 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.755 0.312 . . . . 0.0 111.031 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.662 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.68 170.74 10.48 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.312 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.538 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 55.5 Cg_endo -69.78 127.47 14.63 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.093 1.862 . . . . 0.0 111.669 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.57 -14.9 45.36 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.631 2.22 . . . . 0.0 113.385 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.64 -9.56 58.8 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.686 HD21 HD11 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -121.61 34.3 5.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.762 0.315 . . . . 0.0 111.465 -178.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -76.04 -31.87 1.06 Allowed Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 72.1 Cg_exo -49.06 -46.51 25.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 121.79 1.66 . . . . 0.0 112.817 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.445 HG22 ' CD1' ' A' ' 71' ' ' LEU . 1.5 t -77.41 -50.61 20.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.033 0.444 . . . . 0.0 110.622 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.599 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.4 mm -59.33 -35.06 56.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.248 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.73 -34.82 62.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.999 0.428 . . . . 0.0 110.489 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.75 -53.01 30.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.342 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.962 HD11 HD11 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -78.35 -19.74 52.79 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.699 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.66 ' N ' HD23 ' A' ' 126' ' ' LEU . 10.1 ttpp -66.24 -42.5 88.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.202 0.525 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -70.03 -9.07 54.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.186 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 120.858 0.361 . . . . 0.0 110.652 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.957 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 5107 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 5108 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.817 0.341 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.21 147.02 26.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -137.52 144.26 42.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.917 ' HG ' HG22 ' A' ' 80' ' ' ILE . 1.9 pp -146.14 119.15 8.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.724 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.518 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 16.7 mt-30 -102.01 152.33 21.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.505 0.669 . . . . 0.0 112.341 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.733 HD12 " H2'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -146.54 131.25 11.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.323 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.031 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.35 125.09 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 m -115.6 162.49 13.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.618 0.723 . . . . 0.0 112.714 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.422 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -145.86 112.93 0.66 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.251 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.718 HG22 HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.93 96.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.539 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.7 tt -71.64 117.54 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.205 0.526 . . . . 0.0 112.318 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.588 ' CG ' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -94.92 147.38 23.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.88 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.842 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 9.7 p-10 -103.78 -173.05 2.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.512 0.672 . . . . 0.0 112.225 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.7 tm-20 -71.8 1.6 6.7 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.455 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -124.64 44.59 2.73 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.597 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.9 p30 44.98 28.1 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.303 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 3.2 mt-10 -114.96 161.19 18.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.635 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.844 HD13 HD22 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -124.58 128.39 73.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.913 0.387 . . . . 0.0 111.937 -178.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -76.33 113.31 13.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.182 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.661 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.13 126.17 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.957 179.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.426 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 3.7 p -71.03 112.15 6.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.854 0.359 . . . . 0.0 110.987 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -86.15 83.44 7.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.582 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 0.1 OUTLIER 44.67 46.94 8.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.643 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 65.39 17.12 10.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.768 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.81 48.62 19.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.196 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -114.19 -177.1 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.981 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.75 30.07 6.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.113 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.9 124.84 13.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.779 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 64.28 46.24 3.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.991 0.424 . . . . 0.0 110.756 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.39 -8.8 53.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.824 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -85.0 14.81 4.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.18 26.25 10.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.115 0.483 . . . . 0.0 111.274 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.661 HD21 ' HB ' ' A' ' 20' ' ' ILE . 3.6 tt -45.77 100.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.657 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' OE1' ' N2 ' ' A' ' 131' ' ' 8OG . 14.6 mm-40 -125.12 179.08 5.21 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.227 0.537 . . . . 0.0 112.231 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.545 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.92 163.69 26.44 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.866 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 9.6 Cg_endo -51.49 168.61 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.884 3.056 . . . . 0.0 112.158 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.87 59.5 0.74 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.978 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.618 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.57 123.63 4.19 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 114.519 -0.84 . . . . 0.0 112.234 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.47 1.01 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.031 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -52.8 -27.07 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.627 0.727 . . . . 0.0 110.577 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.536 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -44.32 -60.72 1.79 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.233 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.511 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.3 ttp 11.02 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.936 0.773 . . . . 0.0 112.574 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.89 34.76 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.503 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -90.19 -174.73 4.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.935 0.398 . . . . 0.0 111.118 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.873 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.33 154.44 38.05 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.432 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.873 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.89 -25.6 1.09 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.818 2.345 . . . . 0.0 112.515 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.593 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -104.04 -38.91 6.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.446 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -80.1 -11.81 59.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.614 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.91 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -59.77 -52.9 63.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 0.0 110.815 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.918 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.4 m -78.16 -47.27 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.089 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.6 t -54.88 -37.27 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.26 -51.74 9.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.125 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.484 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.9 mm-40 -66.01 -23.48 66.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.764 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.2 tp -52.69 -44.67 66.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.744 0.307 . . . . 0.0 110.193 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -34.92 76.07 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.8 tt0 -77.43 -24.05 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.797 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.475 ' HG2' ' HA2' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -108.59 6.01 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.899 -179.172 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.645 HG11 ' HG3' ' A' ' 62' ' ' PRO . 16.1 t -133.97 -44.72 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 0.0 110.02 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.13 -39.42 0.2 Allowed Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.628 -0.715 . . . . 0.0 114.0 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.698 HG23 ' NE1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -88.26 -174.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.018 0.437 . . . . 0.0 111.085 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -111.98 88.87 10.69 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.259 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.645 ' HG3' HG11 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -108.63 154.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.915 2.41 . . . . 0.0 114.658 -177.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 89' ' ' ARG . 81.3 mt-30 -75.02 79.72 2.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.024 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -126.37 121.28 32.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.07 -176.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.9 t80 179.43 171.27 0.98 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.436 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.3 t 92.79 147.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.814 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.538 HD22 ' CD2' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -96.12 126.7 41.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.406 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -92.13 -51.77 5.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 179.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 9.4 tt0 -171.63 163.75 6.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.31 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -143.34 132.1 22.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.773 0.321 . . . . 0.0 110.901 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.768 ' HB2' HG22 ' A' ' 122' ' ' VAL . 2.6 tp -122.71 128.52 50.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.658 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -117.2 110.72 18.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.734 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.831 ' CE2' HD11 ' A' ' 80' ' ' ILE . 11.8 p90 -140.97 146.04 36.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -111.37 131.81 54.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.134 0.492 . . . . 0.0 111.241 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -82.04 163.22 54.14 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.489 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.1 Cg_endo -53.36 82.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.895 2.397 . . . . 0.0 112.152 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 17.6 t0 90.96 11.5 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.36 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.687 ' HG2' HD23 ' A' ' 4' ' ' LEU . 5.1 ttp180 -137.35 94.25 2.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.711 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -76.24 119.79 20.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.422 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.917 HG22 ' HG ' ' A' ' 4' ' ' LEU . 5.0 pt -127.52 146.99 32.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.065 0.459 . . . . 0.0 112.179 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -113.52 118.82 35.52 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.704 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.569 HD21 ' OD1' ' A' ' 119' ' ' ASN . 14.8 tp -106.42 114.0 27.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.854 0.359 . . . . 0.0 111.279 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.407 ' CZ3' ' O ' ' A' ' 46' ' ' PRO . 9.5 m0 -112.52 122.49 47.86 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.555 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.52 ' HE1' HD11 ' A' ' 82' ' ' LEU . 4.8 m-30 -106.54 109.87 21.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.591 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.918 ' NE1' HG11 ' A' ' 50' ' ' VAL . 34.9 m95 -101.32 148.48 25.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.455 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 65' ' ' PHE . 22.4 tp -91.69 138.35 31.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.324 0.583 . . . . 0.0 112.05 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.024 HG22 ' ND1' ' A' ' 64' ' ' HIS . 38.3 t -124.44 145.37 31.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.264 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -112.49 -32.34 6.51 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -163.18 165.62 24.27 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.711 0.687 . . . . 0.0 111.645 -178.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.842 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.9 p90 -148.17 133.06 18.06 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.793 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -80.18 144.41 33.01 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.691 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.13 -115.23 7.32 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.45 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 43.2 mt-10 -134.92 138.6 29.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.468 0.175 . . . . 0.0 110.82 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.512 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 3.4 Cg_exo -76.62 128.89 10.52 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.786 2.324 . . . . 0.0 111.12 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.698 ' NE1' HG23 ' A' ' 60' ' ' ILE . 62.4 p-90 -137.08 -60.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.633 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.602 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 52.51 -94.2 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.693 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.1 tttp 179.02 30.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.565 0.221 . . . . 0.0 111.549 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.69 -32.4 70.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.027 0.441 . . . . 0.0 110.143 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.91 32.29 69.96 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.73 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.426 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 76.7 mt-30 -140.56 91.64 9.44 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.973 0.416 . . . . 0.0 111.527 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -44.7 126.53 7.28 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.197 2.598 . . . . 0.0 112.959 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.471 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.47 177.31 19.31 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.823 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.16 157.13 46.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.626 0.25 . . . . 0.0 110.699 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.44 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -68.47 106.71 2.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.887 0.375 . . . . 0.0 110.156 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.5 ptp -119.87 148.52 43.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.159 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.427 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 95.0 p -65.85 114.57 5.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.593 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.844 HD22 HD13 ' A' ' 18' ' ' ILE . 33.5 tp -78.11 -18.87 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.309 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.91 -20.13 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.442 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.99 45.2 1.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.698 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.419 ' CD2' HD12 ' A' ' 123' ' ' ILE . 7.9 tt -62.79 150.57 41.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.627 0.251 . . . . 0.0 110.49 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.91 129.61 56.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.201 0.524 . . . . 0.0 112.377 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.573 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.23 -14.98 61.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.666 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -78.36 -49.17 14.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.578 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.48 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -66.82 -34.93 78.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.91 0.386 . . . . 0.0 110.876 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.573 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -84.74 173.23 7.47 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.345 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.3 Cg_endo -70.68 127.69 14.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.162 1.908 . . . . 0.0 111.857 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.41 -17.57 60.08 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.53 2.154 . . . . 0.0 113.023 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.25 -9.36 58.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.875 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.569 ' OD1' HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -118.51 29.5 7.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.42 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.05 -43.17 3.65 Favored Pre-proline 0 C--O 1.224 -0.25 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 92.4 Cg_exo -44.89 -39.0 13.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.18 1.92 . . . . 0.0 112.971 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.2 t -77.21 -51.14 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.189 0.518 . . . . 0.0 110.77 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.2 mm -64.84 -31.23 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.197 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.82 -30.88 58.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.003 0.43 . . . . 0.0 110.477 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.9 -53.27 18.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.469 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.789 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -78.33 -33.07 49.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.565 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.532 ' HB2' HG22 ' A' ' 123' ' ' ILE . 11.6 ttpp -53.15 -42.64 66.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 111.148 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -67.2 -10.59 52.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.688 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.8 mp . . . . . 0 C--O 1.232 0.155 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.058 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.864 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 5119 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 5120 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ptt? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.862 0.363 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -73.99 139.33 44.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -140.06 137.87 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.972 HD12 HD11 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -146.07 131.95 19.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.736 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -102.84 155.43 18.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 111.666 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.972 HD11 HD12 ' A' ' 4' ' ' LEU . 5.3 mp -144.52 137.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.35 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.881 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -125.41 125.3 43.17 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.329 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.9 m -128.63 155.79 40.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.064 0.459 . . . . 0.0 111.283 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.7 127.09 2.21 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.106 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.09 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -80.99 107.65 13.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.795 HG22 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.17 123.33 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.975 0.417 . . . . 0.0 111.31 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.7 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.9 119.04 23.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.359 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 21.9 t-20 -74.77 -172.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.927 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 32.1 tt0 -82.57 4.11 25.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.151 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -140.08 52.2 1.68 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.0 111.454 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.64 25.21 0.24 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.552 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.702 ' C ' HD12 ' A' ' 18' ' ' ILE . 5.3 pt-20 -120.32 149.88 41.61 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.09 HG21 HG22 ' A' ' 10' ' ' ILE . 1.3 mp -113.36 140.76 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.149 0.5 . . . . 0.0 111.665 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -91.16 103.58 16.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.048 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.695 HG22 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.9 162.12 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.186 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 100' ' ' GLN . 73.7 p -92.61 111.71 23.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.787 0.327 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -91.69 83.5 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.45 ' NH2' ' HB1' ' A' ' 27' ' ' ALA . 11.3 mmm180 33.0 48.22 0.13 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.927 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 65.65 -77.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -175.41 -78.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.248 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -96.75 128.67 43.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.006 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' HB1' ' NH2' ' A' ' 23' ' ' ARG . . . -176.28 178.48 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -98.6 30.53 3.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.14 63.86 0.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.695 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.09 -8.72 56.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.723 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.85 23.21 2.09 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.27 26.34 10.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 111.465 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -46.05 97.44 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.67 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.78 176.94 4.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.168 0.509 . . . . 0.0 111.715 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.695 ' HB3' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.76 161.44 37.95 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.904 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -55.66 168.54 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.671 2.914 . . . . 0.0 111.611 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.67 59.49 0.74 Allowed Glycine 0 C--N 1.33 0.242 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.965 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.604 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.15 121.7 2.64 Favored Glycine 0 C--N 1.315 -0.637 0 CA-C-N 114.576 -0.812 . . . . 0.0 112.086 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.49 -6.62 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.339 0.656 . . . . 0.0 111.565 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.881 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.17 -57.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.303 0.573 . . . . 0.0 111.251 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -19.36 -78.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.305 -179.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.3 mmt 40.2 -93.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.774 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.47 22.06 0.08 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.359 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.45 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -78.84 -159.99 0.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.544 0.211 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.879 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.14 154.7 38.63 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.879 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.2 Cg_endo -44.07 -24.91 0.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.777 2.318 . . . . 0.0 112.456 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.9 mt-10 -99.89 -48.77 4.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.919 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -80.5 -4.89 55.59 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 44' ' ' GLU . . . -65.49 -57.49 8.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.54 0.21 . . . . 0.0 110.955 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.727 HG23 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -78.79 -44.01 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.706 179.163 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.9 t -50.61 -36.06 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 110.73 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -78.59 -49.1 13.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.817 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -65.66 -23.75 66.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.816 HD21 ' NE2' ' A' ' 64' ' ' HIS . 2.5 tp -54.81 -44.56 73.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.467 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -31.29 71.13 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.3 tm-20 -77.44 -23.95 50.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.957 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.433 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 45.3 mm-40 -107.07 3.54 25.98 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.972 HG12 HG13 ' A' ' 60' ' ' ILE . 21.9 t -134.91 -44.21 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.277 0.56 . . . . 0.0 109.847 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.582 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 71.2 -43.91 0.69 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.321 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.972 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.61 -175.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.105 0.478 . . . . 0.0 111.255 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.36 89.14 11.86 Favored Pre-proline 0 N--CA 1.442 -0.852 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.196 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.891 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.8 Cg_endo -108.47 148.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 123.078 2.519 . . . . 0.0 114.133 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 21.3 mt-30 -74.64 79.95 2.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 175.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.003 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.76 127.52 48.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.675 -176.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.628 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.1 t80 -179.83 171.0 1.2 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.518 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 80.57 156.13 0.14 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.749 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.4 pp -117.09 129.28 55.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.436 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.824 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.8 -48.36 18.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.744 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.567 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -171.56 131.73 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.184 179.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.653 ' HD2' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -123.56 132.21 53.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.742 0.305 . . . . 0.0 110.719 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.645 HD22 ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.68 162.25 26.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 111.185 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' N ' HD22 ' A' ' 71' ' ' LEU . 13.4 tt0 -140.14 128.28 22.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.656 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.478 ' HE1' HD12 ' A' ' 82' ' ' LEU . 1.9 p90 -141.07 100.87 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.643 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.8 pt-20 -74.83 122.42 23.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.446 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.99 162.89 60.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.303 179.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.0 Cg_endo -51.0 81.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.025 2.484 . . . . 0.0 112.287 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.4 t70 91.37 10.12 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.57 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -137.34 93.95 2.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.646 0.26 . . . . 0.0 110.854 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.555 ' HE1' HG23 ' A' ' 81' ' ' THR . 52.7 t-80 -74.88 102.1 4.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.819 0.342 . . . . 0.0 110.703 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.587 HG13 HD13 ' A' ' 6' ' ' ILE . 5.6 tt -106.52 111.94 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.555 HG23 ' HE1' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -103.28 128.55 50.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.413 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.478 HD12 ' HE1' ' A' ' 73' ' ' TYR . 1.6 mt -126.25 114.54 18.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.98 0.419 . . . . 0.0 111.497 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -108.12 122.33 46.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.38 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.746 ' CD2' HG11 ' A' ' 122' ' ' VAL . 5.4 m-30 -100.5 113.77 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.754 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.802 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 35.8 m95 -94.29 148.74 21.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.258 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 65' ' ' PHE . 31.1 tp -98.35 103.43 15.38 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 121.159 0.504 . . . . 0.0 111.61 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.003 HG22 ' ND1' ' A' ' 64' ' ' HIS . 25.2 t -87.62 145.79 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.184 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -112.15 -26.74 8.67 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.86 165.11 25.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.796 0.726 . . . . 0.0 111.796 -178.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.662 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.2 p90 -152.72 130.04 11.31 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.511 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -75.84 139.93 41.98 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.694 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.3 -117.82 12.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.347 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 8.0 mt-10 -135.05 140.12 33.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.414 0.149 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HA ' HD11 ' A' ' 60' ' ' ILE . 7.8 Cg_exo -75.5 128.58 11.2 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.943 2.429 . . . . 0.0 111.438 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.61 ' HE1' HG23 ' A' ' 60' ' ' ILE . 45.1 p-90 -128.45 -58.54 1.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.993 0.425 . . . . 0.0 111.383 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.77 -100.07 0.02 OUTLIER Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.877 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 179.08 36.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.775 0.321 . . . . 0.0 111.321 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -56.99 -47.6 80.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.564 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.59 12.08 51.86 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.927 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.424 ' O ' HG22 ' A' ' 21' ' ' THR . 24.3 mt-30 -140.36 91.79 9.61 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 117.24 0.52 . . . . 0.0 111.386 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -44.23 125.39 5.68 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.837 2.358 . . . . 0.0 112.739 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.78 177.59 19.16 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.469 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -129.28 157.1 42.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.672 0.273 . . . . 0.0 110.773 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.45 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.12 107.1 3.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.901 0.381 . . . . 0.0 110.435 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 18' ' ' ILE . 12.5 ptm -119.62 158.1 27.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 p -71.83 121.32 18.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.764 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -80.11 -28.97 38.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.011 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.67 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.7 p -50.72 -24.58 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.232 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.7 43.34 1.4 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.382 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.573 HD22 HD12 ' A' ' 123' ' ' ILE . 9.5 tt -62.55 150.14 41.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.414 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -118.97 132.91 56.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.178 0.513 . . . . 0.0 112.302 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.629 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.42 61.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.48 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -78.77 -49.27 13.31 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.755 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -32.77 74.26 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.799 0.333 . . . . 0.0 111.013 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.629 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -89.16 172.62 7.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.029 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.489 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.8 Cg_endo -67.51 127.58 16.69 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.032 1.822 . . . . 0.0 111.832 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.38 -18.64 60.67 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.552 2.168 . . . . 0.0 113.064 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.87 -9.38 58.24 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.465 ' ND2' ' C6 ' ' A' ' 131' ' ' 8OG . 0.9 OUTLIER -119.36 34.31 5.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.767 0.318 . . . . 0.0 111.464 -178.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -75.6 -44.06 4.16 Favored Pre-proline 0 N--CA 1.463 0.217 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.6 Cg_exo -44.76 -35.38 9.43 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.224 1.949 . . . . 0.0 112.61 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.746 HG11 ' CD2' ' A' ' 84' ' ' PHE . 11.8 t -77.43 -41.05 29.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.136 0.493 . . . . 0.0 110.144 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.777 HG22 ' HB2' ' A' ' 127' ' ' LYS . 17.9 mm -70.28 -32.28 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.707 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.46 -26.96 34.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.086 0.47 . . . . 0.0 110.228 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.09 -50.89 9.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.669 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.824 HD13 ' CD2' ' A' ' 68' ' ' PHE . 8.1 tp -78.09 -33.5 50.69 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 111.693 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.777 ' HB2' HG22 ' A' ' 123' ' ' ILE . 17.7 ttpt -53.27 -42.53 66.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -71.71 -6.09 38.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.975 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.67 HD21 ' O ' ' A' ' 108' ' ' VAL . 2.9 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.189 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.63 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 5131 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 5132 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 mmt . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.785 0.326 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -104.23 136.73 43.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -140.02 137.53 34.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.936 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.7 pp -146.0 135.37 22.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.77 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -102.7 149.19 24.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.388 0.613 . . . . 0.0 112.107 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.936 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.4 mp -146.22 120.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.866 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.063 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.66 143.34 50.79 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.314 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -144.6 162.52 14.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.112 0.482 . . . . 0.0 111.487 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -144.02 123.4 2.01 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.037 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.004 HG22 ' CG2' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.75 108.91 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.765 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -70.83 120.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.224 0.535 . . . . 0.0 112.252 -178.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.95 122.7 28.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.615 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.557 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -81.62 -172.58 3.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.887 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.506 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -82.38 -0.95 48.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.112 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -135.69 49.58 2.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 0.0 111.331 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.27 23.7 0.59 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.183 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 16.2 pt-20 -114.23 153.97 28.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.004 ' CG2' HG22 ' A' ' 10' ' ' ILE . 5.2 mt -128.44 143.32 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.0 112.04 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.464 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.18 122.74 34.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.324 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.043 HD12 HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -118.69 133.36 65.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.274 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.658 HG21 ' HG2' ' A' ' 98' ' ' GLU . 21.4 p -70.82 115.94 10.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.082 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.515 ' CA ' HD23 ' A' ' 33' ' ' LEU . 18.3 ptt85 -114.51 172.06 7.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.704 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.433 ' HD3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -70.79 60.57 0.24 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 44.82 -92.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.567 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -178.18 34.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.782 0.325 . . . . 0.0 111.098 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 172.82 93.23 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.731 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 23' ' ' ARG . . . -162.77 171.87 16.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.144 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -60.61 -68.77 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.8 mtm -93.35 68.94 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.51 -8.9 57.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.614 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -92.15 31.18 1.31 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.354 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -114.23 25.65 10.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.428 . . . . 0.0 111.28 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.043 HD11 HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -46.47 97.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.37 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -106.79 -170.35 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.18 0.514 . . . . 0.0 112.251 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.19 168.59 9.62 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.472 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.586 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 93.7 Cg_endo -79.33 167.58 21.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.688 2.925 . . . . 0.0 113.835 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.87 -5.24 50.38 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.881 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.02 159.16 23.95 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 117.498 0.649 . . . . 0.0 113.327 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 85.14 6.36 0.49 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.061 0.545 . . . . 0.0 111.996 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.063 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.6 pt -54.28 -27.04 16.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.632 0.73 . . . . 0.0 110.167 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.554 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.97 -66.92 0.32 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.035 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.503 ' C ' ' O ' ' A' ' 41' ' ' GLU . 5.4 mmt 14.65 -82.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.876 0.735 . . . . 0.0 112.409 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -177.52 33.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.59 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.6 mp0 -88.76 -172.97 3.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.861 0.362 . . . . 0.0 111.168 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.868 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.76 155.38 36.4 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.36 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.868 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.89 -25.46 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.817 2.345 . . . . 0.0 112.659 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -103.51 -41.6 5.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.386 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 1.6 mm100 -80.28 -4.83 54.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.722 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.914 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.58 -55.41 33.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.9 HG11 ' NE1' ' A' ' 85' ' ' TRP . 2.7 m -78.19 -46.03 26.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.31 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 30.0 t -55.39 -41.13 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.368 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 3.6 tmm_? -77.98 -49.34 14.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.018 0.437 . . . . 0.0 110.451 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.469 ' HG3' ' OE1' ' A' ' 57' ' ' GLU . 14.9 tp10 -63.38 -20.0 65.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.504 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.87 HD21 ' CG ' ' A' ' 64' ' ' HIS . 1.4 tp -59.65 -44.46 93.54 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.303 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -30.16 70.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.827 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.5 tm-20 -77.27 -31.82 55.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.416 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.469 ' OE1' ' HG3' ' A' ' 53' ' ' GLU . 1.2 mp0 -108.68 6.14 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.932 HG12 HG13 ' A' ' 60' ' ' ILE . 43.5 t -133.83 -44.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.161 0.505 . . . . 0.0 110.031 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.599 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.43 -39.82 0.28 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.966 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.932 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.52 -176.29 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 120.968 0.413 . . . . 0.0 110.841 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.22 89.1 11.53 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.468 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.798 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.9 Cg_endo -109.42 143.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.266 2.644 . . . . 0.0 114.243 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 34.5 mt-30 -74.7 80.03 2.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 105.437 -2.061 . . . . 0.0 105.437 175.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.87 ' CG ' HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -120.92 134.53 55.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.418 -175.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 178.92 -139.9 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.089 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 56.46 156.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.206 0.527 . . . . 0.0 112.323 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.4 tt -120.1 109.44 15.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.562 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.74 -43.8 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.369 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.7 tt0 -171.25 163.32 7.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.311 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HE3' ' CZ2' ' A' ' 83' ' ' TRP . 1.1 ttpm? -143.15 132.04 22.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.81 0.338 . . . . 0.0 110.992 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.821 ' HB2' HG22 ' A' ' 122' ' ' VAL . 4.6 tp -115.2 120.41 39.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.418 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -118.57 109.84 16.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.476 ' CE1' HD23 ' A' ' 71' ' ' LEU . 2.0 p90 -141.1 151.64 44.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.46 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -121.14 121.27 37.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 0.0 111.34 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -79.77 162.88 61.04 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.281 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -50.92 81.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.017 2.478 . . . . 0.0 112.097 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 75' ' ' PHE . 3.0 t70 88.79 14.23 0.07 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.329 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.659 ' HE ' HD21 ' A' ' 4' ' ' LEU . 4.7 ttt180 -137.51 93.91 2.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.732 0.301 . . . . 0.0 110.805 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -75.76 97.57 3.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.899 0.38 . . . . 0.0 110.463 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.692 HG13 HD13 ' A' ' 6' ' ' ILE . 1.3 tt -100.84 112.9 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.405 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.48 119.66 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.279 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.943 HD23 HG21 ' A' ' 122' ' ' VAL . 12.7 tp -110.26 114.37 27.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.88 0.372 . . . . 0.0 111.334 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.44 ' CZ2' ' HE3' ' A' ' 70' ' ' LYS . 10.9 m0 -109.47 122.89 48.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.178 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -109.79 109.77 20.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.602 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.9 ' NE1' HG11 ' A' ' 50' ' ' VAL . 48.2 m95 -99.41 148.96 23.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.506 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.8 tp -98.5 102.84 14.7 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.427 0.632 . . . . 0.0 111.726 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.781 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.9 t -81.1 146.47 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.091 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -114.12 -25.68 8.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.9 tpt180 -162.55 161.87 27.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.64 0.654 . . . . 0.0 111.583 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.738 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -155.61 123.46 5.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.316 178.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -72.05 143.94 48.93 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.019 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.2 -129.67 46.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.558 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -121.0 144.0 38.23 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.599 0.238 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.534 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.5 Cg_exo -76.32 128.89 10.76 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.788 2.325 . . . . 0.0 111.031 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.599 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 47.0 p-90 -132.28 -63.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.49 -99.87 0.02 OUTLIER Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.517 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.3 mtpp 164.77 42.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 110.874 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.658 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.4 OUTLIER -58.59 -31.99 68.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.939 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 129.93 -37.84 2.09 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.368 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -129.49 105.71 17.42 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.0 111.86 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -43.76 146.31 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.079 2.52 . . . . 0.0 112.661 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.45 177.18 18.74 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.745 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -131.65 157.38 43.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.506 0.194 . . . . 0.0 110.596 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.483 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -75.82 106.51 7.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.866 0.365 . . . . 0.0 110.203 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.0 ptm -120.16 161.32 21.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.981 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.9 p -76.86 114.98 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.712 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.721 HD22 HD13 ' A' ' 18' ' ' ILE . 2.6 tp -77.32 -18.94 57.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.449 ' O ' HD21 ' A' ' 129' ' ' LEU . 11.3 p -51.0 -24.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.328 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.54 44.37 1.24 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.561 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.695 HD22 HD12 ' A' ' 123' ' ' ILE . 8.4 tt -62.78 150.35 41.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.577 0.227 . . . . 0.0 110.419 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.636 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -117.71 130.12 56.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 112.325 -178.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.56 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.21 -14.8 61.89 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.55 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.43 -49.13 14.04 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.483 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -34.69 77.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.779 0.323 . . . . 0.0 111.054 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.47 174.34 6.21 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.172 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 40.1 Cg_endo -67.71 127.81 16.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 121.926 1.751 . . . . 0.0 111.928 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.85 -21.12 58.06 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.606 2.204 . . . . 0.0 112.693 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.29 -9.6 58.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.719 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.535 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -113.74 23.22 13.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.506 -179.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -66.59 -36.46 12.15 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.578 ' HB2' HD13 ' A' ' 71' ' ' LEU . 73.8 Cg_exo -51.13 -47.74 24.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.952 1.768 . . . . 0.0 112.84 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.943 HG21 HD23 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -77.68 -51.21 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.936 0.398 . . . . 0.0 111.191 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.695 HD12 HD22 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -62.1 -32.84 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.227 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.92 -36.99 65.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.972 0.415 . . . . 0.0 110.374 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -62.92 -46.51 87.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.519 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 13.6 tp -78.13 -27.81 48.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.032 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.657 ' O ' HD12 ' A' ' 129' ' ' LEU . 14.8 tttp -58.99 -42.67 90.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -76.73 -3.29 37.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.111 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 127' ' ' LYS . 4.2 mp . . . . . 0 C--O 1.231 0.126 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.132 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.696 ' N2 ' HD11 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 5143 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 5144 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.4 132.83 35.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 8.8 ttmt -136.25 136.71 40.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.785 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.831 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.1 pp -146.04 137.76 24.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.667 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.766 ' C ' HD13 ' A' ' 6' ' ' ILE . 5.8 mt-30 -109.24 147.53 32.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.331 0.586 . . . . 0.0 111.804 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.915 HD12 " H2'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -136.91 128.49 42.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.014 179.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.837 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -125.14 124.83 42.66 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.518 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.553 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.9 m -124.11 162.35 25.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.033 0.444 . . . . 0.0 111.062 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -150.69 116.12 0.75 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.688 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.966 HG22 HG21 ' A' ' 18' ' ' ILE . 2.4 mp -70.58 104.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.822 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -70.97 120.52 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.21 0.529 . . . . 0.0 112.311 -177.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.437 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.52 119.65 24.5 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.56 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.558 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 25.8 t-20 -78.24 179.93 6.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.434 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.548 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 22.0 tt0 -76.1 1.26 16.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.97 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -139.87 52.57 1.69 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.814 0.34 . . . . 0.0 111.522 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 45.53 27.12 0.37 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.725 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 11.5 pt-20 -117.45 160.6 20.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.966 HG21 HG22 ' A' ' 10' ' ' ILE . 2.8 mp -136.82 142.31 38.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.205 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.7 118.19 30.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.281 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.742 HD11 HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -110.62 138.44 38.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.714 HG23 ' HD3' ' A' ' 36' ' ' PRO . 4.2 p -83.1 111.38 18.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.922 0.391 . . . . 0.0 110.745 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -104.4 172.18 6.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.169 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.555 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 17.1 mmt180 -67.0 -7.59 23.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.031 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 78.78 2.52 2.52 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.657 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 56.08 32.16 19.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.78 0.324 . . . . 0.0 111.287 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -148.26 70.05 1.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.04 -69.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.13 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -170.86 -42.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.3 mtt -121.44 87.89 2.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.55 -8.78 54.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.677 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.44 31.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.414 ' CB ' ' HG2' ' A' ' 23' ' ' ARG . 4.2 mttm -114.24 25.95 10.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.965 0.412 . . . . 0.0 111.441 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -53.45 89.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.216 179.344 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.677 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.1 tt0 -112.87 -168.19 1.29 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.29 0.566 . . . . 0.0 112.143 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.553 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.33 166.3 15.69 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.305 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.714 ' HD3' HG23 ' A' ' 21' ' ' THR . 38.2 Cg_endo -63.93 168.6 11.8 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.334 2.689 . . . . 0.0 111.208 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.9 60.11 0.73 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 119.514 -1.327 . . . . 0.0 114.228 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.63 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -135.21 110.91 0.86 Allowed Glycine 0 C--N 1.314 -0.67 0 CA-C-N 114.581 -0.809 . . . . 0.0 111.732 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.63 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 126.98 -8.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.521 0.728 . . . . 0.0 110.873 -179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.837 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -42.2 -48.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.293 0.568 . . . . 0.0 111.57 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -31.8 -81.16 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.941 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.9 mmm 43.02 -92.82 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.557 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.71 23.8 0.09 OUTLIER Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.215 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -82.44 -162.95 0.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.546 0.213 . . . . 0.0 110.934 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.858 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -107.76 156.07 38.69 Favored Pre-proline 0 C--N 1.333 -0.13 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.858 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.85 -24.71 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.703 2.269 . . . . 0.0 112.456 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.9 mm-40 -95.36 -54.03 3.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -80.44 -5.26 56.28 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -64.99 -57.44 8.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.685 0.278 . . . . 0.0 110.811 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.729 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -79.02 -45.95 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.701 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 47' ' ' GLU . 59.3 t -50.87 -37.76 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.033 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -48.68 14.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.68 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 40' ' ' ILE . 12.8 tp10 -63.92 -25.67 68.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.639 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.824 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.7 tp -55.3 -44.31 75.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.6 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -32.1 71.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.1 tm-20 -77.37 -25.49 51.0 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.848 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.422 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 5.3 mm-40 -108.38 5.18 25.19 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.933 HG12 HG13 ' A' ' 60' ' ' ILE . 31.3 t -134.82 -44.62 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.11 0.481 . . . . 0.0 110.144 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.51 -40.25 0.23 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.893 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.933 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.65 -177.57 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.001 0.429 . . . . 0.0 111.227 -179.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.62 88.54 13.76 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.798 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.786 ' HG3' HG11 ' A' ' 58' ' ' VAL . 1.4 Cg_endo -112.55 147.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 123.322 2.681 . . . . 0.0 114.167 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 22.8 mt-30 -74.7 80.02 2.04 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.007 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.4 128.12 50.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.74 -176.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.7 t80 179.72 175.33 0.77 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.481 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 t 78.79 162.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.077 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.771 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -123.45 129.28 51.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.367 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.963 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.77 -44.24 33.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.292 0.568 . . . . 0.0 109.767 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.3 mt-10 -171.45 131.66 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.845 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.5 132.16 54.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.88 0.372 . . . . 0.0 111.286 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.629 ' HB2' HG22 ' A' ' 122' ' ' VAL . 3.4 tp -109.43 137.56 47.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.626 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -133.56 109.97 9.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.895 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.412 ' CZ ' HG23 ' A' ' 80' ' ' ILE . 2.3 p90 -141.22 146.28 36.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.584 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.16 133.96 55.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.105 0.478 . . . . 0.0 111.306 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.471 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -93.91 163.15 24.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.375 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.8 Cg_endo -54.15 82.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.823 2.349 . . . . 0.0 112.317 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 10.9 t0 93.49 8.53 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.547 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' NH1' HD12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -137.34 93.92 2.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.774 0.321 . . . . 0.0 110.769 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' A' ' 3' ' ' LYS . 1.9 t60 -82.09 96.98 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.0 110.773 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.493 HD12 ' NH1' ' A' ' 78' ' ' ARG . 5.0 tt -98.77 111.7 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.985 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.06 118.71 34.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.115 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.579 HD23 ' HB ' ' A' ' 6' ' ' ILE . 38.5 mt -106.19 114.47 28.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.963 0.411 . . . . 0.0 111.689 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.622 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 12.2 m0 -106.74 122.17 45.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.599 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.698 ' CG ' HG11 ' A' ' 122' ' ' VAL . 3.2 m-85 -112.95 109.78 19.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.0 110.196 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.771 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 15.9 m95 -94.77 148.46 22.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.595 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.613 ' O ' ' O ' ' A' ' 65' ' ' PHE . 59.2 tp -100.09 102.98 14.46 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.037 0.446 . . . . 0.0 111.568 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.007 HG22 ' ND1' ' A' ' 64' ' ' HIS . 25.0 t -83.29 145.83 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.159 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -113.5 -23.53 9.76 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 2.9 ttt-85 -162.91 162.95 26.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.688 0.677 . . . . 0.0 111.287 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.714 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -157.25 125.18 5.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.0 111.674 179.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -76.07 151.9 36.97 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.136 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.21 -132.94 42.2 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.654 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 19.6 tt0 -119.69 146.94 42.75 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.6 0.238 . . . . 0.0 110.721 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.2 Cg_exo -76.69 128.85 10.44 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.904 2.403 . . . . 0.0 111.383 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.536 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 64.9 p-90 -137.08 -59.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.179 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.543 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 49.17 -94.63 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.813 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' GLU . 1.1 mmtm 165.81 34.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.692 0.282 . . . . 0.0 111.114 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.33 -34.66 78.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.415 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.6 21.19 32.24 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.159 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.422 ' O ' ' HB ' ' A' ' 21' ' ' THR . 2.6 mp0 -140.21 92.08 9.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 111.3 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -43.73 131.84 7.71 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.804 2.336 . . . . 0.0 112.374 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.0 177.04 19.42 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.858 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -145.2 157.25 44.12 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -70.19 106.61 3.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.851 0.357 . . . . 0.0 110.216 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -119.97 163.21 17.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.948 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.516 ' OG ' HG12 ' A' ' 108' ' ' VAL . 1.7 t -77.72 114.83 16.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.786 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.8 OUTLIER -80.08 -19.96 46.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.255 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.516 HG12 ' OG ' ' A' ' 106' ' ' SER . 11.9 p -52.97 -20.53 2.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.538 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.06 44.27 1.25 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.85 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.651 HD12 HD21 ' A' ' 107' ' ' LEU . 8.5 tt -62.64 150.13 41.64 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.49 130.52 53.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.16 61.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.402 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.6 -49.26 13.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.749 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -37.43 84.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 111.001 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -80.77 173.98 6.87 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.146 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.477 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.8 Cg_endo -71.23 127.74 13.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.071 1.847 . . . . 0.0 111.659 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.38 -14.97 45.44 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.512 2.141 . . . . 0.0 113.18 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.55 58.65 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.511 ' ND2' HD11 ' A' ' 82' ' ' LEU . 1.1 m-80 -120.23 31.57 6.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.274 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -75.28 -45.07 4.58 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.073 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.521 ' HB2' HD13 ' A' ' 71' ' ' LEU . 85.9 Cg_exo -44.74 -36.27 10.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.242 1.961 . . . . 0.0 112.619 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.698 HG11 ' CG ' ' A' ' 84' ' ' PHE . 5.3 t -77.42 -44.6 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.047 0.451 . . . . 0.0 110.113 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.599 HG22 ' HB2' ' A' ' 127' ' ' LYS . 8.0 mm -68.27 -31.67 52.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.919 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.58 -27.59 40.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.133 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -49.5 11.67 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.634 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.963 HD13 ' CD2' ' A' ' 68' ' ' PHE . 6.8 tp -78.09 -30.75 49.76 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.895 0.378 . . . . 0.0 111.609 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.599 ' HB2' HG22 ' A' ' 123' ' ' ILE . 14.3 ttpt -53.91 -42.62 68.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.949 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -70.5 -7.69 45.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.831 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.334 -0.105 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.298 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.915 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 5155 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 5156 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.8 0.333 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 134.45 42.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 79' ' ' HIS . 4.9 mttt -140.01 129.15 23.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.866 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.812 ' HG ' HG22 ' A' ' 80' ' ' ILE . 2.1 pp -146.16 119.84 9.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.613 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.785 ' C ' HD13 ' A' ' 6' ' ' ILE . 6.6 mt-30 -101.89 157.45 16.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.096 0.474 . . . . 0.0 112.022 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.785 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -142.96 138.99 27.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.46 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.967 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.97 125.68 44.29 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.469 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.471 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -135.81 156.02 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.169 0.509 . . . . 0.0 111.573 -179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -151.37 126.08 2.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.799 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.024 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.87 110.63 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.756 HG22 ' CE3' ' A' ' 90' ' ' TRP . 1.2 mt -71.43 120.27 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.96 0.41 . . . . 0.0 111.4 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -83.15 124.42 30.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.512 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.506 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 4.8 t-20 -70.33 -172.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.979 0.895 . . . . 0.0 112.587 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -64.15 -12.0 35.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.781 -1.554 . . . . 0.0 113.079 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -129.05 -82.26 0.57 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.669 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -153.81 14.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.543 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 1.5 pt-20 -100.98 160.32 14.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.024 HG21 HG22 ' A' ' 10' ' ' ILE . 11.3 mt -135.94 142.18 39.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.007 0.432 . . . . 0.0 111.501 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -93.02 129.46 38.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.992 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' HB ' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.83 140.88 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.957 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.413 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 6.4 p -71.55 111.8 7.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.807 0.336 . . . . 0.0 111.089 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HA ' HD23 ' A' ' 33' ' ' LEU . 3.2 ttt-85 -85.16 83.53 7.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.073 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 43.64 30.77 0.38 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.965 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.927 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . . . 65.22 24.4 12.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.534 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 50.07 49.23 20.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.0 111.334 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -96.87 22.98 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.17 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.66 -80.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.291 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -58.34 153.19 16.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.913 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 mtt 59.46 43.13 16.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.823 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.63 -8.79 57.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.681 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.16 13.47 11.27 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -114.28 26.21 10.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.994 0.426 . . . . 0.0 111.339 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -45.7 100.3 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.485 179.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.9 -174.18 2.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.245 0.545 . . . . 0.0 112.226 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.77 168.33 10.46 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.336 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.439 ' HA ' ' CD ' ' A' ' 98' ' ' GLU . 89.2 Cg_endo -75.41 168.8 23.79 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.6 2.867 . . . . 0.0 112.102 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.723 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.9 59.63 0.73 Allowed Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.19 -1.005 . . . . 0.0 114.213 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -121.42 138.82 12.69 Favored Glycine 0 C--N 1.315 -0.586 0 CA-C-N 114.614 -0.793 . . . . 0.0 112.206 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.62 -4.79 0.13 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.082 0.553 . . . . 0.0 111.901 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.967 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.89 -47.56 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.421 0.629 . . . . 0.0 111.099 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -30.95 -77.57 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.813 -179.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.5 mtp 39.42 -93.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.83 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -171.63 22.92 0.08 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.49 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.68 -158.21 0.11 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.339 0.114 . . . . 0.0 110.876 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.83 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -106.02 153.06 40.43 Favored Pre-proline 0 N--CA 1.455 -0.196 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.83 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.99 -24.76 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.624 2.216 . . . . 0.0 112.373 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.623 ' O ' HG23 ' A' ' 51' ' ' VAL . 37.3 mm-40 -101.61 -47.3 4.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.924 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -80.66 -5.2 56.62 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 44' ' ' GLU . . . -64.82 -57.46 8.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.573 0.225 . . . . 0.0 110.719 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.712 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -79.17 -45.55 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.135 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.8 t -50.58 -38.45 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 0.0 111.146 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -78.64 -51.97 9.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.004 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.431 ' HG3' ' OE2' ' A' ' 57' ' ' GLU . 1.3 tp10 -63.68 -23.9 67.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.867 HD21 ' NE2' ' A' ' 64' ' ' HIS . 3.2 tp -53.95 -44.33 70.62 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.886 0.374 . . . . 0.0 110.054 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -60.81 -32.72 72.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -77.4 -23.95 50.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.733 179.024 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 37' ' ' GLY . 5.7 mp0 -108.15 5.36 25.81 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.968 HG12 HG13 ' A' ' 60' ' ' ILE . 25.3 t -134.63 -44.43 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 109.935 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.562 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.58 -40.17 0.23 Allowed Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.787 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.968 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.72 -177.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.06 0.457 . . . . 0.0 111.059 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.05 88.41 14.64 Favored Pre-proline 0 N--CA 1.442 -0.831 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.942 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.807 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.6 Cg_endo -111.1 148.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 123.446 2.764 . . . . 0.0 113.848 -177.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -74.67 79.73 2.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.006 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -122.72 126.96 48.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.885 -176.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.2 t80 -179.62 167.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.676 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.5 t 79.54 177.4 0.12 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.395 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.868 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -135.61 130.78 34.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.458 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.78 ' CD2' HD22 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -76.86 -41.6 43.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.218 0.533 . . . . 0.0 109.696 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.691 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.9 mt-10 -171.39 131.35 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.786 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 132.16 56.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.836 0.351 . . . . 0.0 111.554 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.777 HD22 ' HB2' ' A' ' 121' ' ' PRO . 14.7 tp -112.04 132.81 54.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.472 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -123.9 110.96 15.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.817 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.801 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.0 p90 -141.01 153.07 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.764 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' OE1' ' CE1' ' A' ' 79' ' ' HIS . 8.0 pt-20 -116.27 138.35 51.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.185 0.516 . . . . 0.0 111.289 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -93.21 163.22 25.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.339 179.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -52.49 82.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.935 2.423 . . . . 0.0 112.168 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.5 t0 88.74 13.29 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.355 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.451 ' NE ' HD21 ' A' ' 4' ' ' LEU . 7.1 ttp180 -137.36 96.18 3.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.759 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.403 ' CE1' ' OE1' ' A' ' 74' ' ' GLU . 2.4 t60 -80.38 117.66 21.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.582 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.812 HG22 ' HG ' ' A' ' 4' ' ' LEU . 7.9 pt -125.32 128.31 72.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.172 0.51 . . . . 0.0 111.931 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.32 118.58 35.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.815 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.849 HD22 ' CE1' ' A' ' 84' ' ' PHE . 1.1 mt -101.57 113.61 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.908 0.385 . . . . 0.0 111.416 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 10.0 m0 -116.25 122.6 45.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.741 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.898 ' CE1' HG21 ' A' ' 122' ' ' VAL . 1.2 m-85 -110.84 111.36 22.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.924 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.868 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 24.4 m95 -94.29 136.55 34.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.983 0.42 . . . . 0.0 111.376 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 55.2 tp -88.37 102.93 15.35 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.232 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.006 HG22 ' ND1' ' A' ' 64' ' ' HIS . 37.0 t -83.08 145.52 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.122 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -110.24 -25.73 9.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.81 163.33 26.64 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.706 0.684 . . . . 0.0 111.408 -179.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.756 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.27 120.69 4.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.967 0.413 . . . . 0.0 111.324 178.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -77.5 153.47 33.42 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.067 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.46 -121.04 21.15 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.528 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.2 tt0 -134.96 147.6 63.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.547 0.213 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.516 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.57 128.76 10.47 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.859 2.373 . . . . 0.0 111.241 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.562 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 57.7 p-90 -137.42 -60.24 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.161 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.518 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 53.93 -97.64 0.03 OUTLIER Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.688 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 178.06 22.94 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.439 ' CD ' ' HA ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -67.96 -32.9 73.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.934 0.397 . . . . 0.0 110.682 179.52 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.61 35.12 29.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.779 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.927 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 66.0 mt-30 -140.11 91.9 9.88 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.022 0.439 . . . . 0.0 111.178 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -43.69 137.38 6.27 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.025 2.483 . . . . 0.0 112.758 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . -134.22 177.01 19.48 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.596 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.8 157.0 44.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.576 0.227 . . . . 0.0 110.641 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -78.15 107.18 10.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.95 0.405 . . . . 0.0 110.509 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.4 ptm -119.61 163.23 17.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.908 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p -77.98 114.97 17.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.661 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.755 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -73.54 -28.14 61.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 p -53.01 -22.7 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.315 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.3 42.69 1.59 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.337 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.511 HD13 HD22 ' A' ' 107' ' ' LEU . 10.9 tp -62.66 147.22 50.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.11 132.1 53.95 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.61 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.35 -15.2 61.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.498 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.67 -49.31 13.38 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.574 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -32.88 74.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.086 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.61 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -87.97 173.14 6.73 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.408 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.497 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.2 Cg_endo -72.19 127.72 13.05 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.122 1.881 . . . . 0.0 111.701 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.44 -14.96 45.51 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.568 2.179 . . . . 0.0 113.125 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.49 58.57 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.843 ' ND2' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -121.35 32.17 6.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.729 0.3 . . . . 0.0 111.278 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -75.93 -36.1 1.86 Allowed Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.777 ' HB2' HD22 ' A' ' 71' ' ' LEU . 71.4 Cg_exo -49.56 -43.19 40.21 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 121.971 1.78 . . . . 0.0 112.918 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.898 HG21 ' CE1' ' A' ' 84' ' ' PHE . 1.8 t -77.36 -51.25 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.105 0.479 . . . . 0.0 111.099 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.558 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.1 mm -63.65 -32.58 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.273 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.9 -31.26 59.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.038 0.447 . . . . 0.0 110.477 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -72.78 -52.54 14.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.617 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.78 HD22 ' CD2' ' A' ' 68' ' ' PHE . 1.8 tp -78.19 -33.01 50.34 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.558 ' HB2' HG22 ' A' ' 123' ' ' ILE . 3.2 ttpm? -53.73 -42.61 68.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.067 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -67.85 -9.46 44.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.792 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 126' ' ' LEU . 11.0 mp . . . . . 0 C--N 1.333 -0.112 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.888 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.748 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 5167 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 5168 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.85 0.357 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.65 133.76 33.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.99 126.54 20.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.829 HD12 ' CD1' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -133.51 140.33 47.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.771 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.747 ' C ' HD13 ' A' ' 6' ' ' ILE . 9.4 mt-30 -106.61 150.43 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.279 0.561 . . . . 0.0 111.915 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.829 ' CD1' HD12 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -140.7 139.09 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.41 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.941 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.47 140.63 52.77 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -144.56 151.24 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.242 0.544 . . . . 0.0 111.327 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.56 130.67 3.21 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.17 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.877 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -88.43 108.0 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.727 HG23 HG11 ' A' ' 87' ' ' VAL . 1.1 mt -71.28 124.99 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.133 0.492 . . . . 0.0 111.479 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -87.06 127.12 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.969 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.465 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 14.8 t30 -81.95 -172.29 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.858 0.837 . . . . 0.0 112.012 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -81.82 3.59 25.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.227 -1.351 . . . . 0.0 112.261 -179.225 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -139.2 51.88 1.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.741 0.305 . . . . 0.0 111.425 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.7 p30 45.3 26.29 0.26 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.421 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 8.1 pt-20 -118.81 144.08 46.55 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.877 HG21 HG22 ' A' ' 10' ' ' ILE . 10.1 mt -114.22 142.86 25.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.162 0.506 . . . . 0.0 111.459 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -95.92 128.4 42.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.671 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.65 162.14 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.489 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.617 HG23 ' HD3' ' A' ' 36' ' ' PRO . 38.2 p -91.99 111.97 23.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.755 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -101.15 165.9 11.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.219 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -71.45 55.86 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.958 0.408 . . . . 0.0 110.305 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 43.51 -164.63 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.489 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.78 47.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.018 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -131.29 -174.48 3.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.992 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.29 -163.08 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.3 m80 64.33 99.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.95 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.3 mmt 57.51 52.04 8.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.0 -8.84 56.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.639 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.82 31.04 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.517 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 26.26 10.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.859 0.362 . . . . 0.0 111.532 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -48.61 95.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.508 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.7 tt0 -113.11 -179.14 3.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.196 0.522 . . . . 0.0 111.64 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.95 162.05 35.21 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.517 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.617 ' HD3' HG23 ' A' ' 21' ' ' THR . 9.3 Cg_endo -50.29 168.76 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.569 2.846 . . . . 0.0 111.526 178.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.678 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.04 59.69 0.73 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.757 -1.211 . . . . 0.0 113.86 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -138.3 117.73 1.49 Allowed Glycine 0 C--N 1.313 -0.71 0 CA-C-N 114.548 -0.826 . . . . 0.0 111.91 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.82 -6.9 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.307 0.643 . . . . 0.0 111.215 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.941 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -43.62 -62.65 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.258 0.551 . . . . 0.0 111.375 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.499 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -16.77 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.425 -179.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.5 mmt 43.14 -94.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.511 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.83 17.82 0.09 OUTLIER Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.598 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -77.74 -161.66 0.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.532 0.206 . . . . 0.0 110.742 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.883 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.66 154.4 39.26 Favored Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.883 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -44.0 -24.87 0.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.694 2.263 . . . . 0.0 112.406 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.646 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -98.48 -50.38 4.31 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.985 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -80.45 -4.99 55.86 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -65.49 -57.5 8.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.574 0.226 . . . . 0.0 110.819 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.707 ' CG2' HD13 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -78.68 -43.32 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.029 179.279 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.9 t -50.63 -36.45 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.344 . . . . 0.0 110.721 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.67 -48.47 14.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.747 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -67.03 -20.0 65.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.03 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.707 HD13 ' CG2' ' A' ' 50' ' ' VAL . 3.3 tp -57.47 -44.82 85.18 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 110.477 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -32.28 73.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 97' ' ' LYS . 5.7 tm-20 -77.37 -25.48 51.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.92 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -108.15 5.36 25.81 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.93 HG12 HG13 ' A' ' 60' ' ' ILE . 30.0 t -134.33 -44.31 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.139 0.495 . . . . 0.0 109.94 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.535 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.57 -41.62 0.31 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.463 -0.789 . . . . 0.0 113.715 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.93 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.64 -177.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 120.975 0.417 . . . . 0.0 111.107 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.36 88.41 15.46 Favored Pre-proline 0 N--CA 1.441 -0.897 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.969 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.8 ' HG3' HG11 ' A' ' 58' ' ' VAL . 9.1 Cg_endo -109.69 150.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.393 2.729 . . . . 0.0 113.659 -177.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.66 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -77.02 80.72 3.55 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 175.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.996 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.65 128.0 50.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.298 -176.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.5 t80 -179.35 168.54 1.48 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.593 -0.443 . . . . 0.0 112.106 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.411 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 0.3 OUTLIER 77.26 -166.93 0.05 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.453 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -151.8 133.42 14.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.056 -179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.66 ' CE1' HG12 ' A' ' 122' ' ' VAL . 15.7 p90 -76.7 -41.78 43.98 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.663 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.3 mt-10 -171.6 131.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.083 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG2' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.7 132.42 42.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.759 0.314 . . . . 0.0 111.643 -179.082 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.846 HD22 HG22 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -112.31 156.52 22.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.791 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -137.12 110.0 7.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.658 ' HE1' HD12 ' A' ' 82' ' ' LEU . 7.2 p90 -128.84 153.12 47.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.757 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -121.05 119.4 32.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 111.212 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -73.97 163.07 71.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.52 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.4 Cg_endo -53.79 82.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.92 2.413 . . . . 0.0 112.087 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.9 t70 91.86 11.08 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.373 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.425 ' CG ' HD21 ' A' ' 4' ' ' LEU . 2.7 ttt180 -137.29 93.81 2.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 0.0 110.846 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.21 103.11 6.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 1.1 tt -106.17 111.75 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.015 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.428 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -94.36 118.47 31.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.77 179.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.668 HD11 HD21 ' A' ' 119' ' ' ASN . 10.4 mt -107.35 114.03 27.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 111.612 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.431 ' O ' HG13 ' A' ' 8' ' ' VAL . 11.2 m0 -108.62 122.47 47.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.139 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.663 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 6.3 m-85 -112.67 112.25 23.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.4 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.702 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 30.1 m95 -94.75 148.21 22.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.57 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 65' ' ' PHE . 47.2 tp -100.76 102.96 14.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.057 0.456 . . . . 0.0 110.809 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.996 HG22 ' ND1' ' A' ' 64' ' ' HIS . 33.4 t -84.81 145.35 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.733 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HB2' ' CG ' ' A' ' 63' ' ' GLN . 3.9 mt-10 -106.36 -33.47 7.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.08 165.4 24.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.927 0.785 . . . . 0.0 111.813 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.703 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -151.56 127.52 10.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 111.53 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -76.89 147.76 36.84 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.11 -121.2 25.93 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.438 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -133.99 148.09 66.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.631 0.253 . . . . 0.0 110.82 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.49 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.65 128.71 10.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.948 2.432 . . . . 0.0 111.566 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.535 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 62.1 p-90 -136.16 -58.61 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.716 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.578 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.1 -95.72 0.01 OUTLIER Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.01 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' GLU . 2.8 tttp 174.25 37.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 110.938 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.459 ' OE2' HG22 ' A' ' 21' ' ' THR . 1.8 pt-20 -66.94 -30.63 70.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.512 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 10.3 79.39 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.391 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.406 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 4.7 mt-30 -140.24 91.88 9.73 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.356 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -43.72 138.48 5.74 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 123.054 2.503 . . . . 0.0 112.643 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.19 177.07 19.43 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.747 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -136.4 157.17 47.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.567 0.222 . . . . 0.0 110.577 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -72.98 107.16 5.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.88 0.372 . . . . 0.0 110.278 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.455 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -119.63 163.04 17.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.432 ' OG ' HG12 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -78.97 114.85 18.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.807 ' CD1' HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -72.27 -18.73 61.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.838 HG22 HD21 ' A' ' 129' ' ' LEU . 14.8 p -62.52 -10.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.446 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.25 50.48 0.89 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.63 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.807 HD23 ' CD1' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -62.09 138.86 58.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.678 0.275 . . . . 0.0 110.538 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.604 ' H ' HD13 ' A' ' 110' ' ' LEU . 1.1 m-80 -116.87 121.75 42.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.169 0.509 . . . . 0.0 111.885 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.663 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.1 -15.13 62.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.977 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -78.33 -49.46 13.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -70.64 -22.54 62.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.546 0.212 . . . . 0.0 111.367 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.663 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -100.35 170.81 6.19 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.5 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 43.7 Cg_endo -68.09 127.67 16.34 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.234 1.956 . . . . 0.0 111.898 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.38 -19.65 61.54 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.577 2.184 . . . . 0.0 113.001 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.93 -9.37 58.25 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.668 HD21 HD11 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -117.72 29.54 7.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.779 0.323 . . . . 0.0 111.408 -178.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.3 mt-10 -76.24 -31.87 1.03 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.789 ' HB2' HD13 ' A' ' 71' ' ' LEU . 82.3 Cg_exo -48.52 -45.44 27.14 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 121.869 1.712 . . . . 0.0 113.04 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.846 HG22 HD22 ' A' ' 71' ' ' LEU . 1.4 t -77.41 -51.4 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.07 0.462 . . . . 0.0 111.205 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.495 ' CG2' ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -62.42 -36.89 77.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.612 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.62 -29.77 52.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.905 0.384 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -79.74 -48.47 13.58 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.593 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.454 HD13 ' CD1' ' A' ' 68' ' ' PHE . 3.4 tp -78.09 -46.6 20.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.852 0.358 . . . . 0.0 111.269 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.571 ' O ' HD13 ' A' ' 129' ' ' LEU . 8.2 ttpp -51.95 -42.24 62.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.879 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -63.96 -7.08 7.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.142 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.838 HD21 HG22 ' A' ' 108' ' ' VAL . 8.1 mp . . . . . 0 C--O 1.231 0.119 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.813 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 5179 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 5180 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.924 0.393 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -74.96 134.16 41.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HG2' ' CG ' ' A' ' 79' ' ' HIS . 23.1 mtpt -140.0 135.02 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.766 HD12 ' CD1' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -146.04 141.08 27.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.768 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.753 ' C ' HD13 ' A' ' 6' ' ' ILE . 28.1 mt-30 -106.16 149.9 26.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.405 0.622 . . . . 0.0 112.316 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.766 ' CD1' HD12 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.31 116.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.611 178.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.969 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.98 135.81 53.15 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.352 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 0.9 OUTLIER -144.54 163.1 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.98 0.419 . . . . 0.0 111.19 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -141.25 130.35 4.41 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.091 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.964 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -72.0 108.45 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.74 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.5 mt -70.97 125.98 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.623 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.628 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -87.7 127.25 35.3 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.62 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.536 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 6.1 t-20 -69.93 -172.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.458 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.04 -10.7 31.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.77 -1.559 . . . . 0.0 112.895 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -133.82 -82.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.785 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -149.97 16.21 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 0.0 111.613 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.821 ' C ' HD12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -100.61 160.56 14.25 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.964 HG21 HG22 ' A' ' 10' ' ' ILE . 1.8 mp -130.64 138.14 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.094 0.473 . . . . 0.0 111.482 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.585 ' CZ ' HG23 ' A' ' 21' ' ' THR . 0.5 OUTLIER -85.96 116.02 23.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.332 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.505 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.05 120.11 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.745 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.86 HG21 ' HG2' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -70.73 115.97 10.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.575 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 19.6 ptt-85 -106.89 172.33 6.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.66 62.03 0.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.496 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 46.23 -169.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.412 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.19 -33.68 38.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.069 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -159.42 138.01 10.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -171.18 -75.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -151.69 -66.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 tpt -106.4 79.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.788 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.93 -8.97 58.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.621 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -96.33 26.48 4.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.744 0.307 . . . . 0.0 111.144 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -114.22 26.2 10.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.018 0.437 . . . . 0.0 111.191 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.489 HD21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -45.47 114.12 0.7 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.619 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' OE1' ' CD ' ' A' ' 116' ' ' PRO . 0.5 OUTLIER -124.85 -171.66 2.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.195 0.521 . . . . 0.0 112.094 -179.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.611 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.55 168.59 9.79 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.146 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.562 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 87.5 Cg_endo -81.74 167.29 16.79 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.628 2.885 . . . . 0.0 113.799 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.39 -5.44 52.05 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.371 -0.831 . . . . 0.0 114.988 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -59.25 171.68 4.97 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.5 0.65 . . . . 0.0 113.214 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 76.58 7.03 3.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 122.517 0.327 . . . . 0.0 111.811 179.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.969 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.3 pt -55.44 -26.84 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.673 0.749 . . . . 0.0 110.032 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.542 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.98 -60.17 1.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.692 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER 5.37 -79.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.471 179.283 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.54 33.63 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.643 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.4 mp0 -88.95 -174.82 4.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.821 0.343 . . . . 0.0 111.09 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.852 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.5 154.14 38.09 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.322 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.852 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.97 -25.25 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.872 2.381 . . . . 0.0 112.448 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.8 mt-10 -104.02 -40.4 6.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.405 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.402 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 34.4 mt-30 -80.29 -4.91 55.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.654 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.919 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.89 -57.11 14.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.409 . . . . 0.0 110.667 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.803 HG11 ' NE1' ' A' ' 85' ' ' TRP . 2.5 m -78.64 -45.99 25.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.48 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.489 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 29.0 t -56.33 -36.66 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.141 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -77.95 -49.78 13.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.983 0.42 . . . . 0.0 110.193 179.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.53 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.5 mm-40 -65.56 -19.89 66.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.334 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.534 HD11 ' CD2' ' A' ' 64' ' ' HIS . 8.6 tp -56.55 -44.49 80.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -31.81 69.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.075 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.45 -31.09 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.572 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HA ' ' H ' ' A' ' 97' ' ' LYS . 4.0 mp0 -108.06 5.37 25.99 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.866 HG13 ' HB3' ' A' ' 94' ' ' PRO . 16.0 t -134.39 -43.96 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.104 0.478 . . . . 0.0 110.067 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.574 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.86 -38.32 0.29 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.614 -0.721 . . . . 0.0 114.207 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.845 HG22 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.71 -178.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.64 88.98 6.97 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.696 ' HG3' HG11 ' A' ' 58' ' ' VAL . 10.6 Cg_endo -108.28 144.07 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.475 2.783 . . . . 0.0 113.987 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -74.81 79.44 2.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.84 ' CB ' HG13 ' A' ' 87' ' ' VAL . 1.1 t-80 -123.23 122.36 38.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.65 -1.613 . . . . 0.0 109.895 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 6.5 t80 -179.41 161.07 1.04 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.177 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 9.3 t 77.01 166.93 0.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.783 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.797 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.2 pp -119.54 130.08 54.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.873 ' CE2' HD11 ' A' ' 10' ' ' ILE . 7.1 p90 -78.2 -41.33 34.84 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.598 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -171.31 131.75 0.77 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.328 178.037 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.796 ' HG2' HD13 ' A' ' 67' ' ' LEU . 50.4 pttt -139.39 132.75 30.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 111.483 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.023 HD12 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -123.43 151.38 42.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.952 0.406 . . . . 0.0 110.996 179.455 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -121.59 133.91 55.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.757 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -141.03 145.81 36.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.568 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.08 126.35 49.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.095 0.474 . . . . 0.0 111.365 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -86.4 163.1 43.51 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.319 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.6 Cg_endo -53.97 82.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.825 2.35 . . . . 0.0 112.166 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.7 t70 93.25 9.67 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.52 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.482 ' CZ ' HD21 ' A' ' 4' ' ' LEU . 10.2 ttt85 -137.34 93.78 2.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.299 . . . . 0.0 110.759 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.416 ' CG ' ' HG2' ' A' ' 3' ' ' LYS . 1.1 m-70 -82.3 102.28 11.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.921 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 2.0 tt -106.32 111.73 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.025 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.422 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -92.54 118.45 31.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.015 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.531 HD23 HD11 ' A' ' 71' ' ' LEU . 14.8 tp -108.0 114.09 27.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 111.577 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.405 ' HA ' ' HB2' ' A' ' 70' ' ' LYS . 9.8 m0 -112.22 122.2 47.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.46 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 5.8 m-30 -109.84 109.63 20.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.911 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.803 ' NE1' HG11 ' A' ' 50' ' ' VAL . 32.5 m95 -95.79 148.65 22.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.622 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.0 pp -87.29 138.12 31.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.433 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.84 HG13 ' CB ' ' A' ' 64' ' ' HIS . 17.5 t -123.65 145.52 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.018 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.87 -30.68 8.01 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.572 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.28 165.01 24.71 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.221 0.919 . . . . 0.0 112.111 -178.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.74 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -154.64 130.15 9.86 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.133 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.23 132.71 47.62 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.055 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 48.79 -105.23 0.12 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.416 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 26.5 tt0 -134.32 137.65 28.46 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.812 -0.194 . . . . 0.0 110.759 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.866 ' HB3' HG13 ' A' ' 58' ' ' VAL . 4.7 Cg_exo -74.13 128.9 12.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.596 2.197 . . . . 0.0 110.682 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.574 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 21.5 p-90 -118.15 -63.95 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.583 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.43 -100.16 0.02 OUTLIER Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.853 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 160.56 74.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.584 0.354 . . . . 0.0 110.774 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.86 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.9 OUTLIER -88.6 -33.2 17.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.803 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 142.44 -38.5 1.45 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.323 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.487 ' O ' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -140.01 110.76 7.22 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.018 0.437 . . . . 0.0 111.885 -179.333 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -43.84 146.39 1.58 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.121 2.547 . . . . 0.0 112.55 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.19 177.29 17.48 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.001 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -128.85 157.23 42.11 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -77.99 106.83 10.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.4 ptp -119.99 163.08 18.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.924 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 95.8 p -75.04 114.98 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.859 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.69 HD12 ' CD2' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -78.97 -18.92 52.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.306 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.42 ' HA ' HD21 ' A' ' 129' ' ' LEU . 25.0 t -54.28 -18.52 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.424 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.39 55.1 0.57 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.268 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.533 HD22 HG23 ' A' ' 123' ' ' ILE . 5.6 tt -62.15 150.43 38.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -107.87 126.01 52.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.334 0.588 . . . . 0.0 112.428 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.656 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -15.2 61.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.791 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -78.11 -49.14 14.46 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.654 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -26.33 65.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.79 0.329 . . . . 0.0 110.8 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.656 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -98.36 166.96 12.33 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.17 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 59.6 Cg_endo -72.61 127.81 12.81 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.393 2.062 . . . . 0.0 111.937 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.54 -14.92 42.55 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.595 2.197 . . . . 0.0 113.05 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.69 -9.51 57.3 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.433 ' OD1' HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -121.72 31.17 6.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.827 0.346 . . . . 0.0 111.277 -179.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.2 -34.13 1.37 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -179.162 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 93.1 Cg_exo -44.73 -46.28 12.69 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.21 1.94 . . . . 0.0 113.193 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 1.023 HG22 HD12 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -77.14 -33.98 20.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.029 0.442 . . . . 0.0 110.048 179.666 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.581 HG13 ' CE2' ' A' ' 115' ' ' PHE . 7.8 mm -68.18 -39.79 81.77 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.839 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.55 -29.44 50.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.436 . . . . 0.0 110.371 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -80.27 -53.21 6.86 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.782 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.69 ' CD2' HD12 ' A' ' 107' ' ' LEU . 1.7 tp -78.3 -19.79 52.84 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.513 ' HB2' HG22 ' A' ' 123' ' ' ILE . 54.6 tttm -78.21 -42.71 30.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.081 0.467 . . . . 0.0 110.745 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -69.65 -7.03 35.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.905 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.123 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.683 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.749 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 5191 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 5192 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.875 0.369 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -109.75 121.5 45.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -128.62 134.72 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.912 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.537 HD13 HD11 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -139.13 143.03 38.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.419 ' C ' HD12 ' A' ' 6' ' ' ILE . 30.9 mt-30 -102.61 153.1 20.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.335 0.588 . . . . 0.0 112.02 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.83 ' HB ' HD23 ' A' ' 82' ' ' LEU . 4.9 mp -146.2 127.93 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.743 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.063 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.58 124.56 42.5 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.581 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 2.0 m -116.53 162.23 14.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.345 0.593 . . . . 0.0 111.912 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -143.25 109.57 0.56 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.848 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -70.53 98.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.733 HG22 ' CE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.14 123.72 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 121.21 0.529 . . . . 0.0 112.121 -178.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.528 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -96.23 127.19 42.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.363 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.536 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -79.58 -172.63 3.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.113 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.483 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 14.9 tp10 -80.48 -2.72 47.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.299 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -134.16 49.61 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.879 0.371 . . . . 0.0 111.229 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 48.04 22.62 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.448 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 13' ' ' ASN . 18.4 pt-20 -110.44 141.08 44.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.628 HG21 HG13 ' A' ' 10' ' ' ILE . 2.6 mt -110.82 151.44 12.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.284 0.564 . . . . 0.0 112.296 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -101.01 99.96 10.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.517 178.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.419 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -104.81 120.1 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.569 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.628 HG23 ' HD3' ' A' ' 36' ' ' PRO . 18.2 p -71.08 111.85 6.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.998 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 2.5 ptm180 -98.71 172.09 7.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.451 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -72.06 58.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.967 0.413 . . . . 0.0 110.235 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 46.25 -169.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.419 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.22 27.31 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -180.0 38.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.78 -70.38 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -177.64 -68.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.21 85.27 3.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.01 -8.79 57.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.64 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.09 20.36 5.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.468 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 26.26 10.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 111.501 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -46.8 120.21 2.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.696 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.533 ' HG2' ' N2 ' ' A' ' 131' ' ' 8OG . 7.8 mt-10 -137.19 -174.11 3.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.045 0.45 . . . . 0.0 111.473 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.561 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.03 161.17 39.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.23 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.628 ' HD3' HG23 ' A' ' 21' ' ' THR . 12.2 Cg_endo -54.65 167.76 1.34 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.374 2.716 . . . . 0.0 111.715 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.61 59.56 0.75 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.768 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -124.96 132.15 8.01 Favored Glycine 0 C--N 1.311 -0.818 0 CA-C-N 114.406 -0.897 . . . . 0.0 111.78 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.41 5.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.936 0.494 . . . . 0.0 112.297 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.063 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.27 -28.11 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.601 0.715 . . . . 0.0 110.279 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.578 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.98 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.787 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.5 mmm 31.77 -86.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.52 0.513 . . . . 0.0 111.827 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -158.96 24.38 0.33 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.605 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -102.64 -179.51 3.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.892 0.377 . . . . 0.0 111.051 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.906 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.55 158.52 34.46 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.929 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.906 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.86 -24.7 0.85 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.726 2.284 . . . . 0.0 112.473 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -85.24 -61.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -80.4 -20.13 44.69 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.883 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -56.87 -48.43 78.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.734 0.302 . . . . 0.0 111.093 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.729 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.0 OUTLIER -78.11 -47.29 25.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.549 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.7 t -57.4 -38.49 63.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.624 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -78.44 -46.54 19.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.989 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -69.79 -21.66 63.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.344 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.678 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -57.39 -44.68 84.71 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.777 0.322 . . . . 0.0 110.565 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -30.9 71.94 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.1 tm-20 -77.63 -29.05 51.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.104 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.68 5.85 25.23 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.955 HG12 HG13 ' A' ' 60' ' ' ILE . 21.3 t -134.04 -44.3 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.956 0.408 . . . . 0.0 109.989 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.598 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.68 -41.33 0.31 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.648 -0.705 . . . . 0.0 113.488 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.955 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.55 -176.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -113.06 89.1 13.24 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.306 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.88 ' HG3' HG11 ' A' ' 58' ' ' VAL . 7.9 Cg_endo -108.79 148.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 123.205 2.604 . . . . 0.0 114.139 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' CG ' ' HG2' ' A' ' 89' ' ' ARG . 86.6 mt-30 -74.76 79.8 2.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.958 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -123.11 125.55 45.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.374 -176.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.6 t80 -177.77 159.12 1.38 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.128 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER 84.21 -170.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.298 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.689 HD13 ' HD3' ' A' ' 70' ' ' LYS . 3.5 pp -145.02 130.58 18.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.056 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.619 ' CE1' HG12 ' A' ' 122' ' ' VAL . 1.3 p90 -76.67 -35.18 58.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.212 0.529 . . . . 0.0 109.678 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.7 OUTLIER -171.2 163.53 7.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.504 179.038 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.689 ' HD3' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.53 132.41 22.74 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.684 -179.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.739 ' HB2' HG22 ' A' ' 122' ' ' VAL . 9.0 tp -119.25 142.45 48.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.727 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -140.0 111.02 6.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.505 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.579 ' HE1' HD12 ' A' ' 82' ' ' LEU . 8.8 p90 -138.67 153.27 48.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.767 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.06 140.02 52.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.176 0.512 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -89.2 163.18 35.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.545 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.3 Cg_endo -51.9 83.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.103 2.536 . . . . 0.0 112.036 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 8.1 m-20 93.96 16.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.142 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 35.1 ttt180 -137.32 150.13 47.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.489 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.83 99.72 6.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.763 0.316 . . . . 0.0 110.719 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.506 HD12 H2'' ' A' ' 131' ' ' 8OG . 4.7 tt -104.35 111.75 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 120.956 0.408 . . . . 0.0 110.96 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.438 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -103.88 118.99 38.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.235 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.83 HD23 ' HB ' ' A' ' 6' ' ' ILE . 66.3 mt -118.86 114.35 22.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.877 0.37 . . . . 0.0 111.615 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.472 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.8 m0 -106.29 122.37 46.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.142 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.908 ' CG ' HG11 ' A' ' 122' ' ' VAL . 2.2 m-85 -98.94 110.39 23.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.71 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.729 ' NE1' HG11 ' A' ' 50' ' ' VAL . 31.9 m95 -94.85 148.77 21.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.822 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.746 HD13 ' N ' ' A' ' 87' ' ' VAL . 3.1 tm? -94.17 137.36 33.44 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.356 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.958 HG22 ' ND1' ' A' ' 64' ' ' HIS . 41.1 t -124.14 145.01 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.499 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.59 -27.68 8.84 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.1 165.2 24.93 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.716 0.689 . . . . 0.0 111.766 -179.26 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.733 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -155.72 122.36 5.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.293 178.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.24 145.25 49.72 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.069 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.49 -116.82 6.9 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.582 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.6 tt0 -134.47 145.77 56.53 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.591 0.234 . . . . 0.0 110.819 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.53 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.4 Cg_exo -76.5 128.78 10.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.913 2.408 . . . . 0.0 111.135 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.598 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 47.5 p-90 -130.84 -62.54 0.9 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.549 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.37 -97.5 0.01 OUTLIER Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.613 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.6 tptp 178.77 35.49 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.636 0.255 . . . . 0.0 111.389 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.523 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -62.35 -46.21 89.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.334 179.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.34 14.91 46.15 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.353 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.434 ' O ' ' HB ' ' A' ' 21' ' ' THR . 49.9 mt-30 -140.31 92.91 9.18 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 111.539 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -43.78 138.42 5.93 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.901 2.401 . . . . 0.0 112.534 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.457 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.18 177.13 19.39 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.645 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.07 157.09 45.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.641 0.258 . . . . 0.0 110.785 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.464 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.45 107.13 6.4 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.876 0.37 . . . . 0.0 110.391 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -119.67 163.42 17.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.871 -179.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.603 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.2 p -82.0 114.94 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.851 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.625 ' CD2' HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -71.88 -18.79 62.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.112 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.912 ' HA ' HD21 ' A' ' 129' ' ' LEU . 10.9 p -57.29 -11.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.632 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.2 51.42 0.84 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.157 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.612 HD23 ' CD1' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -61.92 134.59 56.87 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.522 ' H ' HD13 ' A' ' 110' ' ' LEU . 1.6 m-20 -111.2 121.58 45.66 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.747 ' HB2' ' HE2' ' A' ' 127' ' ' LYS . . . -72.42 -14.72 61.77 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.801 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -76.41 -49.05 17.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.483 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -27.19 64.47 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.085 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.689 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -93.78 169.8 9.48 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.249 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.524 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 40.3 Cg_endo -67.33 127.58 16.85 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.216 1.944 . . . . 0.0 111.837 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.86 -15.01 47.29 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.588 2.192 . . . . 0.0 113.151 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.3 -9.19 59.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.553 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.6 m-80 -114.96 28.58 8.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.579 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -69.26 -34.48 4.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.259 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 61.8 Cg_exo -51.82 -45.87 35.7 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 121.962 1.775 . . . . 0.0 113.218 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.908 HG11 ' CG ' ' A' ' 84' ' ' PHE . 2.1 t -77.44 -51.34 18.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.328 . . . . 0.0 111.314 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.509 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -64.95 -29.81 48.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.064 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.38 -33.03 63.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.031 0.443 . . . . 0.0 110.257 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -78.3 -47.51 17.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.556 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.594 HD13 ' CG ' ' A' ' 68' ' ' PHE . 2.8 tp -78.17 -19.75 53.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.651 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.747 ' HE2' ' HB2' ' A' ' 112' ' ' ALA . 15.8 ttpp -83.64 -42.39 16.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.131 0.491 . . . . 0.0 110.524 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -63.91 -10.37 20.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.824 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.912 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.213 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.006 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.627 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 5203 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 5204 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.878 0.371 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -110.0 147.05 34.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HG2' ' CG ' ' A' ' 79' ' ' HIS . 7.6 mtmt -132.53 148.98 52.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.68 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.978 HD13 " O3'" ' A' ' 131' ' ' 8OG . 4.5 pp -146.07 132.45 19.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.283 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.465 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 42.3 mt-30 -102.78 153.6 20.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.353 0.597 . . . . 0.0 111.756 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 81' ' ' THR . 10.4 mm -146.46 130.22 10.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.085 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.021 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.84 124.21 41.61 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 9' ' ' GLY . 1.6 m -120.01 162.23 18.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.06 0.457 . . . . 0.0 111.564 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.93 109.4 0.48 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.81 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.74 HD11 HD13 ' A' ' 107' ' ' LEU . 1.1 tp -70.47 99.46 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.86 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -71.2 119.79 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -82.54 124.02 29.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.06 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.516 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 19.1 t-20 -69.63 177.6 2.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.851 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -54.59 -20.08 7.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.261 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -119.54 -82.46 0.64 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.67 0.271 . . . . 0.0 111.408 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.11 14.1 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 17.2 pt-20 -100.89 160.15 14.61 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.86 HG23 ' O ' ' A' ' 11' ' ' ILE . 3.4 mt -138.29 140.88 39.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.899 0.381 . . . . 0.0 111.895 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.724 ' CD2' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -86.15 113.08 21.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -111.81 119.53 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.168 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.731 HG22 ' HD3' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -74.99 111.8 10.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.95 0.405 . . . . 0.0 110.666 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.463 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 2.2 ptt180 -94.92 172.37 8.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.742 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.48 -18.66 4.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.265 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 100' ' ' GLN . . . 67.81 -81.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.227 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -177.94 87.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.093 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -113.78 -36.89 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -171.37 52.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 61.25 30.74 19.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.89 40.8 1.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.06 -8.72 55.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.773 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.63 16.39 5.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.26 26.23 10.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.083 0.468 . . . . 0.0 111.371 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.48 HD21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -47.48 122.22 4.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.705 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.825 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.4 tt0 -138.41 -167.25 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.005 0.431 . . . . 0.0 111.653 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.547 ' CD2' HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -119.15 155.2 53.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.499 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.731 ' HD3' HG22 ' A' ' 21' ' ' THR . 10.2 Cg_endo -52.9 167.67 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.324 2.683 . . . . 0.0 111.341 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.53 59.71 0.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 119.852 -1.166 . . . . 0.0 114.318 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -123.62 136.47 10.38 Favored Glycine 0 C--N 1.31 -0.863 0 CA-C-N 114.919 -0.64 . . . . 0.0 111.971 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 1.2 ttpt 91.27 4.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.006 0.522 . . . . 0.0 112.305 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.021 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -50.51 -29.14 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 110.364 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.17 -79.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.966 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 37.45 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.445 0.466 . . . . 0.0 111.634 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -161.93 26.14 0.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.691 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -99.45 -176.51 3.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.863 0.363 . . . . 0.0 111.125 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.917 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.93 162.92 18.66 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.405 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.917 ' HD2' HG22 ' A' ' 45' ' ' THR . 9.3 Cg_endo -49.14 -24.53 8.03 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.639 2.226 . . . . 0.0 112.425 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.77 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mm-40 -98.91 -48.04 5.05 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -77.17 -26.61 53.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.66 0.266 . . . . 0.0 111.615 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.967 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -57.79 -45.31 86.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.727 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.24 -46.63 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.516 179.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.4 t -60.03 -39.48 80.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.077 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -78.23 -45.77 22.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.963 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.68 -22.12 62.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.778 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.2 tp -53.87 -44.59 70.54 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.836 0.35 . . . . 0.0 110.082 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -59.54 -33.68 71.71 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.41 -26.25 51.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.994 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HG2' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -108.02 6.04 26.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.673 HG11 ' HG3' ' A' ' 62' ' ' PRO . 10.3 t -134.32 -44.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.214 0.53 . . . . 0.0 109.876 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.44 -43.43 0.57 Allowed Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.866 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.682 HG23 ' NE1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -84.36 -175.08 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.079 0.466 . . . . 0.0 111.292 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 p -112.64 89.09 12.32 Favored Pre-proline 0 N--CA 1.442 -0.875 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.554 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.673 ' HG3' HG11 ' A' ' 58' ' ' VAL . 4.9 Cg_endo -107.62 152.46 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.96 2.44 . . . . 0.0 114.203 -177.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -74.85 79.9 2.12 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.022 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.65 126.13 44.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.738 -176.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.9 t80 -179.35 165.66 1.43 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.9 0.381 . . . . 0.0 111.93 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 83.1 160.33 0.13 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.762 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.9 pp -113.77 131.97 56.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 111.363 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -88.61 -33.91 17.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.102 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.1 tt0 -171.56 149.93 2.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.471 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.1 108.16 4.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.74 0.305 . . . . 0.0 110.689 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.723 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -120.85 140.55 51.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.794 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.475 ' CB ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER -140.14 139.47 35.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.964 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.591 ' O ' HG22 ' A' ' 80' ' ' ILE . 69.9 t80 -141.05 100.98 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.4 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 1.8 pm0 -64.76 136.88 57.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.159 0.504 . . . . 0.0 111.41 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.485 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -101.54 162.89 19.04 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.434 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.579 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.4 Cg_endo -53.06 81.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.019 2.479 . . . . 0.0 112.353 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 13.3 t70 102.23 -24.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.267 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.686 ' HE ' HD21 ' A' ' 4' ' ' LEU . 5.4 ttt180 -109.65 95.19 5.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.712 0.292 . . . . 0.0 111.09 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.413 ' CG ' ' HG2' ' A' ' 3' ' ' LYS . 18.9 m170 -77.85 93.87 4.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 0.0 110.542 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.873 HG13 HD11 ' A' ' 4' ' ' LEU . 2.4 tt -85.78 131.8 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.475 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.475 HG23 ' CB ' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -134.06 118.63 17.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.178 179.668 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.667 HD13 ' CE1' ' A' ' 84' ' ' PHE . 1.6 pp -126.35 117.09 22.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 111.343 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.416 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.9 m0 -102.82 122.86 45.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.667 ' CE1' HD13 ' A' ' 82' ' ' LEU . 3.5 m-30 -95.08 109.89 21.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.311 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.653 ' CE2' HG11 ' A' ' 50' ' ' VAL . 21.3 m95 -95.58 148.6 22.34 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.166 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 65' ' ' PHE . 12.2 tp -92.62 138.1 31.79 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.567 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.022 HG22 ' ND1' ' A' ' 64' ' ' HIS . 38.0 t -124.33 145.71 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.67 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -111.27 -30.57 7.38 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.4 165.24 24.15 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.925 0.784 . . . . 0.0 111.688 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.662 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.8 p90 -148.23 130.25 15.36 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.538 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -78.06 145.08 36.06 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.935 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.14 -116.29 8.16 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.383 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 7.0 mt-10 -135.05 139.29 31.56 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.458 0.171 . . . . 0.0 110.848 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.465 ' HA ' HG12 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -76.35 128.6 10.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.812 2.341 . . . . 0.0 111.537 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.682 ' NE1' HG23 ' A' ' 60' ' ' ILE . 55.5 p-90 -132.32 -60.22 0.9 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.879 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.597 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.28 -107.31 0.1 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.248 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 96' ' ' GLY . 1.3 tptt 178.1 72.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.755 0.312 . . . . 0.0 110.728 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.524 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -89.78 -30.66 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.911 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.11 -66.23 0.4 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.885 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -101.1 104.97 36.12 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.002 0.43 . . . . 0.0 111.384 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -43.64 144.77 2.04 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.912 2.408 . . . . 0.0 112.748 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.482 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.08 177.12 19.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.393 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -133.14 153.6 51.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.644 0.259 . . . . 0.0 110.922 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 1.1 m0 -63.03 107.22 0.97 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.815 0.34 . . . . 0.0 110.357 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 27.4 ptm -119.44 140.5 50.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.08 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.1 p -63.19 114.89 4.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.087 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.74 HD13 HD11 ' A' ' 10' ' ' ILE . 12.4 tp -64.6 -18.76 65.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.073 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.8 t -55.73 -15.13 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.6 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.18 42.16 1.88 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.371 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.446 ' CD2' HD11 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -62.3 128.47 36.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -119.66 129.38 54.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.158 0.504 . . . . 0.0 112.241 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.654 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -15.17 61.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.817 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -78.35 -48.97 14.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.581 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -29.86 68.18 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.659 0.266 . . . . 0.0 111.246 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.654 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -91.41 171.9 7.36 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.183 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.5 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.6 Cg_endo -70.86 127.67 14.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.13 1.886 . . . . 0.0 111.714 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.61 -14.94 45.69 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.586 2.191 . . . . 0.0 113.095 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.5 -9.29 58.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -119.76 31.31 6.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.698 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -70.19 -37.24 7.02 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 64.6 Cg_exo -51.81 -43.44 51.51 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.09 1.86 . . . . 0.0 113.081 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 71' ' ' LEU . 2.4 t -77.48 -51.27 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.962 0.411 . . . . 0.0 111.364 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.9 OUTLIER -66.34 -32.13 56.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.343 -179.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.55 -29.67 59.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.847 0.356 . . . . 0.0 110.713 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -73.56 -53.24 11.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.74 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.711 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -78.4 -36.22 46.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.48 -179.417 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.602 ' N ' HD23 ' A' ' 126' ' ' LEU . 3.1 ttpm? -53.13 -42.51 66.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.084 0.469 . . . . 0.0 111.15 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -63.99 -11.63 30.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.684 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 126' ' ' LEU . 3.8 mp . . . . . 0 C--O 1.231 0.102 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.089 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.978 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 5215 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 5216 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.777 0.322 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.47 120.6 42.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.832 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -137.64 138.72 39.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.839 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.612 HD13 " O3'" ' A' ' 131' ' ' 8OG . 1.4 pp -144.01 139.82 29.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.966 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.515 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.1 mt-30 -102.7 153.83 19.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.4 0.619 . . . . 0.0 112.032 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.738 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.6 mp -146.02 128.42 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.9 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.069 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 124.56 42.44 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.163 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.568 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.6 m -117.9 158.41 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.362 0.601 . . . . 0.0 111.713 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.08 108.66 0.54 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.345 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -70.69 96.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.358 0.599 . . . . 0.0 110.051 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.668 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 1.4 tt -71.44 121.34 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.592 ' CG ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -94.93 144.83 25.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.695 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.958 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.7 p-10 -102.67 -173.28 2.29 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.595 0.712 . . . . 0.0 112.164 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.3 tm-20 -71.85 1.48 6.97 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.425 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -124.05 43.25 3.04 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.099 -0.376 . . . . 0.0 111.695 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 45.87 27.3 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.098 0.475 . . . . 0.0 111.163 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 6.3 mt-10 -114.83 161.4 18.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.794 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.722 HG22 HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -125.72 132.63 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.792 0.33 . . . . 0.0 111.347 -178.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE1' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -85.26 125.72 33.11 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.021 0.439 . . . . 0.0 110.629 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.848 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -122.19 122.81 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.08 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.575 HG22 ' CE1' ' A' ' 19' ' ' PHE . 19.7 p -71.01 111.96 6.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.818 0.342 . . . . 0.0 111.165 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.0 172.14 7.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.334 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.505 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 2.5 mmp_? -64.03 -9.79 18.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.154 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.732 ' HB2' HE22 ' A' ' 100' ' ' GLN . . . 74.66 8.52 4.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.472 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 56.54 76.17 0.31 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.823 0.344 . . . . 0.0 111.261 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -178.88 60.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.886 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -177.5 -172.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -98.3 29.18 3.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.14 55.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.58 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.11 -8.77 56.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.788 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.42 31.03 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.485 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.35 26.23 10.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.893 0.377 . . . . 0.0 111.671 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.848 HD21 ' HB ' ' A' ' 20' ' ' ILE . 5.5 tt -42.79 121.64 2.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.751 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' N ' HD23 ' A' ' 33' ' ' LEU . 3.9 mt-10 -140.69 -176.03 4.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.145 0.497 . . . . 0.0 111.972 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.864 ' CD2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.92 163.32 28.55 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.557 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.461 ' HD3' HG23 ' A' ' 21' ' ' THR . 19.3 Cg_endo -57.22 168.08 2.97 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.508 2.805 . . . . 0.0 111.801 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.22 59.67 0.76 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.01 -1.091 . . . . 0.0 113.788 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.27 126.07 5.27 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 114.556 -0.822 . . . . 0.0 112.19 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER 103.46 2.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.248 0.619 . . . . 0.0 112.305 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.069 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -51.5 -27.82 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.511 0.672 . . . . 0.0 110.754 179.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.577 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.44 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.016 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.4 mmm 33.75 -86.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.538 0.524 . . . . 0.0 111.841 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -164.3 27.57 0.21 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.565 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -95.62 -176.23 3.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.852 0.358 . . . . 0.0 111.138 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.912 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.81 155.75 38.49 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.235 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.912 ' HD2' HG22 ' A' ' 45' ' ' THR . 3.0 Cg_endo -44.74 -24.71 1.26 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.736 2.29 . . . . 0.0 112.608 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -95.21 -49.63 5.41 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -80.08 -24.15 40.83 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.719 0.295 . . . . 0.0 111.741 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.876 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -55.43 -47.41 76.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.001 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.754 HG12 ' CB ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.17 -47.89 23.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.823 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.7 t -56.76 -36.5 49.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.103 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -78.18 -50.66 11.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.9 mm-40 -66.9 -24.46 66.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.748 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.2 tp -51.8 -44.22 63.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.886 0.374 . . . . 0.0 110.272 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -33.93 75.01 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.58 -26.33 50.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.249 179.405 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mt-10 -108.14 5.17 25.65 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.99 HG12 HG13 ' A' ' 60' ' ' ILE . 17.7 t -134.6 -43.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.191 0.52 . . . . 0.0 109.741 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.587 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.52 -43.94 0.59 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.215 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.99 HG13 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.57 -177.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.094 0.473 . . . . 0.0 111.175 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -111.29 89.22 9.87 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.368 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.926 ' HG3' HG11 ' A' ' 58' ' ' VAL . 1.4 Cg_endo -108.7 156.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.864 2.376 . . . . 0.0 115.211 -176.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.426 ' HB2' ' CB ' ' A' ' 89' ' ' ARG . 75.8 mt-30 -77.93 80.17 4.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.997 ' CD2' HG22 ' A' ' 87' ' ' VAL . 1.9 t-160 -127.07 124.24 38.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.669 -176.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.6 t80 -179.06 162.73 1.26 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.677 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER 83.84 155.77 0.1 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.943 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.7 pp -113.66 126.21 55.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.317 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.692 ' CE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -78.18 -36.75 47.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.253 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.06 162.03 7.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.469 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -143.08 132.14 23.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.889 0.376 . . . . 0.0 111.155 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.725 ' HB2' HG22 ' A' ' 122' ' ' VAL . 22.6 tp -119.01 121.98 41.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.648 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -120.91 109.95 15.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.685 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.415 ' HE1' HD12 ' A' ' 82' ' ' LEU . 3.3 p90 -141.04 150.85 43.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.649 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.19 122.28 39.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.097 0.475 . . . . 0.0 111.354 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.88 163.09 63.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.457 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.67 82.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.056 2.504 . . . . 0.0 112.149 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 14.3 t0 95.94 16.64 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.202 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -137.31 145.92 44.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.615 179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -118.29 94.0 4.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 110.547 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.466 HD12 H2'' ' A' ' 131' ' ' 8OG . 2.6 tt -103.08 111.8 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.195 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.413 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -105.85 122.44 46.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.377 179.554 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.738 HD23 ' HB ' ' A' ' 6' ' ' ILE . 32.3 mt -122.27 114.71 21.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.875 0.369 . . . . 0.0 111.367 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.464 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.9 m0 -104.89 122.51 45.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.749 ' CD2' HG11 ' A' ' 122' ' ' VAL . 2.9 m-85 -98.64 110.12 22.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.387 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.741 ' CE2' HG11 ' A' ' 50' ' ' VAL . 25.0 m95 -94.65 148.54 22.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.583 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.634 HD12 ' OE2' ' A' ' 88' ' ' GLU . 1.6 tm? -100.36 103.85 15.27 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.116 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.997 HG22 ' CD2' ' A' ' 64' ' ' HIS . 43.1 t -91.82 145.47 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.382 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.634 ' OE2' HD12 ' A' ' 86' ' ' LEU . 3.2 mm-40 -111.52 -29.52 7.73 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.16 165.5 24.44 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.182 0.901 . . . . 0.0 111.824 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.958 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.6 p90 -149.4 132.67 16.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.667 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -81.23 128.38 33.73 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.749 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.2 -116.05 4.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.442 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 33.0 mt-10 -135.06 141.04 36.68 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.556 0.217 . . . . 0.0 110.93 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.568 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.1 Cg_exo -76.51 128.88 10.61 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.894 2.396 . . . . 0.0 111.199 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.657 ' HE1' HG23 ' A' ' 60' ' ' ILE . 55.6 p-90 -136.8 -64.81 0.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.846 -0.742 . . . . 0.0 112.811 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.599 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 49.21 -100.36 0.03 OUTLIER Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.65 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER 175.71 42.2 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.709 0.29 . . . . 0.0 111.091 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.405 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.8 OUTLIER -59.53 -52.34 65.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.39 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 123.79 -11.06 8.38 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.723 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.732 HE22 ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -140.17 98.94 7.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 117.38 0.59 . . . . 0.0 111.995 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -44.06 140.21 5.41 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.751 2.301 . . . . 0.0 112.269 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.515 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.18 177.28 19.27 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.897 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -129.75 157.29 42.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.693 0.283 . . . . 0.0 110.624 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.87 106.42 6.39 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.867 0.365 . . . . 0.0 110.178 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.5 ptp -120.2 149.76 41.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.075 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.505 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -66.68 114.9 5.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.626 179.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.1 tm? -69.95 -18.92 63.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.321 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.564 ' O ' HD21 ' A' ' 129' ' ' LEU . 12.9 p -56.1 -17.86 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.519 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.34 45.39 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.619 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.664 HD12 HD21 ' A' ' 107' ' ' LEU . 8.6 tt -62.65 150.49 40.74 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.422 ' N ' HD23 ' A' ' 110' ' ' LEU . 1.2 m-20 -119.26 127.43 53.23 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.641 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -14.89 61.88 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.496 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -48.97 15.21 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.397 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -35.21 79.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.847 0.356 . . . . 0.0 110.701 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.641 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -85.41 168.16 21.6 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.27 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.513 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 41.2 Cg_endo -67.54 127.71 16.89 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.263 1.976 . . . . 0.0 111.918 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.02 -19.17 63.64 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.539 2.159 . . . . 0.0 112.892 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.64 -9.33 58.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.512 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.4 m-80 -116.2 29.43 7.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.463 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.4 pt-20 -71.86 -31.92 1.94 Allowed Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 50.9 Cg_exo -53.89 -37.31 85.35 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 121.875 1.716 . . . . 0.0 112.567 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.749 HG11 ' CD2' ' A' ' 84' ' ' PHE . 22.7 t -77.35 -48.42 24.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.507 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.598 HG13 ' CE2' ' A' ' 115' ' ' PHE . 3.4 mm -67.44 -30.25 48.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.897 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.65 -28.33 46.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 0.0 110.317 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -48.26 16.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.428 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.692 HD13 ' CE2' ' A' ' 68' ' ' PHE . 7.8 tp -78.2 -30.42 48.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 0.0 111.499 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.473 ' HB2' HG22 ' A' ' 123' ' ' ILE . 10.5 ttpp -54.61 -42.55 71.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -72.96 -5.69 40.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.005 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.564 HD21 ' O ' ' A' ' 108' ' ' VAL . 1.3 mp . . . . . 0 CA--C 1.528 0.127 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.284 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.631 " H4'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 5227 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 5228 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.882 0.372 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.08 103.25 15.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.94 143.38 49.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.878 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 4' ' ' LEU . 1.6 pp -141.84 137.0 31.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.773 ' C ' HD13 ' A' ' 6' ' ' ILE . 42.8 mt-30 -102.62 151.74 21.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.446 0.641 . . . . 0.0 112.392 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.95 HD12 " H2'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -142.38 128.19 17.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.476 179.026 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.052 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.55 125.06 43.57 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.323 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.586 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.3 m -120.7 162.37 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.424 0.63 . . . . 0.0 112.167 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.06 113.47 0.59 Allowed Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.587 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.574 HG22 HG12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.86 101.66 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.809 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.38 119.84 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.932 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.501 ' CG ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -101.74 150.88 22.69 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.236 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.662 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 8.4 p-10 -121.34 -173.97 2.74 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -56.45 -25.93 52.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.506 -1.224 . . . . 0.0 113.867 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -98.27 31.52 2.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.158 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 p30 49.12 23.21 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.182 0.515 . . . . 0.0 110.508 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -101.02 160.77 14.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.037 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.769 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -124.78 118.96 54.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.245 0.545 . . . . 0.0 111.943 -178.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.456 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 15.2 t80 -66.96 100.66 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.527 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.553 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -109.0 123.01 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.538 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.752 HG21 ' HG3' ' A' ' 98' ' ' GLU . 24.0 p -70.99 111.83 6.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.036 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -96.98 166.49 11.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 30' ' ' ALA . 0.2 OUTLIER -70.74 56.5 0.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.102 0.477 . . . . 0.0 110.352 179.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 47.51 -172.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.411 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.33 -40.22 85.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.108 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -177.69 152.49 0.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -173.73 -70.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.112 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -140.73 -76.68 0.31 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.783 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.9 85.19 2.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.68 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 23' ' ' ARG . . . -71.52 -8.9 56.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.69 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -95.1 28.42 2.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.611 0.243 . . . . 0.0 111.43 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.52 26.5 10.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.922 0.392 . . . . 0.0 111.7 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -47.55 113.51 0.71 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.0 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.77 177.04 8.03 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.152 0.501 . . . . 0.0 111.779 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -119.9 162.02 35.27 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.941 -179.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 21' ' ' THR . 6.5 Cg_endo -48.16 167.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.812 3.008 . . . . 0.0 112.177 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 101.89 59.71 0.77 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.051 -1.071 . . . . 0.0 114.186 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -131.76 130.24 5.9 Favored Glycine 0 C--N 1.312 -0.798 0 CA-C-N 114.724 -0.738 . . . . 0.0 111.952 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.43 6.64 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.986 0.515 . . . . 0.0 112.037 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.052 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.53 -28.09 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.667 0.746 . . . . 0.0 110.192 179.202 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.586 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.61 -73.57 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.552 -1.203 . . . . 0.0 111.13 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 41' ' ' GLU . 1.0 OUTLIER 26.85 -85.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.562 0.539 . . . . 0.0 112.119 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.28 28.36 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.676 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.3 mp0 -97.44 -175.13 3.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.713 0.292 . . . . 0.0 111.192 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.922 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -102.23 160.74 25.48 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.358 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.922 ' HD2' HG22 ' A' ' 45' ' ' THR . 9.7 Cg_endo -49.3 -24.63 8.7 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.623 2.215 . . . . 0.0 112.316 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.1 mt-10 -99.14 -45.66 5.83 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -80.05 -23.81 41.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.667 0.27 . . . . 0.0 111.624 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.872 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -56.79 -47.56 79.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.021 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.685 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -78.25 -46.07 26.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.768 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.1 t -59.39 -36.81 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.174 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -78.15 -47.15 18.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.742 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.3 mt-10 -70.09 -20.83 63.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.736 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.997 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -51.36 -44.45 62.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.229 0.538 . . . . 0.0 109.602 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -32.21 73.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.937 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.48 -32.43 54.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.767 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.14 5.07 25.57 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.754 HG11 ' HG3' ' A' ' 62' ' ' PRO . 21.8 t -134.65 -44.23 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.44 . . . . 0.0 110.146 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.599 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.75 -45.32 0.39 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.449 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.763 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -77.97 152.34 5.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.494 ' H ' HD13 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -84.89 96.71 0.43 Allowed Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.49 -179.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.763 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 19.7 Cg_endo -113.72 148.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.699 0 C-N-CA 123.443 2.762 . . . . 0.0 114.163 -177.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -74.8 79.58 2.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.997 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -124.92 121.18 33.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.274 -176.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.1 t80 -178.64 169.08 1.73 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.096 0.474 . . . . 0.0 112.142 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.461 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 82.7 162.36 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.383 179.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 8.0 tt -105.47 131.84 52.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.611 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -98.59 -32.28 11.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.916 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.487 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -171.61 159.96 5.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.945 179.491 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HB3' HD11 ' A' ' 67' ' ' LEU . 2.6 ptpp? -143.48 132.08 22.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.726 0.298 . . . . 0.0 110.936 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.79 ' HB2' HG22 ' A' ' 122' ' ' VAL . 37.5 tp -118.9 120.41 37.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.639 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -115.97 109.82 18.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.697 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.561 ' HE1' HD12 ' A' ' 82' ' ' LEU . 2.1 p90 -141.14 145.85 36.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.612 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.11 121.7 38.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.132 0.492 . . . . 0.0 111.203 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -70.0 163.07 64.38 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.506 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.8 Cg_endo -51.85 83.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.063 2.509 . . . . 0.0 112.078 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 27.8 m-20 95.56 15.33 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.295 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.547 ' HE ' HD21 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -137.35 149.84 47.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.566 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -124.17 106.1 10.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 tt -111.35 112.33 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.429 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -98.42 118.64 35.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.415 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.561 HD12 ' HE1' ' A' ' 73' ' ' TYR . 6.7 mt -115.32 114.48 25.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.987 0.422 . . . . 0.0 111.764 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -108.99 122.56 47.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.315 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.547 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 2.6 m-85 -100.47 125.79 46.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.657 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.685 ' CE2' HG11 ' A' ' 50' ' ' VAL . 15.6 m95 -107.19 148.66 28.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 112.014 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.527 ' O ' HD12 ' A' ' 86' ' ' LEU . 2.0 pp -97.69 103.85 15.82 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.306 0.574 . . . . 0.0 111.446 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.995 HG22 ' ND1' ' A' ' 64' ' ' HIS . 41.2 t -84.83 144.76 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.229 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -32.24 7.88 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.73 165.02 26.08 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.56 -179.189 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.809 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.4 p90 -149.64 136.61 19.59 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.331 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.683 ' CB ' HD12 ' A' ' 60' ' ' ILE . 1.5 mt-10 -73.77 134.04 43.37 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.735 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 51.13 -107.85 0.46 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.86 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 21.8 mt-10 -135.56 142.11 39.82 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.49 0.186 . . . . 0.0 111.038 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.548 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.3 Cg_exo -76.05 128.57 10.77 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.459 2.106 . . . . 0.0 110.672 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.599 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 35.8 p-90 -124.6 -59.05 1.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.966 0.412 . . . . 0.0 111.861 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.59 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.01 -95.75 0.01 OUTLIER Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.875 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.71 37.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.72 0.295 . . . . 0.0 110.895 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.752 ' HG3' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -64.54 -44.88 89.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.189 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.77 -98.76 0.23 Allowed Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.44 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -75.92 114.41 36.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.077 0.465 . . . . 0.0 112.248 -178.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -43.9 146.44 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.179 2.586 . . . . 0.0 112.648 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.449 ' CA ' ' CE2' ' A' ' 19' ' ' PHE . . . -123.37 177.07 16.68 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.966 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -138.98 157.53 45.83 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.494 ' CD1' ' HZ2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -72.24 105.99 4.24 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.928 0.394 . . . . 0.0 110.085 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.29 140.0 51.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.714 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.2 p -58.89 114.55 2.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.782 0.325 . . . . 0.0 110.44 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.815 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.8 tm? -61.67 -18.84 61.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.311 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 108' ' ' VAL . 27.9 t -59.75 -12.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.331 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.11 37.63 3.68 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.284 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.558 ' HG ' HD21 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -62.11 123.63 18.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.503 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -123.07 128.65 50.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.251 0.548 . . . . 0.0 112.412 -179.084 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.636 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.26 -14.91 61.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.399 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.36 -49.41 13.63 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.737 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -31.0 70.94 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.877 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.636 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -90.5 172.28 7.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.095 179.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.504 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 56.7 Cg_endo -71.45 127.64 13.52 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.12 1.88 . . . . 0.0 111.666 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.8 -14.95 46.05 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.63 2.22 . . . . 0.0 113.153 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.56 -9.58 58.75 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.84 33.78 5.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 111.439 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.49 -34.95 2.01 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.308 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 74.2 Cg_exo -49.69 -45.57 31.01 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 121.87 1.713 . . . . 0.0 113.056 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.6 t -77.6 -51.31 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.987 0.422 . . . . 0.0 111.428 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.617 ' O ' HD23 ' A' ' 126' ' ' LEU . 0.9 OUTLIER -64.89 -34.07 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.634 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 120' ' ' GLU . . . -54.93 -31.19 60.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.861 0.362 . . . . 0.0 110.79 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.05 -53.63 16.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.564 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.793 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -78.72 -30.02 45.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.726 0.298 . . . . 0.0 111.394 -179.556 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.793 ' N ' HD23 ' A' ' 126' ' ' LEU . 5.4 ttpm? -54.65 -42.51 71.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.025 0.44 . . . . 0.0 110.741 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -66.14 -10.51 41.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.624 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.221 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.95 " H2'" HD12 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 5239 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 5240 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_